
<html lang="en"     class="pb-page"  data-request-id="66cffe46-0eb3-437d-b261-d1f3667fd8e3"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;issue:issue:10.1021/jmcmar.2020.63.issue-14;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;article:article:10.1021/acs.jmedchem.0c00191;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="N-Acylethanolamine Acid Amidase (NAAA): Structure, Function, and Inhibition" /></meta><meta name="dc.Creator" content="Daniele  Piomelli" /></meta><meta name="dc.Creator" content="Laura  Scalvini" /></meta><meta name="dc.Creator" content="Yannick  Fotio" /></meta><meta name="dc.Creator" content="Alessio  Lodola" /></meta><meta name="dc.Creator" content="Gilberto  Spadoni" /></meta><meta name="dc.Creator" content="Giorgio  Tarzia" /></meta><meta name="dc.Creator" content="Marco  Mor" /></meta><meta name="dc.Description" content="N-Acylethanolamine acid amidase (NAAA) is an N-terminal cysteine hydrolase primarily found in the endosomal–lysosomal compartment of innate and adaptive immune cells. NAAA catalyzes the hydrolytic ..." /></meta><meta name="Description" content="N-Acylethanolamine acid amidase (NAAA) is an N-terminal cysteine hydrolase primarily found in the endosomal–lysosomal compartment of innate and adaptive immune cells. NAAA catalyzes the hydrolytic ..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="March 19, 2020" /></meta><meta name="dc.Type" content="review-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.0c00191" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2020 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c00191" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.0c00191" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c00191" /></link>
        
    
    

<title>N-Acylethanolamine Acid Amidase (NAAA): Structure, Function, and Inhibition | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.0c00191" /></meta><meta property="og:title" content="N-Acylethanolamine Acid Amidase (NAAA): Structure, Function, and Inhibition" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00191/20200716/images/large/jm0c00191_0016.jpeg" /></meta><meta property="og:description" content="N-Acylethanolamine acid amidase (NAAA) is an N-terminal cysteine hydrolase primarily found in the endosomal–lysosomal compartment of innate and adaptive immune cells. NAAA catalyzes the hydrolytic deactivation of palmitoylethanolamide (PEA), a lipid-derived peroxisome proliferator-activated receptor-α (PPAR-α) agonist that exerts profound anti-inflammatory effects in animal models. Emerging evidence points to NAAA-regulated PEA signaling at PPAR-α as a critical control point for the induction and the resolution of inflammation and to NAAA itself as a target for anti-inflammatory medicines. The present Perspective discusses three key aspects of this hypothesis: the role of NAAA in controlling the signaling activity of PEA; the structural bases for NAAA function and inhibition by covalent and noncovalent agents; and finally, the potential value of NAAA-targeting drugs in the treatment of human inflammatory disorders." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.0c00191"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c00191">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-14/achre4.2021.54.issue-14/20210720/achre4.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-29/aamick.2021.13.issue-29/20210728/aamick.2021.13.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-14/acncdm.2021.12.issue-14/20210721/acncdm.2021.12.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-29/acsodf.2021.6.issue-29/20210727/acsodf.2021.6.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-29/ascecg.2021.9.issue-29/20210726/ascecg.2021.9.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-29/ancham.2021.93.issue-29/20210727/ancham.2021.93.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-29/bichaw.2021.60.issue-29/20210727/bichaw.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-27/cgeabj.2021.99.issue-27/20210726-01/cgeabj.2021.99.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-14/esthag.2021.55.issue-14/20210720/esthag.2021.55.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-29/iecred.2021.60.issue-29/20210728/iecred.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-14/inocaj.2021.60.issue-14/20210719/inocaj.2021.60.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-29/jafcau.2021.69.issue-29/20210728/jafcau.2021.69.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-29/jacsat.2021.143.issue-29/20210728/jacsat.2021.143.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-29/langd5.2021.37.issue-29/20210727/langd5.2021.37.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.0c00191&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.0c00191&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.0c00191&amp;href=/doi/10.1021/acs.jmedchem.0c00191" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2020</span><span class="cit-fg-volume">, 63</span><span class="cit-fg-issue">, 14</span><span class="cit-fg-pageRange">, 7475-7490</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/63/14" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.9b01985" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Perspective</span><a href="/doi/10.1021/acs.jmedchem.9b01976" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title"><i>N</i>-Acylethanolamine Acid Amidase (NAAA): Structure, Function, and Inhibition</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Daniele Piomelli</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Daniele Piomelli</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Anatomy and Neurobiology, University of California, Irvine, California 92697-4625, United States</div><div class="loa-info-affiliations-info">Department of Pharmaceutical Sciences, University of California, Irvine, California 92697-4625, United States</div><div class="loa-info-affiliations-info">Department of Biological Chemistry and Molecular Biology, University of California, Irvine, California 92697-4625, United States</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#bfcfd6d0d2dad3d3d6ffcadcd691dadbca"><span class="__cf_email__" data-cfemail="c5b5acaaa8a0a9a9ac85b0a6aceba0a1b0">[email protected]</span></a></span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Daniele++Piomelli">Daniele Piomelli</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath1">View Biography</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-2983-774X" title="Orcid link">http://orcid.org/0000-0002-2983-774X</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Laura Scalvini</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Laura Scalvini</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Dipartimento di Scienze degli Alimenti e del Farmaco, Università degli Studi di Parma, Parco Area delle Scienze 27/A, I- 43124 Parma, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Laura++Scalvini">Laura Scalvini</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath2">View Biography</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-3610-527X" title="Orcid link">http://orcid.org/0000-0003-3610-527X</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Yannick Fotio</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Yannick Fotio</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Anatomy and Neurobiology, University of California, Irvine, California 92697-4625, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Yannick++Fotio">Yannick Fotio</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath3">View Biography</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Alessio Lodola</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Alessio Lodola</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Dipartimento di Scienze degli Alimenti e del Farmaco, Università degli Studi di Parma, Parco Area delle Scienze 27/A, I- 43124 Parma, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Alessio++Lodola">Alessio Lodola</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath4">View Biography</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-8675-1002" title="Orcid link">http://orcid.org/0000-0002-8675-1002</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Gilberto Spadoni</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Gilberto Spadoni</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Dipartimento di Scienze Biomolecolari, Università degli Studi di Urbino “Carlo Bo”, Piazza Rinascimento 6, I-61029 Urbino, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Gilberto++Spadoni">Gilberto Spadoni</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath5">View Biography</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-7253-6902" title="Orcid link">http://orcid.org/0000-0001-7253-6902</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Giorgio Tarzia</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Giorgio Tarzia</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Dipartimento di Scienze Biomolecolari, Università degli Studi di Urbino “Carlo Bo”, Piazza Rinascimento 6, I-61029 Urbino, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Giorgio++Tarzia">Giorgio Tarzia</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath6">View Biography</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Marco Mor</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Marco Mor</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Dipartimento di Scienze degli Alimenti e del Farmaco, Università degli Studi di Parma, Parco Area delle Scienze 27/A, I- 43124 Parma, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Marco++Mor">Marco Mor</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath7">View Biography</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-0199-1849" title="Orcid link">http://orcid.org/0000-0003-0199-1849</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c00191&amp;href=/doi/10.1021%2Facs.jmedchem.0c00191" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2020</span></span><span class="cit-volume">, 63</span><span class="cit-issue">, 14</span><span class="cit-pageRange">, 7475–7490</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">March 19, 2020</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>3 February 2020</li><li><span class="item_label"><b>Published</b> online</span>19 March 2020</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 23 July 2020</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.0c00191" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00191</a></div><div class="article_header-article-copyright"><strong>Copyright © 2020 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D7475%26pageCount%3D16%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DDaniele%2BPiomelli%252C%2BLaura%2BScalvini%252C%2BYannick%2BFotio%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D63%26issueNum%3D14%26contentID%3Dacs.jmedchem.0c00191%26title%3DN-Acylethanolamine%2BAcid%2BAmidase%2B%2528NAAA%2529%253A%2BStructure%252C%2BFunction%252C%2Band%2BInhibition%26numPages%3D16%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D7490%26publicationDate%3DJuly%2B2020">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.0c00191"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1697</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">18</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.0c00191" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;N-Acylethanolamine Acid Amidase (NAAA): Structure, Function, and Inhibition&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Daniele&quot;,&quot;last_name&quot;:&quot;Piomelli&quot;},{&quot;first_name&quot;:&quot;Laura&quot;,&quot;last_name&quot;:&quot;Scalvini&quot;},{&quot;first_name&quot;:&quot;Yannick&quot;,&quot;last_name&quot;:&quot;Fotio&quot;},{&quot;first_name&quot;:&quot;Alessio&quot;,&quot;last_name&quot;:&quot;Lodola&quot;},{&quot;first_name&quot;:&quot;Gilberto&quot;,&quot;last_name&quot;:&quot;Spadoni&quot;},{&quot;first_name&quot;:&quot;Giorgio&quot;,&quot;last_name&quot;:&quot;Tarzia&quot;},{&quot;first_name&quot;:&quot;Marco&quot;,&quot;last_name&quot;:&quot;Mor&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2020&quot;,&quot;month&quot;:&quot;03&quot;,&quot;day&quot;:&quot;19&quot;,&quot;issue&quot;:&quot;14&quot;,&quot;volume&quot;:&quot;63&quot;,&quot;pages&quot;:&quot;7475-7490&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.0c00191&quot;},&quot;abstract&quot;:&quot;N-Acylethanolamine acid amidase (NAAA) is an N-terminal cysteine hydrolase primarily found in the endosomal–lysosomal compartment of innate and adaptive immune cells. NAAA catalyzes the hydrolytic deactivation of palmitoylethanolamide (PEA), a lipid-derived peroxisome proliferator-activated receptor-α (PPAR-α) agonist that exerts profound anti-inflammatory effects in animal models. Emerging evidence points to NAAA-regulated PEA signaling at PPAR-α as a critical control point for the induction and the resolution of inflammation and to NAAA itself as a target for anti-inflammatory medicines. The present Perspective discusses three key aspects of this hypothesis: the role of NAAA in controlling the signaling activity of PEA; the structural bases for NAAA function and inhibition by covalent and noncovalent agents; and finally, the potential value of NAAA-targeting drugs in the treatment of human inflammatory disorders.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c00191&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00191" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c00191&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00191" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c00191&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00191" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c00191&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00191&amp;href=/doi/10.1021/acs.jmedchem.0c00191" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.0c00191" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.0c00191" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (6 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00191&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.0c00191%26sid%3Dliteratum%253Aachs%26pmid%3D32191459%26genre%3Darticle%26aulast%3DPiomelli%26date%3D2020%26atitle%3DN-Acylethanolamine%2BAcid%2BAmidase%2B%2528NAAA%2529%253A%2BStructure%252C%2BFunction%252C%2Band%2BInhibition%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D63%26issue%3D14%26spage%3D7475%26epage%3D7490%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=290831" title="Monomers">Monomers</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291161" title="Inflammation">Inflammation</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/63/14" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/jmcmar.2020.63.issue-14/20200723/jmcmar.2020.63.issue-14.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00191/20200716/images/medium/jm0c00191_0016.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00191/20200716/images/large/jm0c00191_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00191&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText"><i>N</i>-Acylethanolamine acid amidase (NAAA) is an N-terminal cysteine hydrolase primarily found in the endosomal–lysosomal compartment of innate and adaptive immune cells. NAAA catalyzes the hydrolytic deactivation of palmitoylethanolamide (PEA), a lipid-derived peroxisome proliferator-activated receptor-α (PPAR-α) agonist that exerts profound anti-inflammatory effects in animal models. Emerging evidence points to NAAA-regulated PEA signaling at PPAR-α as a critical control point for the induction and the resolution of inflammation and to NAAA itself as a target for anti-inflammatory medicines. The present Perspective discusses three key aspects of this hypothesis: the role of NAAA in controlling the signaling activity of PEA; the structural bases for NAAA function and inhibition by covalent and noncovalent agents; and finally, the potential value of NAAA-targeting drugs in the treatment of human inflammatory disorders.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_60816" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_60816" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Mammalian host-defense cells produce a diverse array of lipid-derived signaling molecules that enable the initial escalation of the inflammatory response. For example, macrophages and neutrophils release cyclooxygenase metabolites of arachidonic acid that cause local vasodilation and sensitization of nociceptive nerve fibers, two key signs of acute inflammation (for review, see ref <a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a>). The history of cyclooxygenase inhibitors proves that interrupting the formation of these proinflammatory mediators can have remarkable therapeutic benefits. But host-defense cells also generate signals that <i>counter</i> inflammation, either by heightening the intrinsic resistance of tissues to injury and infection or by facilitating the transition toward resolution and healing. Lipid messengers involved in these defensive and reconstructive actions include products of oxidative polyunsaturated fatty acid metabolism (e.g., lipoxins and resolvins; for review, see refs <a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> and <a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a>) as well as amides of polyunsaturated and saturated fatty acids, such as anandamide and palmitoylethanolamide (PEA) (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>).</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00191/20200716/images/medium/jm0c00191_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00191/20200716/images/large/jm0c00191_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Bioactive amides of long-chain fatty acids that are preferred substrates either for NAAA (blue) or FAAH (red). Fatty acid ethanolamides (also known as <i>N</i>-fatty acylethanolamines, left) include endogenous agonists for the ligand-operated transcription factor PPAR-α (e.g., PEA, oleoylethanolamide) and for G-protein-coupled cannabinoid-1 receptor (e.g., anandamide). In animal models, <i>N</i>-fatty acyltaurines (center) accelerate skin wound healing<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> and modulate feeding and glucose homeostasis,<a onclick="showRef(event, 'ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref4 ref5">(4,5)</a> while <i>N</i>-fatty acylglycines (right) exert analgesic and anti-inflammatory effects.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> The receptor mechanisms underpinning the latter effects are only partially understood.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00191/20200716/images/large/jm0c00191_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00191&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Anandamide and PEA are generated, either constitutively or upon demand, by various types of host-defense cells.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> They ligate cannabinoid receptors<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> and peroxisome proliferator-activated receptor-α (PPAR-α),<a onclick="showRef(event, 'ref9 ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref9 ref10 ref11">(9−11)</a> respectively, to attenuate nociceptive responding,<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> diminish production of proinflammatory cytokines and eicosanoids,<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> and stimulate macrophages to remove invading bacteria and apoptotic neutrophils.<a onclick="showRef(event, 'ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref13 ref14">(13,14)</a> The two intracellular enzymes responsible for terminating these actions, <i>N</i>-acylethanolamine acid amidase (NAAA) and fatty acid amide hydrolase (FAAH), share the ability to cleave lipid amides but differ in virtually every other respect (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>). FAAH uses the side chain of an internal serine as catalytic nucleophile to attack amide bonds in a diverse set of fatty acid amides that can access its relatively spacious substrate-binding cavity (for review, see ref <a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a>). An integral membrane protein, FAAH functions as a homodimer and is found in the endoplasmic reticulum and mitochondria of most mammalian cells. NAAA, on the other hand, utilizes as nucleophile an N-terminal cysteine exposed during protein maturation and recognizes substrates that, like PEA, are able to fit into the narrow hydrophobic pocket that lies at the core of its active site. It is a soluble heterodimeric protein and is primarily, albeit not exclusively, localized to the lysosomal compartment of innate and adaptive immune cells (for earlier reviews on NAAA, see refs <a onclick="showRef(event, 'ref16 ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref16 ref17 ref18">(16−18)</a>).</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00191/20200716/images/medium/jm0c00191_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00191/20200716/images/large/jm0c00191_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structural and functional differences between FAAH and NAAA. Left: structure of the FAAH homodimer modeled from crystal coordinates (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1MT5">1MT5</a>),<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> adding the membrane-spanning helix and a model phospholipid bilayer (polar heads shown as spheres). The two monomers (identified in cyan and red) are oriented in parallel, each with an α-helix spanning the membrane and pointing their large substrate-binding cavities (green in the monomer to the right) in the same direction, toward the membrane. The red circle marks the position of the catalytic triad (Ser241, Lys142, and Ser217), which is magnified in the inset. Right: representation of NAAA based on the crystal structure of its rabbit orthologue (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6DY1">6DY1</a>).<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> The closely juxtaposed α (orange) and β (gray) subunits shape a rectilinear and relatively narrow substrate-binding pocket (green). Substrate recruitment may occur through an opening created by the interaction of α-helices 3 and 6 with the lipid membrane. The N-terminal catalytic nucleophile (Cys127 for rabbit NAAA; the residues are numbered following the primary sequence deposited in UniProt)<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> and Asp146, which interacts with the amine group of the N-terminal cysteine, are highlighted in the inset.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00191/20200716/images/large/jm0c00191_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00191&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Since its characterization as an anandamide amide hydrolase in 1995<a onclick="showRef(event, 'ref22 ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref22 ref23 ref24">(22−24)</a> (for a review of previous work see ref <a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a>), FAAH has been the object of intensive study and is now undergoing clinical evaluation as target for social anxiety, post-traumatic stress disorder, and painful peripheral neuropathies. NAAA, which was first identified by Natsuo Ueda, Shozo Yamamoto, and collaborators in 1999,<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> has attracted comparatively less attention. Nevertheless, the discovery of several classes of small-molecule inhibitors has revealed potentially important functions for NAAA in the tissue response to injury. In particular, recent studies have shed new light on three areas, which are the focus of the present review: first, the role of NAAA in the regulation of PEA-mediated signaling at PPAR-α; second, the structural requirements for NAAA inhibition by covalent and noncovalent agents; and finally, the potential utility of NAAA-targeting drugs in the treatment of human inflammatory disorders.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">PEA-Mediated Signaling and the Role of NAAA</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_80437" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_80437" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">PEA was identified in 1957 as an anti-inflammatory lipid constituent of egg yolk, soybeans, and peanuts.<a onclick="showRef(event, 'ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref27 ref28">(27,28)</a> Preclinical and clinical studies in the 1960s and 1970s documented its ability to dampen allergic and inflammatory responses in animal models<a onclick="showRef(event, 'ref29 ref30 ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref29 ref30 ref31 ref32">(29−32)</a> and to alleviate symptoms of viral respiratory tract infection in young and adult humans.<a onclick="showRef(event, 'ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref33 ref34">(33,34)</a> In the 1990s, after a hiatus of more than 10 years, renewed interest in PEA led to a further appraisal of its anti-inflammatory effects,<a onclick="showRef(event, 'ref35 ref36 ref37 ref38 ref39'); return false;" href="javascript:void(0);" class="ref ref35 ref36 ref37 ref38 ref39">(35−39)</a> to the discovery of its neuroprotective<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> and antinociceptive<a onclick="showRef(event, 'ref41 ref42'); return false;" href="javascript:void(0);" class="ref ref41 ref42">(41,42)</a> properties, and eventually to the identification of the ligand-operated transcription factor PPAR-α as its primary molecular target.<a onclick="showRef(event, 'ref9 ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref9 ref10 ref11">(9−11)</a> The past decade of preclinical research has firmly established PEA as an analgesic and anti-inflammatory agent and has confirmed that the majority of its actions are rooted in the ability to engage PPAR-α (for review, see ref <a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a>). Strengthening the translational significance of these findings, preliminary clinical evidence indicates that PEA (which is now commercially available in many countries as cream for topical use (Mimyx) and dietary supplement) may be beneficial in inflammatory pathologies such as atopic dermatitis<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> and irritable bowel syndrome<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> as well as in painful disorders such as fibromyalgia,<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> chemotherapy-induced neuropathy,<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> chronic prostatitis,<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> and the side effects of interferon-γ treatment in persons with multiple sclerosis<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> (for a systematic review and meta-analysis, see ref <a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a>).</div><div class="NLM_p">Shortly after its isolation from food sources<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> PEA was also discovered in mammalian tissues,<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> and efforts were soon undertaken to elucidate the mechanisms responsible for its formation and degradation. Early studies suggested (for review, see ref <a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a>) and subsequent work confirmed (for review, see ref <a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a>) that PEA and its fatty acid ethanolamide congeners are produced through a pathway consisting of two enzyme-catalyzed steps (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>). First, the calcium-dependent phospholipase A<sub>2</sub> PLA2G4E catalyzes the transfer of a fatty acyl group (e.g., palmitate) from the <i>sn</i>-1 position of phosphatidylcholine to the free amine of phosphatidylethanolamine (PE).<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> This reaction produces a set of <i>N</i>-acyl PE species with varying <i>N</i>-, <i>sn</i>-1, <i>sn</i>-2 substituents, which are then cleaved by the zinc-containing hydrolase <i>N</i>-acyl PE-selective phospholipase D (NAPE-PLD)<a onclick="showRef(event, 'ref54 ref55 ref56'); return false;" href="javascript:void(0);" class="ref ref54 ref55 ref56">(54−56)</a> to generate PEA and other fatty acid ethanolamides (also known as <i>N</i>-acylethanolamines). This NAPE-PLD-dependent (or “canonical”) pathway is critical for PEA mobilization in mouse macrophages,<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> but as illustrated in <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>, other multistep mechanisms of <i>N</i>-acyl PE cleavage may exist (for review, see ref <a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a>). Like its formation, PEA degradation involves more than one enzyme since, as mentioned earlier, both NAAA and FAAH can degrade the compound in intact cells.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> Even though the biological significance of this catabolic redundancy is unclear, the different subcellular and cellular distributions of the two enzymes (along with the lack of compensation by FAAH after genetic deletion of NAAA<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a>) imply that they might act on topologically and functionally distinct pools of PEA.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00191/20200716/images/medium/jm0c00191_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00191/20200716/images/large/jm0c00191_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Formation and degradation of PEA. The “canonical” pathway of PEA production, shown in the middle, proceeds through two steps: first, the transfer of palmitate from the <i>sn</i>-1 position of phosphatidylcholine (PC) to the free amine group of phosphatidylethanolamine (PE), catalyzed by PLA2G4E, yields <i>N</i>-palmitoyl PE;<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> second, NAPE-PLD-mediated cleavage of <i>N</i>-palmitoyl PEs generates PEA.<a onclick="showRef(event, 'ref54 ref55 ref56'); return false;" href="javascript:void(0);" class="ref ref54 ref55 ref56">(54−56)</a> The acyl chain giving rise to PEA is highlighted in red. Multistep “noncanonical” routes also transit through <i>N</i>-palmitoyl PE but involve different enzymes and metabolic intermediates.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> The hydrolytic deactivation of PEA may be catalyzed by either NAAA or FAAH, which has broadly different subcellular and cellular distributions.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00191/20200716/images/large/jm0c00191_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00191&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">What controls PEA mobilization? Unlike anandamide, which is primarily generated upon demand via activity- or receptor-dependent mechanisms, PEA appears to be constitutively produced in macrophages and other peripheral cells.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> This process is suppressed in inflammatory states, when the formation and degradation of PEA are altered in opposite directions. NAPE-PLD expression is lowered, whereas NAAA activity and/or expression is heightened in mouse macrophages incubated with Gram-negative bacterial endotoxin (lipopolysaccharide),<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> paws and dorsal root ganglia of rats challenged with complete Freund’s adjuvant,<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> synovial membrane and lumbar spinal cord of rats treated with monoiodoacetate,<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> and intestinal biopsies of persons suffering from ulcerative colitis.<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> Furthermore, marked decreases in PEA content have been observed in inflammatory exudates of endotoxin- or carrageenan-exposed mice,<a onclick="showRef(event, 'ref63 ref64 ref65'); return false;" href="javascript:void(0);" class="ref ref63 ref64 ref65">(63−65)</a> skin of mice challenged with a phorbol ester,<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> and small intestine of mice treated with croton oil.<a onclick="showRef(event, 'ref66 ref67'); return false;" href="javascript:void(0);" class="ref ref66 ref67">(66,67)</a> Strikingly low PEA levels were also found in synovial fluid of patients with rheumatoid arthritis or osteoarthritis, compared to healthy subjects.<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a></div><div class="NLM_p">The possibility, raised by these findings, that NAAA might contribute to the induction and maintenance of inflammation is supported by three additional lines of evidence. First, the enzyme is primarily expressed in cell lineages that mediate innate and adaptive immune reactions, including tissue-resident macrophages, circulating monocytes, B-lymphocytes, and CD8+ cytotoxic T cells.<a onclick="showRef(event, 'ref69 ref70 ref71'); return false;" href="javascript:void(0);" class="ref ref69 ref70 ref71">(69−71)</a> Second, mice in which the <i>Naaa</i> gene is deleted by homologous recombination fail to develop allergic contact dermatitis when challenged with the sensitizing hapten 1-fluoro-2,4-dinitrobenzene.<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a> Lastly, as discussed in a subsequent section of this review, small-molecule NAAA inhibitors exert beneficial effects in animal models used to investigate acute and chronic inflammation. The fact that such effects depend, in a majority of cases, on the activation of PPAR-α by endogenously produced PEA<a onclick="showRef(event, 'ref61 ref63 ref70 ref72 ref73'); return false;" href="javascript:void(0);" class="ref ref61 ref63 ref70 ref72 ref73">(61,63,70,72,73)</a> prompted the suggestion that NAAA activity might promote inflammation and delay resolution by suppressing PEA-dependent PPAR-α activation (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). It should be noted that palmitic acid, one of the two products of PEA hydrolysis, disables the obligatory PPAR-α coactivator PGC-1α<a onclick="showRef(event, 'ref74 ref75'); return false;" href="javascript:void(0);" class="ref ref74 ref75">(74,75)</a> and heightens the ability of macrophages to respond to inflammatory triggers.<a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a> It is thus possible, though it remains to be demonstrated, that NAAA could serve as a “rheostat” to balance the availability of these metabolically linked but functionally antagonistic lipid substances.</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00191/20200716/images/medium/jm0c00191_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00191/20200716/images/large/jm0c00191_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Hypothetical model of the role of NAAA in inflammation. NAAA catalyzes the hydrolytic cleavage of PEA into palmitic acid and ethanolamine. PEA is an endogenous agonist of the anti-inflammatory nuclear receptor PPAR-α. Conversely, palmitic acid may promote inflammation, at least in part, by suppressing expression of the transcription coactivator PGC1-α,<a onclick="showRef(event, 'ref74 ref75'); return false;" href="javascript:void(0);" class="ref ref74 ref75">(74,75)</a> which enables PPAR-α (dashed arrow) and other transcriptional regulators of inflammation (e.g., PPAR-γ).<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a> The model posits that NAAA activity might promote and sustain inflammation (i.e., slow down or prevent resolution) by removing the protective influence of PEA while concomitantly accelerating the generation of palmitic acid.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00191/20200716/images/large/jm0c00191_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00191&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Structure and Function of NAAA</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_81751" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_81751" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">NAAA belongs to the N-terminal nucleophile (Ntn) superfamily of enzymes but shares significant sequence homology (35% identity) with only one other member of that group, acid ceramidase (<i>ASAH1</i>), a lysosomal cysteine hydrolase that converts various ceramide species into fatty acid and sphingosine.<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a> Ntn enzymes owe their name to a shared catalytic mechanism in which the nucleophilic side chain of the protein’s amino terminal (cysteine, serine, or threonine) attacks susceptible carbonyl groups in a variety of structurally diverse substrates.<a onclick="showRef(event, 'ref79 ref80'); return false;" href="javascript:void(0);" class="ref ref79 ref80">(79,80)</a> Translated as inactive precursors, Ntn proteins are activated by removal of the initiator methionine or by self-catalyzed cleavage of an internal peptide bond. The latter reaction involves the same amino acid residue responsible for catalysis proper and yields a mature protein whose two subunits (conventionally termed α and β) remain physically attached.<a onclick="showRef(event, 'ref79 ref80'); return false;" href="javascript:void(0);" class="ref ref79 ref80">(79,80)</a></div><div class="NLM_p">The sequence alignment of NAAA across three mammalian species is reported in <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>. Its signal peptide is removed during translation, and self-proteolysis gives rise to a heterodimer in which a relatively small α-subunit is closely associated with a larger β-subunit that starts with the catalytic nucleophile: Cys126 for human NAAA, Cys131 for mouse and rat, Cys127 for rabbit, and Cys123 for guinea pig (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>).<a onclick="showRef(event, 'ref20 ref81'); return false;" href="javascript:void(0);" class="ref ref20 ref81">(20,81)</a></div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00191/20200716/images/medium/jm0c00191_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00191/20200716/images/large/jm0c00191_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Sequence alignment of crystallized NAAA orthologues discussed in this review. Numbers on the top of the graph refer to human NAAA, and numbers on the right refer to rabbit or guinea-pig NAAA. The catalytic cysteine residues (Cys126 for human NAAA, corresponding to Cys127 in rabbit and Cys123 in guinea pig) are highlighted in yellow. Other residues involved in catalysis are highlighted in cyan.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00191/20200716/images/large/jm0c00191_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00191&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00191/20200716/images/medium/jm0c00191_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00191/20200716/images/large/jm0c00191_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Structures of (A) human NAAA precursor (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6DXW">6DXW</a>)<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> and (B) mature rabbit NAAA (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6DY1">6DY1</a>).<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> (A) Maturation occurs via self-catalyzed cleavage of the peptide bond between Phe125 and Cys126 (mutated to alanine in the crystallized protein and labeled as C126A). Residues Phe125, Ala126, and Asp145 are represented as balls and sticks. The backbone of residues 123–128 is colored in magenta. (B) Mature rabbit NAAA in complex with myristic acid (green), which occupies the binding pocket shaped by subunits α (orange) and β (gray). The catalytic nucleophile Cys127 (corresponding to Cys126 in the human orthologue; residues are numbered following the primary sequence deposited in UniProt)<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> is located at the N-terminal end of the β subunit, within a calix-shaped cavity exposed to the solvent. Several amino acids are involved in the catalytic process: Asp146 interacts with the amine group of the N-terminal cysteine, while Asn288 and Glu196 form the oxyanion hole with their side-chain amide and backbone NH group, respectively. Self-catalyzed cleavage may cause a conformational change in the C-terminal α-helix 5 of NAAA α-subunit, as well as in α-helices 3 (α-subunit) and 6 (β-subunit), which are presumed to interact with the membrane. A molecule of the detergent TritonX-100 is cocrystallized between α-helices 3 and 6 (light cyan carbons).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00191/20200716/images/large/jm0c00191_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00191&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Consistent with its postulated (but not yet fully proven) subcellular localization to lysosomes,<a onclick="showRef(event, 'ref58 ref69'); return false;" href="javascript:void(0);" class="ref ref58 ref69">(58,69)</a> which maintain an internal pH of 4.6–5,<a onclick="showRef(event, 'ref82'); return false;" href="javascript:void(0);" class="ref ref82">(82)</a> NAAA undergoes self-cleavage only in an acidic environment.<a onclick="showRef(event, 'ref81'); return false;" href="javascript:void(0);" class="ref ref81">(81)</a> This presumably involves the attack by Cys126 to the carbonyl group in the preceding peptide bond (with Phe125) to generate a catalytically competent dimer.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> It is possible, but remains to be tested, that self-proteolysis might enable the recruitment of NAAA by specific cellular signals (e.g., inflammatory triggers) and/or within appropriate subcellular compartments in which signaling-competent PEA might also be found (e.g., in acidic late-stage endosomes and lysosomes versus pH-neutral early stage endosomes). Before self-cleavage, NAAA undergoes N-glycosylation.<a onclick="showRef(event, 'ref20 ref81 ref83'); return false;" href="javascript:void(0);" class="ref ref20 ref81 ref83">(20,81,83)</a> This modification occurs at four highly conserved sites, two in each subunit of the mature protein,<a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">(83)</a> and may contribute to its subcellular targeting and stabilization.<a onclick="showRef(event, 'ref83 ref84'); return false;" href="javascript:void(0);" class="ref ref83 ref84">(83,84)</a></div><div class="NLM_p">Structural studies have provided important insights into the association of NAAA with the lipid bilayer as well as into the topography of its substrate-binding site<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>). NAAA is a soluble protein,<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> but its α-helices 3 and 6 shape a largely hydrophobic and positively charged surface that may enable binding to the specialized anionic lipids that compose lysosomal luminal vesicles [e.g., bis(monoacylglycero)phosphate].<a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a> Once embedded in the membrane, NAAA might undergo a conformational change that exposes its previously hidden substrate-binding site and thus allows catalysis to occur at an optimal velocity. Partial support for this hypothetical model comes from structural data<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> as well as from experiments showing that certain phospholipid species (e.g., PE and sphingomyelin) are able to stimulate NAAA activity <i>in vitro</i>.<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a></div><div class="NLM_p">The crystal structure of rabbit NAAA in complex with myristic acid suggests that PEA may position its 16-carbon saturated tail in the site’s narrow hydrophobic pocket, at the interface between the α- and β-subunits, and its polar ethanolamine head in a calyx-shaped cavity open to the solvent (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>B).<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> It is currently unknown whether this arrangement permits naturally occurring lipid amides with polar heads bulkier than ethanolamine, such as taurine and glycine (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>), to serve as substrates for NAAA.</div><div class="NLM_p last">How does NAAA effect catalysis? Structural considerations<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> and comparison with acid ceramidase and other Ntn enzymes<a onclick="showRef(event, 'ref20 ref79 ref80'); return false;" href="javascript:void(0);" class="ref ref20 ref79 ref80">(20,79,80)</a> point to four probable steps: (i) transfer of a proton from the thiol group of Cys126 (for human NAAA) to the α-amino group of the same residue, resulting in the formation of a reactive thiolate anion; (ii) nucleophilic attack by the thiolate on the carbonyl carbon of PEA and stabilization of the resulting oxyanion by a network of hydrogen bonds with Glu195 and Asn287; (iii) protonation and exit of PEA’s ethanolamine moiety with concomitant formation of the acyl-enzyme intermediate; and finally, (iv) regeneration of the initial enzyme. This scenario is plausible, but significant details are still missing. For example, we do not know whether catalysis might be influenced by the protonation state of critical amino acid residues, which is not revealed by current structural data. Given the role played by ambient pH in NAAA activation, filling this gap appears to be especially important.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i5">Discovery of NAAA Inhibitors</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_02847" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_02847" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The resolution of NAAA’s structure in various activation states and in complex with different ligands<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> has offered invaluable insights into the enzyme’s inner working and will undoubtedly accelerate the discovery of new inhibitors. But efforts to identify potent and selective NAAA-targeting agents began well before structural information had become available. Early studies adopted one of two strategies: they either utilized PEA as a starting point for chemical modulation or searched for covalent modifiers of the catalytic cysteine.</div><div class="NLM_p">As illustrated in <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>, systematic changes to the polar head of PEA (<b>1</b>) led to the identification of <i>N</i>-pentadecylcyclohexanecarboxamide (<b>2</b>), which was initially reported to inhibit rat NAAA with a median effective concentration (IC<sub>50</sub>) of 4.5 μM.<a onclick="showRef(event, 'ref86'); return false;" href="javascript:void(0);" class="ref ref86">(86)</a> This effect was not readily reproducible, however,<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> and subsequent work suggested that it may have been caused by the synthetic intermediate pentadecylamine (<b>3</b>; IC<sub>50</sub> = 5.7 μM on rat NAAA).<a onclick="showRef(event, 'ref87'); return false;" href="javascript:void(0);" class="ref ref87">(87)</a> Consistent with this possibility, another lipophilic amine, tridecyl 2-aminoacetate (<b>4</b>), was also found to inhibit rat NAAA with micromolar potency (IC<sub>50</sub> = 11.8 μM).<a onclick="showRef(event, 'ref87'); return false;" href="javascript:void(0);" class="ref ref87">(87)</a> Comparable pharmacological activities were reported for cyclopentyl palmitate (<b>5</b>) (IC<sub>50</sub> = 10 μM on human NAAA)<a onclick="showRef(event, 'ref88'); return false;" href="javascript:void(0);" class="ref ref88">(88)</a> and, more recently, for <i>N</i>-pentadecyl-3-hydroxypropanamide (<b>6</b>) (IC<sub>50</sub> = 34 μM on human NAAA)<a onclick="showRef(event, 'ref89'); return false;" href="javascript:void(0);" class="ref ref89">(89)</a> and 2-pentadecyl-2-oxazoline (IC<sub>50</sub> not determined but probably >30 μM on human NAAA).<a onclick="showRef(event, 'ref90'); return false;" href="javascript:void(0);" class="ref ref90">(90)</a> All these compounds retain the two most salient structural features of PEA (its long-chain carbon tail and small polar head) and possibly compete with it for binding to NAAA’s hydrophobic pocket. However, their weak potencies are suggestive of minimal productive interactions with other components of the substrate-binding site.</div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00191/20200716/images/medium/jm0c00191_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00191/20200716/images/large/jm0c00191_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. First-generation NAAA inhibitors designed to mimic the two salient structural features of PEA, namely, its long-chain carbon tail and small polar head. The micromolar activity initially reported for compound <b>2</b> is now attributed to its synthetic intermediate <b>3</b>. The lipophilic amine <b>4</b>, the ester <b>5</b>, and the retroamide <b>6</b> inhibit NAAA with double-digit micromolar potencies.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00191/20200716/images/large/jm0c00191_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00191&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The search for covalent modifiers proved to be more fruitful. Guided by a homology model of NAAA built using the crystallographic coordinates of the Ntn enzyme, conjugated bile acid hydrolase (CBAH),<a onclick="showRef(event, 'ref91'); return false;" href="javascript:void(0);" class="ref ref91">(91)</a> Solorzano and collaborators screened a library of cysteine-reactive probes and identified the β-lactone <b>7</b> (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>A) as a single-digit micromolar NAAA inhibitor (IC<sub>50</sub> = 3 μM on rat NAAA).<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> The compound had been previously shown to react with the catalytic cysteine of hepatitis A virus proteinase 3C via its β-lactone ring,<a onclick="showRef(event, 'ref92'); return false;" href="javascript:void(0);" class="ref ref92">(92)</a> whose essential role in NAAA inhibition was confirmed by demonstrating that analogs in which the ring was opened or replaced with a cyclobutanone or cyclobutane were inactive. Importantly, isosteric substitution of the <i>N</i>-benzylcarbamate with an amide and separation of the two enantiomers led to <i>N</i>-[(3<i>S</i>)-2-oxo-3-oxetanyl]-3-phenylpropanamide (<i>S</i>-OOPP; <b>8</b>), which inhibited rat NAAA with submicromolar potency (IC<sub>50</sub> = 420 nM) through a partially reversible and noncompetitive mechanism.<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a></div><figure id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00191/20200716/images/medium/jm0c00191_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00191/20200716/images/large/jm0c00191_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. First-generation NAAA inhibitors designed to interact with the catalytic cysteine via a β-lactone warhead. (A) Structures of the hepatitis A virus proteinase 3C inhibitor <b>7</b>,<a onclick="showRef(event, 'ref92'); return false;" href="javascript:void(0);" class="ref ref92">(92)</a> a single-digit micromolar NAAA inhibitor; <b>8</b>, the first submicromolar NAAA inhibitor;<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a><b>9</b>, weakly active enantiomer of <b>8</b>; and <b>10</b>, inactive derivative of <b>8</b> that lacks the side chain amide-like fragment. (B) Theoretical mechanisms for the covalent inhibition of NAAA by β-lactones: (top) attack on the 4-methylene carbon produces a hydrolysis-resistant thioether, whereas (bottom) attack on the 2-carbonyl carbon yields a hydrolyzable thioester. Kinetic and mass spectrometry studies<a onclick="showRef(event, 'ref95'); return false;" href="javascript:void(0);" class="ref ref95">(95)</a> support the latter mechanism.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00191/20200716/images/large/jm0c00191_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00191&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Despite its propensity for hydrolytic deactivation (due to opening of the β-lactone ring), compound <b>8</b> had two properties that encouraged its use as a tool for biological studies. First, it was selective for NAAA over other structurally (acid ceramidase) or functionally (FAAH) related enzymes.<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> Second, it was substantially more potent at inhibiting NAAA than its <i>R</i>-enantiomer <b>9</b> (IC<sub>50</sub> = 6 μM on rat NAAA), which could thus be used as a negative control in pharmacological experiments. Indeed, when incubated with RAW264.7 macrophages stimulated with bacterial endotoxin, compound <b>8</b> normalized PEA levels, which were reduced by exposure to the toxin, whereas its enantiomer <b>9</b> had no such effect.<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> Furthermore, subdermal application of compound <b>8</b>, but not <b>9</b>, prevented carrageenan-induced neutrophil infiltration and plasma extravasation in mice, two effects that were abrogated by targeted PPAR-α deletion and were mimicked by administration of PEA or a synthetic PPAR-α agonist.<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> These findings pointed for the first time to NAAA as a druggable anti-inflammatory target and identified its N-terminal nucleophile as an accessible site for intervention. Efforts were soon undertaken to test these ideas further.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i6">Inhibitors Targeting the Catalytic Cysteine</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_73776" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_73776" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In theory, NAAA’s catalytic nucleophile could attack the β-lactone ring of compound <b>8</b> at two distinct positions: the 2-carbonyl carbon, producing a hydrolyzable thioester, and the 4-methylene carbon, yielding a hydrolysis-resistant thioether (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>B). The literature offers support to both scenarios,<a onclick="showRef(event, 'ref92 ref93 ref94'); return false;" href="javascript:void(0);" class="ref ref92 ref93 ref94">(92−94)</a> but the finding that overnight dialysis of the enzyme–inhibitor complex reversed in part the effect of <b>8</b> tentatively implicated cysteine acylation rather than alkylation.<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> Guided by this hypothesis, which was later confirmed in mass spectrometry experiments,<a onclick="showRef(event, 'ref95'); return false;" href="javascript:void(0);" class="ref ref95">(95)</a> Solorzano and collaborators carried out a systematic structure–activity relationship (SAR) exploration aimed at elucidating the roles played by the β-lactone ring and by the shape and size of its side chain (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>). Computational studies with the CBAH homology model mentioned above suggested that the β-lactone and amide moieties engage in favorable polar interactions with amino acid residues critical for enzyme function.<a onclick="showRef(event, 'ref96'); return false;" href="javascript:void(0);" class="ref ref96">(96)</a> The importance of the side chain amide was confirmed by the potency loss caused by its removal, as in the phenylbutyl lactone <b>10</b> (IC<sub>50</sub> = 11 μM on rat NAAA). The model also offered a tentative explanation for the stereoselectivity observed with <i>syn</i>-β-methyl lactones, which were either completely inactive (α<i>R</i>,β<i>S</i> enantiomer <b>11</b>) or weakly active (α<i>S</i>,β<i>R</i> enantiomer <b>12</b>; IC<sub>50</sub> = 3.2 μM on rat NAAA). Exploration of SARs with lipophilic substituents, including rigid scaffolds with various substitution patterns, showed higher inhibitory potencies for straight hydrophobic chains and highlighted, among aromatic amides, the good performance of 2-naphthamide, (1,1′-biphenyl)-4-carboxamide, and 4-(benzyloxy)benzamide derivatives (<b>13</b>–<b>15</b>) (IC<sub>50</sub> = 160, 115, and 90 nM, respectively, on rat NAAA).</div><figure id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00191/20200716/images/medium/jm0c00191_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00191/20200716/images/large/jm0c00191_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Second-generation β-lactone NAAA inhibitors with enhanced NAAA inhibitory potency and improved chemical and metabolic stability. The high inhibitory potency demonstrated by compounds <b>13</b>, <b>14</b>, and <b>17</b> reveals that replacement of the flexible carbon chain of PEA with straight and rigid structures leads to increased activity.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00191/20200716/images/large/jm0c00191_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00191&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The propensity to undergo hydrolytic deactivation hindered broad experimental use of the first β-lactone NAAA inhibitors. Searching for more stable molecules, Duranti and collaborators investigated further the <i>N</i>-(2-oxo-3oxetanyl)amide core (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>) and found that replacing the amide group with a carbamate or introducing a <i>syn</i>-methyl group at the β position of the ring improved stability without affecting potency.<a onclick="showRef(event, 'ref97'); return false;" href="javascript:void(0);" class="ref ref97">(97)</a> Among these threonine-β-lactones, compound <b>16</b> (URB913, ARN077) stood out for its improved chemical stability and strong inhibitory potency (IC<sub>50</sub> = 50 nM and 7 nM on rat and human NAAA, respectively). Further SAR investigations of its side chain led to the biphenyl derivative <b>17</b>,<a onclick="showRef(event, 'ref98'); return false;" href="javascript:void(0);" class="ref ref98">(98)</a> whose strong activity (IC<sub>50</sub> = 7 nM on both rat and human enzymes) was the starting point for a 3D-QSAR analysis, which confirmed that aromatic or aliphatic structures designed to rigidify the flexible carbon tail of PEA enhance target recognition.<a onclick="showRef(event, 'ref99'); return false;" href="javascript:void(0);" class="ref ref99">(99)</a> As discussed below, the presence of a rigid and straight lipophilic chain turned out to be a critical feature also for the design of other covalent and noncovalent inhibitors. Local application of <b>16</b> alleviated skin inflammation<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a> and pain-related responses<a onclick="showRef(event, 'ref100 ref101'); return false;" href="javascript:void(0);" class="ref ref100 ref101">(100,101)</a> in mouse and rat models. Furthermore, the compound was found to be selective for NAAA when assessed in a broad panel of potential off-targets and to be safe in preclinical toxicology studies. Advanced to clinical testing, <b>16</b> was shown to be safe in healthy volunteers and in persons with eczematous skin lesions. However, as discussed in a later section, its clinical development was prematurely terminated.</div><div class="NLM_p">Despite the significant steps forward made with compounds <b>16</b> and <b>17</b>, the inherently low stability of the β-lactone ring posed an unresolved challenge to the systemic use of this class of inhibitors. In an effort to overcome this problem, Fiasella and colleagues adopted a core-hopping strategy and substituted the β-lactone with a β-lactam.<a onclick="showRef(event, 'ref102'); return false;" href="javascript:void(0);" class="ref ref102">(102)</a> Their SAR studies showed that, similar to β-lactones, opening the four-term β-lactam ring or modifying its endocyclic nitrogen by substitution or methylation was detrimental to activity. The <i>S</i> configuration of the α-acylamino group was strongly favored over the <i>R</i> configuration, and the amide could be replaced by a carbamic acid ester, resulting in accrued potency. Once again, the shape and length of the lipophilic side chain proved to be a critical determinant for activity. More importantly, β-lactam derivatives such as <b>18</b> (ARN726, <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>) were found to be potent at inhibiting human NAAA (IC<sub>50</sub> = 27 nM), relatively stable to chemical and enzymatic hydrolysis, and systemically active.<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a></div><figure id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00191/20200716/images/medium/jm0c00191_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00191/20200716/images/large/jm0c00191_0010.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Structures of representative β-lactam NAAA inhibitors. Compound <b>18</b> (ARN726) is a potent and systemically active NAAA inhibitor.<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00191/20200716/images/large/jm0c00191_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00191&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Subsequent structural studies showed that <b>18</b> forms a covalent adduct with NAAA’s N-terminal cysteine and positions the carbonyl fragment of its carbamate group in close proximity of the oxyanion hole formed by NH dipoles in the side chain of Asn288 and the backbone of Glu196 in rabbit NAAA (<a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>A).<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Superseding the CBAH homology model,<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> the X-ray structure of rabbit NAAA demonstrated that the open β-lactam ring of <b>18</b> is located in the solvent-exposed cavity of the active site and engages in stabilizing polar interactions with both the catalytic cysteine and Asp146.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Pharmacokinetic and pharmacodynamic studies further showed that despite its rapid elimination <i>in vivo</i>, compound <b>18</b> effectively inhibited NAAA in peripheral mouse and rat tissues.<a onclick="showRef(event, 'ref60 ref70'); return false;" href="javascript:void(0);" class="ref ref60 ref70">(60,70)</a> (Its brain penetration was limited; however, see ref <a onclick="showRef(event, 'ref103'); return false;" href="javascript:void(0);" class="ref ref103">(103)</a>.) Additional SAR investigation of the β-lactam side chain yielded compound <b>19</b>, which maintained considerable potency (IC<sub>50</sub> = 85 nM on human NAAA) while displaying improved stability compared to <b>18</b>.<a onclick="showRef(event, 'ref104'); return false;" href="javascript:void(0);" class="ref ref104">(104)</a></div><figure id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00191/20200716/images/medium/jm0c00191_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00191/20200716/images/large/jm0c00191_0011.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Interaction of NAAA with covalent (A) and noncovalent (B) inhibitors. (A) Detail of rabbit NAAA (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6DY0">6DY0</a>) with the sulfur atom of the N-terminal cysteine acylated by the β-lactam <b>18</b> (ARN726)<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a> (light pink carbons). The aminopropionate portion of the β-lactam ring points toward the solvent-accessible region lined by N-terminal Cys127 and the backbone of Asp146 (residues are numbered following the primary sequence deposited in UniProt). The carbamate carbonyl points toward the oxyanion hole formed by the side-chain amide of Asn288 and the backbone of Glu196, while the cyclohexylbutyl group lies within the lipophilic pocket that is likely occupied by the acyl chain of PEA (see <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>). (B) Detail of the substrate-binding site of human NAAA (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6DXX">6DXX</a>)<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> bound to the noncovalent inhibitor <b>37</b> (ARN19702)<a onclick="showRef(event, 'ref103'); return false;" href="javascript:void(0);" class="ref ref103">(103)</a> (green carbons). The sulfonyl group of <b>37</b> lies within the solvent-accessible cavity with an oxygen positioned 3.9 Å away from the sulfur atom of the catalytic cysteine (Cys126). The benzothiazole nucleus is inserted within the lipophilic pocket. Other interactions that may stabilize the enzyme–inhibitor complex (e.g., between the benzoyl carbonyl and Trp181, the fluorine atom, and the backbone of Met64) are not shown for clarity.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00191/20200716/images/large/jm0c00191_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00191&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">More recently, Petracca and colleagues investigated the role of <i>N</i>-<i>O</i>-aryl and <i>N</i>-<i>O</i>-alkyl substituents at the endocyclic nitrogen of the β-lactam nucleus as well as the impact of introducing a methyl group at its C3 position.<a onclick="showRef(event, 'ref105'); return false;" href="javascript:void(0);" class="ref ref105">(105)</a> The researchers found that addition of a methyl, acetyl, or methylcarbamoyl group on the nitrogen attenuated or abolished activity, whereas insertion of a methoxy group had an opposite effect. Interestingly, among the four stereoisomeric <i>N</i>-<i>O</i>-methyl threonine derivatives, only the isomer with (2<i>S</i>,3<i>S</i>) configuration (<b>20</b>) maintained adequate potency and target selectivity (IC<sub>50</sub> = 69 nM on human NAAA). Focusing on this structure, Petracca and collaborators examined the effects of bulkier <i>N</i>-<i>O</i>-alkyl and <i>N</i>-<i>O</i>-aryl groups and found that aryl moieties with polar substituents conferred greater potency, as shown by the methylsulfonyl-containing inhibitor <b>21</b> (IC<sub>50</sub> = 6 nM on human NAAA) (<a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>).</div><div class="NLM_p">The progress outlined above laid the foundation for the discovery of chemical probes that should facilitate future investigation of NAAA in broken cell preparations (e.g., in activity-based profiling studies), intact cell cultures, and live animals (<a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a></a>). The first such probe, <b>22</b> (ARN14686), combined key features of <b>18</b> with a terminal alkyne tag enabling the copper-catalyzed “click” cycloaddition reaction with azide-bearing reporter molecules (e.g., biotin and rhodamine).<a onclick="showRef(event, 'ref106 ref107'); return false;" href="javascript:void(0);" class="ref ref106 ref107">(106,107)</a> The compound’s nanomolar potency (IC<sub>50</sub> = 6 nM and 13 nM on human and rat NAAA, respectively) and selectivity over other cysteine hydrolases<a onclick="showRef(event, 'ref106'); return false;" href="javascript:void(0);" class="ref ref106">(106)</a> prompted its use <i>in vivo</i> to quantify catalytically active NAAA in inflamed paws of arthritic rats.<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> The <i>N</i>-<i>O</i>-aryl β-lactam <b>21</b> provided the starting point for the design of two fluorescent molecules that contained either a boron-dipyrromethene (BODIPY; <b>23</b>) or norbornene moiety (<b>24)</b>.<a onclick="showRef(event, 'ref108'); return false;" href="javascript:void(0);" class="ref ref108">(108)</a> The latter’s ability to cross cell membranes may allow its application to monitor, for example, the acid-catalyzed generation of active NAAA in its natural setting.</div><figure id="fig12" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00191/20200716/images/medium/jm0c00191_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00191/20200716/images/large/jm0c00191_0012.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Chemical probes for the study of NAAA <i>in vitro</i> and <i>in vivo</i>. The figure shows three β-lactam-based molecules: <b>22</b> bears a terminal alkyne group that allows the “click” reaction with an appropriate azide-bearing reporter; <b>23</b> and <b>24</b>, whose design is based on <b>21</b> (see <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>), contain fluorescent moieties and may be used to tag NAAA in broken (<b>23</b>) or intact (<b>24</b>) cell preparations.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00191/20200716/images/large/jm0c00191_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00191&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The general strategy based on merging a mimic of PEA’s carbon tail with a cysteine modifier was also exploited by the laboratory of Alexandros Makriyannis in a series of compounds bearing an isothiocyanate warhead<a onclick="showRef(event, 'ref109'); return false;" href="javascript:void(0);" class="ref ref109">(109)</a> (<a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">13</a></a>). Despite the known propensity of this moiety to form covalent adducts with biological thiols,<a onclick="showRef(event, 'ref110'); return false;" href="javascript:void(0);" class="ref ref110">(110)</a> the pentadecyl isothiocyanate <b>25</b> (AM9023) was found to inhibit NAAA in a reversible manner.<a onclick="showRef(event, 'ref111'); return false;" href="javascript:void(0);" class="ref ref111">(111)</a> Introduction of a terminal phenyl ring on its carbon chain yielded compound <b>26</b> (AM9053),<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> which was reported in a published patent<a onclick="showRef(event, 'ref109'); return false;" href="javascript:void(0);" class="ref ref109">(109)</a> as being potent (IC<sub>50</sub> = 30 nM on the human enzyme) and selective for NAAA over acid ceramidase. Tested in a mouse model of colitis, AM9053 was effective at restoring normal PEA levels (which were reduced in inflamed colon) and alleviating inflammatory symptoms.<a onclick="showRef(event, 'ref112'); return false;" href="javascript:void(0);" class="ref ref112">(112)</a></div><figure id="fig13" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00191/20200716/images/medium/jm0c00191_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00191/20200716/images/large/jm0c00191_0013.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. NAAA inhibitors containing isothiocyanate (<b>25</b>, <b>26</b>) and cyanamide (<b>27</b>–<b>30</b>) warheads. Compound <b>29</b> is potent and selective for NAAA, whereas compound <b>30</b> is a balanced high potency dual inhibitor of NAAA and FAAH activities.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00191/20200716/images/large/jm0c00191_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00191&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Efforts aimed at modulating the reactivity of the isothiocyanate group led to the discovery of the first class of NAAA-targeting agents containing a cyanamide functionality (<a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">13</a></a>), whose chemical affinity toward thiols had been previously exploited to create reversible cathepsin K inhibitors.<a onclick="showRef(event, 'ref113'); return false;" href="javascript:void(0);" class="ref ref113">(113)</a> Building on this knowledge and on the pharmacophoric model emerged from the β-lactone experience, Malamas and colleagues<a onclick="showRef(event, 'ref109 ref114'); return false;" href="javascript:void(0);" class="ref ref109 ref114">(109,114)</a> attached a biphenyl scaffold to an azetidine-nitrile nucleus that incorporated the cyanamide function, obtaining the single-digit nanomolar inhibitor <b>27</b> (IC<sub>50</sub> = 3 nM on human NAAA). Covalent and induced-fit docking simulations, informed by structural data, confirmed that the cyanamide moiety can form an isothiourea adduct with the cysteine nucleophile, while the lipophilic portion of the inhibitor can maintain the binding pose assumed before formation of the covalent bond. To enhance selectivity for NAAA and reduce cytochrome P<sub>450</sub>-mediated oxidation of the benzylic fragment, bulky groups and conformational restrictions were inserted in proximity of the cyanamide warhead. In particular, a cyclopropyl substituent was aimed at filling an unoccupied pocket of the enzyme close to the azetidine ring. The modification (<b>28</b>) produced a significant improvement in potency but did not remove cross-reactivity with FAAH (IC<sub>50</sub> = 0.3 nM and 1 nM on human NAAA on FAAH, respectively). By contrast, adding a 3-methyl group on the azetidine nucleus and a methoxy group on the distal phenyl ring, while replacing the flexible benzyloxy linker with a rigid benzamide fragment, resulted in the potent NAAA-preferring inhibitor <b>29</b> (IC<sub>50</sub> = 1.6 nM; >100-fold selectivity for human NAAA over FAAH and cathepsin K). Of note, addition of a sulfonamide linker fully restored activity toward FAAH, yielding an interesting dual inhibitor (<b>30</b>) that targets both human NAAA and FAAH with balanced high potency (IC<sub>50</sub> = 3 nM and 10 nM, respectively). Lastly, cyanamide-based agents were found to be stable in rat and human plasma (<i>t</i><sub>1/2</sub> > 120 min) but also to undergo rapid metabolism when incubated with liver microsomal preparations (<i>t</i><sub>1/2</sub> values ranging from 5 to 15 min).<a onclick="showRef(event, 'ref114'); return false;" href="javascript:void(0);" class="ref ref114">(114)</a></div></div><div id="sec6" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i7">Beyond the Catalytic Cysteine</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_86706" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_86706" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In addition to targeting the N-terminal nucleophile, the search for NAAA inhibitors continued to focus on agents inspired by the scaffold of PEA or, alternatively, turned to the identification of entirely novel scaffolds by chemical library screening. We have seen before that simple changes to PEA’s structure (in analogs like cyclopentyl palmitate (<b>5</b>)<a onclick="showRef(event, 'ref88'); return false;" href="javascript:void(0);" class="ref ref88">(88)</a> and <i>N</i>-pentadecyl-3-hydroxypropanamide (<b>6</b>)<a onclick="showRef(event, 'ref89'); return false;" href="javascript:void(0);" class="ref ref89">(89)</a>) had led to an apparent dead end. In an effort to break this impasse, Li and colleagues replaced the ethanolamine head of PEA with a pyrrolidine nucleus and rigidified its hydrophobic tail by introducing a biphenyl group. This led to the micromolar inhibitor <b>31</b> (IC<sub>50</sub> = 2.1 μM on human NAAA)<a onclick="showRef(event, 'ref115'); return false;" href="javascript:void(0);" class="ref ref115">(115)</a> (<a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">14</a></a>), which was further modified to produce the 4-phenylcinnamoyl analog <b>32</b>, which showed improved selectivity toward NAAA and anti-inflammatory activity in the mouse lipopolysaccharide model of acute lung injury.<a onclick="showRef(event, 'ref116'); return false;" href="javascript:void(0);" class="ref ref116">(116)</a> A similar approach led to the potent and <i>in vivo</i> active oxazolidinone imide <b>33</b> (F96; IC<sub>50</sub> = 267 nM on human NAAA).<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a> Further work on the alkyl-phenyl tail of this molecule and, more specifically, addition of a chlorine atom in the <i>meta</i> position of its phenyl ring yielded the potent (IC<sub>50</sub> = 9 nM on rat NAAA), reversible, and <i>in vivo</i> active inhibitor <b>34</b> (F215).<a onclick="showRef(event, 'ref61 ref117'); return false;" href="javascript:void(0);" class="ref ref61 ref117">(61,117)</a></div><figure id="fig14" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00191/20200716/images/medium/jm0c00191_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00191/20200716/images/large/jm0c00191_0014.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. <i>N</i>-Acylpyrrolidine (<b>31</b>–<b>32</b>) and oxazolidinone imide (<b>33</b>-<b>34</b>) derivatives targeting NAAA. Compounds <b>32</b> and <b>34</b> (F215) are potent, reversible, and <i>in vivo</i> active NAAA inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00191/20200716/images/large/jm0c00191_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00191&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Advances in unexpected directions were made by screening chemical libraries, which was combined in some cases with SAR-based optimization (<a data-tab="pane-pcw-Figures" href="#fig15" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig15" id="" class=" internalNav">15</a></a>). Testing a collection of known anti-inflammatory drugs, Petrosino and collaborators found that the anthraquinone derivative diacerein (EPT4900, <b>35</b>) inhibited human NAAA with moderate potency (IC<sub>50</sub> = 0.7 μM) via a noncompetitive and time-dependent mechanism.<a onclick="showRef(event, 'ref118'); return false;" href="javascript:void(0);" class="ref ref118">(118)</a> Diacerein, which is approved in some countries to treat osteoarthritis,<a onclick="showRef(event, 'ref119 ref120'); return false;" href="javascript:void(0);" class="ref ref119 ref120">(119,120)</a> also reduced paw inflammation and normalized paw skin PEA levels in rats that had received intraplantar injections of carrageenan.<a onclick="showRef(event, 'ref118'); return false;" href="javascript:void(0);" class="ref ref118">(118)</a> Another clinically used drug, the antineoplastic agent carmofur (<b>36</b>), was shown to inhibit NAAA with nanomolar potency but also to display comparable activities toward FAAH and acid ceramidase.<a onclick="showRef(event, 'ref121 ref122'); return false;" href="javascript:void(0);" class="ref ref121 ref122">(121,122)</a></div><figure id="fig15" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 15</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00191/20200716/images/medium/jm0c00191_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00191/20200716/images/large/jm0c00191_0015.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 15. NAAA inhibitors identified by testing compounds used in the clinic (diacerein <b>35</b> and carmofur <b>36</b>) or by high-throughput screening of chemical libraries (<b>37</b>) followed by SAR-driven optimization (<b>38</b>, <b>39</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00191/20200716/images/large/jm0c00191_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00191&amp;id=fig15"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">A random screening campaign of a library comprising ∼58 000 molecules identified 45 active hits, including the benzothiazole derivative <b>37</b><a onclick="showRef(event, 'ref103'); return false;" href="javascript:void(0);" class="ref ref103">(103)</a> (<a data-tab="pane-pcw-Figures" href="#fig15" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig15" id="" class=" internalNav">15</a></a>). Starting from this low-potency inhibitor, Migliore and colleagues carried out an SAR investigation to evaluate the effects of substituents at the benzamide and benzothiazole groups and to determine the role of the piperazine ring. Replacing the <i>ortho</i> methyl group of the benzamide with an ethylsulfonyl moiety was sufficient to achieve a remarkable increase in potency, while other modifications at the same position were either less favorable or not tolerated. Removal of the benzothiazole fluorine or insertion of halogen atoms at various positions of the benzothiazole nucleus had minor effects, while substituting piperazine with piperidine was detrimental to the activity. Conversely, introducing a methyl group at a strategic position of the piperazine ring produced compound <b>38</b> (ARN19702), which inhibited human NAAA in a reversible manner and with an IC<sub>50</sub> of 230 nM.<a onclick="showRef(event, 'ref103'); return false;" href="javascript:void(0);" class="ref ref103">(103)</a> Structural analysis of the enzyme–inhibitor complex<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> revealed that the ethylsulfonyl group of the inhibitor protrudes toward the solvent-accessible portion of the catalytic site, with the closest sulfonyl oxygen located at a distance of approximately 4 Å from the cysteine sulfur atom and the benzene ring accommodated in a nearby pocket. The benzothiazole and the piperazine, with its methyl group in an axial arrangement, are lodged within the lipophilic pocket and participate in a number of weak interactions that likely concur to the compound’s overall potency (<a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>B). Metabolically stable, selective in a broad panel of potential off-targets and orally active, <b>38</b> was also found to partially cross the blood–brain barrier (brain-to-plasma ratio of 0.2) and to elevate the levels of PEA and oleoylethanolamide (but not anandamide) in brain tissue. Pharmacological studies further showed that subchronic administration of <b>38</b> alleviated neural inflammation and motor dysfunction in the experimental allergic encephalomyelitis model of multiple sclerosis.<a onclick="showRef(event, 'ref103'); return false;" href="javascript:void(0);" class="ref ref103">(103)</a> Lastly, the same screening campaign that had led to the discovery of <b>38</b> yielded a second promising hit, which was modified to produce the azabicyclo-octane derivative <b>39</b> (ARN16186). Data reported in a published patent suggest that this inhibitor may be potent (IC<sub>50</sub> = 23 nM on human NAAA), reversible, and active <i>in vivo</i>.<a onclick="showRef(event, 'ref123'); return false;" href="javascript:void(0);" class="ref ref123">(123)</a></div></div><div id="sec7" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i8">Summary of Lead Discovery</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_81703" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_81703" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The qualitative pharmacophore model illustrated in <a data-tab="pane-pcw-Figures" href="#fig16" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig16" id="" class=" internalNav">16</a></a> summarizes the SARs documented thus far for NAAA inhibitors. While early compounds (e.g., <b>4</b>) closely mimicked the structure of PEA, introduction of a cysteine-reacting group and replacement of the flexible carbon chain with more rigid and rectilinear hydrophobic fragments led to the identification of potent and selective covalent inhibitors (e.g., <b>14</b>, <b>16</b>, <b>18</b>, <b>27</b>, and <b>29</b>). Subsequent studies exploited additional interactions at the binding site, such as the lipophilic pocket targeted by the cyclopropyl group of <b>28</b>, and led to the discovery of NAAA-targeting agents in which a balanced combination of various pharmacophoric elements (e.g., in <b>38</b>) results in potent inhibitory activity even in the absence of a cysteine-reactive warhead.</div><figure id="fig16" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 16</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00191/20200716/images/medium/jm0c00191_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00191/20200716/images/large/jm0c00191_0019.jpeg" id="GRAPHIC-d7e1671-autogenerated" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 16. Pharmacophore elements common to current NAAA inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00191/20200716/images/large/jm0c00191_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00191&amp;id=fig16"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec8" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i9">NAAA as a Target for Anti-Inflammatory Drugs</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_04070" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_04070" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Translational evidence for a role of NAAA inhibition in the treatment of chronic inflammation (an unmet medical need of gigantic proportions) remains sparse. As pointed out at the beginning of this article, deficits in PEA availability have been documented for only two human inflammatory disorders, arthritis (synovial fluid) and ulcerative colitis (active inflammatory foci).<a onclick="showRef(event, 'ref62 ref68'); return false;" href="javascript:void(0);" class="ref ref62 ref68">(62,68)</a> Nevertheless, the fact that chemically diverse classes of NAAA-targeting agents display clear anti-inflammatory efficacy in animal models gives grounds for cautious optimism. Indeed, while no animal model captures the complexity of human inflammation, the mechanistic diversity of the paradigms investigated thus far offers intriguing clues about possible applications of NAAA inhibitors in therapy.</div><div class="NLM_p">Topical application of the β-lactone <b>16</b> (ARN077, URB913) (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>) suppressed cutaneous inflammatory reactions evoked by exposure to phorbol ester in mice and to ultraviolet B-radiation in rats.<a onclick="showRef(event, 'ref101'); return false;" href="javascript:void(0);" class="ref ref101">(101)</a> The inhibitor also reversed redness and edema, attenuated pruritus, and normalized circulating levels of interleukin 4 and immunoglobulin E in sensitized mice challenged with the hapten 1-fluoro-2,4-dinitrobenzene.<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a> In those studies, the effects of <b>16</b> were strictly dependent on PPAR-α activation and were accompanied by restoration of normal PEA content in inflamed skin tissue.<a onclick="showRef(event, 'ref72 ref101'); return false;" href="javascript:void(0);" class="ref ref72 ref101">(72,101)</a> Because of its potency and target selectivity, <b>16</b> was advanced to clinical development as topical treatment for atopic dermatitis (eczema). However, after a successful phase 1a safety trial, a subsequent phase 1b study in patients with eczematous skin lesions failed to provide initial indications of efficacy. It is unclear whether this failure was due to true lack of activity, insufficient target engagement, acuity of the disease state, or possibly, underpowering or bias in the design of the study, which included only ∼10 subjects. Despite this setback, the favorable selectivity and safety profile demonstrated by <b>16</b> in preclinical and clinical tests, its striking effects on critical mediators of the allergic response (e.g., interleukin 4 and immunoglobulin E),<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a> and the preliminary efficacy demonstrated by PEA as an adjuvant treatment for eczema<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> encourage further evaluation of NAAA as a target for either “soft drugs”<a onclick="showRef(event, 'ref124'); return false;" href="javascript:void(0);" class="ref ref124">(124)</a> (i.e., drugs that undergo predictable metabolic deactivation after exerting their effects) or systemically active drugs to treat disorders of the atopic diathesis, a broad rubric that encompasses eczema, bronchial asthma, hay fever, and allergic rhinitis.</div><div class="NLM_p">The improved metabolic stability of the β-lactam NAAA inhibitor <b>18</b> (ARN726) (<a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>) provided the opportunity of examining the role of NAAA in models of lung or joint inflammation, which do not readily lend themselves to topical drug application. When administered orally to mice, <b>18</b> prevented carrageenan- and endotoxin-induced pleural damage in a dose-dependent manner, whereas its weakly active (<i>R</i>)-enantiomer had no such effect. Importantly, <i>in vitro</i> experiments showed that <b>18</b> also suppressed inducible nitric oxide synthase (iNOS) expression and tumor necrosis factor-α (TNF-α) release from CD68+ human macrophages stimulated with endotoxin,<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a> a critical translational finding that needs to be replicated and expanded. In a subsequent study, Bonezzi and collaborators reported that compound <b>18</b> was as effective as the potent steroid dexamethasone at attenuating edema and hyperalgesia evoked in rats by intraplantar injection of complete Freund’s adjuvant.<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> Other NAAA inhibitors that have been successfully tested in rodent models used to study inflammation are the pyrrolidine amide <b>32</b> (mouse lipopolysaccaride-induced acute lung injury),<a onclick="showRef(event, 'ref116'); return false;" href="javascript:void(0);" class="ref ref116">(116)</a> the oxazolidinone imide <b>34</b> (F215; rat monoiodoacetate model of osteoarthritis),<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> the benzothiazole <b>38</b> (ARN19702, mouse model of multiple sclerosis),<a onclick="showRef(event, 'ref103'); return false;" href="javascript:void(0);" class="ref ref103">(103)</a> and the isothiocyanate derivative <b>26</b> (AM9053, mouse models of colitis).<a onclick="showRef(event, 'ref112'); return false;" href="javascript:void(0);" class="ref ref112">(112)</a> The available data are still limited in scope, but when weighed together with evidence from human studies,<a onclick="showRef(event, 'ref62 ref68 ref70'); return false;" href="javascript:void(0);" class="ref ref62 ref68 ref70">(62,68,70)</a> they do point to osteoarthritis and inflammatory bowel disease as potential therapeutic targets for systemic NAAA inhibition.</div><div class="NLM_p last">In addition to peripheral inflammation, evidence suggests that NAAA blockade might also ameliorate neural inflammation and persistent pain states. As mentioned above, administration of the reversible inhibitor <b>38</b> (ARN19702) alleviated symptoms of neuroinflammation in a mouse model of multiple sclerosis.<a onclick="showRef(event, 'ref103'); return false;" href="javascript:void(0);" class="ref ref103">(103)</a> Moreover, the β-lactone derivative <b>16</b> (ARN077) demonstrated analgesic efficacy in mouse and rat models of inflammation and nerve damage,<a onclick="showRef(event, 'ref125'); return false;" href="javascript:void(0);" class="ref ref125">(125)</a> while the oxazolidinone imide <b>33</b> (F96) attenuated acetic acid-induced writhing and tactile allodynia evoked by sciatic nerve injury in mice.<a onclick="showRef(event, 'ref126'); return false;" href="javascript:void(0);" class="ref ref126">(126)</a></div></div><div id="sec9" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i10">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_88557" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_88557" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Building a strong case for NAAA as a viable target for anti-inflammatory (and/or proresolution) medicines will largely depend on our ability to elucidate the precise functions served by this enzyme (and the signaling complex it controls) in the induction and resolution of human inflammation. With only a small number of studies published on this subject, we are still a long way from achieving this goal. Critical aspects of NAAA’s basic biology remain unclear, including the localization of precursor versus mature NAAA within the endosome/lysosomal compartment, the mechanisms through which competing signals regulate its expression and activity in response to tissue damage and infection, the role it may play in resolution and tissue healing, and its possible function as a “rheostat switch” to generate a signaling-competent pool of proinflammatory palmitic acid. Our understanding of NAAA’s place in human pathology is also rudimentary and worthy of additional study, especially considering the enzyme’s striking localization to cells of the innate and adaptive immune systems. Informed by animal data, translational experiments should probe the contributions of NAAA to inflammatory disorders such as eczema, osteoarthritis, and ulcerative colitis. In these pathologies, selective inhibition of intracellular NAAA activity might offer greater efficacy than exogenously administered PEA (whose range of clinical applications is restricted by poor solubility, rapid metabolism, and limited bioavailability) and greater safety than direct-acting high-affinity PPAR-α agonists (whose unfavorable side-effect profile has led to multiple late-stage development failures).<a onclick="showRef(event, 'ref127'); return false;" href="javascript:void(0);" class="ref ref127">(127)</a> The chemical tools already available to researchers will facilitate these investigations, but efforts should also be made to expand our armamentarium of small-molecule NAAA inhibitors and to develop new agents with improved potency, target selectivity, and <i>in vivo</i> activity.</div></div><div class="NLM_back"><div class="article_supporting-info" id=""></div><div class="testing" data-doi="10.1021/acs.jmedchem.0c00191" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_54231" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_54231" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Daniele Piomelli</span> - <span class="hlFld-Affiliation affiliation">Department
of Anatomy and Neurobiology, University
of California, Irvine, California 92697-4625, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Pharmaceutical Sciences, University of
California, Irvine, California 92697-4625, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Biological Chemistry and Molecular Biology, University of California, Irvine, California 92697-4625, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-2983-774X" title="Orcid link">http://orcid.org/0000-0002-2983-774X</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#98e8f1f7f5fdf4f4f1d8edfbf1b6fdfced"><span class="__cf_email__" data-cfemail="a6d6cfc9cbc3cacacfe6d3c5cf88c3c2d3">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Laura Scalvini</span> - <span class="hlFld-Affiliation affiliation">Dipartimento
di Scienze degli Alimenti e del Farmaco, Università degli Studi di Parma, Parco Area delle Scienze 27/A, I- 43124 Parma, Italy</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-3610-527X" title="Orcid link">http://orcid.org/0000-0003-3610-527X</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yannick Fotio</span> - <span class="hlFld-Affiliation affiliation">Department
of Anatomy and Neurobiology, University
of California, Irvine, California 92697-4625, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alessio Lodola</span> - <span class="hlFld-Affiliation affiliation">Dipartimento
di Scienze degli Alimenti e del Farmaco, Università degli Studi di Parma, Parco Area delle Scienze 27/A, I- 43124 Parma, Italy</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-8675-1002" title="Orcid link">http://orcid.org/0000-0002-8675-1002</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gilberto Spadoni</span> - <span class="hlFld-Affiliation affiliation">Dipartimento
di Scienze Biomolecolari, Università
degli Studi di Urbino “Carlo Bo”, Piazza Rinascimento 6, I-61029 Urbino, Italy</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-7253-6902" title="Orcid link">http://orcid.org/0000-0001-7253-6902</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Giorgio Tarzia</span> - <span class="hlFld-Affiliation affiliation">Dipartimento
di Scienze Biomolecolari, Università
degli Studi di Urbino “Carlo Bo”, Piazza Rinascimento 6, I-61029 Urbino, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Marco Mor</span> - <span class="hlFld-Affiliation affiliation">Dipartimento
di Scienze degli Alimenti e del Farmaco, Università degli Studi di Parma, Parco Area delle Scienze 27/A, I- 43124 Parma, Italy</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-0199-1849" title="Orcid link">http://orcid.org/0000-0003-0199-1849</a></span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>The manuscript was written through contributions of all authors. All authors have given approval to the final version of the manuscript.</p></li><li><span class="author-information-subsection-header">Funding</span><p>This work was partially supported by the Italian Ministry for University and Research (MIUR, PRIN 2017, 20175SA5JJ Project, to M.M.) and the University of Parma (Progetti di Ateneo FIL Quota Incentivante 2019, to A.L.).</p></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare the following competing financial interest(s): The following authors are inventors of patents and patent applications (owned by the University of California, the University of Urbino Carlo Bo, and the University of Parma) that protect composition of matter and use of various NAAA inhibitor classes: D.P., WO 2009049238, WO 2013078430, WO 2014144547, WO 2014144836; G.T. and M.M., WO 2009049238, WO 2013078430, WO 2014144547, WO 2014144836.<br /></br></div></li></ul></div><div class="bio" rid="ath1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="biographies">Biographies</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_06333" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_06333" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><figure id="ath1" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Daniele Piomelli</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00191&amp;id=BIO-d7e1803-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Daniele Piomelli</b> received his Ph.D. in Pharmacology at Columbia University and carried out postdoctoral work in neuroscience at the Rockefeller University (both in New York, NY). He is Distinguished Professor and Louise Turner Arnold Chair in Neurosciences at the University of California, Irvine, as well as Visiting Professor at the University of Parma, Italy, under the TeachinParma project. Research in his laboratory is focused on the functions of endocannabinoid molecules and other lipid-derived signals.</p></figure></div><div class="bio" rid="ath2"><figure id="ath2" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Laura Scalvini</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00191&amp;id=BIO-d7e1808-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Laura Scalvini</b> received her Ph.D. at the University of Parma, where she is a postdoctoral scholar in the Drug Design and Discovery group led by Prof. Marco Mor. In her work, Dr. Scalvini uses computational free-energy approaches to investigate the function of NAAA and other lipid-metabolizing enzymes.</p></figure></div><div class="bio" rid="ath3"><figure id="ath3" data-index="19" class="article__inlineFigure"><h2 class="fig-label">Yannick Fotio</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00191&amp;id=BIO-d7e1813-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Yannick Fotio</b> completed his Pharm.D. and Ph.D. degrees at the University of Camerino, Italy. He is currently a postdoctoral scholar at the University of California, Irvine, where he studies the role of lipid-derived mediators in pain and inflammation.</p></figure></div><div class="bio" rid="ath4"><figure id="ath4" data-index="20" class="article__inlineFigure"><h2 class="fig-label">Alessio Lodola</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00191&amp;id=BIO-d7e1818-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Alessio Lodola</b> graduated in Pharmaceutical Chemistry and Technology at the University of Parma and received his Ph.D. in Medicinal Chemistry from the University of Pavia. After a stint as Visiting Researcher in the group of Prof. Adrian Mulholland at the University of Bristol, U.K., Dr. Lodola returned to Italy where he is now Associate Professor at the University of Parma. A member of the Drug Design and Discovery group supervised by Prof. Mor, Dr. Lodola’s research centers on the use of atomistic simulations for the design of endocannabinoid modulators, covalent inhibitors of EGFR, and antagonists of the Eph-ephrin system.</p></figure></div><div class="bio" rid="ath5"><figure id="ath5" data-index="21" class="article__inlineFigure"><h2 class="fig-label">Gilberto Spadoni</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00191&amp;id=BIO-d7e1823-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Gilberto Spadoni</b> is Full Professor of Medicinal Chemistry at the University of Urbino “Carlo Bo”, Italy. His research is focused on the design and synthesis of selective ligands for melatonin receptors, small molecules with endocannabinoid-modulating activity, and multitarget compounds for the treatment of diseases ranging from cancer to psychiatric and neurodegenerative disorders.</p></figure></div><div class="bio" rid="ath6"><figure id="ath6" data-index="22" class="article__inlineFigure"><h2 class="fig-label">Giorgio Tarzia</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00191&amp;id=BIO-d7e1828-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Giorgio Tarzia</b> graduated in Organic Chemistry at the University of Rome and did postdoctoral research at the Syntex Research Institute in Palo Alto (CA) and the Research Institute for Medicine and Chemistry in Cambridge (MA). Back in Italy, he joined the medicinal chemistry research departments first of Dow-Lepetit (Milan) and subsequently of Glaxo (Verona). Eventually he became Full Professor of Medicinal Chemistry at the University of Urbino (Italy), where he is now Professor Emeritus. Over the past 20 years, his research activity has focused on the design and synthesis of endocannabinoid signaling modulators and selective melatonin ligands.</p></figure></div><div class="bio" rid="ath7"><figure id="ath7" data-index="23" class="article__inlineFigure"><h2 class="fig-label">Marco Mor</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00191&amp;id=BIO-d7e1833-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Marco Mor</b> received his degree in Pharmaceutical Chemistry and Technology from the University of Parma and did postdoctoral studies at the Glaxo Research Center in Verona. He is Full Professor of Medicinal Chemistry, director of the Ph.D. course in Drug Sciences, and head of the Drug Design Discovery group and at the University of Parma. Research in his group is centered on computer-aided design and SAR analysis of endocannabinoid modulators, GPCR ligands, and tyrosine kinase inhibitors.</p></figure></div><div class="ack" id="ACK-d7e1844-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i19">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_53736" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_53736" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors are grateful to Andrea Ghidini for help with illustrations.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">CBAH</td><td class="NLM_def"><p class="first last">conjugated bile acid hydrolase</p></td></tr><tr><td class="NLM_term">FAAH</td><td class="NLM_def"><p class="first last">fatty acid amide hydrolase</p></td></tr><tr><td class="NLM_term">NAAA</td><td class="NLM_def"><p class="first last"><i>N</i>-acylethanolamine acid amidase</p></td></tr><tr><td class="NLM_term">NAPE-PLD</td><td class="NLM_def"><p class="first last"><i>N</i>-acylphosphatidylethanolamine phospholipase D</p></td></tr><tr><td class="NLM_term">Ntn</td><td class="NLM_def"><p class="first last">N-terminal nucleophile</p></td></tr><tr><td class="NLM_term">PC</td><td class="NLM_def"><p class="first last">phosphatidylcholine</p></td></tr><tr><td class="NLM_term">PE</td><td class="NLM_def"><p class="first last">phosphatidylethanolamine</p></td></tr><tr><td class="NLM_term">PEA</td><td class="NLM_def"><p class="first last">palmitoylethanolamide</p></td></tr><tr><td class="NLM_term">PLA2</td><td class="NLM_def"><p class="first last">phospholipase A2</p></td></tr><tr><td class="NLM_term">PPAR</td><td class="NLM_def"><p class="first last">peroxisome proliferator-activated receptor</p></td></tr><tr><td class="NLM_term">PGC-1α</td><td class="NLM_def"><p class="first last">peroxisome proliferator-activated receptor γ coactivator-1α</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">TNF-α</td><td class="NLM_def"><p class="first last">tumor necrosis factor-α</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i21">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_53380" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_53380" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 127 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dennis, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norris, P. C.</span></span> <span> </span><span class="NLM_article-title">Eicosanoid storm in infection and inflammation</span>. <i>Nat. Rev. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">511</span>– <span class="NLM_lpage">523</span>, <span class="refDoi"> DOI: 10.1038/nri3859</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1038%2Fnri3859" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=26139350" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFyks7bL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2015&pages=511-523&author=E.+A.+Dennisauthor=P.+C.+Norris&title=Eicosanoid+storm+in+infection+and+inflammation&doi=10.1038%2Fnri3859"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Eicosanoid storm in infection and inflammation</span></div><div class="casAuthors">Dennis, Edward A.; Norris, Paul C.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">511-523</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Controlled immune responses to infection and injury involve complex mol. signalling networks with coordinated and often opposing actions.  Eicosanoids and related bioactive lipid mediators derived from polyunsatd. fatty acids constitute a major bioactive lipid network that is among the most complex and challenging pathways to map in a physiol. context.  Eicosanoid signalling, similar to cytokine signalling and inflammasome formation, has primarily been viewed as a pro-inflammatory component of the innate immune response; however, recent advances in lipidomics have helped to elucidate unique eicosanoids and related docosanoids with anti-inflammatory and pro-resoln. functions.  This has advanced our overall understanding of the inflammatory response and its therapeutic implications.  The induction of a pro-inflammatory and anti-inflammatory eicosanoid storm through the activation of inflammatory receptors by infectious agents is reviewed here.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFiadfYUUu57Vg90H21EOLACvtfcHk0ljlx3u9nkoFpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFyks7bL&md5=1266833ea2b64dc373755fd072d40396</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnri3859&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri3859%26sid%3Dliteratum%253Aachs%26aulast%3DDennis%26aufirst%3DE.%2BA.%26aulast%3DNorris%26aufirst%3DP.%2BC.%26atitle%3DEicosanoid%2520storm%2520in%2520infection%2520and%2520inflammation%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2015%26volume%3D15%26spage%3D511%26epage%3D523%26doi%3D10.1038%2Fnri3859" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Serhan, C. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levy, B. D.</span></span> <span> </span><span class="NLM_article-title">Resolvins in inflammation: emergence of the pro-resolving superfamily of mediators</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>128</i></span>,  <span class="NLM_fpage">2657</span>– <span class="NLM_lpage">2669</span>, <span class="refDoi"> DOI: 10.1172/JCI97943</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1172%2FJCI97943" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=29757195" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A280%3ADC%252BC1MfivVKlsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2018&pages=2657-2669&author=C.+N.+Serhanauthor=B.+D.+Levy&title=Resolvins+in+inflammation%3A+emergence+of+the+pro-resolving+superfamily+of+mediators&doi=10.1172%2FJCI97943"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Resolvins in inflammation: emergence of the pro-resolving superfamily of mediators</span></div><div class="casAuthors">Serhan Charles N; Levy Bruce D</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of clinical investigation</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">128</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2657-2669</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Countless times each day, the acute inflammatory response protects us from invading microbes, injuries, and insults from within, as in surgery-induced tissue injury.  These challenges go unnoticed because they are self-limited and naturally resolve without progressing to chronic inflammation.  Peripheral blood markers of inflammation are present in many common diseases, including inflammatory bowel disease, cardiovascular disease, neurodegenerative disease, and cancer.  While acute inflammation is protective, excessive swarming of neutrophils amplifies collateral tissue damage and inflammation.  Hence, understanding the mechanisms that control the resolution of acute inflammation provides insight into preventing and treating inflammatory diseases in multiple organs.  This Review focuses on the resolution phase of inflammation with identification of specialized pro-resolving mediators (SPMs) that involve three separate biosynthetic and potent mediator families, which are defined using the first quantitative resolution indices to score this vital process.  These are the resolvins, protectins, and maresins: bioactive metabolomes that each stimulate self-limited innate responses, enhance innate microbial killing and clearance, and are organ-protective.  We briefly address biosynthesis of SPMs and their activation of endogenous resolution programs as terrain for new therapeutic approaches that are not, by definition, immunosuppressive, but rather new immunoresolvent therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTU73_HFSJ6o2yYR5VtavbzfW6udTcc2ebehnn4VFIeo7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1MfivVKlsA%253D%253D&md5=6d2ee6f561693d9d06944cd7dbe7aa75</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1172%2FJCI97943&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI97943%26sid%3Dliteratum%253Aachs%26aulast%3DSerhan%26aufirst%3DC.%2BN.%26aulast%3DLevy%26aufirst%3DB.%2BD.%26atitle%3DResolvins%2520in%2520inflammation%253A%2520emergence%2520of%2520the%2520pro-resolving%2520superfamily%2520of%2520mediators%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2018%26volume%3D128%26spage%3D2657%26epage%3D2669%26doi%3D10.1172%2FJCI97943" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sasso, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pontis, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Armirotti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cardinali, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kovacs, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Migliore, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Summa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreno-Sanz, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Picardo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piomelli, D.</span></span> <span> </span><span class="NLM_article-title">Endogenous N-acyl taurines regulate skin wound healing</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>113</i></span>,  <span class="NLM_fpage">4397</span>– <span class="NLM_lpage">4406</span>, <span class="refDoi"> DOI: 10.1073/pnas.1605578113</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1073%2Fpnas.1605578113" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtFKktr%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2016&pages=4397-4406&author=O.+Sassoauthor=S.+Pontisauthor=A.+Armirottiauthor=G.+Cardinaliauthor=D.+Kovacsauthor=M.+Miglioreauthor=M.+Summaauthor=G.+Moreno-Sanzauthor=M.+Picardoauthor=D.+Piomelli&title=Endogenous+N-acyl+taurines+regulate+skin+wound+healing&doi=10.1073%2Fpnas.1605578113"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Endogenous N-acyl taurines regulate skin wound healing</span></div><div class="casAuthors">Sasso, Oscar; Pontis, Silvia; Armirotti, Andrea; Cardinali, Giorgia; Kovacs, Daniela; Migliore, Marco; Summa, Maria; Moreno-Sanz, Guillermo; Picardo, Mauro; Piomelli, Daniele</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">30</span>),
    <span class="NLM_cas:pages">E4397-E4406</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The intracellular serine amidase, fatty acid amide hydrolase (FAAH), degrades a heterogeneous family of lipid-derived bioactive mols. that include amides of long-chain fatty acids with taurine [N-acyl-taurines (NATs)].  The physiol. functions of the NATs are unknown.  Here we show that genetic or pharmacol. disruption of FAAH activity accelerates skin wound healing in mice and stimulates motogenesis of human keratinocytes and differentiation of human fibroblasts in primary cultures.  Using untargeted and targeted lipidomics strategies, we identify two long-chain satd. NATs - N-tetracosanoyl-taurine [NAT(24:0)] and N-eicosanoyl-taurine [NAT(20:0)] - as primary substrates for FAAH in mouse skin, and show that the levels of these substances sharply decrease at the margins of a freshly inflicted wound to increase again as healing begins.  Addnl., we demonstrate that local administration of synthetic NATs accelerates wound closure in mice and stimulates repair-assocd. responses in primary cultures of human keratinocytes and fibroblasts, through a mechanism that involves tyrosine phosphorylation of the epidermal growth factor receptor and an increase in intracellular calcium levels, under the permissive control of transient receptor potential vanilloid-1 receptors.  The results point to FAAH-regulated NAT signaling as an unprecedented lipid-based mechanism of wound-healing control in mammalian skin, which might be targeted for chronic wound therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZZpzBVMWzvrVg90H21EOLACvtfcHk0ljTaf7MrLCCTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtFKktr%252FL&md5=4ca3de983f5ceac2912c37b05f8d012f</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1605578113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1605578113%26sid%3Dliteratum%253Aachs%26aulast%3DSasso%26aufirst%3DO.%26aulast%3DPontis%26aufirst%3DS.%26aulast%3DArmirotti%26aufirst%3DA.%26aulast%3DCardinali%26aufirst%3DG.%26aulast%3DKovacs%26aufirst%3DD.%26aulast%3DMigliore%26aufirst%3DM.%26aulast%3DSumma%26aufirst%3DM.%26aulast%3DMoreno-Sanz%26aufirst%3DG.%26aulast%3DPicardo%26aufirst%3DM.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DEndogenous%2520N-acyl%2520taurines%2520regulate%2520skin%2520wound%2520healing%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2016%26volume%3D113%26spage%3D4397%26epage%3D4406%26doi%3D10.1073%2Fpnas.1605578113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aichler, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borgmann, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krumsiek, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buck, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacDonald, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fox, J. E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyon, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Light, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keipert, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jastroch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feuchtinger, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mueller, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palmer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexandrov, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hrabe de Angelis, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neschen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tschöp, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walch, A.</span></span> <span> </span><span class="NLM_article-title">N-acyl taurines and acylcarnitines cause an imbalance in insulin synthesis and secretion provoking β cell dysfunction in type 2 diabetes</span>. <i>Cell Metab.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">1334</span>– <span class="NLM_lpage">1347</span>, <span class="refDoi"> DOI: 10.1016/j.cmet.2017.04.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1016%2Fj.cmet.2017.04.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=28591636" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BC2sXpslWgtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2017&pages=1334-1347&author=M.+Aichlerauthor=D.+Borgmannauthor=J.+Krumsiekauthor=A.+Buckauthor=P.+E.+MacDonaldauthor=J.+E.+M.+Foxauthor=J.+Lyonauthor=P.+E.+Lightauthor=S.+Keipertauthor=M.+Jastrochauthor=A.+Feuchtingerauthor=N.+S.+Muellerauthor=N.+Sunauthor=A.+Palmerauthor=T.+Alexandrovauthor=M.+Hrabe+de+Angelisauthor=S.+Neschenauthor=M.+H.+Tsch%C3%B6pauthor=A.+Walch&title=N-acyl+taurines+and+acylcarnitines+cause+an+imbalance+in+insulin+synthesis+and+secretion+provoking+%CE%B2+cell+dysfunction+in+type+2+diabetes&doi=10.1016%2Fj.cmet.2017.04.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">N-acyl Taurines and Acylcarnitines Cause an Imbalance in Insulin Synthesis and Secretion Provoking β Cell Dysfunction in Type 2 Diabetes</span></div><div class="casAuthors">Aichler, Michaela; Borgmann, Daniela; Krumsiek, Jan; Buck, Achim; MacDonald, Patrick E.; Fox, Jocelyn E. Manning; Lyon, James; Light, Peter E.; Keipert, Susanne; Jastroch, Martin; Feuchtinger, Annette; Mueller, Nikola S.; Sun, Na; Palmer, Andrew; Alexandrov, Theodore; Hrabe de Angelis, Martin; Neschen, Susanne; Tschoep, Matthias H.; Walch, Axel</div><div class="citationInfo"><span class="NLM_cas:title">Cell Metabolism</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1334-1347.e4</span>CODEN:
                <span class="NLM_cas:coden">CMEEB5</span>;
        ISSN:<span class="NLM_cas:issn">1550-4131</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">The processes contributing to β cell dysfunction in type 2 diabetes (T2D) are uncertain, largely because it is difficult to access β cells in their intact immediate environment.  We examd. the pathophysiol. of β cells under T2D progression directly in pancreatic tissues.  We used MALDI imaging of Langerhans islets (LHIs) within mouse tissues or from human tissues to generate in situ-omics data, which we supported with in vitro expts.  Mol. interaction networks provided information on functional pathways and mols.  We found that stearoylcarnitine accumulated in β cells, leading to arrest of insulin synthesis and energy deficiency via excessive β-oxidn. and depletion of TCA cycle and oxidative phosphorylation metabolites.  Acetylcarnitine and an accumulation of N-acyl taurines, a group not previously detected in β cells, provoked insulin secretion.  Thus, β cell dysfunction results from enhanced insulin secretion combined with an arrest of insulin synthesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnar12qoZDFrVg90H21EOLACvtfcHk0ljTaf7MrLCCTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXpslWgtro%253D&md5=5cd568071c9c83b9d7d8b6b12a0dc6de</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.cmet.2017.04.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cmet.2017.04.012%26sid%3Dliteratum%253Aachs%26aulast%3DAichler%26aufirst%3DM.%26aulast%3DBorgmann%26aufirst%3DD.%26aulast%3DKrumsiek%26aufirst%3DJ.%26aulast%3DBuck%26aufirst%3DA.%26aulast%3DMacDonald%26aufirst%3DP.%2BE.%26aulast%3DFox%26aufirst%3DJ.%2BE.%2BM.%26aulast%3DLyon%26aufirst%3DJ.%26aulast%3DLight%26aufirst%3DP.%2BE.%26aulast%3DKeipert%26aufirst%3DS.%26aulast%3DJastroch%26aufirst%3DM.%26aulast%3DFeuchtinger%26aufirst%3DA.%26aulast%3DMueller%26aufirst%3DN.%2BS.%26aulast%3DSun%26aufirst%3DN.%26aulast%3DPalmer%26aufirst%3DA.%26aulast%3DAlexandrov%26aufirst%3DT.%26aulast%3DHrabe%2Bde%2BAngelis%26aufirst%3DM.%26aulast%3DNeschen%26aufirst%3DS.%26aulast%3DTsch%25C3%25B6p%26aufirst%3DM.%2BH.%26aulast%3DWalch%26aufirst%3DA.%26atitle%3DN-acyl%2520taurines%2520and%2520acylcarnitines%2520cause%2520an%2520imbalance%2520in%2520insulin%2520synthesis%2520and%2520secretion%2520provoking%2520%25CE%25B2%2520cell%2520dysfunction%2520in%2520type%25202%2520diabetes%26jtitle%3DCell%2520Metab.%26date%3D2017%26volume%3D25%26spage%3D1334%26epage%3D1347%26doi%3D10.1016%2Fj.cmet.2017.04.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Grevengoed, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trammell, S. A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKinney, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petersen, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cardone, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Svenningsen, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogasawara, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nexøe-Larsen, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knop, F. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwartz, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kibbey, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cravatt, B. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gillum, M. P.</span></span> <span> </span><span class="NLM_article-title">N-acyl taurines are endogenous lipid messengers that improve glucose homeostasis</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>116</i></span>,  <span class="NLM_fpage">24770</span>– <span class="NLM_lpage">24778</span>, <span class="refDoi"> DOI: 10.1073/pnas.1916288116</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1073%2Fpnas.1916288116" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=31740614" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitlejsLzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2019&pages=24770-24778&author=T.+J.+Grevengoedauthor=S.+A.+J.+Trammellauthor=M.+K.+McKinneyauthor=N.+Petersenauthor=R.+L.+Cardoneauthor=J.+S.+Svenningsenauthor=D.+Ogasawaraauthor=C.+C.+Nex%C3%B8e-Larsenauthor=F.+K.+Knopauthor=T.+W.+Schwartzauthor=R.+G.+Kibbeyauthor=B.+F.+Cravattauthor=M.+P.+Gillum&title=N-acyl+taurines+are+endogenous+lipid+messengers+that+improve+glucose+homeostasis&doi=10.1073%2Fpnas.1916288116"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">N-acyl taurines are endogenous lipid messengers that improve glucose homeostasis</span></div><div class="casAuthors">Grevengoed, Trisha J.; Trammell, Samuel A. J.; McKinney, Michele K.; Petersen, Natalia; Cardone, Rebecca L.; Svenningsen, Jens S.; Ogasawara, Daisuke; NexA¸ e-Larsen, Christina C.; Knop, Filip K.; Schwartz, Thue W.; Kibbey, Richard G.; Cravatt, Benjamin F.; Gillum, Matthew P.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">49</span>),
    <span class="NLM_cas:pages">24770-24778</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Fatty acid amide hydrolase (FAAH) degrades 2 major classes of bioactive fatty acid amides, the N-acyl ethanolamines (NAEs) and N-acyl taurines (NATs), in central and peripheral tissues.  A functional polymorphism in the human FAAH gene is linked to obesity and mice lacking FAAH show altered metabolic states, but whether these phenotypes are caused by elevations in NAEs or NATs is unknown.  To overcome the problem of concurrent elevation of NAEs and NATs caused by genetic or pharmacol. disruption of FAAH in vivo, we developed an engineered mouse model harboring a single-amino acid substitution in FAAH (S268D) that selectively disrupts NAT, but not NAE, hydrolytic activity.  The FAAH-S268D mice accordingly show substantial elevations in NATs without alterations in NAE content, a unique metabolic profile that correlates with heightened insulin sensitivity and GLP-1 secretion.  Together, these data suggest that NATs act as a class of lipid messengers that improve postprandial glucose regulation and may have potential as investigational metabolites to modify metabolic disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWVQawX3EmmbVg90H21EOLACvtfcHk0ljTaf7MrLCCTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitlejsLzE&md5=328c5495be24993c9948675e39119092</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1916288116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1916288116%26sid%3Dliteratum%253Aachs%26aulast%3DGrevengoed%26aufirst%3DT.%2BJ.%26aulast%3DTrammell%26aufirst%3DS.%2BA.%2BJ.%26aulast%3DMcKinney%26aufirst%3DM.%2BK.%26aulast%3DPetersen%26aufirst%3DN.%26aulast%3DCardone%26aufirst%3DR.%2BL.%26aulast%3DSvenningsen%26aufirst%3DJ.%2BS.%26aulast%3DOgasawara%26aufirst%3DD.%26aulast%3DNex%25C3%25B8e-Larsen%26aufirst%3DC.%2BC.%26aulast%3DKnop%26aufirst%3DF.%2BK.%26aulast%3DSchwartz%26aufirst%3DT.%2BW.%26aulast%3DKibbey%26aufirst%3DR.%2BG.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26aulast%3DGillum%26aufirst%3DM.%2BP.%26atitle%3DN-acyl%2520taurines%2520are%2520endogenous%2520lipid%2520messengers%2520that%2520improve%2520glucose%2520homeostasis%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2019%26volume%3D116%26spage%3D24770%26epage%3D24778%26doi%3D10.1073%2Fpnas.1916288116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merkler, D. J.</span></span> <span> </span><span class="NLM_article-title">N-fatty acylglycines: underappreciated endocannabinoid-like fatty acid amides?</span>. <i>J. Biol. Nat.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">156</span>– <span class="NLM_lpage">165</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=29607420" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A280%3ADC%252BC1MnnvFansQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=156-165&author=R.+L.+Andersonauthor=D.+J.+Merkler&title=N-fatty+acylglycines%3A+underappreciated+endocannabinoid-like+fatty+acid+amides%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">N-FATTY ACYLGLYCINES: UNDERAPPRECIATED ENDOCANNABINOID-LIKE FATTY ACID AMIDES?</span></div><div class="casAuthors">Anderson Ryan L; Merkler David J</div><div class="citationInfo"><span class="NLM_cas:title">Journal of biology and nature</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">156-165</span>
        ISSN:<span class="NLM_cas:issn">2395-5376</span>.
    </div><div class="casAbstract">Long-chain N-fatty acylglycines, R-CO-NH-CH2-COOH (where "R" refers to an unsaturated or saturated alkyl chain of at least 14 carbons) are found in mammals and insects and are structurally related to the cell-signaling, lipid-like, N-fatty acylethanolamines, R-CO-NH-CH2-CH2-OH (where "R" refers to an alkyl chain of at least 14 carbons).  Accumulating evidence demonstrates that the N-fatty acylglycines have important cellular functions, but much work remains in order to fully appreciate and understand these biomolecules including: (a) more work on their functions in vivo, (b) measuring their concentrations in the cell, (c) defining the pathways for the biosynthesis and degradation, and (d) understanding the metabolic interconversion(s) between the N-fatty acylglycines and other fatty acid amides.  The purpose of reviewing the current state-of-knowledge about the N-fatty acylglycines is to stimulate future research about this intriguing family of biomolecules.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ21-ojBQLwKfh3YQQtAhNufW6udTcc2eYs6Zh1yzmxarntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1MnnvFansQ%253D%253D&md5=125c88690c980ed9e1e6dec9c12349bd</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAnderson%26aufirst%3DR.%2BL.%26aulast%3DMerkler%26aufirst%3DD.%2BJ.%26atitle%3DN-fatty%2520acylglycines%253A%2520underappreciated%2520endocannabinoid-like%2520fatty%2520acid%2520amides%253F%26jtitle%3DJ.%2520Biol.%2520Nat.%26date%3D2017%26volume%3D8%26spage%3D156%26epage%3D165" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Piomelli, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sasso, O.</span></span> <span> </span><span class="NLM_article-title">Peripheral gating of pain signals by endogenous lipid mediators</span>. <i>Nat. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">164</span>– <span class="NLM_lpage">174</span>, <span class="refDoi"> DOI: 10.1038/nn.3612</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1038%2Fnn.3612" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=24473264" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtlaqtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2014&pages=164-174&author=D.+Piomelliauthor=O.+Sasso&title=Peripheral+gating+of+pain+signals+by+endogenous+lipid+mediators&doi=10.1038%2Fnn.3612"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Peripheral gating of pain signals by endogenous lipid mediators</span></div><div class="casAuthors">Piomelli, Daniele; Sasso, Oscar</div><div class="citationInfo"><span class="NLM_cas:title">Nature Neuroscience</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">164-174</span>CODEN:
                <span class="NLM_cas:coden">NANEFN</span>;
        ISSN:<span class="NLM_cas:issn">1097-6256</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Primary sensory afferents and their neighboring host-defense cells are a rich source of lipid-derived mediators that contribute to the sensation of pain caused by tissue damage and inflammation.  But an increasing no. of lipid mols. have been shown to act in an opposite way, to suppress the inflammatory process, restore homeostasis in damaged tissues and attenuate pain sensitivity by regulating neural pathways that transmit nociceptive signals from the periphery of the body to the CNS.  Here we review the mol. and cellular mechanisms that contribute to the modulatory actions of lipid mediators in peripheral nociceptive signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3SUeSBaNEzbVg90H21EOLACvtfcHk0lhUbvGdk6XO3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtlaqtrg%253D&md5=cedccbc9ba2c37ec111eefdf19c065a6</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnn.3612&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnn.3612%26sid%3Dliteratum%253Aachs%26aulast%3DPiomelli%26aufirst%3DD.%26aulast%3DSasso%26aufirst%3DO.%26atitle%3DPeripheral%2520gating%2520of%2520pain%2520signals%2520by%2520endogenous%2520lipid%2520mediators%26jtitle%3DNat.%2520Neurosci.%26date%3D2014%26volume%3D17%26spage%3D164%26epage%3D174%26doi%3D10.1038%2Fnn.3612" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Devane, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanus, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Breuer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pertwee, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevenson, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffin, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mandelbaum, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Etinger, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mechoulam, R.</span></span> <span> </span><span class="NLM_article-title">Isolation and structure of a brain constituent that binds to the cannabinoid receptor</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>258</i></span>,  <span class="NLM_fpage">1946</span>– <span class="NLM_lpage">1949</span>, <span class="refDoi"> DOI: 10.1126/science.1470919</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1126%2Fscience.1470919" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1470919" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADyaK3sXpvVKntg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=258&publication_year=1992&pages=1946-1949&author=W.+A.+Devaneauthor=L.+Hanusauthor=A.+Breuerauthor=R.+G.+Pertweeauthor=L.+A.+Stevensonauthor=G.+Griffinauthor=D.+Gibsonauthor=A.+Mandelbaumauthor=A.+Etingerauthor=R.+Mechoulam&title=Isolation+and+structure+of+a+brain+constituent+that+binds+to+the+cannabinoid+receptor&doi=10.1126%2Fscience.1470919"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Isolation and structure of a brain constituent that binds to the cannabinoid receptor</span></div><div class="casAuthors">Devane, William A.; Hanus, Lumir; Breuer, Aviva; Pertwee, Roger G.; Stevenson, Lesley A.; Griffin, Graeme; Gibson, Dan; Mandelbaum, Asher; Etinger, Alexander; Mechoulam, Raphael</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">258</span>
        (<span class="NLM_cas:issue">5090</span>),
    <span class="NLM_cas:pages">1946-9</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">Arachidonylethanolamide, an arachidonic acid deriv. in the porcine brain, was identified as an endogenous ligand for the cannabinoid receptor.  The structure of this compd., anandamide, was detd. by mass spectrometry and NMR spectroscopy and was confirmed by synthesis.  Anandamide inhibited the specific binding of a radiolabeled cannabinoid probe to synaptosomal membranes in a manner typical of competitive ligands and produced a concn.-dependent inhibition of the elec. evoked twitch responses of the mouse vas deferens, a characteristic effect of psychotropic cannabinoids.  Anandamide may function as a natural ligand for the cannabinoid receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXqh5E4vHczbVg90H21EOLACvtfcHk0lhUbvGdk6XO3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXpvVKntg%253D%253D&md5=13c7aa7316cd687240779f7f192d086b</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1126%2Fscience.1470919&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1470919%26sid%3Dliteratum%253Aachs%26aulast%3DDevane%26aufirst%3DW.%2BA.%26aulast%3DHanus%26aufirst%3DL.%26aulast%3DBreuer%26aufirst%3DA.%26aulast%3DPertwee%26aufirst%3DR.%2BG.%26aulast%3DStevenson%26aufirst%3DL.%2BA.%26aulast%3DGriffin%26aufirst%3DG.%26aulast%3DGibson%26aufirst%3DD.%26aulast%3DMandelbaum%26aufirst%3DA.%26aulast%3DEtinger%26aufirst%3DA.%26aulast%3DMechoulam%26aufirst%3DR.%26atitle%3DIsolation%2520and%2520structure%2520of%2520a%2520brain%2520constituent%2520that%2520binds%2520to%2520the%2520cannabinoid%2520receptor%26jtitle%3DScience%26date%3D1992%26volume%3D258%26spage%3D1946%26epage%3D1949%26doi%3D10.1126%2Fscience.1470919" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lo
Verme, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Astarita, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La Rana, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calignano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piomelli, D.</span></span> <span> </span><span class="NLM_article-title">The nuclear receptor peroxisome proliferator-activated receptor-alpha mediates the anti-inflammatory actions of palmitoylethanolamide</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">15</span>– <span class="NLM_lpage">19</span>, <span class="refDoi"> DOI: 10.1124/mol.104.006353</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1124%2Fmol.104.006353" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=15465922" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlt12ksA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2005&pages=15-19&author=J.+Lo%0AVermeauthor=J.+Fuauthor=G.+Astaritaauthor=G.+La+Ranaauthor=R.+Russoauthor=A.+Calignanoauthor=D.+Piomelli&title=The+nuclear+receptor+peroxisome+proliferator-activated+receptor-alpha+mediates+the+anti-inflammatory+actions+of+palmitoylethanolamide&doi=10.1124%2Fmol.104.006353"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">The nuclear receptor peroxisome proliferator-activated receptor-α mediates the anti-inflammatory actions of palmitoylethanolamide</span></div><div class="casAuthors">Lo Verme, Jesse; Fu, Jin; Astarita, Giuseppe; La Rana, Giovanna; Russo, Roberto; Calignano, Antonio; Piomelli, Daniele</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">15-19</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Palmitoylethanolamide (PEA), the naturally occurring amide of palmitic acid and ethanolamine, reduces pain and inflammation through an as-yet-uncharacterized mechanism.  Here, we identify the nuclear receptor peroxisome proliferator-activated receptor-α (PPAR-α) as the mol. target responsible for the anti-inflammatory properties of PEA.  PEA selectively activates PPAR-α in vitro with an EC50 value of 3.1±0.4 μM and induces the expression of PPAR-α mRNA when applied topically to mouse skin.  In two animal models, carrageenan-induced paw edema and phorbol ester-induced ear edema, PEA attenuates inflammation in wild-type mice but has no effect in mice deficient in PPAR-α.  The natural PPAR-α agonist oleoylethanolamide (OEA) and the synthetic PPAR-α agonists GW7647 and Wy-14643 mimic these effects in a PPAR-α-dependent manner.  These findings indicate that PPAR-α mediates the anti-inflammatory effects of PEA and suggest that this fatty-acid ethanolamide may serve, like its analog OEA, as an endogenous ligand of PPAR-α.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqw2rfZ_7rANLVg90H21EOLACvtfcHk0lgHl7Sa3jyL-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlt12ksA%253D%253D&md5=c6c20156b93828c507ecbdee107c7061</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1124%2Fmol.104.006353&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.104.006353%26sid%3Dliteratum%253Aachs%26aulast%3DLo%2BVerme%26aufirst%3DJ.%26aulast%3DFu%26aufirst%3DJ.%26aulast%3DAstarita%26aufirst%3DG.%26aulast%3DLa%2BRana%26aufirst%3DG.%26aulast%3DRusso%26aufirst%3DR.%26aulast%3DCalignano%26aufirst%3DA.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DThe%2520nuclear%2520receptor%2520peroxisome%2520proliferator-activated%2520receptor-alpha%2520mediates%2520the%2520anti-inflammatory%2520actions%2520of%2520palmitoylethanolamide%26jtitle%3DMol.%2520Pharmacol.%26date%3D2005%26volume%3D67%26spage%3D15%26epage%3D19%26doi%3D10.1124%2Fmol.104.006353" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lo
Verme, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La Rana, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calignano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piomelli, D.</span></span> <span> </span><span class="NLM_article-title">The search for the palmitoylethanolamide receptor</span>. <i>Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>77</i></span>,  <span class="NLM_fpage">1685</span>– <span class="NLM_lpage">1698</span>, <span class="refDoi"> DOI: 10.1016/j.lfs.2005.05.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1016%2Fj.lfs.2005.05.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=15963531" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2005&pages=1685-1698&author=J.+Lo%0AVermeauthor=G.+La+Ranaauthor=R.+Russoauthor=A.+Calignanoauthor=D.+Piomelli&title=The+search+for+the+palmitoylethanolamide+receptor&doi=10.1016%2Fj.lfs.2005.05.012"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.lfs.2005.05.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.lfs.2005.05.012%26sid%3Dliteratum%253Aachs%26aulast%3DLo%2BVerme%26aufirst%3DJ.%26aulast%3DLa%2BRana%26aufirst%3DG.%26aulast%3DRusso%26aufirst%3DR.%26aulast%3DCalignano%26aufirst%3DA.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DThe%2520search%2520for%2520the%2520palmitoylethanolamide%2520receptor%26jtitle%3DLife%2520Sci.%26date%3D2005%26volume%3D77%26spage%3D1685%26epage%3D1698%26doi%3D10.1016%2Fj.lfs.2005.05.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lo
Verme, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La Rana, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farthing, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mattace-Raso, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meli, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hohmann, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calignano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piomelli, D.</span></span> <span> </span><span class="NLM_article-title">Rapid broad-spectrum analgesia through activation of peroxisome proliferator-activated receptor-alpha</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>319</i></span>,  <span class="NLM_fpage">1051</span>– <span class="NLM_lpage">1061</span>, <span class="refDoi"> DOI: 10.1124/jpet.106.111385</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1124%2Fjpet.106.111385" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=16997973" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=319&publication_year=2006&pages=1051-1061&author=J.+Lo%0AVermeauthor=R.+Russoauthor=G.+La+Ranaauthor=J.+Fuauthor=J.+Farthingauthor=G.+Mattace-Rasoauthor=R.+Meliauthor=A.+Hohmannauthor=A.+Calignanoauthor=D.+Piomelli&title=Rapid+broad-spectrum+analgesia+through+activation+of+peroxisome+proliferator-activated+receptor-alpha&doi=10.1124%2Fjpet.106.111385"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1124%2Fjpet.106.111385&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.106.111385%26sid%3Dliteratum%253Aachs%26aulast%3DLo%2BVerme%26aufirst%3DJ.%26aulast%3DRusso%26aufirst%3DR.%26aulast%3DLa%2BRana%26aufirst%3DG.%26aulast%3DFu%26aufirst%3DJ.%26aulast%3DFarthing%26aufirst%3DJ.%26aulast%3DMattace-Raso%26aufirst%3DG.%26aulast%3DMeli%26aufirst%3DR.%26aulast%3DHohmann%26aufirst%3DA.%26aulast%3DCalignano%26aufirst%3DA.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DRapid%2520broad-spectrum%2520analgesia%2520through%2520activation%2520of%2520peroxisome%2520proliferator-activated%2520receptor-alpha%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2006%26volume%3D319%26spage%3D1051%26epage%3D1061%26doi%3D10.1124%2Fjpet.106.111385" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chiurchiù, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rapino, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talamonti, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leuti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lanuti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gueniche, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jourdain, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Breton, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maccarrone, M.</span></span> <span> </span><span class="NLM_article-title">Anandamide suppresses proinflammatory T cell responses in vitro through type-1 cannabinoid receptor-mediated mTOR inhibition in human keratinocytes</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>197</i></span>,  <span class="NLM_fpage">3545</span>– <span class="NLM_lpage">3553</span>, <span class="refDoi"> DOI: 10.4049/jimmunol.1500546</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.4049%2Fjimmunol.1500546" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=27694494" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsVagsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=197&publication_year=2016&pages=3545-3553&author=V.+Chiurchi%C3%B9author=C.+Rapinoauthor=E.+Talamontiauthor=A.+Leutiauthor=M.+Lanutiauthor=A.+Guenicheauthor=R.+Jourdainauthor=L.+Bretonauthor=M.+Maccarrone&title=Anandamide+suppresses+proinflammatory+T+cell+responses+in+vitro+through+type-1+cannabinoid+receptor-mediated+mTOR+inhibition+in+human+keratinocytes&doi=10.4049%2Fjimmunol.1500546"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Anandamide Suppresses Proinflammatory T Cell Responses In Vitro through Type-1 Cannabinoid Receptor-Mediated mTOR Inhibition in Human Keratinocytes</span></div><div class="casAuthors">Chiurchiu, Valerio; Rapino, Cinzia; Talamonti, Emanuela; Leuti, Alessandro; Lanuti, Mirko; Gueniche, Audrey; Jourdain, Roland; Breton, Lionel; Maccarrone, Mauro</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">197</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3545-3553</span>CODEN:
                <span class="NLM_cas:coden">JOIMA3</span>;
        ISSN:<span class="NLM_cas:issn">0022-1767</span>.
    
            (<span class="NLM_cas:orgname">American Association of Immunologists</span>)
        </div><div class="casAbstract">The endocannabinoid system comprises cannabinoid receptors 1 and 2 (CB1 and CB2), their endogenous ligands, anandamide (AEA) and 2-arachidonoylglycerol, and metabolic enzymes of these ligands.  The endocannabinoid system has recently been implicated in the regulation of various pathophysiol. processes of the skin that include immune competence and/or tolerance of keratinocytes, the disruption of which might promote the development of skin diseases.  Recent evidence showed that CB1 in keratinocytes limits the secretion of proinflammatory chemokines, suggesting that this receptor might also regulate T cell dependent inflammatory diseases of the skin.  In this article, we sought to investigate the cytokine profile of IFN-γ-activated keratinocytes, and found that CB1 activation by AEA suppressed prodn. and release of signature TH1- and TH17-polarizing cytokines, IL-12 and IL-23, resp.  We also set up cocultures between a conditioned medium of treated keratinocytes and naive T cells to disclose the mol. details that regulate the activation of highly proinflammatory TH1 and TH17 cells.  AEA-treated keratinocytes showed reduced an induction of IFN-γ-producing TH1 and IL-17-producing TH17 cells, and these effects were reverted by pharmacol. inhibition of CB1.  Further analyses identified mammalian target of rapamycin as a proinflammatory signaling pathway regulated by CB1, able to promote either IL-12 and IL-23 release from keratinocytes or TH1 and TH17 polarization.  Taken together, these findings demonstrate that AEA suppresses highly pathogenic T cell subsets through CB1-mediated mammalian target of rapamycin inhibition in human keratinocytes.  Thus, it can be speculated that the latter pathway might be beneficial to the physiol. function of the skin, and can be targeted toward inflammation-related skin diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQDTxXY91tM7Vg90H21EOLACvtfcHk0lgHl7Sa3jyL-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsVagsrk%253D&md5=44ed23d6b88c95edb126ac7e78348724</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.1500546&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.1500546%26sid%3Dliteratum%253Aachs%26aulast%3DChiurchi%25C3%25B9%26aufirst%3DV.%26aulast%3DRapino%26aufirst%3DC.%26aulast%3DTalamonti%26aufirst%3DE.%26aulast%3DLeuti%26aufirst%3DA.%26aulast%3DLanuti%26aufirst%3DM.%26aulast%3DGueniche%26aufirst%3DA.%26aulast%3DJourdain%26aufirst%3DR.%26aulast%3DBreton%26aufirst%3DL.%26aulast%3DMaccarrone%26aufirst%3DM.%26atitle%3DAnandamide%2520suppresses%2520proinflammatory%2520T%2520cell%2520responses%2520in%2520vitro%2520through%2520type-1%2520cannabinoid%2520receptor-mediated%2520mTOR%2520inhibition%2520in%2520human%2520keratinocytes%26jtitle%3DJ.%2520Immunol.%26date%3D2016%26volume%3D197%26spage%3D3545%26epage%3D3553%26doi%3D10.4049%2Fjimmunol.1500546" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Redlich, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ribes, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schütze, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nau, R.</span></span> <span> </span><span class="NLM_article-title">Palmitoylethanolamide stimulates phagocytosis of Escherichia coli K1 by macrophages and increases the resistance of mice against infections</span>. <i>J. Neuroinflammation</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">108</span>, <span class="refDoi"> DOI: 10.1186/1742-2094-11-108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1186%2F1742-2094-11-108" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=24927796" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVCitrzK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2014&pages=108&author=S.+Redlichauthor=S.+Ribesauthor=S.+Sch%C3%BCtzeauthor=R.+Nau&title=Palmitoylethanolamide+stimulates+phagocytosis+of+Escherichia+coli+K1+by+macrophages+and+increases+the+resistance+of+mice+against+infections&doi=10.1186%2F1742-2094-11-108"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Palmitoylethanolamide stimulates phagocytosis of Escherichia coli K1 by macrophages and increases the resistance of mice against infections</span></div><div class="casAuthors">Redlich, Sandra; Ribes, Sandra; Schuetze, Sandra; Nau, Roland</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroinflammation</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">108/1-108/11</span>CODEN:
                <span class="NLM_cas:coden">JNOEB3</span>;
        ISSN:<span class="NLM_cas:issn">1742-2094</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Palmitoylethanolamide (PEA), an endogenous lipid and a congener of anandamide, possesses a wide range of effects related to metabolic and cellular homeostasis including anti-inflammatory and neuroprotective properties.  Methods:In vitro, we studied the ability of macrophages to phagocytose Escherichia coli K1 after stimulation with increasing doses of PEA.  In vivo, wild-type mice were treated with PEA i.p. 12 h and 30 min before infection.  Meningoencephalitis or sepsis was induced by intracerebral or i.p. infection with E. coli K1.  Results: Stimulation of macrophages with PEA for 30 min increased the phagocytosis of E. coli K1 without inducing the release of TNFα or CXCL1.  Intracellular killing of E. coli K1 was higher in PEA-stimulated than in unstimulated peritoneal macrophages and microglial cells.  Pre-treatment with PEA significantly increased survival of mice challenged intracerebrally or i.p. with E. coli K1.  This effect was assocd. with a decreased prodn. of CXCL1, IL-1β and IL-6 in homogenates of spleen and cerebellum in mice treated with PEA.  Conclusions: Our observations suggest that these protective effects of PEA in mice can increase the resistance to bacterial infections without the hazard of collateral damage by excessive stimulation of phagocytes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGravmrrtpg2NLVg90H21EOLACvtfcHk0linQh8Z4uvQvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVCitrzK&md5=9354dbf98fabfb17d413f2fd26ade834</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1186%2F1742-2094-11-108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1742-2094-11-108%26sid%3Dliteratum%253Aachs%26aulast%3DRedlich%26aufirst%3DS.%26aulast%3DRibes%26aufirst%3DS.%26aulast%3DSch%25C3%25BCtze%26aufirst%3DS.%26aulast%3DNau%26aufirst%3DR.%26atitle%3DPalmitoylethanolamide%2520stimulates%2520phagocytosis%2520of%2520Escherichia%2520coli%2520K1%2520by%2520macrophages%2520and%2520increases%2520the%2520resistance%2520of%2520mice%2520against%2520infections%26jtitle%3DJ.%2520Neuroinflammation%26date%3D2014%26volume%3D11%26spage%3D108%26doi%3D10.1186%2F1742-2094-11-108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rinne, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guillamat-Prats, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rami, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bindila, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ring, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyytikäinen, L. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raitoharju, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oksala, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehtimäki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weber, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der
Vorst, E. P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steffens, S.</span></span> <span> </span><span class="NLM_article-title">Palmitoylethanolamide promotes a proresolving macrophage phenotype and attenuates atherosclerotic plaque formation</span>. <i>Arterioscler., Thromb., Vasc. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">2562</span>– <span class="NLM_lpage">2575</span>, <span class="refDoi"> DOI: 10.1161/ATVBAHA.118.311185</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1161%2FATVBAHA.118.311185" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=30354245" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BC1MXivFaguw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2018&pages=2562-2575&author=P.+Rinneauthor=R.+Guillamat-Pratsauthor=M.+Ramiauthor=L.+Bindilaauthor=L.+Ringauthor=L.+P.+Lyytik%C3%A4inenauthor=E.+Raitoharjuauthor=N.+Oksalaauthor=T.+Lehtim%C3%A4kiauthor=C.+Weberauthor=E.+P.+C.+van+der%0AVorstauthor=S.+Steffens&title=Palmitoylethanolamide+promotes+a+proresolving+macrophage+phenotype+and+attenuates+atherosclerotic+plaque+formation&doi=10.1161%2FATVBAHA.118.311185"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Palmitoylethanolamide Promotes a Proresolving Macrophage Phenotype and Attenuates Atherosclerotic Plaque Formation</span></div><div class="casAuthors">Rinne, Petteri; Guillamat-Prats, Raquel; Rami, Martina; Bindila, Laura; Ring, Larisa; Lyytikaeinen, Leo-Pekka; Raitoharju, Emma; Oksala, Niku; Lehtimaeki, Terho; Weber, Christian; van der Vorst, Emiel P. C.; Steffens, Sabine</div><div class="citationInfo"><span class="NLM_cas:title">Arteriosclerosis, Thrombosis, and Vascular Biology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2562-2575</span>CODEN:
                <span class="NLM_cas:coden">ATVBFA</span>;
        ISSN:<span class="NLM_cas:issn">1079-5642</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">OBJECTIVE-: Palmitoylethanolamide is an endogenous fatty acid mediator that is synthesized from membrane phospholipids by N-acyl phosphatidylethanolamine phospholipase D. Its biol. actions are primarily mediated by PPAR-α (peroxisome proliferator-activated receptors α) and the orphan receptor GPR55.  Palmitoylethanolamide exerts potent anti-inflammatory actions but its physiol. role and promise as a therapeutic agent in chronic arterial inflammation, such as atherosclerosis remain unexplored.  APPROACH AND RESULTS-: First, the polarization of mouse primary macrophages towards a proinflammatory phenotype was found to reduce N-acyl phosphatidylethanolamine phospholipase D expression and palmitoylethanolamide bioavailability.  N-acyl phosphatidylethanolamine phospholipase D expression was progressively downregulated in the aorta of apolipoprotein E deficient (ApoE) mice during atherogenesis.  N-acyl phosphatidylethanolamine phospholipase D mRNA levels were also downregulated in unstable human plaques and they pos. assocd. with smooth muscle cell markers and neg. with macrophage markers.  Second, ApoE mice were fed a high-fat diet for 4 or 16 wk and treated with either vehicle or palmitoylethanolamide (3 mg/kg per day, 4 wk) to study the effects of palmitoylethanolamide on early established and pre-established atherosclerosis.  Palmitoylethanolamide treatment reduced plaque size in early atherosclerosis, whereas in pre-established atherosclerosis, palmitoylethanolamide promoted signs of plaque stability as evidenced by reduced macrophage accumulation and necrotic core size, increased collagen deposition and downregulation of M1-type macrophage markers.  Mechanistically, we found that palmitoylethanolamide, by activating GPR55, increases the expression of the phagocytosis receptor MerTK (proto-oncogene tyrosine-protein kinase MER) and enhances macrophage efferocytosis, indicative of proresolving properties.  CONCLUSIONS-: The present study demonstrates that palmitoylethanolamide protects against atherosclerosis by promoting an anti-inflammatory and proresolving phenotype of lesional macrophages, representing a new therapeutic approach to resolve arterial inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrw4ExKfHrffLVg90H21EOLACvtfcHk0linQh8Z4uvQvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXivFaguw%253D%253D&md5=ee3f69d727904a9fb6cc724258624e2e</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1161%2FATVBAHA.118.311185&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FATVBAHA.118.311185%26sid%3Dliteratum%253Aachs%26aulast%3DRinne%26aufirst%3DP.%26aulast%3DGuillamat-Prats%26aufirst%3DR.%26aulast%3DRami%26aufirst%3DM.%26aulast%3DBindila%26aufirst%3DL.%26aulast%3DRing%26aufirst%3DL.%26aulast%3DLyytik%25C3%25A4inen%26aufirst%3DL.%2BP.%26aulast%3DRaitoharju%26aufirst%3DE.%26aulast%3DOksala%26aufirst%3DN.%26aulast%3DLehtim%25C3%25A4ki%26aufirst%3DT.%26aulast%3DWeber%26aufirst%3DC.%26aulast%3Dvan%2Bder%2BVorst%26aufirst%3DE.%2BP.%2BC.%26aulast%3DSteffens%26aufirst%3DS.%26atitle%3DPalmitoylethanolamide%2520promotes%2520a%2520proresolving%2520macrophage%2520phenotype%2520and%2520attenuates%2520atherosclerotic%2520plaque%2520formation%26jtitle%3DArterioscler.%252C%2520Thromb.%252C%2520Vasc.%2520Biol.%26date%3D2018%26volume%3D38%26spage%3D2562%26epage%3D2575%26doi%3D10.1161%2FATVBAHA.118.311185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McKinney, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cravatt, B. F.</span></span> <span> </span><span class="NLM_article-title">Structure and function of fatty acid amide hydrolase</span>. <i>Annu. Rev. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>74</i></span>,  <span class="NLM_fpage">411</span>– <span class="NLM_lpage">432</span>, <span class="refDoi"> DOI: 10.1146/annurev.biochem.74.082803.133450</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1146%2Fannurev.biochem.74.082803.133450" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=15952893" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpsVensL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2005&pages=411-432&author=M.+K.+McKinneyauthor=B.+F.+Cravatt&title=Structure+and+function+of+fatty+acid+amide+hydrolase&doi=10.1146%2Fannurev.biochem.74.082803.133450"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Structure and function of fatty acid amide hydrolase</span></div><div class="casAuthors">McKinney, Michele K.; Cravatt, Benjamin F.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Biochemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">411-432</span>CODEN:
                <span class="NLM_cas:coden">ARBOAW</span>;
        ISSN:<span class="NLM_cas:issn">0066-4154</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  Fatty acid amide hydrolase (FAAH) is a mammalian integral membrane enzyme that degrades the fatty acid amide family of endogenous signaling lipids, which includes the endogenous cannabinoid, anandamide, and the sleep-inducing substance, oleamide.  FAAH belongs to a large and diverse class of enzymes referred to as the amidase signature (AS) family.  Investigations into the structure and function of FAAH, in combination with complementary studies of other AS enzymes, have engendered provocative mol. models to explain how this enzyme integrates into cell membranes and terminates fatty acid amide signaling in vivo.  These studies, as well as their biol. and therapeutic implications, are the subject of this review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprO7TpUTr6n7Vg90H21EOLACvtfcHk0linQh8Z4uvQvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpsVensL4%253D&md5=d28b43f14feb6894d48e907064087867</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1146%2Fannurev.biochem.74.082803.133450&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.biochem.74.082803.133450%26sid%3Dliteratum%253Aachs%26aulast%3DMcKinney%26aufirst%3DM.%2BK.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26atitle%3DStructure%2520and%2520function%2520of%2520fatty%2520acid%2520amide%2520hydrolase%26jtitle%3DAnnu.%2520Rev.%2520Biochem.%26date%3D2005%26volume%3D74%26spage%3D411%26epage%3D432%26doi%3D10.1146%2Fannurev.biochem.74.082803.133450" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tuo, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leleu-Chavain, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spencer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sansook, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Millet, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chavatte, P.</span></span> <span> </span><span class="NLM_article-title">Therapeutic potential of fatty acid amide hydrolase, monoacylglycerol lipase, and N-acylethanolamine acid amidase inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">4</span>– <span class="NLM_lpage">46</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00538</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00538" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslWjsLzI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=4-46&author=W.+Tuoauthor=N.+Leleu-Chavainauthor=J.+Spencerauthor=S.+Sansookauthor=R.+Milletauthor=P.+Chavatte&title=Therapeutic+potential+of+fatty+acid+amide+hydrolase%2C+monoacylglycerol+lipase%2C+and+N-acylethanolamine+acid+amidase+inhibitors&doi=10.1021%2Facs.jmedchem.6b00538"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic Potential of Fatty Acid Amide Hydrolase, Monoacylglycerol Lipase, and N-Acylethanolamine Acid Amidase Inhibitors</span></div><div class="casAuthors">Tuo, Wei; Leleu-Chavain, Natascha; Spencer, John; Sansook, Supojjanee; Millet, Regis; Chavatte, Philippe</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">4-46</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Fatty acid ethanolamides (FAEs) and endocannabinoids (ECs) have been shown to alleviate pain and inflammation, regulate motility and appetite, and produce anti-cancer, anxiolytic, and neuroprotective efficacies via cannabinoid receptor type 1 (CB1) or type 2 (CB2), or via peroxisome proliferator-activated receptor α (PPAR-α) stimulation.  FAEs and ECs are synthesized by a series of endogenous enzymes, including N-acylphosphatidylethanolamine-phospholipase D (NAPE-PLD), diacylglycerol lipase (DAGL), or phospholipase C (PLC), and their metab. is mediated by several metabolic enzymes, including fatty acid amide hydrolase (FAAH), monoacylglycerol lipase (MAGL), N-acylethanolamine acid amidase (NAAA), or cyclooxygenase-2 (COX-2).  Over the last decades, increasing the concn. of FAEs and ECs through the inhibition of degrading enzymes has been considered to be a viable therapeutic approach to enhance their anti-nociceptive and anti-inflammatory effects, as well as protecting the nervous system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoamrYPCqYEIbVg90H21EOLACvtfcHk0lgWFL2FdLo7Gg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslWjsLzI&md5=dd509179171644767726a67cb42dd074</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00538%26sid%3Dliteratum%253Aachs%26aulast%3DTuo%26aufirst%3DW.%26aulast%3DLeleu-Chavain%26aufirst%3DN.%26aulast%3DSpencer%26aufirst%3DJ.%26aulast%3DSansook%26aufirst%3DS.%26aulast%3DMillet%26aufirst%3DR.%26aulast%3DChavatte%26aufirst%3DP.%26atitle%3DTherapeutic%2520potential%2520of%2520fatty%2520acid%2520amide%2520hydrolase%252C%2520monoacylglycerol%2520lipase%252C%2520and%2520N-acylethanolamine%2520acid%2520amidase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D4%26epage%3D46%26doi%3D10.1021%2Facs.jmedchem.6b00538" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ueda, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsuboi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uyama, T.</span></span> <span> </span><span class="NLM_article-title">N-acylethanolamine metabolism with special reference to N-acylethanolamine-hydrolyzing acid amidase (NAAA)</span>. <i>Prog. Lipid Res.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">299</span>– <span class="NLM_lpage">315</span>, <span class="refDoi"> DOI: 10.1016/j.plipres.2010.02.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1016%2Fj.plipres.2010.02.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=20152858" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFWqsLvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2010&pages=299-315&author=N.+Uedaauthor=K.+Tsuboiauthor=T.+Uyama&title=N-acylethanolamine+metabolism+with+special+reference+to+N-acylethanolamine-hydrolyzing+acid+amidase+%28NAAA%29&doi=10.1016%2Fj.plipres.2010.02.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">N-acylethanolamine metabolism with special reference to N-acylethanolamine-hydrolyzing acid amidase (NAAA)</span></div><div class="casAuthors">Ueda, Natsuo; Tsuboi, Kazuhito; Uyama, Toru</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Lipid Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">299-315</span>CODEN:
                <span class="NLM_cas:coden">PLIRDW</span>;
        ISSN:<span class="NLM_cas:issn">0163-7827</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  N-acylethanolamines (NAEs) constitute a class of bioactive lipid mols. present in animal and plant tissues.  Among the NAEs, N-arachidonoylethanolamine (anandamide), N-palmitoylethanolamine, and N-oleoylethanolamine attract much attention due to cannabimimetic activity as an endocannabinoid, anti-inflammatory and analgesic activities, and anorexic activity, resp.  In mammalian tissues, NAEs are formed from glycerophospholipids through the phosphodiesterase-transacylation pathway consisting of Ca2+-dependent N-acyltransferase and N-acylphosphatidylethanolamine-hydrolyzing phospholipase D.  Recent studies revealed the presence of alternative pathways and enzymes responsible for the NAE formation.  As for the degrdn. of NAEs, fatty acid amide hydrolase (FAAH), which hydrolyzes NAEs to fatty acids and ethanolamine, plays a central role.  However, a lysosomal enzyme referred to as NAE-hydrolyzing acid amidase (NAAA) also catalyzes the same reaction and may be a new target for the development of therapeutic drugs.  In this article we discuss recent progress in the studies on the enzymes involved in the biosynthesis and degrdn. of NAEs with special ref. to NAAA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNqB2KZKbKuLVg90H21EOLACvtfcHk0lgWFL2FdLo7Gg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFWqsLvK&md5=286dd6b1ccaa5965fb5ca79abcf859af</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.plipres.2010.02.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.plipres.2010.02.003%26sid%3Dliteratum%253Aachs%26aulast%3DUeda%26aufirst%3DN.%26aulast%3DTsuboi%26aufirst%3DK.%26aulast%3DUyama%26aufirst%3DT.%26atitle%3DN-acylethanolamine%2520metabolism%2520with%2520special%2520reference%2520to%2520N-acylethanolamine-hydrolyzing%2520acid%2520amidase%2520%2528NAAA%2529%26jtitle%3DProg.%2520Lipid%2520Res.%26date%3D2010%26volume%3D49%26spage%3D299%26epage%3D315%26doi%3D10.1016%2Fj.plipres.2010.02.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bottemanne, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muccioli, G. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alhouayek, M.</span></span> <span> </span><span class="NLM_article-title">N-acylethanolamine hydrolyzing acid amidase inhibition: tools and potential therapeutic opportunities</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">1520</span>– <span class="NLM_lpage">1529</span>, <span class="refDoi"> DOI: 10.1016/j.drudis.2018.03.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1016%2Fj.drudis.2018.03.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=29567427" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BC1cXmtVWqsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2018&pages=1520-1529&author=P.+Bottemanneauthor=G.+G.+Muccioliauthor=M.+Alhouayek&title=N-acylethanolamine+hydrolyzing+acid+amidase+inhibition%3A+tools+and+potential+therapeutic+opportunities&doi=10.1016%2Fj.drudis.2018.03.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">N-acylethanolamine hydrolyzing acid amidase inhibition: tools and potential therapeutic opportunities</span></div><div class="casAuthors">Bottemanne, Pauline; Muccioli, Giulio G.; Alhouayek, Mireille</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1520-1529</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  N-acylethanolamines (NAEs) (e.g., N-palmitoylethanolamine, N-arachidonoylethanolamine, N-oleoylethanolamine) are bioactive lipids involved in many physiol. processes including pain, inflammation, anxiety, cognition and food intake.  Two enzymes are responsible for the hydrolysis of NAEs and therefore regulate their endogenous levels and effects: fatty acid amide hydrolase (FAAH) and N-acylethanolamine-hydrolyzing acid amidase (NAAA).  As discussed here, extensive biochem. characterization of NAAA was carried out over the years that contributed to a better understanding of NAAA enzymol.  An increasing no. of studies describe the synthesis and pharmacol. characterization of NAAA inhibitors.  Recent medicinal chem. efforts have led to the development of potent and stable inhibitors that enable studying the effects of NAAA inhibition in preclin. disease models, notably in the context of pain and inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowVSQkjk4fCrVg90H21EOLACvtfcHk0lgWFL2FdLo7Gg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXmtVWqsL0%253D&md5=01bd76d3543782664bfeccddc47c3be1</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2018.03.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2018.03.007%26sid%3Dliteratum%253Aachs%26aulast%3DBottemanne%26aufirst%3DP.%26aulast%3DMuccioli%26aufirst%3DG.%2BG.%26aulast%3DAlhouayek%26aufirst%3DM.%26atitle%3DN-acylethanolamine%2520hydrolyzing%2520acid%2520amidase%2520inhibition%253A%2520tools%2520and%2520potential%2520therapeutic%2520opportunities%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2018%26volume%3D23%26spage%3D1520%26epage%3D1529%26doi%3D10.1016%2Fj.drudis.2018.03.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bracey, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanson, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masuda, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cravatt, B. F.</span></span> <span> </span><span class="NLM_article-title">Structural adaptations in a membrane enzyme that terminates endocannabinoid signaling</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>298</i></span>,  <span class="NLM_fpage">1793</span>– <span class="NLM_lpage">1796</span>, <span class="refDoi"> DOI: 10.1126/science.1076535</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1126%2Fscience.1076535" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=12459591" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BD38XovFKmsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=298&publication_year=2002&pages=1793-1796&author=M.+H.+Braceyauthor=M.+A.+Hansonauthor=K.+R.+Masudaauthor=R.+C.+Stevensauthor=B.+F.+Cravatt&title=Structural+adaptations+in+a+membrane+enzyme+that+terminates+endocannabinoid+signaling&doi=10.1126%2Fscience.1076535"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Adaptations in a Membrane Enzyme That Terminates Endocannabinoid Signaling</span></div><div class="casAuthors">Bracey, Michael H.; Hanson, Michael A.; Masuda, Kim R.; Stevens, Raymond C.; Cravatt, Benjamin F.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">298</span>
        (<span class="NLM_cas:issue">5599</span>),
    <span class="NLM_cas:pages">1793-1796</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Cellular communication in the nervous system is mediated by chem. messengers that include amino acids, monoamines, peptide hormones, and lipids.  An interesting question is how neurons regulate signals that are transmitted by membrane-embedded lipids.  Here, we report the 2.8 angstrom crystal structure of the integral membrane protein fatty acid amide hydrolase (FAAH), an enzyme that degrades members of the endocannabinoid class of signaling lipids and terminates their activity.  The structure of FAAH complexed with an arachidonyl inhibitor reveals how a set of discrete structural alterations allows this enzyme, in contrast to sol. hydrolases of the same family, to integrate into cell membranes and establish direct access to the bilayer from its active site.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTj6G-8THMiLVg90H21EOLACvtfcHk0liupxM3eyDs6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XovFKmsLs%253D&md5=01545bfbd00f31af713db259f41cb0ba</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1126%2Fscience.1076535&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1076535%26sid%3Dliteratum%253Aachs%26aulast%3DBracey%26aufirst%3DM.%2BH.%26aulast%3DHanson%26aufirst%3DM.%2BA.%26aulast%3DMasuda%26aufirst%3DK.%2BR.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26atitle%3DStructural%2520adaptations%2520in%2520a%2520membrane%2520enzyme%2520that%2520terminates%2520endocannabinoid%2520signaling%26jtitle%3DScience%26date%3D2002%26volume%3D298%26spage%3D1793%26epage%3D1796%26doi%3D10.1126%2Fscience.1076535" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gorelik, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gebai, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Illes, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piomelli, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagar, B.</span></span> <span> </span><span class="NLM_article-title">Molecular mechanism of activation of the immunoregulatory amidase NAAA</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>115</i></span>,  <span class="NLM_fpage">E10032</span>– <span class="NLM_lpage">E10040</span>, <span class="refDoi"> DOI: 10.1073/pnas.1811759115</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1073%2Fpnas.1811759115" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=30301806" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitVyhsLvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2018&pages=E10032-E10040&author=A.+Gorelikauthor=A.+Gebaiauthor=K.+Illesauthor=D.+Piomelliauthor=B.+Nagar&title=Molecular+mechanism+of+activation+of+the+immunoregulatory+amidase+NAAA&doi=10.1073%2Fpnas.1811759115"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular mechanism of activation of the immunoregulatory amidase NAAA</span></div><div class="casAuthors">Gorelik, Alexei; Gebai, Ahmad; Illes, Katalin; Piomelli, Daniele; Nagar, Bhushan</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue">43</span>),
    <span class="NLM_cas:pages">E10032-E10040</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Palmitoylethanolamide is a bioactive lipid that strongly alleviates pain and inflammation in animal models and in humans.  Its signaling activity is terminated through degrdn. by N-acylethanolamine acid amidase (NAAA), a cysteine hydrolase expressed at high levels in immune cells.  Pharmacol. inhibitors of NAAA activity exert profound analgesic and antiinflammatory effects in rodent models, pointing to this protein as a potential target for therapeutic drug discovery.  To facilitate these efforts and to better understand the mol. mechanism of action of NAAA, we detd. crystal structures of this enzyme in various activation states and in complex with several ligands, including both a covalent and a reversible inhibitor.  Self-proteolysis exposes the otherwise buried active site of NAAA to allow catalysis.  Formation of a stable substrate- or inhibitor-binding site appears to be conformationally coupled to the interaction of a pair of hydrophobic helixes in the enzyme with lipid membranes, resulting in the creation of a linear hydrophobic cavity near the active site that accommodates the liganda's acyl chain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpe4SyudaY7MrVg90H21EOLACvtfcHk0liupxM3eyDs6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitVyhsLvP&md5=9debd68d3239a82bd60849c9cf98e8ae</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1811759115&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1811759115%26sid%3Dliteratum%253Aachs%26aulast%3DGorelik%26aufirst%3DA.%26aulast%3DGebai%26aufirst%3DA.%26aulast%3DIlles%26aufirst%3DK.%26aulast%3DPiomelli%26aufirst%3DD.%26aulast%3DNagar%26aufirst%3DB.%26atitle%3DMolecular%2520mechanism%2520of%2520activation%2520of%2520the%2520immunoregulatory%2520amidase%2520NAAA%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2018%26volume%3D115%26spage%3DE10032%26epage%3DE10040%26doi%3D10.1073%2Fpnas.1811759115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">The
UniProt Consortium.</span> <span> </span><span class="NLM_article-title">UniProt:
a worldwide hub of protein knowledge</span>. <i>Nucleic
Acids Res.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">D506</span>– <span class="NLM_lpage">D515</span>, <span class="refDoi"> DOI: 10.1093/nar/gky1049</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1093%2Fnar%2Fgky1049" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=30395287" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2019&pages=D506-D515&author=The%0AUniProt+Consortium.&title=UniProt%3A%0Aa+worldwide+hub+of+protein+knowledge&doi=10.1093%2Fnar%2Fgky1049"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgky1049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgky1049%26sid%3Dliteratum%253Aachs%26aulast%3D%26atitle%3DUniProt%253A%250Aa%2520worldwide%2520hub%2520of%2520protein%2520knowledge%26jtitle%3DNucleic%250AAcids%2520Res.%26date%3D2019%26volume%3D47%26spage%3DD506%26epage%3DD515%26doi%3D10.1093%2Fnar%2Fgky1049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Désarnaud, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cadas, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piomelli, D.</span></span> <span> </span><span class="NLM_article-title">Anandamide amidohydrolase activity in rat brain microsomes. Identification and partial characterization</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>270</i></span>,  <span class="NLM_fpage">6030</span>– <span class="NLM_lpage">6035</span>, <span class="refDoi"> DOI: 10.1074/jbc.270.11.6030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1074%2Fjbc.270.11.6030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=7890734" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADyaK2MXksVCntLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=270&publication_year=1995&pages=6030-6035&author=F.+D%C3%A9sarnaudauthor=H.+Cadasauthor=D.+Piomelli&title=Anandamide+amidohydrolase+activity+in+rat+brain+microsomes.+Identification+and+partial+characterization&doi=10.1074%2Fjbc.270.11.6030"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Anandamide amidohydrolase activity in rat brain microsomes. Identification and partial characterization</span></div><div class="casAuthors">Desarnaud, Franck; Cadas, Hugues; Piomelli, Daniele</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">270</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">6030-5</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">An amidohydrolase activity present in rat brain microsomes was found to catalyze the hydrolysis of [3H]anadamide (N-arachidonoyl-[3H]ethanolamine), an endogenous cannabimimetic substance, forming [3H]ethanolamine and arachidonic acid.  Anadamide amidohydrolase (I) was maximal at pH 6 and 8, was independent od divalent cations, had an apparent Km for [3H]anandamide of 12.7 μM, and had a Vmax of 5630 pmol/min/mg protein.  Phenylmethylsulfonyl fluoride, a serine protease inhibitor, and p-bromophenacyl bromide, a histidine-alkylating reagent, inhibited I, whereas N-ethylmaleimide and various nonselective peptidase inhibitors (EDTA, o-phenanthroline, bacitracin) had no effect.  Brain I exhibited high substrate specificity for [3H]anandamide; N-γ-linolenoyl-, N-homo-γ-linolenoyl-, and N-11,14-eicosadienoyl-[3H]ethanolamine were hydrolyzed at markedly slower rates.  Moreover, N-11-eicosaenoyl- and N-palmitoyl-[3H]ethanolamine were not hydrolyzed.  [3H]anandamide hydrolysis was inhibited competitively by nonradioactive anandamide and by other N-acylethanolamines with the following rank order of potency: anandamide > N-linoleoyl- = N-cis-linolenoyl- = N-γ-linolenoyl- = N-homo-γ-linolenoyl- > N-11,14-eicosadienoyl- > N-oleoyl- > N docosahexaenoyl- > N-docosatetraenoyl > N-linoelaidoyl- > N-eicosaenoyl- > N-palmitoyl ≥ N-elaidoyl- = N-eicosanoyl-ethanolamine = no effect.  I activity is high in liver and brain and low in heart, kidney, intestine, stomach, lung, spleen, and skeletal muscle.  Within the central nervous system, the highest I activity was found in the globus pallidus and hippocampus, 2 regions rich in cannabinoid receptors, and the lowest activity was found in the brainstem and medulla, where cannabinoid receptors were sparse.  The results, showing that brain I is selective for anandamide and enriched in areas of the central nervous system with a high d. of cannabinoid receptors, suggested that this activity may participate in the inactivation of anandamide at its sites of action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLvCJ97zLAKrVg90H21EOLACvtfcHk0liupxM3eyDs6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXksVCntLk%253D&md5=11d7f2b17b5212d22ff1ca6854d244b5</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1074%2Fjbc.270.11.6030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.270.11.6030%26sid%3Dliteratum%253Aachs%26aulast%3DD%25C3%25A9sarnaud%26aufirst%3DF.%26aulast%3DCadas%26aufirst%3DH.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DAnandamide%2520amidohydrolase%2520activity%2520in%2520rat%2520brain%2520microsomes.%2520Identification%2520and%2520partial%2520characterization%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1995%26volume%3D270%26spage%3D6030%26epage%3D6035%26doi%3D10.1074%2Fjbc.270.11.6030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ueda, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurahashi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tokunaga, T.</span></span> <span> </span><span class="NLM_article-title">Partial purification and characterization of the porcine brain enzyme hydrolyzing and synthesizing anandamide</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>270</i></span>,  <span class="NLM_fpage">23823</span>– <span class="NLM_lpage">23827</span>, <span class="refDoi"> DOI: 10.1074/jbc.270.40.23823</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1074%2Fjbc.270.40.23823" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=7559559" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADyaK2MXos1ehtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=270&publication_year=1995&pages=23823-23827&author=N.+Uedaauthor=Y.+Kurahashiauthor=S.+Yamamotoauthor=T.+Tokunaga&title=Partial+purification+and+characterization+of+the+porcine+brain+enzyme+hydrolyzing+and+synthesizing+anandamide&doi=10.1074%2Fjbc.270.40.23823"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Partial purification and characterization of the porcine brain enzyme hydrolyzing and synthesizing anandamide</span></div><div class="casAuthors">Ueda, Natsuo; Kurahashi, Yuko; Yamamoto, Shozo; Tokunaga, Takashi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">270</span>
        (<span class="NLM_cas:issue">40</span>),
    <span class="NLM_cas:pages">23823-7</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Anandamide (arachidonylethanolamide) is known as an endogenous agonist for cannabinoid receptors.  An amidohydrolase, which hydrolyzed anandamide, was solubilized from the microsomal fraction of porcine brain with 1% Triton X-100.  The enzyme was partially purified by Phenyl-5PW hydrophobic chromatog. to a specific activity of approx. 0.37 μmol/min/mg of protein at 37°.  As assayed with 14C-labeled substrates, the apparent Km value for anandamide was 60 μM, and anandamide was more active than ethanolamides of linoleic, oleic, and palmitic acids.  Ceramidase and protease activities were not detected in the enzyme prepn.  The purified enzyme also synthesized anandamide from free arachidonic acid in the presence of a high concn. of ethanolamine with a specific activity of about 0.16 μmol/min/mg of protein at 37°.  On the basis of cochromatogs., pH dependence, heat inactivation, and effects of inhibitors such as arachidonyl trifluoromethyl ketone, p-chloromercuribenzoic acid, diisopropyl fluorophosphate, and phenylmethylsulfonyl fluoride, it was suggest that the anandamide amidohydrolase and synthase activities were attributable to a single enzyme protein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqoXrN1E9aUHbVg90H21EOLACvtfcHk0lizVded8yn7dw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXos1ehtr4%253D&md5=078dd0d9c568d2cad70feb7b0f606621</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1074%2Fjbc.270.40.23823&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.270.40.23823%26sid%3Dliteratum%253Aachs%26aulast%3DUeda%26aufirst%3DN.%26aulast%3DKurahashi%26aufirst%3DY.%26aulast%3DYamamoto%26aufirst%3DS.%26aulast%3DTokunaga%26aufirst%3DT.%26atitle%3DPartial%2520purification%2520and%2520characterization%2520of%2520the%2520porcine%2520brain%2520enzyme%2520hydrolyzing%2520and%2520synthesizing%2520anandamide%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1995%26volume%3D270%26spage%3D23823%26epage%3D23827%26doi%3D10.1074%2Fjbc.270.40.23823" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hillard, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilkison, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edgemond, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, W. B.</span></span> <span> </span><span class="NLM_article-title">Characterization of the kinetics and distribution of N-arachidonylethanolamine (anandamide) hydrolysis by rat brain</span>. <i>Biochim. Biophys. Acta, Lipids Lipid Metab.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>1257</i></span>,  <span class="NLM_fpage">249</span>– <span class="NLM_lpage">256</span>, <span class="refDoi"> DOI: 10.1016/0005-2760(95)00087-S</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1016%2F0005-2760%2895%2900087-S" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=7647100" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADyaK2MXntl2jtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1257&publication_year=1995&pages=249-256&author=C.+J.+Hillardauthor=D.+M.+Wilkisonauthor=W.+S.+Edgemondauthor=W.+B.+Campbell&title=Characterization+of+the+kinetics+and+distribution+of+N-arachidonylethanolamine+%28anandamide%29+hydrolysis+by+rat+brain&doi=10.1016%2F0005-2760%2895%2900087-S"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of the kinetics and distribution of N-arachidonylethanolamine (anandamide) hydrolysis by rat brain</span></div><div class="casAuthors">Hillard, Cecilia J.; Wilkison, Douglas M.; Edgemond, William S.; Campbell, William B.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Lipids and Lipid Metabolism</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">1257</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">249-56</span>CODEN:
                <span class="NLM_cas:coden">BBLLA6</span>;
        ISSN:<span class="NLM_cas:issn">0925-4439</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Arachidonoylethanolamide or anandamide is a naturally occurring deriv. of arachidonic acid that has been shown to activate cannabinoid receptors in the brain.  Its metabolic inactivation by brain tissue has been investigated.  Anandamide is hydrolyzed by the membrane fraction of rat brain homogenate to arachidonic acid and ethanolamine.  The hydrolysis is temp.- and pH-dependent (pH max. at 8.5) and abolished by boiling.  Anandamide hydrolysis is protein dependent in the range of 25-100 μg protein/mL; does not require calcium and is inhibited by phenylmethylsulfonylfluoride, diisopropylfluorophosphate, thimerosal and arachidonic acid.  Hydrolysis of 10 μM anandamide by brain membranes follows first order kinetics; at 30°, the rate const. for anandamide catabolism is 0.34 min-1 mg protein-1.  The Km for anandamide hydrolysis is 3.4 μM, and the Vmax is 2.2 nmol/min per mg protein.  Hydrolysis occurs in all subcellular fractions except cytosol with the highest specific activity in myelin and microsomes.  The distribution of anandamide hydrolytic activity correlates with the distribution of cannabinoid receptor-binding sites; the hippocampus, cerebellum and cerebral cortex exhibit the highest metabolic activity, while activity is lowest in the striatum, brain stem and white matter.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_wuU3uI6dDLVg90H21EOLACvtfcHk0lizVded8yn7dw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXntl2jtbo%253D&md5=94968f21405527d140e7c51ee6b265db</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2F0005-2760%2895%2900087-S&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0005-2760%252895%252900087-S%26sid%3Dliteratum%253Aachs%26aulast%3DHillard%26aufirst%3DC.%2BJ.%26aulast%3DWilkison%26aufirst%3DD.%2BM.%26aulast%3DEdgemond%26aufirst%3DW.%2BS.%26aulast%3DCampbell%26aufirst%3DW.%2BB.%26atitle%3DCharacterization%2520of%2520the%2520kinetics%2520and%2520distribution%2520of%2520N-arachidonylethanolamine%2520%2528anandamide%2529%2520hydrolysis%2520by%2520rat%2520brain%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Lipids%2520Lipid%2520Metab.%26date%3D1995%26volume%3D1257%26spage%3D249%26epage%3D256%26doi%3D10.1016%2F0005-2760%2895%2900087-S" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schmid, H. H. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmid, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Natarajan, V.</span></span> <span> </span><span class="NLM_article-title">N-Acylated glycerophospholipids and their derivatives</span>. <i>Prog. Lipid Res.</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">43</span>, <span class="refDoi"> DOI: 10.1016/0163-7827(90)90004-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1016%2F0163-7827%2890%2990004-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=2087478" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADyaK3MXisVartLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=1990&pages=1-43&author=H.+H.+O.+Schmidauthor=P.+C.+Schmidauthor=V.+Natarajan&title=N-Acylated+glycerophospholipids+and+their+derivatives&doi=10.1016%2F0163-7827%2890%2990004-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">N-acylated glycerophospholipids and their derivatives</span></div><div class="casAuthors">Schmid, Harald H. O.; Schmid, Patricia C.; Natarajan, V.</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Lipid Research</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-43</span>CODEN:
                <span class="NLM_cas:coden">PLIRDW</span>;
        ISSN:<span class="NLM_cas:issn">0163-7827</span>.
    </div><div class="casAbstract">A review with 204 refs.  A crit. evaluation of current knowledge on N-acylated glycerophospholipids and their derivs. is presented.  Topics include isolation, characterization, occurrence, metab., and pharmacol. effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzU_AOgZGQirVg90H21EOLACvtfcHk0lizVded8yn7dw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXisVartLc%253D&md5=ef0b207cb169b9c103dae883d44b7101</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2F0163-7827%2890%2990004-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0163-7827%252890%252990004-5%26sid%3Dliteratum%253Aachs%26aulast%3DSchmid%26aufirst%3DH.%2BH.%2BO.%26aulast%3DSchmid%26aufirst%3DP.%2BC.%26aulast%3DNatarajan%26aufirst%3DV.%26atitle%3DN-Acylated%2520glycerophospholipids%2520and%2520their%2520derivatives%26jtitle%3DProg.%2520Lipid%2520Res.%26date%3D1990%26volume%3D29%26spage%3D1%26epage%3D43%26doi%3D10.1016%2F0163-7827%2890%2990004-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ueda, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamanaka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terasawa, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, S.</span></span> <span> </span><span class="NLM_article-title">An acid amidase hydrolyzing anandamide as an endogenous ligand for cannabinoid receptors</span>. <i>FEBS Lett.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>454</i></span>,  <span class="NLM_fpage">267</span>– <span class="NLM_lpage">270</span>, <span class="refDoi"> DOI: 10.1016/S0014-5793(99)00820-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1016%2FS0014-5793%2899%2900820-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10431820" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADyaK1MXks1Omu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=454&publication_year=1999&pages=267-270&author=N.+Uedaauthor=K.+Yamanakaauthor=Y.+Terasawaauthor=S.+Yamamoto&title=An+acid+amidase+hydrolyzing+anandamide+as+an+endogenous+ligand+for+cannabinoid+receptors&doi=10.1016%2FS0014-5793%2899%2900820-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">An acid amidase hydrolyzing anandamide as an endogenous ligand for cannabinoid receptors</span></div><div class="casAuthors">Ueda, Natsuo; Yamanaka, Kenji; Terasawa, Yuka; Yamamoto, Shozo</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Letters</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">454</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">267-270</span>CODEN:
                <span class="NLM_cas:coden">FEBLAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-5793</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">Anandamide loses its cannabimimetic activities upon hydrolysis to arachidonic acid and ethanolamine.  Thus far, the anandamide-hydrolyzing activity widely distributed in mammalian organs has been attributed exclusively to an enzyme referred to as anandamide amidohydrolase with an optimum pH of ∼9.  Here, the authors report another enzyme hydrolyzing anandamide in a human megakaryoblastic cell line (CMK).  The enzyme present in the 12,000 g pellet of the cell homogenate was solubilized by freeze-thaw.  The solubilized enzyme showed an optimal pH at ∼5, and was almost inactive at alk. pH.  The enzyme activity was increased by the addn. of dithiothreitol.  In contrast, anandamide amidohydrolase of RBL-1 cells was mostly insol. even after freeze-thaw, showed an optimal pH at 9, and was not affected by dithiothreitol.  Furthermore, the enzyme of CMK cells was much less sensitive to phenylmethylsulfonyl fluoride and Me arachidonoyl fluorophosphonate potently inhibiting anandamide amidohydrolase, and effectively hydrolyzed palmitoylethanolamide, which was a poor substrate for anandamide amidohydrolase.  Thus, the enzyme of CMK cells is distinguishable from anandamide amidohydrolase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPfb7SP8dL4rVg90H21EOLACvtfcHk0lg5pcdluv7iBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXks1Omu7k%253D&md5=36898e76a4091383e536cd3d9b31f191</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2FS0014-5793%2899%2900820-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-5793%252899%252900820-0%26sid%3Dliteratum%253Aachs%26aulast%3DUeda%26aufirst%3DN.%26aulast%3DYamanaka%26aufirst%3DK.%26aulast%3DTerasawa%26aufirst%3DY.%26aulast%3DYamamoto%26aufirst%3DS.%26atitle%3DAn%2520acid%2520amidase%2520hydrolyzing%2520anandamide%2520as%2520an%2520endogenous%2520ligand%2520for%2520cannabinoid%2520receptors%26jtitle%3DFEBS%2520Lett.%26date%3D1999%26volume%3D454%26spage%3D267%26epage%3D270%26doi%3D10.1016%2FS0014-5793%2899%2900820-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kuehl, F. A.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacob, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganley, O. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ormond, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meisinger, M. A. P.</span></span> <span> </span><span class="NLM_article-title">The identification of N-(2-hydroxyethyl)-palmitamide as a naturally occurring anti-inflammatory agent</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1957</span>,  <span class="NLM_volume"><i>79</i></span>,  <span class="NLM_fpage">5577</span>– <span class="NLM_lpage">5578</span>, <span class="refDoi"> DOI: 10.1021/ja01577a066</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja01577a066" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADyaG1cXht1CqtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=1957&pages=5577-5578&author=F.+A.+Kuehlauthor=T.+A.+Jacobauthor=O.+H.+Ganleyauthor=R.+E.+Ormondauthor=M.+A.+P.+Meisinger&title=The+identification+of+N-%282-hydroxyethyl%29-palmitamide+as+a+naturally+occurring+anti-inflammatory+agent&doi=10.1021%2Fja01577a066"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of N-(2-hydroxyethyl)palmitamide as a naturally occurring anti-inflammatory agent</span></div><div class="casAuthors">Kuehl, F. A., Jr.; Jacob, T. A.; Ganley, O. H.; Ormond, R. E.; Meisinger, M. A. P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1957</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">5577-8</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    </div><div class="casAbstract">A cryst. anti-inflammatory factor (I), m. 98-9°, C18H37O2N, was isolated from soybean lecithin, a phospholipide fraction of egg yolk, and from hexane-extd. peanut meal.  I was identified as the title compd.  The basic moiety is responsible for its anti-inflammatory activity; the nature of the acid group is of no consequence.  O-Acetylethanolamine, choline, N-dimethylaminoethanol, and N-methylaminoethanol all had the same order of activity; glycine, serine, sarcosine, and betaine were inactive.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2gELizzTClbVg90H21EOLACvtfcHk0lg5pcdluv7iBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaG1cXht1CqtA%253D%253D&md5=cdfea2a962576ec1c2081021c9a4267f</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fja01577a066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja01577a066%26sid%3Dliteratum%253Aachs%26aulast%3DKuehl%26aufirst%3DF.%2BA.%26aulast%3DJacob%26aufirst%3DT.%2BA.%26aulast%3DGanley%26aufirst%3DO.%2BH.%26aulast%3DOrmond%26aufirst%3DR.%2BE.%26aulast%3DMeisinger%26aufirst%3DM.%2BA.%2BP.%26atitle%3DThe%2520identification%2520of%2520N-%25282-hydroxyethyl%2529-palmitamide%2520as%2520a%2520naturally%2520occurring%2520anti-inflammatory%2520agent%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1957%26volume%3D79%26spage%3D5577%26epage%3D5578%26doi%3D10.1021%2Fja01577a066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ganley, O. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, H. J.</span></span> <span> </span><span class="NLM_article-title">Antianaphylactic and antiserotonin activity of a compound obtained from egg yolk, peanut oil and soybean lecithin</span>. <i>J. Allergy</i> <span class="NLM_year" style="font-weight: bold;">1959</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">415</span>– <span class="NLM_lpage">419</span>, <span class="refDoi"> DOI: 10.1016/0021-8707(59)90019-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1016%2F0021-8707%2859%2990019-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=13826312" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADyaG1MXhtFCltr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=1959&pages=415-419&author=O.+H.+Ganleyauthor=H.+J.+Robinson&title=Antianaphylactic+and+antiserotonin+activity+of+a+compound+obtained+from+egg+yolk%2C+peanut+oil+and+soybean+lecithin&doi=10.1016%2F0021-8707%2859%2990019-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Antianaphylactic and antiserotonin activity of a compound obtained from egg yolk, peanut oil, and soybean lecithin</span></div><div class="casAuthors">Ganley, Oswald H.; Robinson, Harry J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Allergy</span>
        (<span class="NLM_cas:date">1959</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">415-19</span>CODEN:
                <span class="NLM_cas:coden">JOALAS</span>;
        ISSN:<span class="NLM_cas:issn">0021-8707</span>.
    </div><div class="casAbstract">Effect of N-(2-hydroxyethyl)palmitamide, ethanolamine-HCl, and a variety of fatty acids on passive anaphylaxis, serotonin, and histamine toxicity in the mouse were studied.  All compds. suppressed anaphylaxis and serotonin toxicity at low concns. but had no effect on histamine toxicity.  Data indicate that fatty acids can act as potent pharmacologic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_f0Afg_5aFrVg90H21EOLACvtfcHk0lg5pcdluv7iBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaG1MXhtFCltr0%253D&md5=48ce6bb5f728c60c180c61ceb68c75a2</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2F0021-8707%2859%2990019-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0021-8707%252859%252990019-X%26sid%3Dliteratum%253Aachs%26aulast%3DGanley%26aufirst%3DO.%2BH.%26aulast%3DRobinson%26aufirst%3DH.%2BJ.%26atitle%3DAntianaphylactic%2520and%2520antiserotonin%2520activity%2520of%2520a%2520compound%2520obtained%2520from%2520egg%2520yolk%252C%2520peanut%2520oil%2520and%2520soybean%2520lecithin%26jtitle%3DJ.%2520Allergy%26date%3D1959%26volume%3D30%26spage%3D415%26epage%3D419%26doi%3D10.1016%2F0021-8707%2859%2990019-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mašek, K.</span>; <span class="NLM_string-name">Raskova, H.</span></span> <span> </span><span class="NLM_article-title">Pharmacology of Palmitoylethanolamide</span>. In  <i>Drugs of Animal Origin</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leonardi, A.</span>, <span class="NLM_string-name">Walsh, J.</span></span>, Eds.; <span class="NLM_publisher-name">Ferro Edizioni</span>: <span class="NLM_publisher-loc">Milan, Italy</span>, <span class="NLM_year">1967</span>; pp  <span class="NLM_fpage">199</span>– <span class="NLM_lpage">209</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1967&pages=199-209&author=K.+Ma%C5%A1ek&author=H.+Raskovaauthor=A.+Leonardi&author=J.+Walsh&title=Drugs+of+Animal+Origin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DMa%25C5%25A1ek%26aufirst%3DK.%26atitle%3DPharmacology%2520of%2520Palmitoylethanolamide%26btitle%3DDrugs%2520of%2520Animal%2520Origin%26aulast%3DLeonardi%26aufirst%3DA.%26pub%3DFerro%2520Edizioni%26date%3D1967%26spage%3D199%26epage%3D209" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Benvenuti, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lattanzi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Gori, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarli, P.</span></span> <span> </span><span class="NLM_article-title">Activity of some derivatives of palmitoylethanolamide on carragenine-induced edema in the rat paw</span>. <i>Boll. Soc. Ital. Biol. Sper.</i> <span class="NLM_year" style="font-weight: bold;">1968</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">809</span>– <span class="NLM_lpage">813</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=5699335" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADyaF1cXkvVGhsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=1968&pages=809-813&author=F.+Benvenutiauthor=F.+Lattanziauthor=A.+De+Goriauthor=P.+Tarli&title=Activity+of+some+derivatives+of+palmitoylethanolamide+on+carragenine-induced+edema+in+the+rat+paw"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of some palmitoyl ethanolamide derivatives on carrageenin-induced rat paw edema</span></div><div class="casAuthors">Benvenuti, F.; Lattanzi, F.; De Gori, A.; Tarli, P.</div><div class="citationInfo"><span class="NLM_cas:title">Bollettino - Societa Italiana di Biologia Sperimentale</span>
        (<span class="NLM_cas:date">1968</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">809-13</span>CODEN:
                <span class="NLM_cas:coden">BSIBAC</span>;
        ISSN:<span class="NLM_cas:issn">0037-8771</span>.
    </div><div class="casAbstract">The effects of i.p. injected palmitoyl ethanolamide, stearoyl ethanolamide, lauroyl ethanolamide, palmitoyl N-methylethanolamide, palmitoyl propanolamide, and palmitoyl isopropanolamide (25-200 mg./kg.) on carrageenin-induced rat paw edema were compared to those of the standard, indomethacin (5-10 mg./kg.).  None of the compds. tested was more active than indomethacin.  However, 5 of the test compds. were generally more active than palmitoyl ethanolamide at 25-mg./kg. dose levels, while at higher doses the 6 test compds. were comparable in activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4_vRjqecY77Vg90H21EOLACvtfcHk0lgSY7hi4m1nMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF1cXkvVGhsbk%253D&md5=6822f378fa383767969dd67bf3c0d294</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBenvenuti%26aufirst%3DF.%26aulast%3DLattanzi%26aufirst%3DF.%26aulast%3DDe%2BGori%26aufirst%3DA.%26aulast%3DTarli%26aufirst%3DP.%26atitle%3DActivity%2520of%2520some%2520derivatives%2520of%2520palmitoylethanolamide%2520on%2520carragenine-induced%2520edema%2520in%2520the%2520rat%2520paw%26jtitle%3DBoll.%2520Soc.%2520Ital.%2520Biol.%2520Sper.%26date%3D1968%26volume%3D44%26spage%3D809%26epage%3D813" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Perlík, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rasková, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elis, J.</span></span> <span> </span><span class="NLM_article-title">Anti-inflammatory properties of N-(2-hydroxyethyl) palmitamide</span>. <i>Acta Physiol. Acad. Sci. Hung.</i> <span class="NLM_year" style="font-weight: bold;">1971</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">395</span>– <span class="NLM_lpage">400</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=5119194" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADyaE38XlsVCitg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1971&pages=395-400&author=F.+Perl%C3%ADkauthor=H.+Raskov%C3%A1author=J.+Elis&title=Anti-inflammatory+properties+of+N-%282-hydroxyethyl%29+palmitamide"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Antiinflammatory properties of N-(2-hydroxyethyl)palmitamide</span></div><div class="casAuthors">Perlik, F.; Elis, J.; Raskova, Henena</div><div class="citationInfo"><span class="NLM_cas:title">Acta Physiologica Academiae Scientiarum Hungaricae</span>
        (<span class="NLM_cas:date">1971</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">395-400</span>CODEN:
                <span class="NLM_cas:coden">APACAB</span>;
        ISSN:<span class="NLM_cas:issn">0001-6756</span>.
    </div><div class="casAbstract">N-(2-hydroxyethyl)palmitamide (I) [544-31-0] (50 mg/kg/day, orally) had no effect on the primary lesions of adjuvant induced arthritis in rats, but decreased the secondary lesions when administered daily over a 6 week period.  I decreased the induration of the tuberculin reaction in guinea pigs.  I had no relieving effect on serotonin induced edema in the rat.  This data suggests that I acts on delayed hypersensitivity and(or) in the subsequent processes which introduce arthritis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4BmmXOPIk4rVg90H21EOLACvtfcHk0lgSY7hi4m1nMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE38XlsVCitg%253D%253D&md5=9e81bd505e497181464407939a2b5e6a</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPerl%25C3%25ADk%26aufirst%3DF.%26aulast%3DRaskov%25C3%25A1%26aufirst%3DH.%26aulast%3DElis%26aufirst%3DJ.%26atitle%3DAnti-inflammatory%2520properties%2520of%2520N-%25282-hydroxyethyl%2529%2520palmitamide%26jtitle%3DActa%2520Physiol.%2520Acad.%2520Sci.%2520Hung.%26date%3D1971%26volume%3D39%26spage%3D395%26epage%3D400" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Perlík, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krejcí, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elis, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pekárek, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Svejcar, J.</span></span> <span> </span><span class="NLM_article-title">The effect of N-(2-hydroxyethyl)-palmitamide on delayed hypersensitivity in guinea-pig</span>. <i>Experientia</i> <span class="NLM_year" style="font-weight: bold;">1973</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">67</span>– <span class="NLM_lpage">68</span>, <span class="refDoi"> DOI: 10.1007/BF01913256</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1007%2FBF01913256" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=4729458" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADyaE3sXnvFygsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=1973&pages=67-68&author=F.+Perl%C3%ADkauthor=J.+Krejc%C3%ADauthor=J.+Elisauthor=J.+Pek%C3%A1rekauthor=J.+Svejcar&title=The+effect+of+N-%282-hydroxyethyl%29-palmitamide+on+delayed+hypersensitivity+in+guinea-pig&doi=10.1007%2FBF01913256"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of N-(2-hydroxyethyl)palmitamide on delayed hypersensitivity in guinea pig</span></div><div class="casAuthors">Perlik, F.; Krejci, J.; Elis, J.; Pekarek, J.; Svejcar, J.</div><div class="citationInfo"><span class="NLM_cas:title">Experientia</span>
        (<span class="NLM_cas:date">1973</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">67-8</span>CODEN:
                <span class="NLM_cas:coden">EXPEAM</span>;
        ISSN:<span class="NLM_cas:issn">0014-4754</span>.
    </div><div class="casAbstract">N-(2-hydroxyethyl)palmitamide [544-31-0] administered prior to sensitization of guinea pigs to tuberculin purified protein deriv. increased the erythema, diam., and induration values 24 hr after inoculation as well as increasing the inhibition of macrophage migration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonuU4sUyo7YbVg90H21EOLACvtfcHk0lgSY7hi4m1nMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE3sXnvFygsA%253D%253D&md5=199df7530c58258bed270ee4da8fed73</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1007%2FBF01913256&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF01913256%26sid%3Dliteratum%253Aachs%26aulast%3DPerl%25C3%25ADk%26aufirst%3DF.%26aulast%3DKrejc%25C3%25AD%26aufirst%3DJ.%26aulast%3DElis%26aufirst%3DJ.%26aulast%3DPek%25C3%25A1rek%26aufirst%3DJ.%26aulast%3DSvejcar%26aufirst%3DJ.%26atitle%3DThe%2520effect%2520of%2520N-%25282-hydroxyethyl%2529-palmitamide%2520on%2520delayed%2520hypersensitivity%2520in%2520guinea-pig%26jtitle%3DExperientia%26date%3D1973%26volume%3D29%26spage%3D67%26epage%3D68%26doi%3D10.1007%2FBF01913256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Masek, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perlík, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klíma, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kahlich, R.</span></span> <span> </span><span class="NLM_article-title">Prophylactic efficacy of N-2-hydroxyethyl palmitamide (impulsin) in acute respiratory tract infections</span>. <i>Eur. J. Clin. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1974</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">415</span>– <span class="NLM_lpage">419</span>, <span class="refDoi"> DOI: 10.1007/BF00560353</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1007%2FBF00560353" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=4439865" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADyaE2MXhsV2nu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1974&pages=415-419&author=K.+Masekauthor=F.+Perl%C3%ADkauthor=J.+Kl%C3%ADmaauthor=R.+Kahlich&title=Prophylactic+efficacy+of+N-2-hydroxyethyl+palmitamide+%28impulsin%29+in+acute+respiratory+tract+infections&doi=10.1007%2FBF00560353"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Prophylactic efficacy of N-2-Hydroxyethylpalmitamide (Impulsin) in acute respiratory tract infections</span></div><div class="casAuthors">Masek, K.; Perlik, F.; Klima, J.; Kahlich, R.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">1974</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">415-19</span>CODEN:
                <span class="NLM_cas:coden">EJCPAS</span>;
        ISSN:<span class="NLM_cas:issn">0031-6970</span>.
    </div><div class="casAbstract">Repeated daily intake of Impulsin [544-31-0] (30 mg/kg) by volunteers prevented virus infections of the respiratory tract.  The Impulsin treatment decreased the no. of episodes of fever, headache, and sore throat, while catarrhal symptoms were much less affected.  The administration of Impulsin had no effect on the mean duration of disability and fever, which suggests that the severity of the diseases was not affected.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGriLqxhy_o8frVg90H21EOLACvtfcHk0liLqrDm2K6iJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2MXhsV2nu7s%253D&md5=775758357abb648315cde2b5a104692c</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1007%2FBF00560353&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00560353%26sid%3Dliteratum%253Aachs%26aulast%3DMasek%26aufirst%3DK.%26aulast%3DPerl%25C3%25ADk%26aufirst%3DF.%26aulast%3DKl%25C3%25ADma%26aufirst%3DJ.%26aulast%3DKahlich%26aufirst%3DR.%26atitle%3DProphylactic%2520efficacy%2520of%2520N-2-hydroxyethyl%2520palmitamide%2520%2528impulsin%2529%2520in%2520acute%2520respiratory%2520tract%2520infections%26jtitle%3DEur.%2520J.%2520Clin.%2520Pharmacol.%26date%3D1974%26volume%3D7%26spage%3D415%26epage%3D419%26doi%3D10.1007%2FBF00560353" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kahlich, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klíma, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cihla, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franková, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mašek, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosický, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matousek, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruthans, J.</span></span> <span> </span><span class="NLM_article-title">Studies on prophylactic efficacy of N-2-hydroxyethyl palmitamide (Impulsin) in acute respiratory infections. Serologically controlled field trials</span>. <i>J. Hyg. Epidemiol. Microbiol. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">1979</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">11</span>– <span class="NLM_lpage">24</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=392005" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A280%3ADyaL3c%252FpsFCitQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1979&pages=11-24&author=R.+Kahlichauthor=J.+Kl%C3%ADmaauthor=F.+Cihlaauthor=V.+Frankov%C3%A1author=K.+Ma%C5%A1ekauthor=M.+Rosick%C3%BDauthor=F.+Matousekauthor=J.+Bruthans&title=Studies+on+prophylactic+efficacy+of+N-2-hydroxyethyl+palmitamide+%28Impulsin%29+in+acute+respiratory+infections.+Serologically+controlled+field+trials"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Studies on prophylactic efficacy of N-2-hydroxyethyl palmitamide (Impulsin) in acute respiratory infections. Serologically controlled field trials</span></div><div class="casAuthors">Kahlich R; Klima J; Cihla F; Frankova V; Masek K; Rosicky M; Matousek F; Bruthans J</div><div class="citationInfo"><span class="NLM_cas:title">Journal of hygiene, epidemiology, microbiology, and immunology</span>
        (<span class="NLM_cas:date">1979</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">11-24</span>
        ISSN:<span class="NLM_cas:issn">0022-1732</span>.
    </div><div class="casAbstract">The results of three serologically controlled double blind field trials in army units are presented.  The evaluation of results according to morbidity, regardless of aetiology, showed a significant reduction in acute respiratory diseases (ARD) after administration of Impulsin.  In the 1973 trial (901 volunteers), 22.7% of ARD cases were found in the Impulsin group contrary to 34.4% in the placebo group (P less than 0.0002).  The relevant values in the 1974 trial (610 volunteers) were 19.7% and 40.7% (P less than 0.002) and in the 1975 trial (353 volunteers) 10.6% and 28.8% (P less than 0.004).  The study of the immunological background in representative sets of volunteers allowed determination of the aetiology, the proportion of asymptomatic infections and possible deformation of results due to preexisting protective antibodies.  Manifestation rate (MR) expressing the proportion of sick persons out of all sensitive subjects with serologically proved infection was found useful.  This indicator is relatively independent of randomization and is more sensitive as compared to the incidence rate.  In the 1973 trial, influenza A 2 England was prevalent, the MR of infection being 15.4% in the Impulsin group and 44.9% in the placebo group (P less than 0.0002).  After elimination of persons with preinfection antibodies greater than or equal to 1:256 the corresponding values of MR were 17.6% and 46.6% (P less than 0.005), reflecting the "relatively clean effect" of Impulsin.  In the 1974 trial, where influenza B Hong-Kong was prevalent, MR was 14.3% and 57.1%, respectively (P less than 0.001).  Preinfection antibodies were negligible.  The preliminary prophylactic index of the drug seemed to be 4.3 for combined adenoviral infections (trials 1973 and 1974 taken together).  In the 1975 trial, the results of serological examination were unsatisfactory.  Antibodies vs. influenza A Port Chalmers were found in 24.5% of ARD only.  The differnce is aetiologically unclarified ARD was statistically significant.  Although displaying a significant limitation of clinical infections, the administration of Impulsin did not seem to have any influence on the formation of antibodies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQbEh2wDUuI3IvKgEt20y1XfW6udTcc2eaNdlx0QyrwWbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL3c%252FpsFCitQ%253D%253D&md5=0c35acf08419ac5f90615a25de1d73a5</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKahlich%26aufirst%3DR.%26aulast%3DKl%25C3%25ADma%26aufirst%3DJ.%26aulast%3DCihla%26aufirst%3DF.%26aulast%3DFrankov%25C3%25A1%26aufirst%3DV.%26aulast%3DMa%25C5%25A1ek%26aufirst%3DK.%26aulast%3DRosick%25C3%25BD%26aufirst%3DM.%26aulast%3DMatousek%26aufirst%3DF.%26aulast%3DBruthans%26aufirst%3DJ.%26atitle%3DStudies%2520on%2520prophylactic%2520efficacy%2520of%2520N-2-hydroxyethyl%2520palmitamide%2520%2528Impulsin%2529%2520in%2520acute%2520respiratory%2520infections.%2520Serologically%2520controlled%2520field%2520trials%26jtitle%3DJ.%2520Hyg.%2520Epidemiol.%2520Microbiol.%2520Immunol.%26date%3D1979%26volume%3D23%26spage%3D11%26epage%3D24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aloe, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leon, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levi-Montalcini, R.</span></span> <span> </span><span class="NLM_article-title">A proposed autacoid mechanism controlling mastocyte behaviour</span>. <i>Agents Actions</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">145</span>– <span class="NLM_lpage">147</span>, <span class="refDoi"> DOI: 10.1007/BF01972748</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1007%2FBF01972748" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADyaK3sXms1yrtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1993&pages=145-147&author=L.+Aloeauthor=A.+Leonauthor=R.+Levi-Montalcini&title=A+proposed+autacoid+mechanism+controlling+mastocyte+behaviour&doi=10.1007%2FBF01972748"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">A proposed autacoid mechanism controlling mastocyte behavior</span></div><div class="casAuthors">Aloe, Luigi; Leon, Alberta; Levi-Montalcini, Rita</div><div class="citationInfo"><span class="NLM_cas:title">Agents and Actions</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">Spec. Conf. Issue</span>),
    <span class="NLM_cas:pages">C145-C147</span>CODEN:
                <span class="NLM_cas:coden">AGACBH</span>;
        ISSN:<span class="NLM_cas:issn">0065-4299</span>.
    </div><div class="casAbstract">Evidence is provided here supporting the existence of a novel autacoid mechanism neg. modulating mast cell behavior in response to noxious stimuli in vivo; hence, the denomination "autacoid local inflammation antagonism" (ALIA).  In particular, as lipid amides of the N-acylethanolamine type have been reported to accumulate in tissues in degenerative inflammatory conditions, the authors examd. whether these N-acylated lipids could exert regulatory effects on mast cell activation in vivo.  The results reported show that both long- and short-chain N-acylethanolamines, when systemically administered, are effective in reducing mast cell degranulation induced by local injection of substance P in the ear pinna of developing rats.  These and other data suggest that the endogenous prodn. of N-acylethanolamines may constitute a local autocrine/paracrine response for the neg. feedback control of mast cell responses to various activating signals.  Such a process may be of physico-pathol. relevance in the regulation of functional neuro-immune-mast cell interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGov0bUjp51F-LVg90H21EOLACvtfcHk0liLqrDm2K6iJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXms1yrtbc%253D&md5=0e1d3d3032d382ae5ca5c8e848e6bfd6</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1007%2FBF01972748&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF01972748%26sid%3Dliteratum%253Aachs%26aulast%3DAloe%26aufirst%3DL.%26aulast%3DLeon%26aufirst%3DA.%26aulast%3DLevi-Montalcini%26aufirst%3DR.%26atitle%3DA%2520proposed%2520autacoid%2520mechanism%2520controlling%2520mastocyte%2520behaviour%26jtitle%3DAgents%2520Actions%26date%3D1993%26volume%3D39%26spage%3D145%26epage%3D147%26doi%3D10.1007%2FBF01972748" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mazzari, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canella, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petrelli, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marcolongo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leon, A.</span></span> <span> </span><span class="NLM_article-title">N-(2-hydroxyethyl)hexadecanamide is orally active in reducing edema formation and inflammatory hyperalgesia by down-modulating mast cell activation</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>300</i></span>,  <span class="NLM_fpage">227</span>– <span class="NLM_lpage">236</span>, <span class="refDoi"> DOI: 10.1016/0014-2999(96)00015-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1016%2F0014-2999%2896%2900015-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=8739213" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADyaK28XjtFaqtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=300&publication_year=1996&pages=227-236&author=S.+Mazzariauthor=R.+Canellaauthor=L.+Petrelliauthor=G.+Marcolongoauthor=A.+Leon&title=N-%282-hydroxyethyl%29hexadecanamide+is+orally+active+in+reducing+edema+formation+and+inflammatory+hyperalgesia+by+down-modulating+mast+cell+activation&doi=10.1016%2F0014-2999%2896%2900015-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">N-(2-Hydroxyethyl)hexadecanamide is orally active in reducing edema formation and inflammatory hyperalgesia by down-modulating mast cell activation</span></div><div class="casAuthors">Mazzari, Silvio; Canella, Roberto; Petrelli, Lucia; Marcolongo, Gabriele; Leon, Alberta</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">300</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">227-236</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Mast cells play a key role in inflammatory reactions triggered by tissue injury or immune perturbations.  Little is known about endogenous mols. and mechanisms capable of modulating inappropriate mast cell activity.  N-(2-Hydroxyethyl)hexadecanamide (palmitoylethanolamide), found in peripheral tissues, has been proposed to act as a local autacoid capable of neg. regulating mast cell activation and inflammation - hence the acronym Autacoid Local Inflammation Antagonism (ALIA).  Recently, N-(2-hydroxyethyl)hexadecanamide (LG 2110/1) has been reported to down-modulate mast cell activation in vitro by behaving as an agonist at the peripheral cannabinoid CB2 receptor.  Here, we have characterized and functionally correlated the anti-inflammatory actions of LG 2110/1 with its ability to control mast cell activation, when given orally in a battery of rodent models of inflammation.  LG 2110/1 diminished, in a dose-dependent and correlated manner, the no. of degranulated mast cells and plasma extravasation induced by substance P injection in the mouse ear pinna.  In addn., LG 2110/1 reduced dose dependently plasma extravasation induced by passive cutaneous anaphylaxis reaction.  In adult rats LG 2110/1 decreased, in a dose-dependent manner, carrageenan-induced hindpaw edema and hyperalgesia, but not phospholipase A2-induced hindpaw edema.  Further, anti-edema effects were obsd. when utilizing dextran and formalin, known to also cause mast cell activation.  Locally administered LG 2110/1 was likewise effective in minimizing dextran-induced hind paw edema.  In contrast, equiv. amts. of palmitic acid plus ethanolamine were ineffective against plasma extravasation provoked by substance P. LG 2110/1 did not decrease plasma extravasation induced by the substance P fragment, substance P-(6-11), known to be inactive on mast cells.  These results indicate that orally administered N-(2-hydroxyethyl)hexadecanamide is effective in: (a) directly down-modulating mast cell activation in vivo; (b) suppressing pathol. consequences initiated by mast cell activation independently of the activating stimuli; (c) exerting an anti-inflammatory action distinguishable from that of classical steroidal and non-steroidal anti-inflammatory agents.  These findings raise the possibility that N-(2-hydroxyethyl)hexadecanamide and related satd. N-acylamides ('ALIAmides') represent novel therapeutic agents useful in the management of inflammatory disease conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowutxAAnhmebVg90H21EOLACvtfcHk0ljY619OTi0AiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XjtFaqtLw%253D&md5=7d89119c70577cf2f80aaea93e43e439</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2F0014-2999%2896%2900015-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-2999%252896%252900015-5%26sid%3Dliteratum%253Aachs%26aulast%3DMazzari%26aufirst%3DS.%26aulast%3DCanella%26aufirst%3DR.%26aulast%3DPetrelli%26aufirst%3DL.%26aulast%3DMarcolongo%26aufirst%3DG.%26aulast%3DLeon%26aufirst%3DA.%26atitle%3DN-%25282-hydroxyethyl%2529hexadecanamide%2520is%2520orally%2520active%2520in%2520reducing%2520edema%2520formation%2520and%2520inflammatory%2520hyperalgesia%2520by%2520down-modulating%2520mast%2520cell%2520activation%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1996%26volume%3D300%26spage%3D227%26epage%3D236%26doi%3D10.1016%2F0014-2999%2896%2900015-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Berdyshev, E. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boichot, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Germain, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allain, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anger, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lagente, V.</span></span> <span> </span><span class="NLM_article-title">Influence of fatty acid ethanolamides and Δ<sup>9</sup>-tetrahydrocannabinol on cytokine and arachidonate release by mononuclear cells</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>330</i></span>,  <span class="NLM_fpage">231</span>– <span class="NLM_lpage">240</span>, <span class="refDoi"> DOI: 10.1016/S0014-2999(97)01007-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1016%2FS0014-2999%2897%2901007-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=9253958" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADyaK2sXkt1Shtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=330&publication_year=1997&pages=231-240&author=E.+V.+Berdyshevauthor=E.+Boichotauthor=N.+Germainauthor=N.+Allainauthor=J.+P.+Angerauthor=V.+Lagente&title=Influence+of+fatty+acid+ethanolamides+and+%CE%949-tetrahydrocannabinol+on+cytokine+and+arachidonate+release+by+mononuclear+cells&doi=10.1016%2FS0014-2999%2897%2901007-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Influence of fatty acid ethanolamides and Δ9-tetrahydrocannabinol on cytokine and arachidonate release by mononuclear cells</span></div><div class="casAuthors">Berdyshev, Evguenii V.; Boichot, Elisabeth; Germain, Noeella; Allain, Nathalie; Anger, Jean-Pierre; Lagente, Vincent</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">330</span>
        (<span class="NLM_cas:issue">2/3</span>),
    <span class="NLM_cas:pages">231-240</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The effects of arachidonic acid ethanolamide (anandamide), palmitoylethanolamide, and Δ9-tetrahydrocannabinol on the prodn. of tumor necrosis factor-α (TNF-α), interleukin-4, interleukin-6, interleukin-8, interleukin-10, interferon-γ, p55 and p75 TNF-α sol. receptors by stimulated human peripheral blood mononuclear cells as well as [3H]arachidonic acid release by non-stimulated and N-formyl-Met-Leu-Phe (fMLP)-stimulated human monocytes were investigated.  Anandamide was shown to diminish interleukin-6 and interleukin-8 prodn. at low nanomolar concns. (3-30 nM) but inhibited the prodn. of TNF-α, interferon-γ, interleukin-4 and p75 TNF-α sol. receptors at higher concns. (0.3-3 μM).  Palmitoylethanolamide inhibited interleukin-4, interleukin-6, interleukin-8 synthesis and the prodn. of p75 TNF-α sol. receptors at concns. similar to those of anandamide but failed to influence TNF-α and interferon-γ prodn.  The effect of both compds. on interleukin-6 and interleukin-8 prodn. disappeared with an increase in the concn. used.  Neither anandamide nor palmitoylethanolamide influenced interleukin-10 synthesis. Δ9-Tetrahydrocannabinol exerted a biphasic action on pro-inflammatory cytokine prodn.  TNF-α, interleukin-6 and interleukin-8 synthesis was maximally inhibited by 3 nM Δ9-tetrahydrocannabinol but stimulated by 3 μM Δ9-tetrahydrocannabinol, as was interleukin-8 and interferon-γ synthesis.  The level of interleukin-4, interleukin-10 and p75 TNF-α sol. receptors was diminished by 3 μM Δ9-tetrahydrocannabinol. [3H]Arachidonate release was stimulated only by high Δ9-tetrahydrocannabinol and anandamide concns. (30 μM).  These results suggest that the inhibitory properties of anandamide, palmitoylethanolamide and Δ9-tetrahydrocannabinol are detd. by the activation of the peripheral-type cannabinoid receptors, and that various endogenous fatty acid ethanolamides may participate in the regulation of the immune response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_UZuEJzA2brVg90H21EOLACvtfcHk0ljY619OTi0AiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXkt1Shtrc%253D&md5=bc34a1f528f0ff967bbac0865b7c640d</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2FS0014-2999%2897%2901007-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-2999%252897%252901007-8%26sid%3Dliteratum%253Aachs%26aulast%3DBerdyshev%26aufirst%3DE.%2BV.%26aulast%3DBoichot%26aufirst%3DE.%26aulast%3DGermain%26aufirst%3DN.%26aulast%3DAllain%26aufirst%3DN.%26aulast%3DAnger%26aufirst%3DJ.%2BP.%26aulast%3DLagente%26aufirst%3DV.%26atitle%3DInfluence%2520of%2520fatty%2520acid%2520ethanolamides%2520and%2520%25CE%25949-tetrahydrocannabinol%2520on%2520cytokine%2520and%2520arachidonate%2520release%2520by%2520mononuclear%2520cells%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1997%26volume%3D330%26spage%3D231%26epage%3D240%26doi%3D10.1016%2FS0014-2999%2897%2901007-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ross, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brockie, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pertwee, R. G.</span></span> <span> </span><span class="NLM_article-title">Inhibition of nitric oxide production in RAW264.7 macrophages by cannabinoids and palmitoylethanolamide</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>401</i></span>,  <span class="NLM_fpage">121</span>– <span class="NLM_lpage">130</span>, <span class="refDoi"> DOI: 10.1016/S0014-2999(00)00437-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1016%2FS0014-2999%2800%2900437-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10924916" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BD3cXlt1Kntrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=401&publication_year=2000&pages=121-130&author=R.+A.+Rossauthor=H.+C.+Brockieauthor=R.+G.+Pertwee&title=Inhibition+of+nitric+oxide+production+in+RAW264.7+macrophages+by+cannabinoids+and+palmitoylethanolamide&doi=10.1016%2FS0014-2999%2800%2900437-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of nitric oxide production in RAW264.7 macrophages by cannabinoids and palmitoylethanolamide</span></div><div class="casAuthors">Ross, R. A.; Brockie, H. C.; Pertwee, R. G.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">401</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">121-130</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">We have investigated the inhibition of lipopolysaccharide-stimulated nitric oxide prodn. in RAW264.7 macrophages by the cannabinoids and the putative cannabinoid CB2-like receptor ligand, palmitoylethanolamide.  (R)-(+)-[2,3-dihydro-5-methyl-3-(4-morpholinylmethyl)pyrrolo-[1,2,3-de]-1,4-benzoxazin-6-yl]-1-naphthalenylmethanone mesylate ((+)-WIN55212) and, to a lesser extent (-)-cis-3-[2-hydroxy-4-(1,1-dimethylheptyl)phenyl]-trans-4-(3-hydroxy-propyl)cyclohexan-1-ol (CP55940), significantly inhibited lipopolysaccharide stimulated nitric oxide prodn.  The level of inhibition was dependent on the concn. of lipopolysaccharide used to induce nitric oxide prodn.  Palmitoylethanolamide significantly inhibited nitric oxide prodn. induced by lipopolysaccharide.  The inhibition of nitric oxide prodn. by (+)-WIN55212 but not palmitoylethanolamide was significantly attenuated in the presence of the cannabinoid CB2 receptor antagonist, N-[(1S)-endo-1,3,3-trimethyl bicyclo [2.2.1] heptan-2-yl]-5-(4-chloro-3-methylphenyl)-1-(4-methylbenzyl)-pyrazole-3-carboxamide (SR144528).  (+)-WIN55212 produced a pertussis toxin-sensitive parallel rightward shift in the log concn.-response curve for lipopolysaccharide, causing a fivefold increase in the EC50 value for lipopolysaccharide with no change in the Emax value.  (-)-WIN55212 had no effect on the log concn.-response curve for lipopolysaccharide.  Palmitoylethanolamide did not produce a rightward shift in the lipopolysaccharide concn.-response curve.  However, it did produce a pertussis toxin-insensitive redn. in the Emax value.  The results suggest that the inhibition of lipopolysaccharide mediated nitric oxide release by (+)-WIN55212 in murine macrophages is mediated by cannabinoid CB2 receptors.  In contrast, the inhibition by palmitoylethanolamide does not appear to be mediated by cannabinoid receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqX1RWs6xTlCbVg90H21EOLACvtfcHk0ljY619OTi0AiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXlt1Kntrg%253D&md5=4c37657f6218f6770b1798d6a8290f72</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2FS0014-2999%2800%2900437-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-2999%252800%252900437-4%26sid%3Dliteratum%253Aachs%26aulast%3DRoss%26aufirst%3DR.%2BA.%26aulast%3DBrockie%26aufirst%3DH.%2BC.%26aulast%3DPertwee%26aufirst%3DR.%2BG.%26atitle%3DInhibition%2520of%2520nitric%2520oxide%2520production%2520in%2520RAW264.7%2520macrophages%2520by%2520cannabinoids%2520and%2520palmitoylethanolamide%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2000%26volume%3D401%26spage%3D121%26epage%3D130%26doi%3D10.1016%2FS0014-2999%2800%2900437-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Farquhar-Smith, W. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rice, A. S.</span></span> <span> </span><span class="NLM_article-title">A novel neuroimmune mechanism in cannabinoid-mediated attenuation of nerve growth factor-induced hyperalgesia</span>. <i>Anesthesiology</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>99</i></span>,  <span class="NLM_fpage">1391</span>– <span class="NLM_lpage">1401</span>, <span class="refDoi"> DOI: 10.1097/00000542-200312000-00024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1097%2F00000542-200312000-00024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=14639155" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A280%3ADC%252BD3srls1Crug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2003&pages=1391-1401&author=W.+P.+Farquhar-Smithauthor=A.+S.+Rice&title=A+novel+neuroimmune+mechanism+in+cannabinoid-mediated+attenuation+of+nerve+growth+factor-induced+hyperalgesia&doi=10.1097%2F00000542-200312000-00024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">A novel neuroimmune mechanism in cannabinoid-mediated attenuation of nerve growth factor-induced hyperalgesia</span></div><div class="casAuthors">Farquhar-Smith W Paul; Rice Andrew S C</div><div class="citationInfo"><span class="NLM_cas:title">Anesthesiology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1391-401</span>
        ISSN:<span class="NLM_cas:issn">0003-3022</span>.
    </div><div class="casAbstract">BACKGROUND:  Nerve growth factor (NGF) is central to processes involved in an inflammatory hyperalgesia.  Administration of exogenous NGF induces a hyperalgesia that is dependent on local neutrophil influx.  The effects of administration of the cannabinoid anandamide and the cannabimimetic palmitoylethanolamide on an NGF-induced hyperalgesia and neutrophil accumulation were examined in this study.  METHODS:  Baseline hind limb withdrawal latencies to a noxious heat stimulus were recorded before intraplantar administration of NGF (1 microg in 0.05 ml) to the hind paw of 75 male Wistar rats.  Anandamide or palmitoylethanolamide (a substance that has cannabinoid-like actions but little affinity for cannabinoid receptors) at doses of 10 and 25 mg/kg were given (intraperitoneally) immediately after NGF.  CB1 (SR141716A) and CB2 (SR144528) receptor antagonists were coadministered with the higher dose of cannabinoids.  Withdrawal latencies were expressed as difference from baseline.  Seventy rats received intraplantar NGF and intraperitoneal treatments.  Neutrophil accumulation in the injected paw was assessed using a myeloperoxidase assay.  RESULTS:  Administration of NGF reduced latencies consistent with hyperalgesia.  Anandamide and palmitoylethanolamide significantly reduced this hyperalgesia.  The action of anandamide was CB1 receptor-mediated.  SR144528 abrogated the action of palmitoylethanolamide.  NGF also provoked neutrophil accumulation in the injected paw, denoted by an increase in myeloperoxidase.  Palmitoylethanolamide significantly reduced neutrophil accumulation by an SR144528-sensitive action, whereas anandamide was without effect.  CONCLUSIONS:  NGF induced a thermal hyperalgesia that was attenuated by anandamide and palmitoylethanolamide.  Only palmitoylethanolamide reduced neutrophil influx.  Thus, cannabinoids show a neuronal CB1 receptor-mediated antihyperalgesic action and a separate inhibition of a proinflammatory neuroimmune process.  Such a mechanism suggests a therapeutic site of analgesic action separable from central side effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT8e1UQPwC1_bP3FVUi_gf8fW6udTcc2eZd3MPIIcMPzbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3srls1Crug%253D%253D&md5=b8f811a899b7bcc807b270f50d30cd83</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1097%2F00000542-200312000-00024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00000542-200312000-00024%26sid%3Dliteratum%253Aachs%26aulast%3DFarquhar-Smith%26aufirst%3DW.%2BP.%26aulast%3DRice%26aufirst%3DA.%2BS.%26atitle%3DA%2520novel%2520neuroimmune%2520mechanism%2520in%2520cannabinoid-mediated%2520attenuation%2520of%2520nerve%2520growth%2520factor-induced%2520hyperalgesia%26jtitle%3DAnesthesiology%26date%3D2003%26volume%3D99%26spage%3D1391%26epage%3D1401%26doi%3D10.1097%2F00000542-200312000-00024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Skaper, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buriani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dal Toso, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petrelli, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romanello, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Facci, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leon, A.</span></span> <span> </span><span class="NLM_article-title">The ALIAmide palmitoylethanolamide and cannabinoids, but not anandamide, are protective in a delayed postglutamate paradigm of excitotoxic death in cerebellar granule neurons</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>93</i></span>,  <span class="NLM_fpage">3984</span>– <span class="NLM_lpage">3989</span>, <span class="refDoi"> DOI: 10.1073/pnas.93.9.3984</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1073%2Fpnas.93.9.3984" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=8633002" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADyaK28XivVKrtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=1996&pages=3984-3989&author=S.+D.+Skaperauthor=A.+Burianiauthor=R.+Dal+Tosoauthor=L.+Petrelliauthor=S.+Romanelloauthor=L.+Facciauthor=A.+Leon&title=The+ALIAmide+palmitoylethanolamide+and+cannabinoids%2C+but+not+anandamide%2C+are+protective+in+a+delayed+postglutamate+paradigm+of+excitotoxic+death+in+cerebellar+granule+neurons&doi=10.1073%2Fpnas.93.9.3984"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">The ALIAmide palmitoylethanolamide and cannabinoids, but not anandamide, are protective in a delayed postglutamate paradigm of excitotoxic death in cerebellar granule neurons</span></div><div class="casAuthors">Skaper, S. D.; Buriani, A.; Toso, R. Dal; Petrelli, L.; Romanello, S.; Facci, L.; Leon, A.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">93</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3984-3989</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The amino acid L-glutamate is a neurotransmitter that mediates fast neuronal excitation in a majority of synapses in the central nervous system.  Glutamate stimulates both N-methyl-D-aspartate (NMDA) and non-NMDA receptors.  While activation of NMDA receptors has been implicated in a variety of neurophysiol. processes, excessive NMDA receptor stimulation (excitotoxicity) is thought to be primarily responsible for neuronal injury in a wide variety of acute neurol. disorders including hypoxia-ischemia, seizures, and trauma.  Very little is known about endogenous mols. and mechanisms capable of modulating excitotoxic neuronal death.  Satd. N-acylethanolamides like palmitoylethanolamide accumulate in ischemic tissues and are synthesized by neurons upon excitatory amino acid receptor activation.  Here the authors report that palmitoylethanolamide, but not the cognate N-acylamide anandamide (the ethanolamide of arachidonic acid), protects cultured mouse cerebellar granule cells against glutamate toxicity in a delayed postagonist paradigm.  Palmitoylethanolamide reduced this injury in a concn.-dependent manner and was maximally effective when added 15-min postglutamate.  Cannabinoids, which like palmitoylethanolamide are functionally active at the peripheral cannabinoid receptor CB2 on mast cells, also prevented neuron loss in this delayed postglutamate model.  Furthermore, the neuroprotective effects of palmitoylethanolamide, as well as that of the active cannabinoids, were efficiently antagonized by the candidate central cannabinoid receptor (CB1) agonist anandamide.  Analogous pharmacol. behaviors have been obsd. for palmitoylethanolamide (ALIAmides) in downmodulating mast cell activation.  Cerebellar granule cells expressed mRNA for CB1 and CB2 by in situ hybridization, while two cannabinoid binding sites were detected in cerebellar membranes.  The results suggest that (i) non-CB1 cannabinoid receptors control, upon agonist binding, the downstream consequences of an excitotoxic stimulus; (ii) palmitoylethanolamide, unlike anandamide, behaves as an endogenous agonist for CB2-like receptors on granule cells; and (iii) activation of such receptors may serve to downmodulate deleterious cellular processes following pathol. events or noxious stimuli in both the nervous and immune systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdi_p_hdKA6bVg90H21EOLACvtfcHk0liCW-nNCCuzzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XivVKrtbw%253D&md5=6dc2c77bba12ec7a2fc9d4c18ec202a4</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1073%2Fpnas.93.9.3984&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.93.9.3984%26sid%3Dliteratum%253Aachs%26aulast%3DSkaper%26aufirst%3DS.%2BD.%26aulast%3DBuriani%26aufirst%3DA.%26aulast%3DDal%2BToso%26aufirst%3DR.%26aulast%3DPetrelli%26aufirst%3DL.%26aulast%3DRomanello%26aufirst%3DS.%26aulast%3DFacci%26aufirst%3DL.%26aulast%3DLeon%26aufirst%3DA.%26atitle%3DThe%2520ALIAmide%2520palmitoylethanolamide%2520and%2520cannabinoids%252C%2520but%2520not%2520anandamide%252C%2520are%2520protective%2520in%2520a%2520delayed%2520postglutamate%2520paradigm%2520of%2520excitotoxic%2520death%2520in%2520cerebellar%2520granule%2520neurons%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1996%26volume%3D93%26spage%3D3984%26epage%3D3989%26doi%3D10.1073%2Fpnas.93.9.3984" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Calignano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La Rana, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giuffrida, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piomelli, D.</span></span> <span> </span><span class="NLM_article-title">Control of pain initiation by endogenous cannabinoids</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>394</i></span>,  <span class="NLM_fpage">277</span>– <span class="NLM_lpage">281</span>, <span class="refDoi"> DOI: 10.1038/28393</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1038%2F28393" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=9685157" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADyaK1cXkvVKjt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=394&publication_year=1998&pages=277-281&author=A.+Calignanoauthor=G.+La+Ranaauthor=A.+Giuffridaauthor=D.+Piomelli&title=Control+of+pain+initiation+by+endogenous+cannabinoids&doi=10.1038%2F28393"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Control of pain initiation by endogenous cannabinoids</span></div><div class="casAuthors">Calignano, Antonio; La Rana, Giovanna; Giuffrida, Andrea; Piomelli, Daniele</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">394</span>
        (<span class="NLM_cas:issue">6690</span>),
    <span class="NLM_cas:pages">277-281</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">The potent analgesic effects of cannabis-like drugs and the presence of CB1-type cannabinoid receptors in pain-processing areas of the brain and spinal cord indicate that endogenous cannabinoids such as anandamide may contribute to the control of pain transmission within the central nervous system (CNS).  Here the authors show that anandamide attenuates the pain behavior produced by chem. damage to cutaneous tissue by interacting with CB1-like cannabinoid receptors located outside the CNS.  Palmitylethanolamide (PEA), which is released together with anandamide from a common phospholipid precursor, exerts a similar effect by activating peripheral CB2-like receptors.  When administered together, the two compds. at synergistically reducing pain responses 100-fold more potently than does each compd. alone.  Gas-chromatog./mass-spectrometry measurements indicate that the levels of anandamide and PEA in the skin are enough to cause a tonic activation of local cannabinoid receptors.  In agreement with this possibility, the CB1 antagonist SR141716A and the CB2 antagonist SR144528 prolong and enhance the pain behavior produced by tissue damage.  These results indicate that peripheral CB1-like and CB2-like receptors participate in the intrinsic control of pain initiation and that locally generated anandamide and PEA may mediate this effect.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpKwHMI3BI9LVg90H21EOLACvtfcHk0liCW-nNCCuzzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXkvVKjt7w%253D&md5=811026d275d0cba5c01567bdebe16ec8</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1038%2F28393&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F28393%26sid%3Dliteratum%253Aachs%26aulast%3DCalignano%26aufirst%3DA.%26aulast%3DLa%2BRana%26aufirst%3DG.%26aulast%3DGiuffrida%26aufirst%3DA.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DControl%2520of%2520pain%2520initiation%2520by%2520endogenous%2520cannabinoids%26jtitle%3DNature%26date%3D1998%26volume%3D394%26spage%3D277%26epage%3D281%26doi%3D10.1038%2F28393" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Calignano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La Rana, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piomelli, D.</span></span> <span> </span><span class="NLM_article-title">Antinociceptive activity of the endogenous fatty acid amide, palmitylethanolamide</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>419</i></span>,  <span class="NLM_fpage">191</span>– <span class="NLM_lpage">198</span>, <span class="refDoi"> DOI: 10.1016/S0014-2999(01)00988-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1016%2FS0014-2999%2801%2900988-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=11426841" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BD3MXksFCkt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=419&publication_year=2001&pages=191-198&author=A.+Calignanoauthor=G.+La+Ranaauthor=D.+Piomelli&title=Antinociceptive+activity+of+the+endogenous+fatty+acid+amide%2C+palmitylethanolamide&doi=10.1016%2FS0014-2999%2801%2900988-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Antinociceptive activity of the endogenous fatty acid amide, palmitylethanolamide</span></div><div class="casAuthors">Calignano, Antonio; La Rana, Giovanna; Piomelli, Daniele</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">419</span>
        (<span class="NLM_cas:issue">2/3</span>),
    <span class="NLM_cas:pages">191-198</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">The endogenous fatty acid ethanolamide, palmitylethanolamide, alleviated, in a dose-dependent manner, pain behaviors elicited in mice by injections of formalin (5%, intraplantar), acetic acid (0.6%, 0.5 mL per animal, i.p., i.p.), kaolin (2.5 mg per animal, i.p.), and magnesium sulfate (120 mg per kg, i.p.).  The antinociceptive effects of palmitylethanolamide were prevented by the cannabinoid CB2 receptor antagonist SR144528 [N-([1s]-endo-1.3.3-trimethylbicyclo[2.3.1]heptan-2-yl)-5-(4-chloro-3-methylphenyl)-1-(4-methylbenzyl)-pyrazole-3-carboxamide], not by the cannabinoid CB1 receptor antagonist SR141716A [N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide · HCl].  By contrast, palmitylethanolamide had no effect on capsaicin-evoked pain behavior or thermal nociception.  The endogenous cannabinoid, anandamide (arachidonylethanolamide), alleviated nociception in all tests (formalin, acetic acid, kaolin, magnesium sulfate, capsaicin and hot plate).  These effects were prevented by the cannabinoid CB1 receptor antagonist SR141716A, not the cannabinoid CB2 receptor antagonist SR141716A.  Addnl. fatty acid ethanolamides (oleylethanolamide, myristylethanolamide, palmitoleylethanolamide, palmitelaidylethanolamide) had little or no effect on formalin-evoked pain behavior, and were not investigated in other pain models.  These results support the hypothesis that endogenous palmitylethanolamide participates in the intrinsic control of pain initiation.  They also suggest that the putative receptor site activated by palmitylethanolamide may provide a novel target for peripherally acting analgesic drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqn_q63Lj2cLrVg90H21EOLACvtfcHk0liCW-nNCCuzzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXksFCkt78%253D&md5=cff02a881cea2e84d5ae7812ea7cffbc</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2FS0014-2999%2801%2900988-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-2999%252801%252900988-8%26sid%3Dliteratum%253Aachs%26aulast%3DCalignano%26aufirst%3DA.%26aulast%3DLa%2BRana%26aufirst%3DG.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DAntinociceptive%2520activity%2520of%2520the%2520endogenous%2520fatty%2520acid%2520amide%252C%2520palmitylethanolamide%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2001%26volume%3D419%26spage%3D191%26epage%3D198%26doi%3D10.1016%2FS0014-2999%2801%2900988-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pontis, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ribeiro, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sasso, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piomelli, D.</span></span> <span> </span><span class="NLM_article-title">Macrophage-derived lipid agonists of PPAR-α as intrinsic controllers of inflammation</span>. <i>Crit. Rev. Biochem. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">7</span>– <span class="NLM_lpage">14</span>, <span class="refDoi"> DOI: 10.3109/10409238.2015.1092944</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.3109%2F10409238.2015.1092944" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=26585314" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFGjur%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2016&pages=7-14&author=S.+Pontisauthor=A.+Ribeiroauthor=O.+Sassoauthor=D.+Piomelli&title=Macrophage-derived+lipid+agonists+of+PPAR-%CE%B1+as+intrinsic+controllers+of+inflammation&doi=10.3109%2F10409238.2015.1092944"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Macrophage-derived lipid agonists of PPAR-α as intrinsic controllers of inflammation</span></div><div class="casAuthors">Pontis, Silvia; Ribeiro, Alison; Sasso, Oscar; Piomelli, Daniele</div><div class="citationInfo"><span class="NLM_cas:title">Critical Reviews in Biochemistry and Molecular Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">7-14</span>CODEN:
                <span class="NLM_cas:coden">CRBBEJ</span>;
        ISSN:<span class="NLM_cas:issn">1040-9238</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Macrophages are multi-faceted phagocytic effector cells that derive from circulating monocytes and undergo differentiation in target tissues to regulate key aspects of the inflammatory process.  Macrophages produce and degrade a variety of lipid mediators that stimulate or suppress pain and inflammation.  Among the analgesic and anti-inflammatory lipids released from these cells are the fatty acid ethanolamides (FAEs), which produce their effects by engaging nuclear peroxisome proliferator activated receptor-α (PPAR-α).  Two members of this lipid family, palmitoylethanolamide (PEA) and oleoylethanolamide (OEA), have recently emerged as important intrinsic regulators of nociception and inflammation.  These substances are released from the membrane precursor, N-acylphosphatidylethanolamine (NAPE), by the action of a NAPE-specific phospholipase D (NAPE-PLD), and in macrophage are primarily deactivated by the lysosomal cysteine amidase, N-acylethanolamine acid amidase (NAAA).  NAPE-PLD and NAAA regulate FAE levels, exerting a tight control over the ability of these lipid mediators to recruit PPAR-α and attenuate the inflammatory response.  This review summarizes recent findings on the contribution of the FAE-PPAR-α signaling complex in inflammation, and on NAAA inhibition as a novel mechanistic approach to treat chronic inflammatory disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDzzvMKDz_x7Vg90H21EOLACvtfcHk0lgD32F2h98ydw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFGjur%252FN&md5=32cf5a133683714545cb29a2ade73758</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.3109%2F10409238.2015.1092944&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F10409238.2015.1092944%26sid%3Dliteratum%253Aachs%26aulast%3DPontis%26aufirst%3DS.%26aulast%3DRibeiro%26aufirst%3DA.%26aulast%3DSasso%26aufirst%3DO.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DMacrophage-derived%2520lipid%2520agonists%2520of%2520PPAR-%25CE%25B1%2520as%2520intrinsic%2520controllers%2520of%2520inflammation%26jtitle%3DCrit.%2520Rev.%2520Biochem.%2520Mol.%2520Biol.%26date%3D2016%26volume%3D51%26spage%3D7%26epage%3D14%26doi%3D10.3109%2F10409238.2015.1092944" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eberlein, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eicke, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reinhardt, H. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ring, J.</span></span> <span> </span><span class="NLM_article-title">Adjuvant treatment of atopic eczema: assessment of an emollient containing N-palmitoylethanolamine (ATOPA study)</span>. <i>J. Eur. Acad. Dermatol. Venereol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">73</span>– <span class="NLM_lpage">82</span>, <span class="refDoi"> DOI: 10.1111/j.1468-3083.2007.02351.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1111%2Fj.1468-3083.2007.02351.x" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2007&pages=73-82&author=B.+Eberleinauthor=C.+Eickeauthor=H.+W.+Reinhardtauthor=J.+Ring&title=Adjuvant+treatment+of+atopic+eczema%3A+assessment+of+an+emollient+containing+N-palmitoylethanolamine+%28ATOPA+study%29&doi=10.1111%2Fj.1468-3083.2007.02351.x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1111%2Fj.1468-3083.2007.02351.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1468-3083.2007.02351.x%26sid%3Dliteratum%253Aachs%26aulast%3DEberlein%26aufirst%3DB.%26aulast%3DEicke%26aufirst%3DC.%26aulast%3DReinhardt%26aufirst%3DH.%2BW.%26aulast%3DRing%26aufirst%3DJ.%26atitle%3DAdjuvant%2520treatment%2520of%2520atopic%2520eczema%253A%2520assessment%2520of%2520an%2520emollient%2520containing%2520N-palmitoylethanolamine%2520%2528ATOPA%2520study%2529%26jtitle%3DJ.%2520Eur.%2520Acad.%2520Dermatol.%2520Venereol.%26date%3D2007%26volume%3D22%26spage%3D73%26epage%3D82%26doi%3D10.1111%2Fj.1468-3083.2007.02351.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cremon, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stanghellini, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbaro, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cogliandro, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bellacosa, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santos, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vicario, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pigrau, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alonso Cotoner, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lobo, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Azpiroz, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruley des
Varannes, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neunlist, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeFilippis, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iuvone, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petrosino, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Marzo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbara, G.</span></span> <span> </span><span class="NLM_article-title">Randomised clinical trial: the analgesic properties of dietary supplementation with palmitoylethanolamide and polydatin in irritable bowel syndrome</span>. <i>Aliment. Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">909</span>– <span class="NLM_lpage">922</span>, <span class="refDoi"> DOI: 10.1111/apt.13958</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1111%2Fapt.13958" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=28164346" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjs1Sqtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2017&pages=909-922&author=C.+Cremonauthor=V.+Stanghelliniauthor=M.+R.+Barbaroauthor=R.+F.+Cogliandroauthor=L.+Bellacosaauthor=J.+Santosauthor=M.+Vicarioauthor=M.+Pigrauauthor=C.+Alonso+Cotonerauthor=B.+Loboauthor=F.+Azpirozauthor=S.+Bruley+des%0AVarannesauthor=M.+Neunlistauthor=D.+DeFilippisauthor=T.+Iuvoneauthor=S.+Petrosinoauthor=V.+Di+Marzoauthor=G.+Barbara&title=Randomised+clinical+trial%3A+the+analgesic+properties+of+dietary+supplementation+with+palmitoylethanolamide+and+polydatin+in+irritable+bowel+syndrome&doi=10.1111%2Fapt.13958"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Randomised clinical trial: the analgesic properties of dietary supplementation with palmitoylethanolamide and polydatin in irritable bowel syndrome</span></div><div class="casAuthors">Cremon, C.; Stanghellini, V.; Barbaro, M. R.; Cogliandro, R. F.; Bellacosa, L.; Santos, J.; Vicario, M.; Pigrau, M.; Alonso Cotoner, C.; Lobo, B.; Azpiroz, F.; Bruley des Varannes, S.; Neunlist, M.; De Filippis, D.; Iuvone, T.; Petrosino, S.; Di Marzo, V.; Barbara, G.</div><div class="citationInfo"><span class="NLM_cas:title">Alimentary Pharmacology and Therapeutics</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">909-922</span>CODEN:
                <span class="NLM_cas:coden">APTHEN</span>;
        ISSN:<span class="NLM_cas:issn">0269-2813</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Summary: Background : Intestinal immune activation is involved in irritable bowel syndrome (IBS) pathophysiol.  While most dietary approaches in IBS involve food avoidance, there are fewer indications on food supplementation.  Palmithoylethanolamide, structurally related to the endocannabinoid anandamide, and polydatin are dietary compds. which act synergistically to reduce mast cell activation.  Aim: To assess the effect on mast cell count and the efficacy of palmithoylethanolamide/polydatin in patients with IBS.  Methods: We conducted a pilot, 12-wk, randomized, double-blind, placebo-controlled, multicenter study assessing the effect of palmithoylethanolamide/polydatin 200 mg/20 mg or placebo b.d. on low-grade immune activation, endocannabinoid system and symptoms in IBS patients.  Biopsy samples, obtained at screening visit and at the end of the study, were analyzed by immunohistochem., enzyme-linked immunoassay, liq. chromatog. and Western blot.  Results : A total of 54 patients with IBS and 12 healthy controls were enrolled from five European centers.  Compared with controls, IBS patients showed higher mucosal mast cell counts (3.2 ± 1.3 vs. 5.3 ± 2.7%, P = 0.013), reduced fatty acid amide oleoylethanolamide (12.7 ± 9.8 vs. 45.8 ± 55.6 pmol/mg, P = 0.002) and increased expression of cannabinoid receptor 2 (0.7 ± 0.1 vs. 1.0 ± 0.8, P = 0.012).  The treatment did not significantly modify IBS biol. profile, including mast cell count.  Compared with placebo, palmithoylethanolamide/polydatin markedly improved abdominal pain severity (P < 0.05).  Conclusions: The marked effect of the dietary supplement palmithoylethanolamide/polydatin on abdominal pain in patients with IBS suggests that this is a promising natural approach for pain management in this condition.  Further studies are now required to elucidate the mechanism of action of palmithoylethanolamide/polydatin in IBS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrF2HzhKrrP6bVg90H21EOLACvtfcHk0lgD32F2h98ydw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjs1Sqtro%253D&md5=48570ed9f44a4b58a789229dd7aea583</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1111%2Fapt.13958&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fapt.13958%26sid%3Dliteratum%253Aachs%26aulast%3DCremon%26aufirst%3DC.%26aulast%3DStanghellini%26aufirst%3DV.%26aulast%3DBarbaro%26aufirst%3DM.%2BR.%26aulast%3DCogliandro%26aufirst%3DR.%2BF.%26aulast%3DBellacosa%26aufirst%3DL.%26aulast%3DSantos%26aufirst%3DJ.%26aulast%3DVicario%26aufirst%3DM.%26aulast%3DPigrau%26aufirst%3DM.%26aulast%3DAlonso%2BCotoner%26aufirst%3DC.%26aulast%3DLobo%26aufirst%3DB.%26aulast%3DAzpiroz%26aufirst%3DF.%26aulast%3DBruley%2Bdes%2BVarannes%26aufirst%3DS.%26aulast%3DNeunlist%26aufirst%3DM.%26aulast%3DDeFilippis%26aufirst%3DD.%26aulast%3DIuvone%26aufirst%3DT.%26aulast%3DPetrosino%26aufirst%3DS.%26aulast%3DDi%2BMarzo%26aufirst%3DV.%26aulast%3DBarbara%26aufirst%3DG.%26atitle%3DRandomised%2520clinical%2520trial%253A%2520the%2520analgesic%2520properties%2520of%2520dietary%2520supplementation%2520with%2520palmitoylethanolamide%2520and%2520polydatin%2520in%2520irritable%2520bowel%2520syndrome%26jtitle%3DAliment.%2520Pharmacol.%2520Ther.%26date%3D2017%26volume%3D45%26spage%3D909%26epage%3D922%26doi%3D10.1111%2Fapt.13958" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schweiger, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bellamoli, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donadello, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schievano, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balzo, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarzi-Puttini, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parolini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polati, E.</span></span> <span> </span><span class="NLM_article-title">Ultramicronized palmitoylethanolamide (um-PEA) as add-on treatment in fibromyalgia syndrome (FMS): retrospective observational study on 407 patients</span>. <i>CNS Neurol. Disord.: Drug Targets</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">326</span>– <span class="NLM_lpage">333</span>, <span class="refDoi"> DOI: 10.2174/1871527318666190227205359</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.2174%2F1871527318666190227205359" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=30827269" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhsFCisbbL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2019&pages=326-333&author=V.+Schweigerauthor=A.+Martiniauthor=P.+Bellamoliauthor=K.+Donadelloauthor=C.+Schievanoauthor=G.+D.+Balzoauthor=P.+Sarzi-Puttiniauthor=M.+Paroliniauthor=E.+Polati&title=Ultramicronized+palmitoylethanolamide+%28um-PEA%29+as+add-on+treatment+in+fibromyalgia+syndrome+%28FMS%29%3A+retrospective+observational+study+on+407+patients&doi=10.2174%2F1871527318666190227205359"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Ultramicronized Palmitoylethanolamide (um-PEA) as Add-on Treatment in Fibromyalgia Syndrome (FMS): Retrospective Observational Study on 407 Patients</span></div><div class="casAuthors">Schweiger, Vittorio; Martini, Alvise; Bellamoli, Paola; Donadello, Katia; Schievano, Carlo; Balzo, Giovanna D.; Sarzi-Puttini, Piercarlo; Parolini, Massimo; Polati, Enrico</div><div class="citationInfo"><span class="NLM_cas:title">CNS & Neurological Disorders: Drug Targets</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">326-333</span>CODEN:
                <span class="NLM_cas:coden">CNDDA3</span>;
        ISSN:<span class="NLM_cas:issn">1871-5273</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">To date, no medication has been shown to significantly improve pain, assocd. symptoms and Quality of Life in fibromyalgic patients.  Methods: In this retrospective observational study, we analyzed data regarding 407 patients with diagnosis of fibromyalgia syndrome who between 2013 and 2016 have been prescribed orally ultramicronized palmitoylethanolamide tablets (Normast Epitech Group SpA, Saccolongo, Italy) regardless of the concomitant pharmacol. therapy (add-on treatment).  Results: Regarding efficacy, in the 359 analyzed patients, the change over time in Visual Analog Scale pain score was statistically significant, ranging from 75.84 (±15.15) to 52.49 (±16.73) (p<0.001).  Regarding quality of life, the change over time in Fibromyalgia Impact Questionnaire score was statistically significant, ranging from 68.4 (±14.1) to 49.1 (±19.6) (p<0.001).  In the treated population, only 36 patients (13,7%) reported Adverse Events predominantly of gastrointestinal type (diarrhea, dyspepsia, bloating, constipation, vomiting).  Globally, 151 patients (57,63%) left the treatment due to inefficacy.  Conclusion: The results of ultramicronized palmitoylethanolamide treatment in this retrospective anal. represent an important step for the development of a new and well-tolerated therapy for fibromyalgia syndrome, mostly suitable for these patients who need long-term treatments.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprp7XYHweB6LVg90H21EOLACvtfcHk0liU242KO43jFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhsFCisbbL&md5=fd3e052bec0e42d8a70a99d911a76cda</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.2174%2F1871527318666190227205359&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1871527318666190227205359%26sid%3Dliteratum%253Aachs%26aulast%3DSchweiger%26aufirst%3DV.%26aulast%3DMartini%26aufirst%3DA.%26aulast%3DBellamoli%26aufirst%3DP.%26aulast%3DDonadello%26aufirst%3DK.%26aulast%3DSchievano%26aufirst%3DC.%26aulast%3DBalzo%26aufirst%3DG.%2BD.%26aulast%3DSarzi-Puttini%26aufirst%3DP.%26aulast%3DParolini%26aufirst%3DM.%26aulast%3DPolati%26aufirst%3DE.%26atitle%3DUltramicronized%2520palmitoylethanolamide%2520%2528um-PEA%2529%2520as%2520add-on%2520treatment%2520in%2520fibromyalgia%2520syndrome%2520%2528FMS%2529%253A%2520retrospective%2520observational%2520study%2520on%2520407%2520patients%26jtitle%3DCNS%2520Neurol.%2520Disord.%253A%2520Drug%2520Targets%26date%3D2019%26volume%3D18%26spage%3D326%26epage%3D333%26doi%3D10.2174%2F1871527318666190227205359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Truini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biasiotta, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Stefano, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La Cesa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leone, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cartoni, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Federico, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petrucci, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cruccu, G.</span></span> <span> </span><span class="NLM_article-title">Palmitoylethanolamide restores myelinated-fibre function in patients with chemotherapy-induced painful neuropathy</span>. <i>CNS Neurol. Disord.: Drug Targets</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">916</span>– <span class="NLM_lpage">920</span>, <span class="refDoi"> DOI: 10.2174/187152711799219307</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.2174%2F187152711799219307" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=22229320" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BC38XktFOgsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=916-920&author=A.+Truiniauthor=A.+Biasiottaauthor=G.+Di+Stefanoauthor=S.+La+Cesaauthor=C.+Leoneauthor=C.+Cartoniauthor=V.+Federicoauthor=M.+T.+Petrucciauthor=G.+Cruccu&title=Palmitoylethanolamide+restores+myelinated-fibre+function+in+patients+with+chemotherapy-induced+painful+neuropathy&doi=10.2174%2F187152711799219307"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Palmitoylethanolamide restores myelinated-fibre function in patients with chemotherapy-induced painful neuropathy</span></div><div class="casAuthors">Truini, A.; Biasiotta, A.; Di Stefano, G.; La Cesa, S.; Leone, C.; Cartoni, C.; Federico, V.; Petrucci, M. T.; Cruccu, G.</div><div class="citationInfo"><span class="NLM_cas:title">CNS & Neurological Disorders: Drug Targets</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">8, Topological Insulator Materials</span>),
    <span class="NLM_cas:pages">916-920</span>CODEN:
                <span class="NLM_cas:coden">CNDDA3</span>;
        ISSN:<span class="NLM_cas:issn">1871-5273</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">We assessed the effect of palmitoylethanolamide (PEA) on pain and nerve function in patients with chemotherapy-induced painful neuropathy, in 20 patients undergoing thalidomide and bortezomib treatment for multiple myeloma.  All patients were evaluated before and after a two-month treatment with PEA 300 mg BID using pain and warmth thresholds; blinded examiners measured motor and sensory nerve fiber function and laser-evoked potentials.  Although no variables returned to normal values, pain and all neurophysiol. measures-assessing Aα, Aβ, and Aδ fibers- significantly improved (P < 0.05).  In contrast, warmth thresholds, assessing unmyelinated afferents, remained unchanged (P > 0.50).  Although a placebo effect might play a role in the reported pain relief, the changes in neurophysiol. measures indicate that PEA exerted a pos. action on myelinated fiber groups.  PEA, possibly by moderating mast cell hyperactivity, relieved conduction blocks secondary to endoneural edema.  In a severe condition such as painful neuropathy assocd. with multiple myeloma and chemotherapy, a safe substance such as PEA provides significant restoration of nerve function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6hXGzgoWiR7Vg90H21EOLACvtfcHk0liU242KO43jFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XktFOgsrc%253D&md5=c62d48d221f420543b333c8b3920d7e7</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.2174%2F187152711799219307&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F187152711799219307%26sid%3Dliteratum%253Aachs%26aulast%3DTruini%26aufirst%3DA.%26aulast%3DBiasiotta%26aufirst%3DA.%26aulast%3DDi%2BStefano%26aufirst%3DG.%26aulast%3DLa%2BCesa%26aufirst%3DS.%26aulast%3DLeone%26aufirst%3DC.%26aulast%3DCartoni%26aufirst%3DC.%26aulast%3DFederico%26aufirst%3DV.%26aulast%3DPetrucci%26aufirst%3DM.%2BT.%26aulast%3DCruccu%26aufirst%3DG.%26atitle%3DPalmitoylethanolamide%2520restores%2520myelinated-fibre%2520function%2520in%2520patients%2520with%2520chemotherapy-induced%2520painful%2520neuropathy%26jtitle%3DCNS%2520Neurol.%2520Disord.%253A%2520Drug%2520Targets%26date%3D2011%26volume%3D10%26spage%3D916%26epage%3D920%26doi%3D10.2174%2F187152711799219307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Giammusso, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Mauro, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernardini, R.</span></span> <span> </span><span class="NLM_article-title">The efficacy of an association of palmitoylethanolamide and alpha-lipoic acid in patients with chronic prostatitis/chronic pelvic pain syndrome: A randomized clinical trial</span>. <i>Arch. Ital. Urol. Androl.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>89</i></span>,  <span class="NLM_fpage">17</span>– <span class="NLM_lpage">21</span>, <span class="refDoi"> DOI: 10.4081/aiua.2017.1.17</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.4081%2Faiua.2017.1.17" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=28403589" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsFyhtrnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=2017&pages=17-21&author=B.+Giammussoauthor=R.+Di+Mauroauthor=R.+Bernardini&title=The+efficacy+of+an+association+of+palmitoylethanolamide+and+alpha-lipoic+acid+in+patients+with+chronic+prostatitis%2Fchronic+pelvic+pain+syndrome%3A+A+randomized+clinical+trial&doi=10.4081%2Faiua.2017.1.17"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">The efficacy of an association of palmitoylethanolamide and alpha-lipoic acid in patients with chronic prostatitis/chronic pelvic pain syndrome: a randomized clinical trial</span></div><div class="casAuthors">Giammusso, Bruno; Di Mauro, Rosaria; Bernardini, Renato</div><div class="citationInfo"><span class="NLM_cas:title">Archivio Italiano di Urologia e Andrologia</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">89</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">17-21</span>CODEN:
                <span class="NLM_cas:coden">AIUAFR</span>;
        ISSN:<span class="NLM_cas:issn">2282-4197</span>.
    
            (<span class="NLM_cas:orgname">PAGEPress Publications</span>)
        </div><div class="casAbstract">Background: Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) is a complex condition, characterized by uncertain etiol. and by limited response to therapy.  The definition of CP/CPPS includes genitourinary pain with or without voiding symptoms in the absence of uropathogenic bacteria, as detected by std. microbiol. methods, or another identifiable cause such as malignancy.  The efficacy of various medical therapies, has been evaluated in clin. studies, but evidence is lacking or conflicting.  We compared Serenoa Repens in monotherapy vs. Palmitoylethanolamide (PEA) in combination with Alpha-lipoic acid (ALA) and evaluated the efficacy of these treatments in patients with CP/CPPS.  Methods: We conducted a randomized, single-blind trial. 44 patients diagnosed with CP/CPPS (mean age 41.32 ± 1.686 years) were randomly assigned to treatment with Palmitoylethanolamide 300 mg plus Alpha-lipoic acid 300 mg (Peanase), or Serenoa Repens at 320 mg.  Three questionnaires (NIH-CPSI, IPSS and IIEF5) were administered at baseline and after 12 wk of treatment in each group.  Results: 12 wk treatment with Peanase significantly improved the IPSS score compared to the same period of treatment with Serenoa Repens, and significantly reduced NIH-CPSI score.  Similar results were obsd. in the different NIH-CPSI subscores break down.  However, the same treatment did not result in significant improvement of the IIEF5 score.  Both treatments did not produce undesired effects.  Conclusions: The present results document the efficacy of an assocn. of Palmitoylethanolamide (PEA) and Alpha-lipoic acid (ALA) administered for 12 wk for treating patients with CP/CPPS, compared with Serenoa Repens monotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJptRTXZdbebVg90H21EOLACvtfcHk0liU242KO43jFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsFyhtrnK&md5=99a02633870ebb7daf0d8f5fab8b8010</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.4081%2Faiua.2017.1.17&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4081%252Faiua.2017.1.17%26sid%3Dliteratum%253Aachs%26aulast%3DGiammusso%26aufirst%3DB.%26aulast%3DDi%2BMauro%26aufirst%3DR.%26aulast%3DBernardini%26aufirst%3DR.%26atitle%3DThe%2520efficacy%2520of%2520an%2520association%2520of%2520palmitoylethanolamide%2520and%2520alpha-lipoic%2520acid%2520in%2520patients%2520with%2520chronic%2520prostatitis%252Fchronic%2520pelvic%2520pain%2520syndrome%253A%2520A%2520randomized%2520clinical%2520trial%26jtitle%3DArch.%2520Ital.%2520Urol.%2520Androl.%26date%3D2017%26volume%3D89%26spage%3D17%26epage%3D21%26doi%3D10.4081%2Faiua.2017.1.17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Orefice, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alhouayek, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carotenuto, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montella, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbato, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Comelli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calignano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muccioli, G. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orefice, G.</span></span> <span> </span><span class="NLM_article-title">Oral palmitoylethanolamide treatment is associated with reduced cutaneous adverse effects of interferon-β1a and circulating proinflammatory cytokines in relapsing-remitting multiple sclerosis</span>. <i>Neurotherapeutics</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">428</span>– <span class="NLM_lpage">438</span>, <span class="refDoi"> DOI: 10.1007/s13311-016-0420-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1007%2Fs13311-016-0420-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=26857391" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BC28XisFSls7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2016&pages=428-438&author=N.+S.+Oreficeauthor=M.+Alhouayekauthor=A.+Carotenutoauthor=S.+Montellaauthor=F.+Barbatoauthor=A.+Comelliauthor=A.+Calignanoauthor=G.+G.+Muccioliauthor=G.+Orefice&title=Oral+palmitoylethanolamide+treatment+is+associated+with+reduced+cutaneous+adverse+effects+of+interferon-%CE%B21a+and+circulating+proinflammatory+cytokines+in+relapsing-remitting+multiple+sclerosis&doi=10.1007%2Fs13311-016-0420-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Oral Palmitoylethanolamide Treatment Is Associated with Reduced Cutaneous Adverse Effects of Interferon-β1a and Circulating Proinflammatory Cytokines in Relapsing-Remitting Multiple Sclerosis</span></div><div class="casAuthors">Orefice, Nicola S.; Alhouayek, Mireille; Carotenuto, Antonio; Montella, Silvana; Barbato, Franscesco; Comelli, Albert; Calignano, Antonio; Muccioli, Giulio G.; Orefice, Giuseppe</div><div class="citationInfo"><span class="NLM_cas:title">Neurotherapeutics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">428-438</span>CODEN:
                <span class="NLM_cas:coden">NEURNV</span>;
        ISSN:<span class="NLM_cas:issn">1878-7479</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Palmitoylethanolamide (PEA) is an endogenous lipid mediator known to reduce pain and inflammation.  However, only limited clin. studies have evaluated the effects of PEA in neuroinflammatory and neurodegenerative diseases.  Multiple sclerosis (MS) is a chronic autoimmune and inflammatory disease of the central nervous system.  Although s.c. administration of interferon (IFN)-β1a is approved as first-line therapy for the treatment of relapsing-remitting MS (RR-MS), its commonly reported adverse events (AEs) such as pain, myalgia, and erythema at the injection site, deeply affect the quality of life (QoL) of patients with MS.  In this randomized, double-blind, placebo-controlled study, we tested the effect of ultramicronized PEA (um-PEA) added to IFN-β1a in the treatment of clin. defined RR-MS.  The primary objectives were to est. whether, with um-PEA treatment, patients with MS perceived an improvement in pain and a decrease of the erythema width at the IFN-β1a injection site in addn. to an improvement in their QoL.  The secondary objectives were to evaluate the effects of um-PEA on circulating interferon-γ, tumor necrosis factor-α, and interleukin-17 serum levels, N-acylethanolamine plasma levels, Expanded Disability Status Scale (EDSS) progression, and safety and tolerability after 1 yr of treatment.  Patients with MS receiving um-PEA perceived an improvement in pain sensation without a redn. of the erythema at the injection site.  A significant improvement in QoL was obsd.  No significant difference was reported in EDSS score, and um-PEA was well tolerated.  We found a significant increase of palmitoylethanolamide, anandamide and oleoylethanolamide plasma levels, and a significant redn. of interferon-γ, tumor necrosis factor-α, and interleukin-17 serum profile compared with the placebo group.  Our results suggest that um-PEA may be considered as an appropriate add-on therapy for the treatment of IFN-β1a-related adverse effects in RR-MS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4g6LzMLY4F7Vg90H21EOLACvtfcHk0liU242KO43jFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XisFSls7w%253D&md5=8428b841203913c4d08b78a8c617b817</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1007%2Fs13311-016-0420-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs13311-016-0420-z%26sid%3Dliteratum%253Aachs%26aulast%3DOrefice%26aufirst%3DN.%2BS.%26aulast%3DAlhouayek%26aufirst%3DM.%26aulast%3DCarotenuto%26aufirst%3DA.%26aulast%3DMontella%26aufirst%3DS.%26aulast%3DBarbato%26aufirst%3DF.%26aulast%3DComelli%26aufirst%3DA.%26aulast%3DCalignano%26aufirst%3DA.%26aulast%3DMuccioli%26aufirst%3DG.%2BG.%26aulast%3DOrefice%26aufirst%3DG.%26atitle%3DOral%2520palmitoylethanolamide%2520treatment%2520is%2520associated%2520with%2520reduced%2520cutaneous%2520adverse%2520effects%2520of%2520interferon-%25CE%25B21a%2520and%2520circulating%2520proinflammatory%2520cytokines%2520in%2520relapsing-remitting%2520multiple%2520sclerosis%26jtitle%3DNeurotherapeutics%26date%3D2016%26volume%3D13%26spage%3D428%26epage%3D438%26doi%3D10.1007%2Fs13311-016-0420-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Artukoglu, B. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beyer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zuloff-Shani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brener, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bloch, M. H.</span></span> <span> </span><span class="NLM_article-title">Efficacy of palmitoylethanolamide for pain: a meta-analysis</span>. <i>Pain Physician</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">353</span>– <span class="NLM_lpage">362</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=28727699" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A280%3ADC%252BC1cjpsFChsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2017&pages=353-362&author=B.+B.+Artukogluauthor=C.+Beyerauthor=A.+Zuloff-Shaniauthor=E.+Brenerauthor=M.+H.+Bloch&title=Efficacy+of+palmitoylethanolamide+for+pain%3A+a+meta-analysis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Efficacy of Palmitoylethanolamide for Pain: A Meta-Analysis</span></div><div class="casAuthors">Artukoglu Bekir Berker; Beyer Chad; Bloch Michael Howard; Zuloff-Shani Adi; Brener Ephraim</div><div class="citationInfo"><span class="NLM_cas:title">Pain physician</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">353-362</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Palmitoylethanolamide (PEA) is a cannabimimetic compound that has been investigated as an analgesic agent in animal models and clinical trials.  OBJECTIVES:  We conducted a meta-analysis to examine the efficacy of PEA for treating pain in randomized, controlled trials.  STUDY DESIGN:  Systematic review and meta-analysis.  SETTING:  This meta-analysis examined all randomized, controlled trials involving the effect of PEA on pain score.  METHODS:  We searched PubMed and Embase for randomized, active or placebo-controlled trials of PEA for the treatment of acute or chronic pain.  Our primary outcome was the weighted mean difference in visual analog pain scales of PEA treatment compared to inactive controls.  RESULTS:  We identified 10 studies including data from 786 patients who received PEA and 512 controls for inclusion in our systematic review.  Eight trials included an inactive control group and were included in the meta-analysis.  PEA was associated with significantly greater pain reduction compared to inactive control conditions (WMD = 2.03, 95% CI: 1.19 - 2.87, z = 4.75, P < 0.001).  Use of placebo control, presence of blinding, allowance for concomitant treatments, and duration or dose of PEA treatment did not affect the measured efficacy of PEA.  All-cause dropout was non-significantly reduced in the PEA group compared to inactive control conditions (RR = 0.36, 95% CI: 0.10 - 1.26, z = -1.60, P = 0.11).  LIMITATIONS:  This meta-analysis relied on a relatively small number of trials across a variety of conditions causing pain with differing trial designs.  Overall quality of the underlying studies and assessment of side effects were often poor.  CONCLUSIONS:  PEA may be a useful treatment for pain and is generally well tolerated in research populations.  Further, well-designed, randomized, placebo-controlled trials are needed to provide reliable estimates of its efficacy and to identify less serious adverse events associated with this compound.  KEY WORDS:  PEA, palmidrol, palmitoylethanolamide, efficacy, pain, pain management, meta-analysis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS-LIN7cIJ1dHtlzo9xastyfW6udTcc2eaLT_GjLPbR4bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cjpsFChsA%253D%253D&md5=e048a1cd123f89f4a2c78c202c5ebea3</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DArtukoglu%26aufirst%3DB.%2BB.%26aulast%3DBeyer%26aufirst%3DC.%26aulast%3DZuloff-Shani%26aufirst%3DA.%26aulast%3DBrener%26aufirst%3DE.%26aulast%3DBloch%26aufirst%3DM.%2BH.%26atitle%3DEfficacy%2520of%2520palmitoylethanolamide%2520for%2520pain%253A%2520a%2520meta-analysis%26jtitle%3DPain%2520Physician%26date%3D2017%26volume%3D20%26spage%3D353%26epage%3D362" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bachur, N. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masek, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melmon, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Udenfriend, S.</span></span> <span> </span><span class="NLM_article-title">Fatty acid amides of ethanolamine in mammalian tissues</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1965</span>,  <span class="NLM_volume"><i>240</i></span>,  <span class="NLM_fpage">1019</span>– <span class="NLM_lpage">1024</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=14284696" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADyaF2MXksFWgtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=240&publication_year=1965&pages=1019-1024&author=N.+R.+Bachurauthor=K.+Masekauthor=K.+L.+Melmonauthor=S.+Udenfriend&title=Fatty+acid+amides+of+ethanolamine+in+mammalian+tissues"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Fatty acid amides of ethanolamine in mammalian tissues</span></div><div class="casAuthors">Bachur, Nicholas R.; Masek, Karel; Melmon, Kenneth L.; Udenfriend, Sidney</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1965</span>),
    <span class="NLM_cas:volume">240</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1019-24</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    </div><div class="casAbstract">A method for the isolation, purification, and quant. assay of fatty acid ethanolamides from natural sources is described.  In rats and guinea pigs from which food has been withheld, the amide is found in brain, liver, and skeletal muscle, the level being highest and most const. in brain.  Verification of the structure of the isolated palmitoylethanolamide was obtained through gas-liquid chromatography, ir spectroscopy, and hydrolysis and analysis of the component fatty acid and amine.  Evidence was presented to rule out the artifactual production of palmitoylethanolamide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2ihNG2976OLVg90H21EOLACvtfcHk0liZ21RprQfwNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF2MXksFWgtA%253D%253D&md5=c1a2dc22f7dc92c76f006247f44b16e7</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBachur%26aufirst%3DN.%2BR.%26aulast%3DMasek%26aufirst%3DK.%26aulast%3DMelmon%26aufirst%3DK.%2BL.%26aulast%3DUdenfriend%26aufirst%3DS.%26atitle%3DFatty%2520acid%2520amides%2520of%2520ethanolamine%2520in%2520mammalian%2520tissues%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1965%26volume%3D240%26spage%3D1019%26epage%3D1024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tsuboi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uyama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okamoto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueda, N.</span></span> <span> </span><span class="NLM_article-title">Endocannabinoids and related N-acylethanolamines: biological activities and metabolism</span>. <i>Inflammation Regener.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">28</span>, <span class="refDoi"> DOI: 10.1186/s41232-018-0086-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1186%2Fs41232-018-0086-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=30288203" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhs1eqt7zN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2018&pages=28&author=K.+Tsuboiauthor=T.+Uyamaauthor=Y.+Okamotoauthor=N.+Ueda&title=Endocannabinoids+and+related+N-acylethanolamines%3A+biological+activities+and+metabolism&doi=10.1186%2Fs41232-018-0086-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Endocannabinoids and related N-acylethanolamines: biological activities and metabolism</span></div><div class="casAuthors">Tsuboi, Kazuhito; Uyama, Toru; Okamoto, Yasuo; Ueda, Natsuo</div><div class="citationInfo"><span class="NLM_cas:title">Inflammation and Regeneration</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">28</span>CODEN:
                <span class="NLM_cas:coden">IRNECG</span>;
        ISSN:<span class="NLM_cas:issn">1880-9693</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">A review.  The plant Cannabis sativa contains cannabinoids represented by Δ9-tetrahydrocannabinol, which exert psychoactivity and immunomodulation through cannabinoid CB1 and CB2 receptors, resp., in animal tissues.  Arachidonoylethanolamide (also referred to as anandamide) and 2-arachidonoylglycerol (2-AG) are well known as two major endogenous agonists of these receptors (termed "endocannabinoids") and show various cannabimimetic bioactivities.  However, only 2-AG is a full agonist for CB1 and CB2 and mediates retrograde signals at the synapse, strongly suggesting that 2-AG is physiol. more important than anandamide.  The metabolic pathways of these two endocannabinoids are completely different. 2-AG is mostly produced from inositol phospholipids via diacylglycerol by phospholipase C and diacylglycerol lipase and then degraded by monoacylglycerol lipase.  On the other hand, anandamide is concomitantly produced with larger amts. of other N-acylethanolamines via N-acyl-phosphatidylethanolamines (NAPEs).  Although this pathway consists of calcium-dependent N-acyltransferase and NAPE-hydrolyzing phospholipase D, recent studies revealed the involvement of several new enzymes.  Quant. major N-acylethanolamines include palmitoylethanolamide and oleoylethanolamide, which do not bind to cannabinoid receptors but exert anti-inflammatory, analgesic, and anorexic effects through receptors such as peroxisome proliferator-activated receptor α.  The biosynthesis of these non-endocannabinoid N-acylethanolamines rather than anandamide may be the primary significance of this pathway.  Here, we provide an overview of the biol. activities and metabs. of endocannabinoids (2-AG and anandamide) and non-endocannabinoid N-acylethanolamines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUWzSp4LibbLVg90H21EOLACvtfcHk0liZ21RprQfwNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhs1eqt7zN&md5=0ac9f596d18fd9d769a1f67f18bf8223</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1186%2Fs41232-018-0086-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs41232-018-0086-5%26sid%3Dliteratum%253Aachs%26aulast%3DTsuboi%26aufirst%3DK.%26aulast%3DUyama%26aufirst%3DT.%26aulast%3DOkamoto%26aufirst%3DY.%26aulast%3DUeda%26aufirst%3DN.%26atitle%3DEndocannabinoids%2520and%2520related%2520N-acylethanolamines%253A%2520biological%2520activities%2520and%2520metabolism%26jtitle%3DInflammation%2520Regener.%26date%3D2018%26volume%3D38%26spage%3D28%26doi%3D10.1186%2Fs41232-018-0086-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ogura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parsons, W. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamat, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cravatt, B. F.</span></span> <span> </span><span class="NLM_article-title">A calcium-dependent acyltransferase that produces N-acyl phosphatidylethanolamines</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">669</span>– <span class="NLM_lpage">671</span>, <span class="refDoi"> DOI: 10.1038/nchembio.2127</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1038%2Fnchembio.2127" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=27399000" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1Kmu7rP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2016&pages=669-671&author=Y.+Oguraauthor=W.+H.+Parsonsauthor=S.+S.+Kamatauthor=B.+F.+Cravatt&title=A+calcium-dependent+acyltransferase+that+produces+N-acyl+phosphatidylethanolamines&doi=10.1038%2Fnchembio.2127"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">A calcium-dependent acyltransferase that produces N-acyl phosphatidylethanolamines</span></div><div class="casAuthors">Ogura, Yuji; Parsons, William H.; Kamat, Siddhesh S.; Cravatt, Benjamin F.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">669-671</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">More than 30 years ago, a calcium-dependent enzyme activity was described that generates N-acyl phosphatidylethanolamines (NAPEs), which are precursors for N-acyl ethanolamine (NAE) lipid transmitters, including the endocannabinoid anandamide.  The identity of this calcium-dependent N-acyltransferase (Ca-NAT) has remained mysterious.  Here, we use activity-based protein profiling to identify the poorly characterized serine hydrolase PLA2G4E as a mouse brain Ca-NAT and show that this enzyme generates NAPEs and NAEs in mammalian cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvImxXm5qAW7Vg90H21EOLACvtfcHk0li9i1xRrZ6e7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1Kmu7rP&md5=57f720cb6c82b8c40f8ed176815afda3</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.2127&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.2127%26sid%3Dliteratum%253Aachs%26aulast%3DOgura%26aufirst%3DY.%26aulast%3DParsons%26aufirst%3DW.%2BH.%26aulast%3DKamat%26aufirst%3DS.%2BS.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26atitle%3DA%2520calcium-dependent%2520acyltransferase%2520that%2520produces%2520N-acyl%2520phosphatidylethanolamines%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2016%26volume%3D12%26spage%3D669%26epage%3D671%26doi%3D10.1038%2Fnchembio.2127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Okamoto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morishita, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsuboi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tonai, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueda, N.</span></span> <span> </span><span class="NLM_article-title">Molecular characterization of a phospholipase D generating anandamide and its congeners</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>279</i></span>,  <span class="NLM_fpage">5298</span>– <span class="NLM_lpage">5305</span>, <span class="refDoi"> DOI: 10.1074/jbc.M306642200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1074%2Fjbc.M306642200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=14634025" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtFeqtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=5298-5305&author=Y.+Okamotoauthor=J.+Morishitaauthor=K.+Tsuboiauthor=T.+Tonaiauthor=N.+Ueda&title=Molecular+characterization+of+a+phospholipase+D+generating+anandamide+and+its+congeners&doi=10.1074%2Fjbc.M306642200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Characterization of a Phospholipase D Generating Anandamide and Its Congeners</span></div><div class="casAuthors">Okamoto, Yasuo; Morishita, Jun; Tsuboi, Kazuhito; Tonai, Takeharu; Ueda, Natsuo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">279</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">5298-5305</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Anandamide (N-arachidonoylethanolamine) is known to be an endogenous ligand of cannabinoid and vanilloid receptors.  Its congeners (collectively referred to as N-acylethanolamines) also show a variety of biol. activities.  These compds. are principally formed from their corresponding N-acylphosphatidylethanolamines by a phosphodiesterase of the phospholipase D-type in animal tissues.  The authors purified the enzyme from rat heart, and by the use of the sequences of its internal peptides cloned its cDNAs from mouse, rat, and human.  The deduced amino acid sequences were composed of 393-396 residues, and showed that the enzyme has no homol. with the known phospholipase D enzymes but is classified as a member of the zinc metallohydrolase family of the β-lactamase fold.  As was overexpressed in COS-7 cells, the recombinant enzyme generated anandamide and other N-acylethanolamines from their corresponding N-acylphosphatidylethanolamines at comparable rates.  In contrast, the enzyme was inactive with phosphatidylcholine and phosphatidylethanolamine.  Assays of the enzyme activity and the mRNA and protein levels revealed its wide distribution in murine organs with higher contents in the brain, kidney, and testis.  These results confirm that a specific phospholipase D is responsible for the generation of N-acylethanolamines including anandamide, strongly suggesting the physiol. importance of lipid mols. of this class.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpK_-VVe-jk7rVg90H21EOLACvtfcHk0li9i1xRrZ6e7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtFeqtrY%253D&md5=f1c00a4d0e21163c03b5a70d2f46c721</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M306642200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M306642200%26sid%3Dliteratum%253Aachs%26aulast%3DOkamoto%26aufirst%3DY.%26aulast%3DMorishita%26aufirst%3DJ.%26aulast%3DTsuboi%26aufirst%3DK.%26aulast%3DTonai%26aufirst%3DT.%26aulast%3DUeda%26aufirst%3DN.%26atitle%3DMolecular%2520characterization%2520of%2520a%2520phospholipase%2520D%2520generating%2520anandamide%2520and%2520its%2520congeners%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D5298%26epage%3D5305%26doi%3D10.1074%2Fjbc.M306642200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okamoto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morishita, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsuboi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyatake, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueda, N.</span></span> <span> </span><span class="NLM_article-title">Functional analysis of the purified anandamide-generating phospholipase D as a member of the metallo-beta-lactamase family</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>281</i></span>,  <span class="NLM_fpage">12325</span>– <span class="NLM_lpage">12335</span>, <span class="refDoi"> DOI: 10.1074/jbc.M512359200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1074%2Fjbc.M512359200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=16527816" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BD28XjvFKksrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2006&pages=12325-12335&author=J.+Wangauthor=Y.+Okamotoauthor=J.+Morishitaauthor=K.+Tsuboiauthor=A.+Miyatakeauthor=N.+Ueda&title=Functional+analysis+of+the+purified+anandamide-generating+phospholipase+D+as+a+member+of+the+metallo-beta-lactamase+family&doi=10.1074%2Fjbc.M512359200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Functional Analysis of the Purified Anandamide-generating Phospholipase D as a Member of the Metallo-β-lactamase Family</span></div><div class="casAuthors">Wang, Jun; Okamoto, Yasuo; Morishita, Jun; Tsuboi, Kazuhito; Miyatake, Akira; Ueda, Natsuo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">281</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">12325-12335</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">In animal tissues, bioactive N-acylethanolamines including the endocannabinoid anandamide are formed from their corresponding N-acylphosphatidylethanolamines (NAPEs) by the catalysis of a specific phospholipase D (NAPE-PLD) that belongs to the metallo-β-lactamase family.  Despite its potential physiol. importance, NAPE-PLD has not yet been characterized with a purified enzyme prepn.  In the present study we expressed a recombinant NAPE-PLD in Escherichia coli and highly purified it.  The purified enzyme was remarkably activated in a dose-dependent manner by millimolar concns. of Mg2+ as well as Ca2+ and, hence, appeared to be constitutively active.  The enzyme showed extremely high specificity for NAPEs among various glycerophospholipids but did not reveal obvious selectivity for different long chain or medium chain N-acyl species of NAPEs.  These results suggested the ability of NAPE-PLD to degrade different NAPEs without damaging other membrane phospholipids.  Metal anal. revealed the presence of catalytically important zinc in NAPE-PLD.  In addn., site-directed mutagenesis studies were addressed to several histidine and aspartic acid residues of NAPE-PLD that are highly conserved within the metallo-β-lactamase family.  Single mutations of Asp-147, His-185, His-187, Asp-189, His-190, His-253, Asp-284, and His-321 caused abolishment or remarkable redn. of the catalytic activity.  Moreover, when six cysteine residues were individually mutated to serine, only C224S showed a considerably reduced activity.  The activities of L207F and H380R found as single nucleotide polymorphisms were also low.  Thus, NAPE-PLD appeared to function through a mechanism similar to those of the well characterized members of this family but play a unique role in the lipid metab. of animal tissues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHPr_ieu3LxrVg90H21EOLACvtfcHk0li9i1xRrZ6e7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjvFKksrY%253D&md5=aedf6e484205f3af45d2743f551de502</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M512359200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M512359200%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DOkamoto%26aufirst%3DY.%26aulast%3DMorishita%26aufirst%3DJ.%26aulast%3DTsuboi%26aufirst%3DK.%26aulast%3DMiyatake%26aufirst%3DA.%26aulast%3DUeda%26aufirst%3DN.%26atitle%3DFunctional%2520analysis%2520of%2520the%2520purified%2520anandamide-generating%2520phospholipase%2520D%2520as%2520a%2520member%2520of%2520the%2520metallo-beta-lactamase%2520family%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2006%26volume%3D281%26spage%3D12325%26epage%3D12335%26doi%3D10.1074%2Fjbc.M512359200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Magotti, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauer, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Igarashi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Babagoli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marotta, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piomelli, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garau, G.</span></span> <span> </span><span class="NLM_article-title">Structure of human N-acylphosphatidylethanolamine-hydrolyzing phospholipase D: regulation of fatty acid ethanolamide biosynthesis by bile acids</span>. <i>Structure</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">598</span>– <span class="NLM_lpage">604</span>, <span class="refDoi"> DOI: 10.1016/j.str.2014.12.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1016%2Fj.str.2014.12.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=25684574" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BC2MXivVSjt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2015&pages=598-604&author=P.+Magottiauthor=I.+Bauerauthor=M.+Igarashiauthor=M.+Babagoliauthor=R.+Marottaauthor=D.+Piomelliauthor=G.+Garau&title=Structure+of+human+N-acylphosphatidylethanolamine-hydrolyzing+phospholipase+D%3A+regulation+of+fatty+acid+ethanolamide+biosynthesis+by+bile+acids&doi=10.1016%2Fj.str.2014.12.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of human N-acylphosphatidylethanolamine-hydrolyzing phospholipase D: Regulation of fatty acid ethanolamide biosynthesis by bile acids</span></div><div class="casAuthors">Magotti, Paola; Bauer, Inga; Igarashi, Miki; Babagoli, Masih; Marotta, Roberto; Piomelli, Daniele; Garau, Gianpiero</div><div class="citationInfo"><span class="NLM_cas:title">Structure (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">598-604</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The fatty acid ethanolamides (FAEs) are lipid mediators present in all organisms and involved in highly conserved biol. functions, such as innate immunity, energy balance, and stress control.  They are produced from membrane N-acylphosphatidylethanolamines (NAPEs) and include agonists for G protein-coupled receptors (e.g., cannabinoid receptors) and nuclear receptors (e.g., PPAR-α).  Here, the authors report the crystal structure of human NAPE-hydrolyzing phospholipase D (NAPE-PLD) at 2.65 Å resoln., a membrane enzyme that catalyzes FAE formation in mammals.  NAPE-PLD forms homodimers partly sepd. by an internal ∼9-Å-wide channel and uniquely adapted to assoc. with phospholipids.  A hydrophobic cavity provides an entryway for NAPE into the active site, where a binuclear Zn2+ center orchestrates its hydrolysis.  Bile acids bind with high affinity to selective pockets in this cavity, enhancing dimer assembly and enabling catalysis.  These elements offer multiple targets for the design of small-mol. NAPE-PLD modulators with potential applications in inflammation and metabolic disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAkur49s4h2bVg90H21EOLACvtfcHk0li_f87HUJPSNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXivVSjt7s%253D&md5=c80aae05403e5fc59a3bb6db1ec673ec</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1016%2Fj.str.2014.12.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.str.2014.12.018%26sid%3Dliteratum%253Aachs%26aulast%3DMagotti%26aufirst%3DP.%26aulast%3DBauer%26aufirst%3DI.%26aulast%3DIgarashi%26aufirst%3DM.%26aulast%3DBabagoli%26aufirst%3DM.%26aulast%3DMarotta%26aufirst%3DR.%26aulast%3DPiomelli%26aufirst%3DD.%26aulast%3DGarau%26aufirst%3DG.%26atitle%3DStructure%2520of%2520human%2520N-acylphosphatidylethanolamine-hydrolyzing%2520phospholipase%2520D%253A%2520regulation%2520of%2520fatty%2520acid%2520ethanolamide%2520biosynthesis%2520by%2520bile%2520acids%26jtitle%3DStructure%26date%3D2015%26volume%3D23%26spage%3D598%26epage%3D604%26doi%3D10.1016%2Fj.str.2014.12.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solorzano, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sahar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Realini, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fung, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sassone-Corsi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piomelli, D.</span></span> <span> </span><span class="NLM_article-title">Proinflammatory stimuli control N-acylphosphatidylethanolamine-specific phospholipase D expression in macrophages</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>79</i></span>,  <span class="NLM_fpage">786</span>– <span class="NLM_lpage">792</span>, <span class="refDoi"> DOI: 10.1124/mol.110.070201</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1124%2Fmol.110.070201" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=21233218" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktVOlurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2011&pages=786-792&author=C.+Zhuauthor=C.+Solorzanoauthor=S.+Saharauthor=N.+Realiniauthor=E.+Fungauthor=P.+Sassone-Corsiauthor=D.+Piomelli&title=Proinflammatory+stimuli+control+N-acylphosphatidylethanolamine-specific+phospholipase+D+expression+in+macrophages&doi=10.1124%2Fmol.110.070201"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Proinflammatory stimuli control N-acylphosphatidylethanolamine-specific phospholipase D expression in macrophages</span></div><div class="casAuthors">Zhu, Chenggang; Solorzano, Carlos; Sahar, Saurabh; Realini, Natalia; Fung, Ernest; Sassone-Corsi, Paolo; Piomelli, Daniele</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">786-792</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Palmitoylethanolamide (PEA) is an endogenous lipid amide that modulates pain and inflammation by engaging peroxisome proliferator-activated receptor type-α.  Here, we show that the proinflammatory bacterial endotoxin lipopolysaccharide (LPS) decreases PEA biosynthesis in RAW264.7 macrophages by suppressing the transcription of N-acylphosphatidylethanolamine-specific phospholipase D (NAPE-PLD), which catalyzes the prodn. of PEA and other lipid amides.  Using a luciferase reporter construct and chromatin immunopptn., we further show that LPS treatment reduces acetylation of histone proteins bound to the NAPE-PLD promoter, an effect that is blocked by the histone deacetylase inhibitor trichostatin A.  The transcription factor Sp1 is involved in regulating baseline NAPE-PLD expression but not in the transcriptional suppression induced by LPS.  The ability of LPS to down-regulate PEA biosynthesis is impaired in peritoneal macrophages from mutant NAPE-PLD-deficient mice, in which PEA is produced through a compensatory mechanism distinct from NAPE-PLD.  Moreover, NAPE-PLD-deficient mice fail to mount a normal inflammatory reaction in response to carrageenan administration in vivo.  Our findings suggest that proinflammatory stimuli suppress NAPE-PLD expression and PEA biosynthesis in macrophages and that this effect might contribute to the inflammatory response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqif9VxrAyTBLVg90H21EOLACvtfcHk0li_f87HUJPSNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktVOlurY%253D&md5=894e9566ce60e39bd4e599dda155949e</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1124%2Fmol.110.070201&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.110.070201%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DC.%26aulast%3DSolorzano%26aufirst%3DC.%26aulast%3DSahar%26aufirst%3DS.%26aulast%3DRealini%26aufirst%3DN.%26aulast%3DFung%26aufirst%3DE.%26aulast%3DSassone-Corsi%26aufirst%3DP.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DProinflammatory%2520stimuli%2520control%2520N-acylphosphatidylethanolamine-specific%2520phospholipase%2520D%2520expression%2520in%2520macrophages%26jtitle%3DMol.%2520Pharmacol.%26date%3D2011%26volume%3D79%26spage%3D786%26epage%3D792%26doi%3D10.1124%2Fmol.110.070201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Y. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsuboi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, L. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okamoto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambert, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueda, N.</span></span> <span> </span><span class="NLM_article-title">Involvement of N-acylethanolamine-hydrolyzing acid amidase in the degradation of anandamide and other N-acylethanolamines in macrophages</span>. <i>Biochim. Biophys. Acta, Mol. Cell Biol. Lipids</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>1736</i></span>,  <span class="NLM_fpage">211</span>– <span class="NLM_lpage">220</span>, <span class="refDoi"> DOI: 10.1016/j.bbalip.2005.08.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1016%2Fj.bbalip.2005.08.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=16154384" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVOktr7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1736&publication_year=2005&pages=211-220&author=Y.+X.+Sunauthor=K.+Tsuboiauthor=L.+Y.+Zhaoauthor=Y.+Okamotoauthor=D.+M.+Lambertauthor=N.+Ueda&title=Involvement+of+N-acylethanolamine-hydrolyzing+acid+amidase+in+the+degradation+of+anandamide+and+other+N-acylethanolamines+in+macrophages&doi=10.1016%2Fj.bbalip.2005.08.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Involvement of N-acylethanolamine-hydrolyzing acid amidase in the degradation of anandamide and other N-acylethanolamines in macrophages</span></div><div class="casAuthors">Sun, Yong-Xin; Tsuboi, Kazuhito; Zhao, Li-Ying; Okamoto, Yasuo; Lambert, Didier M.; Ueda, Natsuo</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular and Cell Biology of Lipids</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">1736</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">211-220</span>CODEN:
                <span class="NLM_cas:coden">BBMLFG</span>;
        ISSN:<span class="NLM_cas:issn">1388-1981</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Bioactive N-acylethanolamines including the endocannabinoid anandamide are known to be hydrolyzed to fatty acids and ethanolamine by fatty acid amide hydrolase (FAAH).  In addn., we recently cloned an isoenzyme termed "N-acylethanolamine-hydrolyzing acid amidase (NAAA)", which is active only at acidic pH [Tsuboi, Sun, Okamoto, Araki, Tonai, Ueda, J. Biol. Chem. 285 (2005) 11082-11092].  However, physiol. roles of NAAA remained unclear.  Here, we examd. a possible contribution of NAAA to the degrdn. of various N-acylethanolamines in macrophage cells.  NAAA mRNA as well as FAAH mRNA was detected in several macrophage-like cells, including RAW264.7, and mouse peritoneal macrophages.  The homogenates of RAW264.7 cells showed both the NAAA and FAAH activities which were confirmed with the aid of their resp. specific inhibitors, N-cyclohexanecarbonylpentadecylamine (CCP) and URB597.  As analyzed with intact cells, RAW264.7 cells and peritoneal macrophages degraded anandamide, N-palmitoylethanolamine, N-oleoylethanolamine, and N-stearoylethanolamine.  Pretreatment of the cells with CCP or URB597 partially inhibited the degrdn., and a combination of the two compds. caused more profound inhibition.  In contrast, the anandamide hydrolysis in mouse brain appeared to be principally attributable to FAAH despite the expression of NAAA in the brain.  These results suggested that NAAA and FAAH cooperatively degraded various N-acylethanolamines in macrophages.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRw2Yw4epuc7Vg90H21EOLACvtfcHk0li_f87HUJPSNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVOktr7O&md5=d4dbefcb0a2c84be624e98f1ee78f213</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1016%2Fj.bbalip.2005.08.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbalip.2005.08.010%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DY.%2BX.%26aulast%3DTsuboi%26aufirst%3DK.%26aulast%3DZhao%26aufirst%3DL.%2BY.%26aulast%3DOkamoto%26aufirst%3DY.%26aulast%3DLambert%26aufirst%3DD.%2BM.%26aulast%3DUeda%26aufirst%3DN.%26atitle%3DInvolvement%2520of%2520N-acylethanolamine-hydrolyzing%2520acid%2520amidase%2520in%2520the%2520degradation%2520of%2520anandamide%2520and%2520other%2520N-acylethanolamines%2520in%2520macrophages%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Cell%2520Biol.%2520Lipids%26date%3D2005%26volume%3D1736%26spage%3D211%26epage%3D220%26doi%3D10.1016%2Fj.bbalip.2005.08.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tai, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsuboi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uyama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masuda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cravatt, B. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houchi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueda, N.</span></span> <span> </span><span class="NLM_article-title">Endogenous molecules stimulating N-acylethanolamine-hydrolyzing acid amidase (NAAA)</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">379</span>– <span class="NLM_lpage">385</span>, <span class="refDoi"> DOI: 10.1021/cn300007s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn300007s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlSqs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=379-385&author=T.+Taiauthor=K.+Tsuboiauthor=T.+Uyamaauthor=K.+Masudaauthor=B.+F.+Cravattauthor=H.+Houchiauthor=N.+Ueda&title=Endogenous+molecules+stimulating+N-acylethanolamine-hydrolyzing+acid+amidase+%28NAAA%29&doi=10.1021%2Fcn300007s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Endogenous Molecules Stimulating N-Acylethanolamine-Hydrolyzing Acid Amidase (NAAA)</span></div><div class="casAuthors">Tai, Tatsuya; Tsuboi, Kazuhito; Uyama, Toru; Masuda, Kim; Cravatt, Benjamin F.; Houchi, Hitoshi; Ueda, Natsuo</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">379-385</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Fatty acid amide hydrolase (FAAH) plays the central role in the degrdn. of bioactive N-acylethanolamines such as the endocannabinoid arachidonoylethanolamide (anandamide) in brain and peripheral tissues.  A lysosomal enzyme referred to as N-acylethanolamine-hydrolyzing acid amidase (NAAA) catalyzes the same reaction with preference to palmitoylethanolamide, an endogenous analgesic and neuroprotective substance, and is therefore expected as a potential target of therapeutic drugs.  In the in vitro assays thus far performed, the maximal activity of NAAA was achieved in the presence of both nonionic detergent (Triton X-100 or Nonidet P-40) and the SH reagent dithiothreitol.  However, endogenous mols. that might substitute for these synthetic compds. remain poorly understood.  Here, we examd. stimulatory effects of endogenous phospholipids and thiol compds. on recombinant NAAA.  Among different phospholipids tested, choline- or ethanolamine-contg. phospholipids showed potent effects, and 1 mM phosphatidylcholine increased NAAA activity by 6.6-fold.  Concerning endogenous thiol compds., dihydrolipoic acid at 0.1-1 mM was the most active, causing 8.5-9.0-fold stimulation.  These results suggest that endogenous phospholipids and dihydrolipoic acid may contribute in keeping NAAA active in lysosomes.  Even in the presence of phosphatidylcholine and dihydrolipoic acid, however, the preferential hydrolysis of palmitoylethanolamide was unaltered.  We also investigated a possible compensatory induction of NAAA mRNA in brain and other tissues of FAAH-deficient mice.  However, NAAA expression levels in all the tissues examd. were not significantly altered from those in wild-type mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplBbMBMe7ntrVg90H21EOLACvtfcHk0liPKl2vc-UPSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlSqs7o%253D&md5=9efd719439affa31b0197bc8f4707cd7</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1021%2Fcn300007s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn300007s%26sid%3Dliteratum%253Aachs%26aulast%3DTai%26aufirst%3DT.%26aulast%3DTsuboi%26aufirst%3DK.%26aulast%3DUyama%26aufirst%3DT.%26aulast%3DMasuda%26aufirst%3DK.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26aulast%3DHouchi%26aufirst%3DH.%26aulast%3DUeda%26aufirst%3DN.%26atitle%3DEndogenous%2520molecules%2520stimulating%2520N-acylethanolamine-hydrolyzing%2520acid%2520amidase%2520%2528NAAA%2529%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2012%26volume%3D3%26spage%3D379%26epage%3D385%26doi%3D10.1021%2Fcn300007s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bonezzi, F. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sasso, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pontis, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Realini, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romeo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ponzano, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nuzzi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fiasella, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertozzi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piomelli, D.</span></span> <span> </span><span class="NLM_article-title">An important role for N-acylethanolamine acid amidase in the complete Freund’s adjuvant rat model of arthritis</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>356</i></span>,  <span class="NLM_fpage">656</span>– <span class="NLM_lpage">663</span>, <span class="refDoi"> DOI: 10.1124/jpet.115.230516</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1124%2Fjpet.115.230516" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=26769918" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BC28XpvVeks7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=356&publication_year=2016&pages=656-663&author=F.+T.+Bonezziauthor=O.+Sassoauthor=S.+Pontisauthor=N.+Realiniauthor=E.+Romeoauthor=S.+Ponzanoauthor=A.+Nuzziauthor=A.+Fiasellaauthor=F.+Bertozziauthor=D.+Piomelli&title=An+important+role+for+N-acylethanolamine+acid+amidase+in+the+complete+Freund%E2%80%99s+adjuvant+rat+model+of+arthritis&doi=10.1124%2Fjpet.115.230516"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">An important role for N-acylethanolamine acid amidase in the complete Freund's adjuvant rat model of arthritis</span></div><div class="casAuthors">Bonezzi, F. T.; Sasso, O.; Pontis, S.; Realini, N.; Romeo, E.; Ponzano, S.; Nuzzi, A.; Fiasella, A.; Bertozzi, F.; Piomelli, D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">356</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">656-663</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The endogenous lipid amides, palmitoylethanolamide (PEA) and oleoylethanolamide (OEA), exert marked antinociceptive and anti-inflammatory effects in animal models by engaging nuclear peroxisome proliferator-activated receptor-α.  PEA and OEA are produced by macrophages and other host-defense cells and are deactivated by the cysteine amidase, N-acylethanolamine acid amidase (NAAA), which is highly expressed in macrophages and B-lymphocytes.  In the present study, we examd. whether (a) NAAA might be involved in the inflammatory reaction triggered by injection of complete Freund's adjuvant (CFA) into the rat paw and (b) administration of 4-cyclohexylbutyl-N-[(S)-2-oxoazetidin-3-yl]-carbamate (ARN726), a novel systemically active NAAA inhibitor, attenuates such reaction.  Injection of CFA into the paw produced local edema and heat hyperalgesia, which were accompanied by decreased PEA and OEA content (assessed by liq. chromatog./mass spectrometry) and increased NAAA levels (assessed by Western blot and ex vivo enzyme activity measurements) in paw tissue.  Administration of undec-10-ynyl-N-[(3S)-2-oxoazetidin-3-yl] carbamate (ARN14686), a NAAA-preferring activity-based probe, revealed that NAAA was catalytically active in CFA-treated paws.  Administration of ARN726 reduced NAAA activity and restored PEA and OEA levels in inflamed tissues, and significantly decreased CFA-induced inflammatory symptoms, including pus prodn. and myeloperoxidase activity.  The results confirm the usefulness of ARN726 as a probe to investigate the functions of NAAA in health and disease and suggest that this enzyme may provide a new mol. target for the treatment of arthritis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoG6IIltfdLQbVg90H21EOLACvtfcHk0liPKl2vc-UPSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XpvVeks7s%253D&md5=5ce843469c81ad112b95c9a59a8bfbe5</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1124%2Fjpet.115.230516&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.115.230516%26sid%3Dliteratum%253Aachs%26aulast%3DBonezzi%26aufirst%3DF.%2BT.%26aulast%3DSasso%26aufirst%3DO.%26aulast%3DPontis%26aufirst%3DS.%26aulast%3DRealini%26aufirst%3DN.%26aulast%3DRomeo%26aufirst%3DE.%26aulast%3DPonzano%26aufirst%3DS.%26aulast%3DNuzzi%26aufirst%3DA.%26aulast%3DFiasella%26aufirst%3DA.%26aulast%3DBertozzi%26aufirst%3DF.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DAn%2520important%2520role%2520for%2520N-acylethanolamine%2520acid%2520amidase%2520in%2520the%2520complete%2520Freund%25E2%2580%2599s%2520adjuvant%2520rat%2520model%2520of%2520arthritis%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2016%26volume%3D356%26spage%3D656%26epage%3D663%26doi%3D10.1124%2Fjpet.115.230516" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span> <span> </span><span class="NLM_article-title">N-Acylethanolamine acid amidase (NAAA) inhibitor F215 as a novel therapeutic agent for osteoarthritis</span>. <i>Pharmacol. Res.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>145</i></span>,  <span class="NLM_fpage">104264</span>, <span class="refDoi"> DOI: 10.1016/j.phrs.2019.104264</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1016%2Fj.phrs.2019.104264" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=31063807" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A280%3ADC%252BB3M7jt1yktg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=145&publication_year=2019&pages=104264&author=P.+Zhouauthor=L.+Xiangauthor=Y.+Yangauthor=Y.+Wuauthor=T.+Huauthor=X.+Liuauthor=F.+Linauthor=Y.+Xiuauthor=K.+Wuauthor=C.+Luauthor=J.+Renauthor=Y.+Qiuauthor=Y.+Li&title=N-Acylethanolamine+acid+amidase+%28NAAA%29+inhibitor+F215+as+a+novel+therapeutic+agent+for+osteoarthritis&doi=10.1016%2Fj.phrs.2019.104264"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">N-Acylethanolamine acid amidase (NAAA) inhibitor F215 as a novel therapeutic agent for osteoarthritis</span></div><div class="casAuthors">Zhou Pan; Ren Jie; Xiang Lei; Yang Yulong; Wu Yuezhou; Hu Ting; Liu Xiaolong; Lu Canzhong; Lin Feitai; Xiu Yanghui; Wu Kangni; Qiu Yan; Li Yuhang</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological research</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">145</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">104264</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Osteoarthritis (OA), characterized by cartilage damage, synovitis inflammation and chronic pain, is a common degenerative joint disease that may lead to physical disability.  In the present study, we first explored the association between N-Acylethanolamine acid amidase (NAAA) and OA progression, and then examined the capability of the NAAA inhibitor F215 to attenuate osteoarthritis.  Increased NAAA expressions and decreased PEA levels in synovial membrane and lumbar spinal cord were observed in MIA induced osteoarthritic rats.  F215 (i.a., and i.p.) significantly protected against cartilage damage and synovial inflammation by directly increasing PEA levels in joints, or normalization of PEA levels and resolution of inflammation in spinal cord.  Moreover, F215 also markedly alleviated osteoarthritic pain in rats, and the therapeutic effects of F215 were blocked by the PPAR-α antagonist MK886.  The results revealed that NAAA may has been implicated in OA progression, and treatment with NAAA inhibitor F215 alleviated OA development by preventing cartilage damage, reducing inflammation, and alleviating pain.  Our study suggested that NAAA inhibitor might be a novel therapeutic agent for OA treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSiFosVJ8cipUmhnSqMnvzDfW6udTcc2ebUKSZsPlBMArntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3M7jt1yktg%253D%253D&md5=a02aedafa3ee92e2182f4a6a45bd5cd3</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1016%2Fj.phrs.2019.104264&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phrs.2019.104264%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DP.%26aulast%3DXiang%26aufirst%3DL.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DHu%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DLin%26aufirst%3DF.%26aulast%3DXiu%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DK.%26aulast%3DLu%26aufirst%3DC.%26aulast%3DRen%26aufirst%3DJ.%26aulast%3DQiu%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DY.%26atitle%3DN-Acylethanolamine%2520acid%2520amidase%2520%2528NAAA%2529%2520inhibitor%2520F215%2520as%2520a%2520novel%2520therapeutic%2520agent%2520for%2520osteoarthritis%26jtitle%3DPharmacol.%2520Res.%26date%3D2019%26volume%3D145%26spage%3D104264%26doi%3D10.1016%2Fj.phrs.2019.104264" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Suárez, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romero-Zerbo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Márquez, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivera, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iglesias, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bermúdez-Silva, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andreu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodríguez
de Fonseca, F.</span></span> <span> </span><span class="NLM_article-title">Ulcerative colitis impairs the acylethanolamide-based anti-inflammatory system reversal by 5-aminosalicylic acid and glucocorticoids</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">e37729</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0037729</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1371%2Fjournal.pone.0037729" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=22662201" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BC38XotF2hu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=e37729&author=J.+Su%C3%A1rezauthor=Y.+Romero-Zerboauthor=L.+M%C3%A1rquezauthor=P.+Riveraauthor=M.+Iglesiasauthor=F.+J.+Berm%C3%BAdez-Silvaauthor=M.+Andreuauthor=F.+Rodr%C3%ADguez%0Ade+Fonseca&title=Ulcerative+colitis+impairs+the+acylethanolamide-based+anti-inflammatory+system+reversal+by+5-aminosalicylic+acid+and+glucocorticoids&doi=10.1371%2Fjournal.pone.0037729"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Ulcerative colitis impairs the acylethanolamide-based anti-inflammatory system reversal by 5-aminosalicylic acid and glucocorticoids</span></div><div class="casAuthors">Suarez, Juan; Romero-Zerbo, Yanina; Marquez, Lucia; Rivera, Patricia; Iglesias, Mar; Bermudez-Silva, Francisco J.; Andreu, Montserrat; de Fonseca, Fernando Rodriguez</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">e37729</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Studies in animal models and humans suggest anti-inflammatory roles on the N-acylethanolamide (NAE)-peroxisome proliferators activated receptor alpha (PPARα) system in inflammatory bowel diseases.  However, the presence and function of NAE-PPARα signaling system in the ulcerative colitis (UC) of humans remain unknown as well as its response to active anti-inflammatory therapies such as 5-aminosalicylic acid (5-ASA) and glucocorticoids.  Expression of PPARα receptor and PPARα ligands-biosynthetic (NAPE-PLD) and -degrading (FAAH and NAAA) enzymes were analyzed in untreated active and 5-ASA/glucocorticoids/immunomodulators-treated quiescent UC patients compared to healthy human colonic tissue by RT-PCR and immunohistochem. analyses.  PPARα, NAAA, NAPE-PLD, and FAAH showed differential distributions in the colonic epithelium, lamina propria, smooth muscle, and enteric plexus.  Gene expression anal. indicated a decrease of PPARα, PPARγ, and NAAA, and an increase of FAAH and iNOS in the active colitis mucosa.  Immunohistochem. expression in active colitis epithelium confirmed a PPARα decrease, but showed a sharp NAAA increase and a NAPE-PLD decrease, which were partially restored to control levels after treatment.  We also characterized the immune cells of the UC mucosa infiltrate.  We detected a decreased no. of NAAA-pos. and an increased no. of FAAH-pos. immune cells in active UC, which were partially restored to control levels after treatment.  NAE-PPARα signaling system is impaired during active UC and 5-ASA/glucocorticoids treatment restored its normal expression.  Since 5-ASA actions may work through PPARα and glucocorticoids through NAE-producing/degrading enzymes, the use of PPARα agonists or FAAH/NAAA blockers that increases endogenous PPARα ligands may yield similar therapeutics advantages.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGriIHnoNNIqxbVg90H21EOLACvtfcHk0lifkzrtm6uQuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XotF2hu7s%253D&md5=c45410e561b64237af1ccd4d705d903a</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0037729&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0037729%26sid%3Dliteratum%253Aachs%26aulast%3DSu%25C3%25A1rez%26aufirst%3DJ.%26aulast%3DRomero-Zerbo%26aufirst%3DY.%26aulast%3DM%25C3%25A1rquez%26aufirst%3DL.%26aulast%3DRivera%26aufirst%3DP.%26aulast%3DIglesias%26aufirst%3DM.%26aulast%3DBerm%25C3%25BAdez-Silva%26aufirst%3DF.%2BJ.%26aulast%3DAndreu%26aufirst%3DM.%26aulast%3DRodr%25C3%25ADguez%2Bde%2BFonseca%26aufirst%3DF.%26atitle%3DUlcerative%2520colitis%2520impairs%2520the%2520acylethanolamide-based%2520anti-inflammatory%2520system%2520reversal%2520by%25205-aminosalicylic%2520acid%2520and%2520glucocorticoids%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26spage%3De37729%26doi%3D10.1371%2Fjournal.pone.0037729" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Solorzano, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Battista, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Astarita, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lodola, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivara, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mor, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maccarrone, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antonietti, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duranti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tontini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuzzocrea, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarzia, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piomelli, D.</span></span> <span> </span><span class="NLM_article-title">Selective N-acylethanolamine-hydrolyzing acid amidase inhibition reveals a key role for endogenous palmitoylethanolamide in inflammation</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>106</i></span>,  <span class="NLM_fpage">20966</span>– <span class="NLM_lpage">20971</span>, <span class="refDoi"> DOI: 10.1073/pnas.0907417106</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1073%2Fpnas.0907417106" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=19926854" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksFygsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2009&pages=20966-20971&author=C.+Solorzanoauthor=C.+Zhuauthor=N.+Battistaauthor=G.+Astaritaauthor=A.+Lodolaauthor=S.+Rivaraauthor=M.+Morauthor=R.+Russoauthor=M.+Maccarroneauthor=F.+Antoniettiauthor=A.+Durantiauthor=A.+Tontiniauthor=S.+Cuzzocreaauthor=G.+Tarziaauthor=D.+Piomelli&title=Selective+N-acylethanolamine-hydrolyzing+acid+amidase+inhibition+reveals+a+key+role+for+endogenous+palmitoylethanolamide+in+inflammation&doi=10.1073%2Fpnas.0907417106"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Selective N-acylethanolamine-hydrolyzing acid amidase inhibition reveals a key role for endogenous palmitoylethanolamide in inflammation</span></div><div class="casAuthors">Solorzano, Carlos; Zhu, Chenggang; Battista, Natalia; Astarita, Giuseppe; Lodola, Alessio; Rivara, Silvia; Mor, Marco; Russo, Roberto; Maccarrone, Mauro; Antonietti, Francesca; Duranti, Andrea; Tontini, Andrea; Cuzzocrea, Salvatore; Tarzia, Giorgio; Piomelli, Daniele</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">49</span>),
    <span class="NLM_cas:pages">20966-20971, S20966/1-S20966/13</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Identifying points of control in inflammation is essential to discovering safe and effective antiinflammatory medicines.  Palmitoylethanolamide (PEA) is a naturally occurring lipid amide that, when administered as a drug, inhibits inflammatory responses by engaging peroxisome proliferator-activated receptor-α (PPAR-α).  PEA is preferentially hydrolyzed by the cysteine amidase N- acylethanolamine-hydrolyzing acid amidase (NAAA), which is highly expressed in macrophages.  Here we report the discovery of a potent and selective NAAA inhibitor, N-[(3S)-2-oxo-3-oxetanyl]-3-phenylpropanamide [(S)-OOPP], and show that this inhibitor increases PEA levels in activated leukocytes and blunts responses induced by inflammatory stimuli both in vitro and in vivo.  These effects are stereoselective, mimicked by exogenous PEA, and abolished by PPAR-α deletion.  (S)-OOPP also attenuates inflammation and tissue damage and improves recovery of motor function in mice subjected to spinal cord trauma.  The results suggest that PEA activation of PPAR-α in leukocytes serves as an early stop signal that contrasts the progress of inflammation.  The PEA-hydrolyzing amidase NAAA may provide a previously undescribed target for antiinflammatory medicines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojUMad22TONbVg90H21EOLACvtfcHk0lifkzrtm6uQuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksFygsA%253D%253D&md5=9e8f84c9aabfc0d7c9d382d5a4c57706</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0907417106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0907417106%26sid%3Dliteratum%253Aachs%26aulast%3DSolorzano%26aufirst%3DC.%26aulast%3DZhu%26aufirst%3DC.%26aulast%3DBattista%26aufirst%3DN.%26aulast%3DAstarita%26aufirst%3DG.%26aulast%3DLodola%26aufirst%3DA.%26aulast%3DRivara%26aufirst%3DS.%26aulast%3DMor%26aufirst%3DM.%26aulast%3DRusso%26aufirst%3DR.%26aulast%3DMaccarrone%26aufirst%3DM.%26aulast%3DAntonietti%26aufirst%3DF.%26aulast%3DDuranti%26aufirst%3DA.%26aulast%3DTontini%26aufirst%3DA.%26aulast%3DCuzzocrea%26aufirst%3DS.%26aulast%3DTarzia%26aufirst%3DG.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DSelective%2520N-acylethanolamine-hydrolyzing%2520acid%2520amidase%2520inhibition%2520reveals%2520a%2520key%2520role%2520for%2520endogenous%2520palmitoylethanolamide%2520in%2520inflammation%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2009%26volume%3D106%26spage%3D20966%26epage%3D20971%26doi%3D10.1073%2Fpnas.0907417106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">De
Filippis, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Amico, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cinelli, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esposito, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Marzo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iuvone, T.</span></span> <span> </span><span class="NLM_article-title">Adelmidrol, a palmitoylethanolamide analogue, reduces chronic inflammation in a carrageenin-granuloma model in rats</span>. <i>J. Cell. Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">1086</span>– <span class="NLM_lpage">1095</span>, <span class="refDoi"> DOI: 10.1111/j.1582-4934.2008.00353.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1111%2Fj.1582-4934.2008.00353.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=18429935" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVSnurbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2009&pages=1086-1095&author=D.+De%0AFilippisauthor=A.+D%E2%80%99Amicoauthor=M.+P.+Cinelliauthor=G.+Espositoauthor=V.+Di+Marzoauthor=T.+Iuvone&title=Adelmidrol%2C+a+palmitoylethanolamide+analogue%2C+reduces+chronic+inflammation+in+a+carrageenin-granuloma+model+in+rats&doi=10.1111%2Fj.1582-4934.2008.00353.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Adelmidrol, a palmitoylethanolamide analogue, reduces chronic inflammation in a carrageenin-granuloma model in rats</span></div><div class="casAuthors">De Filippis, Daniele; D'Amico, Alessandra; Cinelli, Maria Pia; Esposito, Giuseppe; Di Marzo, Vicenzo; Iuvone, Teresa</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cellular and Molecular Medicine</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1086-1095</span>CODEN:
                <span class="NLM_cas:coden">JCMMC9</span>;
        ISSN:<span class="NLM_cas:issn">1582-1838</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Palmitoylethanolamide (PEA) and some of its analogs have shown great efficacy in the treatment of pain and inflammation.  Adelmidrol - the International Nonproprietary Name (INN) of the di-amide deriv. of azelaic acid - is one of these analogs.  The anti-inflammatory and analgesic effects of PEA and adelmidrol are hypothesized to be mediated, at least in part, by mast cell down-modulation.  Mast cell mediators released at early stage of the inflammatory process drive the inflammatory reaction to chronicity as it happens in λ-carrageenin-induced granulomatous tissue formation.  In the present study, the choice of testing adelmidrol depends upon the physicochem. properties of the compd., i.e. the amphipatic feature, that make it more easily sol. than PEA.  In this study, we investigated the effect of adelmidrol on granuloma formation induced by λ-carrageenin-soaked sponge implant in rats.  Our results show that the local administration of the compd. under study significantly decreases wt. and neo-angiogenesis in granulomatous tissue.  The anti-inflammatory effect was due to the modulation of mast cells degranulation, as shown by histol. anal. and by the inhibition of the release of several pro-inflammatory and pro-angiogenic enzymes (e.g. iNOS, chymase and metalloproteinase MMP-9), and mediators (e.g. nitric oxide and TNF-α).  The results indicate that adelmidrol, given locally, may represent a potential therapeutic tool in controlling chronic inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKwzhZCaiWf7Vg90H21EOLACvtfcHk0lifkzrtm6uQuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVSnurbF&md5=1b88fa81c701afc18c4f7a8987f90811</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1111%2Fj.1582-4934.2008.00353.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1582-4934.2008.00353.x%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BFilippis%26aufirst%3DD.%26aulast%3DD%25E2%2580%2599Amico%26aufirst%3DA.%26aulast%3DCinelli%26aufirst%3DM.%2BP.%26aulast%3DEsposito%26aufirst%3DG.%26aulast%3DDi%2BMarzo%26aufirst%3DV.%26aulast%3DIuvone%26aufirst%3DT.%26atitle%3DAdelmidrol%252C%2520a%2520palmitoylethanolamide%2520analogue%252C%2520reduces%2520chronic%2520inflammation%2520in%2520a%2520carrageenin-granuloma%2520model%2520in%2520rats%26jtitle%3DJ.%2520Cell.%2520Mol.%2520Med.%26date%3D2009%26volume%3D13%26spage%3D1086%26epage%3D1095%26doi%3D10.1111%2Fj.1582-4934.2008.00353.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">De
Filippis, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Amico, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cipriano, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petrosino, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orlando, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Marzo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iuvone, T.</span></span> <span> </span><span class="NLM_article-title">Levels of endocannabinoids and palmitoylethanolamide and their pharmacological manipulation in chronic granulomatous inflammation in rats</span>. <i>Pharmacol. Res.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">321</span>– <span class="NLM_lpage">328</span>, <span class="refDoi"> DOI: 10.1016/j.phrs.2009.11.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1016%2Fj.phrs.2009.11.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=19931394" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjt1WjtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2010&pages=321-328&author=D.+De%0AFilippisauthor=A.+D%E2%80%99Amicoauthor=M.+Ciprianoauthor=S.+Petrosinoauthor=P.+Orlandoauthor=V.+Di+Marzoauthor=T.+Iuvone&title=Levels+of+endocannabinoids+and+palmitoylethanolamide+and+their+pharmacological+manipulation+in+chronic+granulomatous+inflammation+in+rats&doi=10.1016%2Fj.phrs.2009.11.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Levels of endocannabinoids and palmitoylethanolamide and their pharmacological manipulation in chronic granulomatous inflammation in rats</span></div><div class="casAuthors">De Filippis, D.; D'Amico, A.; Cipriano, M.; Petrosino, S.; Orlando, P.; Di Marzo, V.; Iuvone, T.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">321-328</span>CODEN:
                <span class="NLM_cas:coden">PHMREP</span>;
        ISSN:<span class="NLM_cas:issn">1043-6618</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The endocannabinoids anandamide and 2-arachidonoylglycerol, and the anandamide-congener, palmitoylethanolamide, are all substrates for the enzyme fatty acid amide hydrolase, and are endowed with anti-inflammatory actions exerted via cannabinoid receptors or, in the case of palmitoylethanolamide, also via other targets.  We investigated the role of the endocannabinoid system during granuloma formation, a model of chronic inflammation sustained by neoangiogenesis, in rats.  Granuloma was induced by s.c. λ-carrageenin-soaked sponge implants on the back of male Wistar rats.  After 96 h, granulomas were detached and tissue formation was evaluated as wet wt.; the endocannabinoid system was evaluated by the measurement of endocannabinoid levels, by LC-MS, and of cannabinoid receptor expression, by western blot anal.  Moreover, angiogenesis was evaluated by the measurement of both Hb content and CD31 protein expression.  Arachidonoylserotonin (AA-5-HT, 12.5-50 μg/mL), an inhibitor of FAAH, and palmitoylethanolamide (PEA, 200-800 μg/mL) were given locally only once at the time of implantation.  Granuloma formation was accompanied by a significant decrease in endocannabinoid and palmitoylethanolamide levels paralleled by increased levels of the fatty acid amide hydrolase, responsible for their breakdown.  Moreover, an increase of cannabinoid receptor expression was also obsd.  Pharmacol. elevation of endocannabinoids and palmitoylethanolamide, obtained sep. by arachidonoylserotonin and exogenous palmitoylethanolamide treatment, dose-dependently reduced inflammatory hallmarks including tumor necrosis factor-α as well as granuloma-dependent angiogenesis.  The effect of arachidonoylserotonin was accompanied by near-normalization of 2-arachidonoylglycerol and palmitoylethanolamide levels in the tissue.  These findings suggest that chronic inflammation might develop also because of endocannabinoid and palmitoylethanolamide tissue concn. impairment, the correction of which might be exploited to develop new anti-inflammatory drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0U7KGQJfjHrVg90H21EOLACvtfcHk0ljrw37yUbo42Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjt1WjtL0%253D&md5=c3c90d719ce22f0b36170c9afb79157e</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1016%2Fj.phrs.2009.11.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phrs.2009.11.005%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BFilippis%26aufirst%3DD.%26aulast%3DD%25E2%2580%2599Amico%26aufirst%3DA.%26aulast%3DCipriano%26aufirst%3DM.%26aulast%3DPetrosino%26aufirst%3DS.%26aulast%3DOrlando%26aufirst%3DP.%26aulast%3DDi%2BMarzo%26aufirst%3DV.%26aulast%3DIuvone%26aufirst%3DT.%26atitle%3DLevels%2520of%2520endocannabinoids%2520and%2520palmitoylethanolamide%2520and%2520their%2520pharmacological%2520manipulation%2520in%2520chronic%2520granulomatous%2520inflammation%2520in%2520rats%26jtitle%3DPharmacol.%2520Res.%26date%3D2010%26volume%3D61%26spage%3D321%26epage%3D328%26doi%3D10.1016%2Fj.phrs.2009.11.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Capasso, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Izzo, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fezza, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinto, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capasso, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mascolo, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Marzo, V.</span></span> <span> </span><span class="NLM_article-title">Inhibitory effect of palmitoylethanolamide on gastrointestinal motility in mice</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>134</i></span>,  <span class="NLM_fpage">945</span>– <span class="NLM_lpage">950</span>, <span class="refDoi"> DOI: 10.1038/sj.bjp.0704339</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1038%2Fsj.bjp.0704339" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=11682441" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BD3MXosVGrs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2001&pages=945-950&author=R.+Capassoauthor=A.+A.+Izzoauthor=F.+Fezzaauthor=A.+Pintoauthor=F.+Capassoauthor=N.+Mascoloauthor=V.+Di+Marzo&title=Inhibitory+effect+of+palmitoylethanolamide+on+gastrointestinal+motility+in+mice&doi=10.1038%2Fsj.bjp.0704339"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitory effect of palmitoylethanolamide on gastrointestinal motility in mice</span></div><div class="casAuthors">Capasso, Raffaele; Izzo, Angelo A.; Fezza, Filomena; Pinto, Aldo; Capasso, Francesco; Mascolo, Nicola; Di Marzo, Vincenzo</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">134</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">945-950</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">We have studied the effect of palmitoylethanolamide (PEA, 2.5-30 mg kg-1, i.p.) on upper gastrointestinal transit in control mice and in mice with chronic intestinal inflammation induced by croton oil.  PEA significantly and dose-dependently decreased intestinal transit.  The inhibitory effect of PEA (10 mg kg-1) was not modified by the cannabinoid CB1 receptor antagonist SR141716A (0.3 mg kg-1, i.p.), the cannabinoid CB2 receptor antagonist SR144528 (1 mg kg-1, i.p.), NG-nitro-L-arginine Me ester (L-NAME, 25 mg kg-1, i.p.), yohimbine (1 mg kg-1, i.p.), naloxone (2 mg kg-1, i.p.) or hexamethonium (1 mg kg-1, i.p.).  PEA levels were significantly decreased in the small intestine of croton oil-treated mice.  In these animals, PEA also inhibited motility and this effect was not counteracted by SR141716A (0.3 mg kg-1), or SR144528 (1 mg kg-1).  Pre-treatment of mice with the amidase inhibitor phenylmethyl sulfonil fluoride (PMSF, 30 mg kg-1, i.p.) did not modify the inhibitory effect of PEA, either in control or in mice with inflammation.  It is concluded that PEA inhibits intestinal motility with a peripheral mechanism independent from cannabinoid receptor activation.  The decreased levels of PEA in croton oil-treated might contribute, at least in part, to the exaggerated transit obsd. during chronic intestinal inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqky9EFVASu3bVg90H21EOLACvtfcHk0ljrw37yUbo42Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXosVGrs7s%253D&md5=054b9a49959938ac21fb4d3f07c2c6bb</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0704339&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0704339%26sid%3Dliteratum%253Aachs%26aulast%3DCapasso%26aufirst%3DR.%26aulast%3DIzzo%26aufirst%3DA.%2BA.%26aulast%3DFezza%26aufirst%3DF.%26aulast%3DPinto%26aufirst%3DA.%26aulast%3DCapasso%26aufirst%3DF.%26aulast%3DMascolo%26aufirst%3DN.%26aulast%3DDi%2BMarzo%26aufirst%3DV.%26atitle%3DInhibitory%2520effect%2520of%2520palmitoylethanolamide%2520on%2520gastrointestinal%2520motility%2520in%2520mice%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2001%26volume%3D134%26spage%3D945%26epage%3D950%26doi%3D10.1038%2Fsj.bjp.0704339" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Izzo, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capasso, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aviello, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borrelli, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romano, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piscitelli, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capasso, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orlando, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Marzo, V.</span></span> <span> </span><span class="NLM_article-title">Inhibitory effect of cannabichromene, a major non-psychotropic cannabinoid extracted from Cannabis sativa, on inflammation-induced hypermotility in mice</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>166</i></span>,  <span class="NLM_fpage">1444</span>– <span class="NLM_lpage">1460</span>, <span class="refDoi"> DOI: 10.1111/j.1476-5381.2012.01879.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1111%2Fj.1476-5381.2012.01879.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=22300105" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BC38XotlWmtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=166&publication_year=2012&pages=1444-1460&author=A.+A.+Izzoauthor=R.+Capassoauthor=G.+Avielloauthor=F.+Borrelliauthor=B.+Romanoauthor=F.+Piscitelliauthor=L.+Galloauthor=F.+Capassoauthor=P.+Orlandoauthor=V.+Di+Marzo&title=Inhibitory+effect+of+cannabichromene%2C+a+major+non-psychotropic+cannabinoid+extracted+from+Cannabis+sativa%2C+on+inflammation-induced+hypermotility+in+mice&doi=10.1111%2Fj.1476-5381.2012.01879.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitory effect of cannabichromene, a major non-psychotropic cannabinoid extracted from Cannabis sativa, on inflammation-induced hypermotility in mice</span></div><div class="casAuthors">Izzo, Angelo A.; Capasso, Raffaele; Aviello, Gabriella; Borrelli, Francesca; Romano, Barbara; Piscitelli, Fabiana; Gallo, Laura; Capasso, Francesco; Orlando, Pierangelo; Di Marzo, Vincenzo</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">166</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1444-1460</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background and Purpose Cannabichromene (CBC) is a major non-psychotropic phytocannabinoid that inhibits endocannabinoid inactivation and activates the transient receptor potential ankyrin-1 (TRPA1).  Both endocannabinoids and TRPA1 may modulate gastrointestinal motility.  Here, we investigated the effect of CBC on mouse intestinal motility in physiol. and pathol. states.  Exptl. Approach Inflammation was induced in the mouse small intestine by croton oil.  Endocannabinoid (anandamide and 2-arachidonoyl glycerol), palmitoylethanolamide and oleoylethanolamide levels were measured by liq. chromatog.-mass spectrometry; TRPA1 and cannabinoid receptors were analyzed by quant. RT-PCR; upper gastrointestinal transit, colonic propulsion and whole gut transit were evaluated in vivo; contractility was evaluated in vitro by stimulating the isolated ileum, in an organ bath, with ACh or elec. field stimulation (EFS).  Key Results Croton oil administration was assocd. with decreased levels of anandamide (but not 2-arachidonoyl glycerol) and palmitoylethanolamide, up-regulation of TRPA1 and CB1 receptors and down-regulation of CB2 receptors.  Ex vivo CBC did not change endocannabinoid levels, but it altered the mRNA expression of TRPA1 and cannabinoid receptors.  In vivo, CBC did not affect motility in control mice, but normalized croton oil-induced hypermotility.  In vitro, CBC reduced preferentially EFS-vs. ACh-induced contractions.  Both in vitro and in vivo, the inhibitory effect of CBC was not modified by cannabinoid or TRPA1 receptor antagonists.  Conclusion and Implications CBC selectively reduces inflammation-induced hypermotility in vivo in a manner that is not dependent on cannabinoid receptors or TRPA1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZGU21Iu5_krVg90H21EOLACvtfcHk0ljrw37yUbo42Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XotlWmtLg%253D&md5=4a9e11887c3575e1f76fbd3c0b8412de</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2012.01879.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2012.01879.x%26sid%3Dliteratum%253Aachs%26aulast%3DIzzo%26aufirst%3DA.%2BA.%26aulast%3DCapasso%26aufirst%3DR.%26aulast%3DAviello%26aufirst%3DG.%26aulast%3DBorrelli%26aufirst%3DF.%26aulast%3DRomano%26aufirst%3DB.%26aulast%3DPiscitelli%26aufirst%3DF.%26aulast%3DGallo%26aufirst%3DL.%26aulast%3DCapasso%26aufirst%3DF.%26aulast%3DOrlando%26aufirst%3DP.%26aulast%3DDi%2BMarzo%26aufirst%3DV.%26atitle%3DInhibitory%2520effect%2520of%2520cannabichromene%252C%2520a%2520major%2520non-psychotropic%2520cannabinoid%2520extracted%2520from%2520Cannabis%2520sativa%252C%2520on%2520inflammation-induced%2520hypermotility%2520in%2520mice%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2012%26volume%3D166%26spage%3D1444%26epage%3D1460%26doi%3D10.1111%2Fj.1476-5381.2012.01879.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pearson, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurian, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Latif, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garle, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barrett, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kendall, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scammell, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reeve, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chapman, V.</span></span> <span> </span><span class="NLM_article-title">Characterisation of the cannabinoid receptor system in synovial tissue and fluid in patients with osteoarthritis and rheumatoid arthritis</span>. <i>Arthritis Res. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">R43</span>, <span class="refDoi"> DOI: 10.1186/ar2401</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1186%2Far2401" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=18416822" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A280%3ADC%252BD1cvhtF2hsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2008&pages=R43&author=D.+Richardsonauthor=R.+G.+Pearsonauthor=N.+Kurianauthor=M.+L.+Latifauthor=M.+J.+Garleauthor=D.+A.+Barrettauthor=D.+A.+Kendallauthor=B.+E.+Scammellauthor=A.+J.+Reeveauthor=V.+Chapman&title=Characterisation+of+the+cannabinoid+receptor+system+in+synovial+tissue+and+fluid+in+patients+with+osteoarthritis+and+rheumatoid+arthritis&doi=10.1186%2Far2401"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Characterisation of the cannabinoid receptor system in synovial tissue and fluid in patients with osteoarthritis and rheumatoid arthritis</span></div><div class="casAuthors">Richardson Denise; Pearson Richard G; Kurian Nisha; Latif M Liaque; Garle Michael J; Barrett David A; Kendall David A; Scammell Brigitte E; Reeve Alison J; Chapman Victoria</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis research & therapy</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">R43</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">INTRODUCTION:  Cannabis-based medicines have a number of therapeutic indications, including anti-inflammatory and analgesic effects.  The endocannabinoid receptor system, including the cannabinoid receptor 1 (CB1) and receptor 2 (CB2) and the endocannabinoids, are implicated in a wide range of physiological and pathophysiological processes.  Pre-clinical and clinical studies have demonstrated that cannabis-based drugs have therapeutic potential in inflammatory diseases, including rheumatoid arthritis (RA) and multiple sclerosis.  The aim of this study was to determine whether the key elements of the endocannabinoid signalling system, which produces immunosuppression and analgesia, are expressed in the synovia of patients with osteoarthritis (OA) or RA.  METHODS:  Thirty-two OA and 13 RA patients undergoing total knee arthroplasty were included in this study.  Clinical staging was conducted from x-rays scored according to Kellgren-Lawrence and Larsen scales, and synovitis of synovial biopsies was graded.  Endocannabinoid levels were quantified in synovial fluid by liquid chromatography-mass spectrometry.  The expression of CB1 and CB2 protein and RNA in synovial biopsies was investigated.  Functional activity of these receptors was determined with mitogen-activated protein kinase assays.  To assess the impact of OA and RA on this receptor system, levels of endocannabinoids in the synovial fluid of patients and non-inflamed healthy volunteers were compared.  The activity of fatty acid amide hydrolase (FAAH), the predominant catabolic endocannabinoid enzyme, was measured in synovium.  RESULTS:  CB1 and CB2 protein and RNA were present in the synovia of OA and RA patients.  Cannabinoid receptor stimulation of fibroblast-like cells from OA and RA patients produced a time-dependent phosphorylation of extracellular signal-regulated kinase (ERK)-1 and ERK-2 which was significantly blocked by the CB1 antagonist SR141716A.  The endocannabinoids anandamide (AEA) and 2-arachidonyl glycerol (2-AG) were identified in the synovial fluid of OA and RA patients.  However, neither AEA nor 2-AG was detected in synovial fluid from normal volunteers.  FAAH was active in the synovia of OA and RA patients and was sensitive to inhibition by URB597 (3'-(aminocarbonyl) [1,1'-biphenyl]-3-yl)-cyclohexylcarbamate).  CONCLUSION:  Our data predict that the cannabinoid receptor system present in the synovium may be an important therapeutic target for the treatment of pain and inflammation associated with OA and RA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQlMMSg0l8H7AHqQV89nF-2fW6udTcc2ebfrpg1qiFfy7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1cvhtF2hsg%253D%253D&md5=74e8bf21212fb4b328ec9ae5310c5275</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1186%2Far2401&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Far2401%26sid%3Dliteratum%253Aachs%26aulast%3DRichardson%26aufirst%3DD.%26aulast%3DPearson%26aufirst%3DR.%2BG.%26aulast%3DKurian%26aufirst%3DN.%26aulast%3DLatif%26aufirst%3DM.%2BL.%26aulast%3DGarle%26aufirst%3DM.%2BJ.%26aulast%3DBarrett%26aufirst%3DD.%2BA.%26aulast%3DKendall%26aufirst%3DD.%2BA.%26aulast%3DScammell%26aufirst%3DB.%2BE.%26aulast%3DReeve%26aufirst%3DA.%2BJ.%26aulast%3DChapman%26aufirst%3DV.%26atitle%3DCharacterisation%2520of%2520the%2520cannabinoid%2520receptor%2520system%2520in%2520synovial%2520tissue%2520and%2520fluid%2520in%2520patients%2520with%2520osteoarthritis%2520and%2520rheumatoid%2520arthritis%26jtitle%3DArthritis%2520Res.%2520Ther.%26date%3D2008%26volume%3D10%26spage%3DR43%26doi%3D10.1186%2Far2401" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tsuboi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, L. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okamoto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Araki, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueno, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakamoto, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueda, N.</span></span> <span> </span><span class="NLM_article-title">Predominant expression of lysosomal N-acylethanolamine-hydrolyzing acid amidase in macrophages revealed by immunochemical studies</span>. <i>Biochim. Biophys. Acta, Mol. Cell Biol. Lipids</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>1771</i></span>,  <span class="NLM_fpage">623</span>– <span class="NLM_lpage">632</span>, <span class="refDoi"> DOI: 10.1016/j.bbalip.2007.03.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1016%2Fj.bbalip.2007.03.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=17462942" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BD2sXkvFGqurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1771&publication_year=2007&pages=623-632&author=K.+Tsuboiauthor=L.+Y.+Zhaoauthor=Y.+Okamotoauthor=N.+Arakiauthor=M.+Uenoauthor=H.+Sakamotoauthor=N.+Ueda&title=Predominant+expression+of+lysosomal+N-acylethanolamine-hydrolyzing+acid+amidase+in+macrophages+revealed+by+immunochemical+studies&doi=10.1016%2Fj.bbalip.2007.03.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Predominant expression of lysosomal N-acylethanolamine-hydrolyzing acid amidase in macrophages revealed by immunochemical studies</span></div><div class="casAuthors">Tsuboi, Kazuhito; Zhao, Li-Ying; Okamoto, Yasuo; Araki, Nobukazu; Ueno, Masaki; Sakamoto, Haruhiko; Ueda, Natsuo</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular and Cell Biology of Lipids</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">1771</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">623-632</span>CODEN:
                <span class="NLM_cas:coden">BBMLFG</span>;
        ISSN:<span class="NLM_cas:issn">1388-1981</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Bioactive N-acylethanolamines, including anandamide (an endocannabinoid), N-palmitoylethanolamine (an anti-inflammatory substance), and N-oleoylethanolamine (an anorexic substance) are enzymically hydrolyzed to fatty acids and ethanolamine.  Fatty acid amide hydrolase plays a major role in this reaction.  In addn., we cloned cDNA of an isoenzyme termed "N-acylethanolamine-hydrolyzing acid amidase (NAAA)" [K. Tsuboi, Y.-X. Sun, Y. Okamoto, N. Araki, T. Tonai, N. Ueda, Mol. characterization of N-acylethanolamine-hydrolyzing acid amidase, a novel member of the choloylglycine hydrolase family with structural and functional similarity to acid ceramidase, J. Biol. Chem. 280 (2005) 11082-11092].  Previous biochem. analyses suggested the expression of NAAA in macrophage cells and various rat tissues including lung and brain.  To clarify the physiol. significance of NAAA, here we immunochem. studied NAAA for the first time.  We developed an antibody specific for rat NAAA, and by Western blotting revealed that NAAA is glycosylated and subjected to specific proteolysis.  In alveolar macrophages isolated from rat lung, NAAA was immunocytochem. localized in lysosomes.  In the whole lung tissue, only alveolar macrophages were immunostained for NAAA.  Conformably, the mRNA and protein levels and activity of NAAA in alveolar macrophages were much higher than those in the whole lung tissue.  In brain, intraventricular macrophages were pos. stained with anti-NAAA antibody, while microglia appeared to be neg.  These results strongly suggested the importance of macrophages as an expression site of NAAA in rat tissues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowY-OXLo7L6LVg90H21EOLACvtfcHk0lhmQMks0s8kSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXkvFGqurY%253D&md5=4e3a565943630fb15763161bf5513577</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1016%2Fj.bbalip.2007.03.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbalip.2007.03.005%26sid%3Dliteratum%253Aachs%26aulast%3DTsuboi%26aufirst%3DK.%26aulast%3DZhao%26aufirst%3DL.%2BY.%26aulast%3DOkamoto%26aufirst%3DY.%26aulast%3DAraki%26aufirst%3DN.%26aulast%3DUeno%26aufirst%3DM.%26aulast%3DSakamoto%26aufirst%3DH.%26aulast%3DUeda%26aufirst%3DN.%26atitle%3DPredominant%2520expression%2520of%2520lysosomal%2520N-acylethanolamine-hydrolyzing%2520acid%2520amidase%2520in%2520macrophages%2520revealed%2520by%2520immunochemical%2520studies%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Cell%2520Biol.%2520Lipids%26date%3D2007%26volume%3D1771%26spage%3D623%26epage%3D632%26doi%3D10.1016%2Fj.bbalip.2007.03.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ribeiro, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pontis, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mengatto, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Armirotti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiurchiù, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capurro, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fiasella, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nuzzi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romeo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreno-Sanz, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maccarrone, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reggiani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarzia, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mor, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertozzi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bandiera, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piomelli, D.</span></span> <span> </span><span class="NLM_article-title">A potent systemically active N-acylethanolamine acid amidase inhibitor that suppresses inflammation and human macrophage activation</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">1838</span>– <span class="NLM_lpage">1846</span>, <span class="refDoi"> DOI: 10.1021/acschembio.5b00114</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.5b00114" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmsV2lsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=1838-1846&author=A.+Ribeiroauthor=S.+Pontisauthor=L.+Mengattoauthor=A.+Armirottiauthor=V.+Chiurchi%C3%B9author=V.+Capurroauthor=A.+Fiasellaauthor=A.+Nuzziauthor=E.+Romeoauthor=G.+Moreno-Sanzauthor=M.+Maccarroneauthor=A.+Reggianiauthor=G.+Tarziaauthor=M.+Morauthor=F.+Bertozziauthor=T.+Bandieraauthor=D.+Piomelli&title=A+potent+systemically+active+N-acylethanolamine+acid+amidase+inhibitor+that+suppresses+inflammation+and+human+macrophage+activation&doi=10.1021%2Facschembio.5b00114"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">A Potent Systemically Active N-Acylethanolamine Acid Amidase Inhibitor that Suppresses Inflammation and Human Macrophage Activation</span></div><div class="casAuthors">Ribeiro, Alison; Pontis, Silvia; Mengatto, Luisa; Armirotti, Andrea; Chiurchiu, Valerio; Capurro, Valeria; Fiasella, Annalisa; Nuzzi, Andrea; Romeo, Elisa; Moreno-Sanz, Guillermo; Maccarrone, Mauro; Reggiani, Angelo; Tarzia, Giorgio; Mor, Marco; Bertozzi, Fabio; Bandiera, Tiziano; Piomelli, Daniele</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1838-1846</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Fatty acid ethanolamides such as palmitoylethanolamide (PEA) and oleoylethanolamide (OEA) are lipid-derived mediators that potently inhibit pain and inflammation by ligating type-α peroxisome proliferator-activated receptors (PPAR-α).  These bioactive substances are preferentially degraded by the cysteine hydrolase, N-acylethanolamine acid amidase (NAAA), which is highly expressed in macrophages.  Here, we describe a new class of β-lactam derivs. that are potent, selective, and systemically active inhibitors of intracellular NAAA activity.  The prototype of this class deactivates NAAA by covalently binding the enzyme's catalytic cysteine and exerts profound anti-inflammatory effects in both mouse models and human macrophages.  This agent may be used to probe the functions of NAAA in health and disease and as a starting point to discover better anti-inflammatory drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrD6Y2cNKursLVg90H21EOLACvtfcHk0lhmQMks0s8kSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmsV2lsrw%253D&md5=a240d871adfc85b99c7e148600573217</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1021%2Facschembio.5b00114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.5b00114%26sid%3Dliteratum%253Aachs%26aulast%3DRibeiro%26aufirst%3DA.%26aulast%3DPontis%26aufirst%3DS.%26aulast%3DMengatto%26aufirst%3DL.%26aulast%3DArmirotti%26aufirst%3DA.%26aulast%3DChiurchi%25C3%25B9%26aufirst%3DV.%26aulast%3DCapurro%26aufirst%3DV.%26aulast%3DFiasella%26aufirst%3DA.%26aulast%3DNuzzi%26aufirst%3DA.%26aulast%3DRomeo%26aufirst%3DE.%26aulast%3DMoreno-Sanz%26aufirst%3DG.%26aulast%3DMaccarrone%26aufirst%3DM.%26aulast%3DReggiani%26aufirst%3DA.%26aulast%3DTarzia%26aufirst%3DG.%26aulast%3DMor%26aufirst%3DM.%26aulast%3DBertozzi%26aufirst%3DF.%26aulast%3DBandiera%26aufirst%3DT.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DA%2520potent%2520systemically%2520active%2520N-acylethanolamine%2520acid%2520amidase%2520inhibitor%2520that%2520suppresses%2520inflammation%2520and%2520human%2520macrophage%2520activation%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2015%26volume%3D10%26spage%3D1838%26epage%3D1846%26doi%3D10.1021%2Facschembio.5b00114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span>ImmGen. <a href="http://www.immgen.org" class="extLink">http://www.immgen.org</a> (accessed
Jan 28, 2020).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=ImmGen.+http%3A%2F%2Fwww.immgen.org+%28accessed%0AJan+28%2C+2020%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sasso, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Summa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Armirotti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pontis, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Mei, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piomelli, D.</span></span> <span> </span><span class="NLM_article-title">The N-acylethanolamine acid amidase inhibitor ARN077 suppresses inflammation and pruritus in a mouse model of allergic dermatitis</span>. <i>J. Invest. Dermatol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>138</i></span>,  <span class="NLM_fpage">562</span>– <span class="NLM_lpage">569</span>, <span class="refDoi"> DOI: 10.1016/j.jid.2017.07.853</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1016%2Fj.jid.2017.07.853" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=29054595" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitl2qtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=138&publication_year=2018&pages=562-569&author=O.+Sassoauthor=M.+Summaauthor=A.+Armirottiauthor=S.+Pontisauthor=C.+De+Meiauthor=D.+Piomelli&title=The+N-acylethanolamine+acid+amidase+inhibitor+ARN077+suppresses+inflammation+and+pruritus+in+a+mouse+model+of+allergic+dermatitis&doi=10.1016%2Fj.jid.2017.07.853"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">The N-Acylethanolamine Acid Amidase Inhibitor ARN077 Suppresses Inflammation and Pruritus in a Mouse Model of Allergic Dermatitis</span></div><div class="casAuthors">Sasso, O.; Summa, M.; Armirotti, A.; Pontis, S.; De Mei, C.; Piomelli, Daniele</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Investigative Dermatology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">138</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">562-569</span>CODEN:
                <span class="NLM_cas:coden">JIDEAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-202X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">N-acylethanolamine acid amidase (NAAA), a cysteine hydrolase highly expressed in macrophages and B lymphocytes, catalyzes the degrdn. of palmitoylethanolamide.  Palmitoylethanolamide is an agonist of PPAR-α and an important regulator of pain and innate immunity.  In this study, we investigated the properties of the NAAA inhibitor, ARN077, in a mouse model of allergic contact dermatitis.  Acute topical applications of ARN077 attenuated key signs of DNFB-induced dermatitis in a dose-dependent manner.  Moreover, ARN077 increased tissue palmitoylethanolamide content and normalized circulating levels of cytokines and IgE.  No such effect was seen in PPAR-α-deficient mice.  Moreover, mice lacking NAAA failed to develop edema or scratching behavior after challenge with DNFB, confirming that this enzyme plays an important role in dermatitis.  Consistent with this conclusion, subchronic applications of ARN077 suppressed DNFB-induced inflammation when administered either before or after the DNFB challenge.  The effects of subchronic ARN077 were dose dependent and comparable in size to those produced by the steroids clobetasol and dexamethasone.  Unlike the latter, however, ARN077 did not cause skin atrophy.  The results identify NAAA as a promising target for the development of effective and safe treatments for atopic dermatitis and other inflammatory disorders of the skin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGKONQ-rQpLbVg90H21EOLACvtfcHk0lidcFiz2tpKLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitl2qtr8%253D&md5=47e862197856ce83e51fc7c8a34ada85</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1016%2Fj.jid.2017.07.853&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jid.2017.07.853%26sid%3Dliteratum%253Aachs%26aulast%3DSasso%26aufirst%3DO.%26aulast%3DSumma%26aufirst%3DM.%26aulast%3DArmirotti%26aufirst%3DA.%26aulast%3DPontis%26aufirst%3DS.%26aulast%3DDe%2BMei%26aufirst%3DC.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DThe%2520N-acylethanolamine%2520acid%2520amidase%2520inhibitor%2520ARN077%2520suppresses%2520inflammation%2520and%2520pruritus%2520in%2520a%2520mouse%2520model%2520of%2520allergic%2520dermatitis%26jtitle%3DJ.%2520Invest.%2520Dermatol.%26date%3D2018%26volume%3D138%26spage%3D562%26epage%3D569%26doi%3D10.1016%2Fj.jid.2017.07.853" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, Y.</span></span> <span> </span><span class="NLM_article-title">Potential analgesic effects of a novel N-acylethanolamine acid amidase inhibitor F96 through PPAR-α</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">13565</span>, <span class="refDoi"> DOI: 10.1038/srep13565</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1038%2Fsrep13565" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=26310614" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVKhtLzK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&pages=13565&author=L.+Yangauthor=L.+Liauthor=L.+Chenauthor=Y.+Liauthor=H.+Chenauthor=Y.+Liauthor=G.+Jiauthor=D.+Linauthor=Z.+Liuauthor=Y.+Qiu&title=Potential+analgesic+effects+of+a+novel+N-acylethanolamine+acid+amidase+inhibitor+F96+through+PPAR-%CE%B1&doi=10.1038%2Fsrep13565"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Potential analgesic effects of a novel N-acylethanolamine acid amidase inhibitor F96 through PPAR-α</span></div><div class="casAuthors">Yang, Longhe; Li, Long; Chen, Ling; Li, Yanting; Chen, Huixia; Li, Yuhang; Ji, Guangnian; Lin, Donghai; Liu, Zuguo; Qiu, Yan</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">13565</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Pharmacol. blockade of N-acylethanolamine acid amidase (NAAA) activity is an available approach for inflammation and pain control through restoring the ability of endogenous PEA.  But the recently reported NAAA inhibitors suffer from the chem. and biol. unstable properties, which restrict functions of NAAA inhibition in vivo.  It is still unrevealed whether systematic inhibition of NAAA could modulate PEA-mediated pain signalings.  Here we reported an oxazolidinone imide compd. 3-(6-phenylhexanoyl) oxazolidin-2-one (F96), which potently and selectively inhibited NAAA activity (IC50 = 270 nM).  I.p. (i.p.) injection of F96 (3-30 mg/kg) dose-dependently reduced ear edema and restored PEA levels of ear tissues in 12-O-Tetradecanoylphorbol-13-acetate (TPA) induced ear edema models.  Furthermore, F96 inhibited acetic acid-induced writhing and increased spared nerve injury induced tactile allodynia thresholds in a dose-dependent manner.  Pharmacol. effects of F96 (10 mg/kg, i.p.) on various animal models were abolished in PPAR-α-/- mice, and were prevented by PPAR-α antagonist MK886 but not by canabinoid receptor type 1 (CB1) antagonist Rimonabant nor canabinoid receptor type 2 (CB2) antagonist SR144528.  Zebrafish embryos expts. showed better security and lower toxicity for F96 than ibuprofen.  These results revealed that F96 might be useful in treating inflammatory and neuropathic pain by NAAA inhibition depending on PPAR-α receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsP6tlGryp3LVg90H21EOLACvtfcHk0lidcFiz2tpKLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVKhtLzK&md5=237e107001c9eef18e130d12a0724300</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1038%2Fsrep13565&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep13565%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DJi%26aufirst%3DG.%26aulast%3DLin%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DQiu%26aufirst%3DY.%26atitle%3DPotential%2520analgesic%2520effects%2520of%2520a%2520novel%2520N-acylethanolamine%2520acid%2520amidase%2520inhibitor%2520F96%2520through%2520PPAR-%25CE%25B1%26jtitle%3DSci.%2520Rep.%26date%3D2015%26volume%3D5%26spage%3D13565%26doi%3D10.1038%2Fsrep13565" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Locascio, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lesniak, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roderick, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watt, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eklund, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang-James, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hauser, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grünblatt, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moran, L. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mandel, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riederer, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Federoff, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wüllner, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papapetropoulos, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Youdim, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cantuti-Castelvetri, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vance, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hedreen, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adler, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beach, T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graeber, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Middleton, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rochet, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scherzer, C. R.</span></span> <span> </span><span class="NLM_article-title">Global PD Gene Expression (GPEX) Consortium. PGC-1α, a potential therapeutic target for early intervention in Parkinson’s disease</span>. <i>Sci. Transl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">52ra73</span>, <span class="refDoi"> DOI: 10.1126/scitranslmed.3001059</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1126%2Fscitranslmed.3001059" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=20926834" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2010&pages=52ra73&author=B.+Zhengauthor=Z.+Liaoauthor=J.+J.+Locascioauthor=K.+A.+Lesniakauthor=S.+S.+Roderickauthor=M.+L.+Wattauthor=A.+C.+Eklundauthor=Y.+Zhang-Jamesauthor=P.+D.+Kimauthor=M.+A.+Hauserauthor=E.+Gr%C3%BCnblattauthor=L.+B.+Moranauthor=S.+A.+Mandelauthor=P.+Riedererauthor=R.+M.+Millerauthor=H.+J.+Federoffauthor=U.+W%C3%BCllnerauthor=S.+Papapetropoulosauthor=M.+B.+Youdimauthor=I.+Cantuti-Castelvetriauthor=A.+B.+Youngauthor=J.+M.+Vanceauthor=R.+L.+Davisauthor=J.+C.+Hedreenauthor=C.+H.+Adlerauthor=T.+G.+Beachauthor=M.+B.+Graeberauthor=F.+A.+Middletonauthor=J.+C.+Rochetauthor=C.+R.+Scherzer&title=Global+PD+Gene+Expression+%28GPEX%29+Consortium.+PGC-1%CE%B1%2C+a+potential+therapeutic+target+for+early+intervention+in+Parkinson%E2%80%99s+disease&doi=10.1126%2Fscitranslmed.3001059"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.3001059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.3001059%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DB.%26aulast%3DLiao%26aufirst%3DZ.%26aulast%3DLocascio%26aufirst%3DJ.%2BJ.%26aulast%3DLesniak%26aufirst%3DK.%2BA.%26aulast%3DRoderick%26aufirst%3DS.%2BS.%26aulast%3DWatt%26aufirst%3DM.%2BL.%26aulast%3DEklund%26aufirst%3DA.%2BC.%26aulast%3DZhang-James%26aufirst%3DY.%26aulast%3DKim%26aufirst%3DP.%2BD.%26aulast%3DHauser%26aufirst%3DM.%2BA.%26aulast%3DGr%25C3%25BCnblatt%26aufirst%3DE.%26aulast%3DMoran%26aufirst%3DL.%2BB.%26aulast%3DMandel%26aufirst%3DS.%2BA.%26aulast%3DRiederer%26aufirst%3DP.%26aulast%3DMiller%26aufirst%3DR.%2BM.%26aulast%3DFederoff%26aufirst%3DH.%2BJ.%26aulast%3DW%25C3%25BCllner%26aufirst%3DU.%26aulast%3DPapapetropoulos%26aufirst%3DS.%26aulast%3DYoudim%26aufirst%3DM.%2BB.%26aulast%3DCantuti-Castelvetri%26aufirst%3DI.%26aulast%3DYoung%26aufirst%3DA.%2BB.%26aulast%3DVance%26aufirst%3DJ.%2BM.%26aulast%3DDavis%26aufirst%3DR.%2BL.%26aulast%3DHedreen%26aufirst%3DJ.%2BC.%26aulast%3DAdler%26aufirst%3DC.%2BH.%26aulast%3DBeach%26aufirst%3DT.%2BG.%26aulast%3DGraeber%26aufirst%3DM.%2BB.%26aulast%3DMiddleton%26aufirst%3DF.%2BA.%26aulast%3DRochet%26aufirst%3DJ.%2BC.%26aulast%3DScherzer%26aufirst%3DC.%2BR.%26atitle%3DGlobal%2520PD%2520Gene%2520Expression%2520%2528GPEX%2529%2520Consortium.%2520PGC-1%25CE%25B1%252C%2520a%2520potential%2520therapeutic%2520target%2520for%2520early%2520intervention%2520in%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2010%26volume%3D2%26spage%3D52ra73%26doi%3D10.1126%2Fscitranslmed.3001059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Su, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kordower, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishida, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Federoff, H. J.</span></span> <span> </span><span class="NLM_article-title">PGC1α promoter methylation in Parkinson’s disease</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">e0134087</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0134087</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1371%2Fjournal.pone.0134087" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=26317511" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BC28XosVeisw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=e0134087&author=X.+Suauthor=Y.+Chuauthor=J.+H.+Kordowerauthor=B.+Liauthor=H.+Caoauthor=L.+Huangauthor=M.+Nishidaauthor=L.+Songauthor=D.+Wangauthor=H.+J.+Federoff&title=PGC1%CE%B1+promoter+methylation+in+Parkinson%E2%80%99s+disease&doi=10.1371%2Fjournal.pone.0134087"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">PCG1α promoter methylation in parkinson's</span></div><div class="casAuthors">Su, Xiaomin; Chu, Yaping; Kordower, Jeffrey H.; Li, Bin; Cao, Hong; Huang, Liang; Nishida, Maki; Song, Lei; Wang, Difei; Federoff, Howard J.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">e0134087/1-e0134087/24</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">The etiopathogenesis of sporadic Parkinson's disease (PD) remains elusive although mitochondrial dysfunction has long been implicated.  Recent evidence revealed reduced expression of peroxisome proliferator-activated receptor gamma coactivator α (PGC1α) and downstream regulated nuclear encoded respiratory complex genes in affected brain tissue from PD patients.  We sought to det. whether epigenetic modification of the PGC1α gene could account for diminished expression.  In substantia nigra from PD patients but not control subjects, we show significant promoter-proximal non-canonical cytosine methylation of the PGC1α gene but not an adjacent gene.  As neuroinflammation is a prominent feature of PD and a mediator of epigenetic change, we evaluated whether the pro-inflammatory fatty acid, palmitate, would stimulate PGC1α promoter methylation in different cell types from the CNS.  Indeed, in mouse primary cortical neurons, microglia and astrocytes, palmitate causes PGC1α gene promoter non-canonical cytosine methylation, reduced expression of the gene and reduced mitochondrial content.  Moreover, intracerebroventricular (ICV) injection of palmitate to transgenic human synuclein mutant mice resulted in increased PGC1α promoter methylation, decreased PGC1α expression and reduced mitochondrial content in substantia nigra.  Finally we provide evidence that dysregulation of ER stress and inflammatory signaling is assocd. with PGC1α promoter methylation.  Together, these data strengthen the connection between satd. fatty acids, neuroflammation, ER stress, epigenetic alteration and bioenergetic compromise in PD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0ke8RDhyA7LVg90H21EOLACvtfcHk0livxJq_ZiygfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XosVeisw%253D%253D&md5=8e65a52b339e5dcc4d39962a84f8215a</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0134087&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0134087%26sid%3Dliteratum%253Aachs%26aulast%3DSu%26aufirst%3DX.%26aulast%3DChu%26aufirst%3DY.%26aulast%3DKordower%26aufirst%3DJ.%2BH.%26aulast%3DLi%26aufirst%3DB.%26aulast%3DCao%26aufirst%3DH.%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DNishida%26aufirst%3DM.%26aulast%3DSong%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DD.%26aulast%3DFederoff%26aufirst%3DH.%2BJ.%26atitle%3DPGC1%25CE%25B1%2520promoter%2520methylation%2520in%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DPLoS%2520One%26date%3D2015%26volume%3D10%26spage%3De0134087%26doi%3D10.1371%2Fjournal.pone.0134087" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Korbecki, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bajdak-Rusinek, K.</span></span> <span> </span><span class="NLM_article-title">The effect of palmitic acid on inflammatory response in macrophages: an overview of molecular mechanisms</span>. <i>Inflammation Res.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>68</i></span>,  <span class="NLM_fpage">915</span>– <span class="NLM_lpage">932</span>, <span class="refDoi"> DOI: 10.1007/s00011-019-01273-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1007%2Fs00011-019-01273-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=31363792" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhsVOgt7vK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2019&pages=915-932&author=J.+Korbeckiauthor=K.+Bajdak-Rusinek&title=The+effect+of+palmitic+acid+on+inflammatory+response+in+macrophages%3A+an+overview+of+molecular+mechanisms&doi=10.1007%2Fs00011-019-01273-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">The effect of palmitic acid on inflammatory response in macrophages: an overview of molecular mechanisms</span></div><div class="casAuthors">Korbecki, Jan; Bajdak-Rusinek, Karolina</div><div class="citationInfo"><span class="NLM_cas:title">Inflammation Research</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">915-932</span>CODEN:
                <span class="NLM_cas:coden">INREFB</span>;
        ISSN:<span class="NLM_cas:issn">1023-3830</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Basel</span>)
        </div><div class="casAbstract">A review.  Palmitic acid is a satd. fatty acid whose blood concn. is elevated in obese patients.  This causes inflammatory responses, where toll-like receptors (TLR), TLR2 and TLR4, play an important role.  Nevertheless, palmitic acid is not only a TLR agonist.  In the cell, this fatty acid is converted into phospholipids, diacylglycerol and ceramides.  They trigger the activation of various signaling pathways that are common for LPS-mediated TLR4 activation.  In particular, metabolic products of palmitic acid affect the activation of various PKCs, ER stress and cause an increase in ROS generation.  Thanks to this, palmitic acid also strengthens the TLR4-induced signaling.  In this review, we discuss the mechanisms of inflammatory response induced by palmitic acid.  In particular, we focus on describing its effect on ER stress and IRE1α, and the mechanisms of NF-κB activation.  We also present the mechanisms of inflammasome NLRP3 activation and the effect of palmitic acid on enhanced inflammatory response by increasing the expression of FABP4/aP2.  Finally, we focus on the consequences of inflammatory responses, in particular, the effect of TNF-α, IL-1β and IL-6 on insulin resistance.  Due to the high importance of macrophages and the prodn. of proinflammatory cytokines by them, this work mainly focuses on these cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTpJNTdlIwQLVg90H21EOLACvtfcHk0liQ9OVbGq_RdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhsVOgt7vK&md5=781bc67fe4540acaa5b7eafd0b3cc2c4</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1007%2Fs00011-019-01273-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00011-019-01273-5%26sid%3Dliteratum%253Aachs%26aulast%3DKorbecki%26aufirst%3DJ.%26aulast%3DBajdak-Rusinek%26aufirst%3DK.%26atitle%3DThe%2520effect%2520of%2520palmitic%2520acid%2520on%2520inflammatory%2520response%2520in%2520macrophages%253A%2520an%2520overview%2520of%2520molecular%2520mechanisms%26jtitle%3DInflammation%2520Res.%26date%3D2019%26volume%3D68%26spage%3D915%26epage%3D932%26doi%3D10.1007%2Fs00011-019-01273-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Handschin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spiegelman, B. M.</span></span> <span> </span><span class="NLM_article-title">Peroxisome proliferator-activated receptor gamma coactivator 1 coactivators, energy homeostasis, and metabolism</span>. <i>Endocr. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">728</span>– <span class="NLM_lpage">735</span>, <span class="refDoi"> DOI: 10.1210/er.2006-0037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1210%2Fer.2006-0037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=17018837" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BD2sXns1Wrtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2006&pages=728-735&author=C.+Handschinauthor=B.+M.+Spiegelman&title=Peroxisome+proliferator-activated+receptor+gamma+coactivator+1+coactivators%2C+energy+homeostasis%2C+and+metabolism&doi=10.1210%2Fer.2006-0037"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Peroxisome proliferator-activated receptor γ coactivator 1 coactivators, energy homeostasis, and metabolism</span></div><div class="casAuthors">Handschin, Christoph; Spiegelman, Bruce M.</div><div class="citationInfo"><span class="NLM_cas:title">Endocrine Reviews</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">728-735</span>CODEN:
                <span class="NLM_cas:coden">ERVIDP</span>;
        ISSN:<span class="NLM_cas:issn">0163-769X</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">A review.  Many biol. programs are regulated at the transcriptional level.  This is generally achieved by the concerted actions of several transcription factors.  Recent findings have shown that, in many cases, transcriptional coactivators coordinate the overall regulation of the biol. programs.  One of the best-studied examples of coactivator control of metabolic pathways is the peroxisome proliferator-activated receptor γ coactivator 1 (PGC-1) family.  These proteins are strong activators of mitochondrial function and are thus dominant regulators of oxidative metab. in a variety of tissues.  The PGC-1 coactivators themselves are subject to powerful regulation at the transcriptional and posttranslational levels.  Recent studies have elucidated the function of the PGC-1 coactivators in different tissues and have highlighted the implications of PGC-1 dysregulation in diseases such as diabetes, obesity, cardiomyopathy, or neurodegeneration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrIMWEUPwupbVg90H21EOLACvtfcHk0liQ9OVbGq_RdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXns1Wrtw%253D%253D&md5=6873c38a0a99b61fe6b384056ca309ee</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1210%2Fer.2006-0037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fer.2006-0037%26sid%3Dliteratum%253Aachs%26aulast%3DHandschin%26aufirst%3DC.%26aulast%3DSpiegelman%26aufirst%3DB.%2BM.%26atitle%3DPeroxisome%2520proliferator-activated%2520receptor%2520gamma%2520coactivator%25201%2520coactivators%252C%2520energy%2520homeostasis%252C%2520and%2520metabolism%26jtitle%3DEndocr.%2520Rev.%26date%3D2006%26volume%3D27%26spage%3D728%26epage%3D735%26doi%3D10.1210%2Fer.2006-0037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gebai, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gorelik, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Illes, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagar, B.</span></span> <span> </span><span class="NLM_article-title">Structural basis for the activation of acid ceramidase</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1621</span>, <span class="refDoi"> DOI: 10.1038/s41467-018-03844-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1038%2Fs41467-018-03844-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=29692406" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A280%3ADC%252BC1Mjmtl2rtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=1621&author=A.+Gebaiauthor=A.+Gorelikauthor=Z.+Liauthor=K.+Illesauthor=B.+Nagar&title=Structural+basis+for+the+activation+of+acid+ceramidase&doi=10.1038%2Fs41467-018-03844-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis for the activation of acid ceramidase</span></div><div class="casAuthors">Gebai Ahmad; Gorelik Alexei; Li Zixian; Illes Katalin; Nagar Bhushan</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1621</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Acid ceramidase (aCDase, ASAH1) hydrolyzes lysosomal membrane ceramide into sphingosine, the backbone of all sphingolipids, to regulate many cellular processes.  Abnormal function of aCDase leads to Farber disease, spinal muscular atrophy with progressive myoclonic epilepsy, and is associated with Alzheimer's, diabetes, and cancer.  Here, we present crystal structures of mammalian aCDases in both proenzyme and autocleaved forms.  In the proenzyme, the catalytic center is buried and protected from solvent.  Autocleavage triggers a conformational change exposing a hydrophobic channel leading to the active site.  Substrate modeling suggests distinct catalytic mechanisms for substrate hydrolysis versus autocleavage.  A hydrophobic surface surrounding the substrate binding channel appears to be a site of membrane attachment where the enzyme accepts substrates facilitated by the accessory protein, saposin-D.  Structural mapping of disease mutations reveals that most would destabilize the protein fold.  These results will inform the rational design of aCDase inhibitors and recombinant aCDase for disease therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT6RpR0JSKnbwHqQV89nF-2fW6udTcc2eY1tbOKDrItj7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1Mjmtl2rtg%253D%253D&md5=a7fb6f187dc50d25c9a14597053718c1</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1038%2Fs41467-018-03844-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41467-018-03844-2%26sid%3Dliteratum%253Aachs%26aulast%3DGebai%26aufirst%3DA.%26aulast%3DGorelik%26aufirst%3DA.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DIlles%26aufirst%3DK.%26aulast%3DNagar%26aufirst%3DB.%26atitle%3DStructural%2520basis%2520for%2520the%2520activation%2520of%2520acid%2520ceramidase%26jtitle%3DNat.%2520Commun.%26date%3D2018%26volume%3D9%26spage%3D1621%26doi%3D10.1038%2Fs41467-018-03844-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brannigan, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dodson, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duggleby, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moody, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomchick, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murzin, A. G.</span></span> <span> </span><span class="NLM_article-title">A protein catalytic framework with an N-terminal nucleophile is capable of self-activation</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>378</i></span>,  <span class="NLM_fpage">416</span>– <span class="NLM_lpage">419</span>, <span class="refDoi"> DOI: 10.1038/378416a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1038%2F378416a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=7477383" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADyaK2MXps1amsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=378&publication_year=1995&pages=416-419&author=J.+A.+Branniganauthor=G.+Dodsonauthor=H.+J.+Dugglebyauthor=P.+C.+Moodyauthor=J.+L.+Smithauthor=D.+R.+Tomchickauthor=A.+G.+Murzin&title=A+protein+catalytic+framework+with+an+N-terminal+nucleophile+is+capable+of+self-activation&doi=10.1038%2F378416a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">A protein catalytic framework with an N-terminal nucleophile is capable of self-activation</span></div><div class="casAuthors">Brannigan, James; Dodson, Guy; Duggleby, Helen J.; Moody, Peter C. E.; Smith, Janet L.; Tomchick, Diana R.; Murzin, Alexey G.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">378</span>
        (<span class="NLM_cas:issue">6555</span>),
    <span class="NLM_cas:pages">416-19</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">The crystal structures of three amidohydrolases have been detd. recently, glutamine PRPP amidotransferase (GAT), penicillin acylase, and the proteasome.  These enzymes use the side chain of the amino-terminal residue, incorporated in a β-sheet, as the nucleophile in the catalytic attack at the carbonyl carbon.  The nucleophile is cysteine in GAT, serine in penicillin acylase, and threonine in the proteasome.  Here we show that all three enzymes share an unusual fold in which the nucleophile and other catalytic groups occupy equiv. sites.  This fold provides both the capacity for nucleophilic attack and the possibility of autocatalytic processing.  We suggest the name Ntn(N-terminal nucleophilic) hydrolases for this structural superfamily of enzymes which appear to be evolutionarily related but which have diverged beyond any recognizable sequence similarity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppQXl5VIHNVbVg90H21EOLACvtfcHk0li7VEcedpGPLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXps1amsLw%253D&md5=669ac5c5a3c69354b34316b5befec3f1</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1038%2F378416a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F378416a0%26sid%3Dliteratum%253Aachs%26aulast%3DBrannigan%26aufirst%3DJ.%2BA.%26aulast%3DDodson%26aufirst%3DG.%26aulast%3DDuggleby%26aufirst%3DH.%2BJ.%26aulast%3DMoody%26aufirst%3DP.%2BC.%26aulast%3DSmith%26aufirst%3DJ.%2BL.%26aulast%3DTomchick%26aufirst%3DD.%2BR.%26aulast%3DMurzin%26aufirst%3DA.%2BG.%26atitle%3DA%2520protein%2520catalytic%2520framework%2520with%2520an%2520N-terminal%2520nucleophile%2520is%2520capable%2520of%2520self-activation%26jtitle%3DNature%26date%3D1995%26volume%3D378%26spage%3D416%26epage%3D419%26doi%3D10.1038%2F378416a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oinonen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rouvinen, J.</span></span> <span> </span><span class="NLM_article-title">Structural comparison of Ntn-hydrolases</span>. <i>Protein Sci.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">2329</span>– <span class="NLM_lpage">2337</span>, <span class="refDoi"> DOI: 10.1110/ps.9.12.2329</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1110%2Fps.9.12.2329" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=11206054" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BD3MXns1aksQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2000&pages=2329-2337&author=C.+Oinonenauthor=J.+Rouvinen&title=Structural+comparison+of+Ntn-hydrolases&doi=10.1110%2Fps.9.12.2329"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Structural comparison of Ntn-hydrolases</span></div><div class="casAuthors">Oinonen, Carita; Rouvinen, Juha</div><div class="citationInfo"><span class="NLM_cas:title">Protein Science</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2329-2337</span>CODEN:
                <span class="NLM_cas:coden">PRCIEI</span>;
        ISSN:<span class="NLM_cas:issn">0961-8368</span>.
    
            (<span class="NLM_cas:orgname">Cambridge University Press</span>)
        </div><div class="casAbstract">The Ntn-hydrolases (N-terminal nucleophile) are a superfamily of diverse enzymes that has recently been characterized.  All of the proteins in this family are activated autocatalytically; they contain an N-terminally located catalytic nucleophile, and they cleave an amide bond.  In the present study, the structures of four enzymes of this superfamily are compared in more detail.  Although the amino acid sequence homol. is almost completely absent, the enzymes share a similar αββα-core structure.  The central β-sheets in the core were found to have different packing angles, ranging from 5 to 35°.  In the Ntn-hydrolases under study, eight totally conserved secondary structure units were found (region C).  Five of them were obsd. to contain the greatest no. of conserved and functionally important residues and are therefore crucial for the structure and function of Ntn-hydrolases.  Two addnl. regions, consisting of secondary structure units (regions A and B), were found to be in structurally similar locations, but in different orders in the polypeptide chain.  The catalytic machinery is located in the structures in a similar manner, and thus the catalytic mechanisms of all of the enzymes are probably similar.  However, the substrate binding and the oxyanion hole differed partially.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKH8HvK9V2YrVg90H21EOLACvtfcHk0li7VEcedpGPLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXns1aksQ%253D%253D&md5=48f7c5ed5839f4bcec76c2dcc5003d76</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1110%2Fps.9.12.2329&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1110%252Fps.9.12.2329%26sid%3Dliteratum%253Aachs%26aulast%3DOinonen%26aufirst%3DC.%26aulast%3DRouvinen%26aufirst%3DJ.%26atitle%3DStructural%2520comparison%2520of%2520Ntn-hydrolases%26jtitle%3DProtein%2520Sci.%26date%3D2000%26volume%3D9%26spage%3D2329%26epage%3D2337%26doi%3D10.1110%2Fps.9.12.2329" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tsuboi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Y. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okamoto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Araki, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tonai, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueda, N.</span></span> <span> </span><span class="NLM_article-title">Molecular characterization of N-acylethanolamine-hydrolyzing acid amidase, a novel member of the choloylglycine hydrolase family with structural and functional similarity to acid ceramidase</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>280</i></span>,  <span class="NLM_fpage">11082</span>– <span class="NLM_lpage">11092</span>, <span class="refDoi"> DOI: 10.1074/jbc.M413473200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1074%2Fjbc.M413473200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=15655246" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BD2MXisVOqu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=11082-11092&author=K.+Tsuboiauthor=Y.+X.+Sunauthor=Y.+Okamotoauthor=N.+Arakiauthor=T.+Tonaiauthor=N.+Ueda&title=Molecular+characterization+of+N-acylethanolamine-hydrolyzing+acid+amidase%2C+a+novel+member+of+the+choloylglycine+hydrolase+family+with+structural+and+functional+similarity+to+acid+ceramidase&doi=10.1074%2Fjbc.M413473200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Characterization of N-Acylethanolamine-hydrolyzing Acid Amidase, a Novel Member of the Choloylglycine Hydrolase Family with Structural and Functional Similarity to Acid Ceramidase</span></div><div class="casAuthors">Tsuboi, Kazuhito; Sun, Yong-Xin; Okamoto, Yasuo; Araki, Nobukazu; Tonai, Takeharu; Ueda, Natsuo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">280</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">11082-11092</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Bioactive N-acylethanolamines, including anandamide (an endocannabinoid) and N-palmitoylethanolamine (an anti-inflammatory and neuroprotective substance), are hydrolyzed to fatty acids and ethanolamine by fatty acid amide hydrolase.  Moreover, we found another amidohydrolase catalyzing the same reaction only at acidic pH, and we purified it from rat lung (Ueda, N., Yamanaka, K., and Yamamoto, S. (2001) J. Biol. Chem. 276, 35552-35557).  Here we report complementary DNA cloning and functional expression of the enzyme termed "N-acylethanolamine-hydrolyzing acid amidase (NAAA)" from human, rat, and mouse.  The deduced primary structures revealed that NAAA had no homol. to fatty acid amide hydrolase but belonged to the choloylglycine hydrolase family.  Human NAAA was essentially identical to a gene product that had been noted to resemble acid ceramidase but lacked ceramide hydrolyzing activity.  The recombinant human NAAA overexpressed in HEK293 cells hydrolyzed various N-acylethanolamines with N-palmitoylethanolamine as the most reactive substrate.  Most interestingly, a very low ceramide hydrolyzing activity was also detected with NAAA, and N-lauroylethanolamine hydrolyzing activity was obsd. with acid ceramidase.  By the use of tunicamycin and endoglycosidase, NAAA was found to be a glycoprotein.  Furthermore, the enzyme was proteolytically processed to a shorter form at pH 4.5 but not at pH 7.4.  Expression anal. of a green fluorescent protein-NAAA fusion protein showed a lysosome-like distribution in HEK293 cells.  The organ distribution of the mRNA in rats revealed its wide distribution with the highest expression in lung.  These results demonstrated that NAAA is a novel N-acylethanolamine-hydrolyzing enzyme that shows structural and functional similarity to acid ceramidase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWVjmZKJjGKLVg90H21EOLACvtfcHk0li7VEcedpGPLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXisVOqu78%253D&md5=2b108cd3e23441001b040085eea0fdc0</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M413473200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M413473200%26sid%3Dliteratum%253Aachs%26aulast%3DTsuboi%26aufirst%3DK.%26aulast%3DSun%26aufirst%3DY.%2BX.%26aulast%3DOkamoto%26aufirst%3DY.%26aulast%3DAraki%26aufirst%3DN.%26aulast%3DTonai%26aufirst%3DT.%26aulast%3DUeda%26aufirst%3DN.%26atitle%3DMolecular%2520characterization%2520of%2520N-acylethanolamine-hydrolyzing%2520acid%2520amidase%252C%2520a%2520novel%2520member%2520of%2520the%2520choloylglycine%2520hydrolase%2520family%2520with%2520structural%2520and%2520functional%2520similarity%2520to%2520acid%2520ceramidase%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D11082%26epage%3D11092%26doi%3D10.1074%2Fjbc.M413473200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mellman, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuchs, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Helenius, A.</span></span> <span> </span><span class="NLM_article-title">Acidification of the endocytic and exocytic pathways</span>. <i>Annu. Rev. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">1986</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">663</span>– <span class="NLM_lpage">700</span>, <span class="refDoi"> DOI: 10.1146/annurev.bi.55.070186.003311</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1146%2Fannurev.bi.55.070186.003311" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=2874766" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADyaL28XlsVyhsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=1986&pages=663-700&author=I.+Mellmanauthor=R.+Fuchsauthor=A.+Helenius&title=Acidification+of+the+endocytic+and+exocytic+pathways&doi=10.1146%2Fannurev.bi.55.070186.003311"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Acidification of the endocytic and exocytic pathways</span></div><div class="casAuthors">Mellman, Ira; Fuchs, Renate; Helenius, Ari</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Biochemistry</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">663-700</span>CODEN:
                <span class="NLM_cas:coden">ARBOAW</span>;
        ISSN:<span class="NLM_cas:issn">0066-4154</span>.
    </div><div class="casAbstract">A review with 271 refs., of the role of H+-ATPases of organelles in endocytosis and exocytosis pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmp4xBlOQJfbVg90H21EOLACvtfcHk0li7VEcedpGPLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL28XlsVyhsbY%253D&md5=b81f35dde2ace12012f9a17df9aac3f2</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1146%2Fannurev.bi.55.070186.003311&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.bi.55.070186.003311%26sid%3Dliteratum%253Aachs%26aulast%3DMellman%26aufirst%3DI.%26aulast%3DFuchs%26aufirst%3DR.%26aulast%3DHelenius%26aufirst%3DA.%26atitle%3DAcidification%2520of%2520the%2520endocytic%2520and%2520exocytic%2520pathways%26jtitle%3DAnnu.%2520Rev.%2520Biochem.%26date%3D1986%26volume%3D55%26spage%3D663%26epage%3D700%26doi%3D10.1146%2Fannurev.bi.55.070186.003311" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, L. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsuboi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okamoto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagahata, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueda, N.</span></span> <span> </span><span class="NLM_article-title">Proteolytic activation and glycosylation of N-acylethanolamine-hydrolyzing acid amidase, a lysosomal enzyme involved in the endocannabinoid metabolism</span>. <i>Biochim. Biophys. Acta, Mol. Cell Biol. Lipids</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>1771</i></span>,  <span class="NLM_fpage">1397</span>– <span class="NLM_lpage">1405</span>, <span class="refDoi"> DOI: 10.1016/j.bbalip.2007.10.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1016%2Fj.bbalip.2007.10.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=17980170" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVeqtb7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1771&publication_year=2007&pages=1397-1405&author=L.+Y.+Zhaoauthor=K.+Tsuboiauthor=Y.+Okamotoauthor=S.+Nagahataauthor=N.+Ueda&title=Proteolytic+activation+and+glycosylation+of+N-acylethanolamine-hydrolyzing+acid+amidase%2C+a+lysosomal+enzyme+involved+in+the+endocannabinoid+metabolism&doi=10.1016%2Fj.bbalip.2007.10.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Proteolytic activation and glycosylation of N-acylethanolamine-hydrolyzing acid amidase, a lysosomal enzyme involved in the endocannabinoid metabolism</span></div><div class="casAuthors">Zhao, Li-Ying; Tsuboi, Kazuhito; Okamoto, Yasuo; Nagahata, Shunichiro; Ueda, Natsuo</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular and Cell Biology of Lipids</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">1771</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1397-1405</span>CODEN:
                <span class="NLM_cas:coden">BBMLFG</span>;
        ISSN:<span class="NLM_cas:issn">1388-1981</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">N-acylethanolamine-hydrolyzing acid amidase (NAAA) is a lysosomal enzyme hydrolyzing bioactive N-acylethanolamines, including anandamide and N-palmitoylethanolamine.  Previously, we suggested that NAAA is glycosylated and proteolytically cleaved.  Here, we investigated the mechanism and significance of the cleavage of human NAAA overexpressed in human embryonic kidney 293 cells.  Western blotting with anti-NAAA antibody revealed that most of NAAA in the cell homogenate was the cleaved 30-kDa form.  However, some of NAAA were released outside the cells and the extracellular enzyme was mostly the uncleaved 48-kDa form.  When incubated at pH 4.5, the 48-kDa form was time-dependently converted to the 30-kDa form with concomitant increase in the N-palmitoylethanolamine-hydrolyzing activity.  The purified 48-kDa form was also cleaved and activated.  However, the cleavage did not proceed at pH 7.4 or in the presence of p-chloromercuribenzoic acid.  The mutant C126S was resistant to the cleavage and remained inactive.  These results suggested that this specific proteolysis is a self-catalyzed activation step.  We next detd. N-glycosylation sites of human NAAA by site-directed mutagenesis addressed to asparagine residues in six potential N-glycosylation sites.  The results exhibited that Asn-37, Asn-107, Asn-309, and Asn-333 are actual N-glycosylation sites.  The glycosylation appeared to play an important role in stabilizing the enzyme protein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYFuWgy8q2PbVg90H21EOLACvtfcHk0lgWrV_8DMVXsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVeqtb7J&md5=db9d83135905d5558679f307517e92b7</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1016%2Fj.bbalip.2007.10.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbalip.2007.10.002%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DL.%2BY.%26aulast%3DTsuboi%26aufirst%3DK.%26aulast%3DOkamoto%26aufirst%3DY.%26aulast%3DNagahata%26aufirst%3DS.%26aulast%3DUeda%26aufirst%3DN.%26atitle%3DProteolytic%2520activation%2520and%2520glycosylation%2520of%2520N-acylethanolamine-hydrolyzing%2520acid%2520amidase%252C%2520a%2520lysosomal%2520enzyme%2520involved%2520in%2520the%2520endocannabinoid%2520metabolism%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Cell%2520Biol.%2520Lipids%26date%3D2007%26volume%3D1771%26spage%3D1397%26epage%3D1405%26doi%3D10.1016%2Fj.bbalip.2007.10.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">West, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zvonok, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitten, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makriyannis, A.</span></span> <span> </span><span class="NLM_article-title">Mass spectrometric characterization of human N-acylethanolamine-hydrolyzing acid amidase</span>. <i>J. Proteome Res.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">972</span>– <span class="NLM_lpage">981</span>, <span class="refDoi"> DOI: 10.1021/pr200735a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/pr200735a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlyhurnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2012&pages=972-981&author=J.+M.+Westauthor=N.+Zvonokauthor=K.+M.+Whittenauthor=J.+T.+Woodauthor=A.+Makriyannis&title=Mass+spectrometric+characterization+of+human+N-acylethanolamine-hydrolyzing+acid+amidase&doi=10.1021%2Fpr200735a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Mass Spectrometric Characterization of Human N-Acylethanolamine-hydrolyzing Acid Amidase</span></div><div class="casAuthors">West, Jay M.; Zvonok, Nikolai; Whitten, Kyle M.; Wood, JodiAnne T.; Makriyannis, Alexandros</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Proteome Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">972-981</span>CODEN:
                <span class="NLM_cas:coden">JPROBS</span>;
        ISSN:<span class="NLM_cas:issn">1535-3893</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">N-Acylethanolamine-hydrolyzing acid amidase (NAAA) is a lysosomal enzyme that primarily degrades palmitoylethanolamine (PEA), a lipid amide that inhibits inflammatory responses.  We developed a HEK293 cell line stably expressing the NAAA pro-enzyme (zymogen) and a single step chromatog. purifn. of the protein from the media.  Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry MALDI-TOF MS anal. of the zymogen (47.7 kDa) treated with peptide-N-glycosidase F (PNGase F) identified 4 glycosylation sites, and acid cleavage of the zymogen into α- and β-subunits (14.6 and 33.3 kDa) activated the enzyme.  Size exclusion chromatog. estd. the mass of the active enzyme as 45±3 kDa, suggesting formation of an α/β heterodimer.  MALDI-TOF MS fingerprinting covered more than 80% of the amino acid sequence, including the N-terminal peptides, and evidence for the lack of a disulfide bond between subunits.  The significance of the cysteine residues was established by their selective alkylation resulting in almost complete loss of activity.  The purified enzyme was kinetically characterized with PEA and a novel fluorogenic substrate, N-(4-Me coumarin) palmitamide (PAMCA).  The prodn. of sufficient quantities of NAAA and a high throughput assay could be useful in discovering novel inhibitors and detg. the structure and function of this enzyme.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsHb2ZNlA6QbVg90H21EOLACvtfcHk0lgWrV_8DMVXsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlyhurnL&md5=b90eb948e0d859a08f4a777114820c94</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1021%2Fpr200735a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fpr200735a%26sid%3Dliteratum%253Aachs%26aulast%3DWest%26aufirst%3DJ.%2BM.%26aulast%3DZvonok%26aufirst%3DN.%26aulast%3DWhitten%26aufirst%3DK.%2BM.%26aulast%3DWood%26aufirst%3DJ.%2BT.%26aulast%3DMakriyannis%26aufirst%3DA.%26atitle%3DMass%2520spectrometric%2520characterization%2520of%2520human%2520N-acylethanolamine-hydrolyzing%2520acid%2520amidase%26jtitle%3DJ.%2520Proteome%2520Res.%26date%3D2012%26volume%3D11%26spage%3D972%26epage%3D981%26doi%3D10.1021%2Fpr200735a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kolter, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sandhoff, K.</span></span> <span> </span><span class="NLM_article-title">Lysosomal degradation of membrane lipids</span>. <i>FEBS Lett.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>584</i></span>,  <span class="NLM_fpage">1700</span>– <span class="NLM_lpage">1712</span>, <span class="refDoi"> DOI: 10.1016/j.febslet.2009.10.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1016%2Fj.febslet.2009.10.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=19836391" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BC3cXkvFKqur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=584&publication_year=2010&pages=1700-1712&author=T.+Kolterauthor=K.+Sandhoff&title=Lysosomal+degradation+of+membrane+lipids&doi=10.1016%2Fj.febslet.2009.10.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Lysosomal degradation of membrane lipids</span></div><div class="casAuthors">Kolter, Thomas; Sandhoff, Konrad</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">584</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1700-1712</span>CODEN:
                <span class="NLM_cas:coden">FEBLAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-5793</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The constitutive degrdn. of membrane components takes place in the acidic compartments of a cell, the endosomes and lysosomes.  Sites of lipid degrdn. are intralysosomal membranes that are formed in endosomes, where the lipid compn. is adjusted for degrdn.  Cholesterol is sorted out of the inner membranes; their content in bis(monoacylglycero)phosphate increases, and, most likely, sphingomyelin is degraded to ceramide.  Together with endosomal and lysosomal lipid-binding proteins, the Niemann-Pick disease type C2-protein, the GM2-activator, and saposins A, B, C, and D, a suitable membrane lipid compn. is required for degrdn. of complex lipids by hydrolytic enzymes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrd_f-eSsXQLrVg90H21EOLACvtfcHk0lgWrV_8DMVXsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXkvFKqur4%253D&md5=219903b5b3afe13c6fff01388a3c8f03</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1016%2Fj.febslet.2009.10.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.febslet.2009.10.021%26sid%3Dliteratum%253Aachs%26aulast%3DKolter%26aufirst%3DT.%26aulast%3DSandhoff%26aufirst%3DK.%26atitle%3DLysosomal%2520degradation%2520of%2520membrane%2520lipids%26jtitle%3DFEBS%2520Lett.%26date%3D2010%26volume%3D584%26spage%3D1700%26epage%3D1712%26doi%3D10.1016%2Fj.febslet.2009.10.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref86"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref86'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tsuboi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hilligsmann, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vandevoorde, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambert, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueda, N.</span></span> <span> </span><span class="NLM_article-title">N-Cyclohexanecarbonylpentadecylamine: a selective inhibitor of the acid amidase hydrolysing N-acylethanolamines, as a tool to distinguish acid amidase from fatty acid amide hydrolase</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>379</i></span>,  <span class="NLM_fpage">99</span>– <span class="NLM_lpage">106</span>, <span class="refDoi"> DOI: 10.1042/bj20031695</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1042%2Fbj20031695" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=14686878" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BD2cXisVyrsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=379&publication_year=2004&pages=99-106&author=K.+Tsuboiauthor=C.+Hilligsmannauthor=S.+Vandevoordeauthor=D.+M.+Lambertauthor=N.+Ueda&title=N-Cyclohexanecarbonylpentadecylamine%3A+a+selective+inhibitor+of+the+acid+amidase+hydrolysing+N-acylethanolamines%2C+as+a+tool+to+distinguish+acid+amidase+from+fatty+acid+amide+hydrolase&doi=10.1042%2Fbj20031695"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">N-Cyclohexanecarbonylpentadecylamine: a selective inhibitor of the acid amidase hydrolysing N-acylethanolamines, as a tool to distinguish acid amidase from fatty acid amide hydrolase</span></div><div class="casAuthors">Tsuboi, Kazuhito; Hilligsmann, Christine; Vandevoorde, Severine; Lambert, Didier M.; Ueda, Natsuo</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">379</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">99-106</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">Anandamide (N-arachidonoylethanolamine) and other bioactive N -acylethanolamines are degraded to their corresponding fatty acids and ethanolamine.  This hydrolysis is mostly attributed to catalysis by FAAH (fatty acid amide hydrolase), which exhibits an alk. pH optimum.  In addn., we have identified another amidase which catalyzes the same reaction exclusively at acidic pH values [Ueda, Yamanaka and Yamamoto (2001) J. Biol. Chem. 276, 35552-35557].  In attempts to find selective inhibitors of this acid amidase, we screened various derivs. of palmitic acid, 1-hexadecanol, and 1-pentadecylamine with N -palmitoylethanolamine as substrate.  Here we show that N-cyclohexanecarbonylpentadecylamine inhibits the acid amidase from rat lung with an IC50 of 4.5 μM, without inhibiting FAAH at concns. up to 100 μM.  The inhibition was reversible and non-competitive.  This compd. also inhibited the acid amidase in intact alveolar macrophages.  With the aid of this inhibitor, it was revealed that rat basophilic leukemia cells possess the acid amidase as well as FAAH.  Thus the inhibitor may be a useful tool to distinguish the acid amidase from FAAH in various tissues and cells and to elucidate the physiol. role of the enzyme.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoieQh-ts3EC7Vg90H21EOLACvtfcHk0ljnr8DYYm5d2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXisVyrsrs%253D&md5=5ea93d8cafe6d3d3151f896bc2185547</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1042%2Fbj20031695&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbj20031695%26sid%3Dliteratum%253Aachs%26aulast%3DTsuboi%26aufirst%3DK.%26aulast%3DHilligsmann%26aufirst%3DC.%26aulast%3DVandevoorde%26aufirst%3DS.%26aulast%3DLambert%26aufirst%3DD.%2BM.%26aulast%3DUeda%26aufirst%3DN.%26atitle%3DN-Cyclohexanecarbonylpentadecylamine%253A%2520a%2520selective%2520inhibitor%2520of%2520the%2520acid%2520amidase%2520hydrolysing%2520N-acylethanolamines%252C%2520as%2520a%2520tool%2520to%2520distinguish%2520acid%2520amidase%2520from%2520fatty%2520acid%2520amide%2520hydrolase%26jtitle%3DBiochem.%2520J.%26date%3D2004%26volume%3D379%26spage%3D99%26epage%3D106%26doi%3D10.1042%2Fbj20031695" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref87"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref87'); return false;" data-citation="" class="refNumLink">87</a></strong><div class="NLM_citation" id="cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yamano, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsuboi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hozaki, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, X. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueda, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wada, A.</span></span> <span> </span><span class="NLM_article-title">Lipophilic amines as potent inhibitors of N-acylethanolamine-hydrolyzing acid amidase</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">3658</span>– <span class="NLM_lpage">3665</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2012.03.065</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1016%2Fj.bmc.2012.03.065" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=22542283" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BC38Xmt1antL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2012&pages=3658-3665&author=Y.+Yamanoauthor=K.+Tsuboiauthor=Y.+Hozakiauthor=K.+Takahashiauthor=X.+H.+Jinauthor=N.+Uedaauthor=A.+Wada&title=Lipophilic+amines+as+potent+inhibitors+of+N-acylethanolamine-hydrolyzing+acid+amidase&doi=10.1016%2Fj.bmc.2012.03.065"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">Lipophilic amines as potent inhibitors of N-acylethanolamine-hydrolyzing acid amidase</span></div><div class="casAuthors">Yamano, Yumiko; Tsuboi, Kazuhito; Hozaki, Yuki; Takahashi, Kiyohiro; Jin, Xing-Hua; Ueda, Natsuo; Wada, Akimori</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3658-3665</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">N-Acylethanolamines (NAEs) including N-arachidonoylethanolamine (anandamide) and N-palmitoylethanolamine are endogenous lipid mediators.  These mols. are degraded to the corresponding fatty acids and ethanolamine by fatty acid amide hydrolase (FAAH) or NAE-hydrolyzing acid amidase (NAAA).  Lipophilic amines, esp. pentadecylamine (2c) and tridecyl 2-aminoacetate (11b), were found to exhibit potent NAAA inhibitory activities (IC50 = 5.7 and 11.8 μM), with much weaker effects on FAAH.  These simple structures would provide a scaffold for further improvement in NAAA inhibitory activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpX4k9qI0AqY7Vg90H21EOLACvtfcHk0ljnr8DYYm5d2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xmt1antL0%253D&md5=fbe85f4e5fdca44bee1f6d4902c4f1d0</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2012.03.065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2012.03.065%26sid%3Dliteratum%253Aachs%26aulast%3DYamano%26aufirst%3DY.%26aulast%3DTsuboi%26aufirst%3DK.%26aulast%3DHozaki%26aufirst%3DY.%26aulast%3DTakahashi%26aufirst%3DK.%26aulast%3DJin%26aufirst%3DX.%2BH.%26aulast%3DUeda%26aufirst%3DN.%26aulast%3DWada%26aufirst%3DA.%26atitle%3DLipophilic%2520amines%2520as%2520potent%2520inhibitors%2520of%2520N-acylethanolamine-hydrolyzing%2520acid%2520amidase%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2012%26volume%3D20%26spage%3D3658%26epage%3D3665%26doi%3D10.1016%2Fj.bmc.2012.03.065" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref88"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref88'); return false;" data-citation="" class="refNumLink">88</a></strong><div class="NLM_citation" id="cit88"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Saturnino, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petrosino, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ligresti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palladino, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Martino, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bisogno, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Marzo, V.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological evaluation of new potential inhibitors of N-acylethanolamine hydrolyzing acid amidase</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">1210</span>– <span class="NLM_lpage">1213</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2009.11.134</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1016%2Fj.bmcl.2009.11.134" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=20022504" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVGrt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=1210-1213&author=C.+Saturninoauthor=S.+Petrosinoauthor=A.+Ligrestiauthor=C.+Palladinoauthor=G.+De+Martinoauthor=T.+Bisognoauthor=V.+Di+Marzo&title=Synthesis+and+biological+evaluation+of+new+potential+inhibitors+of+N-acylethanolamine+hydrolyzing+acid+amidase&doi=10.1016%2Fj.bmcl.2009.11.134"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and biological evaluation of new potential inhibitors of N-acylethanolamine hydrolyzing acid amidase</span></div><div class="casAuthors">Saturnino, Carmela; Petrosino, Stefania; Ligresti, Alessia; Palladino, Chiara; De Martino, Giovanni; Bisogno, Tiziana; Di Marzo, Vincenzo</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1210-1213</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">N-Acylethanolamines, including N-palmitoyl-ethanolamine (PEA), are hydrolyzed to the corresponding fatty acids and ethanolamine by fatty acid amide hydrolase (FAAH).  Recently, N-acylethanolamine-hydrolyzing acid amidase (NAAA) was identified as being able to specifically hydrolyze PEA.  In order to find selective and effective inhibitors of this enzyme, we synthesized and screened several amides, retroamides, esters, retroesters and carbamates of palmitic acid (1-21) and esters with C15 and C17 alkyl chains (22-27).  Cyclopentylhexadecanoate (13) exhibited the highest inhibitory activity on NAAA (IC50 = 10.0 μM), without inhibiting FAAH up to 50 μM.  Compd. 13 may become a useful template to design new NAAA inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNWUZja4X4JbVg90H21EOLACvtfcHk0ljnr8DYYm5d2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVGrt7s%253D&md5=fc638f889e58e9fbf3467a90effbcc80</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.11.134&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.11.134%26sid%3Dliteratum%253Aachs%26aulast%3DSaturnino%26aufirst%3DC.%26aulast%3DPetrosino%26aufirst%3DS.%26aulast%3DLigresti%26aufirst%3DA.%26aulast%3DPalladino%26aufirst%3DC.%26aulast%3DDe%2BMartino%26aufirst%3DG.%26aulast%3DBisogno%26aufirst%3DT.%26aulast%3DDi%2BMarzo%26aufirst%3DV.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520new%2520potential%2520inhibitors%2520of%2520N-acylethanolamine%2520hydrolyzing%2520acid%2520amidase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D1210%26epage%3D1213%26doi%3D10.1016%2Fj.bmcl.2009.11.134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref89"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref89'); return false;" data-citation="" class="refNumLink">89</a></strong><div class="NLM_citation" id="cit89"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vago, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bettiga, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salonia, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciuffreda, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ottria, R.</span></span> <span> </span><span class="NLM_article-title">Development of new inhibitors for N-acylethanolamine-hydrolyzing acid amidase as promising tool against bladder cancer</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">1242</span>– <span class="NLM_lpage">1249</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2016.12.042</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1016%2Fj.bmc.2016.12.042" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=28062195" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BC2sXitlOjsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2017&pages=1242-1249&author=R.+Vagoauthor=A.+Bettigaauthor=A.+Saloniaauthor=P.+Ciuffredaauthor=R.+Ottria&title=Development+of+new+inhibitors+for+N-acylethanolamine-hydrolyzing+acid+amidase+as+promising+tool+against+bladder+cancer&doi=10.1016%2Fj.bmc.2016.12.042"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">Development of new inhibitors for N-acylethanolamine-hydrolyzing acid amidase as promising tool against bladder cancer</span></div><div class="casAuthors">Vago, Riccardo; Bettiga, Arianna; Salonia, Andrea; Ciuffreda, Pierangela; Ottria, Roberta</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1242-1249</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The endocannabinoid system is a signaling system involved in a wide range of biol. effects.  Literature strongly suggests the endocannabinoid system role in the pathogenesis of cancer and that its pharmacol. activation produces therapeutic benefits.  Last research promotes the endocannabinoid system modulation by inhibition of endocannabinoids hydrolytic enzymes instead of direct activation of endocannabinoid receptors to avoid detrimental effects on cognition and motor control.  Here we report the identification of N-acylethanolamine-hydrolyzing acid amidase (NAAA) inhibitors able to reduce cell proliferation and migration and cause cell death on different bladder cancer cell lines.  These mols. were designed, synthesized and characterized and active compds. were selected by a fluorescence high-throughput screening method set-up on human recombinant NAAA that also allows to characterize the mechanism of inhibition.  Together our results suggest an important role for NAAA in cell migration and in inducing tumor cell death promoting this enzyme as pharmacol. target against bladder cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpeZMJmpMmoV7Vg90H21EOLACvtfcHk0liD0jGJBmIoiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXitlOjsw%253D%253D&md5=408693a59ec65a8364711366d3b04b29</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2016.12.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2016.12.042%26sid%3Dliteratum%253Aachs%26aulast%3DVago%26aufirst%3DR.%26aulast%3DBettiga%26aufirst%3DA.%26aulast%3DSalonia%26aufirst%3DA.%26aulast%3DCiuffreda%26aufirst%3DP.%26aulast%3DOttria%26aufirst%3DR.%26atitle%3DDevelopment%2520of%2520new%2520inhibitors%2520for%2520N-acylethanolamine-hydrolyzing%2520acid%2520amidase%2520as%2520promising%2520tool%2520against%2520bladder%2520cancer%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2017%26volume%3D25%26spage%3D1242%26epage%3D1249%26doi%3D10.1016%2Fj.bmc.2016.12.042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref90"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref90'); return false;" data-citation="" class="refNumLink">90</a></strong><div class="NLM_citation" id="cit90"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Petrosino, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campolo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Impellizzeri, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paterniti, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allarà, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gugliandolo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Amico, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siracusa, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cordaro, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esposito, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Marzo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuzzocrea, S.</span></span> <span> </span><span class="NLM_article-title">2-Pentadecyl-2-oxazoline, the oxazoline of PEA, modulates carrageenan-induced acute inflammation</span>. <i>Front. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">308</span>, <span class="refDoi"> DOI: 10.3389/fphar.2017.00308</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.3389%2Ffphar.2017.00308" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=28611664" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvFenu7vF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=308&author=S.+Petrosinoauthor=M.+Campoloauthor=D.+Impellizzeriauthor=I.+Paternitiauthor=M.+Allar%C3%A0author=E.+Gugliandoloauthor=R.+D%E2%80%99Amicoauthor=R.+Siracusaauthor=M.+Cordaroauthor=E.+Espositoauthor=V.+Di+Marzoauthor=S.+Cuzzocrea&title=2-Pentadecyl-2-oxazoline%2C+the+oxazoline+of+PEA%2C+modulates+carrageenan-induced+acute+inflammation&doi=10.3389%2Ffphar.2017.00308"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">2-Pentadecyl-2-oxazoline, the oxazoline of pea, modulates carrageenan-induced acute inflammation</span></div><div class="casAuthors">Petrosino, Stefania; Campolo, Michela; Impellizzeri, Daniela; Paterniti, Irene; Allara, Marco; Gugliandolo, Enrico; D'amico, Ramona; Siracusa, Rosalba; Cordaro, Marika; Esposito, Emanuela; Di Marzo, Vincenzo; Cuzzocrea, Salvatore</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Pharmacology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">308/1-308/16</span>CODEN:
                <span class="NLM_cas:coden">FPRHAU</span>;
        ISSN:<span class="NLM_cas:issn">1663-9812</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">N-acylethanolamines (NAEs) involve a family of lipid mols. existent in animal and plant, with N-palmitoylethanolamide (PEA) that arouses great attention owing to its anti- inflammatory, analgesic and neuroprotective activities.  Because PEA is produced on demand and exerts pleiotropic effects, the modulation of specific amidases for NAEs (and in particular NAE-hydrolyzing acid amidase NAAA, which is more selective for PEA) could be a condition to preserve its levels.  Here we investigate the effect of 2-Pentadecyl-2-oxazoline (PEA-OXA) the oxazoline of PEA, on human recombinant NAAA in vitro and in an established model of Carrageenan (CAR)-induced rat paw inflammation.  PEA-OXA dose-dependently significantly inhibited recombinant NAAA and, orally administered to rats (10 mg/kg), limiting histol. damage, thermal hyperalgesia and the increase of infiltrating inflammatory cells after CAR injection in the rat right hindpaw, compared to ultramicronized PEA given orally at the same dose (10 mg/kg).  These effects were accompanied by elevation of paw PEA levels.  Moreover, PEA-OXA markedly reduced neutrophil infiltration and pro-inflammatory cytokine release and prevented CAR-induced IκB-α degrdn., nuclear translocation of NF-κB p65, the increase of inducible nitric oxide synthase, cyclooxygenase-2, intercellular adhesion mol.-1, and mast cell activation.  Expts. in PPAR-α knockout mice showed that the anti-inflammatory effects of PEA-OXA were not dependent on the presence of PPAR-α receptors.  In conclusion, NAAA modulators as PEA-OXA could help to maximize the tissue availability of PEA by increasing its levels and anti-inflammatory effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqn273XvrvHbbVg90H21EOLACvtfcHk0liD0jGJBmIoiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvFenu7vF&md5=23898efd143bd1506d64425dbe349a52</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.3389%2Ffphar.2017.00308&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphar.2017.00308%26sid%3Dliteratum%253Aachs%26aulast%3DPetrosino%26aufirst%3DS.%26aulast%3DCampolo%26aufirst%3DM.%26aulast%3DImpellizzeri%26aufirst%3DD.%26aulast%3DPaterniti%26aufirst%3DI.%26aulast%3DAllar%25C3%25A0%26aufirst%3DM.%26aulast%3DGugliandolo%26aufirst%3DE.%26aulast%3DD%25E2%2580%2599Amico%26aufirst%3DR.%26aulast%3DSiracusa%26aufirst%3DR.%26aulast%3DCordaro%26aufirst%3DM.%26aulast%3DEsposito%26aufirst%3DE.%26aulast%3DDi%2BMarzo%26aufirst%3DV.%26aulast%3DCuzzocrea%26aufirst%3DS.%26atitle%3D2-Pentadecyl-2-oxazoline%252C%2520the%2520oxazoline%2520of%2520PEA%252C%2520modulates%2520carrageenan-induced%2520acute%2520inflammation%26jtitle%3DFront.%2520Pharmacol.%26date%3D2017%26volume%3D8%26spage%3D308%26doi%3D10.3389%2Ffphar.2017.00308" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref91"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref91'); return false;" data-citation="" class="refNumLink">91</a></strong><div class="NLM_citation" id="cit91"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rossocha, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schultz-Heienbrok, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Moeller, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coleman, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saenger, W.</span></span> <span> </span><span class="NLM_article-title">Conjugated bile acid hydrolase is a tetrameric N-terminal thiol hydrolase with specific recognition of its cholyl but not of its tauryl product</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">5739</span>– <span class="NLM_lpage">5748</span>, <span class="refDoi"> DOI: 10.1021/bi0473206</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi0473206" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BD2MXisFOns78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2005&pages=5739-5748&author=M.+Rossochaauthor=R.+Schultz-Heienbrokauthor=H.+von+Moellerauthor=J.+P.+Colemanauthor=W.+Saenger&title=Conjugated+bile+acid+hydrolase+is+a+tetrameric+N-terminal+thiol+hydrolase+with+specific+recognition+of+its+cholyl+but+not+of+its+tauryl+product&doi=10.1021%2Fbi0473206"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">Conjugated Bile Acid Hydrolase Is a Tetrameric N-Terminal Thiol Hydrolase with Specific Recognition of Its Cholyl but Not of Its Tauryl Product</span></div><div class="casAuthors">Rossocha, Maksim; Schultz-Heienbrok, Robert; von Moeller, Holger; Coleman, James P.; Saenger, Wolfram</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">5739-5748</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Bacterial bile salt hydrolases catalyze the degrdn. of conjugated bile acids in the mammalian gut.  The crystal structures of conjugated bile acid hydrolase (CBAH) from Clostridium perfringens as apoenzyme and in complex with taurodeoxycholate that was hydrolyzed to the reaction products taurine and deoxycholate are described here at 2.1 and 1.7 Å resoln., resp.  The crystal structures reveal a close relationship between CBAH and penicillin V acylase from Bacillus sphaericus.  This similarity together with the N-terminal cysteine classifies CBAH as a member of the N-terminal nucleophile (Ntn) hydrolase superfamily.  Both crystal structures show an identical homotetrameric organization with dihedral (D2 or 222) point group symmetry.  The structure anal. of C. perfringens CBAH identifies crit. residues in catalysis, substrate recognition, and tetramer formation which may serve in further biochem. characterization of bile acid hydrolases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGHd2eLCdd87Vg90H21EOLACvtfcHk0liD0jGJBmIoiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXisFOns78%253D&md5=86620200d7d88e539bc7c926cf78d689</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1021%2Fbi0473206&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi0473206%26sid%3Dliteratum%253Aachs%26aulast%3DRossocha%26aufirst%3DM.%26aulast%3DSchultz-Heienbrok%26aufirst%3DR.%26aulast%3Dvon%2BMoeller%26aufirst%3DH.%26aulast%3DColeman%26aufirst%3DJ.%2BP.%26aulast%3DSaenger%26aufirst%3DW.%26atitle%3DConjugated%2520bile%2520acid%2520hydrolase%2520is%2520a%2520tetrameric%2520N-terminal%2520thiol%2520hydrolase%2520with%2520specific%2520recognition%2520of%2520its%2520cholyl%2520but%2520not%2520of%2520its%2520tauryl%2520product%26jtitle%3DBiochemistry%26date%3D2005%26volume%3D44%26spage%3D5739%26epage%3D5748%26doi%3D10.1021%2Fbi0473206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref92"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref92'); return false;" data-citation="" class="refNumLink">92</a></strong><div class="NLM_citation" id="cit92"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lall, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karvellas, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vederas, J. C.</span></span> <span> </span><span class="NLM_article-title">Beta-lactones as a new class of cysteine proteinase inhibitors: inhibition of hepatitis A virus 3C proteinase by N-Cbz-serine beta-lactone</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">803</span>– <span class="NLM_lpage">806</span>, <span class="refDoi"> DOI: 10.1021/ol990148r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol990148r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADyaK1MXltVaqu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=1999&pages=803-806&author=M.+S.+Lallauthor=C.+Karvellasauthor=J.+C.+Vederas&title=Beta-lactones+as+a+new+class+of+cysteine+proteinase+inhibitors%3A+inhibition+of+hepatitis+A+virus+3C+proteinase+by+N-Cbz-serine+beta-lactone&doi=10.1021%2Fol990148r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">β-Lactones as a New Class of Cysteine Proteinase Inhibitors: Inhibition of Hepatitis A Virus 3C Proteinase by N-Cbz-serine β-Lactone</span></div><div class="casAuthors">Lall, Manjinder S.; Karvellas, Constantine; Vederas, John C.</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">803-806</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7060</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">N-Benzyloxycarbonyl-L-serine β-lactone (I) is shown to irreversibly inactivate the 3C cysteine proteinase of hepatitis A virus (HAV) with kinact = 0.70 min-1, KΙ = 1.84×10-4 M and kinact/KΙ = 3800 M-1 min-1 at an enzyme concn. of 0.1 μM.  Mass spectrometric and HMQC NMR studies using 13C-labeled I show that the active site cysteine (Cys-172) thiol of the HAV 3C proteinase attacks the β-position (i.e. C-4) of the oxetanone ring, thereby leading to ring opening and alkylation of the sulfur.  In contrast, the enantiomer of this β-lactone is a reversible competitive inhibitor (Ki = 1.50×10-6 M) at similar enzyme concns.  The β-lactone motif represents a new class of inhibitors of cysteine proteinases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr30zXvA06cvLVg90H21EOLACvtfcHk0lj06Dzz0llz_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXltVaqu7g%253D&md5=87541b4f3686fddd094b012b56089319</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1021%2Fol990148r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol990148r%26sid%3Dliteratum%253Aachs%26aulast%3DLall%26aufirst%3DM.%2BS.%26aulast%3DKarvellas%26aufirst%3DC.%26aulast%3DVederas%26aufirst%3DJ.%2BC.%26atitle%3DBeta-lactones%2520as%2520a%2520new%2520class%2520of%2520cysteine%2520proteinase%2520inhibitors%253A%2520inhibition%2520of%2520hepatitis%2520A%2520virus%25203C%2520proteinase%2520by%2520N-Cbz-serine%2520beta-lactone%26jtitle%3DOrg.%2520Lett.%26date%3D1999%26volume%3D1%26spage%3D803%26epage%3D806%26doi%3D10.1021%2Fol990148r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref93"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref93'); return false;" data-citation="" class="refNumLink">93</a></strong><div class="NLM_citation" id="cit93"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Greenspan, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bull, H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yudkovitz, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanf, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alberts, A. W.</span></span> <span> </span><span class="NLM_article-title">Inhibition of 3-hydroxy-3-methylglutaryl-CoA synthase and cholesterol biosynthesis by beta-lactone inhibitors and binding of these inhibitors to the enzyme</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>289</i></span>,  <span class="NLM_fpage">889</span>– <span class="NLM_lpage">895</span>, <span class="refDoi"> DOI: 10.1042/bj2890889</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1042%2Fbj2890889" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=8094614" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADyaK3sXhvVeitbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=1993&pages=889-895&author=M.+D.+Greenspanauthor=H.+G.+Bullauthor=J.+B.+Yudkovitzauthor=D.+P.+Hanfauthor=A.+W.+Alberts&title=Inhibition+of+3-hydroxy-3-methylglutaryl-CoA+synthase+and+cholesterol+biosynthesis+by+beta-lactone+inhibitors+and+binding+of+these+inhibitors+to+the+enzyme&doi=10.1042%2Fbj2890889"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of 3-hydroxy-3-methylglutaryl-CoA synthase and cholesterol biosynthesis by β-lactone inhibitors and binding of these inhibitors to the enzyme</span></div><div class="casAuthors">Greenspan, Michael D.; Bull, Herb G.; Yudkovitz, Joel B.; Hanf, Darlene P.; Alberts, Alfred W.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">289</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">889-95</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    </div><div class="casAbstract">The β-lactones L-659,699 (I) and its radioactive deriv. 3H-L-668,411 (the 2,3-ditritiated Me ester of I) inhibited a partially purified prepn. of rat liver cytosolic 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) synthase with an IC50 of 0.1 μM.  These compds. were also found to inhibit the incorporation of [14C]acetate into sterols in cultured Hep G2 cells with an IC50 of 3 μM.  New kinetic evidence indicated that inhibition of the isolated enzyme was irreversible.  In contrast, sterol biosynthesis in cultured Hep G2 cells was rapidly restored upon removal of the compd. from the medium of inhibited cultures, suggesting reversibility of inhibition in the cells.  Radioactivity was found to be assocd. with a single cytoplasmic protein by SDS/PAGE of the cytoplasm of Hep G2 cells after incubation of the cells with the inhibitor 3H-L-668,411.  This protein was identified as cytoplasmic HMG-CoA synthase.  Binding of the radioactive compd. to the enzyme was decreased with time if the radioactive inhibitor was removed from the medium.  Exposure of a gel contg. the radioactive enzyme-inhibitor complex to neutral hydroxylamine also resulted in a loss of radioactivity from the gel.  The purified rat liver enzyme reacted with the 3H-ligand to form a stable enzyme-inhibitor complex which could be isolated by HPLC.  Radioactivity was also subsequently lost from this complex when it was incubated with neutral hydroxylamine.  Incorporation of [14C]acetate into cholesterol in mouse liver was inhibited in a reversible manner after oral administration of the β-lactone inhibitor.  These studies, as well as the kinetic evidence presented, suggest that the β-lactone inhibitors acylate HMG-CoA synthase in a reaction which appears to be irreversible in vitro, but is easily reversed in cultured cells and in animals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_kFglYNzBRrVg90H21EOLACvtfcHk0lj06Dzz0llz_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXhvVeitbs%253D&md5=51792ae96fe2099d3980c94f0c1857e4</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1042%2Fbj2890889&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbj2890889%26sid%3Dliteratum%253Aachs%26aulast%3DGreenspan%26aufirst%3DM.%2BD.%26aulast%3DBull%26aufirst%3DH.%2BG.%26aulast%3DYudkovitz%26aufirst%3DJ.%2BB.%26aulast%3DHanf%26aufirst%3DD.%2BP.%26aulast%3DAlberts%26aufirst%3DA.%2BW.%26atitle%3DInhibition%2520of%25203-hydroxy-3-methylglutaryl-CoA%2520synthase%2520and%2520cholesterol%2520biosynthesis%2520by%2520beta-lactone%2520inhibitors%2520and%2520binding%2520of%2520these%2520inhibitors%2520to%2520the%2520enzyme%26jtitle%3DBiochem.%2520J.%26date%3D1993%26volume%3D289%26spage%3D889%26epage%3D895%26doi%3D10.1042%2Fbj2890889" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref94"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref94'); return false;" data-citation="" class="refNumLink">94</a></strong><div class="NLM_citation" id="cit94"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pojer, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrer, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richard, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagegowda, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chye, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bach, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noel, J. P.</span></span> <span> </span><span class="NLM_article-title">Structural basis for the design of potent and species-specific inhibitors of 3-hydroxy-3-methylglutaryl CoA synthases</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>103</i></span>,  <span class="NLM_fpage">11491</span>– <span class="NLM_lpage">11496</span>, <span class="refDoi"> DOI: 10.1073/pnas.0604935103</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1073%2Fpnas.0604935103" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=16864776" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BD28XotFegtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2006&pages=11491-11496&author=F.+Pojerauthor=J.+L.+Ferrerauthor=S.+B.+Richardauthor=D.+A.+Nagegowdaauthor=M.+L.+Chyeauthor=T.+J.+Bachauthor=J.+P.+Noel&title=Structural+basis+for+the+design+of+potent+and+species-specific+inhibitors+of+3-hydroxy-3-methylglutaryl+CoA+synthases&doi=10.1073%2Fpnas.0604935103"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis for the design of potent and species-specific inhibitors of 3-hydroxy-3-methylglutaryl CoA synthases</span></div><div class="casAuthors">Pojer, Florence; Ferrer, Jean-Luc; Richard, Stephane B.; Nagegowda, Dinesh A.; Chye, Mee-Len; Bach, Thomas J.; Noel, Joseph P.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue">31</span>),
    <span class="NLM_cas:pages">11491-11496</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">3-Hydroxy-3-methylglutaryl Co-A synthase (HMGS) catalyzes the first committed step in the mevalonate metabolic pathway for isoprenoid biosynthesis and serves as an alternative target for cholesterol-lowering and antibiotic drugs.  The authors have detd. a previously undescribed crystal structure of a eukaryotic HMGS bound covalently to a potent and specific inhibitor F-244 [(E,E)-11-[3-(hydroxymethyl)-4-oxo-2-oxytanyl]-3,5,7-trimethyl-2,4-undecadienenoic acid].  Given the accessibility of synthetic analogs of the F-244 natural product, this inhibited eukaryotic HMGS structure serves as a necessary starting point for structure-based methods that may improve the potency and species-specific selectivity of the next generation of F-244 analogs designed to target particular eukaryotic and prokaryotic HMGS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0PPqownf7DbVg90H21EOLACvtfcHk0lj06Dzz0llz_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XotFegtLY%253D&md5=847c953cd06656bd9d5ff9409a090258</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0604935103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0604935103%26sid%3Dliteratum%253Aachs%26aulast%3DPojer%26aufirst%3DF.%26aulast%3DFerrer%26aufirst%3DJ.%2BL.%26aulast%3DRichard%26aufirst%3DS.%2BB.%26aulast%3DNagegowda%26aufirst%3DD.%2BA.%26aulast%3DChye%26aufirst%3DM.%2BL.%26aulast%3DBach%26aufirst%3DT.%2BJ.%26aulast%3DNoel%26aufirst%3DJ.%2BP.%26atitle%3DStructural%2520basis%2520for%2520the%2520design%2520of%2520potent%2520and%2520species-specific%2520inhibitors%2520of%25203-hydroxy-3-methylglutaryl%2520CoA%2520synthases%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2006%26volume%3D103%26spage%3D11491%26epage%3D11496%26doi%3D10.1073%2Fpnas.0604935103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref95"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref95'); return false;" data-citation="" class="refNumLink">95</a></strong><div class="NLM_citation" id="cit95"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Armirotti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romeo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ponzano, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mengatto, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dionisi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karacsonyi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertozzi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garau, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarozzo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reggiani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bandiera, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarzia, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mor, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piomelli, D.</span></span> <span> </span><span class="NLM_article-title">β-Lactones inhibit N-acylethanolamine acid amidase by S-acylation of the catalytic N-terminal cysteine</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">422</span>– <span class="NLM_lpage">426</span>, <span class="refDoi"> DOI: 10.1021/ml300056y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml300056y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BC38Xlt1SnurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=422-426&author=A.+Armirottiauthor=E.+Romeoauthor=S.+Ponzanoauthor=L.+Mengattoauthor=M.+Dionisiauthor=C.+Karacsonyiauthor=F.+Bertozziauthor=G.+Garauauthor=G.+Tarozzoauthor=A.+Reggianiauthor=T.+Bandieraauthor=G.+Tarziaauthor=M.+Morauthor=D.+Piomelli&title=%CE%B2-Lactones+inhibit+N-acylethanolamine+acid+amidase+by+S-acylation+of+the+catalytic+N-terminal+cysteine&doi=10.1021%2Fml300056y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">β-Lactones Inhibit N-acylethanolamine Acid Amidase by S-Acylation of the Catalytic N-Terminal Cysteine</span></div><div class="casAuthors">Armirotti, Andrea; Romeo, Elisa; Ponzano, Stefano; Mengatto, Luisa; Dionisi, Mauro; Karacsonyi, Claudia; Bertozzi, Fabio; Garau, Gianpiero; Tarozzo, Glauco; Reggiani, Angelo; Bandiera, Tiziano; Tarzia, Giorgio; Mor, Marco; Piomelli, Daniele</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">422-426</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The cysteine amidase N-acylethanolamine acid amidase (NAAA) is a member of the N-terminal nucleophile class of enzymes and a potential target for anti-inflammatory drugs.  We investigated the mechanism of inhibition of human NAAA by substituted β-lactones.  We characterized pharmacol. a representative member of this class, ARN077, and showed, using high-resoln. liq. chromatog.-tandem mass spectrometry, that this compd. forms a thioester bond with the N-terminal catalytic cysteine in human NAAA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGooO8IxuG5LzLVg90H21EOLACvtfcHk0ljedLGKCP703g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xlt1SnurY%253D&md5=482d17b3fb0c13c8356f27a4b3f97e93</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1021%2Fml300056y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml300056y%26sid%3Dliteratum%253Aachs%26aulast%3DArmirotti%26aufirst%3DA.%26aulast%3DRomeo%26aufirst%3DE.%26aulast%3DPonzano%26aufirst%3DS.%26aulast%3DMengatto%26aufirst%3DL.%26aulast%3DDionisi%26aufirst%3DM.%26aulast%3DKaracsonyi%26aufirst%3DC.%26aulast%3DBertozzi%26aufirst%3DF.%26aulast%3DGarau%26aufirst%3DG.%26aulast%3DTarozzo%26aufirst%3DG.%26aulast%3DReggiani%26aufirst%3DA.%26aulast%3DBandiera%26aufirst%3DT.%26aulast%3DTarzia%26aufirst%3DG.%26aulast%3DMor%26aufirst%3DM.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3D%25CE%25B2-Lactones%2520inhibit%2520N-acylethanolamine%2520acid%2520amidase%2520by%2520S-acylation%2520of%2520the%2520catalytic%2520N-terminal%2520cysteine%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D3%26spage%3D422%26epage%3D426%26doi%3D10.1021%2Fml300056y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref96"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref96'); return false;" data-citation="" class="refNumLink">96</a></strong><div class="NLM_citation" id="cit96"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Solorzano, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antonietti, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duranti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tontini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivara, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lodola, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vacondio, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarzia, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piomelli, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mor, M.</span></span> <span> </span><span class="NLM_article-title">Synthesis and structure–activity relationships of N-(2-oxo-3-oxetanyl)amides as N-acylethanolamine-hydrolyzing acid amidase inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">5770</span>– <span class="NLM_lpage">5781</span>, <span class="refDoi"> DOI: 10.1021/jm100582w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100582w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BC3cXosVGhsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=5770-5781&author=C.+Solorzanoauthor=F.+Antoniettiauthor=A.+Durantiauthor=A.+Tontiniauthor=S.+Rivaraauthor=A.+Lodolaauthor=F.+Vacondioauthor=G.+Tarziaauthor=D.+Piomelliauthor=M.+Mor&title=Synthesis+and+structure%E2%80%93activity+relationships+of+N-%282-oxo-3-oxetanyl%29amides+as+N-acylethanolamine-hydrolyzing+acid+amidase+inhibitors&doi=10.1021%2Fjm100582w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Structure-Activity Relationships of N-(2-Oxo-3-oxetanyl)amides as N-Acylethanolamine-hydrolyzing Acid Amidase Inhibitors</span></div><div class="casAuthors">Solorzano, Carlos; Antonietti, Francesca; Duranti, Andrea; Tontini, Andrea; Rivara, Silvia; Lodola, Alessio; Vacondio, Federica; Tarzia, Giorgio; Piomelli, Daniele; Mor, Marco</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">5770-5781</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The fatty acid ethanolamides (FAEs) are a family of bioactive lipid mediators that include the endogenous agonist of peroxisome proliferator-activated receptor-α, palmitoylethanolamide (PEA).  FAEs are hydrolyzed intracellularly by either fatty acid amide hydrolase or N-acylethanolamine-hydrolyzing acid amidase (NAAA).  Selective inhibition of NAAA by I [R = PhCH2CH2 (II)] was found to prevent PEA degrdn. in mouse leukocytes and attenuated responses to proinflammatory stimuli.  Starting from the structure of II, a series of β-lactones was prepd. and tested on recombinant rat NAAA to explore structure-activity relationships (SARs) for this class of inhibitors and improve their in vitro potency.  Following the hypothesis that these compds. inhibited NAAA by acylation of the catalytic cysteine, several requirements for recognition at the active site were identified and new potent inhibitors obtained.  In particular, I [R = 4-PhC6H4 (III)] was more potent than II at inhibiting recombinant rat NAAA activity (II, IC50 = 420 nM; III, IC50 = 115 nM) in vitro and at reducing carrageenan-induced leukocyte infiltration in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgnb77O8b6N7Vg90H21EOLACvtfcHk0ljedLGKCP703g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXosVGhsLw%253D&md5=205063c7b40e432bd79a2254ec7d448c</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1021%2Fjm100582w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100582w%26sid%3Dliteratum%253Aachs%26aulast%3DSolorzano%26aufirst%3DC.%26aulast%3DAntonietti%26aufirst%3DF.%26aulast%3DDuranti%26aufirst%3DA.%26aulast%3DTontini%26aufirst%3DA.%26aulast%3DRivara%26aufirst%3DS.%26aulast%3DLodola%26aufirst%3DA.%26aulast%3DVacondio%26aufirst%3DF.%26aulast%3DTarzia%26aufirst%3DG.%26aulast%3DPiomelli%26aufirst%3DD.%26aulast%3DMor%26aufirst%3DM.%26atitle%3DSynthesis%2520and%2520structure%25E2%2580%2593activity%2520relationships%2520of%2520N-%25282-oxo-3-oxetanyl%2529amides%2520as%2520N-acylethanolamine-hydrolyzing%2520acid%2520amidase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D5770%26epage%3D5781%26doi%3D10.1021%2Fjm100582w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref97"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref97'); return false;" data-citation="" class="refNumLink">97</a></strong><div class="NLM_citation" id="cit97"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Duranti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tontini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antonietti, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vacondio, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fioni, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silva, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lodola, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivara, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solorzano, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piomelli, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarzia, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mor, M.</span></span> <span> </span><span class="NLM_article-title">N-(2-Oxo-3-oxetanyl)carbamic acid esters as N-acylethanolamine acid amidase inhibitors: synthesis and structure–activity and structure–property relationships</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">4824</span>– <span class="NLM_lpage">4836</span>, <span class="refDoi"> DOI: 10.1021/jm300349j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300349j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BC38XlslGrtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=4824-4836&author=A.+Durantiauthor=A.+Tontiniauthor=F.+Antoniettiauthor=F.+Vacondioauthor=A.+Fioniauthor=C.+Silvaauthor=A.+Lodolaauthor=S.+Rivaraauthor=C.+Solorzanoauthor=D.+Piomelliauthor=G.+Tarziaauthor=M.+Mor&title=N-%282-Oxo-3-oxetanyl%29carbamic+acid+esters+as+N-acylethanolamine+acid+amidase+inhibitors%3A+synthesis+and+structure%E2%80%93activity+and+structure%E2%80%93property+relationships&doi=10.1021%2Fjm300349j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">N-(2-Oxo-3-oxetanyl)carbamic acid esters as N-acylethanolamine acid amidase inhibitors: synthesis and structure-activity and structure-property relationships</span></div><div class="casAuthors">Duranti, Andrea; Tontini, Andrea; Antonietti, Francesca; Vacondio, Federica; Fioni, Alessandro; Silva, Claudia; Lodola, Alessio; Rivara, Silvia; Solorzano, Carlos; Piomelli, Daniele; Tarzia, Giorgio; Mor, Marco</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4824-4836</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The β-lactone ring of N-(2-oxo-3-oxetanyl)amides, a class of N-acylethanolamine acid amidase (NAAA) inhibitors endowed with anti-inflammatory properties, is responsible for both NAAA inhibition and low compd. stability.  Here, we investigate the structure-activity and structure-property relationships for a set of known and new β-lactone derivs., focusing on the new class of N-(2-oxo-3-oxetanyl)carbamates.  Replacement of the amide group with a carbamate one led to different stereoselectivity for NAAA inhibition and higher intrinsic stability, because of the reduced level of intramol. attack at the lactone ring.  The introduction of a syn Me at the β-position of the lactone further improved chem. stability.  A tert-Bu substituent in the side chain reduced the reactivity with bovine serum albumin.  Compd. I (URB913/ARN077) inhibited NAAA with good in vitro potency (IC50 = 127 nM) and showed improved stability.  It is rapidly cleaved in plasma, which supports its use for topical applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1ZiDApcso2rVg90H21EOLACvtfcHk0ljedLGKCP703g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlslGrtLo%253D&md5=c60261cf6c43b497bc39f43adb9f177f</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1021%2Fjm300349j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300349j%26sid%3Dliteratum%253Aachs%26aulast%3DDuranti%26aufirst%3DA.%26aulast%3DTontini%26aufirst%3DA.%26aulast%3DAntonietti%26aufirst%3DF.%26aulast%3DVacondio%26aufirst%3DF.%26aulast%3DFioni%26aufirst%3DA.%26aulast%3DSilva%26aufirst%3DC.%26aulast%3DLodola%26aufirst%3DA.%26aulast%3DRivara%26aufirst%3DS.%26aulast%3DSolorzano%26aufirst%3DC.%26aulast%3DPiomelli%26aufirst%3DD.%26aulast%3DTarzia%26aufirst%3DG.%26aulast%3DMor%26aufirst%3DM.%26atitle%3DN-%25282-Oxo-3-oxetanyl%2529carbamic%2520acid%2520esters%2520as%2520N-acylethanolamine%2520acid%2520amidase%2520inhibitors%253A%2520synthesis%2520and%2520structure%25E2%2580%2593activity%2520and%2520structure%25E2%2580%2593property%2520relationships%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D4824%26epage%3D4836%26doi%3D10.1021%2Fjm300349j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref98"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref98'); return false;" data-citation="" class="refNumLink">98</a></strong><div class="NLM_citation" id="cit98"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ponzano, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertozzi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mengatto, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dionisi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Armirotti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romeo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berteotti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fiorelli, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarozzo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reggiani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duranti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarzia, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mor, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cavalli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piomelli, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bandiera, T.</span></span> <span> </span><span class="NLM_article-title">Synthesis and structure–activity relationship (SAR) of 2-methyl-4-oxo-3-oxetanylcarbamic acid esters, a class of potent N-acylethanolamine acid amidase (NAAA) inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">6917</span>– <span class="NLM_lpage">6934</span>, <span class="refDoi"> DOI: 10.1021/jm400739u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400739u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlOktr3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=6917-6934&author=S.+Ponzanoauthor=F.+Bertozziauthor=L.+Mengattoauthor=M.+Dionisiauthor=A.+Armirottiauthor=E.+Romeoauthor=A.+Berteottiauthor=C.+Fiorelliauthor=G.+Tarozzoauthor=A.+Reggianiauthor=A.+Durantiauthor=G.+Tarziaauthor=M.+Morauthor=A.+Cavalliauthor=D.+Piomelliauthor=T.+Bandiera&title=Synthesis+and+structure%E2%80%93activity+relationship+%28SAR%29+of+2-methyl-4-oxo-3-oxetanylcarbamic+acid+esters%2C+a+class+of+potent+N-acylethanolamine+acid+amidase+%28NAAA%29+inhibitors&doi=10.1021%2Fjm400739u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Structure-Activity Relationship (SAR) of 2-Methyl-4-oxo-3-oxetanylcarbamic Acid Esters, a Class of Potent N-Acylethanolamine Acid Amidase (NAAA) Inhibitors</span></div><div class="casAuthors">Ponzano, Stefano; Bertozzi, Fabio; Mengatto, Luisa; Dionisi, Mauro; Armirotti, Andrea; Romeo, Elisa; Berteotti, Anna; Fiorelli, Claudio; Tarozzo, Glauco; Reggiani, Angelo; Duranti, Andrea; Tarzia, Giorgio; Mor, Marco; Cavalli, Andrea; Piomelli, Daniele; Bandiera, Tiziano</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">6917-6934</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">N-Acylethanolamine acid amidase (NAAA) is a lysosomal cysteine hydrolase involved in the degrdn. of satd. and monounsatd. fatty acid ethanolamides (FAEs), a family of endogenous lipid agonists of peroxisome proliferator-activated receptor-α, which include oleoylethanolamide (OEA) and palmitoylethanolamide (PEA).  The β-lactone derivs. (S)-N-(2-oxo-3-oxetanyl)-3-phenylpropionamide and (S)-N-(2-oxo-3-oxetanyl)-biphenyl-4-carboxamide inhibit NAAA, prevent FAE hydrolysis in activated inflammatory cells, and reduce tissue reactions to pro-inflammatory stimuli.  Recently, our group disclosed ARN077 (I), a potent NAAA inhibitor that is active in vivo by topical administration in rodent models of hyperalgesia and allodynia.  In the present study, we investigated the structure-activity relationship (SAR) of threonine-derived β-lactone analogs of compd. I.  The main results of this work were an enhancement of the inhibitory potency of β-lactone carbamate derivs. for NAAA and the identification of (4-phenylphenyl)-methyl-N-[(2S,3R)-2-methyl-4-oxo-oxetan-3-yl]-carbamate (II) as the first single-digit nanomolar inhibitor of intracellular NAAA activity (IC50 = 7 nM on both rat NAAA and human NAAA).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBN8FAZ7r4FbVg90H21EOLACvtfcHk0lidjCVb861aRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlOktr3L&md5=dfb2cdc18820af044a769e1b903d5a67</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1021%2Fjm400739u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400739u%26sid%3Dliteratum%253Aachs%26aulast%3DPonzano%26aufirst%3DS.%26aulast%3DBertozzi%26aufirst%3DF.%26aulast%3DMengatto%26aufirst%3DL.%26aulast%3DDionisi%26aufirst%3DM.%26aulast%3DArmirotti%26aufirst%3DA.%26aulast%3DRomeo%26aufirst%3DE.%26aulast%3DBerteotti%26aufirst%3DA.%26aulast%3DFiorelli%26aufirst%3DC.%26aulast%3DTarozzo%26aufirst%3DG.%26aulast%3DReggiani%26aufirst%3DA.%26aulast%3DDuranti%26aufirst%3DA.%26aulast%3DTarzia%26aufirst%3DG.%26aulast%3DMor%26aufirst%3DM.%26aulast%3DCavalli%26aufirst%3DA.%26aulast%3DPiomelli%26aufirst%3DD.%26aulast%3DBandiera%26aufirst%3DT.%26atitle%3DSynthesis%2520and%2520structure%25E2%2580%2593activity%2520relationship%2520%2528SAR%2529%2520of%25202-methyl-4-oxo-3-oxetanylcarbamic%2520acid%2520esters%252C%2520a%2520class%2520of%2520potent%2520N-acylethanolamine%2520acid%2520amidase%2520%2528NAAA%2529%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D6917%26epage%3D6934%26doi%3D10.1021%2Fjm400739u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref99"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref99'); return false;" data-citation="" class="refNumLink">99</a></strong><div class="NLM_citation" id="cit99"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ponzano, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berteotti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petracca, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vitale, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mengatto, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bandiera, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cavalli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piomelli, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertozzi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bottegoni, G.</span></span> <span> </span><span class="NLM_article-title">Synthesis, biological evaluation, and 3D QSAR study of 2-methyl-4-oxo-3-oxetanylcarbamic acid esters as N-acylethanolamine acid amidase (NAAA) inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">10101</span>– <span class="NLM_lpage">10111</span>, <span class="refDoi"> DOI: 10.1021/jm501455s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501455s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVyrtLrN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=10101-10111&author=S.+Ponzanoauthor=A.+Berteottiauthor=R.+Petraccaauthor=R.+Vitaleauthor=L.+Mengattoauthor=T.+Bandieraauthor=A.+Cavalliauthor=D.+Piomelliauthor=F.+Bertozziauthor=G.+Bottegoni&title=Synthesis%2C+biological+evaluation%2C+and+3D+QSAR+study+of+2-methyl-4-oxo-3-oxetanylcarbamic+acid+esters+as+N-acylethanolamine+acid+amidase+%28NAAA%29+inhibitors&doi=10.1021%2Fjm501455s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, Biological Evaluation, and 3D QSAR Study of 2-Methyl-4-oxo-3-oxetanylcarbamic Acid Esters as N-Acylethanolamine Acid Amidase (NAAA) Inhibitors</span></div><div class="casAuthors">Ponzano, Stefano; Berteotti, Anna; Petracca, Rita; Vitale, Romina; Mengatto, Luisa; Bandiera, Tiziano; Cavalli, Andrea; Piomelli, Daniele; Bertozzi, Fabio; Bottegoni, Giovanni</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">10101-10111</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">N-(2-Oxo-3-oxetanyl)carbamic acid esters e. g., I, have recently been reported to be noncompetitive inhibitors of the N-acylethanolamine acid amidase (NAAA) potentially useful for the treatment of pain and inflammation.  In the present study, we further explored the structure-activity relationships of the carbamic acid ester side chain of 2-methyl-4-oxo-3-oxetanylcarbamic acid ester derivs.  Addnl. favorable features in the design of potent NAAA inhibitors have been found together with the identification of a single digit nanomolar inhibitor.  In addn., we devised a 3D QSAR using the at. property field method.  The model turned out to be able to account for the structural variability and was prospectively validated by designing, synthesizing, and testing novel inhibitors.  The fairly good agreement between predictions and exptl. potency values points to this 3D QSAR model as the first example of quant. structure-activity relationships in the field of NAAA inhibitors .</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVpHkND7iUzbVg90H21EOLACvtfcHk0lidjCVb861aRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVyrtLrN&md5=1c863895692bf0e2bd76956ae1c0fda4</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1021%2Fjm501455s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501455s%26sid%3Dliteratum%253Aachs%26aulast%3DPonzano%26aufirst%3DS.%26aulast%3DBerteotti%26aufirst%3DA.%26aulast%3DPetracca%26aufirst%3DR.%26aulast%3DVitale%26aufirst%3DR.%26aulast%3DMengatto%26aufirst%3DL.%26aulast%3DBandiera%26aufirst%3DT.%26aulast%3DCavalli%26aufirst%3DA.%26aulast%3DPiomelli%26aufirst%3DD.%26aulast%3DBertozzi%26aufirst%3DF.%26aulast%3DBottegoni%26aufirst%3DG.%26atitle%3DSynthesis%252C%2520biological%2520evaluation%252C%2520and%25203D%2520QSAR%2520study%2520of%25202-methyl-4-oxo-3-oxetanylcarbamic%2520acid%2520esters%2520as%2520N-acylethanolamine%2520acid%2520amidase%2520%2528NAAA%2529%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D10101%26epage%3D10111%26doi%3D10.1021%2Fjm501455s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref100"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref100'); return false;" data-citation="" class="refNumLink">100</a></strong><div class="NLM_citation" id="cit100"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Khasabova, I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coicou, L. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piomelli, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seybold, V.</span></span> <span> </span><span class="NLM_article-title">Peroxisome proliferator-activated receptor α mediates acute effects of palmitoylethanolamide on sensory neurons</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">12735</span>– <span class="NLM_lpage">12743</span>, <span class="refDoi"> DOI: 10.1523/JNEUROSCI.0130-12.2012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1523%2FJNEUROSCI.0130-12.2012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=22972997" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVSlsbjM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2012&pages=12735-12743&author=I.+A.+Khasabovaauthor=Y.+Xiongauthor=L.+G.+Coicouauthor=D.+Piomelliauthor=V.+Seybold&title=Peroxisome+proliferator-activated+receptor+%CE%B1+mediates+acute+effects+of+palmitoylethanolamide+on+sensory+neurons&doi=10.1523%2FJNEUROSCI.0130-12.2012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit100R"><div class="casContent"><span class="casTitleNuber">100</span><div class="casTitle"><span class="NLM_cas:atitle">Peroxisome proliferator-activated receptor α mediates acute effects of palmitoylethanolamide on sensory neurons</span></div><div class="casAuthors">Khasabova, Iryna A.; Xiong, Yee; Coicou, Lia G.; Piomelli, Daniele; Seybold, Virginia</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">37</span>),
    <span class="NLM_cas:pages">12735-12743</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">The amplitude of the depolarization-evoked Ca2+ transient is larger in dorsal root ganglion (DRG) neurons from tumor-bearing mice compared with that of neurons from naive mice, and the change is mimicked by coculturing DRG neurons with the fibrosarcoma cells used to generate the tumors.  The effect of palmitoylethanolamide (PEA), a ligand for the peroxisome proliferator-activated receptor α (PPARα), was detd. on the evoked-Ca2+ transient in the coculture condition.  The level of PEA was reduced in DRG cells from tumor-bearing mice as well as those cocultured with fibrosarcoma cells.  Pretreatment with PEA, a synthetic PPARα agonist (GW7647), or ARN077, an inhibitor of the enzyme that hydrolyzes PEA, acutely decreased the amplitude of the evoked Ca2+ transient in small DRG neurons cocultured with fibrosarcoma cells.  The PPARα antagonist GW6471 blocked the effect of each.  In contrast, the PPARα agonist was without effect in the control condition, but the antagonist increased the amplitude of the Ca2+ transient, suggesting that PPARα receptors are satd. by endogenous ligand under basal conditions.  Effects of drugs on mech. sensitivity in vivo paralleled their effects on DRG neurons in vitro.  Local injection of ARN077 decreased mech. hyperalgesia in tumor-bearing mice, and the effect was blocked by GW6471.  These data support the conclusion that the activity of DRG neurons is rapidly modulated by PEA through a PPARα-dependent mechanism.  Moreover, agents that increase the activity of PPARα may provide a therapeutic strategy to reduce tumor-evoked pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofcnSjBUw1-7Vg90H21EOLACvtfcHk0lidjCVb861aRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVSlsbjM&md5=a94261dbf634cb244d328ea384da88d5</span></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.0130-12.2012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.0130-12.2012%26sid%3Dliteratum%253Aachs%26aulast%3DKhasabova%26aufirst%3DI.%2BA.%26aulast%3DXiong%26aufirst%3DY.%26aulast%3DCoicou%26aufirst%3DL.%2BG.%26aulast%3DPiomelli%26aufirst%3DD.%26aulast%3DSeybold%26aufirst%3DV.%26atitle%3DPeroxisome%2520proliferator-activated%2520receptor%2520%25CE%25B1%2520mediates%2520acute%2520effects%2520of%2520palmitoylethanolamide%2520on%2520sensory%2520neurons%26jtitle%3DJ.%2520Neurosci.%26date%3D2012%26volume%3D32%26spage%3D12735%26epage%3D12743%26doi%3D10.1523%2FJNEUROSCI.0130-12.2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref101"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref101'); return false;" data-citation="" class="refNumLink">101</a></strong><div class="NLM_citation" id="cit101"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sasso, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreno-Sanz, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martucci, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Realini, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dionisi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mengatto, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duranti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarozzo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarzia, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mor, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertorelli, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reggiani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piomelli, D.</span></span> <span> </span><span class="NLM_article-title">Antinociceptive effects of the N-acylethanolamine acid amidase inhibitor ARN077 in rodent pain models</span>. <i>Pain</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>154</i></span>,  <span class="NLM_fpage">350</span>– <span class="NLM_lpage">360</span>, <span class="refDoi"> DOI: 10.1016/j.pain.2012.10.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1016%2Fj.pain.2012.10.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=23218523" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BC3sXivF2jtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=154&publication_year=2013&pages=350-360&author=O.+Sassoauthor=G.+Moreno-Sanzauthor=C.+Martucciauthor=N.+Realiniauthor=M.+Dionisiauthor=L.+Mengattoauthor=A.+Durantiauthor=G.+Tarozzoauthor=G.+Tarziaauthor=M.+Morauthor=R.+Bertorelliauthor=A.+Reggianiauthor=D.+Piomelli&title=Antinociceptive+effects+of+the+N-acylethanolamine+acid+amidase+inhibitor+ARN077+in+rodent+pain+models&doi=10.1016%2Fj.pain.2012.10.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit101R"><div class="casContent"><span class="casTitleNuber">101</span><div class="casTitle"><span class="NLM_cas:atitle">Antinociceptive effects of the N-acylethanolamine acid amidase inhibitor ARN077 in rodent pain models</span></div><div class="casAuthors">Sasso, Oscar; Moreno-Sanz, Guillermo; Martucci, Cataldo; Realini, Natalia; Dionisi, Mauro; Mengatto, Luisa; Duranti, Andrea; Tarozzo, Glauco; Tarzia, Giorgio; Mor, Marco; Bertorelli, Rosalia; Reggiani, Angelo; Piomelli, Daniele</div><div class="citationInfo"><span class="NLM_cas:title">Pain</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">154</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">350-360</span>CODEN:
                <span class="NLM_cas:coden">PAINDB</span>;
        ISSN:<span class="NLM_cas:issn">0304-3959</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Fatty acid ethanolamides (FAEs), which include palmitoylethanolamide (PEA) and oleoylethanolamide (OEA), are endogenous agonists of peroxisome proliferator-activated receptor-α (PPAR-α) and important regulators of the inflammatory response.  They are degraded in macrophages by the lysosomal cysteine amidase, N-acylethanolamine acid amidase (NAAA).  Previous studies have shown that pharmacol. inhibition of NAAA activity suppresses macrophage activation in vitro and causes marked anti-inflammatory effects in vivo, which is suggestive of a role for NAAA in the control of inflammation.  It is still unknown, however, whether NAAA-mediated FAE deactivation might regulate pain signaling.  The present study examd. the effects of ARN077, a potent and selective NAAA inhibitor recently disclosed by our group, in rodent models of hyperalgesia and allodynia caused by inflammation or nerve damage.  Topical administration of ARN077 attenuated, in a dose-dependent manner, heat hyperalgesia and mech. allodynia elicited in mice by carrageenan injection or sciatic nerve ligation.  The antinociceptive effects of ARN077 were prevented by the selective PPAR-α antagonist GW6471 and did not occur in PPAR-α-deficient mice.  Furthermore, topical ARN077 reversed the allodynia caused by UV B radiation in rats, and this effect was blocked by pretreatment with GW6471.  Sciatic nerve ligation or application of the proinflammatory phorbol ester 12-O-tetradecanoylphorbol 13-acetate decreased FAE levels in sciatic nerve and skin tissue, resp.  ARN077 reversed these biochem. effects.  The results identify ARN077 as a potent inhibitor of intracellular NAAA activity, which is active in vivo by topical administration.  The findings further suggest that NAAA regulates peripheral pain initiation by interrupting endogenous FAE signaling at PPAR-α.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVAH4mpvyphbVg90H21EOLACvtfcHk0ljqNjHxJLcIMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXivF2jtrk%253D&md5=08c067a44b1f75e7e0192fdbdeccccd4</span></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1016%2Fj.pain.2012.10.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pain.2012.10.018%26sid%3Dliteratum%253Aachs%26aulast%3DSasso%26aufirst%3DO.%26aulast%3DMoreno-Sanz%26aufirst%3DG.%26aulast%3DMartucci%26aufirst%3DC.%26aulast%3DRealini%26aufirst%3DN.%26aulast%3DDionisi%26aufirst%3DM.%26aulast%3DMengatto%26aufirst%3DL.%26aulast%3DDuranti%26aufirst%3DA.%26aulast%3DTarozzo%26aufirst%3DG.%26aulast%3DTarzia%26aufirst%3DG.%26aulast%3DMor%26aufirst%3DM.%26aulast%3DBertorelli%26aufirst%3DR.%26aulast%3DReggiani%26aufirst%3DA.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DAntinociceptive%2520effects%2520of%2520the%2520N-acylethanolamine%2520acid%2520amidase%2520inhibitor%2520ARN077%2520in%2520rodent%2520pain%2520models%26jtitle%3DPain%26date%3D2013%26volume%3D154%26spage%3D350%26epage%3D360%26doi%3D10.1016%2Fj.pain.2012.10.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref102"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref102'); return false;" data-citation="" class="refNumLink">102</a></strong><div class="NLM_citation" id="cit102"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fiasella, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nuzzi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Summa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Armirotti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarozzo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarzia, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mor, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertozzi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bandiera, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piomelli, D.</span></span> <span> </span><span class="NLM_article-title">3-Aminoazetidin-2-one derivatives as N-acylethanolamine acid amidase (NAAA) inhibitors suitable for systemic administration</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1602</span>– <span class="NLM_lpage">1614</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201300546</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1002%2Fcmdc.201300546" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=24828120" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BC2cXnvF2ks74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=1602-1614&author=A.+Fiasellaauthor=A.+Nuzziauthor=M.+Summaauthor=A.+Armirottiauthor=G.+Tarozzoauthor=G.+Tarziaauthor=M.+Morauthor=F.+Bertozziauthor=T.+Bandieraauthor=D.+Piomelli&title=3-Aminoazetidin-2-one+derivatives+as+N-acylethanolamine+acid+amidase+%28NAAA%29+inhibitors+suitable+for+systemic+administration&doi=10.1002%2Fcmdc.201300546"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit102R"><div class="casContent"><span class="casTitleNuber">102</span><div class="casTitle"><span class="NLM_cas:atitle">3-Aminoazetidin-2-one Derivatives as N-Acylethanolamine Acid Amidase (NAAA) Inhibitors Suitable for Systemic Administration</span></div><div class="casAuthors">Fiasella, Annalisa; Nuzzi, Andrea; Summa, Maria; Armirotti, Andrea; Tarozzo, Glauco; Tarzia, Giorgio; Mor, Marco; Bertozzi, Fabio; Bandiera, Tiziano; Piomelli, Daniele</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1602-1614</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">N-Acylethanolamine acid amidase (NAAA) is a cysteine hydrolase that catalyzes the hydrolysis of endogenous lipid mediators such as palmitoylethanolamide (PEA).  PEA has been shown to exert anti-inflammatory and antinociceptive effects in animals by engaging peroxisome proliferator-activated receptor α (PPAR-α).  Thus, preventing PEA degrdn. by inhibiting NAAA may provide a novel approach for the treatment of pain and inflammatory states.  Recently, 3-aminooxetan-2-one compds. were identified as a class of highly potent NAAA inhibitors.  The utility of these compds. is limited, however, by their low chem. and plasma stabilities.  In the present study, we synthesized and tested a series of N-(2-oxoazetidin-3-yl)amides as a novel class of NAAA inhibitors with good potency and improved physicochem. properties, suitable for systemic administration.  Moreover, we elucidated the main structural features of 3-aminoazetidin-2-one derivs. that are crit. for NAAA inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocn1G5QzPtHLVg90H21EOLACvtfcHk0ljqNjHxJLcIMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXnvF2ks74%253D&md5=beee5cde68184abb3c47e4631c56497f</span></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201300546&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201300546%26sid%3Dliteratum%253Aachs%26aulast%3DFiasella%26aufirst%3DA.%26aulast%3DNuzzi%26aufirst%3DA.%26aulast%3DSumma%26aufirst%3DM.%26aulast%3DArmirotti%26aufirst%3DA.%26aulast%3DTarozzo%26aufirst%3DG.%26aulast%3DTarzia%26aufirst%3DG.%26aulast%3DMor%26aufirst%3DM.%26aulast%3DBertozzi%26aufirst%3DF.%26aulast%3DBandiera%26aufirst%3DT.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3D3-Aminoazetidin-2-one%2520derivatives%2520as%2520N-acylethanolamine%2520acid%2520amidase%2520%2528NAAA%2529%2520inhibitors%2520suitable%2520for%2520systemic%2520administration%26jtitle%3DChemMedChem%26date%3D2014%26volume%3D9%26spage%3D1602%26epage%3D1614%26doi%3D10.1002%2Fcmdc.201300546" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref103"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref103'); return false;" data-citation="" class="refNumLink">103</a></strong><div class="NLM_citation" id="cit103"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Migliore, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pontis, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuentes
de Arriba, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Realini, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torrente, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Armirotti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romeo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Martino, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pizzirani, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Summa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lanfranco, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ottonello, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Busquet, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Guzman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heim, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scarpelli, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piomelli, D.</span></span> <span> </span><span class="NLM_article-title">Second-generation non-covalent NAAA inhibitors are protective in a model of multiple sclerosis</span>. <i>Angew. Chem. Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">11193</span>– <span class="NLM_lpage">11197</span>, <span class="refDoi"> DOI: 10.1002/anie.201603746</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1002%2Fanie.201603746" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtFKmt77K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2016&pages=11193-11197&author=M.+Miglioreauthor=S.+Pontisauthor=A.+L.+Fuentes%0Ade+Arribaauthor=N.+Realiniauthor=E.+Torrenteauthor=A.+Armirottiauthor=E.+Romeoauthor=S.+Di+Martinoauthor=D.+Russoauthor=D.+Pizziraniauthor=M.+Summaauthor=M.+Lanfrancoauthor=G.+Ottonelloauthor=P.+Busquetauthor=K.+M.+Jungauthor=M.+Garcia-Guzmanauthor=R.+Heimauthor=R.+Scarpelliauthor=D.+Piomelli&title=Second-generation+non-covalent+NAAA+inhibitors+are+protective+in+a+model+of+multiple+sclerosis&doi=10.1002%2Fanie.201603746"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit103R"><div class="casContent"><span class="casTitleNuber">103</span><div class="casTitle"><span class="NLM_cas:atitle">Second-Generation Non-Covalent NAAA Inhibitors are Protective in a Model of Multiple Sclerosis</span></div><div class="casAuthors">Migliore, Marco; Pontis, Silvia; Fuentes de Arriba, Angel Luis; Realini, Natalia; Torrente, Esther; Armirotti, Andrea; Romeo, Elisa; Di Martino, Simona; Russo, Debora; Pizzirani, Daniela; Summa, Maria; Lanfranco, Massimiliano; Ottonello, Giuliana; Busquet, Perrine; Jung, Kwang-Mook; Garcia-Guzman, Miguel; Heim, Roger; Scarpelli, Rita; Piomelli, Daniele</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">37</span>),
    <span class="NLM_cas:pages">11193-11197</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Palmitoylethanolamide (PEA) and oleoylethanolamide (OEA) are endogenous lipid mediators that suppress inflammation.  Their actions are terminated by the intracellular cysteine amidase, N-acylethanolamine acid amidase (NAAA).  Even though NAAA may offer a new target for anti-inflammatory therapy, the lipid-like structures and reactive warheads of current NAAA inhibitors limit the use of these agents as oral drugs.  A series of novel benzothiazole-piperazine derivs. that inhibit NAAA in a potent and selective manner by a non-covalent mechanism are described.  A prototype member of this class (8) displays high oral bioavailability, access to the central nervous system (CNS), and strong activity in a mouse model of multiple sclerosis (MS).  This compd. exemplifies a second generation of non-covalent NAAA inhibitors that may be useful in the treatment of MS and other chronic CNS disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpuWcI9qbPxD7Vg90H21EOLACvtfcHk0ljqNjHxJLcIMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtFKmt77K&md5=3a0393efde3a858d2bef8af194b65a21</span></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.1002%2Fanie.201603746&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201603746%26sid%3Dliteratum%253Aachs%26aulast%3DMigliore%26aufirst%3DM.%26aulast%3DPontis%26aufirst%3DS.%26aulast%3DFuentes%2Bde%2BArriba%26aufirst%3DA.%2BL.%26aulast%3DRealini%26aufirst%3DN.%26aulast%3DTorrente%26aufirst%3DE.%26aulast%3DArmirotti%26aufirst%3DA.%26aulast%3DRomeo%26aufirst%3DE.%26aulast%3DDi%2BMartino%26aufirst%3DS.%26aulast%3DRusso%26aufirst%3DD.%26aulast%3DPizzirani%26aufirst%3DD.%26aulast%3DSumma%26aufirst%3DM.%26aulast%3DLanfranco%26aufirst%3DM.%26aulast%3DOttonello%26aufirst%3DG.%26aulast%3DBusquet%26aufirst%3DP.%26aulast%3DJung%26aufirst%3DK.%2BM.%26aulast%3DGarcia-Guzman%26aufirst%3DM.%26aulast%3DHeim%26aufirst%3DR.%26aulast%3DScarpelli%26aufirst%3DR.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DSecond-generation%2520non-covalent%2520NAAA%2520inhibitors%2520are%2520protective%2520in%2520a%2520model%2520of%2520multiple%2520sclerosis%26jtitle%3DAngew.%2520Chem.%2520Int.%2520Ed.%26date%3D2016%26volume%3D55%26spage%3D11193%26epage%3D11197%26doi%3D10.1002%2Fanie.201603746" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref104"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref104'); return false;" data-citation="" class="refNumLink">104</a></strong><div class="NLM_citation" id="cit104"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nuzzi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fiasella, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortega, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pagliuca, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ponzano, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pizzirani, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertozzi, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ottonello, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarozzo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reggiani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bandiera, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertozzi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piomelli, D.</span></span> <span> </span><span class="NLM_article-title">Potent α-amino-β-lactam carbamic acid ester as NAAA inhibitors. Synthesis and structure-activity relationship (SAR) studies</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>111</i></span>,  <span class="NLM_fpage">138</span>– <span class="NLM_lpage">159</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2016.01.046</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1016%2Fj.ejmech.2016.01.046" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=26866968" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BC28XisVansL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2016&pages=138-159&author=A.+Nuzziauthor=A.+Fiasellaauthor=J.+A.+Ortegaauthor=C.+Pagliucaauthor=S.+Ponzanoauthor=D.+Pizziraniauthor=S.+M.+Bertozziauthor=G.+Ottonelloauthor=G.+Tarozzoauthor=A.+Reggianiauthor=T.+Bandieraauthor=F.+Bertozziauthor=D.+Piomelli&title=Potent+%CE%B1-amino-%CE%B2-lactam+carbamic+acid+ester+as+NAAA+inhibitors.+Synthesis+and+structure-activity+relationship+%28SAR%29+studies&doi=10.1016%2Fj.ejmech.2016.01.046"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit104R"><div class="casContent"><span class="casTitleNuber">104</span><div class="casTitle"><span class="NLM_cas:atitle">Potent α-amino-β-lactam carbamic acid ester as NAAA inhibitors. Synthesis and structure-activity relationship (SAR) studies</span></div><div class="casAuthors">Nuzzi, Andrea; Fiasella, Annalisa; Ortega, Jose Antonio; Pagliuca, Chiara; Ponzano, Stefano; Pizzirani, Daniela; Bertozzi, Sine Mandrup; Ottonello, Giuliana; Tarozzo, Glauco; Reggiani, Angelo; Bandiera, Tiziano; Bertozzi, Fabio; Piomelli, Daniele</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">138-159</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">4-Cyclohexylbutyl-N-[(S)-2-oxoazetidin-3-yl]carbamate I is a potent, selective and systemically active inhibitor of intracellular NAAA activity, which produces profound anti-inflammatory effects in animal models.  In the present work, the authors describe structure-activity relationship (SAR) studies on 3-aminoazetidin-2-one derivs., which have led to the identification of I, and expand these studies to elucidate the principal structural and stereochem. features needed to achieve effective NAAA inhibition.  Investigations on the influence of the substitution at the β-position of the 2-oxo-3-azetidinyl ring as well as on the effect of size and shape of the carbamic acid ester side chain led to the discovery of II, a novel inhibitor of human NAAA that shows an improved physicochem. and drug-like profile relative to I.  This favorable profile, along with the structural diversity of the carbamic acid chain of I, identify this compd. as a promising new tool to investigate the potential of NAAA inhibitors as therapeutic agents for the treatment of pain and inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoaN0JjRB6bmrVg90H21EOLACvtfcHk0li75wV3L6mbZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XisVansL4%253D&md5=639c2848d70ba68008db89244c2c8657</span></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2016.01.046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2016.01.046%26sid%3Dliteratum%253Aachs%26aulast%3DNuzzi%26aufirst%3DA.%26aulast%3DFiasella%26aufirst%3DA.%26aulast%3DOrtega%26aufirst%3DJ.%2BA.%26aulast%3DPagliuca%26aufirst%3DC.%26aulast%3DPonzano%26aufirst%3DS.%26aulast%3DPizzirani%26aufirst%3DD.%26aulast%3DBertozzi%26aufirst%3DS.%2BM.%26aulast%3DOttonello%26aufirst%3DG.%26aulast%3DTarozzo%26aufirst%3DG.%26aulast%3DReggiani%26aufirst%3DA.%26aulast%3DBandiera%26aufirst%3DT.%26aulast%3DBertozzi%26aufirst%3DF.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DPotent%2520%25CE%25B1-amino-%25CE%25B2-lactam%2520carbamic%2520acid%2520ester%2520as%2520NAAA%2520inhibitors.%2520Synthesis%2520and%2520structure-activity%2520relationship%2520%2528SAR%2529%2520studies%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2016%26volume%3D111%26spage%3D138%26epage%3D159%26doi%3D10.1016%2Fj.ejmech.2016.01.046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref105"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref105'); return false;" data-citation="" class="refNumLink">105</a></strong><div class="NLM_citation" id="cit105"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Petracca, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ponzano, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertozzi, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sasso, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piomelli, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bandiera, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertozzi, F.</span></span> <span> </span><span class="NLM_article-title">Progress in the development of β-lactams as N-acylethanolamine acid amidase (NAAA) inhibitors: synthesis and SAR study of new, potent N-O-substituted derivatives</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>126</i></span>,  <span class="NLM_fpage">561</span>– <span class="NLM_lpage">575</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2016.11.039</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1016%2Fj.ejmech.2016.11.039" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=27915171" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BC28XitVGhsbzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2017&pages=561-575&author=R.+Petraccaauthor=S.+Ponzanoauthor=S.+M.+Bertozziauthor=O.+Sassoauthor=D.+Piomelliauthor=T.+Bandieraauthor=F.+Bertozzi&title=Progress+in+the+development+of+%CE%B2-lactams+as+N-acylethanolamine+acid+amidase+%28NAAA%29+inhibitors%3A+synthesis+and+SAR+study+of+new%2C+potent+N-O-substituted+derivatives&doi=10.1016%2Fj.ejmech.2016.11.039"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit105R"><div class="casContent"><span class="casTitleNuber">105</span><div class="casTitle"><span class="NLM_cas:atitle">Progress in the development of β-lactams as N-Acylethanolamine Acid Amidase (NAAA) inhibitors: Synthesis and SAR study of new, potent N-O-substituted derivatives</span></div><div class="casAuthors">Petracca, R.; Ponzano, S.; Bertozzi, S. M.; Sasso, O.; Piomelli, D.; Bandiera, T.; Bertozzi, F.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">126</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">561-575</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">The anti-inflammatory effects resulting from raising the levels of palmitoylethanolamide (PEA), an endogenous bioactive lipid, led to envisage N-Acylethanolamine Acid Amidase (NAAA), the cysteine hydrolase mainly responsible for PEA degrdn., as an attractive target for small mol. inhibitors.  Previous work in our group identified serine-derived β-lactams as potent and systemically active inhibitors of NAAA activity.  Aiming to expand the SAR study around this class of compds., we investigated the effect of the substitution on the endocyclic nitrogen by designing and synthesizing a series of N-substituted β-lactams.  The present work describes the synthesis of new N-O-alkyl and N-O-aryl substituted β-lactams and reports the results of the structure activity relationship (SAR) study leading to the discovery of a novel, single-digit nanomolar NAAA inhibitor (I).  Compd. I was shown in vitro to inhibit human NAAA via S-acylation of the catalytic cysteine, and to display very good selectivity vs. human Acid Ceramidase, a cysteine amidase structurally related to NAAA.  Preliminary in vivo studies showed that compd. I, administered topically, reduced paw edema and heat hyperalgesia in a carrageenan-induced inflammation mouse model.  The high in vitro potency of I as NAAA inhibitor, and its encouraging in vivo activity qualify this compd. as a new tool for the study of the role of NAAA in inflammatory and pain states.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5Ajl1yXbDTbVg90H21EOLACvtfcHk0li75wV3L6mbZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitVGhsbzP&md5=d5bc0ac0a10268a0eb10847a2c18d3dc</span></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2016.11.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2016.11.039%26sid%3Dliteratum%253Aachs%26aulast%3DPetracca%26aufirst%3DR.%26aulast%3DPonzano%26aufirst%3DS.%26aulast%3DBertozzi%26aufirst%3DS.%2BM.%26aulast%3DSasso%26aufirst%3DO.%26aulast%3DPiomelli%26aufirst%3DD.%26aulast%3DBandiera%26aufirst%3DT.%26aulast%3DBertozzi%26aufirst%3DF.%26atitle%3DProgress%2520in%2520the%2520development%2520of%2520%25CE%25B2-lactams%2520as%2520N-acylethanolamine%2520acid%2520amidase%2520%2528NAAA%2529%2520inhibitors%253A%2520synthesis%2520and%2520SAR%2520study%2520of%2520new%252C%2520potent%2520N-O-substituted%2520derivatives%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2017%26volume%3D126%26spage%3D561%26epage%3D575%26doi%3D10.1016%2Fj.ejmech.2016.11.039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref106"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref106'); return false;" data-citation="" class="refNumLink">106</a></strong><div class="NLM_citation" id="cit106"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Romeo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ponzano, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Armirotti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Summa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertozzi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garau, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bandiera, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piomelli, D.</span></span> <span> </span><span class="NLM_article-title">Activity-based probe for N-acylethanolamine acid amidase</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">2057</span>– <span class="NLM_lpage">2064</span>, <span class="refDoi"> DOI: 10.1021/acschembio.5b00197</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.5b00197" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVeks7%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=2057-2064&author=E.+Romeoauthor=S.+Ponzanoauthor=A.+Armirottiauthor=M.+Summaauthor=F.+Bertozziauthor=G.+Garauauthor=T.+Bandieraauthor=D.+Piomelli&title=Activity-based+probe+for+N-acylethanolamine+acid+amidase&doi=10.1021%2Facschembio.5b00197"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit106R"><div class="casContent"><span class="casTitleNuber">106</span><div class="casTitle"><span class="NLM_cas:atitle">Activity-Based Probe for N-Acylethanolamine Acid Amidase</span></div><div class="casAuthors">Romeo, Elisa; Ponzano, Stefano; Armirotti, Andrea; Summa, Maria; Bertozzi, Fabio; Garau, Gianpiero; Bandiera, Tiziano; Piomelli, Daniele</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2057-2064</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">N-Acylethanolamine acid amidase (NAAA) is a lysosomal cysteine hydrolase involved in the degrdn. of satd. and monounsatd. fatty acid ethanolamides (FAEs), a family of endogenous lipid signaling mols. that includes oleoylethanolamide (OEA, 18:1Δ) and palmitoylethanolamide (PEA, 16:0).  Among the reported NAAA inhibitors, α-amino-β-lactone (3-aminooxetan-2-one) derivs. have been shown to prevent FAE hydrolysis in innate-immune and neural cells and to reduce reactions to inflammatory stimuli.  Recently, we disclosed two potent and selective NAAA inhibitors, the compds. ARN077 (5-phenylpentyl-N-[(2S,3R)-2-methyl-4-oxo-oxetan-3-yl]carbamate) and ARN726 (4-cyclohexylbutyl-N-[(S)-2-oxoazetidin-3-yl]carbamate).  The former is active in vivo by topical administration in rodent models of hyperalgesia and allodynia, while the latter exerts systemic anti-inflammatory effects in mouse models of lung inflammation.  In the present study, we designed and validated a deriv. of ARN726 as the first activity-based protein profiling (ABPP) probe for the in vivo detection of NAAA.  The newly synthesized mol. ARN14686 is an effective in vitro and in vivo click chem. activity-based probe (ABP), which is able to capture the catalytically active form of NAAA in Human Embryonic Kidney 293 (HEK293) cells overexpressing human NAAA as well as in rat lung tissue.  Competitive ABPP with 1 confirmed that ARN726 and ARN077 inhibit NAAA in vitro and in vivo.  Compd. 1 is a useful new tool to identify activated NAAA both in vitro and in vivo and to investigate the physiol. and pathol. roles of this enzyme.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTLtN6tIDDZbVg90H21EOLACvtfcHk0ljL0-cDoCptsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVeks7%252FO&md5=1c76c7ac8597a15ce6b2bad6c5372d5d</span></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1021%2Facschembio.5b00197&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.5b00197%26sid%3Dliteratum%253Aachs%26aulast%3DRomeo%26aufirst%3DE.%26aulast%3DPonzano%26aufirst%3DS.%26aulast%3DArmirotti%26aufirst%3DA.%26aulast%3DSumma%26aufirst%3DM.%26aulast%3DBertozzi%26aufirst%3DF.%26aulast%3DGarau%26aufirst%3DG.%26aulast%3DBandiera%26aufirst%3DT.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DActivity-based%2520probe%2520for%2520N-acylethanolamine%2520acid%2520amidase%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2015%26volume%3D10%26spage%3D2057%26epage%3D2064%26doi%3D10.1021%2Facschembio.5b00197" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref107"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref107'); return false;" data-citation="" class="refNumLink">107</a></strong><div class="NLM_citation" id="cit107"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Romeo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pontis, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ponzano, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonezzi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Migliore, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Martino, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Summa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piomelli, D.</span></span> <span> </span><span class="NLM_article-title">Preparation and in vivo use of an activity-based probe for N-acylethanolamine acid amidase</span>. <i>J. Visualized Exp.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>117</i></span>,  <span class="NLM_fpage">e54652</span>, <span class="refDoi"> DOI: 10.3791/54652</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.3791%2F54652" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2016&pages=e54652&author=E.+Romeoauthor=S.+Pontisauthor=S.+Ponzanoauthor=F.+Bonezziauthor=M.+Miglioreauthor=S.+Di+Martinoauthor=M.+Summaauthor=D.+Piomelli&title=Preparation+and+in+vivo+use+of+an+activity-based+probe+for+N-acylethanolamine+acid+amidase&doi=10.3791%2F54652"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.3791%2F54652&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3791%252F54652%26sid%3Dliteratum%253Aachs%26aulast%3DRomeo%26aufirst%3DE.%26aulast%3DPontis%26aufirst%3DS.%26aulast%3DPonzano%26aufirst%3DS.%26aulast%3DBonezzi%26aufirst%3DF.%26aulast%3DMigliore%26aufirst%3DM.%26aulast%3DDi%2BMartino%26aufirst%3DS.%26aulast%3DSumma%26aufirst%3DM.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DPreparation%2520and%2520in%2520vivo%2520use%2520of%2520an%2520activity-based%2520probe%2520for%2520N-acylethanolamine%2520acid%2520amidase%26jtitle%3DJ.%2520Visualized%2520Exp.%26date%3D2016%26volume%3D117%26spage%3De54652%26doi%3D10.3791%2F54652" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref108"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref108'); return false;" data-citation="" class="refNumLink">108</a></strong><div class="NLM_citation" id="cit108"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Petracca, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romeo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baggelaar, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Artola, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pontis, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ponzano, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Overkleeft, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Stelt, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piomelli, D.</span></span> <span> </span><span class="NLM_article-title">Novel activity-based probes for N-acylethanolamine acid amidase</span>. <i>Chem. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">11810</span>– <span class="NLM_lpage">11813</span>, <span class="refDoi"> DOI: 10.1039/C7CC06838G</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1039%2FC7CC06838G" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=29035406" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1arsL3N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2017&pages=11810-11813&author=R.+Petraccaauthor=E.+Romeoauthor=M.+P.+Baggelaarauthor=M.+Artolaauthor=S.+Pontisauthor=S.+Ponzanoauthor=H.+S.+Overkleeftauthor=M.+van+der+Steltauthor=D.+Piomelli&title=Novel+activity-based+probes+for+N-acylethanolamine+acid+amidase&doi=10.1039%2FC7CC06838G"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">Novel activity-based probes for N-acylethanolamine acid amidase</span></div><div class="casAuthors">Petracca, Rita; Romeo, Elisa; Baggelaar, Marc P.; Artola, Marta; Pontis, Silvia; Ponzano, Stefano; Overkleeft, Herman S.; van der Stelt, Mario; Piomelli, Daniele</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Communications (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">86</span>),
    <span class="NLM_cas:pages">11810-11813</span>CODEN:
                <span class="NLM_cas:coden">CHCOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-7345</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The cysteine hydrolase, N-acylethanolamine acid amidase (NAAA) is a promising target for analgesic and anti-inflammatory drugs.  Here, we describe the development of two unprecedented NAAA-reactive activity-based probes as research tools for application in the discovery of new inhibitors and for the in-depth characterization of NAAA in its cellular environment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoiwHqA8xDk8rVg90H21EOLACvtfcHk0ljL0-cDoCptsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1arsL3N&md5=a3e0529825b9f5c902f409c3da527c88</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1039%2FC7CC06838G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC7CC06838G%26sid%3Dliteratum%253Aachs%26aulast%3DPetracca%26aufirst%3DR.%26aulast%3DRomeo%26aufirst%3DE.%26aulast%3DBaggelaar%26aufirst%3DM.%2BP.%26aulast%3DArtola%26aufirst%3DM.%26aulast%3DPontis%26aufirst%3DS.%26aulast%3DPonzano%26aufirst%3DS.%26aulast%3DOverkleeft%26aufirst%3DH.%2BS.%26aulast%3Dvan%2Bder%2BStelt%26aufirst%3DM.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DNovel%2520activity-based%2520probes%2520for%2520N-acylethanolamine%2520acid%2520amidase%26jtitle%3DChem.%2520Commun.%26date%3D2017%26volume%3D53%26spage%3D11810%26epage%3D11813%26doi%3D10.1039%2FC7CC06838G" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref109"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref109'); return false;" data-citation="" class="refNumLink">109</a></strong><div class="NLM_citation" id="cit109"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Malamas, M.</span>; <span class="NLM_string-name">Makriyannis, A.</span>; <span class="NLM_string-name">Subramian, K. V.</span>; <span class="NLM_string-name">Whitten, K. M.</span></span> <span> </span><span class="NLM_article-title">N-Acylethanolamine Hydrolyzing Acid Amidase (NAAA) Inhibitors and Their Use Thereof</span>. <span class="NLM_patent">WO2015179190A1</span>, Nov 26, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=M.+Malamas&author=A.+Makriyannis&author=K.+V.+Subramian&author=K.+M.+Whitten&title=N-Acylethanolamine+Hydrolyzing+Acid+Amidase+%28NAAA%29+Inhibitors+and+Their+Use+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMalamas%26aufirst%3DM.%26atitle%3DN-Acylethanolamine%2520Hydrolyzing%2520Acid%2520Amidase%2520%2528NAAA%2529%2520Inhibitors%2520and%2520Their%2520Use%2520Thereof%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref110"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref110'); return false;" data-citation="" class="refNumLink">110</a></strong><div class="NLM_citation" id="cit110"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tarozzi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marchetti, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicolini, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Amico, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ticchi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pruccoli, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tumiatti, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simoni, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lodola, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mor, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milelli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minarini, A.</span></span> <span> </span><span class="NLM_article-title">Combined inhibition of the EGFR/AKT pathways by a novel conjugate of quinazoline with isothiocyanate</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>117</i></span>,  <span class="NLM_fpage">283</span>– <span class="NLM_lpage">291</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2016.04.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1016%2Fj.ejmech.2016.04.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=27135370" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BC28Xnt1Kqtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2016&pages=283-291&author=A.+Tarozziauthor=C.+Marchettiauthor=B.+Nicoliniauthor=M.+D%E2%80%99Amicoauthor=N.+Ticchiauthor=L.+Pruccoliauthor=V.+Tumiattiauthor=E.+Simoniauthor=A.+Lodolaauthor=M.+Morauthor=A.+Milelliauthor=A.+Minarini&title=Combined+inhibition+of+the+EGFR%2FAKT+pathways+by+a+novel+conjugate+of+quinazoline+with+isothiocyanate&doi=10.1016%2Fj.ejmech.2016.04.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit110R"><div class="casContent"><span class="casTitleNuber">110</span><div class="casTitle"><span class="NLM_cas:atitle">Combined inhibition of the EGFR/AKT pathways by a novel conjugate of quinazoline with isothiocyanate</span></div><div class="casAuthors">Tarozzi, Andrea; Marchetti, Chiara; Nicolini, Benedetta; D'Amico, Massimo; Ticchi, Nicole; Pruccoli, Letizia; Tumiatti, Vincenzo; Simoni, Elena; Lodola, Alessio; Mor, Marco; Milelli, Andrea; Minarini, Anna</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">283-291</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Epidermal growth factor receptor inhibitors (EGFR-TKIs) represent a class of compds. widely used in anticancer therapy.  An increasing no. of studies reports on combination therapies in which the block of the EGFR-TK activity is assocd. with inhibition of its downstream pathways, as PI3K-Akt.  Sulforaphane targets the PI3K-Akt pathway whose dysregulation is implicated in many functions of cancer cells.  According to these considerations, a series of multitarget mols. have been designed by combining key structural features derived from an EGFR-TKI, PD168393, and the isothiocyanate sulforaphane.  Among the obtained mols., compd. N-(3-bromophenyl)-6-isothiocyanatoquinazolin-4-amine (6) emerges as a promising lead compd. able to exert antiproliferative and proapoptotic effects in A431 epithelial cancer cell line by covalently binding to EGFR-TK, and reducing the phosphorylation of Akt without affecting the total Akt levels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpANqinYVd38rVg90H21EOLACvtfcHk0ljL0-cDoCptsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xnt1Kqtr4%253D&md5=e941bda4b6bb7c58f05fd997dc7b9db5</span></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2016.04.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2016.04.002%26sid%3Dliteratum%253Aachs%26aulast%3DTarozzi%26aufirst%3DA.%26aulast%3DMarchetti%26aufirst%3DC.%26aulast%3DNicolini%26aufirst%3DB.%26aulast%3DD%25E2%2580%2599Amico%26aufirst%3DM.%26aulast%3DTicchi%26aufirst%3DN.%26aulast%3DPruccoli%26aufirst%3DL.%26aulast%3DTumiatti%26aufirst%3DV.%26aulast%3DSimoni%26aufirst%3DE.%26aulast%3DLodola%26aufirst%3DA.%26aulast%3DMor%26aufirst%3DM.%26aulast%3DMilelli%26aufirst%3DA.%26aulast%3DMinarini%26aufirst%3DA.%26atitle%3DCombined%2520inhibition%2520of%2520the%2520EGFR%252FAKT%2520pathways%2520by%2520a%2520novel%2520conjugate%2520of%2520quinazoline%2520with%2520isothiocyanate%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2016%26volume%3D117%26spage%3D283%26epage%3D291%26doi%3D10.1016%2Fj.ejmech.2016.04.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref111"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref111'); return false;" data-citation="" class="refNumLink">111</a></strong><div class="NLM_citation" id="cit111"><span><span class="NLM_contrib-group"><span class="NLM_string-name">West, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zvonok, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitten, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vadivel, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowman, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makriyannis, A.</span></span> <span> </span><span class="NLM_article-title">Biochemical and mass spectrometric characterization of human N-acylethanolamine-hydrolyzing acid amidase inhibition</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">e43877</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0043877</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1371%2Fjournal.pone.0043877" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=22952796" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlSltr7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=e43877&author=J.+M.+Westauthor=N.+Zvonokauthor=K.+M.+Whittenauthor=S.+K.+Vadivelauthor=A.+L.+Bowmanauthor=A.+Makriyannis&title=Biochemical+and+mass+spectrometric+characterization+of+human+N-acylethanolamine-hydrolyzing+acid+amidase+inhibition&doi=10.1371%2Fjournal.pone.0043877"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit111R"><div class="casContent"><span class="casTitleNuber">111</span><div class="casTitle"><span class="NLM_cas:atitle">Biochemical and mass spectrometric characterization of human N-acylethanolamine-hydrolyzing acid amidase inhibition</span></div><div class="casAuthors">West, Jay M.; Zvonok, Nikolai; Whitten, Kyle M.; Vadivel, Subramanian K.; Bowman, Anna L.; Makriyannis, Alexandros</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">e43877</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">The mechanism of inactivation of human enzyme N-acylethanolamine-hydrolyzing acid amidase (hNAAA), with selected inhibitors identified in a novel fluorescent based assay developed for characterization of both reversible and irreversible inhibitors, was investigated kinetically and using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS).  1-Isothiocyanatopentadecane (AM9023) was found to be a potent, selective and reversible hNAAA inhibitor, while two others, 5-((biphenyl-4-yl)methyl)-N,N-dimethyl-2H-tetrazole-2-carboxamide (AM6701) and N-Benzyloxycarbonyl--serine β-lactone (N-Cbz-serine β-lactone), inhibited hNAAA in a covalent and irreversible manner.  MS anal. of the hNAAA/covalent inhibitor complexes identified modification only of the N-terminal cysteine (Cys126) of the β-subunit, confirming a suggested mechanism of hNAAA inactivation by the β-lactone contg. inhibitors.  These expts. provide direct evidence of the key role of Cys126 in hNAAA inactivation by different classes of covalent inhibitors, confirming the essential role of cysteine for catalysis and inhibition in this cysteine N-terminal nucleophile hydrolase enzyme.  They also provide a methodol. for the rapid screening and characterization of large libraries of compds. as potential inhibitors of NAAA, and subsequent characterization or their mechanism through MALDI-TOF MS based bottom up-proteomics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgYtxfkhdQ5rVg90H21EOLACvtfcHk0lgMO_wnlmDQlw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlSltr7E&md5=f1cedb03b771c71caef095bf138627bd</span></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0043877&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0043877%26sid%3Dliteratum%253Aachs%26aulast%3DWest%26aufirst%3DJ.%2BM.%26aulast%3DZvonok%26aufirst%3DN.%26aulast%3DWhitten%26aufirst%3DK.%2BM.%26aulast%3DVadivel%26aufirst%3DS.%2BK.%26aulast%3DBowman%26aufirst%3DA.%2BL.%26aulast%3DMakriyannis%26aufirst%3DA.%26atitle%3DBiochemical%2520and%2520mass%2520spectrometric%2520characterization%2520of%2520human%2520N-acylethanolamine-hydrolyzing%2520acid%2520amidase%2520inhibition%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26spage%3De43877%26doi%3D10.1371%2Fjournal.pone.0043877" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref112"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref112'); return false;" data-citation="" class="refNumLink">112</a></strong><div class="NLM_citation" id="cit112"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alhouayek, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bottemanne, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Subramanian, K. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambert, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makriyannis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cani, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muccioli, G. G.</span></span> <span> </span><span class="NLM_article-title">N-Acylethanolamine-hydrolyzing acid amidase inhibition increases colon N-palmitoylethanolamine levels and counteracts murine colitis</span>. <i>FASEB J.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">650</span>– <span class="NLM_lpage">661</span>, <span class="refDoi"> DOI: 10.1096/fj.14-255208</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1096%2Ffj.14-255208" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=25384424" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BC2MXislGis7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2015&pages=650-661&author=M.+Alhouayekauthor=P.+Bottemanneauthor=K.+V.+Subramanianauthor=D.+M.+Lambertauthor=A.+Makriyannisauthor=P.+D.+Caniauthor=G.+G.+Muccioli&title=N-Acylethanolamine-hydrolyzing+acid+amidase+inhibition+increases+colon+N-palmitoylethanolamine+levels+and+counteracts+murine+colitis&doi=10.1096%2Ffj.14-255208"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit112R"><div class="casContent"><span class="casTitleNuber">112</span><div class="casTitle"><span class="NLM_cas:atitle">N-acylethanolamine-hydrolyzing acid amidase inhibition increases colon N-palmitoylethanolamine levels and counteracts murine colitis</span></div><div class="casAuthors">Alhouayek, Mireille; Bottemanne, Pauline; Subramanian, Kumar V.; Lambert, Didier M.; Makriyannis, Alexandros; Cani, Patrice D.; Muccioli, Giulio G.</div><div class="citationInfo"><span class="NLM_cas:title">FASEB Journal</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">650-661, 10.1096/fj.14-255208</span>CODEN:
                <span class="NLM_cas:coden">FAJOEC</span>;
        ISSN:<span class="NLM_cas:issn">0892-6638</span>.
    
            (<span class="NLM_cas:orgname">Federation of American Societies for Experimental Biology</span>)
        </div><div class="casAbstract">N-Palmitoylethanolamine or palmitoylethanolamide (PEA) is an anti-inflammatory compd. that was recently shown to exert peroxisome proliferator-activated receptor-α-dependent beneficial effects on colon inflammation.  The actions of PEA are terminated following hydrolysis by 2 enzymes: fatty acid amide hydrolase (FAAH), and the less-studied N-acylethanolamine-hydrolyzing acid amidase (NAAA).  This study aims to investigate the effects of inhibiting the enzymes responsible for PEA hydrolysis in colon inflammation in order to propose a potential therapeutic target for inflammatory bowel diseases (IBDs).  Two murine models of IBD were used to assess the effects of NAAA inhibition, FAAH inhibition, and PEA on macroscopic signs of colon inflammation, macrophage/neutrophil infiltration, and the expression of proinflammatory mediators in the colon, as well as on the colitis-related systemic inflammation.  NAAA inhibition increases PEA levels in the colon and reduces colon inflammation and systemic inflammation, similarly to PEA.  FAAH inhibition, however, does not increase PEA levels in the colon and does not affect the macroscopic signs of colon inflammation or immune cell infiltration.  This is the first report of an anti-inflammatory effect of a systemically administered NAAA inhibitor.  Because NAAA is the enzyme responsible for the control of PEA levels in the colon, we put forth this enzyme as a potential therapeutic target in chronic inflammation in general and IBD in particular.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1s3Cs4nu0sbVg90H21EOLACvtfcHk0lgMO_wnlmDQlw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXislGis7Y%253D&md5=608b15a459887f1cde27f68e241d85b2</span></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.1096%2Ffj.14-255208&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1096%252Ffj.14-255208%26sid%3Dliteratum%253Aachs%26aulast%3DAlhouayek%26aufirst%3DM.%26aulast%3DBottemanne%26aufirst%3DP.%26aulast%3DSubramanian%26aufirst%3DK.%2BV.%26aulast%3DLambert%26aufirst%3DD.%2BM.%26aulast%3DMakriyannis%26aufirst%3DA.%26aulast%3DCani%26aufirst%3DP.%2BD.%26aulast%3DMuccioli%26aufirst%3DG.%2BG.%26atitle%3DN-Acylethanolamine-hydrolyzing%2520acid%2520amidase%2520inhibition%2520increases%2520colon%2520N-palmitoylethanolamine%2520levels%2520and%2520counteracts%2520murine%2520colitis%26jtitle%3DFASEB%2520J.%26date%3D2015%26volume%3D29%26spage%3D650%26epage%3D661%26doi%3D10.1096%2Ffj.14-255208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref113"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref113'); return false;" data-citation="" class="refNumLink">113</a></strong><div class="NLM_citation" id="cit113"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Falgueyret, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oballa, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okamoto, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wesolowski, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aubin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rydzewski, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prasit, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riendeau, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodan, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Percival, M. D.</span></span> <span> </span><span class="NLM_article-title">Novel, nonpeptidic cyanamides as potent and reversible inhibitors of human cathepsins K and L</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">94</span>– <span class="NLM_lpage">104</span>, <span class="refDoi"> DOI: 10.1021/jm0003440</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0003440" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BD3cXos1ajs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=94-104&author=J.+P.+Falgueyretauthor=R.+M.+Oballaauthor=O.+Okamotoauthor=G.+Wesolowskiauthor=Y.+Aubinauthor=R.+M.+Rydzewskiauthor=P.+Prasitauthor=D.+Riendeauauthor=S.+B.+Rodanauthor=M.+D.+Percival&title=Novel%2C+nonpeptidic+cyanamides+as+potent+and+reversible+inhibitors+of+human+cathepsins+K+and+L&doi=10.1021%2Fjm0003440"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit113R"><div class="casContent"><span class="casTitleNuber">113</span><div class="casTitle"><span class="NLM_cas:atitle">Novel, Nonpeptidic Cyanamides as Potent and Reversible Inhibitors of Human Cathepsins K and L</span></div><div class="casAuthors">Falgueyret, Jean-Pierre; Oballa, Renata M.; Okamoto, Osamu; Wesolowski, Gregg; Aubin, Yves; Rydzewski, Robert M.; Prasit, Peppi; Riendeau, Denis; Rodan, Sevgi B.; Percival, M. David</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">94-104</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Compds. contg. a 1-cyanopyrrolidinyl ring were identified as potent and reversible inhibitors of cathepsins K and L.  The original lead compd. I inhibits cathepsins K and L with IC50 values of 0.37 and 0.45 μM, resp.  Modification of compd. I by replacement of the quinoline moiety led to the synthesis of N-(1-cyano-3-pyrrolidinyl)benzenesulfonamide (2).  Compd. II was found to be a potent inhibitor of cathepsins K and L with a Ki value of 50 nM for cathepsin K.  Replacement of the 1-cyanopyrrolidine of compd. II by a 1-cyanoazetidine increased the potency of the inhibitor by 10-fold.  This increase in potency is probably due to an enhanced chem. reactivity of the compd. toward the thiolate of the active site of the enzyme.  This is demonstrated when the assay is performed in the presence of glutathione at pH 7.0 which favors the formation of a GSH thiolate anion.  Under these assay conditions, there is a loss of potency in the 1-cyanoazetidine series due to the formation of an inactive complex between the GSH thiolate and the 1-cyanoazetidine inhibitors. 1-Cyanopyrrolidinyl inhibitors exhibited time-dependent inhibition which allowed us to det. the assocn. and dissocn. rate consts. with human cathepsin K.  The kinetic data obtained showed that the increase of potency obsd. between different 1-cyanopyrrolidinyl inhibitors is due to an increase of kon values and that the assocn. of the compd. with the enzyme fits an apparent one-step mechanism. 13C NMR expts. performed with the enzyme papain showed that compd. 2 forms a covalent isothiourea ester adduct with the enzyme.  As predicted by the kinetic anal., the addn. of the irreversible inhibitor E64 to the enzyme-cyanopyrrolidinyl complex totally abolished the signal of the isothiourea bond as obsd. by 13C NMR, thereby demonstrating that the formation of the covalent bond with the active site cysteine residue is reversible. Finally, compd. II inhibits bone resorption in an in vitro assay involving rabbit osteoclasts and bovine bone with an IC50 value of 0.7 μM. 1-Cyanopyrrolidine represents a new class of nonpeptidic compds. that inhibit cathepsin K and L activity and proteolysis of bone collagen.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWnsb8us0GkrVg90H21EOLACvtfcHk0lgMO_wnlmDQlw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXos1ajs7g%253D&md5=aed27c1353797e413890ea02d900095b</span></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1021%2Fjm0003440&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0003440%26sid%3Dliteratum%253Aachs%26aulast%3DFalgueyret%26aufirst%3DJ.%2BP.%26aulast%3DOballa%26aufirst%3DR.%2BM.%26aulast%3DOkamoto%26aufirst%3DO.%26aulast%3DWesolowski%26aufirst%3DG.%26aulast%3DAubin%26aufirst%3DY.%26aulast%3DRydzewski%26aufirst%3DR.%2BM.%26aulast%3DPrasit%26aufirst%3DP.%26aulast%3DRiendeau%26aufirst%3DD.%26aulast%3DRodan%26aufirst%3DS.%2BB.%26aulast%3DPercival%26aufirst%3DM.%2BD.%26atitle%3DNovel%252C%2520nonpeptidic%2520cyanamides%2520as%2520potent%2520and%2520reversible%2520inhibitors%2520of%2520human%2520cathepsins%2520K%2520and%2520L%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D94%26epage%3D104%26doi%3D10.1021%2Fjm0003440" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref114"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref114'); return false;" data-citation="" class="refNumLink">114</a></strong><div class="NLM_citation" id="cit114"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Malamas, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farah, S. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pelekoudas, D. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perry, N. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajarshi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyabe, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chandrashekhar, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">West, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pavlopoulos, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makriyannis, A.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of cyanamides as potent and selective N-acylethanolamine acid amidase inhibitors</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">115195</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2019.115195</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1016%2Fj.bmc.2019.115195" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=31761726" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BC1MXit1ars7rE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2020&pages=115195&author=M.+S.+Malamasauthor=S.+I.+Farahauthor=M.+Lamaniauthor=D.+N.+Pelekoudasauthor=N.+T.+Perryauthor=G.+Rajarshiauthor=C.+Y.+Miyabeauthor=H.+Chandrashekharauthor=J.+Westauthor=S.+Pavlopoulosauthor=A.+Makriyannis&title=Design+and+synthesis+of+cyanamides+as+potent+and+selective+N-acylethanolamine+acid+amidase+inhibitors&doi=10.1016%2Fj.bmc.2019.115195"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit114R"><div class="casContent"><span class="casTitleNuber">114</span><div class="casTitle"><span class="NLM_cas:atitle">Design and synthesis of cyanamides as potent and selective N-acylethanolamine acid amidase inhibitors</span></div><div class="casAuthors">Malamas, Michael S.; Farah, Shrouq I.; Lamani, Manjunath; Pelekoudas, Dimitrios N.; Perry, Nicholas Thomas; Rajarshi, Girija; Miyabe, Christina Yume; Chandrashekhar, Honrao; West, Jay; Pavlopoulos, Spiro; Makriyannis, Alexandros</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">115195</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">N-acylethanolamine acid amidase (NAAA) inhibition represents an exciting novel approach to treat inflammation and pain.  NAAA is a cysteine amidase which preferentially hydrolyzes the endogenous biolipids palmitoylethanolamide (PEA) and oleoylethanolamide (OEA).  PEA is an endogenous agonist of the nuclear peroxisome proliferator-activated receptor-α (PPAR-α), which is a key regulator of inflammation and pain.  Thus, blocking the degrdn. of PEA with NAAA inhibitors results in augmentation of the PEA/PPAR-α signaling pathway and regulation of inflammatory and pain processes.  We have prepd. a new series of NAAA inhibitors exploring the azetidine-nitrile (cyanamide) pharmacophore that led to the discovery of highly potent and selective compds.  Key analogs demonstrated single-digit nanomolar potency for hNAAA and showed &amp;gt;100-fold selectivity against serine hydrolases FAAH, MGL and ABHD6, and cysteine protease cathepsin K.  Addnl., we have identified potent and selective dual NAAA-FAAH inhibitors to investigate a potential synergism between two distinct anti-inflammatory mol. pathways, the PEA/PPAR-α anti-inflammatory signaling pathway,1-4 and the cannabinoid receptors CB1 and CB2 pathways which are known for their antiinflammatory and antinociceptive properties.5-8 Our ligand design strategy followed a traditional structure-activity relationship (SAR) approach and was supported by mol. modeling studies of reported X-ray structures of hNAAA.  Several inhibitors were evaluated in stability assays and demonstrated very good plasma stability (t1/2 &amp;gt; 2 h; human and rodents).  The disclosed cyanamides represent promising new pharmacol. tools to investigate the potential role of NAAA inhibitors and dual NAAA-FAAH inhibitors as therapeutic agents for the treatment of inflammation and pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-A_C3n2MNkbVg90H21EOLACvtfcHk0liUSH-HLW268w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXit1ars7rE&md5=f5330d39907df730c82cca041803b7da</span></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2019.115195&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2019.115195%26sid%3Dliteratum%253Aachs%26aulast%3DMalamas%26aufirst%3DM.%2BS.%26aulast%3DFarah%26aufirst%3DS.%2BI.%26aulast%3DLamani%26aufirst%3DM.%26aulast%3DPelekoudas%26aufirst%3DD.%2BN.%26aulast%3DPerry%26aufirst%3DN.%2BT.%26aulast%3DRajarshi%26aufirst%3DG.%26aulast%3DMiyabe%26aufirst%3DC.%2BY.%26aulast%3DChandrashekhar%26aufirst%3DH.%26aulast%3DWest%26aufirst%3DJ.%26aulast%3DPavlopoulos%26aufirst%3DS.%26aulast%3DMakriyannis%26aufirst%3DA.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520cyanamides%2520as%2520potent%2520and%2520selective%2520N-acylethanolamine%2520acid%2520amidase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2020%26volume%3D28%26spage%3D115195%26doi%3D10.1016%2Fj.bmc.2019.115195" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref115"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref115'); return false;" data-citation="" class="refNumLink">115</a></strong><div class="NLM_citation" id="cit115"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, J.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of potent N-acylethanolamine hydrolyzing acid amidase (NAAA) inhibitor as anti-inflammatory compounds</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">e43023</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0043023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1371%2Fjournal.pone.0043023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=22916199" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1Gnsr%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=e43023&author=Y.+Liauthor=L.+Yangauthor=L.+Chenauthor=C.+Zhuauthor=R.+Huangauthor=X.+Zhengauthor=Y.+Qiuauthor=J.+Fu&title=Design+and+synthesis+of+potent+N-acylethanolamine+hydrolyzing+acid+amidase+%28NAAA%29+inhibitor+as+anti-inflammatory+compounds&doi=10.1371%2Fjournal.pone.0043023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit115R"><div class="casContent"><span class="casTitleNuber">115</span><div class="casTitle"><span class="NLM_cas:atitle">Design and synthesis of potent N-acylethanolamine-hydrolyzing acid amidase (NAAA) inhibitor as anti-inflammatory compounds</span></div><div class="casAuthors">Li, Yuhang; Yang, Longhe; Chen, Ling; Zhu, Chenggang; Huang, Rui; Zheng, Xiao; Qiu, Yan; Fu, Jin</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">e43023</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">N-acylethanolamine-hydrolyzing acid amidase (NAAA) is a lysosomal enzyme involved in biol. deactivation of N-palmitoylethanolamide (PEA), which exerts anti-inflammatory and analgesic effects through the activation of nuclear receptor peroxisome proliferator-activated receptor-alpha (PPAR-α).  To develop selective and potent NAAA inhibitors, we designed and synthesized a series of derivs. of 1-pentadecanyl-carbonyl pyrrolidine (compd. 1), a general amidase inhibitor.  Structure activity relationship (SAR) studies have identified a compd. 16, 1-(2-Biphenyl-4-yl)ethyl-carbonyl pyrrolidine, which has shown the highest inhibition on NAAA activity (IC50 = 2.12 ± 0.41 μM) and is characterized as a reversible and competitive NAAA inhibitor.  Computational docking anal. and mutagenesis study revealed that compd. 16 interacted with Asparagine 209 (Asn209) residue flanking the catalytic pocket of NAAA so as to block the substrate entrance.  In vitro pharmacol. studies demonstrated that compd. 16 dose-dependently reduced mRNA expression levels of iNOS and IL-6, along with an increase of intracellular PEA levels, in mouse macrophages with lipopolysaccharides (LPS) induced inflammation.  Our study discovered a novel NAAA inhibitor, compd. 16, that could serve as a potential anti-inflammatory agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjj_FwM6WnALVg90H21EOLACvtfcHk0liUSH-HLW268w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1Gnsr%252FJ&md5=12369bcfbbe53a5f4c65c68df0a59945</span></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0043023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0043023%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DZhu%26aufirst%3DC.%26aulast%3DHuang%26aufirst%3DR.%26aulast%3DZheng%26aufirst%3DX.%26aulast%3DQiu%26aufirst%3DY.%26aulast%3DFu%26aufirst%3DJ.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520potent%2520N-acylethanolamine%2520hydrolyzing%2520acid%2520amidase%2520%2528NAAA%2529%2520inhibitor%2520as%2520anti-inflammatory%2520compounds%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26spage%3De43023%26doi%3D10.1371%2Fjournal.pone.0043023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref116"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref116'); return false;" data-citation="" class="refNumLink">116</a></strong><div class="NLM_citation" id="cit116"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span> <span> </span><span class="NLM_article-title">Synthesis, biological evaluation, and structure activity relationship (SAR) study of pyrrolidine amide derivatives as N-acylethanolamine acid amidase (NAAA) inhibitors</span>. <i>MedChemComm</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">252</span>– <span class="NLM_lpage">262</span>, <span class="refDoi"> DOI: 10.1039/C8MD00432C</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1039%2FC8MD00432C" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=30931090" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisFersbnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=252-262&author=P.+Zhouauthor=L.+Xiangauthor=D.+Zhaoauthor=J.+Renauthor=Y.+Qiuauthor=Y.+Li&title=Synthesis%2C+biological+evaluation%2C+and+structure+activity+relationship+%28SAR%29+study+of+pyrrolidine+amide+derivatives+as+N-acylethanolamine+acid+amidase+%28NAAA%29+inhibitors&doi=10.1039%2FC8MD00432C"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit116R"><div class="casContent"><span class="casTitleNuber">116</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, biological evaluation, and structure activity relationship (SAR) study of pyrrolidine amide derivatives as N-acylethanolamine acid amidase (NAAA) inhibitors</span></div><div class="casAuthors">Zhou, Pan; Xiang, Lei; Zhao, Dongsheng; Ren, Jie; Qiu, Yan; Li, Yuhang</div><div class="citationInfo"><span class="NLM_cas:title">MedChemComm</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">252-262</span>CODEN:
                <span class="NLM_cas:coden">MCCEAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-2503</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">N-Acylethanolamine acid amidase (NAAA) is one of the key enzymes involved in the degrdn. of fatty acid ethanolamides (FAEs), esp. for palmitoylethanolamide (PEA).  Pharmacol. blockage of NAAA restores PEA levels, providing therapeutic benefits in the management of inflammation and pain.  In the current work, the authors present structure-activity relationship (SAR) studies for pyrrolidine amide derivs. as NAAA inhibitors.  A series of arom. replacements or substituents for the terminal Ph group of pyrrolidine amides were examd.  SAR data showed that small lipophilic 3-Ph substituents were preferable for optimal potency.  The conformationally flexible linkers increased the inhibitory potency of pyrrolidine amide derivs. but reduced their selectivity toward fatty acid amide hydrolase (FAAH).  The conformationally restricted linkers did not enhance the inhibitor potency toward NAAA but improved the selectivity over FAAH.  Several low micromolar potent NAAA inhibitors were developed, including compd. I bearing a rigid 4-phenylcinnamoyl group.  Dialysis and kinetic anal. suggested that compd. I inhibited NAAA via a competitive and reversible mechanism.  Furthermore, compd. I showed high anti-inflammatory activities in lipopolysaccharide (LPS) induced acute lung injury (ALI) model; and this effect was blocked by pre-treatment with the PPAR-α antagonist MK886.  We anticipate that compd. I (E93) will enable a new agent to treat inflammation and related diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqn4RGjqYy3qLVg90H21EOLACvtfcHk0lie82CvW5d97g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisFersbnO&md5=144ee64a8a6041fd7a0a4bd5aef3977d</span></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=10.1039%2FC8MD00432C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC8MD00432C%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DP.%26aulast%3DXiang%26aufirst%3DL.%26aulast%3DZhao%26aufirst%3DD.%26aulast%3DRen%26aufirst%3DJ.%26aulast%3DQiu%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DY.%26atitle%3DSynthesis%252C%2520biological%2520evaluation%252C%2520and%2520structure%2520activity%2520relationship%2520%2528SAR%2529%2520study%2520of%2520pyrrolidine%2520amide%2520derivatives%2520as%2520N-acylethanolamine%2520acid%2520amidase%2520%2528NAAA%2529%2520inhibitors%26jtitle%3DMedChemComm%26date%3D2019%26volume%3D10%26spage%3D252%26epage%3D262%26doi%3D10.1039%2FC8MD00432C" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref117"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref117'); return false;" data-citation="" class="refNumLink">117</a></strong><div class="NLM_citation" id="cit117"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, C.</span></span> <span> </span><span class="NLM_article-title">Identification of highly potent N-acylethanolamine acid amidase (NAAA) inhibitors: Optimization of the terminal phenyl moiety of oxazolidone derivatives</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>139</i></span>,  <span class="NLM_fpage">214</span>– <span class="NLM_lpage">221</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2017.08.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1016%2Fj.ejmech.2017.08.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=28802121" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtlarsrfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=139&publication_year=2017&pages=214-221&author=Y.+Liauthor=Q.+Chenauthor=L.+Yangauthor=Y.+Liauthor=Y.+Zhangauthor=Y.+Qiuauthor=J.+Renauthor=C.+Lu&title=Identification+of+highly+potent+N-acylethanolamine+acid+amidase+%28NAAA%29+inhibitors%3A+Optimization+of+the+terminal+phenyl+moiety+of+oxazolidone+derivatives&doi=10.1016%2Fj.ejmech.2017.08.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit117R"><div class="casContent"><span class="casTitleNuber">117</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of highly potent N-acylethanolamine acid amidase (NAAA) inhibitors: Optimization of the terminal phenyl moiety of oxazolidone derivatives</span></div><div class="casAuthors">Li, Yuhang; Chen, Qi; Yang, Longhe; Li, Yanting; Zhang, Yang; Qiu, Yan; Ren, Jie; Lu, Canzhong</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">139</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">214-221</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">N-acylethanolamine acid amidase (NAAA) is a cysteine hydrolase that participates in the deactivation of fatty acid ethanolamides, such as palmitoylethanolamide (PEA).  NAAA inhibition may provide a potential therapeutic strategy for the treatment of diseases in which higher PEA level is desired.  In the present study, we reported the structure-activity relationship (SAR) studies for oxazolidone derivs. as NAAA inhibitors.  A series of substituents or alkyl replacements for the terminal Ph ring of oxazolidone derivs. were examd.  The results showed that the inhibition potency of these oxazolidone derivs. towards NAAA depends on the sizes, flexibility, and lipophilicity of the terminal groups.  SAR results suggested that small lipophilic 3-Ph substituents or hydroxy-contg. 4-Ph substituents were preferable for optimal potency.  Furthermore, the distal aliph. replacement is also preferred for high inhibitory potency.  Rapid diln. and kinetic anal. suggested that oxazolidone derivs. with different terminal Ph moieties inhibited NAAA via different mechanisms.  This study identified several highly potent NAAA inhibitors, including 1a (F215, IC50 = 0.009 μM), 1o (IC50 = 0.061 μM) and 2e (IC50 = 0.092 μM), and also detd. structural requirements of oxazolidone derivs. for potent inhibition against NAAA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCt5BDoxRb7LVg90H21EOLACvtfcHk0lie82CvW5d97g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtlarsrfF&md5=d4d34c95deea24435ceb35348c39d279</span></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2017.08.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2017.08.004%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DQ.%26aulast%3DYang%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DQiu%26aufirst%3DY.%26aulast%3DRen%26aufirst%3DJ.%26aulast%3DLu%26aufirst%3DC.%26atitle%3DIdentification%2520of%2520highly%2520potent%2520N-acylethanolamine%2520acid%2520amidase%2520%2528NAAA%2529%2520inhibitors%253A%2520Optimization%2520of%2520the%2520terminal%2520phenyl%2520moiety%2520of%2520oxazolidone%2520derivatives%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2017%26volume%3D139%26spage%3D214%26epage%3D221%26doi%3D10.1016%2Fj.ejmech.2017.08.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref118"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref118'); return false;" data-citation="" class="refNumLink">118</a></strong><div class="NLM_citation" id="cit118"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Petrosino, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmad, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marcolongo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esposito, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allarà, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verde, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuzzocrea, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Marzo, V.</span></span> <span> </span><span class="NLM_article-title">Diacerein is a potent and selective inhibitor of palmitoylethanolamide inactivation with analgesic activity in a rat model of acute inflammatory pain</span>. <i>Pharmacol. Res.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>91</i></span>,  <span class="NLM_fpage">9</span>– <span class="NLM_lpage">14</span>, <span class="refDoi"> DOI: 10.1016/j.phrs.2014.10.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1016%2Fj.phrs.2014.10.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=25447594" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFShtrrI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=2015&pages=9-14&author=S.+Petrosinoauthor=A.+Ahmadauthor=G.+Marcolongoauthor=E.+Espositoauthor=M.+Allar%C3%A0author=R.+Verdeauthor=S.+Cuzzocreaauthor=V.+Di+Marzo&title=Diacerein+is+a+potent+and+selective+inhibitor+of+palmitoylethanolamide+inactivation+with+analgesic+activity+in+a+rat+model+of+acute+inflammatory+pain&doi=10.1016%2Fj.phrs.2014.10.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit118R"><div class="casContent"><span class="casTitleNuber">118</span><div class="casTitle"><span class="NLM_cas:atitle">Diacerein is a potent and selective inhibitor of palmitoylethanolamide inactivation with analgesic activity in a rat model of acute inflammatory pain</span></div><div class="casAuthors">Petrosino, Stefania; Ahmad, Akbar; Marcolongo, Gabriele; Esposito, Emanuela; Allara, Marco; Verde, Roberta; Cuzzocrea, Salvatore; Di Marzo, Vincenzo</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">91</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">9-14</span>CODEN:
                <span class="NLM_cas:coden">PHMREP</span>;
        ISSN:<span class="NLM_cas:issn">1043-6618</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Palmitoylethanolamide (PEA) is produced by mammalian cells from its biosynthetic precursor, N-palmitoyl-phosphatidyl-ethanolamine, and inactivated by enzymic hydrolysis to palmitic acid and ethanolamine.  Apart from fatty acid amide hydrolase (FAAH), the N-acylethanolamine-hydrolyzing acid amidase (NAAA), a lysosomal enzyme, was also shown to catalyze the hydrolysis of PEA and to limit its analgesic and anti-inflammatory action.  Here we report the finding of a new potential inhibitor of NAAA, EPT4900 (4,5-diacetyloxy-9,10-dioxo-anthracene-2-carboxylic acid, diacerein).  EPT4900 exhibited a high inhibitory activity on human recombinant NAAA over-expressed in HEK293 cells (HEK-NAAA cells).  EPT4900 selectively increased the levels of PEA in intact HEK-NAAA cells, and inhibited inflammation as well as hyperalgesia in rats treated with an intraplantar injection of carrageenan.  This latter effect was accompanied by elevation of PEA endogenous levels in the paw skin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjQUYAZlW4FrVg90H21EOLACvtfcHk0lie82CvW5d97g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFShtrrI&md5=2cc594bdb0bfc697de0d7b2189a7ecb9</span></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=10.1016%2Fj.phrs.2014.10.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phrs.2014.10.008%26sid%3Dliteratum%253Aachs%26aulast%3DPetrosino%26aufirst%3DS.%26aulast%3DAhmad%26aufirst%3DA.%26aulast%3DMarcolongo%26aufirst%3DG.%26aulast%3DEsposito%26aufirst%3DE.%26aulast%3DAllar%25C3%25A0%26aufirst%3DM.%26aulast%3DVerde%26aufirst%3DR.%26aulast%3DCuzzocrea%26aufirst%3DS.%26aulast%3DDi%2BMarzo%26aufirst%3DV.%26atitle%3DDiacerein%2520is%2520a%2520potent%2520and%2520selective%2520inhibitor%2520of%2520palmitoylethanolamide%2520inactivation%2520with%2520analgesic%2520activity%2520in%2520a%2520rat%2520model%2520of%2520acute%2520inflammatory%2520pain%26jtitle%3DPharmacol.%2520Res.%26date%3D2015%26volume%3D91%26spage%3D9%26epage%3D14%26doi%3D10.1016%2Fj.phrs.2014.10.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref119"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref119'); return false;" data-citation="" class="refNumLink">119</a></strong><div class="NLM_citation" id="cit119"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fidelix, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macedo, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maxwell, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernandes
Moça Trevisani, V.</span></span> <span> </span><span class="NLM_article-title">Diacerein for osteoarthritis</span>. <i>Cochrane Database Syst. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">CD005117</span>, <span class="refDoi"> DOI: 10.1002/14651858.CD005117.pub3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1002%2F14651858.CD005117.pub3" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2014&pages=CD005117&author=T.+S.+Fidelixauthor=C.+R.+Macedoauthor=L.+J.+Maxwellauthor=V.+Fernandes%0AMo%C3%A7a+Trevisani&title=Diacerein+for+osteoarthritis&doi=10.1002%2F14651858.CD005117.pub3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.1002%2F14651858.CD005117.pub3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F14651858.CD005117.pub3%26sid%3Dliteratum%253Aachs%26aulast%3DFidelix%26aufirst%3DT.%2BS.%26aulast%3DMacedo%26aufirst%3DC.%2BR.%26aulast%3DMaxwell%26aufirst%3DL.%2BJ.%26aulast%3DFernandes%2BMo%25C3%25A7a%2BTrevisani%26aufirst%3DV.%26atitle%3DDiacerein%2520for%2520osteoarthritis%26jtitle%3DCochrane%2520Database%2520Syst.%2520Rev.%26date%3D2014%26volume%3D2%26spage%3DCD005117%26doi%3D10.1002%2F14651858.CD005117.pub3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref120"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref120'); return false;" data-citation="" class="refNumLink">120</a></strong><div class="NLM_citation" id="cit120"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pavelka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruyere, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanis, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leeb, B. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maheu, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martel-Pelletier, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monfort, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pelletier, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rizzoli, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reginster, J. Y.</span></span> <span> </span><span class="NLM_article-title">Diacerein: benefits, risks and place in the management of osteoarthritis. An opinion-based report from the ESCEO</span>. <i>Drugs Aging</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">75</span>– <span class="NLM_lpage">85</span>, <span class="refDoi"> DOI: 10.1007/s40266-016-0347-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1007%2Fs40266-016-0347-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=26849131" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BC28Xitlyntbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2016&pages=75-85&author=K.+Pavelkaauthor=O.+Bruyereauthor=C.+Cooperauthor=J.+A.+Kanisauthor=B.+F.+Leebauthor=E.+Maheuauthor=J.+Martel-Pelletierauthor=J.+Monfortauthor=J.+P.+Pelletierauthor=R.+Rizzoliauthor=J.+Y.+Reginster&title=Diacerein%3A+benefits%2C+risks+and+place+in+the+management+of+osteoarthritis.+An+opinion-based+report+from+the+ESCEO&doi=10.1007%2Fs40266-016-0347-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit120R"><div class="casContent"><span class="casTitleNuber">120</span><div class="casTitle"><span class="NLM_cas:atitle">Diacerein: Benefits, Risks and Place in the Management of Osteoarthritis. An Opinion-Based Report from the ESCEO</span></div><div class="casAuthors">Pavelka, Karel; Bruyere, Olivier; Cooper, Cyrus; Kanis, John A.; Leeb, Burkhard F.; Maheu, Emmanuel; Martel-Pelletier, Johanne; Monfort, Jordi; Pelletier, Jean-Pierre; Rizzoli, Rene; Reginster, Jean-Yves</div><div class="citationInfo"><span class="NLM_cas:title">Drugs & Aging</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">75-85</span>CODEN:
                <span class="NLM_cas:coden">DRAGE6</span>;
        ISSN:<span class="NLM_cas:issn">1170-229X</span>.
    
            (<span class="NLM_cas:orgname">Springer International Publishing AG</span>)
        </div><div class="casAbstract">Diacerein is a symptomatic slow-acting drug in osteoarthritis (SYSADOA) with anti-inflammatory, anti-catabolic and pro-anabolic properties on cartilage and synovial membrane.  It has also recently been shown to have protective effects against subchondral bone remodelling.  Following the end of the revision procedure by the Pharmacovigilance Risk Assessment Committee of the European Medicines Agency, the European Society for Clin. and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) constituted a panel of 11 experts to better define the real place of diacerein in the armamentarium for treating OA.  Based on a literature review of clin. trials and meta-analyses, the ESCEO confirms that the efficacy of diacerein is similar to that of non-steroidal anti-inflammatory drugs (NSAIDs) after the first month of treatment, and superior to that of paracetamol.  Addnl., diacerein has shown a prolonged effect on symptoms of several months once treatment was stopped.  The use of diacerein is assocd. with common gastrointestinal disorders such as soft stools and diarrhea, common mild skin reactions, and, uncommonly, hepatobiliary disorders.  However, NSAIDs and paracetamol are known to cause potentially severe hepatic, gastrointestinal, renal, cutaneous and cardiovascular reactions.  Therefore, the ESCEO concludes that the benefit-risk balance of diacerein remains pos. in the symptomatic treatment of hip and knee osteoarthritis.  Furthermore, similarly to other SYSADOAs, the ESCEO positions diacerein as a first-line pharmacol. background treatment of osteoarthritis, particularly for patients in whom NSAIDs or paracetamol are contraindicated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcgbKEWuefh7Vg90H21EOLACvtfcHk0linL74rsPLVHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xitlyntbo%253D&md5=698383aa62dacd67da31fed815948cab</span></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1007%2Fs40266-016-0347-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs40266-016-0347-4%26sid%3Dliteratum%253Aachs%26aulast%3DPavelka%26aufirst%3DK.%26aulast%3DBruyere%26aufirst%3DO.%26aulast%3DCooper%26aufirst%3DC.%26aulast%3DKanis%26aufirst%3DJ.%2BA.%26aulast%3DLeeb%26aufirst%3DB.%2BF.%26aulast%3DMaheu%26aufirst%3DE.%26aulast%3DMartel-Pelletier%26aufirst%3DJ.%26aulast%3DMonfort%26aufirst%3DJ.%26aulast%3DPelletier%26aufirst%3DJ.%2BP.%26aulast%3DRizzoli%26aufirst%3DR.%26aulast%3DReginster%26aufirst%3DJ.%2BY.%26atitle%3DDiacerein%253A%2520benefits%252C%2520risks%2520and%2520place%2520in%2520the%2520management%2520of%2520osteoarthritis.%2520An%2520opinion-based%2520report%2520from%2520the%2520ESCEO%26jtitle%3DDrugs%2520Aging%26date%3D2016%26volume%3D33%26spage%3D75%26epage%3D85%26doi%3D10.1007%2Fs40266-016-0347-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref121"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref121'); return false;" data-citation="" class="refNumLink">121</a></strong><div class="NLM_citation" id="cit121"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Realini, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solorzano, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pagliuca, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pizzirani, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Armirotti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luciani, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costi, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bandiera, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piomelli, D.</span></span> <span> </span><span class="NLM_article-title">Discovery of highly potent acid ceramidase inhibitors with in vitro tumor chemosensitizing activity</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">1035</span>, <span class="refDoi"> DOI: 10.1038/srep01035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1038%2Fsrep01035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=23301156" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFaqt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2013&pages=1035&author=N.+Realiniauthor=C.+Solorzanoauthor=C.+Pagliucaauthor=D.+Pizziraniauthor=A.+Armirottiauthor=R.+Lucianiauthor=M.+P.+Costiauthor=T.+Bandieraauthor=D.+Piomelli&title=Discovery+of+highly+potent+acid+ceramidase+inhibitors+with+in+vitro+tumor+chemosensitizing+activity&doi=10.1038%2Fsrep01035"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit121R"><div class="casContent"><span class="casTitleNuber">121</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of highly potent acid ceramidase inhibitors with in vitro tumor chemosensitizing activity</span></div><div class="casAuthors">Realini, Natalia; Solorzano, Carlos; Pagliuca, Chiara; Pizzirani, Daniela; Armirotti, Andrea; Luciani, Rosaria; Costi, Maria Paola; Bandiera, Tiziano; Piomelli, Daniele</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">srep01035, 7 pp.</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The expression of acid ceramidase (AC) - a cysteine amidase that hydrolyzes the proapoptotic lipid ceramide - is abnormally high in several human tumors, which is suggestive of a role in chemoresistance.  Available AC inhibitors lack, however, the potency and drug-likeness necessary to test this idea.  Here we show that the antineoplastic drug carmofur, which is used in the clinic to treat colorectal cancers, is a potent AC inhibitor and that this property is essential to its anti-proliferative effects.  Modifications in the chem. scaffold of carmofur yield new AC inhibitors that act synergistically with std. antitumoral drugs to prevent cancer cell proliferation.  These findings identify AC as an unexpected target for carmofur, and suggest that this mol. can be used as starting point for the design of novel chemosensitizing agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoknWbdLSLhRbVg90H21EOLACvtfcHk0linL74rsPLVHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFaqt7w%253D&md5=7ff74388fc2bea42c0e97fa8cbcfe61f</span></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.1038%2Fsrep01035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep01035%26sid%3Dliteratum%253Aachs%26aulast%3DRealini%26aufirst%3DN.%26aulast%3DSolorzano%26aufirst%3DC.%26aulast%3DPagliuca%26aufirst%3DC.%26aulast%3DPizzirani%26aufirst%3DD.%26aulast%3DArmirotti%26aufirst%3DA.%26aulast%3DLuciani%26aufirst%3DR.%26aulast%3DCosti%26aufirst%3DM.%2BP.%26aulast%3DBandiera%26aufirst%3DT.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DDiscovery%2520of%2520highly%2520potent%2520acid%2520ceramidase%2520inhibitors%2520with%2520in%2520vitro%2520tumor%2520chemosensitizing%2520activity%26jtitle%3DSci.%2520Rep.%26date%3D2013%26volume%3D3%26spage%3D1035%26doi%3D10.1038%2Fsrep01035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref122"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref122'); return false;" data-citation="" class="refNumLink">122</a></strong><div class="NLM_citation" id="cit122"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span> <span> </span><span class="NLM_article-title">A new use for an old drug: carmofur attenuates lipopolysaccharide (LPS)-induced acute lung injury via inhibition of FAAH and NAAA activities</span>. <i>Front. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">818</span>, <span class="refDoi"> DOI: 10.3389/fphar.2019.00818</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.3389%2Ffphar.2019.00818" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=31379583" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BB3cXksValu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=818&author=K.+Wuauthor=Y.+Xiuauthor=P.+Zhouauthor=Y.+Qiuauthor=Y.+Li&title=A+new+use+for+an+old+drug%3A+carmofur+attenuates+lipopolysaccharide+%28LPS%29-induced+acute+lung+injury+via+inhibition+of+FAAH+and+NAAA+activities&doi=10.3389%2Ffphar.2019.00818"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit122R"><div class="casContent"><span class="casTitleNuber">122</span><div class="casTitle"><span class="NLM_cas:atitle">A new use for an old drug: carmofur attenuates lipopolysaccharide (LPS)-induced acute lung injury via inhibition of FAAH and NAAA activities</span></div><div class="casAuthors">Wu, Kangni; Xiu, Yanghui; Zhou, Pan; Qiu, Yan; Li, Yuhang</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Pharmacology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">818</span>CODEN:
                <span class="NLM_cas:coden">FPRHAU</span>;
        ISSN:<span class="NLM_cas:issn">1663-9812</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">Acute lung injury (ALI), characterized by a severe inflammatory process, is a complex syndrome that can lead to multisystem organ failure.  Fatty acid amide hydrolase (FAAH) and N-acylethanolamine acid amidase (NAAA) are two potential therapeutic targets for inflammation-related diseases.  Herein, we identified carmofur, a 5-fluorouracil-releasing drug and clin. used as a chemotherapeutic agent, as a dual FAAH and NAAA inhibitor.  In Raw264.7 macrophages, carmofur effectively reduced the mRNA expression of pro-inflammatory factors, including IL-1β, IL-6, iNOS, and TNF-α, and down-regulated signaling proteins of the nuclear transcription factor κB (NF-κB) pathway.  Furthermore, carmofur significantly ameliorated the inflammatory responses and promoted resoln. of pulmonary injury in lipopolysaccharide (LPS)-induced ALI mice.  The pharmacol. effects of carmofur were partially blocked by peroxisome proliferator-activated receptor-α (PPARα) antagonist MK886 and cannabinoid receptor 2 (CB2) antagonist SR144528, indicating that carmofur attenuated LPS-induced ALI in a PPARα- and CB2-dependent mechanism.  Our study suggested that carmofur might be a novel therapeutic agent for ALI, and drug repurposing may provide us effective therapeutic strategies for ALI.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDK3mm_wpzObVg90H21EOLACvtfcHk0lghXCLo7M9kXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXksValu7w%253D&md5=4ce43d4dcd42abe60d4535fa0a7274b9</span></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.3389%2Ffphar.2019.00818&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphar.2019.00818%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DK.%26aulast%3DXiu%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DP.%26aulast%3DQiu%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DY.%26atitle%3DA%2520new%2520use%2520for%2520an%2520old%2520drug%253A%2520carmofur%2520attenuates%2520lipopolysaccharide%2520%2528LPS%2529-induced%2520acute%2520lung%2520injury%2520via%2520inhibition%2520of%2520FAAH%2520and%2520NAAA%2520activities%26jtitle%3DFront.%2520Pharmacol.%26date%3D2019%26volume%3D10%26spage%3D818%26doi%3D10.3389%2Ffphar.2019.00818" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref123"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref123'); return false;" data-citation="" class="refNumLink">123</a></strong><div class="NLM_citation" id="cit123"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bertozzi, F.</span>; <span class="NLM_string-name">Bandiera, T.</span></span> <span> </span><span class="NLM_article-title">Modulation of N-Acylethanolamine-Hydrolysing Acid Amidase (NAAA) for Disease Treatment</span>. <span class="NLM_patent">US20190135802A1</span>, May 9, <span class="NLM_year">2019</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&author=F.+Bertozzi&author=T.+Bandiera&title=Modulation+of+N-Acylethanolamine-Hydrolysing+Acid+Amidase+%28NAAA%29+for+Disease+Treatment"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBertozzi%26aufirst%3DF.%26atitle%3DModulation%2520of%2520N-Acylethanolamine-Hydrolysing%2520Acid%2520Amidase%2520%2528NAAA%2529%2520for%2520Disease%2520Treatment%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref124"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref124'); return false;" data-citation="" class="refNumLink">124</a></strong><div class="NLM_citation" id="cit124"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bodor, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchwald, P.</span></span> <span> </span><span class="NLM_article-title">Soft drug design: General principles and recent applications</span>. <i>Med. Res. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">58</span>– <span class="NLM_lpage">101</span>, <span class="refDoi"> DOI: 10.1002/(SICI)1098-1128(200001)20:1<58::AID-MED3>3.0.CO;2-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1002%2F%28SICI%291098-1128%28200001%2920%3A1%3C58%3A%3AAID-MED3%3E3.0.CO%3B2-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10608921" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BD3cXltFWqsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2000&pages=58-101&author=N.+Bodorauthor=P.+Buchwald&title=Soft+drug+design%3A+General+principles+and+recent+applications&doi=10.1002%2F%28SICI%291098-1128%28200001%2920%3A1%3C58%3A%3AAID-MED3%3E3.0.CO%3B2-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit124R"><div class="casContent"><span class="casTitleNuber">124</span><div class="casTitle"><span class="NLM_cas:atitle">Soft drug design: general principles and recent applications</span></div><div class="casAuthors">Bodor, Nicholas; Buchwald, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">58-101</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review with 208 refs.  Soft drug design represents a new approach aimed to design safer drugs with an increased therapeutic index by integrating metab. considerations into the drug design process.  Soft drugs are new therapeutic agents that undergo predictable metab. to inactive metabolites after exerting their therapeutic effect.  Hence, they are obtained by building into the mol., in addn. to the activity, the most desired way in which the mol. is to be deactivated and detoxified.  In an attempt to systematize and summarize the related work done in a no. of labs., including ours, the present review presents an overview of the general soft drug design principles and provides a variety of specific examples to illustrate the concepts.  A no. of already marketed drugs, such as esmolol, remifentanil, or loteprednol etabonate, resulted from the successful application of such design principles.  Many other promising drug candidates are currently under investigation in a variety of fields including possible soft antimicrobials, anticholinergics, corticosteroids, β-blockers, analgetics, ACE inhibitors, antiarrhythmics, and others.  Whenever possible, pharmacokinetic and pharmacodynamic properties are briefly summarized and compared to those of other compds. used in the same field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphV1vhXwTl8LVg90H21EOLACvtfcHk0lghXCLo7M9kXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXltFWqsg%253D%253D&md5=e0ca493ba31d001e62a759be0fc4bcc8</span></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291098-1128%28200001%2920%3A1%3C58%3A%3AAID-MED3%3E3.0.CO%3B2-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291098-1128%2528200001%252920%253A1%253C58%253A%253AAID-MED3%253E3.0.CO%253B2-X%26sid%3Dliteratum%253Aachs%26aulast%3DBodor%26aufirst%3DN.%26aulast%3DBuchwald%26aufirst%3DP.%26atitle%3DSoft%2520drug%2520design%253A%2520General%2520principles%2520and%2520recent%2520applications%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2000%26volume%3D20%26spage%3D58%26epage%3D101%26doi%3D10.1002%2F%28SICI%291098-1128%28200001%2920%3A1%3C58%3A%3AAID-MED3%3E3.0.CO%3B2-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref125"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref125'); return false;" data-citation="" class="refNumLink">125</a></strong><div class="NLM_citation" id="cit125"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sasso, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreno-Sanz, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martucci, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Realini, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dionisi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mengatto, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duranti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarozzo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarzia, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mor, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertorelli, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reggiani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piomelli, D.</span></span> <span> </span><span class="NLM_article-title">Antinociceptive effects of the N-acylethanolamine acid amidase inhibitor ARN077 in rodent pain models</span>. <i>Pain</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>154</i></span>,  <span class="NLM_fpage">350</span>– <span class="NLM_lpage">360</span>, <span class="refDoi"> DOI: 10.1016/j.pain.2012.10.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1016%2Fj.pain.2012.10.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=23218523" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BC3sXivF2jtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=154&publication_year=2013&pages=350-360&author=O.+Sassoauthor=G.+Moreno-Sanzauthor=C.+Martucciauthor=N.+Realiniauthor=M.+Dionisiauthor=L.+Mengattoauthor=A.+Durantiauthor=G.+Tarozzoauthor=G.+Tarziaauthor=M.+Morauthor=R.+Bertorelliauthor=A.+Reggianiauthor=D.+Piomelli&title=Antinociceptive+effects+of+the+N-acylethanolamine+acid+amidase+inhibitor+ARN077+in+rodent+pain+models&doi=10.1016%2Fj.pain.2012.10.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit125R"><div class="casContent"><span class="casTitleNuber">125</span><div class="casTitle"><span class="NLM_cas:atitle">Antinociceptive effects of the N-acylethanolamine acid amidase inhibitor ARN077 in rodent pain models</span></div><div class="casAuthors">Sasso, Oscar; Moreno-Sanz, Guillermo; Martucci, Cataldo; Realini, Natalia; Dionisi, Mauro; Mengatto, Luisa; Duranti, Andrea; Tarozzo, Glauco; Tarzia, Giorgio; Mor, Marco; Bertorelli, Rosalia; Reggiani, Angelo; Piomelli, Daniele</div><div class="citationInfo"><span class="NLM_cas:title">Pain</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">154</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">350-360</span>CODEN:
                <span class="NLM_cas:coden">PAINDB</span>;
        ISSN:<span class="NLM_cas:issn">0304-3959</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Fatty acid ethanolamides (FAEs), which include palmitoylethanolamide (PEA) and oleoylethanolamide (OEA), are endogenous agonists of peroxisome proliferator-activated receptor-α (PPAR-α) and important regulators of the inflammatory response.  They are degraded in macrophages by the lysosomal cysteine amidase, N-acylethanolamine acid amidase (NAAA).  Previous studies have shown that pharmacol. inhibition of NAAA activity suppresses macrophage activation in vitro and causes marked anti-inflammatory effects in vivo, which is suggestive of a role for NAAA in the control of inflammation.  It is still unknown, however, whether NAAA-mediated FAE deactivation might regulate pain signaling.  The present study examd. the effects of ARN077, a potent and selective NAAA inhibitor recently disclosed by our group, in rodent models of hyperalgesia and allodynia caused by inflammation or nerve damage.  Topical administration of ARN077 attenuated, in a dose-dependent manner, heat hyperalgesia and mech. allodynia elicited in mice by carrageenan injection or sciatic nerve ligation.  The antinociceptive effects of ARN077 were prevented by the selective PPAR-α antagonist GW6471 and did not occur in PPAR-α-deficient mice.  Furthermore, topical ARN077 reversed the allodynia caused by UV B radiation in rats, and this effect was blocked by pretreatment with GW6471.  Sciatic nerve ligation or application of the proinflammatory phorbol ester 12-O-tetradecanoylphorbol 13-acetate decreased FAE levels in sciatic nerve and skin tissue, resp.  ARN077 reversed these biochem. effects.  The results identify ARN077 as a potent inhibitor of intracellular NAAA activity, which is active in vivo by topical administration.  The findings further suggest that NAAA regulates peripheral pain initiation by interrupting endogenous FAE signaling at PPAR-α.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVAH4mpvyphbVg90H21EOLACvtfcHk0lghXCLo7M9kXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXivF2jtrk%253D&md5=08c067a44b1f75e7e0192fdbdeccccd4</span></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=10.1016%2Fj.pain.2012.10.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pain.2012.10.018%26sid%3Dliteratum%253Aachs%26aulast%3DSasso%26aufirst%3DO.%26aulast%3DMoreno-Sanz%26aufirst%3DG.%26aulast%3DMartucci%26aufirst%3DC.%26aulast%3DRealini%26aufirst%3DN.%26aulast%3DDionisi%26aufirst%3DM.%26aulast%3DMengatto%26aufirst%3DL.%26aulast%3DDuranti%26aufirst%3DA.%26aulast%3DTarozzo%26aufirst%3DG.%26aulast%3DTarzia%26aufirst%3DG.%26aulast%3DMor%26aufirst%3DM.%26aulast%3DBertorelli%26aufirst%3DR.%26aulast%3DReggiani%26aufirst%3DA.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DAntinociceptive%2520effects%2520of%2520the%2520N-acylethanolamine%2520acid%2520amidase%2520inhibitor%2520ARN077%2520in%2520rodent%2520pain%2520models%26jtitle%3DPain%26date%3D2013%26volume%3D154%26spage%3D350%26epage%3D360%26doi%3D10.1016%2Fj.pain.2012.10.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref126"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref126'); return false;" data-citation="" class="refNumLink">126</a></strong><div class="NLM_citation" id="cit126"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, Y.</span></span> <span> </span><span class="NLM_article-title">Potential analgesic effects of a novel N-acylethanolamine acid amidase inhibitor F96 through PPAR-α</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">13565</span>, <span class="refDoi"> DOI: 10.1038/srep13565</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1038%2Fsrep13565" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=26310614" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVKhtLzK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&pages=13565&author=L.+Yangauthor=L.+Liauthor=L.+Chenauthor=Y.+Liauthor=H.+Chenauthor=Y.+Liauthor=G.+Jiauthor=D.+Linauthor=Z.+Liuauthor=Y.+Qiu&title=Potential+analgesic+effects+of+a+novel+N-acylethanolamine+acid+amidase+inhibitor+F96+through+PPAR-%CE%B1&doi=10.1038%2Fsrep13565"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit126R"><div class="casContent"><span class="casTitleNuber">126</span><div class="casTitle"><span class="NLM_cas:atitle">Potential analgesic effects of a novel N-acylethanolamine acid amidase inhibitor F96 through PPAR-α</span></div><div class="casAuthors">Yang, Longhe; Li, Long; Chen, Ling; Li, Yanting; Chen, Huixia; Li, Yuhang; Ji, Guangnian; Lin, Donghai; Liu, Zuguo; Qiu, Yan</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">13565</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Pharmacol. blockade of N-acylethanolamine acid amidase (NAAA) activity is an available approach for inflammation and pain control through restoring the ability of endogenous PEA.  But the recently reported NAAA inhibitors suffer from the chem. and biol. unstable properties, which restrict functions of NAAA inhibition in vivo.  It is still unrevealed whether systematic inhibition of NAAA could modulate PEA-mediated pain signalings.  Here we reported an oxazolidinone imide compd. 3-(6-phenylhexanoyl) oxazolidin-2-one (F96), which potently and selectively inhibited NAAA activity (IC50 = 270 nM).  I.p. (i.p.) injection of F96 (3-30 mg/kg) dose-dependently reduced ear edema and restored PEA levels of ear tissues in 12-O-Tetradecanoylphorbol-13-acetate (TPA) induced ear edema models.  Furthermore, F96 inhibited acetic acid-induced writhing and increased spared nerve injury induced tactile allodynia thresholds in a dose-dependent manner.  Pharmacol. effects of F96 (10 mg/kg, i.p.) on various animal models were abolished in PPAR-α-/- mice, and were prevented by PPAR-α antagonist MK886 but not by canabinoid receptor type 1 (CB1) antagonist Rimonabant nor canabinoid receptor type 2 (CB2) antagonist SR144528.  Zebrafish embryos expts. showed better security and lower toxicity for F96 than ibuprofen.  These results revealed that F96 might be useful in treating inflammatory and neuropathic pain by NAAA inhibition depending on PPAR-α receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsP6tlGryp3LVg90H21EOLACvtfcHk0lhraYxiyDj_LQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVKhtLzK&md5=237e107001c9eef18e130d12a0724300</span></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.1038%2Fsrep13565&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep13565%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DJi%26aufirst%3DG.%26aulast%3DLin%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DQiu%26aufirst%3DY.%26atitle%3DPotential%2520analgesic%2520effects%2520of%2520a%2520novel%2520N-acylethanolamine%2520acid%2520amidase%2520inhibitor%2520F96%2520through%2520PPAR-%25CE%25B1%26jtitle%3DSci.%2520Rep.%26date%3D2015%26volume%3D5%26spage%3D13565%26doi%3D10.1038%2Fsrep13565" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref127"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref127'); return false;" data-citation="" class="refNumLink">127</a></strong><div class="NLM_citation" id="cit127"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rubenstrunk, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanf, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hum, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fruchart, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staels, B.</span></span> <span> </span><span class="NLM_article-title">Safety issues and prospects for future generations of PPAR modulators</span>. <i>Biochim. Biophys. Acta, Mol. Cell Biol. Lipids</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>1771</i></span>,  <span class="NLM_fpage">1065</span>– <span class="NLM_lpage">1081</span>, <span class="refDoi"> DOI: 10.1016/j.bbalip.2007.02.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1016%2Fj.bbalip.2007.02.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=17428730" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BD2sXovFensr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1771&publication_year=2007&pages=1065-1081&author=A.+Rubenstrunkauthor=R.+Hanfauthor=D.+W.+Humauthor=J.+C.+Fruchartauthor=B.+Staels&title=Safety+issues+and+prospects+for+future+generations+of+PPAR+modulators&doi=10.1016%2Fj.bbalip.2007.02.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit127R"><div class="casContent"><span class="casTitleNuber">127</span><div class="casTitle"><span class="NLM_cas:atitle">Safety issues and prospects for future generations of PPAR modulators</span></div><div class="casAuthors">Rubenstrunk, Anne; Hanf, Remy; Hum, Dean W.; Fruchart, Jean-Charles; Staels, Bart</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular and Cell Biology of Lipids</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">1771</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1065-1081</span>CODEN:
                <span class="NLM_cas:coden">BBMLFG</span>;
        ISSN:<span class="NLM_cas:issn">1388-1981</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Because of their wide range of actions on glucose homeostasis, lipid metab. and vascular inflammation, peroxisome proliferator-activated receptors (PPARs) are promising targets for the development of new drugs for the treatment of metabolic disorders such as diabetes, dyslipidemia and atherosclerosis.  In clin. practice, PPARα agonists, such as the already available fibrates, improve dyslipidemia, while PPARγ agonists, such as thiazolidinediones, improve insulin resistance and diabetes.  The complementary action of simultaneous activation of each PPAR in patients suffering from metabolic syndrome and type 2 diabetes has led to new pharmacol. strategies focused on the development of agonists targeting more than one receptor such as the dual PPARα/γ agonists.  However, despite the proven benefits of targeting PPARs, safety concerns have recently led to late stage development failures of various PPAR agonists including novel specific PPARγ agonists and dual PPARα/γ agonists.  These safety concerns include potential carcinogenicity in rodents, signs of myopathy and rhabdomyolysis, increase in plasma creatinine and homocysteine, wt. gain, fluid retention, peripheral edema and potential increased risk of cardiac failure.  Although the discontinued compds. shared common side effects, the reason for discontinuation was always compd. specific and the toxicol. or adverse effects which have motivated the discontinuation could be either due to the activation of PPARγ, PPARα or both (class effect) or due to a PPAR unrelated effect.  Thus, the risk evaluation of each adverse effect should be viewed on a case by case basis considering both the PPAR profile of the drug, its absorption/distribution profile, the nature of the side effect and the putative PPAR-related mechanism of action.  This review mainly focuses on the preclin. and clin. adverse events of PPAR agonists that could be of concern when considering the development of new PPAR agonists.  The selective modulation of PPAR activities is a promising approach to develop new drugs with preserved efficacy but diminished adverse effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPSAxD3yDYDLVg90H21EOLACvtfcHk0lhraYxiyDj_LQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXovFensr4%253D&md5=36a85ef05206f38bfc6db3faa63262c5</span></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1016%2Fj.bbalip.2007.02.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbalip.2007.02.003%26sid%3Dliteratum%253Aachs%26aulast%3DRubenstrunk%26aufirst%3DA.%26aulast%3DHanf%26aufirst%3DR.%26aulast%3DHum%26aufirst%3DD.%2BW.%26aulast%3DFruchart%26aufirst%3DJ.%2BC.%26aulast%3DStaels%26aufirst%3DB.%26atitle%3DSafety%2520issues%2520and%2520prospects%2520for%2520future%2520generations%2520of%2520PPAR%2520modulators%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Cell%2520Biol.%2520Lipids%26date%3D2007%26volume%3D1771%26spage%3D1065%26epage%3D1081%26doi%3D10.1016%2Fj.bbalip.2007.02.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84'],'ref85':['cit85'],'ref86':['cit86'],'ref87':['cit87'],'ref88':['cit88'],'ref89':['cit89'],'ref90':['cit90'],'ref91':['cit91'],'ref92':['cit92'],'ref93':['cit93'],'ref94':['cit94'],'ref95':['cit95'],'ref96':['cit96'],'ref97':['cit97'],'ref98':['cit98'],'ref99':['cit99'],'ref100':['cit100'],'ref101':['cit101'],'ref102':['cit102'],'ref103':['cit103'],'ref104':['cit104'],'ref105':['cit105'],'ref106':['cit106'],'ref107':['cit107'],'ref108':['cit108'],'ref109':['cit109'],'ref110':['cit110'],'ref111':['cit111'],'ref112':['cit112'],'ref113':['cit113'],'ref114':['cit114'],'ref115':['cit115'],'ref116':['cit116'],'ref117':['cit117'],'ref118':['cit118'],'ref119':['cit119'],'ref120':['cit120'],'ref121':['cit121'],'ref122':['cit122'],'ref123':['cit123'],'ref124':['cit124'],'ref125':['cit125'],'ref126':['cit126'],'ref127':['cit127']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 18 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Michael S. Malamas, Spiro Pavlopoulos, Shakiru O. Alapafuja, Shrouq I. Farah, Alexander Zvonok, Khadijah A. Mohammad, Jay West, Nicholas Thomas Perry, Dimitrios N. Pelekoudas, Girija Rajarshi, Christina Shields, Honrao Chandrashekhar, Jodi Wood, <span class="NLM_string-name hlFld-ContribAuthor">Alexandros Makriyannis</span>. </span><span class="cited-content_cbyCitation_article-title">Design and Structure–Activity Relationships of Isothiocyanates as Potent and Selective N-Acylethanolamine-Hydrolyzing Acid Amidase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (9)
                                     , 5956-5972. <a href="https://doi.org/10.1021/acs.jmedchem.1c00076" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00076</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00076&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00076%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Band%252BStructure%2525E2%252580%252593Activity%252BRelationships%252Bof%252BIsothiocyanates%252Bas%252BPotent%252Band%252BSelective%252BN-Acylethanolamine-Hydrolyzing%252BAcid%252BAmidase%252BInhibitors%26aulast%3DMalamas%26aufirst%3DMichael%2BS.%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D15012021%26date%3D26042021%26volume%3D64%26issue%3D9%26spage%3D5956%26epage%3D5972" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Laura Scalvini, Andrea Ghidini, Alessio Lodola, Donatella Callegari, Silvia Rivara, Daniele Piomelli, <span class="NLM_string-name hlFld-ContribAuthor">Marco Mor</span>. </span><span class="cited-content_cbyCitation_article-title">N-Acylethanolamine Acid Amidase (NAAA): Mechanism of Palmitoylethanolamide Hydrolysis Revealed by Mechanistic Simulations. </span><span class="cited-content_cbyCitation_journal-name">ACS Catalysis</span><span> <strong>2020,</strong> <em>10 </em>
                                    (20)
                                     , 11797-11813. <a href="https://doi.org/10.1021/acscatal.0c02903" title="DOI URL">https://doi.org/10.1021/acscatal.0c02903</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acscatal.0c02903&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facscatal.0c02903%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Catalysis%26atitle%3DN-Acylethanolamine%252BAcid%252BAmidase%252B%252528NAAA%252529%25253A%252BMechanism%252Bof%252BPalmitoylethanolamide%252BHydrolysis%252BRevealed%252Bby%252BMechanistic%252BSimulations%26aulast%3DScalvini%26aufirst%3DLaura%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D03072020%26date%3D10092020%26date%3D28092020%26date%3D15092020%26volume%3D10%26issue%3D20%26spage%3D11797%26epage%3D11813" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lisa E.  Flannery</span>, <span class="hlFld-ContribAuthor ">Daniel M.  Kerr</span>, <span class="hlFld-ContribAuthor ">Edel M.  Hughes</span>, <span class="hlFld-ContribAuthor ">Colm  Kelly</span>, <span class="hlFld-ContribAuthor ">Jonathan  Costello</span>, <span class="hlFld-ContribAuthor ">Aoife M.  Thornton</span>, <span class="hlFld-ContribAuthor ">Rachel M.  Humphrey</span>, <span class="hlFld-ContribAuthor ">David P.  Finn</span>, <span class="hlFld-ContribAuthor ">Michelle  Roche</span>. </span><span class="cited-content_cbyCitation_article-title">N-acylethanolamine regulation of TLR3-induced hyperthermia and neuroinflammatory gene expression: A role for PPARα. </span><span class="cited-content_cbyCitation_journal-name">Journal of Neuroimmunology</span><span> <strong>2021,</strong> <em>358 </em>, 577654. <a href="https://doi.org/10.1016/j.jneuroim.2021.577654" title="DOI URL">https://doi.org/10.1016/j.jneuroim.2021.577654</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jneuroim.2021.577654&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jneuroim.2021.577654%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Neuroimmunology%26atitle%3DN-acylethanolamine%252Bregulation%252Bof%252BTLR3-induced%252Bhyperthermia%252Band%252Bneuroinflammatory%252Bgene%252Bexpression%25253A%252BA%252Brole%252Bfor%252BPPAR%2525CE%2525B1%26aulast%3DFlannery%26aufirst%3DLisa%2BE.%26date%3D2021%26volume%3D358%26spage%3D577654" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mark B.  Wiley</span>, <span class="hlFld-ContribAuthor ">Pedro A.  Perez</span>, <span class="hlFld-ContribAuthor ">Donovan A.  Argueta</span>, <span class="hlFld-ContribAuthor ">Bryant  Avalos</span>, <span class="hlFld-ContribAuthor ">Courtney P.  Wood</span>, <span class="hlFld-ContribAuthor ">Nicholas V.  DiPatrizio</span>. </span><span class="cited-content_cbyCitation_article-title">UPLC-MS/MS Method for Analysis of Endocannabinoid and Related Lipid Metabolism in Mouse Mucosal Tissue. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Physiology</span><span> <strong>2021,</strong> <em>12 </em><a href="https://doi.org/10.3389/fphys.2021.699712" title="DOI URL">https://doi.org/10.3389/fphys.2021.699712</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fphys.2021.699712&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffphys.2021.699712%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Physiology%26atitle%3DUPLC-MS%25252FMS%252BMethod%252Bfor%252BAnalysis%252Bof%252BEndocannabinoid%252Band%252BRelated%252BLipid%252BMetabolism%252Bin%252BMouse%252BMucosal%252BTissue%26aulast%3DWiley%26aufirst%3DMark%2BB.%26date%3D2021%26date%3D2021%26volume%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pauline  Bottemanne</span>, <span class="hlFld-ContribAuthor ">Owein  Guillemot-Legris</span>, <span class="hlFld-ContribAuthor ">Adrien  Paquot</span>, <span class="hlFld-ContribAuthor ">Julien  Masquelier</span>, <span class="hlFld-ContribAuthor ">Michael  Malamas</span>, <span class="hlFld-ContribAuthor ">Alexandros  Makriyannis</span>, <span class="hlFld-ContribAuthor ">Mireille  Alhouayek</span>, <span class="hlFld-ContribAuthor ">Giulio G.  Muccioli</span>. </span><span class="cited-content_cbyCitation_article-title">N-Acylethanolamine-Hydrolyzing Acid Amidase Inhibition, but Not Fatty Acid Amide Hydrolase Inhibition, Prevents the Development of Experimental Autoimmune Encephalomyelitis in Mice. </span><span class="cited-content_cbyCitation_journal-name">Neurotherapeutics</span><span> <strong>2021,</strong> <em>15 </em><a href="https://doi.org/10.1007/s13311-021-01074-x" title="DOI URL">https://doi.org/10.1007/s13311-021-01074-x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s13311-021-01074-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs13311-021-01074-x%26sid%3Dliteratum%253Aachs%26jtitle%3DNeurotherapeutics%26atitle%3DN-Acylethanolamine-Hydrolyzing%252BAcid%252BAmidase%252BInhibition%25252C%252Bbut%252BNot%252BFatty%252BAcid%252BAmide%252BHydrolase%252BInhibition%25252C%252BPrevents%252Bthe%252BDevelopment%252Bof%252BExperimental%252BAutoimmune%252BEncephalomyelitis%252Bin%252BMice%26aulast%3DBottemanne%26aufirst%3DPauline%26date%3D2021%26date%3D2021%26volume%3D15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wisam  Toma</span>, <span class="hlFld-ContribAuthor ">Martial  Caillaud</span>, <span class="hlFld-ContribAuthor ">Nipa H.  Patel</span>, <span class="hlFld-ContribAuthor ">Tammy H.  Tran</span>, <span class="hlFld-ContribAuthor ">Giulia  Donvito</span>, <span class="hlFld-ContribAuthor ">Jane  Roberts</span>, <span class="hlFld-ContribAuthor ">Deniz  Bagdas</span>, <span class="hlFld-ContribAuthor ">Asti  Jackson</span>, <span class="hlFld-ContribAuthor ">Aron  Lichtman</span>, <span class="hlFld-ContribAuthor ">David A.  Gewirtz</span>, <span class="hlFld-ContribAuthor ">Alexandros  Makriyannis</span>, <span class="hlFld-ContribAuthor ">Michael S.  Malamas</span>, <span class="hlFld-ContribAuthor ">M.  Imad Damaj</span>. </span><span class="cited-content_cbyCitation_article-title">N‐acylethanolamine‐hydrolysing acid amidase: A new potential target to treat paclitaxel‐induced neuropathy. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Pain</span><span> <strong>2021,</strong> <em>25 </em>
                                    (6)
                                     , 1367-1380. <a href="https://doi.org/10.1002/ejp.1758" title="DOI URL">https://doi.org/10.1002/ejp.1758</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejp.1758&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejp.1758%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Pain%26atitle%3DN%2525E2%252580%252590acylethanolamine%2525E2%252580%252590hydrolysing%252Bacid%252Bamidase%25253A%252BA%252Bnew%252Bpotential%252Btarget%252Bto%252Btreat%252Bpaclitaxel%2525E2%252580%252590induced%252Bneuropathy%26aulast%3DToma%26aufirst%3DWisam%26date%3D2021%26date%3D2021%26volume%3D25%26issue%3D6%26spage%3D1367%26epage%3D1380" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ludmila A.  Kasatkina</span>, <span class="hlFld-ContribAuthor ">Sonja  Rittchen</span>, <span class="hlFld-ContribAuthor ">Eva M.  Sturm</span>. </span><span class="cited-content_cbyCitation_article-title">Neuroprotective and Immunomodulatory Action of the Endocannabinoid System under Neuroinflammation. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2021,</strong> <em>22 </em>
                                    (11)
                                     , 5431. <a href="https://doi.org/10.3390/ijms22115431" title="DOI URL">https://doi.org/10.3390/ijms22115431</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms22115431&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms22115431%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DNeuroprotective%252Band%252BImmunomodulatory%252BAction%252Bof%252Bthe%252BEndocannabinoid%252BSystem%252Bunder%252BNeuroinflammation%26aulast%3DKasatkina%26aufirst%3DLudmila%2BA.%26date%3D2021%26date%3D2021%26volume%3D22%26issue%3D11%26spage%3D5431" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kazuhito  Tsuboi</span>, <span class="hlFld-ContribAuthor ">Tatsuya  Tai</span>, <span class="hlFld-ContribAuthor ">Ryouhei  Yamashita</span>, <span class="hlFld-ContribAuthor ">Hanif  Ali</span>, <span class="hlFld-ContribAuthor ">Takashi  Watanabe</span>, <span class="hlFld-ContribAuthor ">Toru  Uyama</span>, <span class="hlFld-ContribAuthor ">Yoko  Okamoto</span>, <span class="hlFld-ContribAuthor ">Keisuke  Kitakaze</span>, <span class="hlFld-ContribAuthor ">Yasuhiro  Takenouchi</span>, <span class="hlFld-ContribAuthor ">Shinji  Go</span>, <span class="hlFld-ContribAuthor ">Iffat Ara Sonia  Rahman</span>, <span class="hlFld-ContribAuthor ">Hitoshi  Houchi</span>, <span class="hlFld-ContribAuthor ">Tamotsu  Tanaka</span>, <span class="hlFld-ContribAuthor ">Yasuo  Okamoto</span>, <span class="hlFld-ContribAuthor ">Akira  Tokumura</span>, <span class="hlFld-ContribAuthor ">Junko  Matsuda</span>, <span class="hlFld-ContribAuthor ">Natsuo  Ueda</span>. </span><span class="cited-content_cbyCitation_article-title">Involvement of acid ceramidase in the degradation of bioactive N-acylethanolamines. </span><span class="cited-content_cbyCitation_journal-name">Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids</span><span> <strong>2021,</strong> <em>29 </em>, 158972. <a href="https://doi.org/10.1016/j.bbalip.2021.158972" title="DOI URL">https://doi.org/10.1016/j.bbalip.2021.158972</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bbalip.2021.158972&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bbalip.2021.158972%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochimica%2520et%2520Biophysica%2520Acta%2520%2528BBA%2529%2520-%2520Molecular%2520and%2520Cell%2520Biology%2520of%2520Lipids%26atitle%3DInvolvement%252Bof%252Bacid%252Bceramidase%252Bin%252Bthe%252Bdegradation%252Bof%252Bbioactive%252BN-acylethanolamines%26aulast%3DTsuboi%26aufirst%3DKazuhito%26date%3D2021%26volume%3D29%26spage%3D158972" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Karla  Chavira-Ramos</span>, <span class="hlFld-ContribAuthor ">Mario  Orozco-Morales</span>, <span class="hlFld-ContribAuthor ">Çimen  Karasu</span>, <span class="hlFld-ContribAuthor ">Alexey A.  Tinkov</span>, <span class="hlFld-ContribAuthor ">Michael  Aschner</span>, <span class="hlFld-ContribAuthor ">Abel  Santamaría</span>, <span class="hlFld-ContribAuthor ">Ana Laura  Colín-González</span>. </span><span class="cited-content_cbyCitation_article-title">URB597 Prevents the Short-Term Excitotoxic Cell Damage in Rat Cortical Slices: Role of Cannabinoid 1 Receptors. </span><span class="cited-content_cbyCitation_journal-name">Neurotoxicity Research</span><span> <strong>2021,</strong> <em>39 </em>
                                    (2)
                                     , 146-155. <a href="https://doi.org/10.1007/s12640-020-00301-1" title="DOI URL">https://doi.org/10.1007/s12640-020-00301-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s12640-020-00301-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs12640-020-00301-1%26sid%3Dliteratum%253Aachs%26jtitle%3DNeurotoxicity%2520Research%26atitle%3DURB597%252BPrevents%252Bthe%252BShort-Term%252BExcitotoxic%252BCell%252BDamage%252Bin%252BRat%252BCortical%252BSlices%25253A%252BRole%252Bof%252BCannabinoid%252B1%252BReceptors%26aulast%3DChavira-Ramos%26aufirst%3DKarla%26date%3D2021%26date%3D2020%26volume%3D39%26issue%3D2%26spage%3D146%26epage%3D155" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Giorgia  della Rocca</span>, <span class="hlFld-ContribAuthor ">Davide  Gamba</span>. </span><span class="cited-content_cbyCitation_article-title">Chronic Pain in Dogs and Cats: Is There Place for Dietary Intervention with Micro-Palmitoylethanolamide?. </span><span class="cited-content_cbyCitation_journal-name">Animals</span><span> <strong>2021,</strong> <em>11 </em>
                                    (4)
                                     , 952. <a href="https://doi.org/10.3390/ani11040952" title="DOI URL">https://doi.org/10.3390/ani11040952</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ani11040952&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fani11040952%26sid%3Dliteratum%253Aachs%26jtitle%3DAnimals%26atitle%3DChronic%252BPain%252Bin%252BDogs%252Band%252BCats%25253A%252BIs%252BThere%252BPlace%252Bfor%252BDietary%252BIntervention%252Bwith%252BMicro-Palmitoylethanolamide%25253F%26aulast%3Ddella%2BRocca%26aufirst%3DGiorgia%26date%3D2021%26date%3D2021%26volume%3D11%26issue%3D4%26spage%3D952" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Katarina  Grabrijan</span>, <span class="hlFld-ContribAuthor ">Nika  Strašek</span>, <span class="hlFld-ContribAuthor ">Stanislav  Gobec</span>. </span><span class="cited-content_cbyCitation_article-title">Monocyclic beta–lactams for therapeutic uses: a patent overview (2010–2020). </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2021,</strong> <em>31 </em>
                                    (3)
                                     , 247-266. <a href="https://doi.org/10.1080/13543776.2021.1865919" title="DOI URL">https://doi.org/10.1080/13543776.2021.1865919</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543776.2021.1865919&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543776.2021.1865919%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DMonocyclic%252Bbeta%2525E2%252580%252593lactams%252Bfor%252Btherapeutic%252Buses%25253A%252Ba%252Bpatent%252Boverview%252B%2525282010%2525E2%252580%2525932020%252529%26aulast%3DGrabrijan%26aufirst%3DKatarina%26date%3D2021%26date%3D2021%26volume%3D31%26issue%3D3%26spage%3D247%26epage%3D266" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yannick  Fotio</span>, <span class="hlFld-ContribAuthor ">Roberto  Ciccocioppo</span>, <span class="hlFld-ContribAuthor ">Daniele  Piomelli</span>. </span><span class="cited-content_cbyCitation_article-title">N-acylethanolamine acid amidase (NAAA) inhibition decreases the motivation for alcohol in Marchigian Sardinian alcohol-preferring rats. </span><span class="cited-content_cbyCitation_journal-name">Psychopharmacology</span><span> <strong>2021,</strong> <em>238 </em>
                                    (1)
                                     , 249-258. <a href="https://doi.org/10.1007/s00213-020-05678-7" title="DOI URL">https://doi.org/10.1007/s00213-020-05678-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00213-020-05678-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00213-020-05678-7%26sid%3Dliteratum%253Aachs%26jtitle%3DPsychopharmacology%26atitle%3DN-acylethanolamine%252Bacid%252Bamidase%252B%252528NAAA%252529%252Binhibition%252Bdecreases%252Bthe%252Bmotivation%252Bfor%252Balcohol%252Bin%252BMarchigian%252BSardinian%252Balcohol-preferring%252Brats%26aulast%3DFotio%26aufirst%3DYannick%26date%3D2021%26date%3D2020%26volume%3D238%26issue%3D1%26spage%3D249%26epage%3D258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrea  Ghidini</span>, <span class="hlFld-ContribAuthor ">Laura  Scalvini</span>, <span class="hlFld-ContribAuthor ">Francesca  Palese</span>, <span class="hlFld-ContribAuthor ">Alessio  Lodola</span>, <span class="hlFld-ContribAuthor ">Marco  Mor</span>, <span class="hlFld-ContribAuthor ">Daniele  Piomelli</span>. </span><span class="cited-content_cbyCitation_article-title">Different roles for the acyl chain and the amine leaving group in the substrate selectivity of
              N
              -Acylethanolamine acid amidase. </span><span class="cited-content_cbyCitation_journal-name">Journal of Enzyme Inhibition and Medicinal Chemistry</span><span> <strong>2021,</strong> <em>36 </em>
                                    (1)
                                     , 1411-1423. <a href="https://doi.org/10.1080/14756366.2021.1912035" title="DOI URL">https://doi.org/10.1080/14756366.2021.1912035</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14756366.2021.1912035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14756366.2021.1912035%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Enzyme%2520Inhibition%2520and%2520Medicinal%2520Chemistry%26atitle%3DDifferent%252Broles%252Bfor%252Bthe%252Bacyl%252Bchain%252Band%252Bthe%252Bamine%252Bleaving%252Bgroup%252Bin%252Bthe%252Bsubstrate%252Bselectivity%252Bof%252BN%252B-Acylethanolamine%252Bacid%252Bamidase%26aulast%3DGhidini%26aufirst%3DAndrea%26date%3D2021%26date%3D2021%26volume%3D36%26issue%3D1%26spage%3D1411%26epage%3D1423" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alessia  D’Aloia</span>, <span class="hlFld-ContribAuthor ">Federica  Arrigoni</span>, <span class="hlFld-ContribAuthor ">Renata  Tisi</span>, <span class="hlFld-ContribAuthor ">Alessandro  Palmioli</span>, <span class="hlFld-ContribAuthor ">Michela  Ceriani</span>, <span class="hlFld-ContribAuthor ">Valentina  Artusa</span>, <span class="hlFld-ContribAuthor ">Cristina  Airoldi</span>, <span class="hlFld-ContribAuthor ">Giuseppe  Zampella</span>, <span class="hlFld-ContribAuthor ">Barbara  Costa</span>, <span class="hlFld-ContribAuthor ">Laura  Cipolla</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, Molecular Modeling and Biological Evaluation of Metabolically Stable Analogues of the Endogenous Fatty Acid Amide Palmitoylethanolamide. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2020,</strong> <em>21 </em>
                                    (23)
                                     , 9074. <a href="https://doi.org/10.3390/ijms21239074" title="DOI URL">https://doi.org/10.3390/ijms21239074</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms21239074&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms21239074%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DSynthesis%25252C%252BMolecular%252BModeling%252Band%252BBiological%252BEvaluation%252Bof%252BMetabolically%252BStable%252BAnalogues%252Bof%252Bthe%252BEndogenous%252BFatty%252BAcid%252BAmide%252BPalmitoylethanolamide%26aulast%3DD%25E2%2580%2599Aloia%26aufirst%3DAlessia%26date%3D2020%26date%3D2020%26volume%3D21%26issue%3D23%26spage%3D9074" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zheming  Wu</span>, <span class="hlFld-ContribAuthor ">Changfeng  Liu</span>, <span class="hlFld-ContribAuthor ">Zhaoyu  Zhang</span>, <span class="hlFld-ContribAuthor ">Renchao  Zheng</span>, <span class="hlFld-ContribAuthor ">Yuguo  Zheng</span>. </span><span class="cited-content_cbyCitation_article-title">Amidase as a versatile tool in amide-bond cleavage: From molecular features to biotechnological applications. </span><span class="cited-content_cbyCitation_journal-name">Biotechnology Advances</span><span> <strong>2020,</strong> <em>43 </em>, 107574. <a href="https://doi.org/10.1016/j.biotechadv.2020.107574" title="DOI URL">https://doi.org/10.1016/j.biotechadv.2020.107574</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.biotechadv.2020.107574&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.biotechadv.2020.107574%26sid%3Dliteratum%253Aachs%26jtitle%3DBiotechnology%2520Advances%26atitle%3DAmidase%252Bas%252Ba%252Bversatile%252Btool%252Bin%252Bamide-bond%252Bcleavage%25253A%252BFrom%252Bmolecular%252Bfeatures%252Bto%252Bbiotechnological%252Bapplications%26aulast%3DWu%26aufirst%3DZheming%26date%3D2020%26volume%3D43%26spage%3D107574" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Silvia  Pontis</span>, <span class="hlFld-ContribAuthor ">Francesca  Palese</span>, <span class="hlFld-ContribAuthor ">Maria  Summa</span>, <span class="hlFld-ContribAuthor ">Natalia  Realini</span>, <span class="hlFld-ContribAuthor ">Massimiliano  Lanfranco</span>, <span class="hlFld-ContribAuthor ">Claudia  De Mei</span>, <span class="hlFld-ContribAuthor ">Daniele  Piomelli</span>. </span><span class="cited-content_cbyCitation_article-title">N-Acylethanolamine Acid Amidase contributes to disease progression in a mouse model of multiple sclerosis. </span><span class="cited-content_cbyCitation_journal-name">Pharmacological Research</span><span> <strong>2020,</strong> <em>160 </em>, 105064. <a href="https://doi.org/10.1016/j.phrs.2020.105064" title="DOI URL">https://doi.org/10.1016/j.phrs.2020.105064</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.phrs.2020.105064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.phrs.2020.105064%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacological%2520Research%26atitle%3DN-Acylethanolamine%252BAcid%252BAmidase%252Bcontributes%252Bto%252Bdisease%252Bprogression%252Bin%252Ba%252Bmouse%252Bmodel%252Bof%252Bmultiple%252Bsclerosis%26aulast%3DPontis%26aufirst%3DSilvia%26date%3D2020%26volume%3D160%26spage%3D105064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yangyan  Xiu</span>, <span class="hlFld-ContribAuthor ">Kaizhen  Wang</span>, <span class="hlFld-ContribAuthor ">Jingfang  Chen</span>, <span class="hlFld-ContribAuthor ">Zhiqiang  Zhuo</span>, <span class="hlFld-ContribAuthor ">Yanghui  Xiu</span>. </span><span class="cited-content_cbyCitation_article-title">Liposomal
              N
              -acylethanolamine-hydrolyzing acid amidase (NAAA) inhibitor F96 as a new therapy for colitis. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2020,</strong> <em>10 </em>
                                    (56)
                                     , 34197-34202. <a href="https://doi.org/10.1039/D0RA05264G" title="DOI URL">https://doi.org/10.1039/D0RA05264G</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0RA05264G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0RA05264G%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DLiposomal%252BN%252B-acylethanolamine-hydrolyzing%252Bacid%252Bamidase%252B%252528NAAA%252529%252Binhibitor%252BF96%252Bas%252Ba%252Bnew%252Btherapy%252Bfor%252Bcolitis%26aulast%3DXiu%26aufirst%3DYangyan%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D56%26spage%3D34197%26epage%3D34202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wenhui  Jin</span>, <span class="hlFld-ContribAuthor ">Longhe  Yang</span>, <span class="hlFld-ContribAuthor ">Zhiwei  Yi</span>, <span class="hlFld-ContribAuthor ">Hua  Fang</span>, <span class="hlFld-ContribAuthor ">Weizhu  Chen</span>, <span class="hlFld-ContribAuthor ">Zhuan  Hong</span>, <span class="hlFld-ContribAuthor ">Yiping  Zhang</span>, <span class="hlFld-ContribAuthor ">Guangya  Zhang</span>, <span class="hlFld-ContribAuthor ">Long  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Anti-Inflammatory Effects of Fucoxanthinol in LPS-Induced RAW264.7 Cells through the NAAA-PEA Pathway. </span><span class="cited-content_cbyCitation_journal-name">Marine Drugs</span><span> <strong>2020,</strong> <em>18 </em>
                                    (4)
                                     , 222. <a href="https://doi.org/10.3390/md18040222" title="DOI URL">https://doi.org/10.3390/md18040222</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/md18040222&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmd18040222%26sid%3Dliteratum%253Aachs%26jtitle%3DMarine%2520Drugs%26atitle%3DAnti-Inflammatory%252BEffects%252Bof%252BFucoxanthinol%252Bin%252BLPS-Induced%252BRAW264.7%252BCells%252Bthrough%252Bthe%252BNAAA-PEA%252BPathway%26aulast%3DJin%26aufirst%3DWenhui%26date%3D2020%26date%3D2020%26volume%3D18%26issue%3D4%26spage%3D222" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00191/20200716/images/medium/jm0c00191_0016.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00191/20200716/images/large/jm0c00191_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00191&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00191/20200716/images/medium/jm0c00191_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00191/20200716/images/large/jm0c00191_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Bioactive amides of long-chain fatty acids that are preferred substrates either for NAAA (blue) or FAAH (red). Fatty acid ethanolamides (also known as <i>N</i>-fatty acylethanolamines, left) include endogenous agonists for the ligand-operated transcription factor PPAR-α (e.g., PEA, oleoylethanolamide) and for G-protein-coupled cannabinoid-1 receptor (e.g., anandamide). In animal models, <i>N</i>-fatty acyltaurines (center) accelerate skin wound healing<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> and modulate feeding and glucose homeostasis,<a onclick="showRef(event, 'ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref4 ref5">(4,5)</a> while <i>N</i>-fatty acylglycines (right) exert analgesic and anti-inflammatory effects.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> The receptor mechanisms underpinning the latter effects are only partially understood.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00191/20200716/images/large/jm0c00191_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00191&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00191/20200716/images/medium/jm0c00191_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00191/20200716/images/large/jm0c00191_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structural and functional differences between FAAH and NAAA. Left: structure of the FAAH homodimer modeled from crystal coordinates (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1MT5">1MT5</a>),<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> adding the membrane-spanning helix and a model phospholipid bilayer (polar heads shown as spheres). The two monomers (identified in cyan and red) are oriented in parallel, each with an α-helix spanning the membrane and pointing their large substrate-binding cavities (green in the monomer to the right) in the same direction, toward the membrane. The red circle marks the position of the catalytic triad (Ser241, Lys142, and Ser217), which is magnified in the inset. Right: representation of NAAA based on the crystal structure of its rabbit orthologue (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6DY1">6DY1</a>).<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> The closely juxtaposed α (orange) and β (gray) subunits shape a rectilinear and relatively narrow substrate-binding pocket (green). Substrate recruitment may occur through an opening created by the interaction of α-helices 3 and 6 with the lipid membrane. The N-terminal catalytic nucleophile (Cys127 for rabbit NAAA; the residues are numbered following the primary sequence deposited in UniProt)<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> and Asp146, which interacts with the amine group of the N-terminal cysteine, are highlighted in the inset.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00191/20200716/images/large/jm0c00191_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00191&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00191/20200716/images/medium/jm0c00191_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00191/20200716/images/large/jm0c00191_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Formation and degradation of PEA. The “canonical” pathway of PEA production, shown in the middle, proceeds through two steps: first, the transfer of palmitate from the <i>sn</i>-1 position of phosphatidylcholine (PC) to the free amine group of phosphatidylethanolamine (PE), catalyzed by PLA2G4E, yields <i>N</i>-palmitoyl PE;<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> second, NAPE-PLD-mediated cleavage of <i>N</i>-palmitoyl PEs generates PEA.<a onclick="showRef(event, 'ref54 ref55 ref56'); return false;" href="javascript:void(0);" class="ref ref54 ref55 ref56">(54−56)</a> The acyl chain giving rise to PEA is highlighted in red. Multistep “noncanonical” routes also transit through <i>N</i>-palmitoyl PE but involve different enzymes and metabolic intermediates.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> The hydrolytic deactivation of PEA may be catalyzed by either NAAA or FAAH, which has broadly different subcellular and cellular distributions.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00191/20200716/images/large/jm0c00191_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00191&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00191/20200716/images/medium/jm0c00191_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00191/20200716/images/large/jm0c00191_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Hypothetical model of the role of NAAA in inflammation. NAAA catalyzes the hydrolytic cleavage of PEA into palmitic acid and ethanolamine. PEA is an endogenous agonist of the anti-inflammatory nuclear receptor PPAR-α. Conversely, palmitic acid may promote inflammation, at least in part, by suppressing expression of the transcription coactivator PGC1-α,<a onclick="showRef(event, 'ref74 ref75'); return false;" href="javascript:void(0);" class="ref ref74 ref75">(74,75)</a> which enables PPAR-α (dashed arrow) and other transcriptional regulators of inflammation (e.g., PPAR-γ).<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a> The model posits that NAAA activity might promote and sustain inflammation (i.e., slow down or prevent resolution) by removing the protective influence of PEA while concomitantly accelerating the generation of palmitic acid.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00191/20200716/images/large/jm0c00191_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00191&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00191/20200716/images/medium/jm0c00191_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00191/20200716/images/large/jm0c00191_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Sequence alignment of crystallized NAAA orthologues discussed in this review. Numbers on the top of the graph refer to human NAAA, and numbers on the right refer to rabbit or guinea-pig NAAA. The catalytic cysteine residues (Cys126 for human NAAA, corresponding to Cys127 in rabbit and Cys123 in guinea pig) are highlighted in yellow. Other residues involved in catalysis are highlighted in cyan.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00191/20200716/images/large/jm0c00191_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00191&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00191/20200716/images/medium/jm0c00191_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00191/20200716/images/large/jm0c00191_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Structures of (A) human NAAA precursor (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6DXW">6DXW</a>)<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> and (B) mature rabbit NAAA (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6DY1">6DY1</a>).<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> (A) Maturation occurs via self-catalyzed cleavage of the peptide bond between Phe125 and Cys126 (mutated to alanine in the crystallized protein and labeled as C126A). Residues Phe125, Ala126, and Asp145 are represented as balls and sticks. The backbone of residues 123–128 is colored in magenta. (B) Mature rabbit NAAA in complex with myristic acid (green), which occupies the binding pocket shaped by subunits α (orange) and β (gray). The catalytic nucleophile Cys127 (corresponding to Cys126 in the human orthologue; residues are numbered following the primary sequence deposited in UniProt)<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> is located at the N-terminal end of the β subunit, within a calix-shaped cavity exposed to the solvent. Several amino acids are involved in the catalytic process: Asp146 interacts with the amine group of the N-terminal cysteine, while Asn288 and Glu196 form the oxyanion hole with their side-chain amide and backbone NH group, respectively. Self-catalyzed cleavage may cause a conformational change in the C-terminal α-helix 5 of NAAA α-subunit, as well as in α-helices 3 (α-subunit) and 6 (β-subunit), which are presumed to interact with the membrane. A molecule of the detergent TritonX-100 is cocrystallized between α-helices 3 and 6 (light cyan carbons).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00191/20200716/images/large/jm0c00191_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00191&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00191/20200716/images/medium/jm0c00191_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00191/20200716/images/large/jm0c00191_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. First-generation NAAA inhibitors designed to mimic the two salient structural features of PEA, namely, its long-chain carbon tail and small polar head. The micromolar activity initially reported for compound <b>2</b> is now attributed to its synthetic intermediate <b>3</b>. The lipophilic amine <b>4</b>, the ester <b>5</b>, and the retroamide <b>6</b> inhibit NAAA with double-digit micromolar potencies.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00191/20200716/images/large/jm0c00191_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00191&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00191/20200716/images/medium/jm0c00191_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00191/20200716/images/large/jm0c00191_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. First-generation NAAA inhibitors designed to interact with the catalytic cysteine via a β-lactone warhead. (A) Structures of the hepatitis A virus proteinase 3C inhibitor <b>7</b>,<a onclick="showRef(event, 'ref92'); return false;" href="javascript:void(0);" class="ref ref92">(92)</a> a single-digit micromolar NAAA inhibitor; <b>8</b>, the first submicromolar NAAA inhibitor;<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a><b>9</b>, weakly active enantiomer of <b>8</b>; and <b>10</b>, inactive derivative of <b>8</b> that lacks the side chain amide-like fragment. (B) Theoretical mechanisms for the covalent inhibition of NAAA by β-lactones: (top) attack on the 4-methylene carbon produces a hydrolysis-resistant thioether, whereas (bottom) attack on the 2-carbonyl carbon yields a hydrolyzable thioester. Kinetic and mass spectrometry studies<a onclick="showRef(event, 'ref95'); return false;" href="javascript:void(0);" class="ref ref95">(95)</a> support the latter mechanism.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00191/20200716/images/large/jm0c00191_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00191&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00191/20200716/images/medium/jm0c00191_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00191/20200716/images/large/jm0c00191_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Second-generation β-lactone NAAA inhibitors with enhanced NAAA inhibitory potency and improved chemical and metabolic stability. The high inhibitory potency demonstrated by compounds <b>13</b>, <b>14</b>, and <b>17</b> reveals that replacement of the flexible carbon chain of PEA with straight and rigid structures leads to increased activity.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00191/20200716/images/large/jm0c00191_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00191&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00191/20200716/images/medium/jm0c00191_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00191/20200716/images/large/jm0c00191_0010.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Structures of representative β-lactam NAAA inhibitors. Compound <b>18</b> (ARN726) is a potent and systemically active NAAA inhibitor.<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00191/20200716/images/large/jm0c00191_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00191&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00191/20200716/images/medium/jm0c00191_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00191/20200716/images/large/jm0c00191_0011.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Interaction of NAAA with covalent (A) and noncovalent (B) inhibitors. (A) Detail of rabbit NAAA (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6DY0">6DY0</a>) with the sulfur atom of the N-terminal cysteine acylated by the β-lactam <b>18</b> (ARN726)<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a> (light pink carbons). The aminopropionate portion of the β-lactam ring points toward the solvent-accessible region lined by N-terminal Cys127 and the backbone of Asp146 (residues are numbered following the primary sequence deposited in UniProt). The carbamate carbonyl points toward the oxyanion hole formed by the side-chain amide of Asn288 and the backbone of Glu196, while the cyclohexylbutyl group lies within the lipophilic pocket that is likely occupied by the acyl chain of PEA (see <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>). (B) Detail of the substrate-binding site of human NAAA (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6DXX">6DXX</a>)<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> bound to the noncovalent inhibitor <b>37</b> (ARN19702)<a onclick="showRef(event, 'ref103'); return false;" href="javascript:void(0);" class="ref ref103">(103)</a> (green carbons). The sulfonyl group of <b>37</b> lies within the solvent-accessible cavity with an oxygen positioned 3.9 Å away from the sulfur atom of the catalytic cysteine (Cys126). The benzothiazole nucleus is inserted within the lipophilic pocket. Other interactions that may stabilize the enzyme–inhibitor complex (e.g., between the benzoyl carbonyl and Trp181, the fluorine atom, and the backbone of Met64) are not shown for clarity.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00191/20200716/images/large/jm0c00191_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00191&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig12" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00191/20200716/images/medium/jm0c00191_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00191/20200716/images/large/jm0c00191_0012.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Chemical probes for the study of NAAA <i>in vitro</i> and <i>in vivo</i>. The figure shows three β-lactam-based molecules: <b>22</b> bears a terminal alkyne group that allows the “click” reaction with an appropriate azide-bearing reporter; <b>23</b> and <b>24</b>, whose design is based on <b>21</b> (see <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>), contain fluorescent moieties and may be used to tag NAAA in broken (<b>23</b>) or intact (<b>24</b>) cell preparations.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00191/20200716/images/large/jm0c00191_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00191&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig13" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00191/20200716/images/medium/jm0c00191_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00191/20200716/images/large/jm0c00191_0013.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. NAAA inhibitors containing isothiocyanate (<b>25</b>, <b>26</b>) and cyanamide (<b>27</b>–<b>30</b>) warheads. Compound <b>29</b> is potent and selective for NAAA, whereas compound <b>30</b> is a balanced high potency dual inhibitor of NAAA and FAAH activities.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00191/20200716/images/large/jm0c00191_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00191&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig14" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00191/20200716/images/medium/jm0c00191_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00191/20200716/images/large/jm0c00191_0014.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. <i>N</i>-Acylpyrrolidine (<b>31</b>–<b>32</b>) and oxazolidinone imide (<b>33</b>-<b>34</b>) derivatives targeting NAAA. Compounds <b>32</b> and <b>34</b> (F215) are potent, reversible, and <i>in vivo</i> active NAAA inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00191/20200716/images/large/jm0c00191_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00191&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig15" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 15</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00191/20200716/images/medium/jm0c00191_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00191/20200716/images/large/jm0c00191_0015.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 15. NAAA inhibitors identified by testing compounds used in the clinic (diacerein <b>35</b> and carmofur <b>36</b>) or by high-throughput screening of chemical libraries (<b>37</b>) followed by SAR-driven optimization (<b>38</b>, <b>39</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00191/20200716/images/large/jm0c00191_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00191&amp;id=fig15"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig16" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 16</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00191/20200716/images/medium/jm0c00191_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00191/20200716/images/large/jm0c00191_0019.jpeg" id="rightTab-GRAPHIC-d7e1671-autogenerated" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 16. Pharmacophore elements common to current NAAA inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00191/20200716/images/large/jm0c00191_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00191&amp;id=fig16"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i21">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_63376" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_63376" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 127 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dennis, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norris, P. C.</span></span> <span> </span><span class="NLM_article-title">Eicosanoid storm in infection and inflammation</span>. <i>Nat. Rev. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">511</span>– <span class="NLM_lpage">523</span>, <span class="refDoi"> DOI: 10.1038/nri3859</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1038%2Fnri3859" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=26139350" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFyks7bL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2015&pages=511-523&author=E.+A.+Dennisauthor=P.+C.+Norris&title=Eicosanoid+storm+in+infection+and+inflammation&doi=10.1038%2Fnri3859"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Eicosanoid storm in infection and inflammation</span></div><div class="casAuthors">Dennis, Edward A.; Norris, Paul C.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">511-523</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Controlled immune responses to infection and injury involve complex mol. signalling networks with coordinated and often opposing actions.  Eicosanoids and related bioactive lipid mediators derived from polyunsatd. fatty acids constitute a major bioactive lipid network that is among the most complex and challenging pathways to map in a physiol. context.  Eicosanoid signalling, similar to cytokine signalling and inflammasome formation, has primarily been viewed as a pro-inflammatory component of the innate immune response; however, recent advances in lipidomics have helped to elucidate unique eicosanoids and related docosanoids with anti-inflammatory and pro-resoln. functions.  This has advanced our overall understanding of the inflammatory response and its therapeutic implications.  The induction of a pro-inflammatory and anti-inflammatory eicosanoid storm through the activation of inflammatory receptors by infectious agents is reviewed here.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFiadfYUUu57Vg90H21EOLACvtfcHk0liftosJpx-JGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFyks7bL&md5=1266833ea2b64dc373755fd072d40396</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnri3859&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri3859%26sid%3Dliteratum%253Aachs%26aulast%3DDennis%26aufirst%3DE.%2BA.%26aulast%3DNorris%26aufirst%3DP.%2BC.%26atitle%3DEicosanoid%2520storm%2520in%2520infection%2520and%2520inflammation%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2015%26volume%3D15%26spage%3D511%26epage%3D523%26doi%3D10.1038%2Fnri3859" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Serhan, C. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levy, B. D.</span></span> <span> </span><span class="NLM_article-title">Resolvins in inflammation: emergence of the pro-resolving superfamily of mediators</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>128</i></span>,  <span class="NLM_fpage">2657</span>– <span class="NLM_lpage">2669</span>, <span class="refDoi"> DOI: 10.1172/JCI97943</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1172%2FJCI97943" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=29757195" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A280%3ADC%252BC1MfivVKlsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2018&pages=2657-2669&author=C.+N.+Serhanauthor=B.+D.+Levy&title=Resolvins+in+inflammation%3A+emergence+of+the+pro-resolving+superfamily+of+mediators&doi=10.1172%2FJCI97943"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Resolvins in inflammation: emergence of the pro-resolving superfamily of mediators</span></div><div class="casAuthors">Serhan Charles N; Levy Bruce D</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of clinical investigation</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">128</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2657-2669</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Countless times each day, the acute inflammatory response protects us from invading microbes, injuries, and insults from within, as in surgery-induced tissue injury.  These challenges go unnoticed because they are self-limited and naturally resolve without progressing to chronic inflammation.  Peripheral blood markers of inflammation are present in many common diseases, including inflammatory bowel disease, cardiovascular disease, neurodegenerative disease, and cancer.  While acute inflammation is protective, excessive swarming of neutrophils amplifies collateral tissue damage and inflammation.  Hence, understanding the mechanisms that control the resolution of acute inflammation provides insight into preventing and treating inflammatory diseases in multiple organs.  This Review focuses on the resolution phase of inflammation with identification of specialized pro-resolving mediators (SPMs) that involve three separate biosynthetic and potent mediator families, which are defined using the first quantitative resolution indices to score this vital process.  These are the resolvins, protectins, and maresins: bioactive metabolomes that each stimulate self-limited innate responses, enhance innate microbial killing and clearance, and are organ-protective.  We briefly address biosynthesis of SPMs and their activation of endogenous resolution programs as terrain for new therapeutic approaches that are not, by definition, immunosuppressive, but rather new immunoresolvent therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTU73_HFSJ6o2yYR5VtavbzfW6udTcc2eYdvO2IQAxeVLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1MfivVKlsA%253D%253D&md5=6d2ee6f561693d9d06944cd7dbe7aa75</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1172%2FJCI97943&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI97943%26sid%3Dliteratum%253Aachs%26aulast%3DSerhan%26aufirst%3DC.%2BN.%26aulast%3DLevy%26aufirst%3DB.%2BD.%26atitle%3DResolvins%2520in%2520inflammation%253A%2520emergence%2520of%2520the%2520pro-resolving%2520superfamily%2520of%2520mediators%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2018%26volume%3D128%26spage%3D2657%26epage%3D2669%26doi%3D10.1172%2FJCI97943" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sasso, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pontis, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Armirotti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cardinali, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kovacs, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Migliore, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Summa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreno-Sanz, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Picardo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piomelli, D.</span></span> <span> </span><span class="NLM_article-title">Endogenous N-acyl taurines regulate skin wound healing</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>113</i></span>,  <span class="NLM_fpage">4397</span>– <span class="NLM_lpage">4406</span>, <span class="refDoi"> DOI: 10.1073/pnas.1605578113</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1073%2Fpnas.1605578113" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtFKktr%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2016&pages=4397-4406&author=O.+Sassoauthor=S.+Pontisauthor=A.+Armirottiauthor=G.+Cardinaliauthor=D.+Kovacsauthor=M.+Miglioreauthor=M.+Summaauthor=G.+Moreno-Sanzauthor=M.+Picardoauthor=D.+Piomelli&title=Endogenous+N-acyl+taurines+regulate+skin+wound+healing&doi=10.1073%2Fpnas.1605578113"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Endogenous N-acyl taurines regulate skin wound healing</span></div><div class="casAuthors">Sasso, Oscar; Pontis, Silvia; Armirotti, Andrea; Cardinali, Giorgia; Kovacs, Daniela; Migliore, Marco; Summa, Maria; Moreno-Sanz, Guillermo; Picardo, Mauro; Piomelli, Daniele</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">30</span>),
    <span class="NLM_cas:pages">E4397-E4406</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The intracellular serine amidase, fatty acid amide hydrolase (FAAH), degrades a heterogeneous family of lipid-derived bioactive mols. that include amides of long-chain fatty acids with taurine [N-acyl-taurines (NATs)].  The physiol. functions of the NATs are unknown.  Here we show that genetic or pharmacol. disruption of FAAH activity accelerates skin wound healing in mice and stimulates motogenesis of human keratinocytes and differentiation of human fibroblasts in primary cultures.  Using untargeted and targeted lipidomics strategies, we identify two long-chain satd. NATs - N-tetracosanoyl-taurine [NAT(24:0)] and N-eicosanoyl-taurine [NAT(20:0)] - as primary substrates for FAAH in mouse skin, and show that the levels of these substances sharply decrease at the margins of a freshly inflicted wound to increase again as healing begins.  Addnl., we demonstrate that local administration of synthetic NATs accelerates wound closure in mice and stimulates repair-assocd. responses in primary cultures of human keratinocytes and fibroblasts, through a mechanism that involves tyrosine phosphorylation of the epidermal growth factor receptor and an increase in intracellular calcium levels, under the permissive control of transient receptor potential vanilloid-1 receptors.  The results point to FAAH-regulated NAT signaling as an unprecedented lipid-based mechanism of wound-healing control in mammalian skin, which might be targeted for chronic wound therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZZpzBVMWzvrVg90H21EOLACvtfcHk0livohFVJ2DzGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtFKktr%252FL&md5=4ca3de983f5ceac2912c37b05f8d012f</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1605578113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1605578113%26sid%3Dliteratum%253Aachs%26aulast%3DSasso%26aufirst%3DO.%26aulast%3DPontis%26aufirst%3DS.%26aulast%3DArmirotti%26aufirst%3DA.%26aulast%3DCardinali%26aufirst%3DG.%26aulast%3DKovacs%26aufirst%3DD.%26aulast%3DMigliore%26aufirst%3DM.%26aulast%3DSumma%26aufirst%3DM.%26aulast%3DMoreno-Sanz%26aufirst%3DG.%26aulast%3DPicardo%26aufirst%3DM.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DEndogenous%2520N-acyl%2520taurines%2520regulate%2520skin%2520wound%2520healing%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2016%26volume%3D113%26spage%3D4397%26epage%3D4406%26doi%3D10.1073%2Fpnas.1605578113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aichler, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borgmann, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krumsiek, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buck, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacDonald, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fox, J. E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyon, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Light, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keipert, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jastroch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feuchtinger, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mueller, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palmer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexandrov, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hrabe de Angelis, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neschen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tschöp, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walch, A.</span></span> <span> </span><span class="NLM_article-title">N-acyl taurines and acylcarnitines cause an imbalance in insulin synthesis and secretion provoking β cell dysfunction in type 2 diabetes</span>. <i>Cell Metab.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">1334</span>– <span class="NLM_lpage">1347</span>, <span class="refDoi"> DOI: 10.1016/j.cmet.2017.04.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1016%2Fj.cmet.2017.04.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=28591636" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BC2sXpslWgtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2017&pages=1334-1347&author=M.+Aichlerauthor=D.+Borgmannauthor=J.+Krumsiekauthor=A.+Buckauthor=P.+E.+MacDonaldauthor=J.+E.+M.+Foxauthor=J.+Lyonauthor=P.+E.+Lightauthor=S.+Keipertauthor=M.+Jastrochauthor=A.+Feuchtingerauthor=N.+S.+Muellerauthor=N.+Sunauthor=A.+Palmerauthor=T.+Alexandrovauthor=M.+Hrabe+de+Angelisauthor=S.+Neschenauthor=M.+H.+Tsch%C3%B6pauthor=A.+Walch&title=N-acyl+taurines+and+acylcarnitines+cause+an+imbalance+in+insulin+synthesis+and+secretion+provoking+%CE%B2+cell+dysfunction+in+type+2+diabetes&doi=10.1016%2Fj.cmet.2017.04.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">N-acyl Taurines and Acylcarnitines Cause an Imbalance in Insulin Synthesis and Secretion Provoking β Cell Dysfunction in Type 2 Diabetes</span></div><div class="casAuthors">Aichler, Michaela; Borgmann, Daniela; Krumsiek, Jan; Buck, Achim; MacDonald, Patrick E.; Fox, Jocelyn E. Manning; Lyon, James; Light, Peter E.; Keipert, Susanne; Jastroch, Martin; Feuchtinger, Annette; Mueller, Nikola S.; Sun, Na; Palmer, Andrew; Alexandrov, Theodore; Hrabe de Angelis, Martin; Neschen, Susanne; Tschoep, Matthias H.; Walch, Axel</div><div class="citationInfo"><span class="NLM_cas:title">Cell Metabolism</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1334-1347.e4</span>CODEN:
                <span class="NLM_cas:coden">CMEEB5</span>;
        ISSN:<span class="NLM_cas:issn">1550-4131</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">The processes contributing to β cell dysfunction in type 2 diabetes (T2D) are uncertain, largely because it is difficult to access β cells in their intact immediate environment.  We examd. the pathophysiol. of β cells under T2D progression directly in pancreatic tissues.  We used MALDI imaging of Langerhans islets (LHIs) within mouse tissues or from human tissues to generate in situ-omics data, which we supported with in vitro expts.  Mol. interaction networks provided information on functional pathways and mols.  We found that stearoylcarnitine accumulated in β cells, leading to arrest of insulin synthesis and energy deficiency via excessive β-oxidn. and depletion of TCA cycle and oxidative phosphorylation metabolites.  Acetylcarnitine and an accumulation of N-acyl taurines, a group not previously detected in β cells, provoked insulin secretion.  Thus, β cell dysfunction results from enhanced insulin secretion combined with an arrest of insulin synthesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnar12qoZDFrVg90H21EOLACvtfcHk0ljyVT9EsnDV5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXpslWgtro%253D&md5=5cd568071c9c83b9d7d8b6b12a0dc6de</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.cmet.2017.04.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cmet.2017.04.012%26sid%3Dliteratum%253Aachs%26aulast%3DAichler%26aufirst%3DM.%26aulast%3DBorgmann%26aufirst%3DD.%26aulast%3DKrumsiek%26aufirst%3DJ.%26aulast%3DBuck%26aufirst%3DA.%26aulast%3DMacDonald%26aufirst%3DP.%2BE.%26aulast%3DFox%26aufirst%3DJ.%2BE.%2BM.%26aulast%3DLyon%26aufirst%3DJ.%26aulast%3DLight%26aufirst%3DP.%2BE.%26aulast%3DKeipert%26aufirst%3DS.%26aulast%3DJastroch%26aufirst%3DM.%26aulast%3DFeuchtinger%26aufirst%3DA.%26aulast%3DMueller%26aufirst%3DN.%2BS.%26aulast%3DSun%26aufirst%3DN.%26aulast%3DPalmer%26aufirst%3DA.%26aulast%3DAlexandrov%26aufirst%3DT.%26aulast%3DHrabe%2Bde%2BAngelis%26aufirst%3DM.%26aulast%3DNeschen%26aufirst%3DS.%26aulast%3DTsch%25C3%25B6p%26aufirst%3DM.%2BH.%26aulast%3DWalch%26aufirst%3DA.%26atitle%3DN-acyl%2520taurines%2520and%2520acylcarnitines%2520cause%2520an%2520imbalance%2520in%2520insulin%2520synthesis%2520and%2520secretion%2520provoking%2520%25CE%25B2%2520cell%2520dysfunction%2520in%2520type%25202%2520diabetes%26jtitle%3DCell%2520Metab.%26date%3D2017%26volume%3D25%26spage%3D1334%26epage%3D1347%26doi%3D10.1016%2Fj.cmet.2017.04.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Grevengoed, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trammell, S. A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKinney, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petersen, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cardone, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Svenningsen, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogasawara, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nexøe-Larsen, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knop, F. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwartz, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kibbey, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cravatt, B. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gillum, M. P.</span></span> <span> </span><span class="NLM_article-title">N-acyl taurines are endogenous lipid messengers that improve glucose homeostasis</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>116</i></span>,  <span class="NLM_fpage">24770</span>– <span class="NLM_lpage">24778</span>, <span class="refDoi"> DOI: 10.1073/pnas.1916288116</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1073%2Fpnas.1916288116" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=31740614" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitlejsLzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2019&pages=24770-24778&author=T.+J.+Grevengoedauthor=S.+A.+J.+Trammellauthor=M.+K.+McKinneyauthor=N.+Petersenauthor=R.+L.+Cardoneauthor=J.+S.+Svenningsenauthor=D.+Ogasawaraauthor=C.+C.+Nex%C3%B8e-Larsenauthor=F.+K.+Knopauthor=T.+W.+Schwartzauthor=R.+G.+Kibbeyauthor=B.+F.+Cravattauthor=M.+P.+Gillum&title=N-acyl+taurines+are+endogenous+lipid+messengers+that+improve+glucose+homeostasis&doi=10.1073%2Fpnas.1916288116"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">N-acyl taurines are endogenous lipid messengers that improve glucose homeostasis</span></div><div class="casAuthors">Grevengoed, Trisha J.; Trammell, Samuel A. J.; McKinney, Michele K.; Petersen, Natalia; Cardone, Rebecca L.; Svenningsen, Jens S.; Ogasawara, Daisuke; NexA¸ e-Larsen, Christina C.; Knop, Filip K.; Schwartz, Thue W.; Kibbey, Richard G.; Cravatt, Benjamin F.; Gillum, Matthew P.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">49</span>),
    <span class="NLM_cas:pages">24770-24778</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Fatty acid amide hydrolase (FAAH) degrades 2 major classes of bioactive fatty acid amides, the N-acyl ethanolamines (NAEs) and N-acyl taurines (NATs), in central and peripheral tissues.  A functional polymorphism in the human FAAH gene is linked to obesity and mice lacking FAAH show altered metabolic states, but whether these phenotypes are caused by elevations in NAEs or NATs is unknown.  To overcome the problem of concurrent elevation of NAEs and NATs caused by genetic or pharmacol. disruption of FAAH in vivo, we developed an engineered mouse model harboring a single-amino acid substitution in FAAH (S268D) that selectively disrupts NAT, but not NAE, hydrolytic activity.  The FAAH-S268D mice accordingly show substantial elevations in NATs without alterations in NAE content, a unique metabolic profile that correlates with heightened insulin sensitivity and GLP-1 secretion.  Together, these data suggest that NATs act as a class of lipid messengers that improve postprandial glucose regulation and may have potential as investigational metabolites to modify metabolic disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWVQawX3EmmbVg90H21EOLACvtfcHk0ljyVT9EsnDV5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitlejsLzE&md5=328c5495be24993c9948675e39119092</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1916288116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1916288116%26sid%3Dliteratum%253Aachs%26aulast%3DGrevengoed%26aufirst%3DT.%2BJ.%26aulast%3DTrammell%26aufirst%3DS.%2BA.%2BJ.%26aulast%3DMcKinney%26aufirst%3DM.%2BK.%26aulast%3DPetersen%26aufirst%3DN.%26aulast%3DCardone%26aufirst%3DR.%2BL.%26aulast%3DSvenningsen%26aufirst%3DJ.%2BS.%26aulast%3DOgasawara%26aufirst%3DD.%26aulast%3DNex%25C3%25B8e-Larsen%26aufirst%3DC.%2BC.%26aulast%3DKnop%26aufirst%3DF.%2BK.%26aulast%3DSchwartz%26aufirst%3DT.%2BW.%26aulast%3DKibbey%26aufirst%3DR.%2BG.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26aulast%3DGillum%26aufirst%3DM.%2BP.%26atitle%3DN-acyl%2520taurines%2520are%2520endogenous%2520lipid%2520messengers%2520that%2520improve%2520glucose%2520homeostasis%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2019%26volume%3D116%26spage%3D24770%26epage%3D24778%26doi%3D10.1073%2Fpnas.1916288116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merkler, D. J.</span></span> <span> </span><span class="NLM_article-title">N-fatty acylglycines: underappreciated endocannabinoid-like fatty acid amides?</span>. <i>J. Biol. Nat.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">156</span>– <span class="NLM_lpage">165</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=29607420" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A280%3ADC%252BC1MnnvFansQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=156-165&author=R.+L.+Andersonauthor=D.+J.+Merkler&title=N-fatty+acylglycines%3A+underappreciated+endocannabinoid-like+fatty+acid+amides%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">N-FATTY ACYLGLYCINES: UNDERAPPRECIATED ENDOCANNABINOID-LIKE FATTY ACID AMIDES?</span></div><div class="casAuthors">Anderson Ryan L; Merkler David J</div><div class="citationInfo"><span class="NLM_cas:title">Journal of biology and nature</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">156-165</span>
        ISSN:<span class="NLM_cas:issn">2395-5376</span>.
    </div><div class="casAbstract">Long-chain N-fatty acylglycines, R-CO-NH-CH2-COOH (where "R" refers to an unsaturated or saturated alkyl chain of at least 14 carbons) are found in mammals and insects and are structurally related to the cell-signaling, lipid-like, N-fatty acylethanolamines, R-CO-NH-CH2-CH2-OH (where "R" refers to an alkyl chain of at least 14 carbons).  Accumulating evidence demonstrates that the N-fatty acylglycines have important cellular functions, but much work remains in order to fully appreciate and understand these biomolecules including: (a) more work on their functions in vivo, (b) measuring their concentrations in the cell, (c) defining the pathways for the biosynthesis and degradation, and (d) understanding the metabolic interconversion(s) between the N-fatty acylglycines and other fatty acid amides.  The purpose of reviewing the current state-of-knowledge about the N-fatty acylglycines is to stimulate future research about this intriguing family of biomolecules.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ21-ojBQLwKfh3YQQtAhNufW6udTcc2eYEnInqkEfzLbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1MnnvFansQ%253D%253D&md5=125c88690c980ed9e1e6dec9c12349bd</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAnderson%26aufirst%3DR.%2BL.%26aulast%3DMerkler%26aufirst%3DD.%2BJ.%26atitle%3DN-fatty%2520acylglycines%253A%2520underappreciated%2520endocannabinoid-like%2520fatty%2520acid%2520amides%253F%26jtitle%3DJ.%2520Biol.%2520Nat.%26date%3D2017%26volume%3D8%26spage%3D156%26epage%3D165" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Piomelli, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sasso, O.</span></span> <span> </span><span class="NLM_article-title">Peripheral gating of pain signals by endogenous lipid mediators</span>. <i>Nat. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">164</span>– <span class="NLM_lpage">174</span>, <span class="refDoi"> DOI: 10.1038/nn.3612</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1038%2Fnn.3612" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=24473264" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtlaqtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2014&pages=164-174&author=D.+Piomelliauthor=O.+Sasso&title=Peripheral+gating+of+pain+signals+by+endogenous+lipid+mediators&doi=10.1038%2Fnn.3612"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Peripheral gating of pain signals by endogenous lipid mediators</span></div><div class="casAuthors">Piomelli, Daniele; Sasso, Oscar</div><div class="citationInfo"><span class="NLM_cas:title">Nature Neuroscience</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">164-174</span>CODEN:
                <span class="NLM_cas:coden">NANEFN</span>;
        ISSN:<span class="NLM_cas:issn">1097-6256</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Primary sensory afferents and their neighboring host-defense cells are a rich source of lipid-derived mediators that contribute to the sensation of pain caused by tissue damage and inflammation.  But an increasing no. of lipid mols. have been shown to act in an opposite way, to suppress the inflammatory process, restore homeostasis in damaged tissues and attenuate pain sensitivity by regulating neural pathways that transmit nociceptive signals from the periphery of the body to the CNS.  Here we review the mol. and cellular mechanisms that contribute to the modulatory actions of lipid mediators in peripheral nociceptive signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3SUeSBaNEzbVg90H21EOLACvtfcHk0ljZt6aDQmAvLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtlaqtrg%253D&md5=cedccbc9ba2c37ec111eefdf19c065a6</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnn.3612&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnn.3612%26sid%3Dliteratum%253Aachs%26aulast%3DPiomelli%26aufirst%3DD.%26aulast%3DSasso%26aufirst%3DO.%26atitle%3DPeripheral%2520gating%2520of%2520pain%2520signals%2520by%2520endogenous%2520lipid%2520mediators%26jtitle%3DNat.%2520Neurosci.%26date%3D2014%26volume%3D17%26spage%3D164%26epage%3D174%26doi%3D10.1038%2Fnn.3612" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Devane, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanus, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Breuer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pertwee, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevenson, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffin, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mandelbaum, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Etinger, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mechoulam, R.</span></span> <span> </span><span class="NLM_article-title">Isolation and structure of a brain constituent that binds to the cannabinoid receptor</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>258</i></span>,  <span class="NLM_fpage">1946</span>– <span class="NLM_lpage">1949</span>, <span class="refDoi"> DOI: 10.1126/science.1470919</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1126%2Fscience.1470919" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1470919" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADyaK3sXpvVKntg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=258&publication_year=1992&pages=1946-1949&author=W.+A.+Devaneauthor=L.+Hanusauthor=A.+Breuerauthor=R.+G.+Pertweeauthor=L.+A.+Stevensonauthor=G.+Griffinauthor=D.+Gibsonauthor=A.+Mandelbaumauthor=A.+Etingerauthor=R.+Mechoulam&title=Isolation+and+structure+of+a+brain+constituent+that+binds+to+the+cannabinoid+receptor&doi=10.1126%2Fscience.1470919"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Isolation and structure of a brain constituent that binds to the cannabinoid receptor</span></div><div class="casAuthors">Devane, William A.; Hanus, Lumir; Breuer, Aviva; Pertwee, Roger G.; Stevenson, Lesley A.; Griffin, Graeme; Gibson, Dan; Mandelbaum, Asher; Etinger, Alexander; Mechoulam, Raphael</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">258</span>
        (<span class="NLM_cas:issue">5090</span>),
    <span class="NLM_cas:pages">1946-9</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">Arachidonylethanolamide, an arachidonic acid deriv. in the porcine brain, was identified as an endogenous ligand for the cannabinoid receptor.  The structure of this compd., anandamide, was detd. by mass spectrometry and NMR spectroscopy and was confirmed by synthesis.  Anandamide inhibited the specific binding of a radiolabeled cannabinoid probe to synaptosomal membranes in a manner typical of competitive ligands and produced a concn.-dependent inhibition of the elec. evoked twitch responses of the mouse vas deferens, a characteristic effect of psychotropic cannabinoids.  Anandamide may function as a natural ligand for the cannabinoid receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXqh5E4vHczbVg90H21EOLACvtfcHk0ljZt6aDQmAvLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXpvVKntg%253D%253D&md5=13c7aa7316cd687240779f7f192d086b</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1126%2Fscience.1470919&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1470919%26sid%3Dliteratum%253Aachs%26aulast%3DDevane%26aufirst%3DW.%2BA.%26aulast%3DHanus%26aufirst%3DL.%26aulast%3DBreuer%26aufirst%3DA.%26aulast%3DPertwee%26aufirst%3DR.%2BG.%26aulast%3DStevenson%26aufirst%3DL.%2BA.%26aulast%3DGriffin%26aufirst%3DG.%26aulast%3DGibson%26aufirst%3DD.%26aulast%3DMandelbaum%26aufirst%3DA.%26aulast%3DEtinger%26aufirst%3DA.%26aulast%3DMechoulam%26aufirst%3DR.%26atitle%3DIsolation%2520and%2520structure%2520of%2520a%2520brain%2520constituent%2520that%2520binds%2520to%2520the%2520cannabinoid%2520receptor%26jtitle%3DScience%26date%3D1992%26volume%3D258%26spage%3D1946%26epage%3D1949%26doi%3D10.1126%2Fscience.1470919" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lo
Verme, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Astarita, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La Rana, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calignano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piomelli, D.</span></span> <span> </span><span class="NLM_article-title">The nuclear receptor peroxisome proliferator-activated receptor-alpha mediates the anti-inflammatory actions of palmitoylethanolamide</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">15</span>– <span class="NLM_lpage">19</span>, <span class="refDoi"> DOI: 10.1124/mol.104.006353</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1124%2Fmol.104.006353" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=15465922" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlt12ksA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2005&pages=15-19&author=J.+Lo%0AVermeauthor=J.+Fuauthor=G.+Astaritaauthor=G.+La+Ranaauthor=R.+Russoauthor=A.+Calignanoauthor=D.+Piomelli&title=The+nuclear+receptor+peroxisome+proliferator-activated+receptor-alpha+mediates+the+anti-inflammatory+actions+of+palmitoylethanolamide&doi=10.1124%2Fmol.104.006353"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">The nuclear receptor peroxisome proliferator-activated receptor-α mediates the anti-inflammatory actions of palmitoylethanolamide</span></div><div class="casAuthors">Lo Verme, Jesse; Fu, Jin; Astarita, Giuseppe; La Rana, Giovanna; Russo, Roberto; Calignano, Antonio; Piomelli, Daniele</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">15-19</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Palmitoylethanolamide (PEA), the naturally occurring amide of palmitic acid and ethanolamine, reduces pain and inflammation through an as-yet-uncharacterized mechanism.  Here, we identify the nuclear receptor peroxisome proliferator-activated receptor-α (PPAR-α) as the mol. target responsible for the anti-inflammatory properties of PEA.  PEA selectively activates PPAR-α in vitro with an EC50 value of 3.1±0.4 μM and induces the expression of PPAR-α mRNA when applied topically to mouse skin.  In two animal models, carrageenan-induced paw edema and phorbol ester-induced ear edema, PEA attenuates inflammation in wild-type mice but has no effect in mice deficient in PPAR-α.  The natural PPAR-α agonist oleoylethanolamide (OEA) and the synthetic PPAR-α agonists GW7647 and Wy-14643 mimic these effects in a PPAR-α-dependent manner.  These findings indicate that PPAR-α mediates the anti-inflammatory effects of PEA and suggest that this fatty-acid ethanolamide may serve, like its analog OEA, as an endogenous ligand of PPAR-α.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqw2rfZ_7rANLVg90H21EOLACvtfcHk0ljTqnDLuy1l3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlt12ksA%253D%253D&md5=c6c20156b93828c507ecbdee107c7061</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1124%2Fmol.104.006353&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.104.006353%26sid%3Dliteratum%253Aachs%26aulast%3DLo%2BVerme%26aufirst%3DJ.%26aulast%3DFu%26aufirst%3DJ.%26aulast%3DAstarita%26aufirst%3DG.%26aulast%3DLa%2BRana%26aufirst%3DG.%26aulast%3DRusso%26aufirst%3DR.%26aulast%3DCalignano%26aufirst%3DA.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DThe%2520nuclear%2520receptor%2520peroxisome%2520proliferator-activated%2520receptor-alpha%2520mediates%2520the%2520anti-inflammatory%2520actions%2520of%2520palmitoylethanolamide%26jtitle%3DMol.%2520Pharmacol.%26date%3D2005%26volume%3D67%26spage%3D15%26epage%3D19%26doi%3D10.1124%2Fmol.104.006353" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lo
Verme, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La Rana, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calignano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piomelli, D.</span></span> <span> </span><span class="NLM_article-title">The search for the palmitoylethanolamide receptor</span>. <i>Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>77</i></span>,  <span class="NLM_fpage">1685</span>– <span class="NLM_lpage">1698</span>, <span class="refDoi"> DOI: 10.1016/j.lfs.2005.05.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1016%2Fj.lfs.2005.05.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=15963531" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2005&pages=1685-1698&author=J.+Lo%0AVermeauthor=G.+La+Ranaauthor=R.+Russoauthor=A.+Calignanoauthor=D.+Piomelli&title=The+search+for+the+palmitoylethanolamide+receptor&doi=10.1016%2Fj.lfs.2005.05.012"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.lfs.2005.05.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.lfs.2005.05.012%26sid%3Dliteratum%253Aachs%26aulast%3DLo%2BVerme%26aufirst%3DJ.%26aulast%3DLa%2BRana%26aufirst%3DG.%26aulast%3DRusso%26aufirst%3DR.%26aulast%3DCalignano%26aufirst%3DA.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DThe%2520search%2520for%2520the%2520palmitoylethanolamide%2520receptor%26jtitle%3DLife%2520Sci.%26date%3D2005%26volume%3D77%26spage%3D1685%26epage%3D1698%26doi%3D10.1016%2Fj.lfs.2005.05.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lo
Verme, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La Rana, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farthing, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mattace-Raso, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meli, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hohmann, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calignano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piomelli, D.</span></span> <span> </span><span class="NLM_article-title">Rapid broad-spectrum analgesia through activation of peroxisome proliferator-activated receptor-alpha</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>319</i></span>,  <span class="NLM_fpage">1051</span>– <span class="NLM_lpage">1061</span>, <span class="refDoi"> DOI: 10.1124/jpet.106.111385</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1124%2Fjpet.106.111385" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=16997973" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=319&publication_year=2006&pages=1051-1061&author=J.+Lo%0AVermeauthor=R.+Russoauthor=G.+La+Ranaauthor=J.+Fuauthor=J.+Farthingauthor=G.+Mattace-Rasoauthor=R.+Meliauthor=A.+Hohmannauthor=A.+Calignanoauthor=D.+Piomelli&title=Rapid+broad-spectrum+analgesia+through+activation+of+peroxisome+proliferator-activated+receptor-alpha&doi=10.1124%2Fjpet.106.111385"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1124%2Fjpet.106.111385&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.106.111385%26sid%3Dliteratum%253Aachs%26aulast%3DLo%2BVerme%26aufirst%3DJ.%26aulast%3DRusso%26aufirst%3DR.%26aulast%3DLa%2BRana%26aufirst%3DG.%26aulast%3DFu%26aufirst%3DJ.%26aulast%3DFarthing%26aufirst%3DJ.%26aulast%3DMattace-Raso%26aufirst%3DG.%26aulast%3DMeli%26aufirst%3DR.%26aulast%3DHohmann%26aufirst%3DA.%26aulast%3DCalignano%26aufirst%3DA.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DRapid%2520broad-spectrum%2520analgesia%2520through%2520activation%2520of%2520peroxisome%2520proliferator-activated%2520receptor-alpha%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2006%26volume%3D319%26spage%3D1051%26epage%3D1061%26doi%3D10.1124%2Fjpet.106.111385" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chiurchiù, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rapino, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talamonti, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leuti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lanuti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gueniche, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jourdain, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Breton, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maccarrone, M.</span></span> <span> </span><span class="NLM_article-title">Anandamide suppresses proinflammatory T cell responses in vitro through type-1 cannabinoid receptor-mediated mTOR inhibition in human keratinocytes</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>197</i></span>,  <span class="NLM_fpage">3545</span>– <span class="NLM_lpage">3553</span>, <span class="refDoi"> DOI: 10.4049/jimmunol.1500546</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.4049%2Fjimmunol.1500546" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=27694494" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsVagsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=197&publication_year=2016&pages=3545-3553&author=V.+Chiurchi%C3%B9author=C.+Rapinoauthor=E.+Talamontiauthor=A.+Leutiauthor=M.+Lanutiauthor=A.+Guenicheauthor=R.+Jourdainauthor=L.+Bretonauthor=M.+Maccarrone&title=Anandamide+suppresses+proinflammatory+T+cell+responses+in+vitro+through+type-1+cannabinoid+receptor-mediated+mTOR+inhibition+in+human+keratinocytes&doi=10.4049%2Fjimmunol.1500546"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Anandamide Suppresses Proinflammatory T Cell Responses In Vitro through Type-1 Cannabinoid Receptor-Mediated mTOR Inhibition in Human Keratinocytes</span></div><div class="casAuthors">Chiurchiu, Valerio; Rapino, Cinzia; Talamonti, Emanuela; Leuti, Alessandro; Lanuti, Mirko; Gueniche, Audrey; Jourdain, Roland; Breton, Lionel; Maccarrone, Mauro</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">197</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3545-3553</span>CODEN:
                <span class="NLM_cas:coden">JOIMA3</span>;
        ISSN:<span class="NLM_cas:issn">0022-1767</span>.
    
            (<span class="NLM_cas:orgname">American Association of Immunologists</span>)
        </div><div class="casAbstract">The endocannabinoid system comprises cannabinoid receptors 1 and 2 (CB1 and CB2), their endogenous ligands, anandamide (AEA) and 2-arachidonoylglycerol, and metabolic enzymes of these ligands.  The endocannabinoid system has recently been implicated in the regulation of various pathophysiol. processes of the skin that include immune competence and/or tolerance of keratinocytes, the disruption of which might promote the development of skin diseases.  Recent evidence showed that CB1 in keratinocytes limits the secretion of proinflammatory chemokines, suggesting that this receptor might also regulate T cell dependent inflammatory diseases of the skin.  In this article, we sought to investigate the cytokine profile of IFN-γ-activated keratinocytes, and found that CB1 activation by AEA suppressed prodn. and release of signature TH1- and TH17-polarizing cytokines, IL-12 and IL-23, resp.  We also set up cocultures between a conditioned medium of treated keratinocytes and naive T cells to disclose the mol. details that regulate the activation of highly proinflammatory TH1 and TH17 cells.  AEA-treated keratinocytes showed reduced an induction of IFN-γ-producing TH1 and IL-17-producing TH17 cells, and these effects were reverted by pharmacol. inhibition of CB1.  Further analyses identified mammalian target of rapamycin as a proinflammatory signaling pathway regulated by CB1, able to promote either IL-12 and IL-23 release from keratinocytes or TH1 and TH17 polarization.  Taken together, these findings demonstrate that AEA suppresses highly pathogenic T cell subsets through CB1-mediated mammalian target of rapamycin inhibition in human keratinocytes.  Thus, it can be speculated that the latter pathway might be beneficial to the physiol. function of the skin, and can be targeted toward inflammation-related skin diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQDTxXY91tM7Vg90H21EOLACvtfcHk0lhPfkxD3YWVeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsVagsrk%253D&md5=44ed23d6b88c95edb126ac7e78348724</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.1500546&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.1500546%26sid%3Dliteratum%253Aachs%26aulast%3DChiurchi%25C3%25B9%26aufirst%3DV.%26aulast%3DRapino%26aufirst%3DC.%26aulast%3DTalamonti%26aufirst%3DE.%26aulast%3DLeuti%26aufirst%3DA.%26aulast%3DLanuti%26aufirst%3DM.%26aulast%3DGueniche%26aufirst%3DA.%26aulast%3DJourdain%26aufirst%3DR.%26aulast%3DBreton%26aufirst%3DL.%26aulast%3DMaccarrone%26aufirst%3DM.%26atitle%3DAnandamide%2520suppresses%2520proinflammatory%2520T%2520cell%2520responses%2520in%2520vitro%2520through%2520type-1%2520cannabinoid%2520receptor-mediated%2520mTOR%2520inhibition%2520in%2520human%2520keratinocytes%26jtitle%3DJ.%2520Immunol.%26date%3D2016%26volume%3D197%26spage%3D3545%26epage%3D3553%26doi%3D10.4049%2Fjimmunol.1500546" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Redlich, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ribes, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schütze, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nau, R.</span></span> <span> </span><span class="NLM_article-title">Palmitoylethanolamide stimulates phagocytosis of Escherichia coli K1 by macrophages and increases the resistance of mice against infections</span>. <i>J. Neuroinflammation</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">108</span>, <span class="refDoi"> DOI: 10.1186/1742-2094-11-108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1186%2F1742-2094-11-108" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=24927796" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVCitrzK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2014&pages=108&author=S.+Redlichauthor=S.+Ribesauthor=S.+Sch%C3%BCtzeauthor=R.+Nau&title=Palmitoylethanolamide+stimulates+phagocytosis+of+Escherichia+coli+K1+by+macrophages+and+increases+the+resistance+of+mice+against+infections&doi=10.1186%2F1742-2094-11-108"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Palmitoylethanolamide stimulates phagocytosis of Escherichia coli K1 by macrophages and increases the resistance of mice against infections</span></div><div class="casAuthors">Redlich, Sandra; Ribes, Sandra; Schuetze, Sandra; Nau, Roland</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroinflammation</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">108/1-108/11</span>CODEN:
                <span class="NLM_cas:coden">JNOEB3</span>;
        ISSN:<span class="NLM_cas:issn">1742-2094</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Palmitoylethanolamide (PEA), an endogenous lipid and a congener of anandamide, possesses a wide range of effects related to metabolic and cellular homeostasis including anti-inflammatory and neuroprotective properties.  Methods:In vitro, we studied the ability of macrophages to phagocytose Escherichia coli K1 after stimulation with increasing doses of PEA.  In vivo, wild-type mice were treated with PEA i.p. 12 h and 30 min before infection.  Meningoencephalitis or sepsis was induced by intracerebral or i.p. infection with E. coli K1.  Results: Stimulation of macrophages with PEA for 30 min increased the phagocytosis of E. coli K1 without inducing the release of TNFα or CXCL1.  Intracellular killing of E. coli K1 was higher in PEA-stimulated than in unstimulated peritoneal macrophages and microglial cells.  Pre-treatment with PEA significantly increased survival of mice challenged intracerebrally or i.p. with E. coli K1.  This effect was assocd. with a decreased prodn. of CXCL1, IL-1β and IL-6 in homogenates of spleen and cerebellum in mice treated with PEA.  Conclusions: Our observations suggest that these protective effects of PEA in mice can increase the resistance to bacterial infections without the hazard of collateral damage by excessive stimulation of phagocytes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGravmrrtpg2NLVg90H21EOLACvtfcHk0lhPfkxD3YWVeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVCitrzK&md5=9354dbf98fabfb17d413f2fd26ade834</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1186%2F1742-2094-11-108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1742-2094-11-108%26sid%3Dliteratum%253Aachs%26aulast%3DRedlich%26aufirst%3DS.%26aulast%3DRibes%26aufirst%3DS.%26aulast%3DSch%25C3%25BCtze%26aufirst%3DS.%26aulast%3DNau%26aufirst%3DR.%26atitle%3DPalmitoylethanolamide%2520stimulates%2520phagocytosis%2520of%2520Escherichia%2520coli%2520K1%2520by%2520macrophages%2520and%2520increases%2520the%2520resistance%2520of%2520mice%2520against%2520infections%26jtitle%3DJ.%2520Neuroinflammation%26date%3D2014%26volume%3D11%26spage%3D108%26doi%3D10.1186%2F1742-2094-11-108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rinne, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guillamat-Prats, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rami, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bindila, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ring, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyytikäinen, L. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raitoharju, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oksala, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehtimäki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weber, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der
Vorst, E. P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steffens, S.</span></span> <span> </span><span class="NLM_article-title">Palmitoylethanolamide promotes a proresolving macrophage phenotype and attenuates atherosclerotic plaque formation</span>. <i>Arterioscler., Thromb., Vasc. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">2562</span>– <span class="NLM_lpage">2575</span>, <span class="refDoi"> DOI: 10.1161/ATVBAHA.118.311185</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1161%2FATVBAHA.118.311185" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=30354245" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BC1MXivFaguw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2018&pages=2562-2575&author=P.+Rinneauthor=R.+Guillamat-Pratsauthor=M.+Ramiauthor=L.+Bindilaauthor=L.+Ringauthor=L.+P.+Lyytik%C3%A4inenauthor=E.+Raitoharjuauthor=N.+Oksalaauthor=T.+Lehtim%C3%A4kiauthor=C.+Weberauthor=E.+P.+C.+van+der%0AVorstauthor=S.+Steffens&title=Palmitoylethanolamide+promotes+a+proresolving+macrophage+phenotype+and+attenuates+atherosclerotic+plaque+formation&doi=10.1161%2FATVBAHA.118.311185"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Palmitoylethanolamide Promotes a Proresolving Macrophage Phenotype and Attenuates Atherosclerotic Plaque Formation</span></div><div class="casAuthors">Rinne, Petteri; Guillamat-Prats, Raquel; Rami, Martina; Bindila, Laura; Ring, Larisa; Lyytikaeinen, Leo-Pekka; Raitoharju, Emma; Oksala, Niku; Lehtimaeki, Terho; Weber, Christian; van der Vorst, Emiel P. C.; Steffens, Sabine</div><div class="citationInfo"><span class="NLM_cas:title">Arteriosclerosis, Thrombosis, and Vascular Biology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2562-2575</span>CODEN:
                <span class="NLM_cas:coden">ATVBFA</span>;
        ISSN:<span class="NLM_cas:issn">1079-5642</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">OBJECTIVE-: Palmitoylethanolamide is an endogenous fatty acid mediator that is synthesized from membrane phospholipids by N-acyl phosphatidylethanolamine phospholipase D. Its biol. actions are primarily mediated by PPAR-α (peroxisome proliferator-activated receptors α) and the orphan receptor GPR55.  Palmitoylethanolamide exerts potent anti-inflammatory actions but its physiol. role and promise as a therapeutic agent in chronic arterial inflammation, such as atherosclerosis remain unexplored.  APPROACH AND RESULTS-: First, the polarization of mouse primary macrophages towards a proinflammatory phenotype was found to reduce N-acyl phosphatidylethanolamine phospholipase D expression and palmitoylethanolamide bioavailability.  N-acyl phosphatidylethanolamine phospholipase D expression was progressively downregulated in the aorta of apolipoprotein E deficient (ApoE) mice during atherogenesis.  N-acyl phosphatidylethanolamine phospholipase D mRNA levels were also downregulated in unstable human plaques and they pos. assocd. with smooth muscle cell markers and neg. with macrophage markers.  Second, ApoE mice were fed a high-fat diet for 4 or 16 wk and treated with either vehicle or palmitoylethanolamide (3 mg/kg per day, 4 wk) to study the effects of palmitoylethanolamide on early established and pre-established atherosclerosis.  Palmitoylethanolamide treatment reduced plaque size in early atherosclerosis, whereas in pre-established atherosclerosis, palmitoylethanolamide promoted signs of plaque stability as evidenced by reduced macrophage accumulation and necrotic core size, increased collagen deposition and downregulation of M1-type macrophage markers.  Mechanistically, we found that palmitoylethanolamide, by activating GPR55, increases the expression of the phagocytosis receptor MerTK (proto-oncogene tyrosine-protein kinase MER) and enhances macrophage efferocytosis, indicative of proresolving properties.  CONCLUSIONS-: The present study demonstrates that palmitoylethanolamide protects against atherosclerosis by promoting an anti-inflammatory and proresolving phenotype of lesional macrophages, representing a new therapeutic approach to resolve arterial inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrw4ExKfHrffLVg90H21EOLACvtfcHk0lhPfkxD3YWVeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXivFaguw%253D%253D&md5=ee3f69d727904a9fb6cc724258624e2e</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1161%2FATVBAHA.118.311185&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FATVBAHA.118.311185%26sid%3Dliteratum%253Aachs%26aulast%3DRinne%26aufirst%3DP.%26aulast%3DGuillamat-Prats%26aufirst%3DR.%26aulast%3DRami%26aufirst%3DM.%26aulast%3DBindila%26aufirst%3DL.%26aulast%3DRing%26aufirst%3DL.%26aulast%3DLyytik%25C3%25A4inen%26aufirst%3DL.%2BP.%26aulast%3DRaitoharju%26aufirst%3DE.%26aulast%3DOksala%26aufirst%3DN.%26aulast%3DLehtim%25C3%25A4ki%26aufirst%3DT.%26aulast%3DWeber%26aufirst%3DC.%26aulast%3Dvan%2Bder%2BVorst%26aufirst%3DE.%2BP.%2BC.%26aulast%3DSteffens%26aufirst%3DS.%26atitle%3DPalmitoylethanolamide%2520promotes%2520a%2520proresolving%2520macrophage%2520phenotype%2520and%2520attenuates%2520atherosclerotic%2520plaque%2520formation%26jtitle%3DArterioscler.%252C%2520Thromb.%252C%2520Vasc.%2520Biol.%26date%3D2018%26volume%3D38%26spage%3D2562%26epage%3D2575%26doi%3D10.1161%2FATVBAHA.118.311185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McKinney, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cravatt, B. F.</span></span> <span> </span><span class="NLM_article-title">Structure and function of fatty acid amide hydrolase</span>. <i>Annu. Rev. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>74</i></span>,  <span class="NLM_fpage">411</span>– <span class="NLM_lpage">432</span>, <span class="refDoi"> DOI: 10.1146/annurev.biochem.74.082803.133450</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1146%2Fannurev.biochem.74.082803.133450" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=15952893" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpsVensL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2005&pages=411-432&author=M.+K.+McKinneyauthor=B.+F.+Cravatt&title=Structure+and+function+of+fatty+acid+amide+hydrolase&doi=10.1146%2Fannurev.biochem.74.082803.133450"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Structure and function of fatty acid amide hydrolase</span></div><div class="casAuthors">McKinney, Michele K.; Cravatt, Benjamin F.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Biochemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">411-432</span>CODEN:
                <span class="NLM_cas:coden">ARBOAW</span>;
        ISSN:<span class="NLM_cas:issn">0066-4154</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  Fatty acid amide hydrolase (FAAH) is a mammalian integral membrane enzyme that degrades the fatty acid amide family of endogenous signaling lipids, which includes the endogenous cannabinoid, anandamide, and the sleep-inducing substance, oleamide.  FAAH belongs to a large and diverse class of enzymes referred to as the amidase signature (AS) family.  Investigations into the structure and function of FAAH, in combination with complementary studies of other AS enzymes, have engendered provocative mol. models to explain how this enzyme integrates into cell membranes and terminates fatty acid amide signaling in vivo.  These studies, as well as their biol. and therapeutic implications, are the subject of this review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprO7TpUTr6n7Vg90H21EOLACvtfcHk0ljMghT5yap8SA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpsVensL4%253D&md5=d28b43f14feb6894d48e907064087867</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1146%2Fannurev.biochem.74.082803.133450&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.biochem.74.082803.133450%26sid%3Dliteratum%253Aachs%26aulast%3DMcKinney%26aufirst%3DM.%2BK.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26atitle%3DStructure%2520and%2520function%2520of%2520fatty%2520acid%2520amide%2520hydrolase%26jtitle%3DAnnu.%2520Rev.%2520Biochem.%26date%3D2005%26volume%3D74%26spage%3D411%26epage%3D432%26doi%3D10.1146%2Fannurev.biochem.74.082803.133450" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tuo, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leleu-Chavain, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spencer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sansook, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Millet, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chavatte, P.</span></span> <span> </span><span class="NLM_article-title">Therapeutic potential of fatty acid amide hydrolase, monoacylglycerol lipase, and N-acylethanolamine acid amidase inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">4</span>– <span class="NLM_lpage">46</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00538</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00538" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslWjsLzI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=4-46&author=W.+Tuoauthor=N.+Leleu-Chavainauthor=J.+Spencerauthor=S.+Sansookauthor=R.+Milletauthor=P.+Chavatte&title=Therapeutic+potential+of+fatty+acid+amide+hydrolase%2C+monoacylglycerol+lipase%2C+and+N-acylethanolamine+acid+amidase+inhibitors&doi=10.1021%2Facs.jmedchem.6b00538"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic Potential of Fatty Acid Amide Hydrolase, Monoacylglycerol Lipase, and N-Acylethanolamine Acid Amidase Inhibitors</span></div><div class="casAuthors">Tuo, Wei; Leleu-Chavain, Natascha; Spencer, John; Sansook, Supojjanee; Millet, Regis; Chavatte, Philippe</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">4-46</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Fatty acid ethanolamides (FAEs) and endocannabinoids (ECs) have been shown to alleviate pain and inflammation, regulate motility and appetite, and produce anti-cancer, anxiolytic, and neuroprotective efficacies via cannabinoid receptor type 1 (CB1) or type 2 (CB2), or via peroxisome proliferator-activated receptor α (PPAR-α) stimulation.  FAEs and ECs are synthesized by a series of endogenous enzymes, including N-acylphosphatidylethanolamine-phospholipase D (NAPE-PLD), diacylglycerol lipase (DAGL), or phospholipase C (PLC), and their metab. is mediated by several metabolic enzymes, including fatty acid amide hydrolase (FAAH), monoacylglycerol lipase (MAGL), N-acylethanolamine acid amidase (NAAA), or cyclooxygenase-2 (COX-2).  Over the last decades, increasing the concn. of FAEs and ECs through the inhibition of degrading enzymes has been considered to be a viable therapeutic approach to enhance their anti-nociceptive and anti-inflammatory effects, as well as protecting the nervous system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoamrYPCqYEIbVg90H21EOLACvtfcHk0ljMghT5yap8SA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslWjsLzI&md5=dd509179171644767726a67cb42dd074</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00538&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00538%26sid%3Dliteratum%253Aachs%26aulast%3DTuo%26aufirst%3DW.%26aulast%3DLeleu-Chavain%26aufirst%3DN.%26aulast%3DSpencer%26aufirst%3DJ.%26aulast%3DSansook%26aufirst%3DS.%26aulast%3DMillet%26aufirst%3DR.%26aulast%3DChavatte%26aufirst%3DP.%26atitle%3DTherapeutic%2520potential%2520of%2520fatty%2520acid%2520amide%2520hydrolase%252C%2520monoacylglycerol%2520lipase%252C%2520and%2520N-acylethanolamine%2520acid%2520amidase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D4%26epage%3D46%26doi%3D10.1021%2Facs.jmedchem.6b00538" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ueda, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsuboi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uyama, T.</span></span> <span> </span><span class="NLM_article-title">N-acylethanolamine metabolism with special reference to N-acylethanolamine-hydrolyzing acid amidase (NAAA)</span>. <i>Prog. Lipid Res.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">299</span>– <span class="NLM_lpage">315</span>, <span class="refDoi"> DOI: 10.1016/j.plipres.2010.02.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1016%2Fj.plipres.2010.02.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=20152858" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFWqsLvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2010&pages=299-315&author=N.+Uedaauthor=K.+Tsuboiauthor=T.+Uyama&title=N-acylethanolamine+metabolism+with+special+reference+to+N-acylethanolamine-hydrolyzing+acid+amidase+%28NAAA%29&doi=10.1016%2Fj.plipres.2010.02.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">N-acylethanolamine metabolism with special reference to N-acylethanolamine-hydrolyzing acid amidase (NAAA)</span></div><div class="casAuthors">Ueda, Natsuo; Tsuboi, Kazuhito; Uyama, Toru</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Lipid Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">299-315</span>CODEN:
                <span class="NLM_cas:coden">PLIRDW</span>;
        ISSN:<span class="NLM_cas:issn">0163-7827</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  N-acylethanolamines (NAEs) constitute a class of bioactive lipid mols. present in animal and plant tissues.  Among the NAEs, N-arachidonoylethanolamine (anandamide), N-palmitoylethanolamine, and N-oleoylethanolamine attract much attention due to cannabimimetic activity as an endocannabinoid, anti-inflammatory and analgesic activities, and anorexic activity, resp.  In mammalian tissues, NAEs are formed from glycerophospholipids through the phosphodiesterase-transacylation pathway consisting of Ca2+-dependent N-acyltransferase and N-acylphosphatidylethanolamine-hydrolyzing phospholipase D.  Recent studies revealed the presence of alternative pathways and enzymes responsible for the NAE formation.  As for the degrdn. of NAEs, fatty acid amide hydrolase (FAAH), which hydrolyzes NAEs to fatty acids and ethanolamine, plays a central role.  However, a lysosomal enzyme referred to as NAE-hydrolyzing acid amidase (NAAA) also catalyzes the same reaction and may be a new target for the development of therapeutic drugs.  In this article we discuss recent progress in the studies on the enzymes involved in the biosynthesis and degrdn. of NAEs with special ref. to NAAA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNqB2KZKbKuLVg90H21EOLACvtfcHk0li5Qrrpvn-5NQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFWqsLvK&md5=286dd6b1ccaa5965fb5ca79abcf859af</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.plipres.2010.02.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.plipres.2010.02.003%26sid%3Dliteratum%253Aachs%26aulast%3DUeda%26aufirst%3DN.%26aulast%3DTsuboi%26aufirst%3DK.%26aulast%3DUyama%26aufirst%3DT.%26atitle%3DN-acylethanolamine%2520metabolism%2520with%2520special%2520reference%2520to%2520N-acylethanolamine-hydrolyzing%2520acid%2520amidase%2520%2528NAAA%2529%26jtitle%3DProg.%2520Lipid%2520Res.%26date%3D2010%26volume%3D49%26spage%3D299%26epage%3D315%26doi%3D10.1016%2Fj.plipres.2010.02.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bottemanne, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muccioli, G. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alhouayek, M.</span></span> <span> </span><span class="NLM_article-title">N-acylethanolamine hydrolyzing acid amidase inhibition: tools and potential therapeutic opportunities</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">1520</span>– <span class="NLM_lpage">1529</span>, <span class="refDoi"> DOI: 10.1016/j.drudis.2018.03.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1016%2Fj.drudis.2018.03.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=29567427" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BC1cXmtVWqsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2018&pages=1520-1529&author=P.+Bottemanneauthor=G.+G.+Muccioliauthor=M.+Alhouayek&title=N-acylethanolamine+hydrolyzing+acid+amidase+inhibition%3A+tools+and+potential+therapeutic+opportunities&doi=10.1016%2Fj.drudis.2018.03.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">N-acylethanolamine hydrolyzing acid amidase inhibition: tools and potential therapeutic opportunities</span></div><div class="casAuthors">Bottemanne, Pauline; Muccioli, Giulio G.; Alhouayek, Mireille</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1520-1529</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  N-acylethanolamines (NAEs) (e.g., N-palmitoylethanolamine, N-arachidonoylethanolamine, N-oleoylethanolamine) are bioactive lipids involved in many physiol. processes including pain, inflammation, anxiety, cognition and food intake.  Two enzymes are responsible for the hydrolysis of NAEs and therefore regulate their endogenous levels and effects: fatty acid amide hydrolase (FAAH) and N-acylethanolamine-hydrolyzing acid amidase (NAAA).  As discussed here, extensive biochem. characterization of NAAA was carried out over the years that contributed to a better understanding of NAAA enzymol.  An increasing no. of studies describe the synthesis and pharmacol. characterization of NAAA inhibitors.  Recent medicinal chem. efforts have led to the development of potent and stable inhibitors that enable studying the effects of NAAA inhibition in preclin. disease models, notably in the context of pain and inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowVSQkjk4fCrVg90H21EOLACvtfcHk0li5Qrrpvn-5NQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXmtVWqsL0%253D&md5=01bd76d3543782664bfeccddc47c3be1</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2018.03.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2018.03.007%26sid%3Dliteratum%253Aachs%26aulast%3DBottemanne%26aufirst%3DP.%26aulast%3DMuccioli%26aufirst%3DG.%2BG.%26aulast%3DAlhouayek%26aufirst%3DM.%26atitle%3DN-acylethanolamine%2520hydrolyzing%2520acid%2520amidase%2520inhibition%253A%2520tools%2520and%2520potential%2520therapeutic%2520opportunities%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2018%26volume%3D23%26spage%3D1520%26epage%3D1529%26doi%3D10.1016%2Fj.drudis.2018.03.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bracey, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanson, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masuda, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cravatt, B. F.</span></span> <span> </span><span class="NLM_article-title">Structural adaptations in a membrane enzyme that terminates endocannabinoid signaling</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>298</i></span>,  <span class="NLM_fpage">1793</span>– <span class="NLM_lpage">1796</span>, <span class="refDoi"> DOI: 10.1126/science.1076535</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1126%2Fscience.1076535" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=12459591" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BD38XovFKmsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=298&publication_year=2002&pages=1793-1796&author=M.+H.+Braceyauthor=M.+A.+Hansonauthor=K.+R.+Masudaauthor=R.+C.+Stevensauthor=B.+F.+Cravatt&title=Structural+adaptations+in+a+membrane+enzyme+that+terminates+endocannabinoid+signaling&doi=10.1126%2Fscience.1076535"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Adaptations in a Membrane Enzyme That Terminates Endocannabinoid Signaling</span></div><div class="casAuthors">Bracey, Michael H.; Hanson, Michael A.; Masuda, Kim R.; Stevens, Raymond C.; Cravatt, Benjamin F.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">298</span>
        (<span class="NLM_cas:issue">5599</span>),
    <span class="NLM_cas:pages">1793-1796</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Cellular communication in the nervous system is mediated by chem. messengers that include amino acids, monoamines, peptide hormones, and lipids.  An interesting question is how neurons regulate signals that are transmitted by membrane-embedded lipids.  Here, we report the 2.8 angstrom crystal structure of the integral membrane protein fatty acid amide hydrolase (FAAH), an enzyme that degrades members of the endocannabinoid class of signaling lipids and terminates their activity.  The structure of FAAH complexed with an arachidonyl inhibitor reveals how a set of discrete structural alterations allows this enzyme, in contrast to sol. hydrolases of the same family, to integrate into cell membranes and establish direct access to the bilayer from its active site.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTj6G-8THMiLVg90H21EOLACvtfcHk0li5Qrrpvn-5NQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XovFKmsLs%253D&md5=01545bfbd00f31af713db259f41cb0ba</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1126%2Fscience.1076535&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1076535%26sid%3Dliteratum%253Aachs%26aulast%3DBracey%26aufirst%3DM.%2BH.%26aulast%3DHanson%26aufirst%3DM.%2BA.%26aulast%3DMasuda%26aufirst%3DK.%2BR.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26atitle%3DStructural%2520adaptations%2520in%2520a%2520membrane%2520enzyme%2520that%2520terminates%2520endocannabinoid%2520signaling%26jtitle%3DScience%26date%3D2002%26volume%3D298%26spage%3D1793%26epage%3D1796%26doi%3D10.1126%2Fscience.1076535" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gorelik, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gebai, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Illes, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piomelli, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagar, B.</span></span> <span> </span><span class="NLM_article-title">Molecular mechanism of activation of the immunoregulatory amidase NAAA</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>115</i></span>,  <span class="NLM_fpage">E10032</span>– <span class="NLM_lpage">E10040</span>, <span class="refDoi"> DOI: 10.1073/pnas.1811759115</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1073%2Fpnas.1811759115" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=30301806" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitVyhsLvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2018&pages=E10032-E10040&author=A.+Gorelikauthor=A.+Gebaiauthor=K.+Illesauthor=D.+Piomelliauthor=B.+Nagar&title=Molecular+mechanism+of+activation+of+the+immunoregulatory+amidase+NAAA&doi=10.1073%2Fpnas.1811759115"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular mechanism of activation of the immunoregulatory amidase NAAA</span></div><div class="casAuthors">Gorelik, Alexei; Gebai, Ahmad; Illes, Katalin; Piomelli, Daniele; Nagar, Bhushan</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue">43</span>),
    <span class="NLM_cas:pages">E10032-E10040</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Palmitoylethanolamide is a bioactive lipid that strongly alleviates pain and inflammation in animal models and in humans.  Its signaling activity is terminated through degrdn. by N-acylethanolamine acid amidase (NAAA), a cysteine hydrolase expressed at high levels in immune cells.  Pharmacol. inhibitors of NAAA activity exert profound analgesic and antiinflammatory effects in rodent models, pointing to this protein as a potential target for therapeutic drug discovery.  To facilitate these efforts and to better understand the mol. mechanism of action of NAAA, we detd. crystal structures of this enzyme in various activation states and in complex with several ligands, including both a covalent and a reversible inhibitor.  Self-proteolysis exposes the otherwise buried active site of NAAA to allow catalysis.  Formation of a stable substrate- or inhibitor-binding site appears to be conformationally coupled to the interaction of a pair of hydrophobic helixes in the enzyme with lipid membranes, resulting in the creation of a linear hydrophobic cavity near the active site that accommodates the liganda's acyl chain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpe4SyudaY7MrVg90H21EOLACvtfcHk0lh_m8bPHqk4PQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitVyhsLvP&md5=9debd68d3239a82bd60849c9cf98e8ae</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1811759115&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1811759115%26sid%3Dliteratum%253Aachs%26aulast%3DGorelik%26aufirst%3DA.%26aulast%3DGebai%26aufirst%3DA.%26aulast%3DIlles%26aufirst%3DK.%26aulast%3DPiomelli%26aufirst%3DD.%26aulast%3DNagar%26aufirst%3DB.%26atitle%3DMolecular%2520mechanism%2520of%2520activation%2520of%2520the%2520immunoregulatory%2520amidase%2520NAAA%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2018%26volume%3D115%26spage%3DE10032%26epage%3DE10040%26doi%3D10.1073%2Fpnas.1811759115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">The
UniProt Consortium.</span> <span> </span><span class="NLM_article-title">UniProt:
a worldwide hub of protein knowledge</span>. <i>Nucleic
Acids Res.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">D506</span>– <span class="NLM_lpage">D515</span>, <span class="refDoi"> DOI: 10.1093/nar/gky1049</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1093%2Fnar%2Fgky1049" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=30395287" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2019&pages=D506-D515&author=The%0AUniProt+Consortium.&title=UniProt%3A%0Aa+worldwide+hub+of+protein+knowledge&doi=10.1093%2Fnar%2Fgky1049"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgky1049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgky1049%26sid%3Dliteratum%253Aachs%26aulast%3D%26atitle%3DUniProt%253A%250Aa%2520worldwide%2520hub%2520of%2520protein%2520knowledge%26jtitle%3DNucleic%250AAcids%2520Res.%26date%3D2019%26volume%3D47%26spage%3DD506%26epage%3DD515%26doi%3D10.1093%2Fnar%2Fgky1049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Désarnaud, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cadas, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piomelli, D.</span></span> <span> </span><span class="NLM_article-title">Anandamide amidohydrolase activity in rat brain microsomes. Identification and partial characterization</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>270</i></span>,  <span class="NLM_fpage">6030</span>– <span class="NLM_lpage">6035</span>, <span class="refDoi"> DOI: 10.1074/jbc.270.11.6030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1074%2Fjbc.270.11.6030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=7890734" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADyaK2MXksVCntLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=270&publication_year=1995&pages=6030-6035&author=F.+D%C3%A9sarnaudauthor=H.+Cadasauthor=D.+Piomelli&title=Anandamide+amidohydrolase+activity+in+rat+brain+microsomes.+Identification+and+partial+characterization&doi=10.1074%2Fjbc.270.11.6030"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Anandamide amidohydrolase activity in rat brain microsomes. Identification and partial characterization</span></div><div class="casAuthors">Desarnaud, Franck; Cadas, Hugues; Piomelli, Daniele</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">270</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">6030-5</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">An amidohydrolase activity present in rat brain microsomes was found to catalyze the hydrolysis of [3H]anadamide (N-arachidonoyl-[3H]ethanolamine), an endogenous cannabimimetic substance, forming [3H]ethanolamine and arachidonic acid.  Anadamide amidohydrolase (I) was maximal at pH 6 and 8, was independent od divalent cations, had an apparent Km for [3H]anandamide of 12.7 μM, and had a Vmax of 5630 pmol/min/mg protein.  Phenylmethylsulfonyl fluoride, a serine protease inhibitor, and p-bromophenacyl bromide, a histidine-alkylating reagent, inhibited I, whereas N-ethylmaleimide and various nonselective peptidase inhibitors (EDTA, o-phenanthroline, bacitracin) had no effect.  Brain I exhibited high substrate specificity for [3H]anandamide; N-γ-linolenoyl-, N-homo-γ-linolenoyl-, and N-11,14-eicosadienoyl-[3H]ethanolamine were hydrolyzed at markedly slower rates.  Moreover, N-11-eicosaenoyl- and N-palmitoyl-[3H]ethanolamine were not hydrolyzed.  [3H]anandamide hydrolysis was inhibited competitively by nonradioactive anandamide and by other N-acylethanolamines with the following rank order of potency: anandamide > N-linoleoyl- = N-cis-linolenoyl- = N-γ-linolenoyl- = N-homo-γ-linolenoyl- > N-11,14-eicosadienoyl- > N-oleoyl- > N docosahexaenoyl- > N-docosatetraenoyl > N-linoelaidoyl- > N-eicosaenoyl- > N-palmitoyl ≥ N-elaidoyl- = N-eicosanoyl-ethanolamine = no effect.  I activity is high in liver and brain and low in heart, kidney, intestine, stomach, lung, spleen, and skeletal muscle.  Within the central nervous system, the highest I activity was found in the globus pallidus and hippocampus, 2 regions rich in cannabinoid receptors, and the lowest activity was found in the brainstem and medulla, where cannabinoid receptors were sparse.  The results, showing that brain I is selective for anandamide and enriched in areas of the central nervous system with a high d. of cannabinoid receptors, suggested that this activity may participate in the inactivation of anandamide at its sites of action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLvCJ97zLAKrVg90H21EOLACvtfcHk0lh_m8bPHqk4PQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXksVCntLk%253D&md5=11d7f2b17b5212d22ff1ca6854d244b5</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1074%2Fjbc.270.11.6030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.270.11.6030%26sid%3Dliteratum%253Aachs%26aulast%3DD%25C3%25A9sarnaud%26aufirst%3DF.%26aulast%3DCadas%26aufirst%3DH.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DAnandamide%2520amidohydrolase%2520activity%2520in%2520rat%2520brain%2520microsomes.%2520Identification%2520and%2520partial%2520characterization%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1995%26volume%3D270%26spage%3D6030%26epage%3D6035%26doi%3D10.1074%2Fjbc.270.11.6030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ueda, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurahashi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tokunaga, T.</span></span> <span> </span><span class="NLM_article-title">Partial purification and characterization of the porcine brain enzyme hydrolyzing and synthesizing anandamide</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>270</i></span>,  <span class="NLM_fpage">23823</span>– <span class="NLM_lpage">23827</span>, <span class="refDoi"> DOI: 10.1074/jbc.270.40.23823</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1074%2Fjbc.270.40.23823" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=7559559" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADyaK2MXos1ehtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=270&publication_year=1995&pages=23823-23827&author=N.+Uedaauthor=Y.+Kurahashiauthor=S.+Yamamotoauthor=T.+Tokunaga&title=Partial+purification+and+characterization+of+the+porcine+brain+enzyme+hydrolyzing+and+synthesizing+anandamide&doi=10.1074%2Fjbc.270.40.23823"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Partial purification and characterization of the porcine brain enzyme hydrolyzing and synthesizing anandamide</span></div><div class="casAuthors">Ueda, Natsuo; Kurahashi, Yuko; Yamamoto, Shozo; Tokunaga, Takashi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">270</span>
        (<span class="NLM_cas:issue">40</span>),
    <span class="NLM_cas:pages">23823-7</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Anandamide (arachidonylethanolamide) is known as an endogenous agonist for cannabinoid receptors.  An amidohydrolase, which hydrolyzed anandamide, was solubilized from the microsomal fraction of porcine brain with 1% Triton X-100.  The enzyme was partially purified by Phenyl-5PW hydrophobic chromatog. to a specific activity of approx. 0.37 μmol/min/mg of protein at 37°.  As assayed with 14C-labeled substrates, the apparent Km value for anandamide was 60 μM, and anandamide was more active than ethanolamides of linoleic, oleic, and palmitic acids.  Ceramidase and protease activities were not detected in the enzyme prepn.  The purified enzyme also synthesized anandamide from free arachidonic acid in the presence of a high concn. of ethanolamine with a specific activity of about 0.16 μmol/min/mg of protein at 37°.  On the basis of cochromatogs., pH dependence, heat inactivation, and effects of inhibitors such as arachidonyl trifluoromethyl ketone, p-chloromercuribenzoic acid, diisopropyl fluorophosphate, and phenylmethylsulfonyl fluoride, it was suggest that the anandamide amidohydrolase and synthase activities were attributable to a single enzyme protein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqoXrN1E9aUHbVg90H21EOLACvtfcHk0lgjplP7txTXzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXos1ehtr4%253D&md5=078dd0d9c568d2cad70feb7b0f606621</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1074%2Fjbc.270.40.23823&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.270.40.23823%26sid%3Dliteratum%253Aachs%26aulast%3DUeda%26aufirst%3DN.%26aulast%3DKurahashi%26aufirst%3DY.%26aulast%3DYamamoto%26aufirst%3DS.%26aulast%3DTokunaga%26aufirst%3DT.%26atitle%3DPartial%2520purification%2520and%2520characterization%2520of%2520the%2520porcine%2520brain%2520enzyme%2520hydrolyzing%2520and%2520synthesizing%2520anandamide%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1995%26volume%3D270%26spage%3D23823%26epage%3D23827%26doi%3D10.1074%2Fjbc.270.40.23823" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hillard, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilkison, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edgemond, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, W. B.</span></span> <span> </span><span class="NLM_article-title">Characterization of the kinetics and distribution of N-arachidonylethanolamine (anandamide) hydrolysis by rat brain</span>. <i>Biochim. Biophys. Acta, Lipids Lipid Metab.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>1257</i></span>,  <span class="NLM_fpage">249</span>– <span class="NLM_lpage">256</span>, <span class="refDoi"> DOI: 10.1016/0005-2760(95)00087-S</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1016%2F0005-2760%2895%2900087-S" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=7647100" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADyaK2MXntl2jtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1257&publication_year=1995&pages=249-256&author=C.+J.+Hillardauthor=D.+M.+Wilkisonauthor=W.+S.+Edgemondauthor=W.+B.+Campbell&title=Characterization+of+the+kinetics+and+distribution+of+N-arachidonylethanolamine+%28anandamide%29+hydrolysis+by+rat+brain&doi=10.1016%2F0005-2760%2895%2900087-S"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of the kinetics and distribution of N-arachidonylethanolamine (anandamide) hydrolysis by rat brain</span></div><div class="casAuthors">Hillard, Cecilia J.; Wilkison, Douglas M.; Edgemond, William S.; Campbell, William B.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Lipids and Lipid Metabolism</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">1257</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">249-56</span>CODEN:
                <span class="NLM_cas:coden">BBLLA6</span>;
        ISSN:<span class="NLM_cas:issn">0925-4439</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Arachidonoylethanolamide or anandamide is a naturally occurring deriv. of arachidonic acid that has been shown to activate cannabinoid receptors in the brain.  Its metabolic inactivation by brain tissue has been investigated.  Anandamide is hydrolyzed by the membrane fraction of rat brain homogenate to arachidonic acid and ethanolamine.  The hydrolysis is temp.- and pH-dependent (pH max. at 8.5) and abolished by boiling.  Anandamide hydrolysis is protein dependent in the range of 25-100 μg protein/mL; does not require calcium and is inhibited by phenylmethylsulfonylfluoride, diisopropylfluorophosphate, thimerosal and arachidonic acid.  Hydrolysis of 10 μM anandamide by brain membranes follows first order kinetics; at 30°, the rate const. for anandamide catabolism is 0.34 min-1 mg protein-1.  The Km for anandamide hydrolysis is 3.4 μM, and the Vmax is 2.2 nmol/min per mg protein.  Hydrolysis occurs in all subcellular fractions except cytosol with the highest specific activity in myelin and microsomes.  The distribution of anandamide hydrolytic activity correlates with the distribution of cannabinoid receptor-binding sites; the hippocampus, cerebellum and cerebral cortex exhibit the highest metabolic activity, while activity is lowest in the striatum, brain stem and white matter.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_wuU3uI6dDLVg90H21EOLACvtfcHk0lgjplP7txTXzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXntl2jtbo%253D&md5=94968f21405527d140e7c51ee6b265db</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2F0005-2760%2895%2900087-S&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0005-2760%252895%252900087-S%26sid%3Dliteratum%253Aachs%26aulast%3DHillard%26aufirst%3DC.%2BJ.%26aulast%3DWilkison%26aufirst%3DD.%2BM.%26aulast%3DEdgemond%26aufirst%3DW.%2BS.%26aulast%3DCampbell%26aufirst%3DW.%2BB.%26atitle%3DCharacterization%2520of%2520the%2520kinetics%2520and%2520distribution%2520of%2520N-arachidonylethanolamine%2520%2528anandamide%2529%2520hydrolysis%2520by%2520rat%2520brain%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Lipids%2520Lipid%2520Metab.%26date%3D1995%26volume%3D1257%26spage%3D249%26epage%3D256%26doi%3D10.1016%2F0005-2760%2895%2900087-S" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schmid, H. H. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmid, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Natarajan, V.</span></span> <span> </span><span class="NLM_article-title">N-Acylated glycerophospholipids and their derivatives</span>. <i>Prog. Lipid Res.</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">43</span>, <span class="refDoi"> DOI: 10.1016/0163-7827(90)90004-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1016%2F0163-7827%2890%2990004-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=2087478" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADyaK3MXisVartLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=1990&pages=1-43&author=H.+H.+O.+Schmidauthor=P.+C.+Schmidauthor=V.+Natarajan&title=N-Acylated+glycerophospholipids+and+their+derivatives&doi=10.1016%2F0163-7827%2890%2990004-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">N-acylated glycerophospholipids and their derivatives</span></div><div class="casAuthors">Schmid, Harald H. O.; Schmid, Patricia C.; Natarajan, V.</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Lipid Research</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-43</span>CODEN:
                <span class="NLM_cas:coden">PLIRDW</span>;
        ISSN:<span class="NLM_cas:issn">0163-7827</span>.
    </div><div class="casAbstract">A review with 204 refs.  A crit. evaluation of current knowledge on N-acylated glycerophospholipids and their derivs. is presented.  Topics include isolation, characterization, occurrence, metab., and pharmacol. effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzU_AOgZGQirVg90H21EOLACvtfcHk0lgcgZ9eSQqd4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXisVartLc%253D&md5=ef0b207cb169b9c103dae883d44b7101</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2F0163-7827%2890%2990004-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0163-7827%252890%252990004-5%26sid%3Dliteratum%253Aachs%26aulast%3DSchmid%26aufirst%3DH.%2BH.%2BO.%26aulast%3DSchmid%26aufirst%3DP.%2BC.%26aulast%3DNatarajan%26aufirst%3DV.%26atitle%3DN-Acylated%2520glycerophospholipids%2520and%2520their%2520derivatives%26jtitle%3DProg.%2520Lipid%2520Res.%26date%3D1990%26volume%3D29%26spage%3D1%26epage%3D43%26doi%3D10.1016%2F0163-7827%2890%2990004-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ueda, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamanaka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terasawa, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, S.</span></span> <span> </span><span class="NLM_article-title">An acid amidase hydrolyzing anandamide as an endogenous ligand for cannabinoid receptors</span>. <i>FEBS Lett.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>454</i></span>,  <span class="NLM_fpage">267</span>– <span class="NLM_lpage">270</span>, <span class="refDoi"> DOI: 10.1016/S0014-5793(99)00820-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1016%2FS0014-5793%2899%2900820-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10431820" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADyaK1MXks1Omu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=454&publication_year=1999&pages=267-270&author=N.+Uedaauthor=K.+Yamanakaauthor=Y.+Terasawaauthor=S.+Yamamoto&title=An+acid+amidase+hydrolyzing+anandamide+as+an+endogenous+ligand+for+cannabinoid+receptors&doi=10.1016%2FS0014-5793%2899%2900820-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">An acid amidase hydrolyzing anandamide as an endogenous ligand for cannabinoid receptors</span></div><div class="casAuthors">Ueda, Natsuo; Yamanaka, Kenji; Terasawa, Yuka; Yamamoto, Shozo</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Letters</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">454</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">267-270</span>CODEN:
                <span class="NLM_cas:coden">FEBLAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-5793</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">Anandamide loses its cannabimimetic activities upon hydrolysis to arachidonic acid and ethanolamine.  Thus far, the anandamide-hydrolyzing activity widely distributed in mammalian organs has been attributed exclusively to an enzyme referred to as anandamide amidohydrolase with an optimum pH of ∼9.  Here, the authors report another enzyme hydrolyzing anandamide in a human megakaryoblastic cell line (CMK).  The enzyme present in the 12,000 g pellet of the cell homogenate was solubilized by freeze-thaw.  The solubilized enzyme showed an optimal pH at ∼5, and was almost inactive at alk. pH.  The enzyme activity was increased by the addn. of dithiothreitol.  In contrast, anandamide amidohydrolase of RBL-1 cells was mostly insol. even after freeze-thaw, showed an optimal pH at 9, and was not affected by dithiothreitol.  Furthermore, the enzyme of CMK cells was much less sensitive to phenylmethylsulfonyl fluoride and Me arachidonoyl fluorophosphonate potently inhibiting anandamide amidohydrolase, and effectively hydrolyzed palmitoylethanolamide, which was a poor substrate for anandamide amidohydrolase.  Thus, the enzyme of CMK cells is distinguishable from anandamide amidohydrolase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPfb7SP8dL4rVg90H21EOLACvtfcHk0lgcgZ9eSQqd4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXks1Omu7k%253D&md5=36898e76a4091383e536cd3d9b31f191</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2FS0014-5793%2899%2900820-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-5793%252899%252900820-0%26sid%3Dliteratum%253Aachs%26aulast%3DUeda%26aufirst%3DN.%26aulast%3DYamanaka%26aufirst%3DK.%26aulast%3DTerasawa%26aufirst%3DY.%26aulast%3DYamamoto%26aufirst%3DS.%26atitle%3DAn%2520acid%2520amidase%2520hydrolyzing%2520anandamide%2520as%2520an%2520endogenous%2520ligand%2520for%2520cannabinoid%2520receptors%26jtitle%3DFEBS%2520Lett.%26date%3D1999%26volume%3D454%26spage%3D267%26epage%3D270%26doi%3D10.1016%2FS0014-5793%2899%2900820-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kuehl, F. A.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacob, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganley, O. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ormond, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meisinger, M. A. P.</span></span> <span> </span><span class="NLM_article-title">The identification of N-(2-hydroxyethyl)-palmitamide as a naturally occurring anti-inflammatory agent</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1957</span>,  <span class="NLM_volume"><i>79</i></span>,  <span class="NLM_fpage">5577</span>– <span class="NLM_lpage">5578</span>, <span class="refDoi"> DOI: 10.1021/ja01577a066</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja01577a066" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADyaG1cXht1CqtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=1957&pages=5577-5578&author=F.+A.+Kuehlauthor=T.+A.+Jacobauthor=O.+H.+Ganleyauthor=R.+E.+Ormondauthor=M.+A.+P.+Meisinger&title=The+identification+of+N-%282-hydroxyethyl%29-palmitamide+as+a+naturally+occurring+anti-inflammatory+agent&doi=10.1021%2Fja01577a066"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of N-(2-hydroxyethyl)palmitamide as a naturally occurring anti-inflammatory agent</span></div><div class="casAuthors">Kuehl, F. A., Jr.; Jacob, T. A.; Ganley, O. H.; Ormond, R. E.; Meisinger, M. A. P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1957</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">5577-8</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    </div><div class="casAbstract">A cryst. anti-inflammatory factor (I), m. 98-9°, C18H37O2N, was isolated from soybean lecithin, a phospholipide fraction of egg yolk, and from hexane-extd. peanut meal.  I was identified as the title compd.  The basic moiety is responsible for its anti-inflammatory activity; the nature of the acid group is of no consequence.  O-Acetylethanolamine, choline, N-dimethylaminoethanol, and N-methylaminoethanol all had the same order of activity; glycine, serine, sarcosine, and betaine were inactive.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2gELizzTClbVg90H21EOLACvtfcHk0lgcgZ9eSQqd4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaG1cXht1CqtA%253D%253D&md5=cdfea2a962576ec1c2081021c9a4267f</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fja01577a066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja01577a066%26sid%3Dliteratum%253Aachs%26aulast%3DKuehl%26aufirst%3DF.%2BA.%26aulast%3DJacob%26aufirst%3DT.%2BA.%26aulast%3DGanley%26aufirst%3DO.%2BH.%26aulast%3DOrmond%26aufirst%3DR.%2BE.%26aulast%3DMeisinger%26aufirst%3DM.%2BA.%2BP.%26atitle%3DThe%2520identification%2520of%2520N-%25282-hydroxyethyl%2529-palmitamide%2520as%2520a%2520naturally%2520occurring%2520anti-inflammatory%2520agent%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1957%26volume%3D79%26spage%3D5577%26epage%3D5578%26doi%3D10.1021%2Fja01577a066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ganley, O. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, H. J.</span></span> <span> </span><span class="NLM_article-title">Antianaphylactic and antiserotonin activity of a compound obtained from egg yolk, peanut oil and soybean lecithin</span>. <i>J. Allergy</i> <span class="NLM_year" style="font-weight: bold;">1959</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">415</span>– <span class="NLM_lpage">419</span>, <span class="refDoi"> DOI: 10.1016/0021-8707(59)90019-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1016%2F0021-8707%2859%2990019-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=13826312" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADyaG1MXhtFCltr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=1959&pages=415-419&author=O.+H.+Ganleyauthor=H.+J.+Robinson&title=Antianaphylactic+and+antiserotonin+activity+of+a+compound+obtained+from+egg+yolk%2C+peanut+oil+and+soybean+lecithin&doi=10.1016%2F0021-8707%2859%2990019-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Antianaphylactic and antiserotonin activity of a compound obtained from egg yolk, peanut oil, and soybean lecithin</span></div><div class="casAuthors">Ganley, Oswald H.; Robinson, Harry J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Allergy</span>
        (<span class="NLM_cas:date">1959</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">415-19</span>CODEN:
                <span class="NLM_cas:coden">JOALAS</span>;
        ISSN:<span class="NLM_cas:issn">0021-8707</span>.
    </div><div class="casAbstract">Effect of N-(2-hydroxyethyl)palmitamide, ethanolamine-HCl, and a variety of fatty acids on passive anaphylaxis, serotonin, and histamine toxicity in the mouse were studied.  All compds. suppressed anaphylaxis and serotonin toxicity at low concns. but had no effect on histamine toxicity.  Data indicate that fatty acids can act as potent pharmacologic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_f0Afg_5aFrVg90H21EOLACvtfcHk0ljuAFss3gQSvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaG1MXhtFCltr0%253D&md5=48ce6bb5f728c60c180c61ceb68c75a2</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2F0021-8707%2859%2990019-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0021-8707%252859%252990019-X%26sid%3Dliteratum%253Aachs%26aulast%3DGanley%26aufirst%3DO.%2BH.%26aulast%3DRobinson%26aufirst%3DH.%2BJ.%26atitle%3DAntianaphylactic%2520and%2520antiserotonin%2520activity%2520of%2520a%2520compound%2520obtained%2520from%2520egg%2520yolk%252C%2520peanut%2520oil%2520and%2520soybean%2520lecithin%26jtitle%3DJ.%2520Allergy%26date%3D1959%26volume%3D30%26spage%3D415%26epage%3D419%26doi%3D10.1016%2F0021-8707%2859%2990019-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mašek, K.</span>; <span class="NLM_string-name">Raskova, H.</span></span> <span> </span><span class="NLM_article-title">Pharmacology of Palmitoylethanolamide</span>. In  <i>Drugs of Animal Origin</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leonardi, A.</span>, <span class="NLM_string-name">Walsh, J.</span></span>, Eds.; <span class="NLM_publisher-name">Ferro Edizioni</span>: <span class="NLM_publisher-loc">Milan, Italy</span>, <span class="NLM_year">1967</span>; pp  <span class="NLM_fpage">199</span>– <span class="NLM_lpage">209</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1967&pages=199-209&author=K.+Ma%C5%A1ek&author=H.+Raskovaauthor=A.+Leonardi&author=J.+Walsh&title=Drugs+of+Animal+Origin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DMa%25C5%25A1ek%26aufirst%3DK.%26atitle%3DPharmacology%2520of%2520Palmitoylethanolamide%26btitle%3DDrugs%2520of%2520Animal%2520Origin%26aulast%3DLeonardi%26aufirst%3DA.%26pub%3DFerro%2520Edizioni%26date%3D1967%26spage%3D199%26epage%3D209" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Benvenuti, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lattanzi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Gori, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarli, P.</span></span> <span> </span><span class="NLM_article-title">Activity of some derivatives of palmitoylethanolamide on carragenine-induced edema in the rat paw</span>. <i>Boll. Soc. Ital. Biol. Sper.</i> <span class="NLM_year" style="font-weight: bold;">1968</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">809</span>– <span class="NLM_lpage">813</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=5699335" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADyaF1cXkvVGhsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=1968&pages=809-813&author=F.+Benvenutiauthor=F.+Lattanziauthor=A.+De+Goriauthor=P.+Tarli&title=Activity+of+some+derivatives+of+palmitoylethanolamide+on+carragenine-induced+edema+in+the+rat+paw"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of some palmitoyl ethanolamide derivatives on carrageenin-induced rat paw edema</span></div><div class="casAuthors">Benvenuti, F.; Lattanzi, F.; De Gori, A.; Tarli, P.</div><div class="citationInfo"><span class="NLM_cas:title">Bollettino - Societa Italiana di Biologia Sperimentale</span>
        (<span class="NLM_cas:date">1968</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">809-13</span>CODEN:
                <span class="NLM_cas:coden">BSIBAC</span>;
        ISSN:<span class="NLM_cas:issn">0037-8771</span>.
    </div><div class="casAbstract">The effects of i.p. injected palmitoyl ethanolamide, stearoyl ethanolamide, lauroyl ethanolamide, palmitoyl N-methylethanolamide, palmitoyl propanolamide, and palmitoyl isopropanolamide (25-200 mg./kg.) on carrageenin-induced rat paw edema were compared to those of the standard, indomethacin (5-10 mg./kg.).  None of the compds. tested was more active than indomethacin.  However, 5 of the test compds. were generally more active than palmitoyl ethanolamide at 25-mg./kg. dose levels, while at higher doses the 6 test compds. were comparable in activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4_vRjqecY77Vg90H21EOLACvtfcHk0ljuAFss3gQSvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF1cXkvVGhsbk%253D&md5=6822f378fa383767969dd67bf3c0d294</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBenvenuti%26aufirst%3DF.%26aulast%3DLattanzi%26aufirst%3DF.%26aulast%3DDe%2BGori%26aufirst%3DA.%26aulast%3DTarli%26aufirst%3DP.%26atitle%3DActivity%2520of%2520some%2520derivatives%2520of%2520palmitoylethanolamide%2520on%2520carragenine-induced%2520edema%2520in%2520the%2520rat%2520paw%26jtitle%3DBoll.%2520Soc.%2520Ital.%2520Biol.%2520Sper.%26date%3D1968%26volume%3D44%26spage%3D809%26epage%3D813" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Perlík, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rasková, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elis, J.</span></span> <span> </span><span class="NLM_article-title">Anti-inflammatory properties of N-(2-hydroxyethyl) palmitamide</span>. <i>Acta Physiol. Acad. Sci. Hung.</i> <span class="NLM_year" style="font-weight: bold;">1971</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">395</span>– <span class="NLM_lpage">400</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=5119194" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADyaE38XlsVCitg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1971&pages=395-400&author=F.+Perl%C3%ADkauthor=H.+Raskov%C3%A1author=J.+Elis&title=Anti-inflammatory+properties+of+N-%282-hydroxyethyl%29+palmitamide"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Antiinflammatory properties of N-(2-hydroxyethyl)palmitamide</span></div><div class="casAuthors">Perlik, F.; Elis, J.; Raskova, Henena</div><div class="citationInfo"><span class="NLM_cas:title">Acta Physiologica Academiae Scientiarum Hungaricae</span>
        (<span class="NLM_cas:date">1971</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">395-400</span>CODEN:
                <span class="NLM_cas:coden">APACAB</span>;
        ISSN:<span class="NLM_cas:issn">0001-6756</span>.
    </div><div class="casAbstract">N-(2-hydroxyethyl)palmitamide (I) [544-31-0] (50 mg/kg/day, orally) had no effect on the primary lesions of adjuvant induced arthritis in rats, but decreased the secondary lesions when administered daily over a 6 week period.  I decreased the induration of the tuberculin reaction in guinea pigs.  I had no relieving effect on serotonin induced edema in the rat.  This data suggests that I acts on delayed hypersensitivity and(or) in the subsequent processes which introduce arthritis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4BmmXOPIk4rVg90H21EOLACvtfcHk0ljuAFss3gQSvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE38XlsVCitg%253D%253D&md5=9e81bd505e497181464407939a2b5e6a</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPerl%25C3%25ADk%26aufirst%3DF.%26aulast%3DRaskov%25C3%25A1%26aufirst%3DH.%26aulast%3DElis%26aufirst%3DJ.%26atitle%3DAnti-inflammatory%2520properties%2520of%2520N-%25282-hydroxyethyl%2529%2520palmitamide%26jtitle%3DActa%2520Physiol.%2520Acad.%2520Sci.%2520Hung.%26date%3D1971%26volume%3D39%26spage%3D395%26epage%3D400" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Perlík, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krejcí, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elis, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pekárek, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Svejcar, J.</span></span> <span> </span><span class="NLM_article-title">The effect of N-(2-hydroxyethyl)-palmitamide on delayed hypersensitivity in guinea-pig</span>. <i>Experientia</i> <span class="NLM_year" style="font-weight: bold;">1973</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">67</span>– <span class="NLM_lpage">68</span>, <span class="refDoi"> DOI: 10.1007/BF01913256</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1007%2FBF01913256" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=4729458" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADyaE3sXnvFygsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=1973&pages=67-68&author=F.+Perl%C3%ADkauthor=J.+Krejc%C3%ADauthor=J.+Elisauthor=J.+Pek%C3%A1rekauthor=J.+Svejcar&title=The+effect+of+N-%282-hydroxyethyl%29-palmitamide+on+delayed+hypersensitivity+in+guinea-pig&doi=10.1007%2FBF01913256"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of N-(2-hydroxyethyl)palmitamide on delayed hypersensitivity in guinea pig</span></div><div class="casAuthors">Perlik, F.; Krejci, J.; Elis, J.; Pekarek, J.; Svejcar, J.</div><div class="citationInfo"><span class="NLM_cas:title">Experientia</span>
        (<span class="NLM_cas:date">1973</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">67-8</span>CODEN:
                <span class="NLM_cas:coden">EXPEAM</span>;
        ISSN:<span class="NLM_cas:issn">0014-4754</span>.
    </div><div class="casAbstract">N-(2-hydroxyethyl)palmitamide [544-31-0] administered prior to sensitization of guinea pigs to tuberculin purified protein deriv. increased the erythema, diam., and induration values 24 hr after inoculation as well as increasing the inhibition of macrophage migration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonuU4sUyo7YbVg90H21EOLACvtfcHk0li36zvNu38Lyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE3sXnvFygsA%253D%253D&md5=199df7530c58258bed270ee4da8fed73</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1007%2FBF01913256&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF01913256%26sid%3Dliteratum%253Aachs%26aulast%3DPerl%25C3%25ADk%26aufirst%3DF.%26aulast%3DKrejc%25C3%25AD%26aufirst%3DJ.%26aulast%3DElis%26aufirst%3DJ.%26aulast%3DPek%25C3%25A1rek%26aufirst%3DJ.%26aulast%3DSvejcar%26aufirst%3DJ.%26atitle%3DThe%2520effect%2520of%2520N-%25282-hydroxyethyl%2529-palmitamide%2520on%2520delayed%2520hypersensitivity%2520in%2520guinea-pig%26jtitle%3DExperientia%26date%3D1973%26volume%3D29%26spage%3D67%26epage%3D68%26doi%3D10.1007%2FBF01913256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Masek, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perlík, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klíma, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kahlich, R.</span></span> <span> </span><span class="NLM_article-title">Prophylactic efficacy of N-2-hydroxyethyl palmitamide (impulsin) in acute respiratory tract infections</span>. <i>Eur. J. Clin. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1974</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">415</span>– <span class="NLM_lpage">419</span>, <span class="refDoi"> DOI: 10.1007/BF00560353</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1007%2FBF00560353" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=4439865" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADyaE2MXhsV2nu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1974&pages=415-419&author=K.+Masekauthor=F.+Perl%C3%ADkauthor=J.+Kl%C3%ADmaauthor=R.+Kahlich&title=Prophylactic+efficacy+of+N-2-hydroxyethyl+palmitamide+%28impulsin%29+in+acute+respiratory+tract+infections&doi=10.1007%2FBF00560353"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Prophylactic efficacy of N-2-Hydroxyethylpalmitamide (Impulsin) in acute respiratory tract infections</span></div><div class="casAuthors">Masek, K.; Perlik, F.; Klima, J.; Kahlich, R.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">1974</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">415-19</span>CODEN:
                <span class="NLM_cas:coden">EJCPAS</span>;
        ISSN:<span class="NLM_cas:issn">0031-6970</span>.
    </div><div class="casAbstract">Repeated daily intake of Impulsin [544-31-0] (30 mg/kg) by volunteers prevented virus infections of the respiratory tract.  The Impulsin treatment decreased the no. of episodes of fever, headache, and sore throat, while catarrhal symptoms were much less affected.  The administration of Impulsin had no effect on the mean duration of disability and fever, which suggests that the severity of the diseases was not affected.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGriLqxhy_o8frVg90H21EOLACvtfcHk0li36zvNu38Lyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2MXhsV2nu7s%253D&md5=775758357abb648315cde2b5a104692c</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1007%2FBF00560353&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00560353%26sid%3Dliteratum%253Aachs%26aulast%3DMasek%26aufirst%3DK.%26aulast%3DPerl%25C3%25ADk%26aufirst%3DF.%26aulast%3DKl%25C3%25ADma%26aufirst%3DJ.%26aulast%3DKahlich%26aufirst%3DR.%26atitle%3DProphylactic%2520efficacy%2520of%2520N-2-hydroxyethyl%2520palmitamide%2520%2528impulsin%2529%2520in%2520acute%2520respiratory%2520tract%2520infections%26jtitle%3DEur.%2520J.%2520Clin.%2520Pharmacol.%26date%3D1974%26volume%3D7%26spage%3D415%26epage%3D419%26doi%3D10.1007%2FBF00560353" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kahlich, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klíma, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cihla, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franková, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mašek, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosický, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matousek, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruthans, J.</span></span> <span> </span><span class="NLM_article-title">Studies on prophylactic efficacy of N-2-hydroxyethyl palmitamide (Impulsin) in acute respiratory infections. Serologically controlled field trials</span>. <i>J. Hyg. Epidemiol. Microbiol. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">1979</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">11</span>– <span class="NLM_lpage">24</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=392005" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A280%3ADyaL3c%252FpsFCitQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1979&pages=11-24&author=R.+Kahlichauthor=J.+Kl%C3%ADmaauthor=F.+Cihlaauthor=V.+Frankov%C3%A1author=K.+Ma%C5%A1ekauthor=M.+Rosick%C3%BDauthor=F.+Matousekauthor=J.+Bruthans&title=Studies+on+prophylactic+efficacy+of+N-2-hydroxyethyl+palmitamide+%28Impulsin%29+in+acute+respiratory+infections.+Serologically+controlled+field+trials"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Studies on prophylactic efficacy of N-2-hydroxyethyl palmitamide (Impulsin) in acute respiratory infections. Serologically controlled field trials</span></div><div class="casAuthors">Kahlich R; Klima J; Cihla F; Frankova V; Masek K; Rosicky M; Matousek F; Bruthans J</div><div class="citationInfo"><span class="NLM_cas:title">Journal of hygiene, epidemiology, microbiology, and immunology</span>
        (<span class="NLM_cas:date">1979</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">11-24</span>
        ISSN:<span class="NLM_cas:issn">0022-1732</span>.
    </div><div class="casAbstract">The results of three serologically controlled double blind field trials in army units are presented.  The evaluation of results according to morbidity, regardless of aetiology, showed a significant reduction in acute respiratory diseases (ARD) after administration of Impulsin.  In the 1973 trial (901 volunteers), 22.7% of ARD cases were found in the Impulsin group contrary to 34.4% in the placebo group (P less than 0.0002).  The relevant values in the 1974 trial (610 volunteers) were 19.7% and 40.7% (P less than 0.002) and in the 1975 trial (353 volunteers) 10.6% and 28.8% (P less than 0.004).  The study of the immunological background in representative sets of volunteers allowed determination of the aetiology, the proportion of asymptomatic infections and possible deformation of results due to preexisting protective antibodies.  Manifestation rate (MR) expressing the proportion of sick persons out of all sensitive subjects with serologically proved infection was found useful.  This indicator is relatively independent of randomization and is more sensitive as compared to the incidence rate.  In the 1973 trial, influenza A 2 England was prevalent, the MR of infection being 15.4% in the Impulsin group and 44.9% in the placebo group (P less than 0.0002).  After elimination of persons with preinfection antibodies greater than or equal to 1:256 the corresponding values of MR were 17.6% and 46.6% (P less than 0.005), reflecting the "relatively clean effect" of Impulsin.  In the 1974 trial, where influenza B Hong-Kong was prevalent, MR was 14.3% and 57.1%, respectively (P less than 0.001).  Preinfection antibodies were negligible.  The preliminary prophylactic index of the drug seemed to be 4.3 for combined adenoviral infections (trials 1973 and 1974 taken together).  In the 1975 trial, the results of serological examination were unsatisfactory.  Antibodies vs. influenza A Port Chalmers were found in 24.5% of ARD only.  The differnce is aetiologically unclarified ARD was statistically significant.  Although displaying a significant limitation of clinical infections, the administration of Impulsin did not seem to have any influence on the formation of antibodies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQbEh2wDUuI3IvKgEt20y1XfW6udTcc2eaKXO230Q1MGLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL3c%252FpsFCitQ%253D%253D&md5=0c35acf08419ac5f90615a25de1d73a5</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKahlich%26aufirst%3DR.%26aulast%3DKl%25C3%25ADma%26aufirst%3DJ.%26aulast%3DCihla%26aufirst%3DF.%26aulast%3DFrankov%25C3%25A1%26aufirst%3DV.%26aulast%3DMa%25C5%25A1ek%26aufirst%3DK.%26aulast%3DRosick%25C3%25BD%26aufirst%3DM.%26aulast%3DMatousek%26aufirst%3DF.%26aulast%3DBruthans%26aufirst%3DJ.%26atitle%3DStudies%2520on%2520prophylactic%2520efficacy%2520of%2520N-2-hydroxyethyl%2520palmitamide%2520%2528Impulsin%2529%2520in%2520acute%2520respiratory%2520infections.%2520Serologically%2520controlled%2520field%2520trials%26jtitle%3DJ.%2520Hyg.%2520Epidemiol.%2520Microbiol.%2520Immunol.%26date%3D1979%26volume%3D23%26spage%3D11%26epage%3D24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aloe, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leon, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levi-Montalcini, R.</span></span> <span> </span><span class="NLM_article-title">A proposed autacoid mechanism controlling mastocyte behaviour</span>. <i>Agents Actions</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">145</span>– <span class="NLM_lpage">147</span>, <span class="refDoi"> DOI: 10.1007/BF01972748</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1007%2FBF01972748" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADyaK3sXms1yrtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1993&pages=145-147&author=L.+Aloeauthor=A.+Leonauthor=R.+Levi-Montalcini&title=A+proposed+autacoid+mechanism+controlling+mastocyte+behaviour&doi=10.1007%2FBF01972748"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">A proposed autacoid mechanism controlling mastocyte behavior</span></div><div class="casAuthors">Aloe, Luigi; Leon, Alberta; Levi-Montalcini, Rita</div><div class="citationInfo"><span class="NLM_cas:title">Agents and Actions</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">Spec. Conf. Issue</span>),
    <span class="NLM_cas:pages">C145-C147</span>CODEN:
                <span class="NLM_cas:coden">AGACBH</span>;
        ISSN:<span class="NLM_cas:issn">0065-4299</span>.
    </div><div class="casAbstract">Evidence is provided here supporting the existence of a novel autacoid mechanism neg. modulating mast cell behavior in response to noxious stimuli in vivo; hence, the denomination "autacoid local inflammation antagonism" (ALIA).  In particular, as lipid amides of the N-acylethanolamine type have been reported to accumulate in tissues in degenerative inflammatory conditions, the authors examd. whether these N-acylated lipids could exert regulatory effects on mast cell activation in vivo.  The results reported show that both long- and short-chain N-acylethanolamines, when systemically administered, are effective in reducing mast cell degranulation induced by local injection of substance P in the ear pinna of developing rats.  These and other data suggest that the endogenous prodn. of N-acylethanolamines may constitute a local autocrine/paracrine response for the neg. feedback control of mast cell responses to various activating signals.  Such a process may be of physico-pathol. relevance in the regulation of functional neuro-immune-mast cell interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGov0bUjp51F-LVg90H21EOLACvtfcHk0lhFeH3P4ZJFWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXms1yrtbc%253D&md5=0e1d3d3032d382ae5ca5c8e848e6bfd6</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1007%2FBF01972748&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF01972748%26sid%3Dliteratum%253Aachs%26aulast%3DAloe%26aufirst%3DL.%26aulast%3DLeon%26aufirst%3DA.%26aulast%3DLevi-Montalcini%26aufirst%3DR.%26atitle%3DA%2520proposed%2520autacoid%2520mechanism%2520controlling%2520mastocyte%2520behaviour%26jtitle%3DAgents%2520Actions%26date%3D1993%26volume%3D39%26spage%3D145%26epage%3D147%26doi%3D10.1007%2FBF01972748" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mazzari, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canella, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petrelli, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marcolongo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leon, A.</span></span> <span> </span><span class="NLM_article-title">N-(2-hydroxyethyl)hexadecanamide is orally active in reducing edema formation and inflammatory hyperalgesia by down-modulating mast cell activation</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>300</i></span>,  <span class="NLM_fpage">227</span>– <span class="NLM_lpage">236</span>, <span class="refDoi"> DOI: 10.1016/0014-2999(96)00015-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1016%2F0014-2999%2896%2900015-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=8739213" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADyaK28XjtFaqtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=300&publication_year=1996&pages=227-236&author=S.+Mazzariauthor=R.+Canellaauthor=L.+Petrelliauthor=G.+Marcolongoauthor=A.+Leon&title=N-%282-hydroxyethyl%29hexadecanamide+is+orally+active+in+reducing+edema+formation+and+inflammatory+hyperalgesia+by+down-modulating+mast+cell+activation&doi=10.1016%2F0014-2999%2896%2900015-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">N-(2-Hydroxyethyl)hexadecanamide is orally active in reducing edema formation and inflammatory hyperalgesia by down-modulating mast cell activation</span></div><div class="casAuthors">Mazzari, Silvio; Canella, Roberto; Petrelli, Lucia; Marcolongo, Gabriele; Leon, Alberta</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">300</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">227-236</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Mast cells play a key role in inflammatory reactions triggered by tissue injury or immune perturbations.  Little is known about endogenous mols. and mechanisms capable of modulating inappropriate mast cell activity.  N-(2-Hydroxyethyl)hexadecanamide (palmitoylethanolamide), found in peripheral tissues, has been proposed to act as a local autacoid capable of neg. regulating mast cell activation and inflammation - hence the acronym Autacoid Local Inflammation Antagonism (ALIA).  Recently, N-(2-hydroxyethyl)hexadecanamide (LG 2110/1) has been reported to down-modulate mast cell activation in vitro by behaving as an agonist at the peripheral cannabinoid CB2 receptor.  Here, we have characterized and functionally correlated the anti-inflammatory actions of LG 2110/1 with its ability to control mast cell activation, when given orally in a battery of rodent models of inflammation.  LG 2110/1 diminished, in a dose-dependent and correlated manner, the no. of degranulated mast cells and plasma extravasation induced by substance P injection in the mouse ear pinna.  In addn., LG 2110/1 reduced dose dependently plasma extravasation induced by passive cutaneous anaphylaxis reaction.  In adult rats LG 2110/1 decreased, in a dose-dependent manner, carrageenan-induced hindpaw edema and hyperalgesia, but not phospholipase A2-induced hindpaw edema.  Further, anti-edema effects were obsd. when utilizing dextran and formalin, known to also cause mast cell activation.  Locally administered LG 2110/1 was likewise effective in minimizing dextran-induced hind paw edema.  In contrast, equiv. amts. of palmitic acid plus ethanolamine were ineffective against plasma extravasation provoked by substance P. LG 2110/1 did not decrease plasma extravasation induced by the substance P fragment, substance P-(6-11), known to be inactive on mast cells.  These results indicate that orally administered N-(2-hydroxyethyl)hexadecanamide is effective in: (a) directly down-modulating mast cell activation in vivo; (b) suppressing pathol. consequences initiated by mast cell activation independently of the activating stimuli; (c) exerting an anti-inflammatory action distinguishable from that of classical steroidal and non-steroidal anti-inflammatory agents.  These findings raise the possibility that N-(2-hydroxyethyl)hexadecanamide and related satd. N-acylamides ('ALIAmides') represent novel therapeutic agents useful in the management of inflammatory disease conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowutxAAnhmebVg90H21EOLACvtfcHk0lj2krfKtbv6ag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XjtFaqtLw%253D&md5=7d89119c70577cf2f80aaea93e43e439</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2F0014-2999%2896%2900015-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-2999%252896%252900015-5%26sid%3Dliteratum%253Aachs%26aulast%3DMazzari%26aufirst%3DS.%26aulast%3DCanella%26aufirst%3DR.%26aulast%3DPetrelli%26aufirst%3DL.%26aulast%3DMarcolongo%26aufirst%3DG.%26aulast%3DLeon%26aufirst%3DA.%26atitle%3DN-%25282-hydroxyethyl%2529hexadecanamide%2520is%2520orally%2520active%2520in%2520reducing%2520edema%2520formation%2520and%2520inflammatory%2520hyperalgesia%2520by%2520down-modulating%2520mast%2520cell%2520activation%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1996%26volume%3D300%26spage%3D227%26epage%3D236%26doi%3D10.1016%2F0014-2999%2896%2900015-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Berdyshev, E. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boichot, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Germain, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allain, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anger, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lagente, V.</span></span> <span> </span><span class="NLM_article-title">Influence of fatty acid ethanolamides and Δ<sup>9</sup>-tetrahydrocannabinol on cytokine and arachidonate release by mononuclear cells</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>330</i></span>,  <span class="NLM_fpage">231</span>– <span class="NLM_lpage">240</span>, <span class="refDoi"> DOI: 10.1016/S0014-2999(97)01007-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1016%2FS0014-2999%2897%2901007-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=9253958" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADyaK2sXkt1Shtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=330&publication_year=1997&pages=231-240&author=E.+V.+Berdyshevauthor=E.+Boichotauthor=N.+Germainauthor=N.+Allainauthor=J.+P.+Angerauthor=V.+Lagente&title=Influence+of+fatty+acid+ethanolamides+and+%CE%949-tetrahydrocannabinol+on+cytokine+and+arachidonate+release+by+mononuclear+cells&doi=10.1016%2FS0014-2999%2897%2901007-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Influence of fatty acid ethanolamides and Δ9-tetrahydrocannabinol on cytokine and arachidonate release by mononuclear cells</span></div><div class="casAuthors">Berdyshev, Evguenii V.; Boichot, Elisabeth; Germain, Noeella; Allain, Nathalie; Anger, Jean-Pierre; Lagente, Vincent</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">330</span>
        (<span class="NLM_cas:issue">2/3</span>),
    <span class="NLM_cas:pages">231-240</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The effects of arachidonic acid ethanolamide (anandamide), palmitoylethanolamide, and Δ9-tetrahydrocannabinol on the prodn. of tumor necrosis factor-α (TNF-α), interleukin-4, interleukin-6, interleukin-8, interleukin-10, interferon-γ, p55 and p75 TNF-α sol. receptors by stimulated human peripheral blood mononuclear cells as well as [3H]arachidonic acid release by non-stimulated and N-formyl-Met-Leu-Phe (fMLP)-stimulated human monocytes were investigated.  Anandamide was shown to diminish interleukin-6 and interleukin-8 prodn. at low nanomolar concns. (3-30 nM) but inhibited the prodn. of TNF-α, interferon-γ, interleukin-4 and p75 TNF-α sol. receptors at higher concns. (0.3-3 μM).  Palmitoylethanolamide inhibited interleukin-4, interleukin-6, interleukin-8 synthesis and the prodn. of p75 TNF-α sol. receptors at concns. similar to those of anandamide but failed to influence TNF-α and interferon-γ prodn.  The effect of both compds. on interleukin-6 and interleukin-8 prodn. disappeared with an increase in the concn. used.  Neither anandamide nor palmitoylethanolamide influenced interleukin-10 synthesis. Δ9-Tetrahydrocannabinol exerted a biphasic action on pro-inflammatory cytokine prodn.  TNF-α, interleukin-6 and interleukin-8 synthesis was maximally inhibited by 3 nM Δ9-tetrahydrocannabinol but stimulated by 3 μM Δ9-tetrahydrocannabinol, as was interleukin-8 and interferon-γ synthesis.  The level of interleukin-4, interleukin-10 and p75 TNF-α sol. receptors was diminished by 3 μM Δ9-tetrahydrocannabinol. [3H]Arachidonate release was stimulated only by high Δ9-tetrahydrocannabinol and anandamide concns. (30 μM).  These results suggest that the inhibitory properties of anandamide, palmitoylethanolamide and Δ9-tetrahydrocannabinol are detd. by the activation of the peripheral-type cannabinoid receptors, and that various endogenous fatty acid ethanolamides may participate in the regulation of the immune response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_UZuEJzA2brVg90H21EOLACvtfcHk0lj2krfKtbv6ag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXkt1Shtrc%253D&md5=bc34a1f528f0ff967bbac0865b7c640d</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2FS0014-2999%2897%2901007-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-2999%252897%252901007-8%26sid%3Dliteratum%253Aachs%26aulast%3DBerdyshev%26aufirst%3DE.%2BV.%26aulast%3DBoichot%26aufirst%3DE.%26aulast%3DGermain%26aufirst%3DN.%26aulast%3DAllain%26aufirst%3DN.%26aulast%3DAnger%26aufirst%3DJ.%2BP.%26aulast%3DLagente%26aufirst%3DV.%26atitle%3DInfluence%2520of%2520fatty%2520acid%2520ethanolamides%2520and%2520%25CE%25949-tetrahydrocannabinol%2520on%2520cytokine%2520and%2520arachidonate%2520release%2520by%2520mononuclear%2520cells%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1997%26volume%3D330%26spage%3D231%26epage%3D240%26doi%3D10.1016%2FS0014-2999%2897%2901007-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ross, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brockie, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pertwee, R. G.</span></span> <span> </span><span class="NLM_article-title">Inhibition of nitric oxide production in RAW264.7 macrophages by cannabinoids and palmitoylethanolamide</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>401</i></span>,  <span class="NLM_fpage">121</span>– <span class="NLM_lpage">130</span>, <span class="refDoi"> DOI: 10.1016/S0014-2999(00)00437-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1016%2FS0014-2999%2800%2900437-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10924916" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BD3cXlt1Kntrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=401&publication_year=2000&pages=121-130&author=R.+A.+Rossauthor=H.+C.+Brockieauthor=R.+G.+Pertwee&title=Inhibition+of+nitric+oxide+production+in+RAW264.7+macrophages+by+cannabinoids+and+palmitoylethanolamide&doi=10.1016%2FS0014-2999%2800%2900437-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of nitric oxide production in RAW264.7 macrophages by cannabinoids and palmitoylethanolamide</span></div><div class="casAuthors">Ross, R. A.; Brockie, H. C.; Pertwee, R. G.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">401</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">121-130</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">We have investigated the inhibition of lipopolysaccharide-stimulated nitric oxide prodn. in RAW264.7 macrophages by the cannabinoids and the putative cannabinoid CB2-like receptor ligand, palmitoylethanolamide.  (R)-(+)-[2,3-dihydro-5-methyl-3-(4-morpholinylmethyl)pyrrolo-[1,2,3-de]-1,4-benzoxazin-6-yl]-1-naphthalenylmethanone mesylate ((+)-WIN55212) and, to a lesser extent (-)-cis-3-[2-hydroxy-4-(1,1-dimethylheptyl)phenyl]-trans-4-(3-hydroxy-propyl)cyclohexan-1-ol (CP55940), significantly inhibited lipopolysaccharide stimulated nitric oxide prodn.  The level of inhibition was dependent on the concn. of lipopolysaccharide used to induce nitric oxide prodn.  Palmitoylethanolamide significantly inhibited nitric oxide prodn. induced by lipopolysaccharide.  The inhibition of nitric oxide prodn. by (+)-WIN55212 but not palmitoylethanolamide was significantly attenuated in the presence of the cannabinoid CB2 receptor antagonist, N-[(1S)-endo-1,3,3-trimethyl bicyclo [2.2.1] heptan-2-yl]-5-(4-chloro-3-methylphenyl)-1-(4-methylbenzyl)-pyrazole-3-carboxamide (SR144528).  (+)-WIN55212 produced a pertussis toxin-sensitive parallel rightward shift in the log concn.-response curve for lipopolysaccharide, causing a fivefold increase in the EC50 value for lipopolysaccharide with no change in the Emax value.  (-)-WIN55212 had no effect on the log concn.-response curve for lipopolysaccharide.  Palmitoylethanolamide did not produce a rightward shift in the lipopolysaccharide concn.-response curve.  However, it did produce a pertussis toxin-insensitive redn. in the Emax value.  The results suggest that the inhibition of lipopolysaccharide mediated nitric oxide release by (+)-WIN55212 in murine macrophages is mediated by cannabinoid CB2 receptors.  In contrast, the inhibition by palmitoylethanolamide does not appear to be mediated by cannabinoid receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqX1RWs6xTlCbVg90H21EOLACvtfcHk0lj2krfKtbv6ag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXlt1Kntrg%253D&md5=4c37657f6218f6770b1798d6a8290f72</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2FS0014-2999%2800%2900437-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-2999%252800%252900437-4%26sid%3Dliteratum%253Aachs%26aulast%3DRoss%26aufirst%3DR.%2BA.%26aulast%3DBrockie%26aufirst%3DH.%2BC.%26aulast%3DPertwee%26aufirst%3DR.%2BG.%26atitle%3DInhibition%2520of%2520nitric%2520oxide%2520production%2520in%2520RAW264.7%2520macrophages%2520by%2520cannabinoids%2520and%2520palmitoylethanolamide%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2000%26volume%3D401%26spage%3D121%26epage%3D130%26doi%3D10.1016%2FS0014-2999%2800%2900437-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Farquhar-Smith, W. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rice, A. S.</span></span> <span> </span><span class="NLM_article-title">A novel neuroimmune mechanism in cannabinoid-mediated attenuation of nerve growth factor-induced hyperalgesia</span>. <i>Anesthesiology</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>99</i></span>,  <span class="NLM_fpage">1391</span>– <span class="NLM_lpage">1401</span>, <span class="refDoi"> DOI: 10.1097/00000542-200312000-00024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1097%2F00000542-200312000-00024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=14639155" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A280%3ADC%252BD3srls1Crug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2003&pages=1391-1401&author=W.+P.+Farquhar-Smithauthor=A.+S.+Rice&title=A+novel+neuroimmune+mechanism+in+cannabinoid-mediated+attenuation+of+nerve+growth+factor-induced+hyperalgesia&doi=10.1097%2F00000542-200312000-00024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">A novel neuroimmune mechanism in cannabinoid-mediated attenuation of nerve growth factor-induced hyperalgesia</span></div><div class="casAuthors">Farquhar-Smith W Paul; Rice Andrew S C</div><div class="citationInfo"><span class="NLM_cas:title">Anesthesiology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1391-401</span>
        ISSN:<span class="NLM_cas:issn">0003-3022</span>.
    </div><div class="casAbstract">BACKGROUND:  Nerve growth factor (NGF) is central to processes involved in an inflammatory hyperalgesia.  Administration of exogenous NGF induces a hyperalgesia that is dependent on local neutrophil influx.  The effects of administration of the cannabinoid anandamide and the cannabimimetic palmitoylethanolamide on an NGF-induced hyperalgesia and neutrophil accumulation were examined in this study.  METHODS:  Baseline hind limb withdrawal latencies to a noxious heat stimulus were recorded before intraplantar administration of NGF (1 microg in 0.05 ml) to the hind paw of 75 male Wistar rats.  Anandamide or palmitoylethanolamide (a substance that has cannabinoid-like actions but little affinity for cannabinoid receptors) at doses of 10 and 25 mg/kg were given (intraperitoneally) immediately after NGF.  CB1 (SR141716A) and CB2 (SR144528) receptor antagonists were coadministered with the higher dose of cannabinoids.  Withdrawal latencies were expressed as difference from baseline.  Seventy rats received intraplantar NGF and intraperitoneal treatments.  Neutrophil accumulation in the injected paw was assessed using a myeloperoxidase assay.  RESULTS:  Administration of NGF reduced latencies consistent with hyperalgesia.  Anandamide and palmitoylethanolamide significantly reduced this hyperalgesia.  The action of anandamide was CB1 receptor-mediated.  SR144528 abrogated the action of palmitoylethanolamide.  NGF also provoked neutrophil accumulation in the injected paw, denoted by an increase in myeloperoxidase.  Palmitoylethanolamide significantly reduced neutrophil accumulation by an SR144528-sensitive action, whereas anandamide was without effect.  CONCLUSIONS:  NGF induced a thermal hyperalgesia that was attenuated by anandamide and palmitoylethanolamide.  Only palmitoylethanolamide reduced neutrophil influx.  Thus, cannabinoids show a neuronal CB1 receptor-mediated antihyperalgesic action and a separate inhibition of a proinflammatory neuroimmune process.  Such a mechanism suggests a therapeutic site of analgesic action separable from central side effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT8e1UQPwC1_bP3FVUi_gf8fW6udTcc2eYj4tom9vYNQLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3srls1Crug%253D%253D&md5=b8f811a899b7bcc807b270f50d30cd83</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1097%2F00000542-200312000-00024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00000542-200312000-00024%26sid%3Dliteratum%253Aachs%26aulast%3DFarquhar-Smith%26aufirst%3DW.%2BP.%26aulast%3DRice%26aufirst%3DA.%2BS.%26atitle%3DA%2520novel%2520neuroimmune%2520mechanism%2520in%2520cannabinoid-mediated%2520attenuation%2520of%2520nerve%2520growth%2520factor-induced%2520hyperalgesia%26jtitle%3DAnesthesiology%26date%3D2003%26volume%3D99%26spage%3D1391%26epage%3D1401%26doi%3D10.1097%2F00000542-200312000-00024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Skaper, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buriani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dal Toso, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petrelli, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romanello, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Facci, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leon, A.</span></span> <span> </span><span class="NLM_article-title">The ALIAmide palmitoylethanolamide and cannabinoids, but not anandamide, are protective in a delayed postglutamate paradigm of excitotoxic death in cerebellar granule neurons</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>93</i></span>,  <span class="NLM_fpage">3984</span>– <span class="NLM_lpage">3989</span>, <span class="refDoi"> DOI: 10.1073/pnas.93.9.3984</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1073%2Fpnas.93.9.3984" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=8633002" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADyaK28XivVKrtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=1996&pages=3984-3989&author=S.+D.+Skaperauthor=A.+Burianiauthor=R.+Dal+Tosoauthor=L.+Petrelliauthor=S.+Romanelloauthor=L.+Facciauthor=A.+Leon&title=The+ALIAmide+palmitoylethanolamide+and+cannabinoids%2C+but+not+anandamide%2C+are+protective+in+a+delayed+postglutamate+paradigm+of+excitotoxic+death+in+cerebellar+granule+neurons&doi=10.1073%2Fpnas.93.9.3984"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">The ALIAmide palmitoylethanolamide and cannabinoids, but not anandamide, are protective in a delayed postglutamate paradigm of excitotoxic death in cerebellar granule neurons</span></div><div class="casAuthors">Skaper, S. D.; Buriani, A.; Toso, R. Dal; Petrelli, L.; Romanello, S.; Facci, L.; Leon, A.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">93</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3984-3989</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The amino acid L-glutamate is a neurotransmitter that mediates fast neuronal excitation in a majority of synapses in the central nervous system.  Glutamate stimulates both N-methyl-D-aspartate (NMDA) and non-NMDA receptors.  While activation of NMDA receptors has been implicated in a variety of neurophysiol. processes, excessive NMDA receptor stimulation (excitotoxicity) is thought to be primarily responsible for neuronal injury in a wide variety of acute neurol. disorders including hypoxia-ischemia, seizures, and trauma.  Very little is known about endogenous mols. and mechanisms capable of modulating excitotoxic neuronal death.  Satd. N-acylethanolamides like palmitoylethanolamide accumulate in ischemic tissues and are synthesized by neurons upon excitatory amino acid receptor activation.  Here the authors report that palmitoylethanolamide, but not the cognate N-acylamide anandamide (the ethanolamide of arachidonic acid), protects cultured mouse cerebellar granule cells against glutamate toxicity in a delayed postagonist paradigm.  Palmitoylethanolamide reduced this injury in a concn.-dependent manner and was maximally effective when added 15-min postglutamate.  Cannabinoids, which like palmitoylethanolamide are functionally active at the peripheral cannabinoid receptor CB2 on mast cells, also prevented neuron loss in this delayed postglutamate model.  Furthermore, the neuroprotective effects of palmitoylethanolamide, as well as that of the active cannabinoids, were efficiently antagonized by the candidate central cannabinoid receptor (CB1) agonist anandamide.  Analogous pharmacol. behaviors have been obsd. for palmitoylethanolamide (ALIAmides) in downmodulating mast cell activation.  Cerebellar granule cells expressed mRNA for CB1 and CB2 by in situ hybridization, while two cannabinoid binding sites were detected in cerebellar membranes.  The results suggest that (i) non-CB1 cannabinoid receptors control, upon agonist binding, the downstream consequences of an excitotoxic stimulus; (ii) palmitoylethanolamide, unlike anandamide, behaves as an endogenous agonist for CB2-like receptors on granule cells; and (iii) activation of such receptors may serve to downmodulate deleterious cellular processes following pathol. events or noxious stimuli in both the nervous and immune systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdi_p_hdKA6bVg90H21EOLACvtfcHk0ljgQnWc4cIyJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XivVKrtbw%253D&md5=6dc2c77bba12ec7a2fc9d4c18ec202a4</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1073%2Fpnas.93.9.3984&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.93.9.3984%26sid%3Dliteratum%253Aachs%26aulast%3DSkaper%26aufirst%3DS.%2BD.%26aulast%3DBuriani%26aufirst%3DA.%26aulast%3DDal%2BToso%26aufirst%3DR.%26aulast%3DPetrelli%26aufirst%3DL.%26aulast%3DRomanello%26aufirst%3DS.%26aulast%3DFacci%26aufirst%3DL.%26aulast%3DLeon%26aufirst%3DA.%26atitle%3DThe%2520ALIAmide%2520palmitoylethanolamide%2520and%2520cannabinoids%252C%2520but%2520not%2520anandamide%252C%2520are%2520protective%2520in%2520a%2520delayed%2520postglutamate%2520paradigm%2520of%2520excitotoxic%2520death%2520in%2520cerebellar%2520granule%2520neurons%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1996%26volume%3D93%26spage%3D3984%26epage%3D3989%26doi%3D10.1073%2Fpnas.93.9.3984" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Calignano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La Rana, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giuffrida, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piomelli, D.</span></span> <span> </span><span class="NLM_article-title">Control of pain initiation by endogenous cannabinoids</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>394</i></span>,  <span class="NLM_fpage">277</span>– <span class="NLM_lpage">281</span>, <span class="refDoi"> DOI: 10.1038/28393</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1038%2F28393" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=9685157" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADyaK1cXkvVKjt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=394&publication_year=1998&pages=277-281&author=A.+Calignanoauthor=G.+La+Ranaauthor=A.+Giuffridaauthor=D.+Piomelli&title=Control+of+pain+initiation+by+endogenous+cannabinoids&doi=10.1038%2F28393"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Control of pain initiation by endogenous cannabinoids</span></div><div class="casAuthors">Calignano, Antonio; La Rana, Giovanna; Giuffrida, Andrea; Piomelli, Daniele</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">394</span>
        (<span class="NLM_cas:issue">6690</span>),
    <span class="NLM_cas:pages">277-281</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">The potent analgesic effects of cannabis-like drugs and the presence of CB1-type cannabinoid receptors in pain-processing areas of the brain and spinal cord indicate that endogenous cannabinoids such as anandamide may contribute to the control of pain transmission within the central nervous system (CNS).  Here the authors show that anandamide attenuates the pain behavior produced by chem. damage to cutaneous tissue by interacting with CB1-like cannabinoid receptors located outside the CNS.  Palmitylethanolamide (PEA), which is released together with anandamide from a common phospholipid precursor, exerts a similar effect by activating peripheral CB2-like receptors.  When administered together, the two compds. at synergistically reducing pain responses 100-fold more potently than does each compd. alone.  Gas-chromatog./mass-spectrometry measurements indicate that the levels of anandamide and PEA in the skin are enough to cause a tonic activation of local cannabinoid receptors.  In agreement with this possibility, the CB1 antagonist SR141716A and the CB2 antagonist SR144528 prolong and enhance the pain behavior produced by tissue damage.  These results indicate that peripheral CB1-like and CB2-like receptors participate in the intrinsic control of pain initiation and that locally generated anandamide and PEA may mediate this effect.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpKwHMI3BI9LVg90H21EOLACvtfcHk0ljgQnWc4cIyJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXkvVKjt7w%253D&md5=811026d275d0cba5c01567bdebe16ec8</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1038%2F28393&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F28393%26sid%3Dliteratum%253Aachs%26aulast%3DCalignano%26aufirst%3DA.%26aulast%3DLa%2BRana%26aufirst%3DG.%26aulast%3DGiuffrida%26aufirst%3DA.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DControl%2520of%2520pain%2520initiation%2520by%2520endogenous%2520cannabinoids%26jtitle%3DNature%26date%3D1998%26volume%3D394%26spage%3D277%26epage%3D281%26doi%3D10.1038%2F28393" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Calignano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La Rana, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piomelli, D.</span></span> <span> </span><span class="NLM_article-title">Antinociceptive activity of the endogenous fatty acid amide, palmitylethanolamide</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>419</i></span>,  <span class="NLM_fpage">191</span>– <span class="NLM_lpage">198</span>, <span class="refDoi"> DOI: 10.1016/S0014-2999(01)00988-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1016%2FS0014-2999%2801%2900988-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=11426841" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BD3MXksFCkt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=419&publication_year=2001&pages=191-198&author=A.+Calignanoauthor=G.+La+Ranaauthor=D.+Piomelli&title=Antinociceptive+activity+of+the+endogenous+fatty+acid+amide%2C+palmitylethanolamide&doi=10.1016%2FS0014-2999%2801%2900988-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Antinociceptive activity of the endogenous fatty acid amide, palmitylethanolamide</span></div><div class="casAuthors">Calignano, Antonio; La Rana, Giovanna; Piomelli, Daniele</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">419</span>
        (<span class="NLM_cas:issue">2/3</span>),
    <span class="NLM_cas:pages">191-198</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">The endogenous fatty acid ethanolamide, palmitylethanolamide, alleviated, in a dose-dependent manner, pain behaviors elicited in mice by injections of formalin (5%, intraplantar), acetic acid (0.6%, 0.5 mL per animal, i.p., i.p.), kaolin (2.5 mg per animal, i.p.), and magnesium sulfate (120 mg per kg, i.p.).  The antinociceptive effects of palmitylethanolamide were prevented by the cannabinoid CB2 receptor antagonist SR144528 [N-([1s]-endo-1.3.3-trimethylbicyclo[2.3.1]heptan-2-yl)-5-(4-chloro-3-methylphenyl)-1-(4-methylbenzyl)-pyrazole-3-carboxamide], not by the cannabinoid CB1 receptor antagonist SR141716A [N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide · HCl].  By contrast, palmitylethanolamide had no effect on capsaicin-evoked pain behavior or thermal nociception.  The endogenous cannabinoid, anandamide (arachidonylethanolamide), alleviated nociception in all tests (formalin, acetic acid, kaolin, magnesium sulfate, capsaicin and hot plate).  These effects were prevented by the cannabinoid CB1 receptor antagonist SR141716A, not the cannabinoid CB2 receptor antagonist SR141716A.  Addnl. fatty acid ethanolamides (oleylethanolamide, myristylethanolamide, palmitoleylethanolamide, palmitelaidylethanolamide) had little or no effect on formalin-evoked pain behavior, and were not investigated in other pain models.  These results support the hypothesis that endogenous palmitylethanolamide participates in the intrinsic control of pain initiation.  They also suggest that the putative receptor site activated by palmitylethanolamide may provide a novel target for peripherally acting analgesic drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqn_q63Lj2cLrVg90H21EOLACvtfcHk0lgWBqy8cJpMtQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXksFCkt78%253D&md5=cff02a881cea2e84d5ae7812ea7cffbc</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2FS0014-2999%2801%2900988-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-2999%252801%252900988-8%26sid%3Dliteratum%253Aachs%26aulast%3DCalignano%26aufirst%3DA.%26aulast%3DLa%2BRana%26aufirst%3DG.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DAntinociceptive%2520activity%2520of%2520the%2520endogenous%2520fatty%2520acid%2520amide%252C%2520palmitylethanolamide%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2001%26volume%3D419%26spage%3D191%26epage%3D198%26doi%3D10.1016%2FS0014-2999%2801%2900988-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pontis, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ribeiro, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sasso, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piomelli, D.</span></span> <span> </span><span class="NLM_article-title">Macrophage-derived lipid agonists of PPAR-α as intrinsic controllers of inflammation</span>. <i>Crit. Rev. Biochem. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">7</span>– <span class="NLM_lpage">14</span>, <span class="refDoi"> DOI: 10.3109/10409238.2015.1092944</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.3109%2F10409238.2015.1092944" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=26585314" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFGjur%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2016&pages=7-14&author=S.+Pontisauthor=A.+Ribeiroauthor=O.+Sassoauthor=D.+Piomelli&title=Macrophage-derived+lipid+agonists+of+PPAR-%CE%B1+as+intrinsic+controllers+of+inflammation&doi=10.3109%2F10409238.2015.1092944"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Macrophage-derived lipid agonists of PPAR-α as intrinsic controllers of inflammation</span></div><div class="casAuthors">Pontis, Silvia; Ribeiro, Alison; Sasso, Oscar; Piomelli, Daniele</div><div class="citationInfo"><span class="NLM_cas:title">Critical Reviews in Biochemistry and Molecular Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">7-14</span>CODEN:
                <span class="NLM_cas:coden">CRBBEJ</span>;
        ISSN:<span class="NLM_cas:issn">1040-9238</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Macrophages are multi-faceted phagocytic effector cells that derive from circulating monocytes and undergo differentiation in target tissues to regulate key aspects of the inflammatory process.  Macrophages produce and degrade a variety of lipid mediators that stimulate or suppress pain and inflammation.  Among the analgesic and anti-inflammatory lipids released from these cells are the fatty acid ethanolamides (FAEs), which produce their effects by engaging nuclear peroxisome proliferator activated receptor-α (PPAR-α).  Two members of this lipid family, palmitoylethanolamide (PEA) and oleoylethanolamide (OEA), have recently emerged as important intrinsic regulators of nociception and inflammation.  These substances are released from the membrane precursor, N-acylphosphatidylethanolamine (NAPE), by the action of a NAPE-specific phospholipase D (NAPE-PLD), and in macrophage are primarily deactivated by the lysosomal cysteine amidase, N-acylethanolamine acid amidase (NAAA).  NAPE-PLD and NAAA regulate FAE levels, exerting a tight control over the ability of these lipid mediators to recruit PPAR-α and attenuate the inflammatory response.  This review summarizes recent findings on the contribution of the FAE-PPAR-α signaling complex in inflammation, and on NAAA inhibition as a novel mechanistic approach to treat chronic inflammatory disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDzzvMKDz_x7Vg90H21EOLACvtfcHk0lgWBqy8cJpMtQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFGjur%252FN&md5=32cf5a133683714545cb29a2ade73758</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.3109%2F10409238.2015.1092944&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F10409238.2015.1092944%26sid%3Dliteratum%253Aachs%26aulast%3DPontis%26aufirst%3DS.%26aulast%3DRibeiro%26aufirst%3DA.%26aulast%3DSasso%26aufirst%3DO.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DMacrophage-derived%2520lipid%2520agonists%2520of%2520PPAR-%25CE%25B1%2520as%2520intrinsic%2520controllers%2520of%2520inflammation%26jtitle%3DCrit.%2520Rev.%2520Biochem.%2520Mol.%2520Biol.%26date%3D2016%26volume%3D51%26spage%3D7%26epage%3D14%26doi%3D10.3109%2F10409238.2015.1092944" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eberlein, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eicke, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reinhardt, H. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ring, J.</span></span> <span> </span><span class="NLM_article-title">Adjuvant treatment of atopic eczema: assessment of an emollient containing N-palmitoylethanolamine (ATOPA study)</span>. <i>J. Eur. Acad. Dermatol. Venereol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">73</span>– <span class="NLM_lpage">82</span>, <span class="refDoi"> DOI: 10.1111/j.1468-3083.2007.02351.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1111%2Fj.1468-3083.2007.02351.x" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2007&pages=73-82&author=B.+Eberleinauthor=C.+Eickeauthor=H.+W.+Reinhardtauthor=J.+Ring&title=Adjuvant+treatment+of+atopic+eczema%3A+assessment+of+an+emollient+containing+N-palmitoylethanolamine+%28ATOPA+study%29&doi=10.1111%2Fj.1468-3083.2007.02351.x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1111%2Fj.1468-3083.2007.02351.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1468-3083.2007.02351.x%26sid%3Dliteratum%253Aachs%26aulast%3DEberlein%26aufirst%3DB.%26aulast%3DEicke%26aufirst%3DC.%26aulast%3DReinhardt%26aufirst%3DH.%2BW.%26aulast%3DRing%26aufirst%3DJ.%26atitle%3DAdjuvant%2520treatment%2520of%2520atopic%2520eczema%253A%2520assessment%2520of%2520an%2520emollient%2520containing%2520N-palmitoylethanolamine%2520%2528ATOPA%2520study%2529%26jtitle%3DJ.%2520Eur.%2520Acad.%2520Dermatol.%2520Venereol.%26date%3D2007%26volume%3D22%26spage%3D73%26epage%3D82%26doi%3D10.1111%2Fj.1468-3083.2007.02351.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cremon, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stanghellini, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbaro, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cogliandro, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bellacosa, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santos, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vicario, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pigrau, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alonso Cotoner, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lobo, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Azpiroz, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruley des
Varannes, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neunlist, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeFilippis, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iuvone, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petrosino, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Marzo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbara, G.</span></span> <span> </span><span class="NLM_article-title">Randomised clinical trial: the analgesic properties of dietary supplementation with palmitoylethanolamide and polydatin in irritable bowel syndrome</span>. <i>Aliment. Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">909</span>– <span class="NLM_lpage">922</span>, <span class="refDoi"> DOI: 10.1111/apt.13958</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1111%2Fapt.13958" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=28164346" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjs1Sqtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2017&pages=909-922&author=C.+Cremonauthor=V.+Stanghelliniauthor=M.+R.+Barbaroauthor=R.+F.+Cogliandroauthor=L.+Bellacosaauthor=J.+Santosauthor=M.+Vicarioauthor=M.+Pigrauauthor=C.+Alonso+Cotonerauthor=B.+Loboauthor=F.+Azpirozauthor=S.+Bruley+des%0AVarannesauthor=M.+Neunlistauthor=D.+DeFilippisauthor=T.+Iuvoneauthor=S.+Petrosinoauthor=V.+Di+Marzoauthor=G.+Barbara&title=Randomised+clinical+trial%3A+the+analgesic+properties+of+dietary+supplementation+with+palmitoylethanolamide+and+polydatin+in+irritable+bowel+syndrome&doi=10.1111%2Fapt.13958"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Randomised clinical trial: the analgesic properties of dietary supplementation with palmitoylethanolamide and polydatin in irritable bowel syndrome</span></div><div class="casAuthors">Cremon, C.; Stanghellini, V.; Barbaro, M. R.; Cogliandro, R. F.; Bellacosa, L.; Santos, J.; Vicario, M.; Pigrau, M.; Alonso Cotoner, C.; Lobo, B.; Azpiroz, F.; Bruley des Varannes, S.; Neunlist, M.; De Filippis, D.; Iuvone, T.; Petrosino, S.; Di Marzo, V.; Barbara, G.</div><div class="citationInfo"><span class="NLM_cas:title">Alimentary Pharmacology and Therapeutics</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">909-922</span>CODEN:
                <span class="NLM_cas:coden">APTHEN</span>;
        ISSN:<span class="NLM_cas:issn">0269-2813</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Summary: Background : Intestinal immune activation is involved in irritable bowel syndrome (IBS) pathophysiol.  While most dietary approaches in IBS involve food avoidance, there are fewer indications on food supplementation.  Palmithoylethanolamide, structurally related to the endocannabinoid anandamide, and polydatin are dietary compds. which act synergistically to reduce mast cell activation.  Aim: To assess the effect on mast cell count and the efficacy of palmithoylethanolamide/polydatin in patients with IBS.  Methods: We conducted a pilot, 12-wk, randomized, double-blind, placebo-controlled, multicenter study assessing the effect of palmithoylethanolamide/polydatin 200 mg/20 mg or placebo b.d. on low-grade immune activation, endocannabinoid system and symptoms in IBS patients.  Biopsy samples, obtained at screening visit and at the end of the study, were analyzed by immunohistochem., enzyme-linked immunoassay, liq. chromatog. and Western blot.  Results : A total of 54 patients with IBS and 12 healthy controls were enrolled from five European centers.  Compared with controls, IBS patients showed higher mucosal mast cell counts (3.2 ± 1.3 vs. 5.3 ± 2.7%, P = 0.013), reduced fatty acid amide oleoylethanolamide (12.7 ± 9.8 vs. 45.8 ± 55.6 pmol/mg, P = 0.002) and increased expression of cannabinoid receptor 2 (0.7 ± 0.1 vs. 1.0 ± 0.8, P = 0.012).  The treatment did not significantly modify IBS biol. profile, including mast cell count.  Compared with placebo, palmithoylethanolamide/polydatin markedly improved abdominal pain severity (P < 0.05).  Conclusions: The marked effect of the dietary supplement palmithoylethanolamide/polydatin on abdominal pain in patients with IBS suggests that this is a promising natural approach for pain management in this condition.  Further studies are now required to elucidate the mechanism of action of palmithoylethanolamide/polydatin in IBS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrF2HzhKrrP6bVg90H21EOLACvtfcHk0lgWBqy8cJpMtQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjs1Sqtro%253D&md5=48570ed9f44a4b58a789229dd7aea583</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1111%2Fapt.13958&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fapt.13958%26sid%3Dliteratum%253Aachs%26aulast%3DCremon%26aufirst%3DC.%26aulast%3DStanghellini%26aufirst%3DV.%26aulast%3DBarbaro%26aufirst%3DM.%2BR.%26aulast%3DCogliandro%26aufirst%3DR.%2BF.%26aulast%3DBellacosa%26aufirst%3DL.%26aulast%3DSantos%26aufirst%3DJ.%26aulast%3DVicario%26aufirst%3DM.%26aulast%3DPigrau%26aufirst%3DM.%26aulast%3DAlonso%2BCotoner%26aufirst%3DC.%26aulast%3DLobo%26aufirst%3DB.%26aulast%3DAzpiroz%26aufirst%3DF.%26aulast%3DBruley%2Bdes%2BVarannes%26aufirst%3DS.%26aulast%3DNeunlist%26aufirst%3DM.%26aulast%3DDeFilippis%26aufirst%3DD.%26aulast%3DIuvone%26aufirst%3DT.%26aulast%3DPetrosino%26aufirst%3DS.%26aulast%3DDi%2BMarzo%26aufirst%3DV.%26aulast%3DBarbara%26aufirst%3DG.%26atitle%3DRandomised%2520clinical%2520trial%253A%2520the%2520analgesic%2520properties%2520of%2520dietary%2520supplementation%2520with%2520palmitoylethanolamide%2520and%2520polydatin%2520in%2520irritable%2520bowel%2520syndrome%26jtitle%3DAliment.%2520Pharmacol.%2520Ther.%26date%3D2017%26volume%3D45%26spage%3D909%26epage%3D922%26doi%3D10.1111%2Fapt.13958" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schweiger, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bellamoli, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donadello, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schievano, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balzo, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarzi-Puttini, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parolini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polati, E.</span></span> <span> </span><span class="NLM_article-title">Ultramicronized palmitoylethanolamide (um-PEA) as add-on treatment in fibromyalgia syndrome (FMS): retrospective observational study on 407 patients</span>. <i>CNS Neurol. Disord.: Drug Targets</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">326</span>– <span class="NLM_lpage">333</span>, <span class="refDoi"> DOI: 10.2174/1871527318666190227205359</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.2174%2F1871527318666190227205359" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=30827269" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhsFCisbbL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2019&pages=326-333&author=V.+Schweigerauthor=A.+Martiniauthor=P.+Bellamoliauthor=K.+Donadelloauthor=C.+Schievanoauthor=G.+D.+Balzoauthor=P.+Sarzi-Puttiniauthor=M.+Paroliniauthor=E.+Polati&title=Ultramicronized+palmitoylethanolamide+%28um-PEA%29+as+add-on+treatment+in+fibromyalgia+syndrome+%28FMS%29%3A+retrospective+observational+study+on+407+patients&doi=10.2174%2F1871527318666190227205359"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Ultramicronized Palmitoylethanolamide (um-PEA) as Add-on Treatment in Fibromyalgia Syndrome (FMS): Retrospective Observational Study on 407 Patients</span></div><div class="casAuthors">Schweiger, Vittorio; Martini, Alvise; Bellamoli, Paola; Donadello, Katia; Schievano, Carlo; Balzo, Giovanna D.; Sarzi-Puttini, Piercarlo; Parolini, Massimo; Polati, Enrico</div><div class="citationInfo"><span class="NLM_cas:title">CNS & Neurological Disorders: Drug Targets</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">326-333</span>CODEN:
                <span class="NLM_cas:coden">CNDDA3</span>;
        ISSN:<span class="NLM_cas:issn">1871-5273</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">To date, no medication has been shown to significantly improve pain, assocd. symptoms and Quality of Life in fibromyalgic patients.  Methods: In this retrospective observational study, we analyzed data regarding 407 patients with diagnosis of fibromyalgia syndrome who between 2013 and 2016 have been prescribed orally ultramicronized palmitoylethanolamide tablets (Normast Epitech Group SpA, Saccolongo, Italy) regardless of the concomitant pharmacol. therapy (add-on treatment).  Results: Regarding efficacy, in the 359 analyzed patients, the change over time in Visual Analog Scale pain score was statistically significant, ranging from 75.84 (±15.15) to 52.49 (±16.73) (p<0.001).  Regarding quality of life, the change over time in Fibromyalgia Impact Questionnaire score was statistically significant, ranging from 68.4 (±14.1) to 49.1 (±19.6) (p<0.001).  In the treated population, only 36 patients (13,7%) reported Adverse Events predominantly of gastrointestinal type (diarrhea, dyspepsia, bloating, constipation, vomiting).  Globally, 151 patients (57,63%) left the treatment due to inefficacy.  Conclusion: The results of ultramicronized palmitoylethanolamide treatment in this retrospective anal. represent an important step for the development of a new and well-tolerated therapy for fibromyalgia syndrome, mostly suitable for these patients who need long-term treatments.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprp7XYHweB6LVg90H21EOLACvtfcHk0lhN5hMfEPW3jA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhsFCisbbL&md5=fd3e052bec0e42d8a70a99d911a76cda</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.2174%2F1871527318666190227205359&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1871527318666190227205359%26sid%3Dliteratum%253Aachs%26aulast%3DSchweiger%26aufirst%3DV.%26aulast%3DMartini%26aufirst%3DA.%26aulast%3DBellamoli%26aufirst%3DP.%26aulast%3DDonadello%26aufirst%3DK.%26aulast%3DSchievano%26aufirst%3DC.%26aulast%3DBalzo%26aufirst%3DG.%2BD.%26aulast%3DSarzi-Puttini%26aufirst%3DP.%26aulast%3DParolini%26aufirst%3DM.%26aulast%3DPolati%26aufirst%3DE.%26atitle%3DUltramicronized%2520palmitoylethanolamide%2520%2528um-PEA%2529%2520as%2520add-on%2520treatment%2520in%2520fibromyalgia%2520syndrome%2520%2528FMS%2529%253A%2520retrospective%2520observational%2520study%2520on%2520407%2520patients%26jtitle%3DCNS%2520Neurol.%2520Disord.%253A%2520Drug%2520Targets%26date%3D2019%26volume%3D18%26spage%3D326%26epage%3D333%26doi%3D10.2174%2F1871527318666190227205359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Truini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biasiotta, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Stefano, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La Cesa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leone, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cartoni, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Federico, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petrucci, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cruccu, G.</span></span> <span> </span><span class="NLM_article-title">Palmitoylethanolamide restores myelinated-fibre function in patients with chemotherapy-induced painful neuropathy</span>. <i>CNS Neurol. Disord.: Drug Targets</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">916</span>– <span class="NLM_lpage">920</span>, <span class="refDoi"> DOI: 10.2174/187152711799219307</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.2174%2F187152711799219307" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=22229320" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BC38XktFOgsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=916-920&author=A.+Truiniauthor=A.+Biasiottaauthor=G.+Di+Stefanoauthor=S.+La+Cesaauthor=C.+Leoneauthor=C.+Cartoniauthor=V.+Federicoauthor=M.+T.+Petrucciauthor=G.+Cruccu&title=Palmitoylethanolamide+restores+myelinated-fibre+function+in+patients+with+chemotherapy-induced+painful+neuropathy&doi=10.2174%2F187152711799219307"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Palmitoylethanolamide restores myelinated-fibre function in patients with chemotherapy-induced painful neuropathy</span></div><div class="casAuthors">Truini, A.; Biasiotta, A.; Di Stefano, G.; La Cesa, S.; Leone, C.; Cartoni, C.; Federico, V.; Petrucci, M. T.; Cruccu, G.</div><div class="citationInfo"><span class="NLM_cas:title">CNS & Neurological Disorders: Drug Targets</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">8, Topological Insulator Materials</span>),
    <span class="NLM_cas:pages">916-920</span>CODEN:
                <span class="NLM_cas:coden">CNDDA3</span>;
        ISSN:<span class="NLM_cas:issn">1871-5273</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">We assessed the effect of palmitoylethanolamide (PEA) on pain and nerve function in patients with chemotherapy-induced painful neuropathy, in 20 patients undergoing thalidomide and bortezomib treatment for multiple myeloma.  All patients were evaluated before and after a two-month treatment with PEA 300 mg BID using pain and warmth thresholds; blinded examiners measured motor and sensory nerve fiber function and laser-evoked potentials.  Although no variables returned to normal values, pain and all neurophysiol. measures-assessing Aα, Aβ, and Aδ fibers- significantly improved (P < 0.05).  In contrast, warmth thresholds, assessing unmyelinated afferents, remained unchanged (P > 0.50).  Although a placebo effect might play a role in the reported pain relief, the changes in neurophysiol. measures indicate that PEA exerted a pos. action on myelinated fiber groups.  PEA, possibly by moderating mast cell hyperactivity, relieved conduction blocks secondary to endoneural edema.  In a severe condition such as painful neuropathy assocd. with multiple myeloma and chemotherapy, a safe substance such as PEA provides significant restoration of nerve function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6hXGzgoWiR7Vg90H21EOLACvtfcHk0lhN5hMfEPW3jA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XktFOgsrc%253D&md5=c62d48d221f420543b333c8b3920d7e7</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.2174%2F187152711799219307&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F187152711799219307%26sid%3Dliteratum%253Aachs%26aulast%3DTruini%26aufirst%3DA.%26aulast%3DBiasiotta%26aufirst%3DA.%26aulast%3DDi%2BStefano%26aufirst%3DG.%26aulast%3DLa%2BCesa%26aufirst%3DS.%26aulast%3DLeone%26aufirst%3DC.%26aulast%3DCartoni%26aufirst%3DC.%26aulast%3DFederico%26aufirst%3DV.%26aulast%3DPetrucci%26aufirst%3DM.%2BT.%26aulast%3DCruccu%26aufirst%3DG.%26atitle%3DPalmitoylethanolamide%2520restores%2520myelinated-fibre%2520function%2520in%2520patients%2520with%2520chemotherapy-induced%2520painful%2520neuropathy%26jtitle%3DCNS%2520Neurol.%2520Disord.%253A%2520Drug%2520Targets%26date%3D2011%26volume%3D10%26spage%3D916%26epage%3D920%26doi%3D10.2174%2F187152711799219307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Giammusso, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Mauro, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernardini, R.</span></span> <span> </span><span class="NLM_article-title">The efficacy of an association of palmitoylethanolamide and alpha-lipoic acid in patients with chronic prostatitis/chronic pelvic pain syndrome: A randomized clinical trial</span>. <i>Arch. Ital. Urol. Androl.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>89</i></span>,  <span class="NLM_fpage">17</span>– <span class="NLM_lpage">21</span>, <span class="refDoi"> DOI: 10.4081/aiua.2017.1.17</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.4081%2Faiua.2017.1.17" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=28403589" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsFyhtrnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=2017&pages=17-21&author=B.+Giammussoauthor=R.+Di+Mauroauthor=R.+Bernardini&title=The+efficacy+of+an+association+of+palmitoylethanolamide+and+alpha-lipoic+acid+in+patients+with+chronic+prostatitis%2Fchronic+pelvic+pain+syndrome%3A+A+randomized+clinical+trial&doi=10.4081%2Faiua.2017.1.17"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">The efficacy of an association of palmitoylethanolamide and alpha-lipoic acid in patients with chronic prostatitis/chronic pelvic pain syndrome: a randomized clinical trial</span></div><div class="casAuthors">Giammusso, Bruno; Di Mauro, Rosaria; Bernardini, Renato</div><div class="citationInfo"><span class="NLM_cas:title">Archivio Italiano di Urologia e Andrologia</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">89</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">17-21</span>CODEN:
                <span class="NLM_cas:coden">AIUAFR</span>;
        ISSN:<span class="NLM_cas:issn">2282-4197</span>.
    
            (<span class="NLM_cas:orgname">PAGEPress Publications</span>)
        </div><div class="casAbstract">Background: Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) is a complex condition, characterized by uncertain etiol. and by limited response to therapy.  The definition of CP/CPPS includes genitourinary pain with or without voiding symptoms in the absence of uropathogenic bacteria, as detected by std. microbiol. methods, or another identifiable cause such as malignancy.  The efficacy of various medical therapies, has been evaluated in clin. studies, but evidence is lacking or conflicting.  We compared Serenoa Repens in monotherapy vs. Palmitoylethanolamide (PEA) in combination with Alpha-lipoic acid (ALA) and evaluated the efficacy of these treatments in patients with CP/CPPS.  Methods: We conducted a randomized, single-blind trial. 44 patients diagnosed with CP/CPPS (mean age 41.32 ± 1.686 years) were randomly assigned to treatment with Palmitoylethanolamide 300 mg plus Alpha-lipoic acid 300 mg (Peanase), or Serenoa Repens at 320 mg.  Three questionnaires (NIH-CPSI, IPSS and IIEF5) were administered at baseline and after 12 wk of treatment in each group.  Results: 12 wk treatment with Peanase significantly improved the IPSS score compared to the same period of treatment with Serenoa Repens, and significantly reduced NIH-CPSI score.  Similar results were obsd. in the different NIH-CPSI subscores break down.  However, the same treatment did not result in significant improvement of the IIEF5 score.  Both treatments did not produce undesired effects.  Conclusions: The present results document the efficacy of an assocn. of Palmitoylethanolamide (PEA) and Alpha-lipoic acid (ALA) administered for 12 wk for treating patients with CP/CPPS, compared with Serenoa Repens monotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJptRTXZdbebVg90H21EOLACvtfcHk0lhN5hMfEPW3jA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsFyhtrnK&md5=99a02633870ebb7daf0d8f5fab8b8010</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.4081%2Faiua.2017.1.17&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4081%252Faiua.2017.1.17%26sid%3Dliteratum%253Aachs%26aulast%3DGiammusso%26aufirst%3DB.%26aulast%3DDi%2BMauro%26aufirst%3DR.%26aulast%3DBernardini%26aufirst%3DR.%26atitle%3DThe%2520efficacy%2520of%2520an%2520association%2520of%2520palmitoylethanolamide%2520and%2520alpha-lipoic%2520acid%2520in%2520patients%2520with%2520chronic%2520prostatitis%252Fchronic%2520pelvic%2520pain%2520syndrome%253A%2520A%2520randomized%2520clinical%2520trial%26jtitle%3DArch.%2520Ital.%2520Urol.%2520Androl.%26date%3D2017%26volume%3D89%26spage%3D17%26epage%3D21%26doi%3D10.4081%2Faiua.2017.1.17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Orefice, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alhouayek, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carotenuto, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montella, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbato, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Comelli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calignano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muccioli, G. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orefice, G.</span></span> <span> </span><span class="NLM_article-title">Oral palmitoylethanolamide treatment is associated with reduced cutaneous adverse effects of interferon-β1a and circulating proinflammatory cytokines in relapsing-remitting multiple sclerosis</span>. <i>Neurotherapeutics</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">428</span>– <span class="NLM_lpage">438</span>, <span class="refDoi"> DOI: 10.1007/s13311-016-0420-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1007%2Fs13311-016-0420-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=26857391" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BC28XisFSls7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2016&pages=428-438&author=N.+S.+Oreficeauthor=M.+Alhouayekauthor=A.+Carotenutoauthor=S.+Montellaauthor=F.+Barbatoauthor=A.+Comelliauthor=A.+Calignanoauthor=G.+G.+Muccioliauthor=G.+Orefice&title=Oral+palmitoylethanolamide+treatment+is+associated+with+reduced+cutaneous+adverse+effects+of+interferon-%CE%B21a+and+circulating+proinflammatory+cytokines+in+relapsing-remitting+multiple+sclerosis&doi=10.1007%2Fs13311-016-0420-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Oral Palmitoylethanolamide Treatment Is Associated with Reduced Cutaneous Adverse Effects of Interferon-β1a and Circulating Proinflammatory Cytokines in Relapsing-Remitting Multiple Sclerosis</span></div><div class="casAuthors">Orefice, Nicola S.; Alhouayek, Mireille; Carotenuto, Antonio; Montella, Silvana; Barbato, Franscesco; Comelli, Albert; Calignano, Antonio; Muccioli, Giulio G.; Orefice, Giuseppe</div><div class="citationInfo"><span class="NLM_cas:title">Neurotherapeutics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">428-438</span>CODEN:
                <span class="NLM_cas:coden">NEURNV</span>;
        ISSN:<span class="NLM_cas:issn">1878-7479</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Palmitoylethanolamide (PEA) is an endogenous lipid mediator known to reduce pain and inflammation.  However, only limited clin. studies have evaluated the effects of PEA in neuroinflammatory and neurodegenerative diseases.  Multiple sclerosis (MS) is a chronic autoimmune and inflammatory disease of the central nervous system.  Although s.c. administration of interferon (IFN)-β1a is approved as first-line therapy for the treatment of relapsing-remitting MS (RR-MS), its commonly reported adverse events (AEs) such as pain, myalgia, and erythema at the injection site, deeply affect the quality of life (QoL) of patients with MS.  In this randomized, double-blind, placebo-controlled study, we tested the effect of ultramicronized PEA (um-PEA) added to IFN-β1a in the treatment of clin. defined RR-MS.  The primary objectives were to est. whether, with um-PEA treatment, patients with MS perceived an improvement in pain and a decrease of the erythema width at the IFN-β1a injection site in addn. to an improvement in their QoL.  The secondary objectives were to evaluate the effects of um-PEA on circulating interferon-γ, tumor necrosis factor-α, and interleukin-17 serum levels, N-acylethanolamine plasma levels, Expanded Disability Status Scale (EDSS) progression, and safety and tolerability after 1 yr of treatment.  Patients with MS receiving um-PEA perceived an improvement in pain sensation without a redn. of the erythema at the injection site.  A significant improvement in QoL was obsd.  No significant difference was reported in EDSS score, and um-PEA was well tolerated.  We found a significant increase of palmitoylethanolamide, anandamide and oleoylethanolamide plasma levels, and a significant redn. of interferon-γ, tumor necrosis factor-α, and interleukin-17 serum profile compared with the placebo group.  Our results suggest that um-PEA may be considered as an appropriate add-on therapy for the treatment of IFN-β1a-related adverse effects in RR-MS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4g6LzMLY4F7Vg90H21EOLACvtfcHk0lgCL0GrKad-NA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XisFSls7w%253D&md5=8428b841203913c4d08b78a8c617b817</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1007%2Fs13311-016-0420-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs13311-016-0420-z%26sid%3Dliteratum%253Aachs%26aulast%3DOrefice%26aufirst%3DN.%2BS.%26aulast%3DAlhouayek%26aufirst%3DM.%26aulast%3DCarotenuto%26aufirst%3DA.%26aulast%3DMontella%26aufirst%3DS.%26aulast%3DBarbato%26aufirst%3DF.%26aulast%3DComelli%26aufirst%3DA.%26aulast%3DCalignano%26aufirst%3DA.%26aulast%3DMuccioli%26aufirst%3DG.%2BG.%26aulast%3DOrefice%26aufirst%3DG.%26atitle%3DOral%2520palmitoylethanolamide%2520treatment%2520is%2520associated%2520with%2520reduced%2520cutaneous%2520adverse%2520effects%2520of%2520interferon-%25CE%25B21a%2520and%2520circulating%2520proinflammatory%2520cytokines%2520in%2520relapsing-remitting%2520multiple%2520sclerosis%26jtitle%3DNeurotherapeutics%26date%3D2016%26volume%3D13%26spage%3D428%26epage%3D438%26doi%3D10.1007%2Fs13311-016-0420-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Artukoglu, B. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beyer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zuloff-Shani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brener, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bloch, M. H.</span></span> <span> </span><span class="NLM_article-title">Efficacy of palmitoylethanolamide for pain: a meta-analysis</span>. <i>Pain Physician</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">353</span>– <span class="NLM_lpage">362</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=28727699" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A280%3ADC%252BC1cjpsFChsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2017&pages=353-362&author=B.+B.+Artukogluauthor=C.+Beyerauthor=A.+Zuloff-Shaniauthor=E.+Brenerauthor=M.+H.+Bloch&title=Efficacy+of+palmitoylethanolamide+for+pain%3A+a+meta-analysis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Efficacy of Palmitoylethanolamide for Pain: A Meta-Analysis</span></div><div class="casAuthors">Artukoglu Bekir Berker; Beyer Chad; Bloch Michael Howard; Zuloff-Shani Adi; Brener Ephraim</div><div class="citationInfo"><span class="NLM_cas:title">Pain physician</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">353-362</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Palmitoylethanolamide (PEA) is a cannabimimetic compound that has been investigated as an analgesic agent in animal models and clinical trials.  OBJECTIVES:  We conducted a meta-analysis to examine the efficacy of PEA for treating pain in randomized, controlled trials.  STUDY DESIGN:  Systematic review and meta-analysis.  SETTING:  This meta-analysis examined all randomized, controlled trials involving the effect of PEA on pain score.  METHODS:  We searched PubMed and Embase for randomized, active or placebo-controlled trials of PEA for the treatment of acute or chronic pain.  Our primary outcome was the weighted mean difference in visual analog pain scales of PEA treatment compared to inactive controls.  RESULTS:  We identified 10 studies including data from 786 patients who received PEA and 512 controls for inclusion in our systematic review.  Eight trials included an inactive control group and were included in the meta-analysis.  PEA was associated with significantly greater pain reduction compared to inactive control conditions (WMD = 2.03, 95% CI: 1.19 - 2.87, z = 4.75, P < 0.001).  Use of placebo control, presence of blinding, allowance for concomitant treatments, and duration or dose of PEA treatment did not affect the measured efficacy of PEA.  All-cause dropout was non-significantly reduced in the PEA group compared to inactive control conditions (RR = 0.36, 95% CI: 0.10 - 1.26, z = -1.60, P = 0.11).  LIMITATIONS:  This meta-analysis relied on a relatively small number of trials across a variety of conditions causing pain with differing trial designs.  Overall quality of the underlying studies and assessment of side effects were often poor.  CONCLUSIONS:  PEA may be a useful treatment for pain and is generally well tolerated in research populations.  Further, well-designed, randomized, placebo-controlled trials are needed to provide reliable estimates of its efficacy and to identify less serious adverse events associated with this compound.  KEY WORDS:  PEA, palmidrol, palmitoylethanolamide, efficacy, pain, pain management, meta-analysis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS-LIN7cIJ1dHtlzo9xastyfW6udTcc2eagax4-YmZDorntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cjpsFChsA%253D%253D&md5=e048a1cd123f89f4a2c78c202c5ebea3</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DArtukoglu%26aufirst%3DB.%2BB.%26aulast%3DBeyer%26aufirst%3DC.%26aulast%3DZuloff-Shani%26aufirst%3DA.%26aulast%3DBrener%26aufirst%3DE.%26aulast%3DBloch%26aufirst%3DM.%2BH.%26atitle%3DEfficacy%2520of%2520palmitoylethanolamide%2520for%2520pain%253A%2520a%2520meta-analysis%26jtitle%3DPain%2520Physician%26date%3D2017%26volume%3D20%26spage%3D353%26epage%3D362" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bachur, N. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masek, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melmon, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Udenfriend, S.</span></span> <span> </span><span class="NLM_article-title">Fatty acid amides of ethanolamine in mammalian tissues</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1965</span>,  <span class="NLM_volume"><i>240</i></span>,  <span class="NLM_fpage">1019</span>– <span class="NLM_lpage">1024</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=14284696" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADyaF2MXksFWgtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=240&publication_year=1965&pages=1019-1024&author=N.+R.+Bachurauthor=K.+Masekauthor=K.+L.+Melmonauthor=S.+Udenfriend&title=Fatty+acid+amides+of+ethanolamine+in+mammalian+tissues"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Fatty acid amides of ethanolamine in mammalian tissues</span></div><div class="casAuthors">Bachur, Nicholas R.; Masek, Karel; Melmon, Kenneth L.; Udenfriend, Sidney</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1965</span>),
    <span class="NLM_cas:volume">240</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1019-24</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    </div><div class="casAbstract">A method for the isolation, purification, and quant. assay of fatty acid ethanolamides from natural sources is described.  In rats and guinea pigs from which food has been withheld, the amide is found in brain, liver, and skeletal muscle, the level being highest and most const. in brain.  Verification of the structure of the isolated palmitoylethanolamide was obtained through gas-liquid chromatography, ir spectroscopy, and hydrolysis and analysis of the component fatty acid and amine.  Evidence was presented to rule out the artifactual production of palmitoylethanolamide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2ihNG2976OLVg90H21EOLACvtfcHk0lgCL0GrKad-NA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF2MXksFWgtA%253D%253D&md5=c1a2dc22f7dc92c76f006247f44b16e7</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBachur%26aufirst%3DN.%2BR.%26aulast%3DMasek%26aufirst%3DK.%26aulast%3DMelmon%26aufirst%3DK.%2BL.%26aulast%3DUdenfriend%26aufirst%3DS.%26atitle%3DFatty%2520acid%2520amides%2520of%2520ethanolamine%2520in%2520mammalian%2520tissues%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1965%26volume%3D240%26spage%3D1019%26epage%3D1024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tsuboi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uyama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okamoto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueda, N.</span></span> <span> </span><span class="NLM_article-title">Endocannabinoids and related N-acylethanolamines: biological activities and metabolism</span>. <i>Inflammation Regener.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">28</span>, <span class="refDoi"> DOI: 10.1186/s41232-018-0086-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1186%2Fs41232-018-0086-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=30288203" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhs1eqt7zN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2018&pages=28&author=K.+Tsuboiauthor=T.+Uyamaauthor=Y.+Okamotoauthor=N.+Ueda&title=Endocannabinoids+and+related+N-acylethanolamines%3A+biological+activities+and+metabolism&doi=10.1186%2Fs41232-018-0086-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Endocannabinoids and related N-acylethanolamines: biological activities and metabolism</span></div><div class="casAuthors">Tsuboi, Kazuhito; Uyama, Toru; Okamoto, Yasuo; Ueda, Natsuo</div><div class="citationInfo"><span class="NLM_cas:title">Inflammation and Regeneration</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">28</span>CODEN:
                <span class="NLM_cas:coden">IRNECG</span>;
        ISSN:<span class="NLM_cas:issn">1880-9693</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">A review.  The plant Cannabis sativa contains cannabinoids represented by Δ9-tetrahydrocannabinol, which exert psychoactivity and immunomodulation through cannabinoid CB1 and CB2 receptors, resp., in animal tissues.  Arachidonoylethanolamide (also referred to as anandamide) and 2-arachidonoylglycerol (2-AG) are well known as two major endogenous agonists of these receptors (termed "endocannabinoids") and show various cannabimimetic bioactivities.  However, only 2-AG is a full agonist for CB1 and CB2 and mediates retrograde signals at the synapse, strongly suggesting that 2-AG is physiol. more important than anandamide.  The metabolic pathways of these two endocannabinoids are completely different. 2-AG is mostly produced from inositol phospholipids via diacylglycerol by phospholipase C and diacylglycerol lipase and then degraded by monoacylglycerol lipase.  On the other hand, anandamide is concomitantly produced with larger amts. of other N-acylethanolamines via N-acyl-phosphatidylethanolamines (NAPEs).  Although this pathway consists of calcium-dependent N-acyltransferase and NAPE-hydrolyzing phospholipase D, recent studies revealed the involvement of several new enzymes.  Quant. major N-acylethanolamines include palmitoylethanolamide and oleoylethanolamide, which do not bind to cannabinoid receptors but exert anti-inflammatory, analgesic, and anorexic effects through receptors such as peroxisome proliferator-activated receptor α.  The biosynthesis of these non-endocannabinoid N-acylethanolamines rather than anandamide may be the primary significance of this pathway.  Here, we provide an overview of the biol. activities and metabs. of endocannabinoids (2-AG and anandamide) and non-endocannabinoid N-acylethanolamines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUWzSp4LibbLVg90H21EOLACvtfcHk0lhqaZURPHWX3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhs1eqt7zN&md5=0ac9f596d18fd9d769a1f67f18bf8223</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1186%2Fs41232-018-0086-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs41232-018-0086-5%26sid%3Dliteratum%253Aachs%26aulast%3DTsuboi%26aufirst%3DK.%26aulast%3DUyama%26aufirst%3DT.%26aulast%3DOkamoto%26aufirst%3DY.%26aulast%3DUeda%26aufirst%3DN.%26atitle%3DEndocannabinoids%2520and%2520related%2520N-acylethanolamines%253A%2520biological%2520activities%2520and%2520metabolism%26jtitle%3DInflammation%2520Regener.%26date%3D2018%26volume%3D38%26spage%3D28%26doi%3D10.1186%2Fs41232-018-0086-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ogura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parsons, W. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamat, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cravatt, B. F.</span></span> <span> </span><span class="NLM_article-title">A calcium-dependent acyltransferase that produces N-acyl phosphatidylethanolamines</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">669</span>– <span class="NLM_lpage">671</span>, <span class="refDoi"> DOI: 10.1038/nchembio.2127</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1038%2Fnchembio.2127" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=27399000" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1Kmu7rP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2016&pages=669-671&author=Y.+Oguraauthor=W.+H.+Parsonsauthor=S.+S.+Kamatauthor=B.+F.+Cravatt&title=A+calcium-dependent+acyltransferase+that+produces+N-acyl+phosphatidylethanolamines&doi=10.1038%2Fnchembio.2127"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">A calcium-dependent acyltransferase that produces N-acyl phosphatidylethanolamines</span></div><div class="casAuthors">Ogura, Yuji; Parsons, William H.; Kamat, Siddhesh S.; Cravatt, Benjamin F.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">669-671</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">More than 30 years ago, a calcium-dependent enzyme activity was described that generates N-acyl phosphatidylethanolamines (NAPEs), which are precursors for N-acyl ethanolamine (NAE) lipid transmitters, including the endocannabinoid anandamide.  The identity of this calcium-dependent N-acyltransferase (Ca-NAT) has remained mysterious.  Here, we use activity-based protein profiling to identify the poorly characterized serine hydrolase PLA2G4E as a mouse brain Ca-NAT and show that this enzyme generates NAPEs and NAEs in mammalian cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvImxXm5qAW7Vg90H21EOLACvtfcHk0lhqaZURPHWX3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1Kmu7rP&md5=57f720cb6c82b8c40f8ed176815afda3</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.2127&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.2127%26sid%3Dliteratum%253Aachs%26aulast%3DOgura%26aufirst%3DY.%26aulast%3DParsons%26aufirst%3DW.%2BH.%26aulast%3DKamat%26aufirst%3DS.%2BS.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26atitle%3DA%2520calcium-dependent%2520acyltransferase%2520that%2520produces%2520N-acyl%2520phosphatidylethanolamines%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2016%26volume%3D12%26spage%3D669%26epage%3D671%26doi%3D10.1038%2Fnchembio.2127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Okamoto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morishita, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsuboi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tonai, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueda, N.</span></span> <span> </span><span class="NLM_article-title">Molecular characterization of a phospholipase D generating anandamide and its congeners</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>279</i></span>,  <span class="NLM_fpage">5298</span>– <span class="NLM_lpage">5305</span>, <span class="refDoi"> DOI: 10.1074/jbc.M306642200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1074%2Fjbc.M306642200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=14634025" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtFeqtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=5298-5305&author=Y.+Okamotoauthor=J.+Morishitaauthor=K.+Tsuboiauthor=T.+Tonaiauthor=N.+Ueda&title=Molecular+characterization+of+a+phospholipase+D+generating+anandamide+and+its+congeners&doi=10.1074%2Fjbc.M306642200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Characterization of a Phospholipase D Generating Anandamide and Its Congeners</span></div><div class="casAuthors">Okamoto, Yasuo; Morishita, Jun; Tsuboi, Kazuhito; Tonai, Takeharu; Ueda, Natsuo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">279</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">5298-5305</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Anandamide (N-arachidonoylethanolamine) is known to be an endogenous ligand of cannabinoid and vanilloid receptors.  Its congeners (collectively referred to as N-acylethanolamines) also show a variety of biol. activities.  These compds. are principally formed from their corresponding N-acylphosphatidylethanolamines by a phosphodiesterase of the phospholipase D-type in animal tissues.  The authors purified the enzyme from rat heart, and by the use of the sequences of its internal peptides cloned its cDNAs from mouse, rat, and human.  The deduced amino acid sequences were composed of 393-396 residues, and showed that the enzyme has no homol. with the known phospholipase D enzymes but is classified as a member of the zinc metallohydrolase family of the β-lactamase fold.  As was overexpressed in COS-7 cells, the recombinant enzyme generated anandamide and other N-acylethanolamines from their corresponding N-acylphosphatidylethanolamines at comparable rates.  In contrast, the enzyme was inactive with phosphatidylcholine and phosphatidylethanolamine.  Assays of the enzyme activity and the mRNA and protein levels revealed its wide distribution in murine organs with higher contents in the brain, kidney, and testis.  These results confirm that a specific phospholipase D is responsible for the generation of N-acylethanolamines including anandamide, strongly suggesting the physiol. importance of lipid mols. of this class.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpK_-VVe-jk7rVg90H21EOLACvtfcHk0lhqaZURPHWX3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtFeqtrY%253D&md5=f1c00a4d0e21163c03b5a70d2f46c721</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M306642200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M306642200%26sid%3Dliteratum%253Aachs%26aulast%3DOkamoto%26aufirst%3DY.%26aulast%3DMorishita%26aufirst%3DJ.%26aulast%3DTsuboi%26aufirst%3DK.%26aulast%3DTonai%26aufirst%3DT.%26aulast%3DUeda%26aufirst%3DN.%26atitle%3DMolecular%2520characterization%2520of%2520a%2520phospholipase%2520D%2520generating%2520anandamide%2520and%2520its%2520congeners%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D5298%26epage%3D5305%26doi%3D10.1074%2Fjbc.M306642200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okamoto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morishita, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsuboi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyatake, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueda, N.</span></span> <span> </span><span class="NLM_article-title">Functional analysis of the purified anandamide-generating phospholipase D as a member of the metallo-beta-lactamase family</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>281</i></span>,  <span class="NLM_fpage">12325</span>– <span class="NLM_lpage">12335</span>, <span class="refDoi"> DOI: 10.1074/jbc.M512359200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1074%2Fjbc.M512359200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=16527816" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BD28XjvFKksrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2006&pages=12325-12335&author=J.+Wangauthor=Y.+Okamotoauthor=J.+Morishitaauthor=K.+Tsuboiauthor=A.+Miyatakeauthor=N.+Ueda&title=Functional+analysis+of+the+purified+anandamide-generating+phospholipase+D+as+a+member+of+the+metallo-beta-lactamase+family&doi=10.1074%2Fjbc.M512359200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Functional Analysis of the Purified Anandamide-generating Phospholipase D as a Member of the Metallo-β-lactamase Family</span></div><div class="casAuthors">Wang, Jun; Okamoto, Yasuo; Morishita, Jun; Tsuboi, Kazuhito; Miyatake, Akira; Ueda, Natsuo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">281</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">12325-12335</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">In animal tissues, bioactive N-acylethanolamines including the endocannabinoid anandamide are formed from their corresponding N-acylphosphatidylethanolamines (NAPEs) by the catalysis of a specific phospholipase D (NAPE-PLD) that belongs to the metallo-β-lactamase family.  Despite its potential physiol. importance, NAPE-PLD has not yet been characterized with a purified enzyme prepn.  In the present study we expressed a recombinant NAPE-PLD in Escherichia coli and highly purified it.  The purified enzyme was remarkably activated in a dose-dependent manner by millimolar concns. of Mg2+ as well as Ca2+ and, hence, appeared to be constitutively active.  The enzyme showed extremely high specificity for NAPEs among various glycerophospholipids but did not reveal obvious selectivity for different long chain or medium chain N-acyl species of NAPEs.  These results suggested the ability of NAPE-PLD to degrade different NAPEs without damaging other membrane phospholipids.  Metal anal. revealed the presence of catalytically important zinc in NAPE-PLD.  In addn., site-directed mutagenesis studies were addressed to several histidine and aspartic acid residues of NAPE-PLD that are highly conserved within the metallo-β-lactamase family.  Single mutations of Asp-147, His-185, His-187, Asp-189, His-190, His-253, Asp-284, and His-321 caused abolishment or remarkable redn. of the catalytic activity.  Moreover, when six cysteine residues were individually mutated to serine, only C224S showed a considerably reduced activity.  The activities of L207F and H380R found as single nucleotide polymorphisms were also low.  Thus, NAPE-PLD appeared to function through a mechanism similar to those of the well characterized members of this family but play a unique role in the lipid metab. of animal tissues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHPr_ieu3LxrVg90H21EOLACvtfcHk0lhqaZURPHWX3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjvFKksrY%253D&md5=aedf6e484205f3af45d2743f551de502</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M512359200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M512359200%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DOkamoto%26aufirst%3DY.%26aulast%3DMorishita%26aufirst%3DJ.%26aulast%3DTsuboi%26aufirst%3DK.%26aulast%3DMiyatake%26aufirst%3DA.%26aulast%3DUeda%26aufirst%3DN.%26atitle%3DFunctional%2520analysis%2520of%2520the%2520purified%2520anandamide-generating%2520phospholipase%2520D%2520as%2520a%2520member%2520of%2520the%2520metallo-beta-lactamase%2520family%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2006%26volume%3D281%26spage%3D12325%26epage%3D12335%26doi%3D10.1074%2Fjbc.M512359200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Magotti, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauer, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Igarashi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Babagoli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marotta, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piomelli, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garau, G.</span></span> <span> </span><span class="NLM_article-title">Structure of human N-acylphosphatidylethanolamine-hydrolyzing phospholipase D: regulation of fatty acid ethanolamide biosynthesis by bile acids</span>. <i>Structure</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">598</span>– <span class="NLM_lpage">604</span>, <span class="refDoi"> DOI: 10.1016/j.str.2014.12.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1016%2Fj.str.2014.12.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=25684574" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BC2MXivVSjt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2015&pages=598-604&author=P.+Magottiauthor=I.+Bauerauthor=M.+Igarashiauthor=M.+Babagoliauthor=R.+Marottaauthor=D.+Piomelliauthor=G.+Garau&title=Structure+of+human+N-acylphosphatidylethanolamine-hydrolyzing+phospholipase+D%3A+regulation+of+fatty+acid+ethanolamide+biosynthesis+by+bile+acids&doi=10.1016%2Fj.str.2014.12.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of human N-acylphosphatidylethanolamine-hydrolyzing phospholipase D: Regulation of fatty acid ethanolamide biosynthesis by bile acids</span></div><div class="casAuthors">Magotti, Paola; Bauer, Inga; Igarashi, Miki; Babagoli, Masih; Marotta, Roberto; Piomelli, Daniele; Garau, Gianpiero</div><div class="citationInfo"><span class="NLM_cas:title">Structure (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">598-604</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The fatty acid ethanolamides (FAEs) are lipid mediators present in all organisms and involved in highly conserved biol. functions, such as innate immunity, energy balance, and stress control.  They are produced from membrane N-acylphosphatidylethanolamines (NAPEs) and include agonists for G protein-coupled receptors (e.g., cannabinoid receptors) and nuclear receptors (e.g., PPAR-α).  Here, the authors report the crystal structure of human NAPE-hydrolyzing phospholipase D (NAPE-PLD) at 2.65 Å resoln., a membrane enzyme that catalyzes FAE formation in mammals.  NAPE-PLD forms homodimers partly sepd. by an internal ∼9-Å-wide channel and uniquely adapted to assoc. with phospholipids.  A hydrophobic cavity provides an entryway for NAPE into the active site, where a binuclear Zn2+ center orchestrates its hydrolysis.  Bile acids bind with high affinity to selective pockets in this cavity, enhancing dimer assembly and enabling catalysis.  These elements offer multiple targets for the design of small-mol. NAPE-PLD modulators with potential applications in inflammation and metabolic disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAkur49s4h2bVg90H21EOLACvtfcHk0ljDrseIn6QFzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXivVSjt7s%253D&md5=c80aae05403e5fc59a3bb6db1ec673ec</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1016%2Fj.str.2014.12.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.str.2014.12.018%26sid%3Dliteratum%253Aachs%26aulast%3DMagotti%26aufirst%3DP.%26aulast%3DBauer%26aufirst%3DI.%26aulast%3DIgarashi%26aufirst%3DM.%26aulast%3DBabagoli%26aufirst%3DM.%26aulast%3DMarotta%26aufirst%3DR.%26aulast%3DPiomelli%26aufirst%3DD.%26aulast%3DGarau%26aufirst%3DG.%26atitle%3DStructure%2520of%2520human%2520N-acylphosphatidylethanolamine-hydrolyzing%2520phospholipase%2520D%253A%2520regulation%2520of%2520fatty%2520acid%2520ethanolamide%2520biosynthesis%2520by%2520bile%2520acids%26jtitle%3DStructure%26date%3D2015%26volume%3D23%26spage%3D598%26epage%3D604%26doi%3D10.1016%2Fj.str.2014.12.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solorzano, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sahar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Realini, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fung, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sassone-Corsi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piomelli, D.</span></span> <span> </span><span class="NLM_article-title">Proinflammatory stimuli control N-acylphosphatidylethanolamine-specific phospholipase D expression in macrophages</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>79</i></span>,  <span class="NLM_fpage">786</span>– <span class="NLM_lpage">792</span>, <span class="refDoi"> DOI: 10.1124/mol.110.070201</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1124%2Fmol.110.070201" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=21233218" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktVOlurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2011&pages=786-792&author=C.+Zhuauthor=C.+Solorzanoauthor=S.+Saharauthor=N.+Realiniauthor=E.+Fungauthor=P.+Sassone-Corsiauthor=D.+Piomelli&title=Proinflammatory+stimuli+control+N-acylphosphatidylethanolamine-specific+phospholipase+D+expression+in+macrophages&doi=10.1124%2Fmol.110.070201"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Proinflammatory stimuli control N-acylphosphatidylethanolamine-specific phospholipase D expression in macrophages</span></div><div class="casAuthors">Zhu, Chenggang; Solorzano, Carlos; Sahar, Saurabh; Realini, Natalia; Fung, Ernest; Sassone-Corsi, Paolo; Piomelli, Daniele</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">786-792</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Palmitoylethanolamide (PEA) is an endogenous lipid amide that modulates pain and inflammation by engaging peroxisome proliferator-activated receptor type-α.  Here, we show that the proinflammatory bacterial endotoxin lipopolysaccharide (LPS) decreases PEA biosynthesis in RAW264.7 macrophages by suppressing the transcription of N-acylphosphatidylethanolamine-specific phospholipase D (NAPE-PLD), which catalyzes the prodn. of PEA and other lipid amides.  Using a luciferase reporter construct and chromatin immunopptn., we further show that LPS treatment reduces acetylation of histone proteins bound to the NAPE-PLD promoter, an effect that is blocked by the histone deacetylase inhibitor trichostatin A.  The transcription factor Sp1 is involved in regulating baseline NAPE-PLD expression but not in the transcriptional suppression induced by LPS.  The ability of LPS to down-regulate PEA biosynthesis is impaired in peritoneal macrophages from mutant NAPE-PLD-deficient mice, in which PEA is produced through a compensatory mechanism distinct from NAPE-PLD.  Moreover, NAPE-PLD-deficient mice fail to mount a normal inflammatory reaction in response to carrageenan administration in vivo.  Our findings suggest that proinflammatory stimuli suppress NAPE-PLD expression and PEA biosynthesis in macrophages and that this effect might contribute to the inflammatory response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqif9VxrAyTBLVg90H21EOLACvtfcHk0ljDrseIn6QFzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktVOlurY%253D&md5=894e9566ce60e39bd4e599dda155949e</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1124%2Fmol.110.070201&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.110.070201%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DC.%26aulast%3DSolorzano%26aufirst%3DC.%26aulast%3DSahar%26aufirst%3DS.%26aulast%3DRealini%26aufirst%3DN.%26aulast%3DFung%26aufirst%3DE.%26aulast%3DSassone-Corsi%26aufirst%3DP.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DProinflammatory%2520stimuli%2520control%2520N-acylphosphatidylethanolamine-specific%2520phospholipase%2520D%2520expression%2520in%2520macrophages%26jtitle%3DMol.%2520Pharmacol.%26date%3D2011%26volume%3D79%26spage%3D786%26epage%3D792%26doi%3D10.1124%2Fmol.110.070201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Y. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsuboi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, L. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okamoto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambert, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueda, N.</span></span> <span> </span><span class="NLM_article-title">Involvement of N-acylethanolamine-hydrolyzing acid amidase in the degradation of anandamide and other N-acylethanolamines in macrophages</span>. <i>Biochim. Biophys. Acta, Mol. Cell Biol. Lipids</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>1736</i></span>,  <span class="NLM_fpage">211</span>– <span class="NLM_lpage">220</span>, <span class="refDoi"> DOI: 10.1016/j.bbalip.2005.08.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1016%2Fj.bbalip.2005.08.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=16154384" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVOktr7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1736&publication_year=2005&pages=211-220&author=Y.+X.+Sunauthor=K.+Tsuboiauthor=L.+Y.+Zhaoauthor=Y.+Okamotoauthor=D.+M.+Lambertauthor=N.+Ueda&title=Involvement+of+N-acylethanolamine-hydrolyzing+acid+amidase+in+the+degradation+of+anandamide+and+other+N-acylethanolamines+in+macrophages&doi=10.1016%2Fj.bbalip.2005.08.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Involvement of N-acylethanolamine-hydrolyzing acid amidase in the degradation of anandamide and other N-acylethanolamines in macrophages</span></div><div class="casAuthors">Sun, Yong-Xin; Tsuboi, Kazuhito; Zhao, Li-Ying; Okamoto, Yasuo; Lambert, Didier M.; Ueda, Natsuo</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular and Cell Biology of Lipids</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">1736</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">211-220</span>CODEN:
                <span class="NLM_cas:coden">BBMLFG</span>;
        ISSN:<span class="NLM_cas:issn">1388-1981</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Bioactive N-acylethanolamines including the endocannabinoid anandamide are known to be hydrolyzed to fatty acids and ethanolamine by fatty acid amide hydrolase (FAAH).  In addn., we recently cloned an isoenzyme termed "N-acylethanolamine-hydrolyzing acid amidase (NAAA)", which is active only at acidic pH [Tsuboi, Sun, Okamoto, Araki, Tonai, Ueda, J. Biol. Chem. 285 (2005) 11082-11092].  However, physiol. roles of NAAA remained unclear.  Here, we examd. a possible contribution of NAAA to the degrdn. of various N-acylethanolamines in macrophage cells.  NAAA mRNA as well as FAAH mRNA was detected in several macrophage-like cells, including RAW264.7, and mouse peritoneal macrophages.  The homogenates of RAW264.7 cells showed both the NAAA and FAAH activities which were confirmed with the aid of their resp. specific inhibitors, N-cyclohexanecarbonylpentadecylamine (CCP) and URB597.  As analyzed with intact cells, RAW264.7 cells and peritoneal macrophages degraded anandamide, N-palmitoylethanolamine, N-oleoylethanolamine, and N-stearoylethanolamine.  Pretreatment of the cells with CCP or URB597 partially inhibited the degrdn., and a combination of the two compds. caused more profound inhibition.  In contrast, the anandamide hydrolysis in mouse brain appeared to be principally attributable to FAAH despite the expression of NAAA in the brain.  These results suggested that NAAA and FAAH cooperatively degraded various N-acylethanolamines in macrophages.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRw2Yw4epuc7Vg90H21EOLACvtfcHk0ljDrseIn6QFzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVOktr7O&md5=d4dbefcb0a2c84be624e98f1ee78f213</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1016%2Fj.bbalip.2005.08.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbalip.2005.08.010%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DY.%2BX.%26aulast%3DTsuboi%26aufirst%3DK.%26aulast%3DZhao%26aufirst%3DL.%2BY.%26aulast%3DOkamoto%26aufirst%3DY.%26aulast%3DLambert%26aufirst%3DD.%2BM.%26aulast%3DUeda%26aufirst%3DN.%26atitle%3DInvolvement%2520of%2520N-acylethanolamine-hydrolyzing%2520acid%2520amidase%2520in%2520the%2520degradation%2520of%2520anandamide%2520and%2520other%2520N-acylethanolamines%2520in%2520macrophages%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Cell%2520Biol.%2520Lipids%26date%3D2005%26volume%3D1736%26spage%3D211%26epage%3D220%26doi%3D10.1016%2Fj.bbalip.2005.08.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tai, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsuboi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uyama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masuda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cravatt, B. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houchi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueda, N.</span></span> <span> </span><span class="NLM_article-title">Endogenous molecules stimulating N-acylethanolamine-hydrolyzing acid amidase (NAAA)</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">379</span>– <span class="NLM_lpage">385</span>, <span class="refDoi"> DOI: 10.1021/cn300007s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn300007s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlSqs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=379-385&author=T.+Taiauthor=K.+Tsuboiauthor=T.+Uyamaauthor=K.+Masudaauthor=B.+F.+Cravattauthor=H.+Houchiauthor=N.+Ueda&title=Endogenous+molecules+stimulating+N-acylethanolamine-hydrolyzing+acid+amidase+%28NAAA%29&doi=10.1021%2Fcn300007s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Endogenous Molecules Stimulating N-Acylethanolamine-Hydrolyzing Acid Amidase (NAAA)</span></div><div class="casAuthors">Tai, Tatsuya; Tsuboi, Kazuhito; Uyama, Toru; Masuda, Kim; Cravatt, Benjamin F.; Houchi, Hitoshi; Ueda, Natsuo</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">379-385</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Fatty acid amide hydrolase (FAAH) plays the central role in the degrdn. of bioactive N-acylethanolamines such as the endocannabinoid arachidonoylethanolamide (anandamide) in brain and peripheral tissues.  A lysosomal enzyme referred to as N-acylethanolamine-hydrolyzing acid amidase (NAAA) catalyzes the same reaction with preference to palmitoylethanolamide, an endogenous analgesic and neuroprotective substance, and is therefore expected as a potential target of therapeutic drugs.  In the in vitro assays thus far performed, the maximal activity of NAAA was achieved in the presence of both nonionic detergent (Triton X-100 or Nonidet P-40) and the SH reagent dithiothreitol.  However, endogenous mols. that might substitute for these synthetic compds. remain poorly understood.  Here, we examd. stimulatory effects of endogenous phospholipids and thiol compds. on recombinant NAAA.  Among different phospholipids tested, choline- or ethanolamine-contg. phospholipids showed potent effects, and 1 mM phosphatidylcholine increased NAAA activity by 6.6-fold.  Concerning endogenous thiol compds., dihydrolipoic acid at 0.1-1 mM was the most active, causing 8.5-9.0-fold stimulation.  These results suggest that endogenous phospholipids and dihydrolipoic acid may contribute in keeping NAAA active in lysosomes.  Even in the presence of phosphatidylcholine and dihydrolipoic acid, however, the preferential hydrolysis of palmitoylethanolamide was unaltered.  We also investigated a possible compensatory induction of NAAA mRNA in brain and other tissues of FAAH-deficient mice.  However, NAAA expression levels in all the tissues examd. were not significantly altered from those in wild-type mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplBbMBMe7ntrVg90H21EOLACvtfcHk0lhgwiQRecX48w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlSqs7o%253D&md5=9efd719439affa31b0197bc8f4707cd7</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1021%2Fcn300007s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn300007s%26sid%3Dliteratum%253Aachs%26aulast%3DTai%26aufirst%3DT.%26aulast%3DTsuboi%26aufirst%3DK.%26aulast%3DUyama%26aufirst%3DT.%26aulast%3DMasuda%26aufirst%3DK.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26aulast%3DHouchi%26aufirst%3DH.%26aulast%3DUeda%26aufirst%3DN.%26atitle%3DEndogenous%2520molecules%2520stimulating%2520N-acylethanolamine-hydrolyzing%2520acid%2520amidase%2520%2528NAAA%2529%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2012%26volume%3D3%26spage%3D379%26epage%3D385%26doi%3D10.1021%2Fcn300007s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bonezzi, F. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sasso, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pontis, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Realini, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romeo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ponzano, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nuzzi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fiasella, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertozzi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piomelli, D.</span></span> <span> </span><span class="NLM_article-title">An important role for N-acylethanolamine acid amidase in the complete Freund’s adjuvant rat model of arthritis</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>356</i></span>,  <span class="NLM_fpage">656</span>– <span class="NLM_lpage">663</span>, <span class="refDoi"> DOI: 10.1124/jpet.115.230516</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1124%2Fjpet.115.230516" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=26769918" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BC28XpvVeks7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=356&publication_year=2016&pages=656-663&author=F.+T.+Bonezziauthor=O.+Sassoauthor=S.+Pontisauthor=N.+Realiniauthor=E.+Romeoauthor=S.+Ponzanoauthor=A.+Nuzziauthor=A.+Fiasellaauthor=F.+Bertozziauthor=D.+Piomelli&title=An+important+role+for+N-acylethanolamine+acid+amidase+in+the+complete+Freund%E2%80%99s+adjuvant+rat+model+of+arthritis&doi=10.1124%2Fjpet.115.230516"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">An important role for N-acylethanolamine acid amidase in the complete Freund's adjuvant rat model of arthritis</span></div><div class="casAuthors">Bonezzi, F. T.; Sasso, O.; Pontis, S.; Realini, N.; Romeo, E.; Ponzano, S.; Nuzzi, A.; Fiasella, A.; Bertozzi, F.; Piomelli, D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">356</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">656-663</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The endogenous lipid amides, palmitoylethanolamide (PEA) and oleoylethanolamide (OEA), exert marked antinociceptive and anti-inflammatory effects in animal models by engaging nuclear peroxisome proliferator-activated receptor-α.  PEA and OEA are produced by macrophages and other host-defense cells and are deactivated by the cysteine amidase, N-acylethanolamine acid amidase (NAAA), which is highly expressed in macrophages and B-lymphocytes.  In the present study, we examd. whether (a) NAAA might be involved in the inflammatory reaction triggered by injection of complete Freund's adjuvant (CFA) into the rat paw and (b) administration of 4-cyclohexylbutyl-N-[(S)-2-oxoazetidin-3-yl]-carbamate (ARN726), a novel systemically active NAAA inhibitor, attenuates such reaction.  Injection of CFA into the paw produced local edema and heat hyperalgesia, which were accompanied by decreased PEA and OEA content (assessed by liq. chromatog./mass spectrometry) and increased NAAA levels (assessed by Western blot and ex vivo enzyme activity measurements) in paw tissue.  Administration of undec-10-ynyl-N-[(3S)-2-oxoazetidin-3-yl] carbamate (ARN14686), a NAAA-preferring activity-based probe, revealed that NAAA was catalytically active in CFA-treated paws.  Administration of ARN726 reduced NAAA activity and restored PEA and OEA levels in inflamed tissues, and significantly decreased CFA-induced inflammatory symptoms, including pus prodn. and myeloperoxidase activity.  The results confirm the usefulness of ARN726 as a probe to investigate the functions of NAAA in health and disease and suggest that this enzyme may provide a new mol. target for the treatment of arthritis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoG6IIltfdLQbVg90H21EOLACvtfcHk0lhgwiQRecX48w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XpvVeks7s%253D&md5=5ce843469c81ad112b95c9a59a8bfbe5</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1124%2Fjpet.115.230516&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.115.230516%26sid%3Dliteratum%253Aachs%26aulast%3DBonezzi%26aufirst%3DF.%2BT.%26aulast%3DSasso%26aufirst%3DO.%26aulast%3DPontis%26aufirst%3DS.%26aulast%3DRealini%26aufirst%3DN.%26aulast%3DRomeo%26aufirst%3DE.%26aulast%3DPonzano%26aufirst%3DS.%26aulast%3DNuzzi%26aufirst%3DA.%26aulast%3DFiasella%26aufirst%3DA.%26aulast%3DBertozzi%26aufirst%3DF.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DAn%2520important%2520role%2520for%2520N-acylethanolamine%2520acid%2520amidase%2520in%2520the%2520complete%2520Freund%25E2%2580%2599s%2520adjuvant%2520rat%2520model%2520of%2520arthritis%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2016%26volume%3D356%26spage%3D656%26epage%3D663%26doi%3D10.1124%2Fjpet.115.230516" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span> <span> </span><span class="NLM_article-title">N-Acylethanolamine acid amidase (NAAA) inhibitor F215 as a novel therapeutic agent for osteoarthritis</span>. <i>Pharmacol. Res.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>145</i></span>,  <span class="NLM_fpage">104264</span>, <span class="refDoi"> DOI: 10.1016/j.phrs.2019.104264</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1016%2Fj.phrs.2019.104264" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=31063807" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A280%3ADC%252BB3M7jt1yktg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=145&publication_year=2019&pages=104264&author=P.+Zhouauthor=L.+Xiangauthor=Y.+Yangauthor=Y.+Wuauthor=T.+Huauthor=X.+Liuauthor=F.+Linauthor=Y.+Xiuauthor=K.+Wuauthor=C.+Luauthor=J.+Renauthor=Y.+Qiuauthor=Y.+Li&title=N-Acylethanolamine+acid+amidase+%28NAAA%29+inhibitor+F215+as+a+novel+therapeutic+agent+for+osteoarthritis&doi=10.1016%2Fj.phrs.2019.104264"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">N-Acylethanolamine acid amidase (NAAA) inhibitor F215 as a novel therapeutic agent for osteoarthritis</span></div><div class="casAuthors">Zhou Pan; Ren Jie; Xiang Lei; Yang Yulong; Wu Yuezhou; Hu Ting; Liu Xiaolong; Lu Canzhong; Lin Feitai; Xiu Yanghui; Wu Kangni; Qiu Yan; Li Yuhang</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological research</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">145</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">104264</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Osteoarthritis (OA), characterized by cartilage damage, synovitis inflammation and chronic pain, is a common degenerative joint disease that may lead to physical disability.  In the present study, we first explored the association between N-Acylethanolamine acid amidase (NAAA) and OA progression, and then examined the capability of the NAAA inhibitor F215 to attenuate osteoarthritis.  Increased NAAA expressions and decreased PEA levels in synovial membrane and lumbar spinal cord were observed in MIA induced osteoarthritic rats.  F215 (i.a., and i.p.) significantly protected against cartilage damage and synovial inflammation by directly increasing PEA levels in joints, or normalization of PEA levels and resolution of inflammation in spinal cord.  Moreover, F215 also markedly alleviated osteoarthritic pain in rats, and the therapeutic effects of F215 were blocked by the PPAR-α antagonist MK886.  The results revealed that NAAA may has been implicated in OA progression, and treatment with NAAA inhibitor F215 alleviated OA development by preventing cartilage damage, reducing inflammation, and alleviating pain.  Our study suggested that NAAA inhibitor might be a novel therapeutic agent for OA treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSiFosVJ8cipUmhnSqMnvzDfW6udTcc2eZv5S34sh2lqrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3M7jt1yktg%253D%253D&md5=a02aedafa3ee92e2182f4a6a45bd5cd3</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1016%2Fj.phrs.2019.104264&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phrs.2019.104264%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DP.%26aulast%3DXiang%26aufirst%3DL.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DHu%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DLin%26aufirst%3DF.%26aulast%3DXiu%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DK.%26aulast%3DLu%26aufirst%3DC.%26aulast%3DRen%26aufirst%3DJ.%26aulast%3DQiu%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DY.%26atitle%3DN-Acylethanolamine%2520acid%2520amidase%2520%2528NAAA%2529%2520inhibitor%2520F215%2520as%2520a%2520novel%2520therapeutic%2520agent%2520for%2520osteoarthritis%26jtitle%3DPharmacol.%2520Res.%26date%3D2019%26volume%3D145%26spage%3D104264%26doi%3D10.1016%2Fj.phrs.2019.104264" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Suárez, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romero-Zerbo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Márquez, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivera, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iglesias, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bermúdez-Silva, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andreu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodríguez
de Fonseca, F.</span></span> <span> </span><span class="NLM_article-title">Ulcerative colitis impairs the acylethanolamide-based anti-inflammatory system reversal by 5-aminosalicylic acid and glucocorticoids</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">e37729</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0037729</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1371%2Fjournal.pone.0037729" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=22662201" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BC38XotF2hu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=e37729&author=J.+Su%C3%A1rezauthor=Y.+Romero-Zerboauthor=L.+M%C3%A1rquezauthor=P.+Riveraauthor=M.+Iglesiasauthor=F.+J.+Berm%C3%BAdez-Silvaauthor=M.+Andreuauthor=F.+Rodr%C3%ADguez%0Ade+Fonseca&title=Ulcerative+colitis+impairs+the+acylethanolamide-based+anti-inflammatory+system+reversal+by+5-aminosalicylic+acid+and+glucocorticoids&doi=10.1371%2Fjournal.pone.0037729"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Ulcerative colitis impairs the acylethanolamide-based anti-inflammatory system reversal by 5-aminosalicylic acid and glucocorticoids</span></div><div class="casAuthors">Suarez, Juan; Romero-Zerbo, Yanina; Marquez, Lucia; Rivera, Patricia; Iglesias, Mar; Bermudez-Silva, Francisco J.; Andreu, Montserrat; de Fonseca, Fernando Rodriguez</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">e37729</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Studies in animal models and humans suggest anti-inflammatory roles on the N-acylethanolamide (NAE)-peroxisome proliferators activated receptor alpha (PPARα) system in inflammatory bowel diseases.  However, the presence and function of NAE-PPARα signaling system in the ulcerative colitis (UC) of humans remain unknown as well as its response to active anti-inflammatory therapies such as 5-aminosalicylic acid (5-ASA) and glucocorticoids.  Expression of PPARα receptor and PPARα ligands-biosynthetic (NAPE-PLD) and -degrading (FAAH and NAAA) enzymes were analyzed in untreated active and 5-ASA/glucocorticoids/immunomodulators-treated quiescent UC patients compared to healthy human colonic tissue by RT-PCR and immunohistochem. analyses.  PPARα, NAAA, NAPE-PLD, and FAAH showed differential distributions in the colonic epithelium, lamina propria, smooth muscle, and enteric plexus.  Gene expression anal. indicated a decrease of PPARα, PPARγ, and NAAA, and an increase of FAAH and iNOS in the active colitis mucosa.  Immunohistochem. expression in active colitis epithelium confirmed a PPARα decrease, but showed a sharp NAAA increase and a NAPE-PLD decrease, which were partially restored to control levels after treatment.  We also characterized the immune cells of the UC mucosa infiltrate.  We detected a decreased no. of NAAA-pos. and an increased no. of FAAH-pos. immune cells in active UC, which were partially restored to control levels after treatment.  NAE-PPARα signaling system is impaired during active UC and 5-ASA/glucocorticoids treatment restored its normal expression.  Since 5-ASA actions may work through PPARα and glucocorticoids through NAE-producing/degrading enzymes, the use of PPARα agonists or FAAH/NAAA blockers that increases endogenous PPARα ligands may yield similar therapeutics advantages.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGriIHnoNNIqxbVg90H21EOLACvtfcHk0lh5sZX3dChdAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XotF2hu7s%253D&md5=c45410e561b64237af1ccd4d705d903a</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0037729&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0037729%26sid%3Dliteratum%253Aachs%26aulast%3DSu%25C3%25A1rez%26aufirst%3DJ.%26aulast%3DRomero-Zerbo%26aufirst%3DY.%26aulast%3DM%25C3%25A1rquez%26aufirst%3DL.%26aulast%3DRivera%26aufirst%3DP.%26aulast%3DIglesias%26aufirst%3DM.%26aulast%3DBerm%25C3%25BAdez-Silva%26aufirst%3DF.%2BJ.%26aulast%3DAndreu%26aufirst%3DM.%26aulast%3DRodr%25C3%25ADguez%2Bde%2BFonseca%26aufirst%3DF.%26atitle%3DUlcerative%2520colitis%2520impairs%2520the%2520acylethanolamide-based%2520anti-inflammatory%2520system%2520reversal%2520by%25205-aminosalicylic%2520acid%2520and%2520glucocorticoids%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26spage%3De37729%26doi%3D10.1371%2Fjournal.pone.0037729" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Solorzano, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Battista, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Astarita, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lodola, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivara, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mor, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maccarrone, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antonietti, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duranti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tontini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuzzocrea, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarzia, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piomelli, D.</span></span> <span> </span><span class="NLM_article-title">Selective N-acylethanolamine-hydrolyzing acid amidase inhibition reveals a key role for endogenous palmitoylethanolamide in inflammation</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>106</i></span>,  <span class="NLM_fpage">20966</span>– <span class="NLM_lpage">20971</span>, <span class="refDoi"> DOI: 10.1073/pnas.0907417106</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1073%2Fpnas.0907417106" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=19926854" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksFygsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2009&pages=20966-20971&author=C.+Solorzanoauthor=C.+Zhuauthor=N.+Battistaauthor=G.+Astaritaauthor=A.+Lodolaauthor=S.+Rivaraauthor=M.+Morauthor=R.+Russoauthor=M.+Maccarroneauthor=F.+Antoniettiauthor=A.+Durantiauthor=A.+Tontiniauthor=S.+Cuzzocreaauthor=G.+Tarziaauthor=D.+Piomelli&title=Selective+N-acylethanolamine-hydrolyzing+acid+amidase+inhibition+reveals+a+key+role+for+endogenous+palmitoylethanolamide+in+inflammation&doi=10.1073%2Fpnas.0907417106"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Selective N-acylethanolamine-hydrolyzing acid amidase inhibition reveals a key role for endogenous palmitoylethanolamide in inflammation</span></div><div class="casAuthors">Solorzano, Carlos; Zhu, Chenggang; Battista, Natalia; Astarita, Giuseppe; Lodola, Alessio; Rivara, Silvia; Mor, Marco; Russo, Roberto; Maccarrone, Mauro; Antonietti, Francesca; Duranti, Andrea; Tontini, Andrea; Cuzzocrea, Salvatore; Tarzia, Giorgio; Piomelli, Daniele</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">49</span>),
    <span class="NLM_cas:pages">20966-20971, S20966/1-S20966/13</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Identifying points of control in inflammation is essential to discovering safe and effective antiinflammatory medicines.  Palmitoylethanolamide (PEA) is a naturally occurring lipid amide that, when administered as a drug, inhibits inflammatory responses by engaging peroxisome proliferator-activated receptor-α (PPAR-α).  PEA is preferentially hydrolyzed by the cysteine amidase N- acylethanolamine-hydrolyzing acid amidase (NAAA), which is highly expressed in macrophages.  Here we report the discovery of a potent and selective NAAA inhibitor, N-[(3S)-2-oxo-3-oxetanyl]-3-phenylpropanamide [(S)-OOPP], and show that this inhibitor increases PEA levels in activated leukocytes and blunts responses induced by inflammatory stimuli both in vitro and in vivo.  These effects are stereoselective, mimicked by exogenous PEA, and abolished by PPAR-α deletion.  (S)-OOPP also attenuates inflammation and tissue damage and improves recovery of motor function in mice subjected to spinal cord trauma.  The results suggest that PEA activation of PPAR-α in leukocytes serves as an early stop signal that contrasts the progress of inflammation.  The PEA-hydrolyzing amidase NAAA may provide a previously undescribed target for antiinflammatory medicines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojUMad22TONbVg90H21EOLACvtfcHk0lh5sZX3dChdAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksFygsA%253D%253D&md5=9e8f84c9aabfc0d7c9d382d5a4c57706</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0907417106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0907417106%26sid%3Dliteratum%253Aachs%26aulast%3DSolorzano%26aufirst%3DC.%26aulast%3DZhu%26aufirst%3DC.%26aulast%3DBattista%26aufirst%3DN.%26aulast%3DAstarita%26aufirst%3DG.%26aulast%3DLodola%26aufirst%3DA.%26aulast%3DRivara%26aufirst%3DS.%26aulast%3DMor%26aufirst%3DM.%26aulast%3DRusso%26aufirst%3DR.%26aulast%3DMaccarrone%26aufirst%3DM.%26aulast%3DAntonietti%26aufirst%3DF.%26aulast%3DDuranti%26aufirst%3DA.%26aulast%3DTontini%26aufirst%3DA.%26aulast%3DCuzzocrea%26aufirst%3DS.%26aulast%3DTarzia%26aufirst%3DG.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DSelective%2520N-acylethanolamine-hydrolyzing%2520acid%2520amidase%2520inhibition%2520reveals%2520a%2520key%2520role%2520for%2520endogenous%2520palmitoylethanolamide%2520in%2520inflammation%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2009%26volume%3D106%26spage%3D20966%26epage%3D20971%26doi%3D10.1073%2Fpnas.0907417106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">De
Filippis, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Amico, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cinelli, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esposito, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Marzo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iuvone, T.</span></span> <span> </span><span class="NLM_article-title">Adelmidrol, a palmitoylethanolamide analogue, reduces chronic inflammation in a carrageenin-granuloma model in rats</span>. <i>J. Cell. Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">1086</span>– <span class="NLM_lpage">1095</span>, <span class="refDoi"> DOI: 10.1111/j.1582-4934.2008.00353.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1111%2Fj.1582-4934.2008.00353.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=18429935" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVSnurbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2009&pages=1086-1095&author=D.+De%0AFilippisauthor=A.+D%E2%80%99Amicoauthor=M.+P.+Cinelliauthor=G.+Espositoauthor=V.+Di+Marzoauthor=T.+Iuvone&title=Adelmidrol%2C+a+palmitoylethanolamide+analogue%2C+reduces+chronic+inflammation+in+a+carrageenin-granuloma+model+in+rats&doi=10.1111%2Fj.1582-4934.2008.00353.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Adelmidrol, a palmitoylethanolamide analogue, reduces chronic inflammation in a carrageenin-granuloma model in rats</span></div><div class="casAuthors">De Filippis, Daniele; D'Amico, Alessandra; Cinelli, Maria Pia; Esposito, Giuseppe; Di Marzo, Vicenzo; Iuvone, Teresa</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cellular and Molecular Medicine</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1086-1095</span>CODEN:
                <span class="NLM_cas:coden">JCMMC9</span>;
        ISSN:<span class="NLM_cas:issn">1582-1838</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Palmitoylethanolamide (PEA) and some of its analogs have shown great efficacy in the treatment of pain and inflammation.  Adelmidrol - the International Nonproprietary Name (INN) of the di-amide deriv. of azelaic acid - is one of these analogs.  The anti-inflammatory and analgesic effects of PEA and adelmidrol are hypothesized to be mediated, at least in part, by mast cell down-modulation.  Mast cell mediators released at early stage of the inflammatory process drive the inflammatory reaction to chronicity as it happens in λ-carrageenin-induced granulomatous tissue formation.  In the present study, the choice of testing adelmidrol depends upon the physicochem. properties of the compd., i.e. the amphipatic feature, that make it more easily sol. than PEA.  In this study, we investigated the effect of adelmidrol on granuloma formation induced by λ-carrageenin-soaked sponge implant in rats.  Our results show that the local administration of the compd. under study significantly decreases wt. and neo-angiogenesis in granulomatous tissue.  The anti-inflammatory effect was due to the modulation of mast cells degranulation, as shown by histol. anal. and by the inhibition of the release of several pro-inflammatory and pro-angiogenic enzymes (e.g. iNOS, chymase and metalloproteinase MMP-9), and mediators (e.g. nitric oxide and TNF-α).  The results indicate that adelmidrol, given locally, may represent a potential therapeutic tool in controlling chronic inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKwzhZCaiWf7Vg90H21EOLACvtfcHk0li8DNnOq9x_qA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVSnurbF&md5=1b88fa81c701afc18c4f7a8987f90811</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1111%2Fj.1582-4934.2008.00353.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1582-4934.2008.00353.x%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BFilippis%26aufirst%3DD.%26aulast%3DD%25E2%2580%2599Amico%26aufirst%3DA.%26aulast%3DCinelli%26aufirst%3DM.%2BP.%26aulast%3DEsposito%26aufirst%3DG.%26aulast%3DDi%2BMarzo%26aufirst%3DV.%26aulast%3DIuvone%26aufirst%3DT.%26atitle%3DAdelmidrol%252C%2520a%2520palmitoylethanolamide%2520analogue%252C%2520reduces%2520chronic%2520inflammation%2520in%2520a%2520carrageenin-granuloma%2520model%2520in%2520rats%26jtitle%3DJ.%2520Cell.%2520Mol.%2520Med.%26date%3D2009%26volume%3D13%26spage%3D1086%26epage%3D1095%26doi%3D10.1111%2Fj.1582-4934.2008.00353.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">De
Filippis, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Amico, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cipriano, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petrosino, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orlando, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Marzo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iuvone, T.</span></span> <span> </span><span class="NLM_article-title">Levels of endocannabinoids and palmitoylethanolamide and their pharmacological manipulation in chronic granulomatous inflammation in rats</span>. <i>Pharmacol. Res.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">321</span>– <span class="NLM_lpage">328</span>, <span class="refDoi"> DOI: 10.1016/j.phrs.2009.11.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1016%2Fj.phrs.2009.11.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=19931394" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjt1WjtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2010&pages=321-328&author=D.+De%0AFilippisauthor=A.+D%E2%80%99Amicoauthor=M.+Ciprianoauthor=S.+Petrosinoauthor=P.+Orlandoauthor=V.+Di+Marzoauthor=T.+Iuvone&title=Levels+of+endocannabinoids+and+palmitoylethanolamide+and+their+pharmacological+manipulation+in+chronic+granulomatous+inflammation+in+rats&doi=10.1016%2Fj.phrs.2009.11.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Levels of endocannabinoids and palmitoylethanolamide and their pharmacological manipulation in chronic granulomatous inflammation in rats</span></div><div class="casAuthors">De Filippis, D.; D'Amico, A.; Cipriano, M.; Petrosino, S.; Orlando, P.; Di Marzo, V.; Iuvone, T.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">321-328</span>CODEN:
                <span class="NLM_cas:coden">PHMREP</span>;
        ISSN:<span class="NLM_cas:issn">1043-6618</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The endocannabinoids anandamide and 2-arachidonoylglycerol, and the anandamide-congener, palmitoylethanolamide, are all substrates for the enzyme fatty acid amide hydrolase, and are endowed with anti-inflammatory actions exerted via cannabinoid receptors or, in the case of palmitoylethanolamide, also via other targets.  We investigated the role of the endocannabinoid system during granuloma formation, a model of chronic inflammation sustained by neoangiogenesis, in rats.  Granuloma was induced by s.c. λ-carrageenin-soaked sponge implants on the back of male Wistar rats.  After 96 h, granulomas were detached and tissue formation was evaluated as wet wt.; the endocannabinoid system was evaluated by the measurement of endocannabinoid levels, by LC-MS, and of cannabinoid receptor expression, by western blot anal.  Moreover, angiogenesis was evaluated by the measurement of both Hb content and CD31 protein expression.  Arachidonoylserotonin (AA-5-HT, 12.5-50 μg/mL), an inhibitor of FAAH, and palmitoylethanolamide (PEA, 200-800 μg/mL) were given locally only once at the time of implantation.  Granuloma formation was accompanied by a significant decrease in endocannabinoid and palmitoylethanolamide levels paralleled by increased levels of the fatty acid amide hydrolase, responsible for their breakdown.  Moreover, an increase of cannabinoid receptor expression was also obsd.  Pharmacol. elevation of endocannabinoids and palmitoylethanolamide, obtained sep. by arachidonoylserotonin and exogenous palmitoylethanolamide treatment, dose-dependently reduced inflammatory hallmarks including tumor necrosis factor-α as well as granuloma-dependent angiogenesis.  The effect of arachidonoylserotonin was accompanied by near-normalization of 2-arachidonoylglycerol and palmitoylethanolamide levels in the tissue.  These findings suggest that chronic inflammation might develop also because of endocannabinoid and palmitoylethanolamide tissue concn. impairment, the correction of which might be exploited to develop new anti-inflammatory drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0U7KGQJfjHrVg90H21EOLACvtfcHk0li8DNnOq9x_qA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjt1WjtL0%253D&md5=c3c90d719ce22f0b36170c9afb79157e</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1016%2Fj.phrs.2009.11.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phrs.2009.11.005%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BFilippis%26aufirst%3DD.%26aulast%3DD%25E2%2580%2599Amico%26aufirst%3DA.%26aulast%3DCipriano%26aufirst%3DM.%26aulast%3DPetrosino%26aufirst%3DS.%26aulast%3DOrlando%26aufirst%3DP.%26aulast%3DDi%2BMarzo%26aufirst%3DV.%26aulast%3DIuvone%26aufirst%3DT.%26atitle%3DLevels%2520of%2520endocannabinoids%2520and%2520palmitoylethanolamide%2520and%2520their%2520pharmacological%2520manipulation%2520in%2520chronic%2520granulomatous%2520inflammation%2520in%2520rats%26jtitle%3DPharmacol.%2520Res.%26date%3D2010%26volume%3D61%26spage%3D321%26epage%3D328%26doi%3D10.1016%2Fj.phrs.2009.11.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Capasso, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Izzo, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fezza, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinto, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capasso, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mascolo, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Marzo, V.</span></span> <span> </span><span class="NLM_article-title">Inhibitory effect of palmitoylethanolamide on gastrointestinal motility in mice</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>134</i></span>,  <span class="NLM_fpage">945</span>– <span class="NLM_lpage">950</span>, <span class="refDoi"> DOI: 10.1038/sj.bjp.0704339</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1038%2Fsj.bjp.0704339" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=11682441" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BD3MXosVGrs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2001&pages=945-950&author=R.+Capassoauthor=A.+A.+Izzoauthor=F.+Fezzaauthor=A.+Pintoauthor=F.+Capassoauthor=N.+Mascoloauthor=V.+Di+Marzo&title=Inhibitory+effect+of+palmitoylethanolamide+on+gastrointestinal+motility+in+mice&doi=10.1038%2Fsj.bjp.0704339"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitory effect of palmitoylethanolamide on gastrointestinal motility in mice</span></div><div class="casAuthors">Capasso, Raffaele; Izzo, Angelo A.; Fezza, Filomena; Pinto, Aldo; Capasso, Francesco; Mascolo, Nicola; Di Marzo, Vincenzo</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">134</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">945-950</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">We have studied the effect of palmitoylethanolamide (PEA, 2.5-30 mg kg-1, i.p.) on upper gastrointestinal transit in control mice and in mice with chronic intestinal inflammation induced by croton oil.  PEA significantly and dose-dependently decreased intestinal transit.  The inhibitory effect of PEA (10 mg kg-1) was not modified by the cannabinoid CB1 receptor antagonist SR141716A (0.3 mg kg-1, i.p.), the cannabinoid CB2 receptor antagonist SR144528 (1 mg kg-1, i.p.), NG-nitro-L-arginine Me ester (L-NAME, 25 mg kg-1, i.p.), yohimbine (1 mg kg-1, i.p.), naloxone (2 mg kg-1, i.p.) or hexamethonium (1 mg kg-1, i.p.).  PEA levels were significantly decreased in the small intestine of croton oil-treated mice.  In these animals, PEA also inhibited motility and this effect was not counteracted by SR141716A (0.3 mg kg-1), or SR144528 (1 mg kg-1).  Pre-treatment of mice with the amidase inhibitor phenylmethyl sulfonil fluoride (PMSF, 30 mg kg-1, i.p.) did not modify the inhibitory effect of PEA, either in control or in mice with inflammation.  It is concluded that PEA inhibits intestinal motility with a peripheral mechanism independent from cannabinoid receptor activation.  The decreased levels of PEA in croton oil-treated might contribute, at least in part, to the exaggerated transit obsd. during chronic intestinal inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqky9EFVASu3bVg90H21EOLACvtfcHk0li8DNnOq9x_qA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXosVGrs7s%253D&md5=054b9a49959938ac21fb4d3f07c2c6bb</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0704339&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0704339%26sid%3Dliteratum%253Aachs%26aulast%3DCapasso%26aufirst%3DR.%26aulast%3DIzzo%26aufirst%3DA.%2BA.%26aulast%3DFezza%26aufirst%3DF.%26aulast%3DPinto%26aufirst%3DA.%26aulast%3DCapasso%26aufirst%3DF.%26aulast%3DMascolo%26aufirst%3DN.%26aulast%3DDi%2BMarzo%26aufirst%3DV.%26atitle%3DInhibitory%2520effect%2520of%2520palmitoylethanolamide%2520on%2520gastrointestinal%2520motility%2520in%2520mice%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2001%26volume%3D134%26spage%3D945%26epage%3D950%26doi%3D10.1038%2Fsj.bjp.0704339" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Izzo, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capasso, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aviello, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borrelli, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romano, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piscitelli, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capasso, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orlando, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Marzo, V.</span></span> <span> </span><span class="NLM_article-title">Inhibitory effect of cannabichromene, a major non-psychotropic cannabinoid extracted from Cannabis sativa, on inflammation-induced hypermotility in mice</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>166</i></span>,  <span class="NLM_fpage">1444</span>– <span class="NLM_lpage">1460</span>, <span class="refDoi"> DOI: 10.1111/j.1476-5381.2012.01879.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1111%2Fj.1476-5381.2012.01879.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=22300105" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BC38XotlWmtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=166&publication_year=2012&pages=1444-1460&author=A.+A.+Izzoauthor=R.+Capassoauthor=G.+Avielloauthor=F.+Borrelliauthor=B.+Romanoauthor=F.+Piscitelliauthor=L.+Galloauthor=F.+Capassoauthor=P.+Orlandoauthor=V.+Di+Marzo&title=Inhibitory+effect+of+cannabichromene%2C+a+major+non-psychotropic+cannabinoid+extracted+from+Cannabis+sativa%2C+on+inflammation-induced+hypermotility+in+mice&doi=10.1111%2Fj.1476-5381.2012.01879.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitory effect of cannabichromene, a major non-psychotropic cannabinoid extracted from Cannabis sativa, on inflammation-induced hypermotility in mice</span></div><div class="casAuthors">Izzo, Angelo A.; Capasso, Raffaele; Aviello, Gabriella; Borrelli, Francesca; Romano, Barbara; Piscitelli, Fabiana; Gallo, Laura; Capasso, Francesco; Orlando, Pierangelo; Di Marzo, Vincenzo</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">166</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1444-1460</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background and Purpose Cannabichromene (CBC) is a major non-psychotropic phytocannabinoid that inhibits endocannabinoid inactivation and activates the transient receptor potential ankyrin-1 (TRPA1).  Both endocannabinoids and TRPA1 may modulate gastrointestinal motility.  Here, we investigated the effect of CBC on mouse intestinal motility in physiol. and pathol. states.  Exptl. Approach Inflammation was induced in the mouse small intestine by croton oil.  Endocannabinoid (anandamide and 2-arachidonoyl glycerol), palmitoylethanolamide and oleoylethanolamide levels were measured by liq. chromatog.-mass spectrometry; TRPA1 and cannabinoid receptors were analyzed by quant. RT-PCR; upper gastrointestinal transit, colonic propulsion and whole gut transit were evaluated in vivo; contractility was evaluated in vitro by stimulating the isolated ileum, in an organ bath, with ACh or elec. field stimulation (EFS).  Key Results Croton oil administration was assocd. with decreased levels of anandamide (but not 2-arachidonoyl glycerol) and palmitoylethanolamide, up-regulation of TRPA1 and CB1 receptors and down-regulation of CB2 receptors.  Ex vivo CBC did not change endocannabinoid levels, but it altered the mRNA expression of TRPA1 and cannabinoid receptors.  In vivo, CBC did not affect motility in control mice, but normalized croton oil-induced hypermotility.  In vitro, CBC reduced preferentially EFS-vs. ACh-induced contractions.  Both in vitro and in vivo, the inhibitory effect of CBC was not modified by cannabinoid or TRPA1 receptor antagonists.  Conclusion and Implications CBC selectively reduces inflammation-induced hypermotility in vivo in a manner that is not dependent on cannabinoid receptors or TRPA1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZGU21Iu5_krVg90H21EOLACvtfcHk0lglz1UhyvTIrw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XotlWmtLg%253D&md5=4a9e11887c3575e1f76fbd3c0b8412de</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2012.01879.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2012.01879.x%26sid%3Dliteratum%253Aachs%26aulast%3DIzzo%26aufirst%3DA.%2BA.%26aulast%3DCapasso%26aufirst%3DR.%26aulast%3DAviello%26aufirst%3DG.%26aulast%3DBorrelli%26aufirst%3DF.%26aulast%3DRomano%26aufirst%3DB.%26aulast%3DPiscitelli%26aufirst%3DF.%26aulast%3DGallo%26aufirst%3DL.%26aulast%3DCapasso%26aufirst%3DF.%26aulast%3DOrlando%26aufirst%3DP.%26aulast%3DDi%2BMarzo%26aufirst%3DV.%26atitle%3DInhibitory%2520effect%2520of%2520cannabichromene%252C%2520a%2520major%2520non-psychotropic%2520cannabinoid%2520extracted%2520from%2520Cannabis%2520sativa%252C%2520on%2520inflammation-induced%2520hypermotility%2520in%2520mice%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2012%26volume%3D166%26spage%3D1444%26epage%3D1460%26doi%3D10.1111%2Fj.1476-5381.2012.01879.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pearson, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurian, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Latif, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garle, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barrett, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kendall, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scammell, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reeve, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chapman, V.</span></span> <span> </span><span class="NLM_article-title">Characterisation of the cannabinoid receptor system in synovial tissue and fluid in patients with osteoarthritis and rheumatoid arthritis</span>. <i>Arthritis Res. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">R43</span>, <span class="refDoi"> DOI: 10.1186/ar2401</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1186%2Far2401" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=18416822" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A280%3ADC%252BD1cvhtF2hsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2008&pages=R43&author=D.+Richardsonauthor=R.+G.+Pearsonauthor=N.+Kurianauthor=M.+L.+Latifauthor=M.+J.+Garleauthor=D.+A.+Barrettauthor=D.+A.+Kendallauthor=B.+E.+Scammellauthor=A.+J.+Reeveauthor=V.+Chapman&title=Characterisation+of+the+cannabinoid+receptor+system+in+synovial+tissue+and+fluid+in+patients+with+osteoarthritis+and+rheumatoid+arthritis&doi=10.1186%2Far2401"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Characterisation of the cannabinoid receptor system in synovial tissue and fluid in patients with osteoarthritis and rheumatoid arthritis</span></div><div class="casAuthors">Richardson Denise; Pearson Richard G; Kurian Nisha; Latif M Liaque; Garle Michael J; Barrett David A; Kendall David A; Scammell Brigitte E; Reeve Alison J; Chapman Victoria</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis research & therapy</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">R43</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">INTRODUCTION:  Cannabis-based medicines have a number of therapeutic indications, including anti-inflammatory and analgesic effects.  The endocannabinoid receptor system, including the cannabinoid receptor 1 (CB1) and receptor 2 (CB2) and the endocannabinoids, are implicated in a wide range of physiological and pathophysiological processes.  Pre-clinical and clinical studies have demonstrated that cannabis-based drugs have therapeutic potential in inflammatory diseases, including rheumatoid arthritis (RA) and multiple sclerosis.  The aim of this study was to determine whether the key elements of the endocannabinoid signalling system, which produces immunosuppression and analgesia, are expressed in the synovia of patients with osteoarthritis (OA) or RA.  METHODS:  Thirty-two OA and 13 RA patients undergoing total knee arthroplasty were included in this study.  Clinical staging was conducted from x-rays scored according to Kellgren-Lawrence and Larsen scales, and synovitis of synovial biopsies was graded.  Endocannabinoid levels were quantified in synovial fluid by liquid chromatography-mass spectrometry.  The expression of CB1 and CB2 protein and RNA in synovial biopsies was investigated.  Functional activity of these receptors was determined with mitogen-activated protein kinase assays.  To assess the impact of OA and RA on this receptor system, levels of endocannabinoids in the synovial fluid of patients and non-inflamed healthy volunteers were compared.  The activity of fatty acid amide hydrolase (FAAH), the predominant catabolic endocannabinoid enzyme, was measured in synovium.  RESULTS:  CB1 and CB2 protein and RNA were present in the synovia of OA and RA patients.  Cannabinoid receptor stimulation of fibroblast-like cells from OA and RA patients produced a time-dependent phosphorylation of extracellular signal-regulated kinase (ERK)-1 and ERK-2 which was significantly blocked by the CB1 antagonist SR141716A.  The endocannabinoids anandamide (AEA) and 2-arachidonyl glycerol (2-AG) were identified in the synovial fluid of OA and RA patients.  However, neither AEA nor 2-AG was detected in synovial fluid from normal volunteers.  FAAH was active in the synovia of OA and RA patients and was sensitive to inhibition by URB597 (3'-(aminocarbonyl) [1,1'-biphenyl]-3-yl)-cyclohexylcarbamate).  CONCLUSION:  Our data predict that the cannabinoid receptor system present in the synovium may be an important therapeutic target for the treatment of pain and inflammation associated with OA and RA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQlMMSg0l8H7AHqQV89nF-2fW6udTcc2eYQwTxHCH6vQrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1cvhtF2hsg%253D%253D&md5=74e8bf21212fb4b328ec9ae5310c5275</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1186%2Far2401&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Far2401%26sid%3Dliteratum%253Aachs%26aulast%3DRichardson%26aufirst%3DD.%26aulast%3DPearson%26aufirst%3DR.%2BG.%26aulast%3DKurian%26aufirst%3DN.%26aulast%3DLatif%26aufirst%3DM.%2BL.%26aulast%3DGarle%26aufirst%3DM.%2BJ.%26aulast%3DBarrett%26aufirst%3DD.%2BA.%26aulast%3DKendall%26aufirst%3DD.%2BA.%26aulast%3DScammell%26aufirst%3DB.%2BE.%26aulast%3DReeve%26aufirst%3DA.%2BJ.%26aulast%3DChapman%26aufirst%3DV.%26atitle%3DCharacterisation%2520of%2520the%2520cannabinoid%2520receptor%2520system%2520in%2520synovial%2520tissue%2520and%2520fluid%2520in%2520patients%2520with%2520osteoarthritis%2520and%2520rheumatoid%2520arthritis%26jtitle%3DArthritis%2520Res.%2520Ther.%26date%3D2008%26volume%3D10%26spage%3DR43%26doi%3D10.1186%2Far2401" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tsuboi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, L. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okamoto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Araki, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueno, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakamoto, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueda, N.</span></span> <span> </span><span class="NLM_article-title">Predominant expression of lysosomal N-acylethanolamine-hydrolyzing acid amidase in macrophages revealed by immunochemical studies</span>. <i>Biochim. Biophys. Acta, Mol. Cell Biol. Lipids</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>1771</i></span>,  <span class="NLM_fpage">623</span>– <span class="NLM_lpage">632</span>, <span class="refDoi"> DOI: 10.1016/j.bbalip.2007.03.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1016%2Fj.bbalip.2007.03.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=17462942" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BD2sXkvFGqurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1771&publication_year=2007&pages=623-632&author=K.+Tsuboiauthor=L.+Y.+Zhaoauthor=Y.+Okamotoauthor=N.+Arakiauthor=M.+Uenoauthor=H.+Sakamotoauthor=N.+Ueda&title=Predominant+expression+of+lysosomal+N-acylethanolamine-hydrolyzing+acid+amidase+in+macrophages+revealed+by+immunochemical+studies&doi=10.1016%2Fj.bbalip.2007.03.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Predominant expression of lysosomal N-acylethanolamine-hydrolyzing acid amidase in macrophages revealed by immunochemical studies</span></div><div class="casAuthors">Tsuboi, Kazuhito; Zhao, Li-Ying; Okamoto, Yasuo; Araki, Nobukazu; Ueno, Masaki; Sakamoto, Haruhiko; Ueda, Natsuo</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular and Cell Biology of Lipids</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">1771</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">623-632</span>CODEN:
                <span class="NLM_cas:coden">BBMLFG</span>;
        ISSN:<span class="NLM_cas:issn">1388-1981</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Bioactive N-acylethanolamines, including anandamide (an endocannabinoid), N-palmitoylethanolamine (an anti-inflammatory substance), and N-oleoylethanolamine (an anorexic substance) are enzymically hydrolyzed to fatty acids and ethanolamine.  Fatty acid amide hydrolase plays a major role in this reaction.  In addn., we cloned cDNA of an isoenzyme termed "N-acylethanolamine-hydrolyzing acid amidase (NAAA)" [K. Tsuboi, Y.-X. Sun, Y. Okamoto, N. Araki, T. Tonai, N. Ueda, Mol. characterization of N-acylethanolamine-hydrolyzing acid amidase, a novel member of the choloylglycine hydrolase family with structural and functional similarity to acid ceramidase, J. Biol. Chem. 280 (2005) 11082-11092].  Previous biochem. analyses suggested the expression of NAAA in macrophage cells and various rat tissues including lung and brain.  To clarify the physiol. significance of NAAA, here we immunochem. studied NAAA for the first time.  We developed an antibody specific for rat NAAA, and by Western blotting revealed that NAAA is glycosylated and subjected to specific proteolysis.  In alveolar macrophages isolated from rat lung, NAAA was immunocytochem. localized in lysosomes.  In the whole lung tissue, only alveolar macrophages were immunostained for NAAA.  Conformably, the mRNA and protein levels and activity of NAAA in alveolar macrophages were much higher than those in the whole lung tissue.  In brain, intraventricular macrophages were pos. stained with anti-NAAA antibody, while microglia appeared to be neg.  These results strongly suggested the importance of macrophages as an expression site of NAAA in rat tissues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowY-OXLo7L6LVg90H21EOLACvtfcHk0lhgwR0mTai_yA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXkvFGqurY%253D&md5=4e3a565943630fb15763161bf5513577</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1016%2Fj.bbalip.2007.03.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbalip.2007.03.005%26sid%3Dliteratum%253Aachs%26aulast%3DTsuboi%26aufirst%3DK.%26aulast%3DZhao%26aufirst%3DL.%2BY.%26aulast%3DOkamoto%26aufirst%3DY.%26aulast%3DAraki%26aufirst%3DN.%26aulast%3DUeno%26aufirst%3DM.%26aulast%3DSakamoto%26aufirst%3DH.%26aulast%3DUeda%26aufirst%3DN.%26atitle%3DPredominant%2520expression%2520of%2520lysosomal%2520N-acylethanolamine-hydrolyzing%2520acid%2520amidase%2520in%2520macrophages%2520revealed%2520by%2520immunochemical%2520studies%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Cell%2520Biol.%2520Lipids%26date%3D2007%26volume%3D1771%26spage%3D623%26epage%3D632%26doi%3D10.1016%2Fj.bbalip.2007.03.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ribeiro, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pontis, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mengatto, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Armirotti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiurchiù, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capurro, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fiasella, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nuzzi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romeo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreno-Sanz, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maccarrone, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reggiani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarzia, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mor, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertozzi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bandiera, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piomelli, D.</span></span> <span> </span><span class="NLM_article-title">A potent systemically active N-acylethanolamine acid amidase inhibitor that suppresses inflammation and human macrophage activation</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">1838</span>– <span class="NLM_lpage">1846</span>, <span class="refDoi"> DOI: 10.1021/acschembio.5b00114</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.5b00114" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmsV2lsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=1838-1846&author=A.+Ribeiroauthor=S.+Pontisauthor=L.+Mengattoauthor=A.+Armirottiauthor=V.+Chiurchi%C3%B9author=V.+Capurroauthor=A.+Fiasellaauthor=A.+Nuzziauthor=E.+Romeoauthor=G.+Moreno-Sanzauthor=M.+Maccarroneauthor=A.+Reggianiauthor=G.+Tarziaauthor=M.+Morauthor=F.+Bertozziauthor=T.+Bandieraauthor=D.+Piomelli&title=A+potent+systemically+active+N-acylethanolamine+acid+amidase+inhibitor+that+suppresses+inflammation+and+human+macrophage+activation&doi=10.1021%2Facschembio.5b00114"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">A Potent Systemically Active N-Acylethanolamine Acid Amidase Inhibitor that Suppresses Inflammation and Human Macrophage Activation</span></div><div class="casAuthors">Ribeiro, Alison; Pontis, Silvia; Mengatto, Luisa; Armirotti, Andrea; Chiurchiu, Valerio; Capurro, Valeria; Fiasella, Annalisa; Nuzzi, Andrea; Romeo, Elisa; Moreno-Sanz, Guillermo; Maccarrone, Mauro; Reggiani, Angelo; Tarzia, Giorgio; Mor, Marco; Bertozzi, Fabio; Bandiera, Tiziano; Piomelli, Daniele</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1838-1846</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Fatty acid ethanolamides such as palmitoylethanolamide (PEA) and oleoylethanolamide (OEA) are lipid-derived mediators that potently inhibit pain and inflammation by ligating type-α peroxisome proliferator-activated receptors (PPAR-α).  These bioactive substances are preferentially degraded by the cysteine hydrolase, N-acylethanolamine acid amidase (NAAA), which is highly expressed in macrophages.  Here, we describe a new class of β-lactam derivs. that are potent, selective, and systemically active inhibitors of intracellular NAAA activity.  The prototype of this class deactivates NAAA by covalently binding the enzyme's catalytic cysteine and exerts profound anti-inflammatory effects in both mouse models and human macrophages.  This agent may be used to probe the functions of NAAA in health and disease and as a starting point to discover better anti-inflammatory drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrD6Y2cNKursLVg90H21EOLACvtfcHk0lhgwR0mTai_yA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmsV2lsrw%253D&md5=a240d871adfc85b99c7e148600573217</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1021%2Facschembio.5b00114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.5b00114%26sid%3Dliteratum%253Aachs%26aulast%3DRibeiro%26aufirst%3DA.%26aulast%3DPontis%26aufirst%3DS.%26aulast%3DMengatto%26aufirst%3DL.%26aulast%3DArmirotti%26aufirst%3DA.%26aulast%3DChiurchi%25C3%25B9%26aufirst%3DV.%26aulast%3DCapurro%26aufirst%3DV.%26aulast%3DFiasella%26aufirst%3DA.%26aulast%3DNuzzi%26aufirst%3DA.%26aulast%3DRomeo%26aufirst%3DE.%26aulast%3DMoreno-Sanz%26aufirst%3DG.%26aulast%3DMaccarrone%26aufirst%3DM.%26aulast%3DReggiani%26aufirst%3DA.%26aulast%3DTarzia%26aufirst%3DG.%26aulast%3DMor%26aufirst%3DM.%26aulast%3DBertozzi%26aufirst%3DF.%26aulast%3DBandiera%26aufirst%3DT.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DA%2520potent%2520systemically%2520active%2520N-acylethanolamine%2520acid%2520amidase%2520inhibitor%2520that%2520suppresses%2520inflammation%2520and%2520human%2520macrophage%2520activation%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2015%26volume%3D10%26spage%3D1838%26epage%3D1846%26doi%3D10.1021%2Facschembio.5b00114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span>ImmGen. <a href="http://www.immgen.org" class="extLink">http://www.immgen.org</a> (accessed
Jan 28, 2020).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=ImmGen.+http%3A%2F%2Fwww.immgen.org+%28accessed%0AJan+28%2C+2020%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sasso, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Summa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Armirotti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pontis, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Mei, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piomelli, D.</span></span> <span> </span><span class="NLM_article-title">The N-acylethanolamine acid amidase inhibitor ARN077 suppresses inflammation and pruritus in a mouse model of allergic dermatitis</span>. <i>J. Invest. Dermatol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>138</i></span>,  <span class="NLM_fpage">562</span>– <span class="NLM_lpage">569</span>, <span class="refDoi"> DOI: 10.1016/j.jid.2017.07.853</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1016%2Fj.jid.2017.07.853" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=29054595" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitl2qtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=138&publication_year=2018&pages=562-569&author=O.+Sassoauthor=M.+Summaauthor=A.+Armirottiauthor=S.+Pontisauthor=C.+De+Meiauthor=D.+Piomelli&title=The+N-acylethanolamine+acid+amidase+inhibitor+ARN077+suppresses+inflammation+and+pruritus+in+a+mouse+model+of+allergic+dermatitis&doi=10.1016%2Fj.jid.2017.07.853"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">The N-Acylethanolamine Acid Amidase Inhibitor ARN077 Suppresses Inflammation and Pruritus in a Mouse Model of Allergic Dermatitis</span></div><div class="casAuthors">Sasso, O.; Summa, M.; Armirotti, A.; Pontis, S.; De Mei, C.; Piomelli, Daniele</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Investigative Dermatology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">138</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">562-569</span>CODEN:
                <span class="NLM_cas:coden">JIDEAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-202X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">N-acylethanolamine acid amidase (NAAA), a cysteine hydrolase highly expressed in macrophages and B lymphocytes, catalyzes the degrdn. of palmitoylethanolamide.  Palmitoylethanolamide is an agonist of PPAR-α and an important regulator of pain and innate immunity.  In this study, we investigated the properties of the NAAA inhibitor, ARN077, in a mouse model of allergic contact dermatitis.  Acute topical applications of ARN077 attenuated key signs of DNFB-induced dermatitis in a dose-dependent manner.  Moreover, ARN077 increased tissue palmitoylethanolamide content and normalized circulating levels of cytokines and IgE.  No such effect was seen in PPAR-α-deficient mice.  Moreover, mice lacking NAAA failed to develop edema or scratching behavior after challenge with DNFB, confirming that this enzyme plays an important role in dermatitis.  Consistent with this conclusion, subchronic applications of ARN077 suppressed DNFB-induced inflammation when administered either before or after the DNFB challenge.  The effects of subchronic ARN077 were dose dependent and comparable in size to those produced by the steroids clobetasol and dexamethasone.  Unlike the latter, however, ARN077 did not cause skin atrophy.  The results identify NAAA as a promising target for the development of effective and safe treatments for atopic dermatitis and other inflammatory disorders of the skin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGKONQ-rQpLbVg90H21EOLACvtfcHk0lhgwR0mTai_yA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitl2qtr8%253D&md5=47e862197856ce83e51fc7c8a34ada85</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1016%2Fj.jid.2017.07.853&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jid.2017.07.853%26sid%3Dliteratum%253Aachs%26aulast%3DSasso%26aufirst%3DO.%26aulast%3DSumma%26aufirst%3DM.%26aulast%3DArmirotti%26aufirst%3DA.%26aulast%3DPontis%26aufirst%3DS.%26aulast%3DDe%2BMei%26aufirst%3DC.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DThe%2520N-acylethanolamine%2520acid%2520amidase%2520inhibitor%2520ARN077%2520suppresses%2520inflammation%2520and%2520pruritus%2520in%2520a%2520mouse%2520model%2520of%2520allergic%2520dermatitis%26jtitle%3DJ.%2520Invest.%2520Dermatol.%26date%3D2018%26volume%3D138%26spage%3D562%26epage%3D569%26doi%3D10.1016%2Fj.jid.2017.07.853" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, Y.</span></span> <span> </span><span class="NLM_article-title">Potential analgesic effects of a novel N-acylethanolamine acid amidase inhibitor F96 through PPAR-α</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">13565</span>, <span class="refDoi"> DOI: 10.1038/srep13565</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1038%2Fsrep13565" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=26310614" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVKhtLzK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&pages=13565&author=L.+Yangauthor=L.+Liauthor=L.+Chenauthor=Y.+Liauthor=H.+Chenauthor=Y.+Liauthor=G.+Jiauthor=D.+Linauthor=Z.+Liuauthor=Y.+Qiu&title=Potential+analgesic+effects+of+a+novel+N-acylethanolamine+acid+amidase+inhibitor+F96+through+PPAR-%CE%B1&doi=10.1038%2Fsrep13565"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Potential analgesic effects of a novel N-acylethanolamine acid amidase inhibitor F96 through PPAR-α</span></div><div class="casAuthors">Yang, Longhe; Li, Long; Chen, Ling; Li, Yanting; Chen, Huixia; Li, Yuhang; Ji, Guangnian; Lin, Donghai; Liu, Zuguo; Qiu, Yan</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">13565</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Pharmacol. blockade of N-acylethanolamine acid amidase (NAAA) activity is an available approach for inflammation and pain control through restoring the ability of endogenous PEA.  But the recently reported NAAA inhibitors suffer from the chem. and biol. unstable properties, which restrict functions of NAAA inhibition in vivo.  It is still unrevealed whether systematic inhibition of NAAA could modulate PEA-mediated pain signalings.  Here we reported an oxazolidinone imide compd. 3-(6-phenylhexanoyl) oxazolidin-2-one (F96), which potently and selectively inhibited NAAA activity (IC50 = 270 nM).  I.p. (i.p.) injection of F96 (3-30 mg/kg) dose-dependently reduced ear edema and restored PEA levels of ear tissues in 12-O-Tetradecanoylphorbol-13-acetate (TPA) induced ear edema models.  Furthermore, F96 inhibited acetic acid-induced writhing and increased spared nerve injury induced tactile allodynia thresholds in a dose-dependent manner.  Pharmacol. effects of F96 (10 mg/kg, i.p.) on various animal models were abolished in PPAR-α-/- mice, and were prevented by PPAR-α antagonist MK886 but not by canabinoid receptor type 1 (CB1) antagonist Rimonabant nor canabinoid receptor type 2 (CB2) antagonist SR144528.  Zebrafish embryos expts. showed better security and lower toxicity for F96 than ibuprofen.  These results revealed that F96 might be useful in treating inflammatory and neuropathic pain by NAAA inhibition depending on PPAR-α receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsP6tlGryp3LVg90H21EOLACvtfcHk0li6PRBE0rB5wg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVKhtLzK&md5=237e107001c9eef18e130d12a0724300</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1038%2Fsrep13565&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep13565%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DJi%26aufirst%3DG.%26aulast%3DLin%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DQiu%26aufirst%3DY.%26atitle%3DPotential%2520analgesic%2520effects%2520of%2520a%2520novel%2520N-acylethanolamine%2520acid%2520amidase%2520inhibitor%2520F96%2520through%2520PPAR-%25CE%25B1%26jtitle%3DSci.%2520Rep.%26date%3D2015%26volume%3D5%26spage%3D13565%26doi%3D10.1038%2Fsrep13565" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Locascio, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lesniak, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roderick, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watt, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eklund, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang-James, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hauser, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grünblatt, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moran, L. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mandel, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riederer, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Federoff, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wüllner, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papapetropoulos, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Youdim, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cantuti-Castelvetri, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vance, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hedreen, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adler, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beach, T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graeber, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Middleton, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rochet, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scherzer, C. R.</span></span> <span> </span><span class="NLM_article-title">Global PD Gene Expression (GPEX) Consortium. PGC-1α, a potential therapeutic target for early intervention in Parkinson’s disease</span>. <i>Sci. Transl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">52ra73</span>, <span class="refDoi"> DOI: 10.1126/scitranslmed.3001059</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1126%2Fscitranslmed.3001059" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=20926834" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2010&pages=52ra73&author=B.+Zhengauthor=Z.+Liaoauthor=J.+J.+Locascioauthor=K.+A.+Lesniakauthor=S.+S.+Roderickauthor=M.+L.+Wattauthor=A.+C.+Eklundauthor=Y.+Zhang-Jamesauthor=P.+D.+Kimauthor=M.+A.+Hauserauthor=E.+Gr%C3%BCnblattauthor=L.+B.+Moranauthor=S.+A.+Mandelauthor=P.+Riedererauthor=R.+M.+Millerauthor=H.+J.+Federoffauthor=U.+W%C3%BCllnerauthor=S.+Papapetropoulosauthor=M.+B.+Youdimauthor=I.+Cantuti-Castelvetriauthor=A.+B.+Youngauthor=J.+M.+Vanceauthor=R.+L.+Davisauthor=J.+C.+Hedreenauthor=C.+H.+Adlerauthor=T.+G.+Beachauthor=M.+B.+Graeberauthor=F.+A.+Middletonauthor=J.+C.+Rochetauthor=C.+R.+Scherzer&title=Global+PD+Gene+Expression+%28GPEX%29+Consortium.+PGC-1%CE%B1%2C+a+potential+therapeutic+target+for+early+intervention+in+Parkinson%E2%80%99s+disease&doi=10.1126%2Fscitranslmed.3001059"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.3001059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.3001059%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DB.%26aulast%3DLiao%26aufirst%3DZ.%26aulast%3DLocascio%26aufirst%3DJ.%2BJ.%26aulast%3DLesniak%26aufirst%3DK.%2BA.%26aulast%3DRoderick%26aufirst%3DS.%2BS.%26aulast%3DWatt%26aufirst%3DM.%2BL.%26aulast%3DEklund%26aufirst%3DA.%2BC.%26aulast%3DZhang-James%26aufirst%3DY.%26aulast%3DKim%26aufirst%3DP.%2BD.%26aulast%3DHauser%26aufirst%3DM.%2BA.%26aulast%3DGr%25C3%25BCnblatt%26aufirst%3DE.%26aulast%3DMoran%26aufirst%3DL.%2BB.%26aulast%3DMandel%26aufirst%3DS.%2BA.%26aulast%3DRiederer%26aufirst%3DP.%26aulast%3DMiller%26aufirst%3DR.%2BM.%26aulast%3DFederoff%26aufirst%3DH.%2BJ.%26aulast%3DW%25C3%25BCllner%26aufirst%3DU.%26aulast%3DPapapetropoulos%26aufirst%3DS.%26aulast%3DYoudim%26aufirst%3DM.%2BB.%26aulast%3DCantuti-Castelvetri%26aufirst%3DI.%26aulast%3DYoung%26aufirst%3DA.%2BB.%26aulast%3DVance%26aufirst%3DJ.%2BM.%26aulast%3DDavis%26aufirst%3DR.%2BL.%26aulast%3DHedreen%26aufirst%3DJ.%2BC.%26aulast%3DAdler%26aufirst%3DC.%2BH.%26aulast%3DBeach%26aufirst%3DT.%2BG.%26aulast%3DGraeber%26aufirst%3DM.%2BB.%26aulast%3DMiddleton%26aufirst%3DF.%2BA.%26aulast%3DRochet%26aufirst%3DJ.%2BC.%26aulast%3DScherzer%26aufirst%3DC.%2BR.%26atitle%3DGlobal%2520PD%2520Gene%2520Expression%2520%2528GPEX%2529%2520Consortium.%2520PGC-1%25CE%25B1%252C%2520a%2520potential%2520therapeutic%2520target%2520for%2520early%2520intervention%2520in%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2010%26volume%3D2%26spage%3D52ra73%26doi%3D10.1126%2Fscitranslmed.3001059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Su, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kordower, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishida, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Federoff, H. J.</span></span> <span> </span><span class="NLM_article-title">PGC1α promoter methylation in Parkinson’s disease</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">e0134087</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0134087</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1371%2Fjournal.pone.0134087" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=26317511" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BC28XosVeisw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=e0134087&author=X.+Suauthor=Y.+Chuauthor=J.+H.+Kordowerauthor=B.+Liauthor=H.+Caoauthor=L.+Huangauthor=M.+Nishidaauthor=L.+Songauthor=D.+Wangauthor=H.+J.+Federoff&title=PGC1%CE%B1+promoter+methylation+in+Parkinson%E2%80%99s+disease&doi=10.1371%2Fjournal.pone.0134087"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">PCG1α promoter methylation in parkinson's</span></div><div class="casAuthors">Su, Xiaomin; Chu, Yaping; Kordower, Jeffrey H.; Li, Bin; Cao, Hong; Huang, Liang; Nishida, Maki; Song, Lei; Wang, Difei; Federoff, Howard J.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">e0134087/1-e0134087/24</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">The etiopathogenesis of sporadic Parkinson's disease (PD) remains elusive although mitochondrial dysfunction has long been implicated.  Recent evidence revealed reduced expression of peroxisome proliferator-activated receptor gamma coactivator α (PGC1α) and downstream regulated nuclear encoded respiratory complex genes in affected brain tissue from PD patients.  We sought to det. whether epigenetic modification of the PGC1α gene could account for diminished expression.  In substantia nigra from PD patients but not control subjects, we show significant promoter-proximal non-canonical cytosine methylation of the PGC1α gene but not an adjacent gene.  As neuroinflammation is a prominent feature of PD and a mediator of epigenetic change, we evaluated whether the pro-inflammatory fatty acid, palmitate, would stimulate PGC1α promoter methylation in different cell types from the CNS.  Indeed, in mouse primary cortical neurons, microglia and astrocytes, palmitate causes PGC1α gene promoter non-canonical cytosine methylation, reduced expression of the gene and reduced mitochondrial content.  Moreover, intracerebroventricular (ICV) injection of palmitate to transgenic human synuclein mutant mice resulted in increased PGC1α promoter methylation, decreased PGC1α expression and reduced mitochondrial content in substantia nigra.  Finally we provide evidence that dysregulation of ER stress and inflammatory signaling is assocd. with PGC1α promoter methylation.  Together, these data strengthen the connection between satd. fatty acids, neuroflammation, ER stress, epigenetic alteration and bioenergetic compromise in PD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0ke8RDhyA7LVg90H21EOLACvtfcHk0li6PRBE0rB5wg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XosVeisw%253D%253D&md5=8e65a52b339e5dcc4d39962a84f8215a</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0134087&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0134087%26sid%3Dliteratum%253Aachs%26aulast%3DSu%26aufirst%3DX.%26aulast%3DChu%26aufirst%3DY.%26aulast%3DKordower%26aufirst%3DJ.%2BH.%26aulast%3DLi%26aufirst%3DB.%26aulast%3DCao%26aufirst%3DH.%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DNishida%26aufirst%3DM.%26aulast%3DSong%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DD.%26aulast%3DFederoff%26aufirst%3DH.%2BJ.%26atitle%3DPGC1%25CE%25B1%2520promoter%2520methylation%2520in%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DPLoS%2520One%26date%3D2015%26volume%3D10%26spage%3De0134087%26doi%3D10.1371%2Fjournal.pone.0134087" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Korbecki, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bajdak-Rusinek, K.</span></span> <span> </span><span class="NLM_article-title">The effect of palmitic acid on inflammatory response in macrophages: an overview of molecular mechanisms</span>. <i>Inflammation Res.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>68</i></span>,  <span class="NLM_fpage">915</span>– <span class="NLM_lpage">932</span>, <span class="refDoi"> DOI: 10.1007/s00011-019-01273-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1007%2Fs00011-019-01273-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=31363792" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhsVOgt7vK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2019&pages=915-932&author=J.+Korbeckiauthor=K.+Bajdak-Rusinek&title=The+effect+of+palmitic+acid+on+inflammatory+response+in+macrophages%3A+an+overview+of+molecular+mechanisms&doi=10.1007%2Fs00011-019-01273-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">The effect of palmitic acid on inflammatory response in macrophages: an overview of molecular mechanisms</span></div><div class="casAuthors">Korbecki, Jan; Bajdak-Rusinek, Karolina</div><div class="citationInfo"><span class="NLM_cas:title">Inflammation Research</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">915-932</span>CODEN:
                <span class="NLM_cas:coden">INREFB</span>;
        ISSN:<span class="NLM_cas:issn">1023-3830</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Basel</span>)
        </div><div class="casAbstract">A review.  Palmitic acid is a satd. fatty acid whose blood concn. is elevated in obese patients.  This causes inflammatory responses, where toll-like receptors (TLR), TLR2 and TLR4, play an important role.  Nevertheless, palmitic acid is not only a TLR agonist.  In the cell, this fatty acid is converted into phospholipids, diacylglycerol and ceramides.  They trigger the activation of various signaling pathways that are common for LPS-mediated TLR4 activation.  In particular, metabolic products of palmitic acid affect the activation of various PKCs, ER stress and cause an increase in ROS generation.  Thanks to this, palmitic acid also strengthens the TLR4-induced signaling.  In this review, we discuss the mechanisms of inflammatory response induced by palmitic acid.  In particular, we focus on describing its effect on ER stress and IRE1α, and the mechanisms of NF-κB activation.  We also present the mechanisms of inflammasome NLRP3 activation and the effect of palmitic acid on enhanced inflammatory response by increasing the expression of FABP4/aP2.  Finally, we focus on the consequences of inflammatory responses, in particular, the effect of TNF-α, IL-1β and IL-6 on insulin resistance.  Due to the high importance of macrophages and the prodn. of proinflammatory cytokines by them, this work mainly focuses on these cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTpJNTdlIwQLVg90H21EOLACvtfcHk0lgljDA_qBEvzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhsVOgt7vK&md5=781bc67fe4540acaa5b7eafd0b3cc2c4</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1007%2Fs00011-019-01273-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00011-019-01273-5%26sid%3Dliteratum%253Aachs%26aulast%3DKorbecki%26aufirst%3DJ.%26aulast%3DBajdak-Rusinek%26aufirst%3DK.%26atitle%3DThe%2520effect%2520of%2520palmitic%2520acid%2520on%2520inflammatory%2520response%2520in%2520macrophages%253A%2520an%2520overview%2520of%2520molecular%2520mechanisms%26jtitle%3DInflammation%2520Res.%26date%3D2019%26volume%3D68%26spage%3D915%26epage%3D932%26doi%3D10.1007%2Fs00011-019-01273-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Handschin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spiegelman, B. M.</span></span> <span> </span><span class="NLM_article-title">Peroxisome proliferator-activated receptor gamma coactivator 1 coactivators, energy homeostasis, and metabolism</span>. <i>Endocr. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">728</span>– <span class="NLM_lpage">735</span>, <span class="refDoi"> DOI: 10.1210/er.2006-0037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1210%2Fer.2006-0037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=17018837" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BD2sXns1Wrtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2006&pages=728-735&author=C.+Handschinauthor=B.+M.+Spiegelman&title=Peroxisome+proliferator-activated+receptor+gamma+coactivator+1+coactivators%2C+energy+homeostasis%2C+and+metabolism&doi=10.1210%2Fer.2006-0037"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Peroxisome proliferator-activated receptor γ coactivator 1 coactivators, energy homeostasis, and metabolism</span></div><div class="casAuthors">Handschin, Christoph; Spiegelman, Bruce M.</div><div class="citationInfo"><span class="NLM_cas:title">Endocrine Reviews</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">728-735</span>CODEN:
                <span class="NLM_cas:coden">ERVIDP</span>;
        ISSN:<span class="NLM_cas:issn">0163-769X</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">A review.  Many biol. programs are regulated at the transcriptional level.  This is generally achieved by the concerted actions of several transcription factors.  Recent findings have shown that, in many cases, transcriptional coactivators coordinate the overall regulation of the biol. programs.  One of the best-studied examples of coactivator control of metabolic pathways is the peroxisome proliferator-activated receptor γ coactivator 1 (PGC-1) family.  These proteins are strong activators of mitochondrial function and are thus dominant regulators of oxidative metab. in a variety of tissues.  The PGC-1 coactivators themselves are subject to powerful regulation at the transcriptional and posttranslational levels.  Recent studies have elucidated the function of the PGC-1 coactivators in different tissues and have highlighted the implications of PGC-1 dysregulation in diseases such as diabetes, obesity, cardiomyopathy, or neurodegeneration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrIMWEUPwupbVg90H21EOLACvtfcHk0lgljDA_qBEvzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXns1Wrtw%253D%253D&md5=6873c38a0a99b61fe6b384056ca309ee</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1210%2Fer.2006-0037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fer.2006-0037%26sid%3Dliteratum%253Aachs%26aulast%3DHandschin%26aufirst%3DC.%26aulast%3DSpiegelman%26aufirst%3DB.%2BM.%26atitle%3DPeroxisome%2520proliferator-activated%2520receptor%2520gamma%2520coactivator%25201%2520coactivators%252C%2520energy%2520homeostasis%252C%2520and%2520metabolism%26jtitle%3DEndocr.%2520Rev.%26date%3D2006%26volume%3D27%26spage%3D728%26epage%3D735%26doi%3D10.1210%2Fer.2006-0037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gebai, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gorelik, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Illes, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagar, B.</span></span> <span> </span><span class="NLM_article-title">Structural basis for the activation of acid ceramidase</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1621</span>, <span class="refDoi"> DOI: 10.1038/s41467-018-03844-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1038%2Fs41467-018-03844-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=29692406" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A280%3ADC%252BC1Mjmtl2rtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=1621&author=A.+Gebaiauthor=A.+Gorelikauthor=Z.+Liauthor=K.+Illesauthor=B.+Nagar&title=Structural+basis+for+the+activation+of+acid+ceramidase&doi=10.1038%2Fs41467-018-03844-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis for the activation of acid ceramidase</span></div><div class="casAuthors">Gebai Ahmad; Gorelik Alexei; Li Zixian; Illes Katalin; Nagar Bhushan</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1621</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Acid ceramidase (aCDase, ASAH1) hydrolyzes lysosomal membrane ceramide into sphingosine, the backbone of all sphingolipids, to regulate many cellular processes.  Abnormal function of aCDase leads to Farber disease, spinal muscular atrophy with progressive myoclonic epilepsy, and is associated with Alzheimer's, diabetes, and cancer.  Here, we present crystal structures of mammalian aCDases in both proenzyme and autocleaved forms.  In the proenzyme, the catalytic center is buried and protected from solvent.  Autocleavage triggers a conformational change exposing a hydrophobic channel leading to the active site.  Substrate modeling suggests distinct catalytic mechanisms for substrate hydrolysis versus autocleavage.  A hydrophobic surface surrounding the substrate binding channel appears to be a site of membrane attachment where the enzyme accepts substrates facilitated by the accessory protein, saposin-D.  Structural mapping of disease mutations reveals that most would destabilize the protein fold.  These results will inform the rational design of aCDase inhibitors and recombinant aCDase for disease therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT6RpR0JSKnbwHqQV89nF-2fW6udTcc2eZMSxuWcfBETLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1Mjmtl2rtg%253D%253D&md5=a7fb6f187dc50d25c9a14597053718c1</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1038%2Fs41467-018-03844-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41467-018-03844-2%26sid%3Dliteratum%253Aachs%26aulast%3DGebai%26aufirst%3DA.%26aulast%3DGorelik%26aufirst%3DA.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DIlles%26aufirst%3DK.%26aulast%3DNagar%26aufirst%3DB.%26atitle%3DStructural%2520basis%2520for%2520the%2520activation%2520of%2520acid%2520ceramidase%26jtitle%3DNat.%2520Commun.%26date%3D2018%26volume%3D9%26spage%3D1621%26doi%3D10.1038%2Fs41467-018-03844-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brannigan, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dodson, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duggleby, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moody, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomchick, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murzin, A. G.</span></span> <span> </span><span class="NLM_article-title">A protein catalytic framework with an N-terminal nucleophile is capable of self-activation</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>378</i></span>,  <span class="NLM_fpage">416</span>– <span class="NLM_lpage">419</span>, <span class="refDoi"> DOI: 10.1038/378416a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1038%2F378416a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=7477383" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADyaK2MXps1amsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=378&publication_year=1995&pages=416-419&author=J.+A.+Branniganauthor=G.+Dodsonauthor=H.+J.+Dugglebyauthor=P.+C.+Moodyauthor=J.+L.+Smithauthor=D.+R.+Tomchickauthor=A.+G.+Murzin&title=A+protein+catalytic+framework+with+an+N-terminal+nucleophile+is+capable+of+self-activation&doi=10.1038%2F378416a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">A protein catalytic framework with an N-terminal nucleophile is capable of self-activation</span></div><div class="casAuthors">Brannigan, James; Dodson, Guy; Duggleby, Helen J.; Moody, Peter C. E.; Smith, Janet L.; Tomchick, Diana R.; Murzin, Alexey G.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">378</span>
        (<span class="NLM_cas:issue">6555</span>),
    <span class="NLM_cas:pages">416-19</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">The crystal structures of three amidohydrolases have been detd. recently, glutamine PRPP amidotransferase (GAT), penicillin acylase, and the proteasome.  These enzymes use the side chain of the amino-terminal residue, incorporated in a β-sheet, as the nucleophile in the catalytic attack at the carbonyl carbon.  The nucleophile is cysteine in GAT, serine in penicillin acylase, and threonine in the proteasome.  Here we show that all three enzymes share an unusual fold in which the nucleophile and other catalytic groups occupy equiv. sites.  This fold provides both the capacity for nucleophilic attack and the possibility of autocatalytic processing.  We suggest the name Ntn(N-terminal nucleophilic) hydrolases for this structural superfamily of enzymes which appear to be evolutionarily related but which have diverged beyond any recognizable sequence similarity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppQXl5VIHNVbVg90H21EOLACvtfcHk0liO1x9iM9q9bA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXps1amsLw%253D&md5=669ac5c5a3c69354b34316b5befec3f1</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1038%2F378416a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F378416a0%26sid%3Dliteratum%253Aachs%26aulast%3DBrannigan%26aufirst%3DJ.%2BA.%26aulast%3DDodson%26aufirst%3DG.%26aulast%3DDuggleby%26aufirst%3DH.%2BJ.%26aulast%3DMoody%26aufirst%3DP.%2BC.%26aulast%3DSmith%26aufirst%3DJ.%2BL.%26aulast%3DTomchick%26aufirst%3DD.%2BR.%26aulast%3DMurzin%26aufirst%3DA.%2BG.%26atitle%3DA%2520protein%2520catalytic%2520framework%2520with%2520an%2520N-terminal%2520nucleophile%2520is%2520capable%2520of%2520self-activation%26jtitle%3DNature%26date%3D1995%26volume%3D378%26spage%3D416%26epage%3D419%26doi%3D10.1038%2F378416a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oinonen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rouvinen, J.</span></span> <span> </span><span class="NLM_article-title">Structural comparison of Ntn-hydrolases</span>. <i>Protein Sci.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">2329</span>– <span class="NLM_lpage">2337</span>, <span class="refDoi"> DOI: 10.1110/ps.9.12.2329</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1110%2Fps.9.12.2329" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=11206054" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BD3MXns1aksQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2000&pages=2329-2337&author=C.+Oinonenauthor=J.+Rouvinen&title=Structural+comparison+of+Ntn-hydrolases&doi=10.1110%2Fps.9.12.2329"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Structural comparison of Ntn-hydrolases</span></div><div class="casAuthors">Oinonen, Carita; Rouvinen, Juha</div><div class="citationInfo"><span class="NLM_cas:title">Protein Science</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2329-2337</span>CODEN:
                <span class="NLM_cas:coden">PRCIEI</span>;
        ISSN:<span class="NLM_cas:issn">0961-8368</span>.
    
            (<span class="NLM_cas:orgname">Cambridge University Press</span>)
        </div><div class="casAbstract">The Ntn-hydrolases (N-terminal nucleophile) are a superfamily of diverse enzymes that has recently been characterized.  All of the proteins in this family are activated autocatalytically; they contain an N-terminally located catalytic nucleophile, and they cleave an amide bond.  In the present study, the structures of four enzymes of this superfamily are compared in more detail.  Although the amino acid sequence homol. is almost completely absent, the enzymes share a similar αββα-core structure.  The central β-sheets in the core were found to have different packing angles, ranging from 5 to 35°.  In the Ntn-hydrolases under study, eight totally conserved secondary structure units were found (region C).  Five of them were obsd. to contain the greatest no. of conserved and functionally important residues and are therefore crucial for the structure and function of Ntn-hydrolases.  Two addnl. regions, consisting of secondary structure units (regions A and B), were found to be in structurally similar locations, but in different orders in the polypeptide chain.  The catalytic machinery is located in the structures in a similar manner, and thus the catalytic mechanisms of all of the enzymes are probably similar.  However, the substrate binding and the oxyanion hole differed partially.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKH8HvK9V2YrVg90H21EOLACvtfcHk0liO1x9iM9q9bA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXns1aksQ%253D%253D&md5=48f7c5ed5839f4bcec76c2dcc5003d76</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1110%2Fps.9.12.2329&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1110%252Fps.9.12.2329%26sid%3Dliteratum%253Aachs%26aulast%3DOinonen%26aufirst%3DC.%26aulast%3DRouvinen%26aufirst%3DJ.%26atitle%3DStructural%2520comparison%2520of%2520Ntn-hydrolases%26jtitle%3DProtein%2520Sci.%26date%3D2000%26volume%3D9%26spage%3D2329%26epage%3D2337%26doi%3D10.1110%2Fps.9.12.2329" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tsuboi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Y. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okamoto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Araki, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tonai, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueda, N.</span></span> <span> </span><span class="NLM_article-title">Molecular characterization of N-acylethanolamine-hydrolyzing acid amidase, a novel member of the choloylglycine hydrolase family with structural and functional similarity to acid ceramidase</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>280</i></span>,  <span class="NLM_fpage">11082</span>– <span class="NLM_lpage">11092</span>, <span class="refDoi"> DOI: 10.1074/jbc.M413473200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1074%2Fjbc.M413473200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=15655246" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BD2MXisVOqu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=11082-11092&author=K.+Tsuboiauthor=Y.+X.+Sunauthor=Y.+Okamotoauthor=N.+Arakiauthor=T.+Tonaiauthor=N.+Ueda&title=Molecular+characterization+of+N-acylethanolamine-hydrolyzing+acid+amidase%2C+a+novel+member+of+the+choloylglycine+hydrolase+family+with+structural+and+functional+similarity+to+acid+ceramidase&doi=10.1074%2Fjbc.M413473200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Characterization of N-Acylethanolamine-hydrolyzing Acid Amidase, a Novel Member of the Choloylglycine Hydrolase Family with Structural and Functional Similarity to Acid Ceramidase</span></div><div class="casAuthors">Tsuboi, Kazuhito; Sun, Yong-Xin; Okamoto, Yasuo; Araki, Nobukazu; Tonai, Takeharu; Ueda, Natsuo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">280</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">11082-11092</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Bioactive N-acylethanolamines, including anandamide (an endocannabinoid) and N-palmitoylethanolamine (an anti-inflammatory and neuroprotective substance), are hydrolyzed to fatty acids and ethanolamine by fatty acid amide hydrolase.  Moreover, we found another amidohydrolase catalyzing the same reaction only at acidic pH, and we purified it from rat lung (Ueda, N., Yamanaka, K., and Yamamoto, S. (2001) J. Biol. Chem. 276, 35552-35557).  Here we report complementary DNA cloning and functional expression of the enzyme termed "N-acylethanolamine-hydrolyzing acid amidase (NAAA)" from human, rat, and mouse.  The deduced primary structures revealed that NAAA had no homol. to fatty acid amide hydrolase but belonged to the choloylglycine hydrolase family.  Human NAAA was essentially identical to a gene product that had been noted to resemble acid ceramidase but lacked ceramide hydrolyzing activity.  The recombinant human NAAA overexpressed in HEK293 cells hydrolyzed various N-acylethanolamines with N-palmitoylethanolamine as the most reactive substrate.  Most interestingly, a very low ceramide hydrolyzing activity was also detected with NAAA, and N-lauroylethanolamine hydrolyzing activity was obsd. with acid ceramidase.  By the use of tunicamycin and endoglycosidase, NAAA was found to be a glycoprotein.  Furthermore, the enzyme was proteolytically processed to a shorter form at pH 4.5 but not at pH 7.4.  Expression anal. of a green fluorescent protein-NAAA fusion protein showed a lysosome-like distribution in HEK293 cells.  The organ distribution of the mRNA in rats revealed its wide distribution with the highest expression in lung.  These results demonstrated that NAAA is a novel N-acylethanolamine-hydrolyzing enzyme that shows structural and functional similarity to acid ceramidase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWVjmZKJjGKLVg90H21EOLACvtfcHk0liO1x9iM9q9bA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXisVOqu78%253D&md5=2b108cd3e23441001b040085eea0fdc0</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M413473200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M413473200%26sid%3Dliteratum%253Aachs%26aulast%3DTsuboi%26aufirst%3DK.%26aulast%3DSun%26aufirst%3DY.%2BX.%26aulast%3DOkamoto%26aufirst%3DY.%26aulast%3DAraki%26aufirst%3DN.%26aulast%3DTonai%26aufirst%3DT.%26aulast%3DUeda%26aufirst%3DN.%26atitle%3DMolecular%2520characterization%2520of%2520N-acylethanolamine-hydrolyzing%2520acid%2520amidase%252C%2520a%2520novel%2520member%2520of%2520the%2520choloylglycine%2520hydrolase%2520family%2520with%2520structural%2520and%2520functional%2520similarity%2520to%2520acid%2520ceramidase%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D11082%26epage%3D11092%26doi%3D10.1074%2Fjbc.M413473200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mellman, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuchs, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Helenius, A.</span></span> <span> </span><span class="NLM_article-title">Acidification of the endocytic and exocytic pathways</span>. <i>Annu. Rev. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">1986</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">663</span>– <span class="NLM_lpage">700</span>, <span class="refDoi"> DOI: 10.1146/annurev.bi.55.070186.003311</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1146%2Fannurev.bi.55.070186.003311" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=2874766" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADyaL28XlsVyhsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=1986&pages=663-700&author=I.+Mellmanauthor=R.+Fuchsauthor=A.+Helenius&title=Acidification+of+the+endocytic+and+exocytic+pathways&doi=10.1146%2Fannurev.bi.55.070186.003311"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Acidification of the endocytic and exocytic pathways</span></div><div class="casAuthors">Mellman, Ira; Fuchs, Renate; Helenius, Ari</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Biochemistry</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">663-700</span>CODEN:
                <span class="NLM_cas:coden">ARBOAW</span>;
        ISSN:<span class="NLM_cas:issn">0066-4154</span>.
    </div><div class="casAbstract">A review with 271 refs., of the role of H+-ATPases of organelles in endocytosis and exocytosis pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmp4xBlOQJfbVg90H21EOLACvtfcHk0ljLOkVaY_-qyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL28XlsVyhsbY%253D&md5=b81f35dde2ace12012f9a17df9aac3f2</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1146%2Fannurev.bi.55.070186.003311&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.bi.55.070186.003311%26sid%3Dliteratum%253Aachs%26aulast%3DMellman%26aufirst%3DI.%26aulast%3DFuchs%26aufirst%3DR.%26aulast%3DHelenius%26aufirst%3DA.%26atitle%3DAcidification%2520of%2520the%2520endocytic%2520and%2520exocytic%2520pathways%26jtitle%3DAnnu.%2520Rev.%2520Biochem.%26date%3D1986%26volume%3D55%26spage%3D663%26epage%3D700%26doi%3D10.1146%2Fannurev.bi.55.070186.003311" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, L. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsuboi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okamoto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagahata, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueda, N.</span></span> <span> </span><span class="NLM_article-title">Proteolytic activation and glycosylation of N-acylethanolamine-hydrolyzing acid amidase, a lysosomal enzyme involved in the endocannabinoid metabolism</span>. <i>Biochim. Biophys. Acta, Mol. Cell Biol. Lipids</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>1771</i></span>,  <span class="NLM_fpage">1397</span>– <span class="NLM_lpage">1405</span>, <span class="refDoi"> DOI: 10.1016/j.bbalip.2007.10.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1016%2Fj.bbalip.2007.10.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=17980170" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVeqtb7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1771&publication_year=2007&pages=1397-1405&author=L.+Y.+Zhaoauthor=K.+Tsuboiauthor=Y.+Okamotoauthor=S.+Nagahataauthor=N.+Ueda&title=Proteolytic+activation+and+glycosylation+of+N-acylethanolamine-hydrolyzing+acid+amidase%2C+a+lysosomal+enzyme+involved+in+the+endocannabinoid+metabolism&doi=10.1016%2Fj.bbalip.2007.10.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Proteolytic activation and glycosylation of N-acylethanolamine-hydrolyzing acid amidase, a lysosomal enzyme involved in the endocannabinoid metabolism</span></div><div class="casAuthors">Zhao, Li-Ying; Tsuboi, Kazuhito; Okamoto, Yasuo; Nagahata, Shunichiro; Ueda, Natsuo</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular and Cell Biology of Lipids</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">1771</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1397-1405</span>CODEN:
                <span class="NLM_cas:coden">BBMLFG</span>;
        ISSN:<span class="NLM_cas:issn">1388-1981</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">N-acylethanolamine-hydrolyzing acid amidase (NAAA) is a lysosomal enzyme hydrolyzing bioactive N-acylethanolamines, including anandamide and N-palmitoylethanolamine.  Previously, we suggested that NAAA is glycosylated and proteolytically cleaved.  Here, we investigated the mechanism and significance of the cleavage of human NAAA overexpressed in human embryonic kidney 293 cells.  Western blotting with anti-NAAA antibody revealed that most of NAAA in the cell homogenate was the cleaved 30-kDa form.  However, some of NAAA were released outside the cells and the extracellular enzyme was mostly the uncleaved 48-kDa form.  When incubated at pH 4.5, the 48-kDa form was time-dependently converted to the 30-kDa form with concomitant increase in the N-palmitoylethanolamine-hydrolyzing activity.  The purified 48-kDa form was also cleaved and activated.  However, the cleavage did not proceed at pH 7.4 or in the presence of p-chloromercuribenzoic acid.  The mutant C126S was resistant to the cleavage and remained inactive.  These results suggested that this specific proteolysis is a self-catalyzed activation step.  We next detd. N-glycosylation sites of human NAAA by site-directed mutagenesis addressed to asparagine residues in six potential N-glycosylation sites.  The results exhibited that Asn-37, Asn-107, Asn-309, and Asn-333 are actual N-glycosylation sites.  The glycosylation appeared to play an important role in stabilizing the enzyme protein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYFuWgy8q2PbVg90H21EOLACvtfcHk0ljLOkVaY_-qyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVeqtb7J&md5=db9d83135905d5558679f307517e92b7</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1016%2Fj.bbalip.2007.10.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbalip.2007.10.002%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DL.%2BY.%26aulast%3DTsuboi%26aufirst%3DK.%26aulast%3DOkamoto%26aufirst%3DY.%26aulast%3DNagahata%26aufirst%3DS.%26aulast%3DUeda%26aufirst%3DN.%26atitle%3DProteolytic%2520activation%2520and%2520glycosylation%2520of%2520N-acylethanolamine-hydrolyzing%2520acid%2520amidase%252C%2520a%2520lysosomal%2520enzyme%2520involved%2520in%2520the%2520endocannabinoid%2520metabolism%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Cell%2520Biol.%2520Lipids%26date%3D2007%26volume%3D1771%26spage%3D1397%26epage%3D1405%26doi%3D10.1016%2Fj.bbalip.2007.10.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">West, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zvonok, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitten, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makriyannis, A.</span></span> <span> </span><span class="NLM_article-title">Mass spectrometric characterization of human N-acylethanolamine-hydrolyzing acid amidase</span>. <i>J. Proteome Res.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">972</span>– <span class="NLM_lpage">981</span>, <span class="refDoi"> DOI: 10.1021/pr200735a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/pr200735a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlyhurnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2012&pages=972-981&author=J.+M.+Westauthor=N.+Zvonokauthor=K.+M.+Whittenauthor=J.+T.+Woodauthor=A.+Makriyannis&title=Mass+spectrometric+characterization+of+human+N-acylethanolamine-hydrolyzing+acid+amidase&doi=10.1021%2Fpr200735a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Mass Spectrometric Characterization of Human N-Acylethanolamine-hydrolyzing Acid Amidase</span></div><div class="casAuthors">West, Jay M.; Zvonok, Nikolai; Whitten, Kyle M.; Wood, JodiAnne T.; Makriyannis, Alexandros</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Proteome Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">972-981</span>CODEN:
                <span class="NLM_cas:coden">JPROBS</span>;
        ISSN:<span class="NLM_cas:issn">1535-3893</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">N-Acylethanolamine-hydrolyzing acid amidase (NAAA) is a lysosomal enzyme that primarily degrades palmitoylethanolamine (PEA), a lipid amide that inhibits inflammatory responses.  We developed a HEK293 cell line stably expressing the NAAA pro-enzyme (zymogen) and a single step chromatog. purifn. of the protein from the media.  Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry MALDI-TOF MS anal. of the zymogen (47.7 kDa) treated with peptide-N-glycosidase F (PNGase F) identified 4 glycosylation sites, and acid cleavage of the zymogen into α- and β-subunits (14.6 and 33.3 kDa) activated the enzyme.  Size exclusion chromatog. estd. the mass of the active enzyme as 45±3 kDa, suggesting formation of an α/β heterodimer.  MALDI-TOF MS fingerprinting covered more than 80% of the amino acid sequence, including the N-terminal peptides, and evidence for the lack of a disulfide bond between subunits.  The significance of the cysteine residues was established by their selective alkylation resulting in almost complete loss of activity.  The purified enzyme was kinetically characterized with PEA and a novel fluorogenic substrate, N-(4-Me coumarin) palmitamide (PAMCA).  The prodn. of sufficient quantities of NAAA and a high throughput assay could be useful in discovering novel inhibitors and detg. the structure and function of this enzyme.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsHb2ZNlA6QbVg90H21EOLACvtfcHk0ljLOkVaY_-qyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlyhurnL&md5=b90eb948e0d859a08f4a777114820c94</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1021%2Fpr200735a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fpr200735a%26sid%3Dliteratum%253Aachs%26aulast%3DWest%26aufirst%3DJ.%2BM.%26aulast%3DZvonok%26aufirst%3DN.%26aulast%3DWhitten%26aufirst%3DK.%2BM.%26aulast%3DWood%26aufirst%3DJ.%2BT.%26aulast%3DMakriyannis%26aufirst%3DA.%26atitle%3DMass%2520spectrometric%2520characterization%2520of%2520human%2520N-acylethanolamine-hydrolyzing%2520acid%2520amidase%26jtitle%3DJ.%2520Proteome%2520Res.%26date%3D2012%26volume%3D11%26spage%3D972%26epage%3D981%26doi%3D10.1021%2Fpr200735a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kolter, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sandhoff, K.</span></span> <span> </span><span class="NLM_article-title">Lysosomal degradation of membrane lipids</span>. <i>FEBS Lett.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>584</i></span>,  <span class="NLM_fpage">1700</span>– <span class="NLM_lpage">1712</span>, <span class="refDoi"> DOI: 10.1016/j.febslet.2009.10.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1016%2Fj.febslet.2009.10.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=19836391" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BC3cXkvFKqur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=584&publication_year=2010&pages=1700-1712&author=T.+Kolterauthor=K.+Sandhoff&title=Lysosomal+degradation+of+membrane+lipids&doi=10.1016%2Fj.febslet.2009.10.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Lysosomal degradation of membrane lipids</span></div><div class="casAuthors">Kolter, Thomas; Sandhoff, Konrad</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">584</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1700-1712</span>CODEN:
                <span class="NLM_cas:coden">FEBLAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-5793</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The constitutive degrdn. of membrane components takes place in the acidic compartments of a cell, the endosomes and lysosomes.  Sites of lipid degrdn. are intralysosomal membranes that are formed in endosomes, where the lipid compn. is adjusted for degrdn.  Cholesterol is sorted out of the inner membranes; their content in bis(monoacylglycero)phosphate increases, and, most likely, sphingomyelin is degraded to ceramide.  Together with endosomal and lysosomal lipid-binding proteins, the Niemann-Pick disease type C2-protein, the GM2-activator, and saposins A, B, C, and D, a suitable membrane lipid compn. is required for degrdn. of complex lipids by hydrolytic enzymes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrd_f-eSsXQLrVg90H21EOLACvtfcHk0ljLOkVaY_-qyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXkvFKqur4%253D&md5=219903b5b3afe13c6fff01388a3c8f03</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1016%2Fj.febslet.2009.10.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.febslet.2009.10.021%26sid%3Dliteratum%253Aachs%26aulast%3DKolter%26aufirst%3DT.%26aulast%3DSandhoff%26aufirst%3DK.%26atitle%3DLysosomal%2520degradation%2520of%2520membrane%2520lipids%26jtitle%3DFEBS%2520Lett.%26date%3D2010%26volume%3D584%26spage%3D1700%26epage%3D1712%26doi%3D10.1016%2Fj.febslet.2009.10.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref86"><div class="reference"><strong class="refLabel"><a href="#ref86" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tsuboi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hilligsmann, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vandevoorde, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambert, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueda, N.</span></span> <span> </span><span class="NLM_article-title">N-Cyclohexanecarbonylpentadecylamine: a selective inhibitor of the acid amidase hydrolysing N-acylethanolamines, as a tool to distinguish acid amidase from fatty acid amide hydrolase</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>379</i></span>,  <span class="NLM_fpage">99</span>– <span class="NLM_lpage">106</span>, <span class="refDoi"> DOI: 10.1042/bj20031695</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1042%2Fbj20031695" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=14686878" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BD2cXisVyrsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=379&publication_year=2004&pages=99-106&author=K.+Tsuboiauthor=C.+Hilligsmannauthor=S.+Vandevoordeauthor=D.+M.+Lambertauthor=N.+Ueda&title=N-Cyclohexanecarbonylpentadecylamine%3A+a+selective+inhibitor+of+the+acid+amidase+hydrolysing+N-acylethanolamines%2C+as+a+tool+to+distinguish+acid+amidase+from+fatty+acid+amide+hydrolase&doi=10.1042%2Fbj20031695"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">N-Cyclohexanecarbonylpentadecylamine: a selective inhibitor of the acid amidase hydrolysing N-acylethanolamines, as a tool to distinguish acid amidase from fatty acid amide hydrolase</span></div><div class="casAuthors">Tsuboi, Kazuhito; Hilligsmann, Christine; Vandevoorde, Severine; Lambert, Didier M.; Ueda, Natsuo</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">379</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">99-106</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">Anandamide (N-arachidonoylethanolamine) and other bioactive N -acylethanolamines are degraded to their corresponding fatty acids and ethanolamine.  This hydrolysis is mostly attributed to catalysis by FAAH (fatty acid amide hydrolase), which exhibits an alk. pH optimum.  In addn., we have identified another amidase which catalyzes the same reaction exclusively at acidic pH values [Ueda, Yamanaka and Yamamoto (2001) J. Biol. Chem. 276, 35552-35557].  In attempts to find selective inhibitors of this acid amidase, we screened various derivs. of palmitic acid, 1-hexadecanol, and 1-pentadecylamine with N -palmitoylethanolamine as substrate.  Here we show that N-cyclohexanecarbonylpentadecylamine inhibits the acid amidase from rat lung with an IC50 of 4.5 μM, without inhibiting FAAH at concns. up to 100 μM.  The inhibition was reversible and non-competitive.  This compd. also inhibited the acid amidase in intact alveolar macrophages.  With the aid of this inhibitor, it was revealed that rat basophilic leukemia cells possess the acid amidase as well as FAAH.  Thus the inhibitor may be a useful tool to distinguish the acid amidase from FAAH in various tissues and cells and to elucidate the physiol. role of the enzyme.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoieQh-ts3EC7Vg90H21EOLACvtfcHk0lgT7NriL2CFeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXisVyrsrs%253D&md5=5ea93d8cafe6d3d3151f896bc2185547</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1042%2Fbj20031695&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbj20031695%26sid%3Dliteratum%253Aachs%26aulast%3DTsuboi%26aufirst%3DK.%26aulast%3DHilligsmann%26aufirst%3DC.%26aulast%3DVandevoorde%26aufirst%3DS.%26aulast%3DLambert%26aufirst%3DD.%2BM.%26aulast%3DUeda%26aufirst%3DN.%26atitle%3DN-Cyclohexanecarbonylpentadecylamine%253A%2520a%2520selective%2520inhibitor%2520of%2520the%2520acid%2520amidase%2520hydrolysing%2520N-acylethanolamines%252C%2520as%2520a%2520tool%2520to%2520distinguish%2520acid%2520amidase%2520from%2520fatty%2520acid%2520amide%2520hydrolase%26jtitle%3DBiochem.%2520J.%26date%3D2004%26volume%3D379%26spage%3D99%26epage%3D106%26doi%3D10.1042%2Fbj20031695" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref87"><div class="reference"><strong class="refLabel"><a href="#ref87" class="rightTabRefNumLink">87</a></strong><div class="NLM_citation" id="rightTab-cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yamano, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsuboi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hozaki, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, X. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueda, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wada, A.</span></span> <span> </span><span class="NLM_article-title">Lipophilic amines as potent inhibitors of N-acylethanolamine-hydrolyzing acid amidase</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">3658</span>– <span class="NLM_lpage">3665</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2012.03.065</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1016%2Fj.bmc.2012.03.065" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=22542283" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BC38Xmt1antL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2012&pages=3658-3665&author=Y.+Yamanoauthor=K.+Tsuboiauthor=Y.+Hozakiauthor=K.+Takahashiauthor=X.+H.+Jinauthor=N.+Uedaauthor=A.+Wada&title=Lipophilic+amines+as+potent+inhibitors+of+N-acylethanolamine-hydrolyzing+acid+amidase&doi=10.1016%2Fj.bmc.2012.03.065"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">Lipophilic amines as potent inhibitors of N-acylethanolamine-hydrolyzing acid amidase</span></div><div class="casAuthors">Yamano, Yumiko; Tsuboi, Kazuhito; Hozaki, Yuki; Takahashi, Kiyohiro; Jin, Xing-Hua; Ueda, Natsuo; Wada, Akimori</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3658-3665</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">N-Acylethanolamines (NAEs) including N-arachidonoylethanolamine (anandamide) and N-palmitoylethanolamine are endogenous lipid mediators.  These mols. are degraded to the corresponding fatty acids and ethanolamine by fatty acid amide hydrolase (FAAH) or NAE-hydrolyzing acid amidase (NAAA).  Lipophilic amines, esp. pentadecylamine (2c) and tridecyl 2-aminoacetate (11b), were found to exhibit potent NAAA inhibitory activities (IC50 = 5.7 and 11.8 μM), with much weaker effects on FAAH.  These simple structures would provide a scaffold for further improvement in NAAA inhibitory activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpX4k9qI0AqY7Vg90H21EOLACvtfcHk0lgT7NriL2CFeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xmt1antL0%253D&md5=fbe85f4e5fdca44bee1f6d4902c4f1d0</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2012.03.065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2012.03.065%26sid%3Dliteratum%253Aachs%26aulast%3DYamano%26aufirst%3DY.%26aulast%3DTsuboi%26aufirst%3DK.%26aulast%3DHozaki%26aufirst%3DY.%26aulast%3DTakahashi%26aufirst%3DK.%26aulast%3DJin%26aufirst%3DX.%2BH.%26aulast%3DUeda%26aufirst%3DN.%26aulast%3DWada%26aufirst%3DA.%26atitle%3DLipophilic%2520amines%2520as%2520potent%2520inhibitors%2520of%2520N-acylethanolamine-hydrolyzing%2520acid%2520amidase%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2012%26volume%3D20%26spage%3D3658%26epage%3D3665%26doi%3D10.1016%2Fj.bmc.2012.03.065" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref88"><div class="reference"><strong class="refLabel"><a href="#ref88" class="rightTabRefNumLink">88</a></strong><div class="NLM_citation" id="rightTab-cit88"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Saturnino, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petrosino, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ligresti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palladino, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Martino, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bisogno, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Marzo, V.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological evaluation of new potential inhibitors of N-acylethanolamine hydrolyzing acid amidase</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">1210</span>– <span class="NLM_lpage">1213</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2009.11.134</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1016%2Fj.bmcl.2009.11.134" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=20022504" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVGrt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=1210-1213&author=C.+Saturninoauthor=S.+Petrosinoauthor=A.+Ligrestiauthor=C.+Palladinoauthor=G.+De+Martinoauthor=T.+Bisognoauthor=V.+Di+Marzo&title=Synthesis+and+biological+evaluation+of+new+potential+inhibitors+of+N-acylethanolamine+hydrolyzing+acid+amidase&doi=10.1016%2Fj.bmcl.2009.11.134"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and biological evaluation of new potential inhibitors of N-acylethanolamine hydrolyzing acid amidase</span></div><div class="casAuthors">Saturnino, Carmela; Petrosino, Stefania; Ligresti, Alessia; Palladino, Chiara; De Martino, Giovanni; Bisogno, Tiziana; Di Marzo, Vincenzo</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1210-1213</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">N-Acylethanolamines, including N-palmitoyl-ethanolamine (PEA), are hydrolyzed to the corresponding fatty acids and ethanolamine by fatty acid amide hydrolase (FAAH).  Recently, N-acylethanolamine-hydrolyzing acid amidase (NAAA) was identified as being able to specifically hydrolyze PEA.  In order to find selective and effective inhibitors of this enzyme, we synthesized and screened several amides, retroamides, esters, retroesters and carbamates of palmitic acid (1-21) and esters with C15 and C17 alkyl chains (22-27).  Cyclopentylhexadecanoate (13) exhibited the highest inhibitory activity on NAAA (IC50 = 10.0 μM), without inhibiting FAAH up to 50 μM.  Compd. 13 may become a useful template to design new NAAA inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNWUZja4X4JbVg90H21EOLACvtfcHk0lgT7NriL2CFeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVGrt7s%253D&md5=fc638f889e58e9fbf3467a90effbcc80</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.11.134&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.11.134%26sid%3Dliteratum%253Aachs%26aulast%3DSaturnino%26aufirst%3DC.%26aulast%3DPetrosino%26aufirst%3DS.%26aulast%3DLigresti%26aufirst%3DA.%26aulast%3DPalladino%26aufirst%3DC.%26aulast%3DDe%2BMartino%26aufirst%3DG.%26aulast%3DBisogno%26aufirst%3DT.%26aulast%3DDi%2BMarzo%26aufirst%3DV.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520new%2520potential%2520inhibitors%2520of%2520N-acylethanolamine%2520hydrolyzing%2520acid%2520amidase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D1210%26epage%3D1213%26doi%3D10.1016%2Fj.bmcl.2009.11.134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref89"><div class="reference"><strong class="refLabel"><a href="#ref89" class="rightTabRefNumLink">89</a></strong><div class="NLM_citation" id="rightTab-cit89"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vago, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bettiga, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salonia, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciuffreda, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ottria, R.</span></span> <span> </span><span class="NLM_article-title">Development of new inhibitors for N-acylethanolamine-hydrolyzing acid amidase as promising tool against bladder cancer</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">1242</span>– <span class="NLM_lpage">1249</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2016.12.042</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1016%2Fj.bmc.2016.12.042" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=28062195" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BC2sXitlOjsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2017&pages=1242-1249&author=R.+Vagoauthor=A.+Bettigaauthor=A.+Saloniaauthor=P.+Ciuffredaauthor=R.+Ottria&title=Development+of+new+inhibitors+for+N-acylethanolamine-hydrolyzing+acid+amidase+as+promising+tool+against+bladder+cancer&doi=10.1016%2Fj.bmc.2016.12.042"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">Development of new inhibitors for N-acylethanolamine-hydrolyzing acid amidase as promising tool against bladder cancer</span></div><div class="casAuthors">Vago, Riccardo; Bettiga, Arianna; Salonia, Andrea; Ciuffreda, Pierangela; Ottria, Roberta</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1242-1249</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The endocannabinoid system is a signaling system involved in a wide range of biol. effects.  Literature strongly suggests the endocannabinoid system role in the pathogenesis of cancer and that its pharmacol. activation produces therapeutic benefits.  Last research promotes the endocannabinoid system modulation by inhibition of endocannabinoids hydrolytic enzymes instead of direct activation of endocannabinoid receptors to avoid detrimental effects on cognition and motor control.  Here we report the identification of N-acylethanolamine-hydrolyzing acid amidase (NAAA) inhibitors able to reduce cell proliferation and migration and cause cell death on different bladder cancer cell lines.  These mols. were designed, synthesized and characterized and active compds. were selected by a fluorescence high-throughput screening method set-up on human recombinant NAAA that also allows to characterize the mechanism of inhibition.  Together our results suggest an important role for NAAA in cell migration and in inducing tumor cell death promoting this enzyme as pharmacol. target against bladder cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpeZMJmpMmoV7Vg90H21EOLACvtfcHk0lj_7qJX-yeMRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXitlOjsw%253D%253D&md5=408693a59ec65a8364711366d3b04b29</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2016.12.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2016.12.042%26sid%3Dliteratum%253Aachs%26aulast%3DVago%26aufirst%3DR.%26aulast%3DBettiga%26aufirst%3DA.%26aulast%3DSalonia%26aufirst%3DA.%26aulast%3DCiuffreda%26aufirst%3DP.%26aulast%3DOttria%26aufirst%3DR.%26atitle%3DDevelopment%2520of%2520new%2520inhibitors%2520for%2520N-acylethanolamine-hydrolyzing%2520acid%2520amidase%2520as%2520promising%2520tool%2520against%2520bladder%2520cancer%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2017%26volume%3D25%26spage%3D1242%26epage%3D1249%26doi%3D10.1016%2Fj.bmc.2016.12.042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref90"><div class="reference"><strong class="refLabel"><a href="#ref90" class="rightTabRefNumLink">90</a></strong><div class="NLM_citation" id="rightTab-cit90"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Petrosino, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campolo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Impellizzeri, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paterniti, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allarà, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gugliandolo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Amico, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siracusa, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cordaro, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esposito, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Marzo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuzzocrea, S.</span></span> <span> </span><span class="NLM_article-title">2-Pentadecyl-2-oxazoline, the oxazoline of PEA, modulates carrageenan-induced acute inflammation</span>. <i>Front. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">308</span>, <span class="refDoi"> DOI: 10.3389/fphar.2017.00308</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.3389%2Ffphar.2017.00308" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=28611664" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvFenu7vF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=308&author=S.+Petrosinoauthor=M.+Campoloauthor=D.+Impellizzeriauthor=I.+Paternitiauthor=M.+Allar%C3%A0author=E.+Gugliandoloauthor=R.+D%E2%80%99Amicoauthor=R.+Siracusaauthor=M.+Cordaroauthor=E.+Espositoauthor=V.+Di+Marzoauthor=S.+Cuzzocrea&title=2-Pentadecyl-2-oxazoline%2C+the+oxazoline+of+PEA%2C+modulates+carrageenan-induced+acute+inflammation&doi=10.3389%2Ffphar.2017.00308"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">2-Pentadecyl-2-oxazoline, the oxazoline of pea, modulates carrageenan-induced acute inflammation</span></div><div class="casAuthors">Petrosino, Stefania; Campolo, Michela; Impellizzeri, Daniela; Paterniti, Irene; Allara, Marco; Gugliandolo, Enrico; D'amico, Ramona; Siracusa, Rosalba; Cordaro, Marika; Esposito, Emanuela; Di Marzo, Vincenzo; Cuzzocrea, Salvatore</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Pharmacology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">308/1-308/16</span>CODEN:
                <span class="NLM_cas:coden">FPRHAU</span>;
        ISSN:<span class="NLM_cas:issn">1663-9812</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">N-acylethanolamines (NAEs) involve a family of lipid mols. existent in animal and plant, with N-palmitoylethanolamide (PEA) that arouses great attention owing to its anti- inflammatory, analgesic and neuroprotective activities.  Because PEA is produced on demand and exerts pleiotropic effects, the modulation of specific amidases for NAEs (and in particular NAE-hydrolyzing acid amidase NAAA, which is more selective for PEA) could be a condition to preserve its levels.  Here we investigate the effect of 2-Pentadecyl-2-oxazoline (PEA-OXA) the oxazoline of PEA, on human recombinant NAAA in vitro and in an established model of Carrageenan (CAR)-induced rat paw inflammation.  PEA-OXA dose-dependently significantly inhibited recombinant NAAA and, orally administered to rats (10 mg/kg), limiting histol. damage, thermal hyperalgesia and the increase of infiltrating inflammatory cells after CAR injection in the rat right hindpaw, compared to ultramicronized PEA given orally at the same dose (10 mg/kg).  These effects were accompanied by elevation of paw PEA levels.  Moreover, PEA-OXA markedly reduced neutrophil infiltration and pro-inflammatory cytokine release and prevented CAR-induced IκB-α degrdn., nuclear translocation of NF-κB p65, the increase of inducible nitric oxide synthase, cyclooxygenase-2, intercellular adhesion mol.-1, and mast cell activation.  Expts. in PPAR-α knockout mice showed that the anti-inflammatory effects of PEA-OXA were not dependent on the presence of PPAR-α receptors.  In conclusion, NAAA modulators as PEA-OXA could help to maximize the tissue availability of PEA by increasing its levels and anti-inflammatory effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqn273XvrvHbbVg90H21EOLACvtfcHk0lj_7qJX-yeMRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvFenu7vF&md5=23898efd143bd1506d64425dbe349a52</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.3389%2Ffphar.2017.00308&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphar.2017.00308%26sid%3Dliteratum%253Aachs%26aulast%3DPetrosino%26aufirst%3DS.%26aulast%3DCampolo%26aufirst%3DM.%26aulast%3DImpellizzeri%26aufirst%3DD.%26aulast%3DPaterniti%26aufirst%3DI.%26aulast%3DAllar%25C3%25A0%26aufirst%3DM.%26aulast%3DGugliandolo%26aufirst%3DE.%26aulast%3DD%25E2%2580%2599Amico%26aufirst%3DR.%26aulast%3DSiracusa%26aufirst%3DR.%26aulast%3DCordaro%26aufirst%3DM.%26aulast%3DEsposito%26aufirst%3DE.%26aulast%3DDi%2BMarzo%26aufirst%3DV.%26aulast%3DCuzzocrea%26aufirst%3DS.%26atitle%3D2-Pentadecyl-2-oxazoline%252C%2520the%2520oxazoline%2520of%2520PEA%252C%2520modulates%2520carrageenan-induced%2520acute%2520inflammation%26jtitle%3DFront.%2520Pharmacol.%26date%3D2017%26volume%3D8%26spage%3D308%26doi%3D10.3389%2Ffphar.2017.00308" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref91"><div class="reference"><strong class="refLabel"><a href="#ref91" class="rightTabRefNumLink">91</a></strong><div class="NLM_citation" id="rightTab-cit91"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rossocha, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schultz-Heienbrok, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Moeller, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coleman, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saenger, W.</span></span> <span> </span><span class="NLM_article-title">Conjugated bile acid hydrolase is a tetrameric N-terminal thiol hydrolase with specific recognition of its cholyl but not of its tauryl product</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">5739</span>– <span class="NLM_lpage">5748</span>, <span class="refDoi"> DOI: 10.1021/bi0473206</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi0473206" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BD2MXisFOns78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2005&pages=5739-5748&author=M.+Rossochaauthor=R.+Schultz-Heienbrokauthor=H.+von+Moellerauthor=J.+P.+Colemanauthor=W.+Saenger&title=Conjugated+bile+acid+hydrolase+is+a+tetrameric+N-terminal+thiol+hydrolase+with+specific+recognition+of+its+cholyl+but+not+of+its+tauryl+product&doi=10.1021%2Fbi0473206"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">Conjugated Bile Acid Hydrolase Is a Tetrameric N-Terminal Thiol Hydrolase with Specific Recognition of Its Cholyl but Not of Its Tauryl Product</span></div><div class="casAuthors">Rossocha, Maksim; Schultz-Heienbrok, Robert; von Moeller, Holger; Coleman, James P.; Saenger, Wolfram</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">5739-5748</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Bacterial bile salt hydrolases catalyze the degrdn. of conjugated bile acids in the mammalian gut.  The crystal structures of conjugated bile acid hydrolase (CBAH) from Clostridium perfringens as apoenzyme and in complex with taurodeoxycholate that was hydrolyzed to the reaction products taurine and deoxycholate are described here at 2.1 and 1.7 Å resoln., resp.  The crystal structures reveal a close relationship between CBAH and penicillin V acylase from Bacillus sphaericus.  This similarity together with the N-terminal cysteine classifies CBAH as a member of the N-terminal nucleophile (Ntn) hydrolase superfamily.  Both crystal structures show an identical homotetrameric organization with dihedral (D2 or 222) point group symmetry.  The structure anal. of C. perfringens CBAH identifies crit. residues in catalysis, substrate recognition, and tetramer formation which may serve in further biochem. characterization of bile acid hydrolases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGHd2eLCdd87Vg90H21EOLACvtfcHk0lj_7qJX-yeMRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXisFOns78%253D&md5=86620200d7d88e539bc7c926cf78d689</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1021%2Fbi0473206&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi0473206%26sid%3Dliteratum%253Aachs%26aulast%3DRossocha%26aufirst%3DM.%26aulast%3DSchultz-Heienbrok%26aufirst%3DR.%26aulast%3Dvon%2BMoeller%26aufirst%3DH.%26aulast%3DColeman%26aufirst%3DJ.%2BP.%26aulast%3DSaenger%26aufirst%3DW.%26atitle%3DConjugated%2520bile%2520acid%2520hydrolase%2520is%2520a%2520tetrameric%2520N-terminal%2520thiol%2520hydrolase%2520with%2520specific%2520recognition%2520of%2520its%2520cholyl%2520but%2520not%2520of%2520its%2520tauryl%2520product%26jtitle%3DBiochemistry%26date%3D2005%26volume%3D44%26spage%3D5739%26epage%3D5748%26doi%3D10.1021%2Fbi0473206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref92"><div class="reference"><strong class="refLabel"><a href="#ref92" class="rightTabRefNumLink">92</a></strong><div class="NLM_citation" id="rightTab-cit92"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lall, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karvellas, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vederas, J. C.</span></span> <span> </span><span class="NLM_article-title">Beta-lactones as a new class of cysteine proteinase inhibitors: inhibition of hepatitis A virus 3C proteinase by N-Cbz-serine beta-lactone</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">803</span>– <span class="NLM_lpage">806</span>, <span class="refDoi"> DOI: 10.1021/ol990148r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol990148r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADyaK1MXltVaqu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=1999&pages=803-806&author=M.+S.+Lallauthor=C.+Karvellasauthor=J.+C.+Vederas&title=Beta-lactones+as+a+new+class+of+cysteine+proteinase+inhibitors%3A+inhibition+of+hepatitis+A+virus+3C+proteinase+by+N-Cbz-serine+beta-lactone&doi=10.1021%2Fol990148r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">β-Lactones as a New Class of Cysteine Proteinase Inhibitors: Inhibition of Hepatitis A Virus 3C Proteinase by N-Cbz-serine β-Lactone</span></div><div class="casAuthors">Lall, Manjinder S.; Karvellas, Constantine; Vederas, John C.</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">803-806</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7060</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">N-Benzyloxycarbonyl-L-serine β-lactone (I) is shown to irreversibly inactivate the 3C cysteine proteinase of hepatitis A virus (HAV) with kinact = 0.70 min-1, KΙ = 1.84×10-4 M and kinact/KΙ = 3800 M-1 min-1 at an enzyme concn. of 0.1 μM.  Mass spectrometric and HMQC NMR studies using 13C-labeled I show that the active site cysteine (Cys-172) thiol of the HAV 3C proteinase attacks the β-position (i.e. C-4) of the oxetanone ring, thereby leading to ring opening and alkylation of the sulfur.  In contrast, the enantiomer of this β-lactone is a reversible competitive inhibitor (Ki = 1.50×10-6 M) at similar enzyme concns.  The β-lactone motif represents a new class of inhibitors of cysteine proteinases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr30zXvA06cvLVg90H21EOLACvtfcHk0lhZdw2N8X3S0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXltVaqu7g%253D&md5=87541b4f3686fddd094b012b56089319</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1021%2Fol990148r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol990148r%26sid%3Dliteratum%253Aachs%26aulast%3DLall%26aufirst%3DM.%2BS.%26aulast%3DKarvellas%26aufirst%3DC.%26aulast%3DVederas%26aufirst%3DJ.%2BC.%26atitle%3DBeta-lactones%2520as%2520a%2520new%2520class%2520of%2520cysteine%2520proteinase%2520inhibitors%253A%2520inhibition%2520of%2520hepatitis%2520A%2520virus%25203C%2520proteinase%2520by%2520N-Cbz-serine%2520beta-lactone%26jtitle%3DOrg.%2520Lett.%26date%3D1999%26volume%3D1%26spage%3D803%26epage%3D806%26doi%3D10.1021%2Fol990148r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref93"><div class="reference"><strong class="refLabel"><a href="#ref93" class="rightTabRefNumLink">93</a></strong><div class="NLM_citation" id="rightTab-cit93"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Greenspan, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bull, H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yudkovitz, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanf, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alberts, A. W.</span></span> <span> </span><span class="NLM_article-title">Inhibition of 3-hydroxy-3-methylglutaryl-CoA synthase and cholesterol biosynthesis by beta-lactone inhibitors and binding of these inhibitors to the enzyme</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>289</i></span>,  <span class="NLM_fpage">889</span>– <span class="NLM_lpage">895</span>, <span class="refDoi"> DOI: 10.1042/bj2890889</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1042%2Fbj2890889" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=8094614" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADyaK3sXhvVeitbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=1993&pages=889-895&author=M.+D.+Greenspanauthor=H.+G.+Bullauthor=J.+B.+Yudkovitzauthor=D.+P.+Hanfauthor=A.+W.+Alberts&title=Inhibition+of+3-hydroxy-3-methylglutaryl-CoA+synthase+and+cholesterol+biosynthesis+by+beta-lactone+inhibitors+and+binding+of+these+inhibitors+to+the+enzyme&doi=10.1042%2Fbj2890889"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of 3-hydroxy-3-methylglutaryl-CoA synthase and cholesterol biosynthesis by β-lactone inhibitors and binding of these inhibitors to the enzyme</span></div><div class="casAuthors">Greenspan, Michael D.; Bull, Herb G.; Yudkovitz, Joel B.; Hanf, Darlene P.; Alberts, Alfred W.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">289</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">889-95</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    </div><div class="casAbstract">The β-lactones L-659,699 (I) and its radioactive deriv. 3H-L-668,411 (the 2,3-ditritiated Me ester of I) inhibited a partially purified prepn. of rat liver cytosolic 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) synthase with an IC50 of 0.1 μM.  These compds. were also found to inhibit the incorporation of [14C]acetate into sterols in cultured Hep G2 cells with an IC50 of 3 μM.  New kinetic evidence indicated that inhibition of the isolated enzyme was irreversible.  In contrast, sterol biosynthesis in cultured Hep G2 cells was rapidly restored upon removal of the compd. from the medium of inhibited cultures, suggesting reversibility of inhibition in the cells.  Radioactivity was found to be assocd. with a single cytoplasmic protein by SDS/PAGE of the cytoplasm of Hep G2 cells after incubation of the cells with the inhibitor 3H-L-668,411.  This protein was identified as cytoplasmic HMG-CoA synthase.  Binding of the radioactive compd. to the enzyme was decreased with time if the radioactive inhibitor was removed from the medium.  Exposure of a gel contg. the radioactive enzyme-inhibitor complex to neutral hydroxylamine also resulted in a loss of radioactivity from the gel.  The purified rat liver enzyme reacted with the 3H-ligand to form a stable enzyme-inhibitor complex which could be isolated by HPLC.  Radioactivity was also subsequently lost from this complex when it was incubated with neutral hydroxylamine.  Incorporation of [14C]acetate into cholesterol in mouse liver was inhibited in a reversible manner after oral administration of the β-lactone inhibitor.  These studies, as well as the kinetic evidence presented, suggest that the β-lactone inhibitors acylate HMG-CoA synthase in a reaction which appears to be irreversible in vitro, but is easily reversed in cultured cells and in animals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_kFglYNzBRrVg90H21EOLACvtfcHk0lhZdw2N8X3S0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXhvVeitbs%253D&md5=51792ae96fe2099d3980c94f0c1857e4</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1042%2Fbj2890889&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbj2890889%26sid%3Dliteratum%253Aachs%26aulast%3DGreenspan%26aufirst%3DM.%2BD.%26aulast%3DBull%26aufirst%3DH.%2BG.%26aulast%3DYudkovitz%26aufirst%3DJ.%2BB.%26aulast%3DHanf%26aufirst%3DD.%2BP.%26aulast%3DAlberts%26aufirst%3DA.%2BW.%26atitle%3DInhibition%2520of%25203-hydroxy-3-methylglutaryl-CoA%2520synthase%2520and%2520cholesterol%2520biosynthesis%2520by%2520beta-lactone%2520inhibitors%2520and%2520binding%2520of%2520these%2520inhibitors%2520to%2520the%2520enzyme%26jtitle%3DBiochem.%2520J.%26date%3D1993%26volume%3D289%26spage%3D889%26epage%3D895%26doi%3D10.1042%2Fbj2890889" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref94"><div class="reference"><strong class="refLabel"><a href="#ref94" class="rightTabRefNumLink">94</a></strong><div class="NLM_citation" id="rightTab-cit94"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pojer, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrer, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richard, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagegowda, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chye, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bach, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noel, J. P.</span></span> <span> </span><span class="NLM_article-title">Structural basis for the design of potent and species-specific inhibitors of 3-hydroxy-3-methylglutaryl CoA synthases</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>103</i></span>,  <span class="NLM_fpage">11491</span>– <span class="NLM_lpage">11496</span>, <span class="refDoi"> DOI: 10.1073/pnas.0604935103</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1073%2Fpnas.0604935103" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=16864776" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BD28XotFegtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2006&pages=11491-11496&author=F.+Pojerauthor=J.+L.+Ferrerauthor=S.+B.+Richardauthor=D.+A.+Nagegowdaauthor=M.+L.+Chyeauthor=T.+J.+Bachauthor=J.+P.+Noel&title=Structural+basis+for+the+design+of+potent+and+species-specific+inhibitors+of+3-hydroxy-3-methylglutaryl+CoA+synthases&doi=10.1073%2Fpnas.0604935103"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis for the design of potent and species-specific inhibitors of 3-hydroxy-3-methylglutaryl CoA synthases</span></div><div class="casAuthors">Pojer, Florence; Ferrer, Jean-Luc; Richard, Stephane B.; Nagegowda, Dinesh A.; Chye, Mee-Len; Bach, Thomas J.; Noel, Joseph P.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue">31</span>),
    <span class="NLM_cas:pages">11491-11496</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">3-Hydroxy-3-methylglutaryl Co-A synthase (HMGS) catalyzes the first committed step in the mevalonate metabolic pathway for isoprenoid biosynthesis and serves as an alternative target for cholesterol-lowering and antibiotic drugs.  The authors have detd. a previously undescribed crystal structure of a eukaryotic HMGS bound covalently to a potent and specific inhibitor F-244 [(E,E)-11-[3-(hydroxymethyl)-4-oxo-2-oxytanyl]-3,5,7-trimethyl-2,4-undecadienenoic acid].  Given the accessibility of synthetic analogs of the F-244 natural product, this inhibited eukaryotic HMGS structure serves as a necessary starting point for structure-based methods that may improve the potency and species-specific selectivity of the next generation of F-244 analogs designed to target particular eukaryotic and prokaryotic HMGS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0PPqownf7DbVg90H21EOLACvtfcHk0lhZdw2N8X3S0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XotFegtLY%253D&md5=847c953cd06656bd9d5ff9409a090258</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0604935103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0604935103%26sid%3Dliteratum%253Aachs%26aulast%3DPojer%26aufirst%3DF.%26aulast%3DFerrer%26aufirst%3DJ.%2BL.%26aulast%3DRichard%26aufirst%3DS.%2BB.%26aulast%3DNagegowda%26aufirst%3DD.%2BA.%26aulast%3DChye%26aufirst%3DM.%2BL.%26aulast%3DBach%26aufirst%3DT.%2BJ.%26aulast%3DNoel%26aufirst%3DJ.%2BP.%26atitle%3DStructural%2520basis%2520for%2520the%2520design%2520of%2520potent%2520and%2520species-specific%2520inhibitors%2520of%25203-hydroxy-3-methylglutaryl%2520CoA%2520synthases%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2006%26volume%3D103%26spage%3D11491%26epage%3D11496%26doi%3D10.1073%2Fpnas.0604935103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref95"><div class="reference"><strong class="refLabel"><a href="#ref95" class="rightTabRefNumLink">95</a></strong><div class="NLM_citation" id="rightTab-cit95"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Armirotti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romeo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ponzano, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mengatto, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dionisi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karacsonyi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertozzi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garau, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarozzo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reggiani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bandiera, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarzia, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mor, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piomelli, D.</span></span> <span> </span><span class="NLM_article-title">β-Lactones inhibit N-acylethanolamine acid amidase by S-acylation of the catalytic N-terminal cysteine</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">422</span>– <span class="NLM_lpage">426</span>, <span class="refDoi"> DOI: 10.1021/ml300056y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml300056y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BC38Xlt1SnurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=422-426&author=A.+Armirottiauthor=E.+Romeoauthor=S.+Ponzanoauthor=L.+Mengattoauthor=M.+Dionisiauthor=C.+Karacsonyiauthor=F.+Bertozziauthor=G.+Garauauthor=G.+Tarozzoauthor=A.+Reggianiauthor=T.+Bandieraauthor=G.+Tarziaauthor=M.+Morauthor=D.+Piomelli&title=%CE%B2-Lactones+inhibit+N-acylethanolamine+acid+amidase+by+S-acylation+of+the+catalytic+N-terminal+cysteine&doi=10.1021%2Fml300056y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">β-Lactones Inhibit N-acylethanolamine Acid Amidase by S-Acylation of the Catalytic N-Terminal Cysteine</span></div><div class="casAuthors">Armirotti, Andrea; Romeo, Elisa; Ponzano, Stefano; Mengatto, Luisa; Dionisi, Mauro; Karacsonyi, Claudia; Bertozzi, Fabio; Garau, Gianpiero; Tarozzo, Glauco; Reggiani, Angelo; Bandiera, Tiziano; Tarzia, Giorgio; Mor, Marco; Piomelli, Daniele</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">422-426</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The cysteine amidase N-acylethanolamine acid amidase (NAAA) is a member of the N-terminal nucleophile class of enzymes and a potential target for anti-inflammatory drugs.  We investigated the mechanism of inhibition of human NAAA by substituted β-lactones.  We characterized pharmacol. a representative member of this class, ARN077, and showed, using high-resoln. liq. chromatog.-tandem mass spectrometry, that this compd. forms a thioester bond with the N-terminal catalytic cysteine in human NAAA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGooO8IxuG5LzLVg90H21EOLACvtfcHk0lhb4jbCv0SAMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xlt1SnurY%253D&md5=482d17b3fb0c13c8356f27a4b3f97e93</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1021%2Fml300056y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml300056y%26sid%3Dliteratum%253Aachs%26aulast%3DArmirotti%26aufirst%3DA.%26aulast%3DRomeo%26aufirst%3DE.%26aulast%3DPonzano%26aufirst%3DS.%26aulast%3DMengatto%26aufirst%3DL.%26aulast%3DDionisi%26aufirst%3DM.%26aulast%3DKaracsonyi%26aufirst%3DC.%26aulast%3DBertozzi%26aufirst%3DF.%26aulast%3DGarau%26aufirst%3DG.%26aulast%3DTarozzo%26aufirst%3DG.%26aulast%3DReggiani%26aufirst%3DA.%26aulast%3DBandiera%26aufirst%3DT.%26aulast%3DTarzia%26aufirst%3DG.%26aulast%3DMor%26aufirst%3DM.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3D%25CE%25B2-Lactones%2520inhibit%2520N-acylethanolamine%2520acid%2520amidase%2520by%2520S-acylation%2520of%2520the%2520catalytic%2520N-terminal%2520cysteine%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D3%26spage%3D422%26epage%3D426%26doi%3D10.1021%2Fml300056y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref96"><div class="reference"><strong class="refLabel"><a href="#ref96" class="rightTabRefNumLink">96</a></strong><div class="NLM_citation" id="rightTab-cit96"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Solorzano, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antonietti, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duranti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tontini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivara, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lodola, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vacondio, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarzia, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piomelli, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mor, M.</span></span> <span> </span><span class="NLM_article-title">Synthesis and structure–activity relationships of N-(2-oxo-3-oxetanyl)amides as N-acylethanolamine-hydrolyzing acid amidase inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">5770</span>– <span class="NLM_lpage">5781</span>, <span class="refDoi"> DOI: 10.1021/jm100582w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100582w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BC3cXosVGhsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=5770-5781&author=C.+Solorzanoauthor=F.+Antoniettiauthor=A.+Durantiauthor=A.+Tontiniauthor=S.+Rivaraauthor=A.+Lodolaauthor=F.+Vacondioauthor=G.+Tarziaauthor=D.+Piomelliauthor=M.+Mor&title=Synthesis+and+structure%E2%80%93activity+relationships+of+N-%282-oxo-3-oxetanyl%29amides+as+N-acylethanolamine-hydrolyzing+acid+amidase+inhibitors&doi=10.1021%2Fjm100582w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Structure-Activity Relationships of N-(2-Oxo-3-oxetanyl)amides as N-Acylethanolamine-hydrolyzing Acid Amidase Inhibitors</span></div><div class="casAuthors">Solorzano, Carlos; Antonietti, Francesca; Duranti, Andrea; Tontini, Andrea; Rivara, Silvia; Lodola, Alessio; Vacondio, Federica; Tarzia, Giorgio; Piomelli, Daniele; Mor, Marco</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">5770-5781</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The fatty acid ethanolamides (FAEs) are a family of bioactive lipid mediators that include the endogenous agonist of peroxisome proliferator-activated receptor-α, palmitoylethanolamide (PEA).  FAEs are hydrolyzed intracellularly by either fatty acid amide hydrolase or N-acylethanolamine-hydrolyzing acid amidase (NAAA).  Selective inhibition of NAAA by I [R = PhCH2CH2 (II)] was found to prevent PEA degrdn. in mouse leukocytes and attenuated responses to proinflammatory stimuli.  Starting from the structure of II, a series of β-lactones was prepd. and tested on recombinant rat NAAA to explore structure-activity relationships (SARs) for this class of inhibitors and improve their in vitro potency.  Following the hypothesis that these compds. inhibited NAAA by acylation of the catalytic cysteine, several requirements for recognition at the active site were identified and new potent inhibitors obtained.  In particular, I [R = 4-PhC6H4 (III)] was more potent than II at inhibiting recombinant rat NAAA activity (II, IC50 = 420 nM; III, IC50 = 115 nM) in vitro and at reducing carrageenan-induced leukocyte infiltration in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgnb77O8b6N7Vg90H21EOLACvtfcHk0lhb4jbCv0SAMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXosVGhsLw%253D&md5=205063c7b40e432bd79a2254ec7d448c</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1021%2Fjm100582w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100582w%26sid%3Dliteratum%253Aachs%26aulast%3DSolorzano%26aufirst%3DC.%26aulast%3DAntonietti%26aufirst%3DF.%26aulast%3DDuranti%26aufirst%3DA.%26aulast%3DTontini%26aufirst%3DA.%26aulast%3DRivara%26aufirst%3DS.%26aulast%3DLodola%26aufirst%3DA.%26aulast%3DVacondio%26aufirst%3DF.%26aulast%3DTarzia%26aufirst%3DG.%26aulast%3DPiomelli%26aufirst%3DD.%26aulast%3DMor%26aufirst%3DM.%26atitle%3DSynthesis%2520and%2520structure%25E2%2580%2593activity%2520relationships%2520of%2520N-%25282-oxo-3-oxetanyl%2529amides%2520as%2520N-acylethanolamine-hydrolyzing%2520acid%2520amidase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D5770%26epage%3D5781%26doi%3D10.1021%2Fjm100582w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref97"><div class="reference"><strong class="refLabel"><a href="#ref97" class="rightTabRefNumLink">97</a></strong><div class="NLM_citation" id="rightTab-cit97"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Duranti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tontini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antonietti, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vacondio, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fioni, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silva, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lodola, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivara, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solorzano, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piomelli, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarzia, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mor, M.</span></span> <span> </span><span class="NLM_article-title">N-(2-Oxo-3-oxetanyl)carbamic acid esters as N-acylethanolamine acid amidase inhibitors: synthesis and structure–activity and structure–property relationships</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">4824</span>– <span class="NLM_lpage">4836</span>, <span class="refDoi"> DOI: 10.1021/jm300349j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300349j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BC38XlslGrtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=4824-4836&author=A.+Durantiauthor=A.+Tontiniauthor=F.+Antoniettiauthor=F.+Vacondioauthor=A.+Fioniauthor=C.+Silvaauthor=A.+Lodolaauthor=S.+Rivaraauthor=C.+Solorzanoauthor=D.+Piomelliauthor=G.+Tarziaauthor=M.+Mor&title=N-%282-Oxo-3-oxetanyl%29carbamic+acid+esters+as+N-acylethanolamine+acid+amidase+inhibitors%3A+synthesis+and+structure%E2%80%93activity+and+structure%E2%80%93property+relationships&doi=10.1021%2Fjm300349j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">N-(2-Oxo-3-oxetanyl)carbamic acid esters as N-acylethanolamine acid amidase inhibitors: synthesis and structure-activity and structure-property relationships</span></div><div class="casAuthors">Duranti, Andrea; Tontini, Andrea; Antonietti, Francesca; Vacondio, Federica; Fioni, Alessandro; Silva, Claudia; Lodola, Alessio; Rivara, Silvia; Solorzano, Carlos; Piomelli, Daniele; Tarzia, Giorgio; Mor, Marco</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4824-4836</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The β-lactone ring of N-(2-oxo-3-oxetanyl)amides, a class of N-acylethanolamine acid amidase (NAAA) inhibitors endowed with anti-inflammatory properties, is responsible for both NAAA inhibition and low compd. stability.  Here, we investigate the structure-activity and structure-property relationships for a set of known and new β-lactone derivs., focusing on the new class of N-(2-oxo-3-oxetanyl)carbamates.  Replacement of the amide group with a carbamate one led to different stereoselectivity for NAAA inhibition and higher intrinsic stability, because of the reduced level of intramol. attack at the lactone ring.  The introduction of a syn Me at the β-position of the lactone further improved chem. stability.  A tert-Bu substituent in the side chain reduced the reactivity with bovine serum albumin.  Compd. I (URB913/ARN077) inhibited NAAA with good in vitro potency (IC50 = 127 nM) and showed improved stability.  It is rapidly cleaved in plasma, which supports its use for topical applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1ZiDApcso2rVg90H21EOLACvtfcHk0lhb4jbCv0SAMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlslGrtLo%253D&md5=c60261cf6c43b497bc39f43adb9f177f</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1021%2Fjm300349j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300349j%26sid%3Dliteratum%253Aachs%26aulast%3DDuranti%26aufirst%3DA.%26aulast%3DTontini%26aufirst%3DA.%26aulast%3DAntonietti%26aufirst%3DF.%26aulast%3DVacondio%26aufirst%3DF.%26aulast%3DFioni%26aufirst%3DA.%26aulast%3DSilva%26aufirst%3DC.%26aulast%3DLodola%26aufirst%3DA.%26aulast%3DRivara%26aufirst%3DS.%26aulast%3DSolorzano%26aufirst%3DC.%26aulast%3DPiomelli%26aufirst%3DD.%26aulast%3DTarzia%26aufirst%3DG.%26aulast%3DMor%26aufirst%3DM.%26atitle%3DN-%25282-Oxo-3-oxetanyl%2529carbamic%2520acid%2520esters%2520as%2520N-acylethanolamine%2520acid%2520amidase%2520inhibitors%253A%2520synthesis%2520and%2520structure%25E2%2580%2593activity%2520and%2520structure%25E2%2580%2593property%2520relationships%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D4824%26epage%3D4836%26doi%3D10.1021%2Fjm300349j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref98"><div class="reference"><strong class="refLabel"><a href="#ref98" class="rightTabRefNumLink">98</a></strong><div class="NLM_citation" id="rightTab-cit98"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ponzano, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertozzi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mengatto, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dionisi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Armirotti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romeo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berteotti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fiorelli, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarozzo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reggiani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duranti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarzia, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mor, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cavalli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piomelli, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bandiera, T.</span></span> <span> </span><span class="NLM_article-title">Synthesis and structure–activity relationship (SAR) of 2-methyl-4-oxo-3-oxetanylcarbamic acid esters, a class of potent N-acylethanolamine acid amidase (NAAA) inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">6917</span>– <span class="NLM_lpage">6934</span>, <span class="refDoi"> DOI: 10.1021/jm400739u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400739u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlOktr3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=6917-6934&author=S.+Ponzanoauthor=F.+Bertozziauthor=L.+Mengattoauthor=M.+Dionisiauthor=A.+Armirottiauthor=E.+Romeoauthor=A.+Berteottiauthor=C.+Fiorelliauthor=G.+Tarozzoauthor=A.+Reggianiauthor=A.+Durantiauthor=G.+Tarziaauthor=M.+Morauthor=A.+Cavalliauthor=D.+Piomelliauthor=T.+Bandiera&title=Synthesis+and+structure%E2%80%93activity+relationship+%28SAR%29+of+2-methyl-4-oxo-3-oxetanylcarbamic+acid+esters%2C+a+class+of+potent+N-acylethanolamine+acid+amidase+%28NAAA%29+inhibitors&doi=10.1021%2Fjm400739u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Structure-Activity Relationship (SAR) of 2-Methyl-4-oxo-3-oxetanylcarbamic Acid Esters, a Class of Potent N-Acylethanolamine Acid Amidase (NAAA) Inhibitors</span></div><div class="casAuthors">Ponzano, Stefano; Bertozzi, Fabio; Mengatto, Luisa; Dionisi, Mauro; Armirotti, Andrea; Romeo, Elisa; Berteotti, Anna; Fiorelli, Claudio; Tarozzo, Glauco; Reggiani, Angelo; Duranti, Andrea; Tarzia, Giorgio; Mor, Marco; Cavalli, Andrea; Piomelli, Daniele; Bandiera, Tiziano</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">6917-6934</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">N-Acylethanolamine acid amidase (NAAA) is a lysosomal cysteine hydrolase involved in the degrdn. of satd. and monounsatd. fatty acid ethanolamides (FAEs), a family of endogenous lipid agonists of peroxisome proliferator-activated receptor-α, which include oleoylethanolamide (OEA) and palmitoylethanolamide (PEA).  The β-lactone derivs. (S)-N-(2-oxo-3-oxetanyl)-3-phenylpropionamide and (S)-N-(2-oxo-3-oxetanyl)-biphenyl-4-carboxamide inhibit NAAA, prevent FAE hydrolysis in activated inflammatory cells, and reduce tissue reactions to pro-inflammatory stimuli.  Recently, our group disclosed ARN077 (I), a potent NAAA inhibitor that is active in vivo by topical administration in rodent models of hyperalgesia and allodynia.  In the present study, we investigated the structure-activity relationship (SAR) of threonine-derived β-lactone analogs of compd. I.  The main results of this work were an enhancement of the inhibitory potency of β-lactone carbamate derivs. for NAAA and the identification of (4-phenylphenyl)-methyl-N-[(2S,3R)-2-methyl-4-oxo-oxetan-3-yl]-carbamate (II) as the first single-digit nanomolar inhibitor of intracellular NAAA activity (IC50 = 7 nM on both rat NAAA and human NAAA).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBN8FAZ7r4FbVg90H21EOLACvtfcHk0lh3INsqrtU_bA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlOktr3L&md5=dfb2cdc18820af044a769e1b903d5a67</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1021%2Fjm400739u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400739u%26sid%3Dliteratum%253Aachs%26aulast%3DPonzano%26aufirst%3DS.%26aulast%3DBertozzi%26aufirst%3DF.%26aulast%3DMengatto%26aufirst%3DL.%26aulast%3DDionisi%26aufirst%3DM.%26aulast%3DArmirotti%26aufirst%3DA.%26aulast%3DRomeo%26aufirst%3DE.%26aulast%3DBerteotti%26aufirst%3DA.%26aulast%3DFiorelli%26aufirst%3DC.%26aulast%3DTarozzo%26aufirst%3DG.%26aulast%3DReggiani%26aufirst%3DA.%26aulast%3DDuranti%26aufirst%3DA.%26aulast%3DTarzia%26aufirst%3DG.%26aulast%3DMor%26aufirst%3DM.%26aulast%3DCavalli%26aufirst%3DA.%26aulast%3DPiomelli%26aufirst%3DD.%26aulast%3DBandiera%26aufirst%3DT.%26atitle%3DSynthesis%2520and%2520structure%25E2%2580%2593activity%2520relationship%2520%2528SAR%2529%2520of%25202-methyl-4-oxo-3-oxetanylcarbamic%2520acid%2520esters%252C%2520a%2520class%2520of%2520potent%2520N-acylethanolamine%2520acid%2520amidase%2520%2528NAAA%2529%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D6917%26epage%3D6934%26doi%3D10.1021%2Fjm400739u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref99"><div class="reference"><strong class="refLabel"><a href="#ref99" class="rightTabRefNumLink">99</a></strong><div class="NLM_citation" id="rightTab-cit99"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ponzano, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berteotti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petracca, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vitale, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mengatto, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bandiera, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cavalli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piomelli, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertozzi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bottegoni, G.</span></span> <span> </span><span class="NLM_article-title">Synthesis, biological evaluation, and 3D QSAR study of 2-methyl-4-oxo-3-oxetanylcarbamic acid esters as N-acylethanolamine acid amidase (NAAA) inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">10101</span>– <span class="NLM_lpage">10111</span>, <span class="refDoi"> DOI: 10.1021/jm501455s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501455s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVyrtLrN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=10101-10111&author=S.+Ponzanoauthor=A.+Berteottiauthor=R.+Petraccaauthor=R.+Vitaleauthor=L.+Mengattoauthor=T.+Bandieraauthor=A.+Cavalliauthor=D.+Piomelliauthor=F.+Bertozziauthor=G.+Bottegoni&title=Synthesis%2C+biological+evaluation%2C+and+3D+QSAR+study+of+2-methyl-4-oxo-3-oxetanylcarbamic+acid+esters+as+N-acylethanolamine+acid+amidase+%28NAAA%29+inhibitors&doi=10.1021%2Fjm501455s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, Biological Evaluation, and 3D QSAR Study of 2-Methyl-4-oxo-3-oxetanylcarbamic Acid Esters as N-Acylethanolamine Acid Amidase (NAAA) Inhibitors</span></div><div class="casAuthors">Ponzano, Stefano; Berteotti, Anna; Petracca, Rita; Vitale, Romina; Mengatto, Luisa; Bandiera, Tiziano; Cavalli, Andrea; Piomelli, Daniele; Bertozzi, Fabio; Bottegoni, Giovanni</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">10101-10111</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">N-(2-Oxo-3-oxetanyl)carbamic acid esters e. g., I, have recently been reported to be noncompetitive inhibitors of the N-acylethanolamine acid amidase (NAAA) potentially useful for the treatment of pain and inflammation.  In the present study, we further explored the structure-activity relationships of the carbamic acid ester side chain of 2-methyl-4-oxo-3-oxetanylcarbamic acid ester derivs.  Addnl. favorable features in the design of potent NAAA inhibitors have been found together with the identification of a single digit nanomolar inhibitor.  In addn., we devised a 3D QSAR using the at. property field method.  The model turned out to be able to account for the structural variability and was prospectively validated by designing, synthesizing, and testing novel inhibitors.  The fairly good agreement between predictions and exptl. potency values points to this 3D QSAR model as the first example of quant. structure-activity relationships in the field of NAAA inhibitors .</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVpHkND7iUzbVg90H21EOLACvtfcHk0lh3INsqrtU_bA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVyrtLrN&md5=1c863895692bf0e2bd76956ae1c0fda4</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1021%2Fjm501455s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501455s%26sid%3Dliteratum%253Aachs%26aulast%3DPonzano%26aufirst%3DS.%26aulast%3DBerteotti%26aufirst%3DA.%26aulast%3DPetracca%26aufirst%3DR.%26aulast%3DVitale%26aufirst%3DR.%26aulast%3DMengatto%26aufirst%3DL.%26aulast%3DBandiera%26aufirst%3DT.%26aulast%3DCavalli%26aufirst%3DA.%26aulast%3DPiomelli%26aufirst%3DD.%26aulast%3DBertozzi%26aufirst%3DF.%26aulast%3DBottegoni%26aufirst%3DG.%26atitle%3DSynthesis%252C%2520biological%2520evaluation%252C%2520and%25203D%2520QSAR%2520study%2520of%25202-methyl-4-oxo-3-oxetanylcarbamic%2520acid%2520esters%2520as%2520N-acylethanolamine%2520acid%2520amidase%2520%2528NAAA%2529%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D10101%26epage%3D10111%26doi%3D10.1021%2Fjm501455s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref100"><div class="reference"><strong class="refLabel"><a href="#ref100" class="rightTabRefNumLink">100</a></strong><div class="NLM_citation" id="rightTab-cit100"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Khasabova, I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coicou, L. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piomelli, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seybold, V.</span></span> <span> </span><span class="NLM_article-title">Peroxisome proliferator-activated receptor α mediates acute effects of palmitoylethanolamide on sensory neurons</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">12735</span>– <span class="NLM_lpage">12743</span>, <span class="refDoi"> DOI: 10.1523/JNEUROSCI.0130-12.2012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1523%2FJNEUROSCI.0130-12.2012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=22972997" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVSlsbjM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2012&pages=12735-12743&author=I.+A.+Khasabovaauthor=Y.+Xiongauthor=L.+G.+Coicouauthor=D.+Piomelliauthor=V.+Seybold&title=Peroxisome+proliferator-activated+receptor+%CE%B1+mediates+acute+effects+of+palmitoylethanolamide+on+sensory+neurons&doi=10.1523%2FJNEUROSCI.0130-12.2012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit100R"><div class="casContent"><span class="casTitleNuber">100</span><div class="casTitle"><span class="NLM_cas:atitle">Peroxisome proliferator-activated receptor α mediates acute effects of palmitoylethanolamide on sensory neurons</span></div><div class="casAuthors">Khasabova, Iryna A.; Xiong, Yee; Coicou, Lia G.; Piomelli, Daniele; Seybold, Virginia</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">37</span>),
    <span class="NLM_cas:pages">12735-12743</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">The amplitude of the depolarization-evoked Ca2+ transient is larger in dorsal root ganglion (DRG) neurons from tumor-bearing mice compared with that of neurons from naive mice, and the change is mimicked by coculturing DRG neurons with the fibrosarcoma cells used to generate the tumors.  The effect of palmitoylethanolamide (PEA), a ligand for the peroxisome proliferator-activated receptor α (PPARα), was detd. on the evoked-Ca2+ transient in the coculture condition.  The level of PEA was reduced in DRG cells from tumor-bearing mice as well as those cocultured with fibrosarcoma cells.  Pretreatment with PEA, a synthetic PPARα agonist (GW7647), or ARN077, an inhibitor of the enzyme that hydrolyzes PEA, acutely decreased the amplitude of the evoked Ca2+ transient in small DRG neurons cocultured with fibrosarcoma cells.  The PPARα antagonist GW6471 blocked the effect of each.  In contrast, the PPARα agonist was without effect in the control condition, but the antagonist increased the amplitude of the Ca2+ transient, suggesting that PPARα receptors are satd. by endogenous ligand under basal conditions.  Effects of drugs on mech. sensitivity in vivo paralleled their effects on DRG neurons in vitro.  Local injection of ARN077 decreased mech. hyperalgesia in tumor-bearing mice, and the effect was blocked by GW6471.  These data support the conclusion that the activity of DRG neurons is rapidly modulated by PEA through a PPARα-dependent mechanism.  Moreover, agents that increase the activity of PPARα may provide a therapeutic strategy to reduce tumor-evoked pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofcnSjBUw1-7Vg90H21EOLACvtfcHk0lh3INsqrtU_bA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVSlsbjM&md5=a94261dbf634cb244d328ea384da88d5</span></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.0130-12.2012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.0130-12.2012%26sid%3Dliteratum%253Aachs%26aulast%3DKhasabova%26aufirst%3DI.%2BA.%26aulast%3DXiong%26aufirst%3DY.%26aulast%3DCoicou%26aufirst%3DL.%2BG.%26aulast%3DPiomelli%26aufirst%3DD.%26aulast%3DSeybold%26aufirst%3DV.%26atitle%3DPeroxisome%2520proliferator-activated%2520receptor%2520%25CE%25B1%2520mediates%2520acute%2520effects%2520of%2520palmitoylethanolamide%2520on%2520sensory%2520neurons%26jtitle%3DJ.%2520Neurosci.%26date%3D2012%26volume%3D32%26spage%3D12735%26epage%3D12743%26doi%3D10.1523%2FJNEUROSCI.0130-12.2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref101"><div class="reference"><strong class="refLabel"><a href="#ref101" class="rightTabRefNumLink">101</a></strong><div class="NLM_citation" id="rightTab-cit101"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sasso, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreno-Sanz, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martucci, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Realini, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dionisi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mengatto, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duranti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarozzo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarzia, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mor, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertorelli, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reggiani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piomelli, D.</span></span> <span> </span><span class="NLM_article-title">Antinociceptive effects of the N-acylethanolamine acid amidase inhibitor ARN077 in rodent pain models</span>. <i>Pain</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>154</i></span>,  <span class="NLM_fpage">350</span>– <span class="NLM_lpage">360</span>, <span class="refDoi"> DOI: 10.1016/j.pain.2012.10.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1016%2Fj.pain.2012.10.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=23218523" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BC3sXivF2jtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=154&publication_year=2013&pages=350-360&author=O.+Sassoauthor=G.+Moreno-Sanzauthor=C.+Martucciauthor=N.+Realiniauthor=M.+Dionisiauthor=L.+Mengattoauthor=A.+Durantiauthor=G.+Tarozzoauthor=G.+Tarziaauthor=M.+Morauthor=R.+Bertorelliauthor=A.+Reggianiauthor=D.+Piomelli&title=Antinociceptive+effects+of+the+N-acylethanolamine+acid+amidase+inhibitor+ARN077+in+rodent+pain+models&doi=10.1016%2Fj.pain.2012.10.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit101R"><div class="casContent"><span class="casTitleNuber">101</span><div class="casTitle"><span class="NLM_cas:atitle">Antinociceptive effects of the N-acylethanolamine acid amidase inhibitor ARN077 in rodent pain models</span></div><div class="casAuthors">Sasso, Oscar; Moreno-Sanz, Guillermo; Martucci, Cataldo; Realini, Natalia; Dionisi, Mauro; Mengatto, Luisa; Duranti, Andrea; Tarozzo, Glauco; Tarzia, Giorgio; Mor, Marco; Bertorelli, Rosalia; Reggiani, Angelo; Piomelli, Daniele</div><div class="citationInfo"><span class="NLM_cas:title">Pain</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">154</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">350-360</span>CODEN:
                <span class="NLM_cas:coden">PAINDB</span>;
        ISSN:<span class="NLM_cas:issn">0304-3959</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Fatty acid ethanolamides (FAEs), which include palmitoylethanolamide (PEA) and oleoylethanolamide (OEA), are endogenous agonists of peroxisome proliferator-activated receptor-α (PPAR-α) and important regulators of the inflammatory response.  They are degraded in macrophages by the lysosomal cysteine amidase, N-acylethanolamine acid amidase (NAAA).  Previous studies have shown that pharmacol. inhibition of NAAA activity suppresses macrophage activation in vitro and causes marked anti-inflammatory effects in vivo, which is suggestive of a role for NAAA in the control of inflammation.  It is still unknown, however, whether NAAA-mediated FAE deactivation might regulate pain signaling.  The present study examd. the effects of ARN077, a potent and selective NAAA inhibitor recently disclosed by our group, in rodent models of hyperalgesia and allodynia caused by inflammation or nerve damage.  Topical administration of ARN077 attenuated, in a dose-dependent manner, heat hyperalgesia and mech. allodynia elicited in mice by carrageenan injection or sciatic nerve ligation.  The antinociceptive effects of ARN077 were prevented by the selective PPAR-α antagonist GW6471 and did not occur in PPAR-α-deficient mice.  Furthermore, topical ARN077 reversed the allodynia caused by UV B radiation in rats, and this effect was blocked by pretreatment with GW6471.  Sciatic nerve ligation or application of the proinflammatory phorbol ester 12-O-tetradecanoylphorbol 13-acetate decreased FAE levels in sciatic nerve and skin tissue, resp.  ARN077 reversed these biochem. effects.  The results identify ARN077 as a potent inhibitor of intracellular NAAA activity, which is active in vivo by topical administration.  The findings further suggest that NAAA regulates peripheral pain initiation by interrupting endogenous FAE signaling at PPAR-α.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVAH4mpvyphbVg90H21EOLACvtfcHk0lhuupigRc4PwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXivF2jtrk%253D&md5=08c067a44b1f75e7e0192fdbdeccccd4</span></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1016%2Fj.pain.2012.10.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pain.2012.10.018%26sid%3Dliteratum%253Aachs%26aulast%3DSasso%26aufirst%3DO.%26aulast%3DMoreno-Sanz%26aufirst%3DG.%26aulast%3DMartucci%26aufirst%3DC.%26aulast%3DRealini%26aufirst%3DN.%26aulast%3DDionisi%26aufirst%3DM.%26aulast%3DMengatto%26aufirst%3DL.%26aulast%3DDuranti%26aufirst%3DA.%26aulast%3DTarozzo%26aufirst%3DG.%26aulast%3DTarzia%26aufirst%3DG.%26aulast%3DMor%26aufirst%3DM.%26aulast%3DBertorelli%26aufirst%3DR.%26aulast%3DReggiani%26aufirst%3DA.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DAntinociceptive%2520effects%2520of%2520the%2520N-acylethanolamine%2520acid%2520amidase%2520inhibitor%2520ARN077%2520in%2520rodent%2520pain%2520models%26jtitle%3DPain%26date%3D2013%26volume%3D154%26spage%3D350%26epage%3D360%26doi%3D10.1016%2Fj.pain.2012.10.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref102"><div class="reference"><strong class="refLabel"><a href="#ref102" class="rightTabRefNumLink">102</a></strong><div class="NLM_citation" id="rightTab-cit102"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fiasella, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nuzzi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Summa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Armirotti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarozzo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarzia, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mor, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertozzi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bandiera, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piomelli, D.</span></span> <span> </span><span class="NLM_article-title">3-Aminoazetidin-2-one derivatives as N-acylethanolamine acid amidase (NAAA) inhibitors suitable for systemic administration</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1602</span>– <span class="NLM_lpage">1614</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201300546</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1002%2Fcmdc.201300546" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=24828120" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BC2cXnvF2ks74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=1602-1614&author=A.+Fiasellaauthor=A.+Nuzziauthor=M.+Summaauthor=A.+Armirottiauthor=G.+Tarozzoauthor=G.+Tarziaauthor=M.+Morauthor=F.+Bertozziauthor=T.+Bandieraauthor=D.+Piomelli&title=3-Aminoazetidin-2-one+derivatives+as+N-acylethanolamine+acid+amidase+%28NAAA%29+inhibitors+suitable+for+systemic+administration&doi=10.1002%2Fcmdc.201300546"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit102R"><div class="casContent"><span class="casTitleNuber">102</span><div class="casTitle"><span class="NLM_cas:atitle">3-Aminoazetidin-2-one Derivatives as N-Acylethanolamine Acid Amidase (NAAA) Inhibitors Suitable for Systemic Administration</span></div><div class="casAuthors">Fiasella, Annalisa; Nuzzi, Andrea; Summa, Maria; Armirotti, Andrea; Tarozzo, Glauco; Tarzia, Giorgio; Mor, Marco; Bertozzi, Fabio; Bandiera, Tiziano; Piomelli, Daniele</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1602-1614</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">N-Acylethanolamine acid amidase (NAAA) is a cysteine hydrolase that catalyzes the hydrolysis of endogenous lipid mediators such as palmitoylethanolamide (PEA).  PEA has been shown to exert anti-inflammatory and antinociceptive effects in animals by engaging peroxisome proliferator-activated receptor α (PPAR-α).  Thus, preventing PEA degrdn. by inhibiting NAAA may provide a novel approach for the treatment of pain and inflammatory states.  Recently, 3-aminooxetan-2-one compds. were identified as a class of highly potent NAAA inhibitors.  The utility of these compds. is limited, however, by their low chem. and plasma stabilities.  In the present study, we synthesized and tested a series of N-(2-oxoazetidin-3-yl)amides as a novel class of NAAA inhibitors with good potency and improved physicochem. properties, suitable for systemic administration.  Moreover, we elucidated the main structural features of 3-aminoazetidin-2-one derivs. that are crit. for NAAA inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocn1G5QzPtHLVg90H21EOLACvtfcHk0lhuupigRc4PwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXnvF2ks74%253D&md5=beee5cde68184abb3c47e4631c56497f</span></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201300546&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201300546%26sid%3Dliteratum%253Aachs%26aulast%3DFiasella%26aufirst%3DA.%26aulast%3DNuzzi%26aufirst%3DA.%26aulast%3DSumma%26aufirst%3DM.%26aulast%3DArmirotti%26aufirst%3DA.%26aulast%3DTarozzo%26aufirst%3DG.%26aulast%3DTarzia%26aufirst%3DG.%26aulast%3DMor%26aufirst%3DM.%26aulast%3DBertozzi%26aufirst%3DF.%26aulast%3DBandiera%26aufirst%3DT.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3D3-Aminoazetidin-2-one%2520derivatives%2520as%2520N-acylethanolamine%2520acid%2520amidase%2520%2528NAAA%2529%2520inhibitors%2520suitable%2520for%2520systemic%2520administration%26jtitle%3DChemMedChem%26date%3D2014%26volume%3D9%26spage%3D1602%26epage%3D1614%26doi%3D10.1002%2Fcmdc.201300546" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref103"><div class="reference"><strong class="refLabel"><a href="#ref103" class="rightTabRefNumLink">103</a></strong><div class="NLM_citation" id="rightTab-cit103"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Migliore, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pontis, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuentes
de Arriba, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Realini, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torrente, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Armirotti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romeo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Martino, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pizzirani, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Summa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lanfranco, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ottonello, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Busquet, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Guzman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heim, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scarpelli, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piomelli, D.</span></span> <span> </span><span class="NLM_article-title">Second-generation non-covalent NAAA inhibitors are protective in a model of multiple sclerosis</span>. <i>Angew. Chem. Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">11193</span>– <span class="NLM_lpage">11197</span>, <span class="refDoi"> DOI: 10.1002/anie.201603746</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1002%2Fanie.201603746" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtFKmt77K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2016&pages=11193-11197&author=M.+Miglioreauthor=S.+Pontisauthor=A.+L.+Fuentes%0Ade+Arribaauthor=N.+Realiniauthor=E.+Torrenteauthor=A.+Armirottiauthor=E.+Romeoauthor=S.+Di+Martinoauthor=D.+Russoauthor=D.+Pizziraniauthor=M.+Summaauthor=M.+Lanfrancoauthor=G.+Ottonelloauthor=P.+Busquetauthor=K.+M.+Jungauthor=M.+Garcia-Guzmanauthor=R.+Heimauthor=R.+Scarpelliauthor=D.+Piomelli&title=Second-generation+non-covalent+NAAA+inhibitors+are+protective+in+a+model+of+multiple+sclerosis&doi=10.1002%2Fanie.201603746"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit103R"><div class="casContent"><span class="casTitleNuber">103</span><div class="casTitle"><span class="NLM_cas:atitle">Second-Generation Non-Covalent NAAA Inhibitors are Protective in a Model of Multiple Sclerosis</span></div><div class="casAuthors">Migliore, Marco; Pontis, Silvia; Fuentes de Arriba, Angel Luis; Realini, Natalia; Torrente, Esther; Armirotti, Andrea; Romeo, Elisa; Di Martino, Simona; Russo, Debora; Pizzirani, Daniela; Summa, Maria; Lanfranco, Massimiliano; Ottonello, Giuliana; Busquet, Perrine; Jung, Kwang-Mook; Garcia-Guzman, Miguel; Heim, Roger; Scarpelli, Rita; Piomelli, Daniele</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">37</span>),
    <span class="NLM_cas:pages">11193-11197</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Palmitoylethanolamide (PEA) and oleoylethanolamide (OEA) are endogenous lipid mediators that suppress inflammation.  Their actions are terminated by the intracellular cysteine amidase, N-acylethanolamine acid amidase (NAAA).  Even though NAAA may offer a new target for anti-inflammatory therapy, the lipid-like structures and reactive warheads of current NAAA inhibitors limit the use of these agents as oral drugs.  A series of novel benzothiazole-piperazine derivs. that inhibit NAAA in a potent and selective manner by a non-covalent mechanism are described.  A prototype member of this class (8) displays high oral bioavailability, access to the central nervous system (CNS), and strong activity in a mouse model of multiple sclerosis (MS).  This compd. exemplifies a second generation of non-covalent NAAA inhibitors that may be useful in the treatment of MS and other chronic CNS disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpuWcI9qbPxD7Vg90H21EOLACvtfcHk0ljfuVRD_eHVDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtFKmt77K&md5=3a0393efde3a858d2bef8af194b65a21</span></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.1002%2Fanie.201603746&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201603746%26sid%3Dliteratum%253Aachs%26aulast%3DMigliore%26aufirst%3DM.%26aulast%3DPontis%26aufirst%3DS.%26aulast%3DFuentes%2Bde%2BArriba%26aufirst%3DA.%2BL.%26aulast%3DRealini%26aufirst%3DN.%26aulast%3DTorrente%26aufirst%3DE.%26aulast%3DArmirotti%26aufirst%3DA.%26aulast%3DRomeo%26aufirst%3DE.%26aulast%3DDi%2BMartino%26aufirst%3DS.%26aulast%3DRusso%26aufirst%3DD.%26aulast%3DPizzirani%26aufirst%3DD.%26aulast%3DSumma%26aufirst%3DM.%26aulast%3DLanfranco%26aufirst%3DM.%26aulast%3DOttonello%26aufirst%3DG.%26aulast%3DBusquet%26aufirst%3DP.%26aulast%3DJung%26aufirst%3DK.%2BM.%26aulast%3DGarcia-Guzman%26aufirst%3DM.%26aulast%3DHeim%26aufirst%3DR.%26aulast%3DScarpelli%26aufirst%3DR.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DSecond-generation%2520non-covalent%2520NAAA%2520inhibitors%2520are%2520protective%2520in%2520a%2520model%2520of%2520multiple%2520sclerosis%26jtitle%3DAngew.%2520Chem.%2520Int.%2520Ed.%26date%3D2016%26volume%3D55%26spage%3D11193%26epage%3D11197%26doi%3D10.1002%2Fanie.201603746" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref104"><div class="reference"><strong class="refLabel"><a href="#ref104" class="rightTabRefNumLink">104</a></strong><div class="NLM_citation" id="rightTab-cit104"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nuzzi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fiasella, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortega, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pagliuca, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ponzano, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pizzirani, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertozzi, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ottonello, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarozzo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reggiani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bandiera, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertozzi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piomelli, D.</span></span> <span> </span><span class="NLM_article-title">Potent α-amino-β-lactam carbamic acid ester as NAAA inhibitors. Synthesis and structure-activity relationship (SAR) studies</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>111</i></span>,  <span class="NLM_fpage">138</span>– <span class="NLM_lpage">159</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2016.01.046</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1016%2Fj.ejmech.2016.01.046" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=26866968" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BC28XisVansL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2016&pages=138-159&author=A.+Nuzziauthor=A.+Fiasellaauthor=J.+A.+Ortegaauthor=C.+Pagliucaauthor=S.+Ponzanoauthor=D.+Pizziraniauthor=S.+M.+Bertozziauthor=G.+Ottonelloauthor=G.+Tarozzoauthor=A.+Reggianiauthor=T.+Bandieraauthor=F.+Bertozziauthor=D.+Piomelli&title=Potent+%CE%B1-amino-%CE%B2-lactam+carbamic+acid+ester+as+NAAA+inhibitors.+Synthesis+and+structure-activity+relationship+%28SAR%29+studies&doi=10.1016%2Fj.ejmech.2016.01.046"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit104R"><div class="casContent"><span class="casTitleNuber">104</span><div class="casTitle"><span class="NLM_cas:atitle">Potent α-amino-β-lactam carbamic acid ester as NAAA inhibitors. Synthesis and structure-activity relationship (SAR) studies</span></div><div class="casAuthors">Nuzzi, Andrea; Fiasella, Annalisa; Ortega, Jose Antonio; Pagliuca, Chiara; Ponzano, Stefano; Pizzirani, Daniela; Bertozzi, Sine Mandrup; Ottonello, Giuliana; Tarozzo, Glauco; Reggiani, Angelo; Bandiera, Tiziano; Bertozzi, Fabio; Piomelli, Daniele</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">138-159</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">4-Cyclohexylbutyl-N-[(S)-2-oxoazetidin-3-yl]carbamate I is a potent, selective and systemically active inhibitor of intracellular NAAA activity, which produces profound anti-inflammatory effects in animal models.  In the present work, the authors describe structure-activity relationship (SAR) studies on 3-aminoazetidin-2-one derivs., which have led to the identification of I, and expand these studies to elucidate the principal structural and stereochem. features needed to achieve effective NAAA inhibition.  Investigations on the influence of the substitution at the β-position of the 2-oxo-3-azetidinyl ring as well as on the effect of size and shape of the carbamic acid ester side chain led to the discovery of II, a novel inhibitor of human NAAA that shows an improved physicochem. and drug-like profile relative to I.  This favorable profile, along with the structural diversity of the carbamic acid chain of I, identify this compd. as a promising new tool to investigate the potential of NAAA inhibitors as therapeutic agents for the treatment of pain and inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoaN0JjRB6bmrVg90H21EOLACvtfcHk0ljfuVRD_eHVDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XisVansL4%253D&md5=639c2848d70ba68008db89244c2c8657</span></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2016.01.046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2016.01.046%26sid%3Dliteratum%253Aachs%26aulast%3DNuzzi%26aufirst%3DA.%26aulast%3DFiasella%26aufirst%3DA.%26aulast%3DOrtega%26aufirst%3DJ.%2BA.%26aulast%3DPagliuca%26aufirst%3DC.%26aulast%3DPonzano%26aufirst%3DS.%26aulast%3DPizzirani%26aufirst%3DD.%26aulast%3DBertozzi%26aufirst%3DS.%2BM.%26aulast%3DOttonello%26aufirst%3DG.%26aulast%3DTarozzo%26aufirst%3DG.%26aulast%3DReggiani%26aufirst%3DA.%26aulast%3DBandiera%26aufirst%3DT.%26aulast%3DBertozzi%26aufirst%3DF.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DPotent%2520%25CE%25B1-amino-%25CE%25B2-lactam%2520carbamic%2520acid%2520ester%2520as%2520NAAA%2520inhibitors.%2520Synthesis%2520and%2520structure-activity%2520relationship%2520%2528SAR%2529%2520studies%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2016%26volume%3D111%26spage%3D138%26epage%3D159%26doi%3D10.1016%2Fj.ejmech.2016.01.046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref105"><div class="reference"><strong class="refLabel"><a href="#ref105" class="rightTabRefNumLink">105</a></strong><div class="NLM_citation" id="rightTab-cit105"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Petracca, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ponzano, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertozzi, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sasso, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piomelli, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bandiera, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertozzi, F.</span></span> <span> </span><span class="NLM_article-title">Progress in the development of β-lactams as N-acylethanolamine acid amidase (NAAA) inhibitors: synthesis and SAR study of new, potent N-O-substituted derivatives</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>126</i></span>,  <span class="NLM_fpage">561</span>– <span class="NLM_lpage">575</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2016.11.039</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1016%2Fj.ejmech.2016.11.039" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=27915171" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BC28XitVGhsbzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2017&pages=561-575&author=R.+Petraccaauthor=S.+Ponzanoauthor=S.+M.+Bertozziauthor=O.+Sassoauthor=D.+Piomelliauthor=T.+Bandieraauthor=F.+Bertozzi&title=Progress+in+the+development+of+%CE%B2-lactams+as+N-acylethanolamine+acid+amidase+%28NAAA%29+inhibitors%3A+synthesis+and+SAR+study+of+new%2C+potent+N-O-substituted+derivatives&doi=10.1016%2Fj.ejmech.2016.11.039"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit105R"><div class="casContent"><span class="casTitleNuber">105</span><div class="casTitle"><span class="NLM_cas:atitle">Progress in the development of β-lactams as N-Acylethanolamine Acid Amidase (NAAA) inhibitors: Synthesis and SAR study of new, potent N-O-substituted derivatives</span></div><div class="casAuthors">Petracca, R.; Ponzano, S.; Bertozzi, S. M.; Sasso, O.; Piomelli, D.; Bandiera, T.; Bertozzi, F.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">126</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">561-575</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">The anti-inflammatory effects resulting from raising the levels of palmitoylethanolamide (PEA), an endogenous bioactive lipid, led to envisage N-Acylethanolamine Acid Amidase (NAAA), the cysteine hydrolase mainly responsible for PEA degrdn., as an attractive target for small mol. inhibitors.  Previous work in our group identified serine-derived β-lactams as potent and systemically active inhibitors of NAAA activity.  Aiming to expand the SAR study around this class of compds., we investigated the effect of the substitution on the endocyclic nitrogen by designing and synthesizing a series of N-substituted β-lactams.  The present work describes the synthesis of new N-O-alkyl and N-O-aryl substituted β-lactams and reports the results of the structure activity relationship (SAR) study leading to the discovery of a novel, single-digit nanomolar NAAA inhibitor (I).  Compd. I was shown in vitro to inhibit human NAAA via S-acylation of the catalytic cysteine, and to display very good selectivity vs. human Acid Ceramidase, a cysteine amidase structurally related to NAAA.  Preliminary in vivo studies showed that compd. I, administered topically, reduced paw edema and heat hyperalgesia in a carrageenan-induced inflammation mouse model.  The high in vitro potency of I as NAAA inhibitor, and its encouraging in vivo activity qualify this compd. as a new tool for the study of the role of NAAA in inflammatory and pain states.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5Ajl1yXbDTbVg90H21EOLACvtfcHk0ljfuVRD_eHVDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitVGhsbzP&md5=d5bc0ac0a10268a0eb10847a2c18d3dc</span></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2016.11.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2016.11.039%26sid%3Dliteratum%253Aachs%26aulast%3DPetracca%26aufirst%3DR.%26aulast%3DPonzano%26aufirst%3DS.%26aulast%3DBertozzi%26aufirst%3DS.%2BM.%26aulast%3DSasso%26aufirst%3DO.%26aulast%3DPiomelli%26aufirst%3DD.%26aulast%3DBandiera%26aufirst%3DT.%26aulast%3DBertozzi%26aufirst%3DF.%26atitle%3DProgress%2520in%2520the%2520development%2520of%2520%25CE%25B2-lactams%2520as%2520N-acylethanolamine%2520acid%2520amidase%2520%2528NAAA%2529%2520inhibitors%253A%2520synthesis%2520and%2520SAR%2520study%2520of%2520new%252C%2520potent%2520N-O-substituted%2520derivatives%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2017%26volume%3D126%26spage%3D561%26epage%3D575%26doi%3D10.1016%2Fj.ejmech.2016.11.039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref106"><div class="reference"><strong class="refLabel"><a href="#ref106" class="rightTabRefNumLink">106</a></strong><div class="NLM_citation" id="rightTab-cit106"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Romeo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ponzano, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Armirotti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Summa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertozzi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garau, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bandiera, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piomelli, D.</span></span> <span> </span><span class="NLM_article-title">Activity-based probe for N-acylethanolamine acid amidase</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">2057</span>– <span class="NLM_lpage">2064</span>, <span class="refDoi"> DOI: 10.1021/acschembio.5b00197</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.5b00197" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVeks7%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=2057-2064&author=E.+Romeoauthor=S.+Ponzanoauthor=A.+Armirottiauthor=M.+Summaauthor=F.+Bertozziauthor=G.+Garauauthor=T.+Bandieraauthor=D.+Piomelli&title=Activity-based+probe+for+N-acylethanolamine+acid+amidase&doi=10.1021%2Facschembio.5b00197"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit106R"><div class="casContent"><span class="casTitleNuber">106</span><div class="casTitle"><span class="NLM_cas:atitle">Activity-Based Probe for N-Acylethanolamine Acid Amidase</span></div><div class="casAuthors">Romeo, Elisa; Ponzano, Stefano; Armirotti, Andrea; Summa, Maria; Bertozzi, Fabio; Garau, Gianpiero; Bandiera, Tiziano; Piomelli, Daniele</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2057-2064</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">N-Acylethanolamine acid amidase (NAAA) is a lysosomal cysteine hydrolase involved in the degrdn. of satd. and monounsatd. fatty acid ethanolamides (FAEs), a family of endogenous lipid signaling mols. that includes oleoylethanolamide (OEA, 18:1Δ) and palmitoylethanolamide (PEA, 16:0).  Among the reported NAAA inhibitors, α-amino-β-lactone (3-aminooxetan-2-one) derivs. have been shown to prevent FAE hydrolysis in innate-immune and neural cells and to reduce reactions to inflammatory stimuli.  Recently, we disclosed two potent and selective NAAA inhibitors, the compds. ARN077 (5-phenylpentyl-N-[(2S,3R)-2-methyl-4-oxo-oxetan-3-yl]carbamate) and ARN726 (4-cyclohexylbutyl-N-[(S)-2-oxoazetidin-3-yl]carbamate).  The former is active in vivo by topical administration in rodent models of hyperalgesia and allodynia, while the latter exerts systemic anti-inflammatory effects in mouse models of lung inflammation.  In the present study, we designed and validated a deriv. of ARN726 as the first activity-based protein profiling (ABPP) probe for the in vivo detection of NAAA.  The newly synthesized mol. ARN14686 is an effective in vitro and in vivo click chem. activity-based probe (ABP), which is able to capture the catalytically active form of NAAA in Human Embryonic Kidney 293 (HEK293) cells overexpressing human NAAA as well as in rat lung tissue.  Competitive ABPP with 1 confirmed that ARN726 and ARN077 inhibit NAAA in vitro and in vivo.  Compd. 1 is a useful new tool to identify activated NAAA both in vitro and in vivo and to investigate the physiol. and pathol. roles of this enzyme.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTLtN6tIDDZbVg90H21EOLACvtfcHk0ljQMfAzlJjzeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVeks7%252FO&md5=1c76c7ac8597a15ce6b2bad6c5372d5d</span></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1021%2Facschembio.5b00197&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.5b00197%26sid%3Dliteratum%253Aachs%26aulast%3DRomeo%26aufirst%3DE.%26aulast%3DPonzano%26aufirst%3DS.%26aulast%3DArmirotti%26aufirst%3DA.%26aulast%3DSumma%26aufirst%3DM.%26aulast%3DBertozzi%26aufirst%3DF.%26aulast%3DGarau%26aufirst%3DG.%26aulast%3DBandiera%26aufirst%3DT.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DActivity-based%2520probe%2520for%2520N-acylethanolamine%2520acid%2520amidase%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2015%26volume%3D10%26spage%3D2057%26epage%3D2064%26doi%3D10.1021%2Facschembio.5b00197" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref107"><div class="reference"><strong class="refLabel"><a href="#ref107" class="rightTabRefNumLink">107</a></strong><div class="NLM_citation" id="rightTab-cit107"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Romeo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pontis, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ponzano, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonezzi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Migliore, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Martino, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Summa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piomelli, D.</span></span> <span> </span><span class="NLM_article-title">Preparation and in vivo use of an activity-based probe for N-acylethanolamine acid amidase</span>. <i>J. Visualized Exp.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>117</i></span>,  <span class="NLM_fpage">e54652</span>, <span class="refDoi"> DOI: 10.3791/54652</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.3791%2F54652" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2016&pages=e54652&author=E.+Romeoauthor=S.+Pontisauthor=S.+Ponzanoauthor=F.+Bonezziauthor=M.+Miglioreauthor=S.+Di+Martinoauthor=M.+Summaauthor=D.+Piomelli&title=Preparation+and+in+vivo+use+of+an+activity-based+probe+for+N-acylethanolamine+acid+amidase&doi=10.3791%2F54652"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.3791%2F54652&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3791%252F54652%26sid%3Dliteratum%253Aachs%26aulast%3DRomeo%26aufirst%3DE.%26aulast%3DPontis%26aufirst%3DS.%26aulast%3DPonzano%26aufirst%3DS.%26aulast%3DBonezzi%26aufirst%3DF.%26aulast%3DMigliore%26aufirst%3DM.%26aulast%3DDi%2BMartino%26aufirst%3DS.%26aulast%3DSumma%26aufirst%3DM.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DPreparation%2520and%2520in%2520vivo%2520use%2520of%2520an%2520activity-based%2520probe%2520for%2520N-acylethanolamine%2520acid%2520amidase%26jtitle%3DJ.%2520Visualized%2520Exp.%26date%3D2016%26volume%3D117%26spage%3De54652%26doi%3D10.3791%2F54652" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref108"><div class="reference"><strong class="refLabel"><a href="#ref108" class="rightTabRefNumLink">108</a></strong><div class="NLM_citation" id="rightTab-cit108"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Petracca, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romeo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baggelaar, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Artola, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pontis, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ponzano, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Overkleeft, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Stelt, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piomelli, D.</span></span> <span> </span><span class="NLM_article-title">Novel activity-based probes for N-acylethanolamine acid amidase</span>. <i>Chem. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">11810</span>– <span class="NLM_lpage">11813</span>, <span class="refDoi"> DOI: 10.1039/C7CC06838G</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1039%2FC7CC06838G" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=29035406" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1arsL3N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2017&pages=11810-11813&author=R.+Petraccaauthor=E.+Romeoauthor=M.+P.+Baggelaarauthor=M.+Artolaauthor=S.+Pontisauthor=S.+Ponzanoauthor=H.+S.+Overkleeftauthor=M.+van+der+Steltauthor=D.+Piomelli&title=Novel+activity-based+probes+for+N-acylethanolamine+acid+amidase&doi=10.1039%2FC7CC06838G"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">Novel activity-based probes for N-acylethanolamine acid amidase</span></div><div class="casAuthors">Petracca, Rita; Romeo, Elisa; Baggelaar, Marc P.; Artola, Marta; Pontis, Silvia; Ponzano, Stefano; Overkleeft, Herman S.; van der Stelt, Mario; Piomelli, Daniele</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Communications (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">86</span>),
    <span class="NLM_cas:pages">11810-11813</span>CODEN:
                <span class="NLM_cas:coden">CHCOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-7345</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The cysteine hydrolase, N-acylethanolamine acid amidase (NAAA) is a promising target for analgesic and anti-inflammatory drugs.  Here, we describe the development of two unprecedented NAAA-reactive activity-based probes as research tools for application in the discovery of new inhibitors and for the in-depth characterization of NAAA in its cellular environment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoiwHqA8xDk8rVg90H21EOLACvtfcHk0ljQMfAzlJjzeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1arsL3N&md5=a3e0529825b9f5c902f409c3da527c88</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1039%2FC7CC06838G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC7CC06838G%26sid%3Dliteratum%253Aachs%26aulast%3DPetracca%26aufirst%3DR.%26aulast%3DRomeo%26aufirst%3DE.%26aulast%3DBaggelaar%26aufirst%3DM.%2BP.%26aulast%3DArtola%26aufirst%3DM.%26aulast%3DPontis%26aufirst%3DS.%26aulast%3DPonzano%26aufirst%3DS.%26aulast%3DOverkleeft%26aufirst%3DH.%2BS.%26aulast%3Dvan%2Bder%2BStelt%26aufirst%3DM.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DNovel%2520activity-based%2520probes%2520for%2520N-acylethanolamine%2520acid%2520amidase%26jtitle%3DChem.%2520Commun.%26date%3D2017%26volume%3D53%26spage%3D11810%26epage%3D11813%26doi%3D10.1039%2FC7CC06838G" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref109"><div class="reference"><strong class="refLabel"><a href="#ref109" class="rightTabRefNumLink">109</a></strong><div class="NLM_citation" id="rightTab-cit109"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Malamas, M.</span>; <span class="NLM_string-name">Makriyannis, A.</span>; <span class="NLM_string-name">Subramian, K. V.</span>; <span class="NLM_string-name">Whitten, K. M.</span></span> <span> </span><span class="NLM_article-title">N-Acylethanolamine Hydrolyzing Acid Amidase (NAAA) Inhibitors and Their Use Thereof</span>. <span class="NLM_patent">WO2015179190A1</span>, Nov 26, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=M.+Malamas&author=A.+Makriyannis&author=K.+V.+Subramian&author=K.+M.+Whitten&title=N-Acylethanolamine+Hydrolyzing+Acid+Amidase+%28NAAA%29+Inhibitors+and+Their+Use+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMalamas%26aufirst%3DM.%26atitle%3DN-Acylethanolamine%2520Hydrolyzing%2520Acid%2520Amidase%2520%2528NAAA%2529%2520Inhibitors%2520and%2520Their%2520Use%2520Thereof%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref110"><div class="reference"><strong class="refLabel"><a href="#ref110" class="rightTabRefNumLink">110</a></strong><div class="NLM_citation" id="rightTab-cit110"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tarozzi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marchetti, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicolini, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Amico, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ticchi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pruccoli, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tumiatti, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simoni, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lodola, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mor, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milelli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minarini, A.</span></span> <span> </span><span class="NLM_article-title">Combined inhibition of the EGFR/AKT pathways by a novel conjugate of quinazoline with isothiocyanate</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>117</i></span>,  <span class="NLM_fpage">283</span>– <span class="NLM_lpage">291</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2016.04.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1016%2Fj.ejmech.2016.04.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=27135370" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BC28Xnt1Kqtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2016&pages=283-291&author=A.+Tarozziauthor=C.+Marchettiauthor=B.+Nicoliniauthor=M.+D%E2%80%99Amicoauthor=N.+Ticchiauthor=L.+Pruccoliauthor=V.+Tumiattiauthor=E.+Simoniauthor=A.+Lodolaauthor=M.+Morauthor=A.+Milelliauthor=A.+Minarini&title=Combined+inhibition+of+the+EGFR%2FAKT+pathways+by+a+novel+conjugate+of+quinazoline+with+isothiocyanate&doi=10.1016%2Fj.ejmech.2016.04.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit110R"><div class="casContent"><span class="casTitleNuber">110</span><div class="casTitle"><span class="NLM_cas:atitle">Combined inhibition of the EGFR/AKT pathways by a novel conjugate of quinazoline with isothiocyanate</span></div><div class="casAuthors">Tarozzi, Andrea; Marchetti, Chiara; Nicolini, Benedetta; D'Amico, Massimo; Ticchi, Nicole; Pruccoli, Letizia; Tumiatti, Vincenzo; Simoni, Elena; Lodola, Alessio; Mor, Marco; Milelli, Andrea; Minarini, Anna</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">283-291</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Epidermal growth factor receptor inhibitors (EGFR-TKIs) represent a class of compds. widely used in anticancer therapy.  An increasing no. of studies reports on combination therapies in which the block of the EGFR-TK activity is assocd. with inhibition of its downstream pathways, as PI3K-Akt.  Sulforaphane targets the PI3K-Akt pathway whose dysregulation is implicated in many functions of cancer cells.  According to these considerations, a series of multitarget mols. have been designed by combining key structural features derived from an EGFR-TKI, PD168393, and the isothiocyanate sulforaphane.  Among the obtained mols., compd. N-(3-bromophenyl)-6-isothiocyanatoquinazolin-4-amine (6) emerges as a promising lead compd. able to exert antiproliferative and proapoptotic effects in A431 epithelial cancer cell line by covalently binding to EGFR-TK, and reducing the phosphorylation of Akt without affecting the total Akt levels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpANqinYVd38rVg90H21EOLACvtfcHk0ljQMfAzlJjzeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xnt1Kqtr4%253D&md5=e941bda4b6bb7c58f05fd997dc7b9db5</span></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2016.04.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2016.04.002%26sid%3Dliteratum%253Aachs%26aulast%3DTarozzi%26aufirst%3DA.%26aulast%3DMarchetti%26aufirst%3DC.%26aulast%3DNicolini%26aufirst%3DB.%26aulast%3DD%25E2%2580%2599Amico%26aufirst%3DM.%26aulast%3DTicchi%26aufirst%3DN.%26aulast%3DPruccoli%26aufirst%3DL.%26aulast%3DTumiatti%26aufirst%3DV.%26aulast%3DSimoni%26aufirst%3DE.%26aulast%3DLodola%26aufirst%3DA.%26aulast%3DMor%26aufirst%3DM.%26aulast%3DMilelli%26aufirst%3DA.%26aulast%3DMinarini%26aufirst%3DA.%26atitle%3DCombined%2520inhibition%2520of%2520the%2520EGFR%252FAKT%2520pathways%2520by%2520a%2520novel%2520conjugate%2520of%2520quinazoline%2520with%2520isothiocyanate%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2016%26volume%3D117%26spage%3D283%26epage%3D291%26doi%3D10.1016%2Fj.ejmech.2016.04.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref111"><div class="reference"><strong class="refLabel"><a href="#ref111" class="rightTabRefNumLink">111</a></strong><div class="NLM_citation" id="rightTab-cit111"><span><span class="NLM_contrib-group"><span class="NLM_string-name">West, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zvonok, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitten, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vadivel, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowman, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makriyannis, A.</span></span> <span> </span><span class="NLM_article-title">Biochemical and mass spectrometric characterization of human N-acylethanolamine-hydrolyzing acid amidase inhibition</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">e43877</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0043877</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1371%2Fjournal.pone.0043877" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=22952796" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlSltr7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=e43877&author=J.+M.+Westauthor=N.+Zvonokauthor=K.+M.+Whittenauthor=S.+K.+Vadivelauthor=A.+L.+Bowmanauthor=A.+Makriyannis&title=Biochemical+and+mass+spectrometric+characterization+of+human+N-acylethanolamine-hydrolyzing+acid+amidase+inhibition&doi=10.1371%2Fjournal.pone.0043877"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit111R"><div class="casContent"><span class="casTitleNuber">111</span><div class="casTitle"><span class="NLM_cas:atitle">Biochemical and mass spectrometric characterization of human N-acylethanolamine-hydrolyzing acid amidase inhibition</span></div><div class="casAuthors">West, Jay M.; Zvonok, Nikolai; Whitten, Kyle M.; Vadivel, Subramanian K.; Bowman, Anna L.; Makriyannis, Alexandros</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">e43877</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">The mechanism of inactivation of human enzyme N-acylethanolamine-hydrolyzing acid amidase (hNAAA), with selected inhibitors identified in a novel fluorescent based assay developed for characterization of both reversible and irreversible inhibitors, was investigated kinetically and using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS).  1-Isothiocyanatopentadecane (AM9023) was found to be a potent, selective and reversible hNAAA inhibitor, while two others, 5-((biphenyl-4-yl)methyl)-N,N-dimethyl-2H-tetrazole-2-carboxamide (AM6701) and N-Benzyloxycarbonyl--serine β-lactone (N-Cbz-serine β-lactone), inhibited hNAAA in a covalent and irreversible manner.  MS anal. of the hNAAA/covalent inhibitor complexes identified modification only of the N-terminal cysteine (Cys126) of the β-subunit, confirming a suggested mechanism of hNAAA inactivation by the β-lactone contg. inhibitors.  These expts. provide direct evidence of the key role of Cys126 in hNAAA inactivation by different classes of covalent inhibitors, confirming the essential role of cysteine for catalysis and inhibition in this cysteine N-terminal nucleophile hydrolase enzyme.  They also provide a methodol. for the rapid screening and characterization of large libraries of compds. as potential inhibitors of NAAA, and subsequent characterization or their mechanism through MALDI-TOF MS based bottom up-proteomics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgYtxfkhdQ5rVg90H21EOLACvtfcHk0lib-0MSX4YcVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlSltr7E&md5=f1cedb03b771c71caef095bf138627bd</span></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0043877&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0043877%26sid%3Dliteratum%253Aachs%26aulast%3DWest%26aufirst%3DJ.%2BM.%26aulast%3DZvonok%26aufirst%3DN.%26aulast%3DWhitten%26aufirst%3DK.%2BM.%26aulast%3DVadivel%26aufirst%3DS.%2BK.%26aulast%3DBowman%26aufirst%3DA.%2BL.%26aulast%3DMakriyannis%26aufirst%3DA.%26atitle%3DBiochemical%2520and%2520mass%2520spectrometric%2520characterization%2520of%2520human%2520N-acylethanolamine-hydrolyzing%2520acid%2520amidase%2520inhibition%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26spage%3De43877%26doi%3D10.1371%2Fjournal.pone.0043877" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref112"><div class="reference"><strong class="refLabel"><a href="#ref112" class="rightTabRefNumLink">112</a></strong><div class="NLM_citation" id="rightTab-cit112"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alhouayek, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bottemanne, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Subramanian, K. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambert, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makriyannis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cani, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muccioli, G. G.</span></span> <span> </span><span class="NLM_article-title">N-Acylethanolamine-hydrolyzing acid amidase inhibition increases colon N-palmitoylethanolamine levels and counteracts murine colitis</span>. <i>FASEB J.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">650</span>– <span class="NLM_lpage">661</span>, <span class="refDoi"> DOI: 10.1096/fj.14-255208</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1096%2Ffj.14-255208" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=25384424" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BC2MXislGis7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2015&pages=650-661&author=M.+Alhouayekauthor=P.+Bottemanneauthor=K.+V.+Subramanianauthor=D.+M.+Lambertauthor=A.+Makriyannisauthor=P.+D.+Caniauthor=G.+G.+Muccioli&title=N-Acylethanolamine-hydrolyzing+acid+amidase+inhibition+increases+colon+N-palmitoylethanolamine+levels+and+counteracts+murine+colitis&doi=10.1096%2Ffj.14-255208"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit112R"><div class="casContent"><span class="casTitleNuber">112</span><div class="casTitle"><span class="NLM_cas:atitle">N-acylethanolamine-hydrolyzing acid amidase inhibition increases colon N-palmitoylethanolamine levels and counteracts murine colitis</span></div><div class="casAuthors">Alhouayek, Mireille; Bottemanne, Pauline; Subramanian, Kumar V.; Lambert, Didier M.; Makriyannis, Alexandros; Cani, Patrice D.; Muccioli, Giulio G.</div><div class="citationInfo"><span class="NLM_cas:title">FASEB Journal</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">650-661, 10.1096/fj.14-255208</span>CODEN:
                <span class="NLM_cas:coden">FAJOEC</span>;
        ISSN:<span class="NLM_cas:issn">0892-6638</span>.
    
            (<span class="NLM_cas:orgname">Federation of American Societies for Experimental Biology</span>)
        </div><div class="casAbstract">N-Palmitoylethanolamine or palmitoylethanolamide (PEA) is an anti-inflammatory compd. that was recently shown to exert peroxisome proliferator-activated receptor-α-dependent beneficial effects on colon inflammation.  The actions of PEA are terminated following hydrolysis by 2 enzymes: fatty acid amide hydrolase (FAAH), and the less-studied N-acylethanolamine-hydrolyzing acid amidase (NAAA).  This study aims to investigate the effects of inhibiting the enzymes responsible for PEA hydrolysis in colon inflammation in order to propose a potential therapeutic target for inflammatory bowel diseases (IBDs).  Two murine models of IBD were used to assess the effects of NAAA inhibition, FAAH inhibition, and PEA on macroscopic signs of colon inflammation, macrophage/neutrophil infiltration, and the expression of proinflammatory mediators in the colon, as well as on the colitis-related systemic inflammation.  NAAA inhibition increases PEA levels in the colon and reduces colon inflammation and systemic inflammation, similarly to PEA.  FAAH inhibition, however, does not increase PEA levels in the colon and does not affect the macroscopic signs of colon inflammation or immune cell infiltration.  This is the first report of an anti-inflammatory effect of a systemically administered NAAA inhibitor.  Because NAAA is the enzyme responsible for the control of PEA levels in the colon, we put forth this enzyme as a potential therapeutic target in chronic inflammation in general and IBD in particular.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1s3Cs4nu0sbVg90H21EOLACvtfcHk0lib-0MSX4YcVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXislGis7Y%253D&md5=608b15a459887f1cde27f68e241d85b2</span></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.1096%2Ffj.14-255208&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1096%252Ffj.14-255208%26sid%3Dliteratum%253Aachs%26aulast%3DAlhouayek%26aufirst%3DM.%26aulast%3DBottemanne%26aufirst%3DP.%26aulast%3DSubramanian%26aufirst%3DK.%2BV.%26aulast%3DLambert%26aufirst%3DD.%2BM.%26aulast%3DMakriyannis%26aufirst%3DA.%26aulast%3DCani%26aufirst%3DP.%2BD.%26aulast%3DMuccioli%26aufirst%3DG.%2BG.%26atitle%3DN-Acylethanolamine-hydrolyzing%2520acid%2520amidase%2520inhibition%2520increases%2520colon%2520N-palmitoylethanolamine%2520levels%2520and%2520counteracts%2520murine%2520colitis%26jtitle%3DFASEB%2520J.%26date%3D2015%26volume%3D29%26spage%3D650%26epage%3D661%26doi%3D10.1096%2Ffj.14-255208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref113"><div class="reference"><strong class="refLabel"><a href="#ref113" class="rightTabRefNumLink">113</a></strong><div class="NLM_citation" id="rightTab-cit113"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Falgueyret, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oballa, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okamoto, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wesolowski, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aubin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rydzewski, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prasit, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riendeau, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodan, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Percival, M. D.</span></span> <span> </span><span class="NLM_article-title">Novel, nonpeptidic cyanamides as potent and reversible inhibitors of human cathepsins K and L</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">94</span>– <span class="NLM_lpage">104</span>, <span class="refDoi"> DOI: 10.1021/jm0003440</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0003440" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BD3cXos1ajs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=94-104&author=J.+P.+Falgueyretauthor=R.+M.+Oballaauthor=O.+Okamotoauthor=G.+Wesolowskiauthor=Y.+Aubinauthor=R.+M.+Rydzewskiauthor=P.+Prasitauthor=D.+Riendeauauthor=S.+B.+Rodanauthor=M.+D.+Percival&title=Novel%2C+nonpeptidic+cyanamides+as+potent+and+reversible+inhibitors+of+human+cathepsins+K+and+L&doi=10.1021%2Fjm0003440"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit113R"><div class="casContent"><span class="casTitleNuber">113</span><div class="casTitle"><span class="NLM_cas:atitle">Novel, Nonpeptidic Cyanamides as Potent and Reversible Inhibitors of Human Cathepsins K and L</span></div><div class="casAuthors">Falgueyret, Jean-Pierre; Oballa, Renata M.; Okamoto, Osamu; Wesolowski, Gregg; Aubin, Yves; Rydzewski, Robert M.; Prasit, Peppi; Riendeau, Denis; Rodan, Sevgi B.; Percival, M. David</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">94-104</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Compds. contg. a 1-cyanopyrrolidinyl ring were identified as potent and reversible inhibitors of cathepsins K and L.  The original lead compd. I inhibits cathepsins K and L with IC50 values of 0.37 and 0.45 μM, resp.  Modification of compd. I by replacement of the quinoline moiety led to the synthesis of N-(1-cyano-3-pyrrolidinyl)benzenesulfonamide (2).  Compd. II was found to be a potent inhibitor of cathepsins K and L with a Ki value of 50 nM for cathepsin K.  Replacement of the 1-cyanopyrrolidine of compd. II by a 1-cyanoazetidine increased the potency of the inhibitor by 10-fold.  This increase in potency is probably due to an enhanced chem. reactivity of the compd. toward the thiolate of the active site of the enzyme.  This is demonstrated when the assay is performed in the presence of glutathione at pH 7.0 which favors the formation of a GSH thiolate anion.  Under these assay conditions, there is a loss of potency in the 1-cyanoazetidine series due to the formation of an inactive complex between the GSH thiolate and the 1-cyanoazetidine inhibitors. 1-Cyanopyrrolidinyl inhibitors exhibited time-dependent inhibition which allowed us to det. the assocn. and dissocn. rate consts. with human cathepsin K.  The kinetic data obtained showed that the increase of potency obsd. between different 1-cyanopyrrolidinyl inhibitors is due to an increase of kon values and that the assocn. of the compd. with the enzyme fits an apparent one-step mechanism. 13C NMR expts. performed with the enzyme papain showed that compd. 2 forms a covalent isothiourea ester adduct with the enzyme.  As predicted by the kinetic anal., the addn. of the irreversible inhibitor E64 to the enzyme-cyanopyrrolidinyl complex totally abolished the signal of the isothiourea bond as obsd. by 13C NMR, thereby demonstrating that the formation of the covalent bond with the active site cysteine residue is reversible. Finally, compd. II inhibits bone resorption in an in vitro assay involving rabbit osteoclasts and bovine bone with an IC50 value of 0.7 μM. 1-Cyanopyrrolidine represents a new class of nonpeptidic compds. that inhibit cathepsin K and L activity and proteolysis of bone collagen.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWnsb8us0GkrVg90H21EOLACvtfcHk0lib-0MSX4YcVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXos1ajs7g%253D&md5=aed27c1353797e413890ea02d900095b</span></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1021%2Fjm0003440&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0003440%26sid%3Dliteratum%253Aachs%26aulast%3DFalgueyret%26aufirst%3DJ.%2BP.%26aulast%3DOballa%26aufirst%3DR.%2BM.%26aulast%3DOkamoto%26aufirst%3DO.%26aulast%3DWesolowski%26aufirst%3DG.%26aulast%3DAubin%26aufirst%3DY.%26aulast%3DRydzewski%26aufirst%3DR.%2BM.%26aulast%3DPrasit%26aufirst%3DP.%26aulast%3DRiendeau%26aufirst%3DD.%26aulast%3DRodan%26aufirst%3DS.%2BB.%26aulast%3DPercival%26aufirst%3DM.%2BD.%26atitle%3DNovel%252C%2520nonpeptidic%2520cyanamides%2520as%2520potent%2520and%2520reversible%2520inhibitors%2520of%2520human%2520cathepsins%2520K%2520and%2520L%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D94%26epage%3D104%26doi%3D10.1021%2Fjm0003440" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref114"><div class="reference"><strong class="refLabel"><a href="#ref114" class="rightTabRefNumLink">114</a></strong><div class="NLM_citation" id="rightTab-cit114"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Malamas, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farah, S. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pelekoudas, D. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perry, N. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajarshi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyabe, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chandrashekhar, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">West, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pavlopoulos, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makriyannis, A.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of cyanamides as potent and selective N-acylethanolamine acid amidase inhibitors</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">115195</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2019.115195</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1016%2Fj.bmc.2019.115195" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=31761726" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BC1MXit1ars7rE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2020&pages=115195&author=M.+S.+Malamasauthor=S.+I.+Farahauthor=M.+Lamaniauthor=D.+N.+Pelekoudasauthor=N.+T.+Perryauthor=G.+Rajarshiauthor=C.+Y.+Miyabeauthor=H.+Chandrashekharauthor=J.+Westauthor=S.+Pavlopoulosauthor=A.+Makriyannis&title=Design+and+synthesis+of+cyanamides+as+potent+and+selective+N-acylethanolamine+acid+amidase+inhibitors&doi=10.1016%2Fj.bmc.2019.115195"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit114R"><div class="casContent"><span class="casTitleNuber">114</span><div class="casTitle"><span class="NLM_cas:atitle">Design and synthesis of cyanamides as potent and selective N-acylethanolamine acid amidase inhibitors</span></div><div class="casAuthors">Malamas, Michael S.; Farah, Shrouq I.; Lamani, Manjunath; Pelekoudas, Dimitrios N.; Perry, Nicholas Thomas; Rajarshi, Girija; Miyabe, Christina Yume; Chandrashekhar, Honrao; West, Jay; Pavlopoulos, Spiro; Makriyannis, Alexandros</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">115195</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">N-acylethanolamine acid amidase (NAAA) inhibition represents an exciting novel approach to treat inflammation and pain.  NAAA is a cysteine amidase which preferentially hydrolyzes the endogenous biolipids palmitoylethanolamide (PEA) and oleoylethanolamide (OEA).  PEA is an endogenous agonist of the nuclear peroxisome proliferator-activated receptor-α (PPAR-α), which is a key regulator of inflammation and pain.  Thus, blocking the degrdn. of PEA with NAAA inhibitors results in augmentation of the PEA/PPAR-α signaling pathway and regulation of inflammatory and pain processes.  We have prepd. a new series of NAAA inhibitors exploring the azetidine-nitrile (cyanamide) pharmacophore that led to the discovery of highly potent and selective compds.  Key analogs demonstrated single-digit nanomolar potency for hNAAA and showed &amp;gt;100-fold selectivity against serine hydrolases FAAH, MGL and ABHD6, and cysteine protease cathepsin K.  Addnl., we have identified potent and selective dual NAAA-FAAH inhibitors to investigate a potential synergism between two distinct anti-inflammatory mol. pathways, the PEA/PPAR-α anti-inflammatory signaling pathway,1-4 and the cannabinoid receptors CB1 and CB2 pathways which are known for their antiinflammatory and antinociceptive properties.5-8 Our ligand design strategy followed a traditional structure-activity relationship (SAR) approach and was supported by mol. modeling studies of reported X-ray structures of hNAAA.  Several inhibitors were evaluated in stability assays and demonstrated very good plasma stability (t1/2 &amp;gt; 2 h; human and rodents).  The disclosed cyanamides represent promising new pharmacol. tools to investigate the potential role of NAAA inhibitors and dual NAAA-FAAH inhibitors as therapeutic agents for the treatment of inflammation and pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-A_C3n2MNkbVg90H21EOLACvtfcHk0liLSWm2Wc6lHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXit1ars7rE&md5=f5330d39907df730c82cca041803b7da</span></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2019.115195&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2019.115195%26sid%3Dliteratum%253Aachs%26aulast%3DMalamas%26aufirst%3DM.%2BS.%26aulast%3DFarah%26aufirst%3DS.%2BI.%26aulast%3DLamani%26aufirst%3DM.%26aulast%3DPelekoudas%26aufirst%3DD.%2BN.%26aulast%3DPerry%26aufirst%3DN.%2BT.%26aulast%3DRajarshi%26aufirst%3DG.%26aulast%3DMiyabe%26aufirst%3DC.%2BY.%26aulast%3DChandrashekhar%26aufirst%3DH.%26aulast%3DWest%26aufirst%3DJ.%26aulast%3DPavlopoulos%26aufirst%3DS.%26aulast%3DMakriyannis%26aufirst%3DA.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520cyanamides%2520as%2520potent%2520and%2520selective%2520N-acylethanolamine%2520acid%2520amidase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2020%26volume%3D28%26spage%3D115195%26doi%3D10.1016%2Fj.bmc.2019.115195" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref115"><div class="reference"><strong class="refLabel"><a href="#ref115" class="rightTabRefNumLink">115</a></strong><div class="NLM_citation" id="rightTab-cit115"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, J.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of potent N-acylethanolamine hydrolyzing acid amidase (NAAA) inhibitor as anti-inflammatory compounds</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">e43023</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0043023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1371%2Fjournal.pone.0043023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=22916199" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1Gnsr%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=e43023&author=Y.+Liauthor=L.+Yangauthor=L.+Chenauthor=C.+Zhuauthor=R.+Huangauthor=X.+Zhengauthor=Y.+Qiuauthor=J.+Fu&title=Design+and+synthesis+of+potent+N-acylethanolamine+hydrolyzing+acid+amidase+%28NAAA%29+inhibitor+as+anti-inflammatory+compounds&doi=10.1371%2Fjournal.pone.0043023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit115R"><div class="casContent"><span class="casTitleNuber">115</span><div class="casTitle"><span class="NLM_cas:atitle">Design and synthesis of potent N-acylethanolamine-hydrolyzing acid amidase (NAAA) inhibitor as anti-inflammatory compounds</span></div><div class="casAuthors">Li, Yuhang; Yang, Longhe; Chen, Ling; Zhu, Chenggang; Huang, Rui; Zheng, Xiao; Qiu, Yan; Fu, Jin</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">e43023</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">N-acylethanolamine-hydrolyzing acid amidase (NAAA) is a lysosomal enzyme involved in biol. deactivation of N-palmitoylethanolamide (PEA), which exerts anti-inflammatory and analgesic effects through the activation of nuclear receptor peroxisome proliferator-activated receptor-alpha (PPAR-α).  To develop selective and potent NAAA inhibitors, we designed and synthesized a series of derivs. of 1-pentadecanyl-carbonyl pyrrolidine (compd. 1), a general amidase inhibitor.  Structure activity relationship (SAR) studies have identified a compd. 16, 1-(2-Biphenyl-4-yl)ethyl-carbonyl pyrrolidine, which has shown the highest inhibition on NAAA activity (IC50 = 2.12 ± 0.41 μM) and is characterized as a reversible and competitive NAAA inhibitor.  Computational docking anal. and mutagenesis study revealed that compd. 16 interacted with Asparagine 209 (Asn209) residue flanking the catalytic pocket of NAAA so as to block the substrate entrance.  In vitro pharmacol. studies demonstrated that compd. 16 dose-dependently reduced mRNA expression levels of iNOS and IL-6, along with an increase of intracellular PEA levels, in mouse macrophages with lipopolysaccharides (LPS) induced inflammation.  Our study discovered a novel NAAA inhibitor, compd. 16, that could serve as a potential anti-inflammatory agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjj_FwM6WnALVg90H21EOLACvtfcHk0liLSWm2Wc6lHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1Gnsr%252FJ&md5=12369bcfbbe53a5f4c65c68df0a59945</span></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0043023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0043023%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DZhu%26aufirst%3DC.%26aulast%3DHuang%26aufirst%3DR.%26aulast%3DZheng%26aufirst%3DX.%26aulast%3DQiu%26aufirst%3DY.%26aulast%3DFu%26aufirst%3DJ.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520potent%2520N-acylethanolamine%2520hydrolyzing%2520acid%2520amidase%2520%2528NAAA%2529%2520inhibitor%2520as%2520anti-inflammatory%2520compounds%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26spage%3De43023%26doi%3D10.1371%2Fjournal.pone.0043023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref116"><div class="reference"><strong class="refLabel"><a href="#ref116" class="rightTabRefNumLink">116</a></strong><div class="NLM_citation" id="rightTab-cit116"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span> <span> </span><span class="NLM_article-title">Synthesis, biological evaluation, and structure activity relationship (SAR) study of pyrrolidine amide derivatives as N-acylethanolamine acid amidase (NAAA) inhibitors</span>. <i>MedChemComm</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">252</span>– <span class="NLM_lpage">262</span>, <span class="refDoi"> DOI: 10.1039/C8MD00432C</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1039%2FC8MD00432C" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=30931090" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisFersbnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=252-262&author=P.+Zhouauthor=L.+Xiangauthor=D.+Zhaoauthor=J.+Renauthor=Y.+Qiuauthor=Y.+Li&title=Synthesis%2C+biological+evaluation%2C+and+structure+activity+relationship+%28SAR%29+study+of+pyrrolidine+amide+derivatives+as+N-acylethanolamine+acid+amidase+%28NAAA%29+inhibitors&doi=10.1039%2FC8MD00432C"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit116R"><div class="casContent"><span class="casTitleNuber">116</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, biological evaluation, and structure activity relationship (SAR) study of pyrrolidine amide derivatives as N-acylethanolamine acid amidase (NAAA) inhibitors</span></div><div class="casAuthors">Zhou, Pan; Xiang, Lei; Zhao, Dongsheng; Ren, Jie; Qiu, Yan; Li, Yuhang</div><div class="citationInfo"><span class="NLM_cas:title">MedChemComm</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">252-262</span>CODEN:
                <span class="NLM_cas:coden">MCCEAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-2503</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">N-Acylethanolamine acid amidase (NAAA) is one of the key enzymes involved in the degrdn. of fatty acid ethanolamides (FAEs), esp. for palmitoylethanolamide (PEA).  Pharmacol. blockage of NAAA restores PEA levels, providing therapeutic benefits in the management of inflammation and pain.  In the current work, the authors present structure-activity relationship (SAR) studies for pyrrolidine amide derivs. as NAAA inhibitors.  A series of arom. replacements or substituents for the terminal Ph group of pyrrolidine amides were examd.  SAR data showed that small lipophilic 3-Ph substituents were preferable for optimal potency.  The conformationally flexible linkers increased the inhibitory potency of pyrrolidine amide derivs. but reduced their selectivity toward fatty acid amide hydrolase (FAAH).  The conformationally restricted linkers did not enhance the inhibitor potency toward NAAA but improved the selectivity over FAAH.  Several low micromolar potent NAAA inhibitors were developed, including compd. I bearing a rigid 4-phenylcinnamoyl group.  Dialysis and kinetic anal. suggested that compd. I inhibited NAAA via a competitive and reversible mechanism.  Furthermore, compd. I showed high anti-inflammatory activities in lipopolysaccharide (LPS) induced acute lung injury (ALI) model; and this effect was blocked by pre-treatment with the PPAR-α antagonist MK886.  We anticipate that compd. I (E93) will enable a new agent to treat inflammation and related diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqn4RGjqYy3qLVg90H21EOLACvtfcHk0liLSWm2Wc6lHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisFersbnO&md5=144ee64a8a6041fd7a0a4bd5aef3977d</span></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=10.1039%2FC8MD00432C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC8MD00432C%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DP.%26aulast%3DXiang%26aufirst%3DL.%26aulast%3DZhao%26aufirst%3DD.%26aulast%3DRen%26aufirst%3DJ.%26aulast%3DQiu%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DY.%26atitle%3DSynthesis%252C%2520biological%2520evaluation%252C%2520and%2520structure%2520activity%2520relationship%2520%2528SAR%2529%2520study%2520of%2520pyrrolidine%2520amide%2520derivatives%2520as%2520N-acylethanolamine%2520acid%2520amidase%2520%2528NAAA%2529%2520inhibitors%26jtitle%3DMedChemComm%26date%3D2019%26volume%3D10%26spage%3D252%26epage%3D262%26doi%3D10.1039%2FC8MD00432C" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref117"><div class="reference"><strong class="refLabel"><a href="#ref117" class="rightTabRefNumLink">117</a></strong><div class="NLM_citation" id="rightTab-cit117"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, C.</span></span> <span> </span><span class="NLM_article-title">Identification of highly potent N-acylethanolamine acid amidase (NAAA) inhibitors: Optimization of the terminal phenyl moiety of oxazolidone derivatives</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>139</i></span>,  <span class="NLM_fpage">214</span>– <span class="NLM_lpage">221</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2017.08.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1016%2Fj.ejmech.2017.08.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=28802121" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtlarsrfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=139&publication_year=2017&pages=214-221&author=Y.+Liauthor=Q.+Chenauthor=L.+Yangauthor=Y.+Liauthor=Y.+Zhangauthor=Y.+Qiuauthor=J.+Renauthor=C.+Lu&title=Identification+of+highly+potent+N-acylethanolamine+acid+amidase+%28NAAA%29+inhibitors%3A+Optimization+of+the+terminal+phenyl+moiety+of+oxazolidone+derivatives&doi=10.1016%2Fj.ejmech.2017.08.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit117R"><div class="casContent"><span class="casTitleNuber">117</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of highly potent N-acylethanolamine acid amidase (NAAA) inhibitors: Optimization of the terminal phenyl moiety of oxazolidone derivatives</span></div><div class="casAuthors">Li, Yuhang; Chen, Qi; Yang, Longhe; Li, Yanting; Zhang, Yang; Qiu, Yan; Ren, Jie; Lu, Canzhong</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">139</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">214-221</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">N-acylethanolamine acid amidase (NAAA) is a cysteine hydrolase that participates in the deactivation of fatty acid ethanolamides, such as palmitoylethanolamide (PEA).  NAAA inhibition may provide a potential therapeutic strategy for the treatment of diseases in which higher PEA level is desired.  In the present study, we reported the structure-activity relationship (SAR) studies for oxazolidone derivs. as NAAA inhibitors.  A series of substituents or alkyl replacements for the terminal Ph ring of oxazolidone derivs. were examd.  The results showed that the inhibition potency of these oxazolidone derivs. towards NAAA depends on the sizes, flexibility, and lipophilicity of the terminal groups.  SAR results suggested that small lipophilic 3-Ph substituents or hydroxy-contg. 4-Ph substituents were preferable for optimal potency.  Furthermore, the distal aliph. replacement is also preferred for high inhibitory potency.  Rapid diln. and kinetic anal. suggested that oxazolidone derivs. with different terminal Ph moieties inhibited NAAA via different mechanisms.  This study identified several highly potent NAAA inhibitors, including 1a (F215, IC50 = 0.009 μM), 1o (IC50 = 0.061 μM) and 2e (IC50 = 0.092 μM), and also detd. structural requirements of oxazolidone derivs. for potent inhibition against NAAA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCt5BDoxRb7LVg90H21EOLACvtfcHk0likX4tyeDKv9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtlarsrfF&md5=d4d34c95deea24435ceb35348c39d279</span></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2017.08.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2017.08.004%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DQ.%26aulast%3DYang%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DQiu%26aufirst%3DY.%26aulast%3DRen%26aufirst%3DJ.%26aulast%3DLu%26aufirst%3DC.%26atitle%3DIdentification%2520of%2520highly%2520potent%2520N-acylethanolamine%2520acid%2520amidase%2520%2528NAAA%2529%2520inhibitors%253A%2520Optimization%2520of%2520the%2520terminal%2520phenyl%2520moiety%2520of%2520oxazolidone%2520derivatives%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2017%26volume%3D139%26spage%3D214%26epage%3D221%26doi%3D10.1016%2Fj.ejmech.2017.08.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref118"><div class="reference"><strong class="refLabel"><a href="#ref118" class="rightTabRefNumLink">118</a></strong><div class="NLM_citation" id="rightTab-cit118"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Petrosino, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmad, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marcolongo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esposito, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allarà, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verde, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuzzocrea, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Marzo, V.</span></span> <span> </span><span class="NLM_article-title">Diacerein is a potent and selective inhibitor of palmitoylethanolamide inactivation with analgesic activity in a rat model of acute inflammatory pain</span>. <i>Pharmacol. Res.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>91</i></span>,  <span class="NLM_fpage">9</span>– <span class="NLM_lpage">14</span>, <span class="refDoi"> DOI: 10.1016/j.phrs.2014.10.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1016%2Fj.phrs.2014.10.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=25447594" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFShtrrI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=2015&pages=9-14&author=S.+Petrosinoauthor=A.+Ahmadauthor=G.+Marcolongoauthor=E.+Espositoauthor=M.+Allar%C3%A0author=R.+Verdeauthor=S.+Cuzzocreaauthor=V.+Di+Marzo&title=Diacerein+is+a+potent+and+selective+inhibitor+of+palmitoylethanolamide+inactivation+with+analgesic+activity+in+a+rat+model+of+acute+inflammatory+pain&doi=10.1016%2Fj.phrs.2014.10.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit118R"><div class="casContent"><span class="casTitleNuber">118</span><div class="casTitle"><span class="NLM_cas:atitle">Diacerein is a potent and selective inhibitor of palmitoylethanolamide inactivation with analgesic activity in a rat model of acute inflammatory pain</span></div><div class="casAuthors">Petrosino, Stefania; Ahmad, Akbar; Marcolongo, Gabriele; Esposito, Emanuela; Allara, Marco; Verde, Roberta; Cuzzocrea, Salvatore; Di Marzo, Vincenzo</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">91</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">9-14</span>CODEN:
                <span class="NLM_cas:coden">PHMREP</span>;
        ISSN:<span class="NLM_cas:issn">1043-6618</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Palmitoylethanolamide (PEA) is produced by mammalian cells from its biosynthetic precursor, N-palmitoyl-phosphatidyl-ethanolamine, and inactivated by enzymic hydrolysis to palmitic acid and ethanolamine.  Apart from fatty acid amide hydrolase (FAAH), the N-acylethanolamine-hydrolyzing acid amidase (NAAA), a lysosomal enzyme, was also shown to catalyze the hydrolysis of PEA and to limit its analgesic and anti-inflammatory action.  Here we report the finding of a new potential inhibitor of NAAA, EPT4900 (4,5-diacetyloxy-9,10-dioxo-anthracene-2-carboxylic acid, diacerein).  EPT4900 exhibited a high inhibitory activity on human recombinant NAAA over-expressed in HEK293 cells (HEK-NAAA cells).  EPT4900 selectively increased the levels of PEA in intact HEK-NAAA cells, and inhibited inflammation as well as hyperalgesia in rats treated with an intraplantar injection of carrageenan.  This latter effect was accompanied by elevation of PEA endogenous levels in the paw skin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjQUYAZlW4FrVg90H21EOLACvtfcHk0likX4tyeDKv9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFShtrrI&md5=2cc594bdb0bfc697de0d7b2189a7ecb9</span></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=10.1016%2Fj.phrs.2014.10.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phrs.2014.10.008%26sid%3Dliteratum%253Aachs%26aulast%3DPetrosino%26aufirst%3DS.%26aulast%3DAhmad%26aufirst%3DA.%26aulast%3DMarcolongo%26aufirst%3DG.%26aulast%3DEsposito%26aufirst%3DE.%26aulast%3DAllar%25C3%25A0%26aufirst%3DM.%26aulast%3DVerde%26aufirst%3DR.%26aulast%3DCuzzocrea%26aufirst%3DS.%26aulast%3DDi%2BMarzo%26aufirst%3DV.%26atitle%3DDiacerein%2520is%2520a%2520potent%2520and%2520selective%2520inhibitor%2520of%2520palmitoylethanolamide%2520inactivation%2520with%2520analgesic%2520activity%2520in%2520a%2520rat%2520model%2520of%2520acute%2520inflammatory%2520pain%26jtitle%3DPharmacol.%2520Res.%26date%3D2015%26volume%3D91%26spage%3D9%26epage%3D14%26doi%3D10.1016%2Fj.phrs.2014.10.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref119"><div class="reference"><strong class="refLabel"><a href="#ref119" class="rightTabRefNumLink">119</a></strong><div class="NLM_citation" id="rightTab-cit119"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fidelix, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macedo, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maxwell, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernandes
Moça Trevisani, V.</span></span> <span> </span><span class="NLM_article-title">Diacerein for osteoarthritis</span>. <i>Cochrane Database Syst. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">CD005117</span>, <span class="refDoi"> DOI: 10.1002/14651858.CD005117.pub3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1002%2F14651858.CD005117.pub3" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2014&pages=CD005117&author=T.+S.+Fidelixauthor=C.+R.+Macedoauthor=L.+J.+Maxwellauthor=V.+Fernandes%0AMo%C3%A7a+Trevisani&title=Diacerein+for+osteoarthritis&doi=10.1002%2F14651858.CD005117.pub3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.1002%2F14651858.CD005117.pub3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F14651858.CD005117.pub3%26sid%3Dliteratum%253Aachs%26aulast%3DFidelix%26aufirst%3DT.%2BS.%26aulast%3DMacedo%26aufirst%3DC.%2BR.%26aulast%3DMaxwell%26aufirst%3DL.%2BJ.%26aulast%3DFernandes%2BMo%25C3%25A7a%2BTrevisani%26aufirst%3DV.%26atitle%3DDiacerein%2520for%2520osteoarthritis%26jtitle%3DCochrane%2520Database%2520Syst.%2520Rev.%26date%3D2014%26volume%3D2%26spage%3DCD005117%26doi%3D10.1002%2F14651858.CD005117.pub3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref120"><div class="reference"><strong class="refLabel"><a href="#ref120" class="rightTabRefNumLink">120</a></strong><div class="NLM_citation" id="rightTab-cit120"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pavelka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruyere, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanis, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leeb, B. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maheu, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martel-Pelletier, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monfort, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pelletier, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rizzoli, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reginster, J. Y.</span></span> <span> </span><span class="NLM_article-title">Diacerein: benefits, risks and place in the management of osteoarthritis. An opinion-based report from the ESCEO</span>. <i>Drugs Aging</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">75</span>– <span class="NLM_lpage">85</span>, <span class="refDoi"> DOI: 10.1007/s40266-016-0347-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1007%2Fs40266-016-0347-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=26849131" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BC28Xitlyntbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2016&pages=75-85&author=K.+Pavelkaauthor=O.+Bruyereauthor=C.+Cooperauthor=J.+A.+Kanisauthor=B.+F.+Leebauthor=E.+Maheuauthor=J.+Martel-Pelletierauthor=J.+Monfortauthor=J.+P.+Pelletierauthor=R.+Rizzoliauthor=J.+Y.+Reginster&title=Diacerein%3A+benefits%2C+risks+and+place+in+the+management+of+osteoarthritis.+An+opinion-based+report+from+the+ESCEO&doi=10.1007%2Fs40266-016-0347-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit120R"><div class="casContent"><span class="casTitleNuber">120</span><div class="casTitle"><span class="NLM_cas:atitle">Diacerein: Benefits, Risks and Place in the Management of Osteoarthritis. An Opinion-Based Report from the ESCEO</span></div><div class="casAuthors">Pavelka, Karel; Bruyere, Olivier; Cooper, Cyrus; Kanis, John A.; Leeb, Burkhard F.; Maheu, Emmanuel; Martel-Pelletier, Johanne; Monfort, Jordi; Pelletier, Jean-Pierre; Rizzoli, Rene; Reginster, Jean-Yves</div><div class="citationInfo"><span class="NLM_cas:title">Drugs & Aging</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">75-85</span>CODEN:
                <span class="NLM_cas:coden">DRAGE6</span>;
        ISSN:<span class="NLM_cas:issn">1170-229X</span>.
    
            (<span class="NLM_cas:orgname">Springer International Publishing AG</span>)
        </div><div class="casAbstract">Diacerein is a symptomatic slow-acting drug in osteoarthritis (SYSADOA) with anti-inflammatory, anti-catabolic and pro-anabolic properties on cartilage and synovial membrane.  It has also recently been shown to have protective effects against subchondral bone remodelling.  Following the end of the revision procedure by the Pharmacovigilance Risk Assessment Committee of the European Medicines Agency, the European Society for Clin. and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) constituted a panel of 11 experts to better define the real place of diacerein in the armamentarium for treating OA.  Based on a literature review of clin. trials and meta-analyses, the ESCEO confirms that the efficacy of diacerein is similar to that of non-steroidal anti-inflammatory drugs (NSAIDs) after the first month of treatment, and superior to that of paracetamol.  Addnl., diacerein has shown a prolonged effect on symptoms of several months once treatment was stopped.  The use of diacerein is assocd. with common gastrointestinal disorders such as soft stools and diarrhea, common mild skin reactions, and, uncommonly, hepatobiliary disorders.  However, NSAIDs and paracetamol are known to cause potentially severe hepatic, gastrointestinal, renal, cutaneous and cardiovascular reactions.  Therefore, the ESCEO concludes that the benefit-risk balance of diacerein remains pos. in the symptomatic treatment of hip and knee osteoarthritis.  Furthermore, similarly to other SYSADOAs, the ESCEO positions diacerein as a first-line pharmacol. background treatment of osteoarthritis, particularly for patients in whom NSAIDs or paracetamol are contraindicated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcgbKEWuefh7Vg90H21EOLACvtfcHk0lhsQHvwmAYe1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xitlyntbo%253D&md5=698383aa62dacd67da31fed815948cab</span></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1007%2Fs40266-016-0347-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs40266-016-0347-4%26sid%3Dliteratum%253Aachs%26aulast%3DPavelka%26aufirst%3DK.%26aulast%3DBruyere%26aufirst%3DO.%26aulast%3DCooper%26aufirst%3DC.%26aulast%3DKanis%26aufirst%3DJ.%2BA.%26aulast%3DLeeb%26aufirst%3DB.%2BF.%26aulast%3DMaheu%26aufirst%3DE.%26aulast%3DMartel-Pelletier%26aufirst%3DJ.%26aulast%3DMonfort%26aufirst%3DJ.%26aulast%3DPelletier%26aufirst%3DJ.%2BP.%26aulast%3DRizzoli%26aufirst%3DR.%26aulast%3DReginster%26aufirst%3DJ.%2BY.%26atitle%3DDiacerein%253A%2520benefits%252C%2520risks%2520and%2520place%2520in%2520the%2520management%2520of%2520osteoarthritis.%2520An%2520opinion-based%2520report%2520from%2520the%2520ESCEO%26jtitle%3DDrugs%2520Aging%26date%3D2016%26volume%3D33%26spage%3D75%26epage%3D85%26doi%3D10.1007%2Fs40266-016-0347-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref121"><div class="reference"><strong class="refLabel"><a href="#ref121" class="rightTabRefNumLink">121</a></strong><div class="NLM_citation" id="rightTab-cit121"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Realini, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solorzano, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pagliuca, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pizzirani, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Armirotti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luciani, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costi, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bandiera, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piomelli, D.</span></span> <span> </span><span class="NLM_article-title">Discovery of highly potent acid ceramidase inhibitors with in vitro tumor chemosensitizing activity</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">1035</span>, <span class="refDoi"> DOI: 10.1038/srep01035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1038%2Fsrep01035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=23301156" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFaqt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2013&pages=1035&author=N.+Realiniauthor=C.+Solorzanoauthor=C.+Pagliucaauthor=D.+Pizziraniauthor=A.+Armirottiauthor=R.+Lucianiauthor=M.+P.+Costiauthor=T.+Bandieraauthor=D.+Piomelli&title=Discovery+of+highly+potent+acid+ceramidase+inhibitors+with+in+vitro+tumor+chemosensitizing+activity&doi=10.1038%2Fsrep01035"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit121R"><div class="casContent"><span class="casTitleNuber">121</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of highly potent acid ceramidase inhibitors with in vitro tumor chemosensitizing activity</span></div><div class="casAuthors">Realini, Natalia; Solorzano, Carlos; Pagliuca, Chiara; Pizzirani, Daniela; Armirotti, Andrea; Luciani, Rosaria; Costi, Maria Paola; Bandiera, Tiziano; Piomelli, Daniele</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">srep01035, 7 pp.</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The expression of acid ceramidase (AC) - a cysteine amidase that hydrolyzes the proapoptotic lipid ceramide - is abnormally high in several human tumors, which is suggestive of a role in chemoresistance.  Available AC inhibitors lack, however, the potency and drug-likeness necessary to test this idea.  Here we show that the antineoplastic drug carmofur, which is used in the clinic to treat colorectal cancers, is a potent AC inhibitor and that this property is essential to its anti-proliferative effects.  Modifications in the chem. scaffold of carmofur yield new AC inhibitors that act synergistically with std. antitumoral drugs to prevent cancer cell proliferation.  These findings identify AC as an unexpected target for carmofur, and suggest that this mol. can be used as starting point for the design of novel chemosensitizing agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoknWbdLSLhRbVg90H21EOLACvtfcHk0lhsQHvwmAYe1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFaqt7w%253D&md5=7ff74388fc2bea42c0e97fa8cbcfe61f</span></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.1038%2Fsrep01035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep01035%26sid%3Dliteratum%253Aachs%26aulast%3DRealini%26aufirst%3DN.%26aulast%3DSolorzano%26aufirst%3DC.%26aulast%3DPagliuca%26aufirst%3DC.%26aulast%3DPizzirani%26aufirst%3DD.%26aulast%3DArmirotti%26aufirst%3DA.%26aulast%3DLuciani%26aufirst%3DR.%26aulast%3DCosti%26aufirst%3DM.%2BP.%26aulast%3DBandiera%26aufirst%3DT.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DDiscovery%2520of%2520highly%2520potent%2520acid%2520ceramidase%2520inhibitors%2520with%2520in%2520vitro%2520tumor%2520chemosensitizing%2520activity%26jtitle%3DSci.%2520Rep.%26date%3D2013%26volume%3D3%26spage%3D1035%26doi%3D10.1038%2Fsrep01035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref122"><div class="reference"><strong class="refLabel"><a href="#ref122" class="rightTabRefNumLink">122</a></strong><div class="NLM_citation" id="rightTab-cit122"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span> <span> </span><span class="NLM_article-title">A new use for an old drug: carmofur attenuates lipopolysaccharide (LPS)-induced acute lung injury via inhibition of FAAH and NAAA activities</span>. <i>Front. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">818</span>, <span class="refDoi"> DOI: 10.3389/fphar.2019.00818</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.3389%2Ffphar.2019.00818" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=31379583" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BB3cXksValu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=818&author=K.+Wuauthor=Y.+Xiuauthor=P.+Zhouauthor=Y.+Qiuauthor=Y.+Li&title=A+new+use+for+an+old+drug%3A+carmofur+attenuates+lipopolysaccharide+%28LPS%29-induced+acute+lung+injury+via+inhibition+of+FAAH+and+NAAA+activities&doi=10.3389%2Ffphar.2019.00818"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit122R"><div class="casContent"><span class="casTitleNuber">122</span><div class="casTitle"><span class="NLM_cas:atitle">A new use for an old drug: carmofur attenuates lipopolysaccharide (LPS)-induced acute lung injury via inhibition of FAAH and NAAA activities</span></div><div class="casAuthors">Wu, Kangni; Xiu, Yanghui; Zhou, Pan; Qiu, Yan; Li, Yuhang</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Pharmacology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">818</span>CODEN:
                <span class="NLM_cas:coden">FPRHAU</span>;
        ISSN:<span class="NLM_cas:issn">1663-9812</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">Acute lung injury (ALI), characterized by a severe inflammatory process, is a complex syndrome that can lead to multisystem organ failure.  Fatty acid amide hydrolase (FAAH) and N-acylethanolamine acid amidase (NAAA) are two potential therapeutic targets for inflammation-related diseases.  Herein, we identified carmofur, a 5-fluorouracil-releasing drug and clin. used as a chemotherapeutic agent, as a dual FAAH and NAAA inhibitor.  In Raw264.7 macrophages, carmofur effectively reduced the mRNA expression of pro-inflammatory factors, including IL-1β, IL-6, iNOS, and TNF-α, and down-regulated signaling proteins of the nuclear transcription factor κB (NF-κB) pathway.  Furthermore, carmofur significantly ameliorated the inflammatory responses and promoted resoln. of pulmonary injury in lipopolysaccharide (LPS)-induced ALI mice.  The pharmacol. effects of carmofur were partially blocked by peroxisome proliferator-activated receptor-α (PPARα) antagonist MK886 and cannabinoid receptor 2 (CB2) antagonist SR144528, indicating that carmofur attenuated LPS-induced ALI in a PPARα- and CB2-dependent mechanism.  Our study suggested that carmofur might be a novel therapeutic agent for ALI, and drug repurposing may provide us effective therapeutic strategies for ALI.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDK3mm_wpzObVg90H21EOLACvtfcHk0lhsQHvwmAYe1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXksValu7w%253D&md5=4ce43d4dcd42abe60d4535fa0a7274b9</span></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.3389%2Ffphar.2019.00818&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphar.2019.00818%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DK.%26aulast%3DXiu%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DP.%26aulast%3DQiu%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DY.%26atitle%3DA%2520new%2520use%2520for%2520an%2520old%2520drug%253A%2520carmofur%2520attenuates%2520lipopolysaccharide%2520%2528LPS%2529-induced%2520acute%2520lung%2520injury%2520via%2520inhibition%2520of%2520FAAH%2520and%2520NAAA%2520activities%26jtitle%3DFront.%2520Pharmacol.%26date%3D2019%26volume%3D10%26spage%3D818%26doi%3D10.3389%2Ffphar.2019.00818" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref123"><div class="reference"><strong class="refLabel"><a href="#ref123" class="rightTabRefNumLink">123</a></strong><div class="NLM_citation" id="rightTab-cit123"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bertozzi, F.</span>; <span class="NLM_string-name">Bandiera, T.</span></span> <span> </span><span class="NLM_article-title">Modulation of N-Acylethanolamine-Hydrolysing Acid Amidase (NAAA) for Disease Treatment</span>. <span class="NLM_patent">US20190135802A1</span>, May 9, <span class="NLM_year">2019</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&author=F.+Bertozzi&author=T.+Bandiera&title=Modulation+of+N-Acylethanolamine-Hydrolysing+Acid+Amidase+%28NAAA%29+for+Disease+Treatment"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBertozzi%26aufirst%3DF.%26atitle%3DModulation%2520of%2520N-Acylethanolamine-Hydrolysing%2520Acid%2520Amidase%2520%2528NAAA%2529%2520for%2520Disease%2520Treatment%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref124"><div class="reference"><strong class="refLabel"><a href="#ref124" class="rightTabRefNumLink">124</a></strong><div class="NLM_citation" id="rightTab-cit124"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bodor, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchwald, P.</span></span> <span> </span><span class="NLM_article-title">Soft drug design: General principles and recent applications</span>. <i>Med. Res. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">58</span>– <span class="NLM_lpage">101</span>, <span class="refDoi"> DOI: 10.1002/(SICI)1098-1128(200001)20:1<58::AID-MED3>3.0.CO;2-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1002%2F%28SICI%291098-1128%28200001%2920%3A1%3C58%3A%3AAID-MED3%3E3.0.CO%3B2-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10608921" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BD3cXltFWqsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2000&pages=58-101&author=N.+Bodorauthor=P.+Buchwald&title=Soft+drug+design%3A+General+principles+and+recent+applications&doi=10.1002%2F%28SICI%291098-1128%28200001%2920%3A1%3C58%3A%3AAID-MED3%3E3.0.CO%3B2-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit124R"><div class="casContent"><span class="casTitleNuber">124</span><div class="casTitle"><span class="NLM_cas:atitle">Soft drug design: general principles and recent applications</span></div><div class="casAuthors">Bodor, Nicholas; Buchwald, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">58-101</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review with 208 refs.  Soft drug design represents a new approach aimed to design safer drugs with an increased therapeutic index by integrating metab. considerations into the drug design process.  Soft drugs are new therapeutic agents that undergo predictable metab. to inactive metabolites after exerting their therapeutic effect.  Hence, they are obtained by building into the mol., in addn. to the activity, the most desired way in which the mol. is to be deactivated and detoxified.  In an attempt to systematize and summarize the related work done in a no. of labs., including ours, the present review presents an overview of the general soft drug design principles and provides a variety of specific examples to illustrate the concepts.  A no. of already marketed drugs, such as esmolol, remifentanil, or loteprednol etabonate, resulted from the successful application of such design principles.  Many other promising drug candidates are currently under investigation in a variety of fields including possible soft antimicrobials, anticholinergics, corticosteroids, β-blockers, analgetics, ACE inhibitors, antiarrhythmics, and others.  Whenever possible, pharmacokinetic and pharmacodynamic properties are briefly summarized and compared to those of other compds. used in the same field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphV1vhXwTl8LVg90H21EOLACvtfcHk0lj2pMpBpQqZYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXltFWqsg%253D%253D&md5=e0ca493ba31d001e62a759be0fc4bcc8</span></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291098-1128%28200001%2920%3A1%3C58%3A%3AAID-MED3%3E3.0.CO%3B2-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291098-1128%2528200001%252920%253A1%253C58%253A%253AAID-MED3%253E3.0.CO%253B2-X%26sid%3Dliteratum%253Aachs%26aulast%3DBodor%26aufirst%3DN.%26aulast%3DBuchwald%26aufirst%3DP.%26atitle%3DSoft%2520drug%2520design%253A%2520General%2520principles%2520and%2520recent%2520applications%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2000%26volume%3D20%26spage%3D58%26epage%3D101%26doi%3D10.1002%2F%28SICI%291098-1128%28200001%2920%3A1%3C58%3A%3AAID-MED3%3E3.0.CO%3B2-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref125"><div class="reference"><strong class="refLabel"><a href="#ref125" class="rightTabRefNumLink">125</a></strong><div class="NLM_citation" id="rightTab-cit125"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sasso, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreno-Sanz, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martucci, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Realini, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dionisi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mengatto, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duranti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarozzo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarzia, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mor, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertorelli, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reggiani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piomelli, D.</span></span> <span> </span><span class="NLM_article-title">Antinociceptive effects of the N-acylethanolamine acid amidase inhibitor ARN077 in rodent pain models</span>. <i>Pain</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>154</i></span>,  <span class="NLM_fpage">350</span>– <span class="NLM_lpage">360</span>, <span class="refDoi"> DOI: 10.1016/j.pain.2012.10.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1016%2Fj.pain.2012.10.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=23218523" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BC3sXivF2jtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=154&publication_year=2013&pages=350-360&author=O.+Sassoauthor=G.+Moreno-Sanzauthor=C.+Martucciauthor=N.+Realiniauthor=M.+Dionisiauthor=L.+Mengattoauthor=A.+Durantiauthor=G.+Tarozzoauthor=G.+Tarziaauthor=M.+Morauthor=R.+Bertorelliauthor=A.+Reggianiauthor=D.+Piomelli&title=Antinociceptive+effects+of+the+N-acylethanolamine+acid+amidase+inhibitor+ARN077+in+rodent+pain+models&doi=10.1016%2Fj.pain.2012.10.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit125R"><div class="casContent"><span class="casTitleNuber">125</span><div class="casTitle"><span class="NLM_cas:atitle">Antinociceptive effects of the N-acylethanolamine acid amidase inhibitor ARN077 in rodent pain models</span></div><div class="casAuthors">Sasso, Oscar; Moreno-Sanz, Guillermo; Martucci, Cataldo; Realini, Natalia; Dionisi, Mauro; Mengatto, Luisa; Duranti, Andrea; Tarozzo, Glauco; Tarzia, Giorgio; Mor, Marco; Bertorelli, Rosalia; Reggiani, Angelo; Piomelli, Daniele</div><div class="citationInfo"><span class="NLM_cas:title">Pain</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">154</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">350-360</span>CODEN:
                <span class="NLM_cas:coden">PAINDB</span>;
        ISSN:<span class="NLM_cas:issn">0304-3959</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Fatty acid ethanolamides (FAEs), which include palmitoylethanolamide (PEA) and oleoylethanolamide (OEA), are endogenous agonists of peroxisome proliferator-activated receptor-α (PPAR-α) and important regulators of the inflammatory response.  They are degraded in macrophages by the lysosomal cysteine amidase, N-acylethanolamine acid amidase (NAAA).  Previous studies have shown that pharmacol. inhibition of NAAA activity suppresses macrophage activation in vitro and causes marked anti-inflammatory effects in vivo, which is suggestive of a role for NAAA in the control of inflammation.  It is still unknown, however, whether NAAA-mediated FAE deactivation might regulate pain signaling.  The present study examd. the effects of ARN077, a potent and selective NAAA inhibitor recently disclosed by our group, in rodent models of hyperalgesia and allodynia caused by inflammation or nerve damage.  Topical administration of ARN077 attenuated, in a dose-dependent manner, heat hyperalgesia and mech. allodynia elicited in mice by carrageenan injection or sciatic nerve ligation.  The antinociceptive effects of ARN077 were prevented by the selective PPAR-α antagonist GW6471 and did not occur in PPAR-α-deficient mice.  Furthermore, topical ARN077 reversed the allodynia caused by UV B radiation in rats, and this effect was blocked by pretreatment with GW6471.  Sciatic nerve ligation or application of the proinflammatory phorbol ester 12-O-tetradecanoylphorbol 13-acetate decreased FAE levels in sciatic nerve and skin tissue, resp.  ARN077 reversed these biochem. effects.  The results identify ARN077 as a potent inhibitor of intracellular NAAA activity, which is active in vivo by topical administration.  The findings further suggest that NAAA regulates peripheral pain initiation by interrupting endogenous FAE signaling at PPAR-α.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVAH4mpvyphbVg90H21EOLACvtfcHk0lj2pMpBpQqZYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXivF2jtrk%253D&md5=08c067a44b1f75e7e0192fdbdeccccd4</span></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=10.1016%2Fj.pain.2012.10.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pain.2012.10.018%26sid%3Dliteratum%253Aachs%26aulast%3DSasso%26aufirst%3DO.%26aulast%3DMoreno-Sanz%26aufirst%3DG.%26aulast%3DMartucci%26aufirst%3DC.%26aulast%3DRealini%26aufirst%3DN.%26aulast%3DDionisi%26aufirst%3DM.%26aulast%3DMengatto%26aufirst%3DL.%26aulast%3DDuranti%26aufirst%3DA.%26aulast%3DTarozzo%26aufirst%3DG.%26aulast%3DTarzia%26aufirst%3DG.%26aulast%3DMor%26aufirst%3DM.%26aulast%3DBertorelli%26aufirst%3DR.%26aulast%3DReggiani%26aufirst%3DA.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DAntinociceptive%2520effects%2520of%2520the%2520N-acylethanolamine%2520acid%2520amidase%2520inhibitor%2520ARN077%2520in%2520rodent%2520pain%2520models%26jtitle%3DPain%26date%3D2013%26volume%3D154%26spage%3D350%26epage%3D360%26doi%3D10.1016%2Fj.pain.2012.10.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref126"><div class="reference"><strong class="refLabel"><a href="#ref126" class="rightTabRefNumLink">126</a></strong><div class="NLM_citation" id="rightTab-cit126"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, Y.</span></span> <span> </span><span class="NLM_article-title">Potential analgesic effects of a novel N-acylethanolamine acid amidase inhibitor F96 through PPAR-α</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">13565</span>, <span class="refDoi"> DOI: 10.1038/srep13565</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1038%2Fsrep13565" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=26310614" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVKhtLzK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&pages=13565&author=L.+Yangauthor=L.+Liauthor=L.+Chenauthor=Y.+Liauthor=H.+Chenauthor=Y.+Liauthor=G.+Jiauthor=D.+Linauthor=Z.+Liuauthor=Y.+Qiu&title=Potential+analgesic+effects+of+a+novel+N-acylethanolamine+acid+amidase+inhibitor+F96+through+PPAR-%CE%B1&doi=10.1038%2Fsrep13565"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit126R"><div class="casContent"><span class="casTitleNuber">126</span><div class="casTitle"><span class="NLM_cas:atitle">Potential analgesic effects of a novel N-acylethanolamine acid amidase inhibitor F96 through PPAR-α</span></div><div class="casAuthors">Yang, Longhe; Li, Long; Chen, Ling; Li, Yanting; Chen, Huixia; Li, Yuhang; Ji, Guangnian; Lin, Donghai; Liu, Zuguo; Qiu, Yan</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">13565</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Pharmacol. blockade of N-acylethanolamine acid amidase (NAAA) activity is an available approach for inflammation and pain control through restoring the ability of endogenous PEA.  But the recently reported NAAA inhibitors suffer from the chem. and biol. unstable properties, which restrict functions of NAAA inhibition in vivo.  It is still unrevealed whether systematic inhibition of NAAA could modulate PEA-mediated pain signalings.  Here we reported an oxazolidinone imide compd. 3-(6-phenylhexanoyl) oxazolidin-2-one (F96), which potently and selectively inhibited NAAA activity (IC50 = 270 nM).  I.p. (i.p.) injection of F96 (3-30 mg/kg) dose-dependently reduced ear edema and restored PEA levels of ear tissues in 12-O-Tetradecanoylphorbol-13-acetate (TPA) induced ear edema models.  Furthermore, F96 inhibited acetic acid-induced writhing and increased spared nerve injury induced tactile allodynia thresholds in a dose-dependent manner.  Pharmacol. effects of F96 (10 mg/kg, i.p.) on various animal models were abolished in PPAR-α-/- mice, and were prevented by PPAR-α antagonist MK886 but not by canabinoid receptor type 1 (CB1) antagonist Rimonabant nor canabinoid receptor type 2 (CB2) antagonist SR144528.  Zebrafish embryos expts. showed better security and lower toxicity for F96 than ibuprofen.  These results revealed that F96 might be useful in treating inflammatory and neuropathic pain by NAAA inhibition depending on PPAR-α receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsP6tlGryp3LVg90H21EOLACvtfcHk0lj2pMpBpQqZYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVKhtLzK&md5=237e107001c9eef18e130d12a0724300</span></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.1038%2Fsrep13565&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep13565%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DJi%26aufirst%3DG.%26aulast%3DLin%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DQiu%26aufirst%3DY.%26atitle%3DPotential%2520analgesic%2520effects%2520of%2520a%2520novel%2520N-acylethanolamine%2520acid%2520amidase%2520inhibitor%2520F96%2520through%2520PPAR-%25CE%25B1%26jtitle%3DSci.%2520Rep.%26date%3D2015%26volume%3D5%26spage%3D13565%26doi%3D10.1038%2Fsrep13565" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref127"><div class="reference"><strong class="refLabel"><a href="#ref127" class="rightTabRefNumLink">127</a></strong><div class="NLM_citation" id="rightTab-cit127"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rubenstrunk, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanf, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hum, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fruchart, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staels, B.</span></span> <span> </span><span class="NLM_article-title">Safety issues and prospects for future generations of PPAR modulators</span>. <i>Biochim. Biophys. Acta, Mol. Cell Biol. Lipids</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>1771</i></span>,  <span class="NLM_fpage">1065</span>– <span class="NLM_lpage">1081</span>, <span class="refDoi"> DOI: 10.1016/j.bbalip.2007.02.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=10.1016%2Fj.bbalip.2007.02.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=17428730" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;key=1%3ACAS%3A528%3ADC%252BD2sXovFensr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1771&publication_year=2007&pages=1065-1081&author=A.+Rubenstrunkauthor=R.+Hanfauthor=D.+W.+Humauthor=J.+C.+Fruchartauthor=B.+Staels&title=Safety+issues+and+prospects+for+future+generations+of+PPAR+modulators&doi=10.1016%2Fj.bbalip.2007.02.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit127R"><div class="casContent"><span class="casTitleNuber">127</span><div class="casTitle"><span class="NLM_cas:atitle">Safety issues and prospects for future generations of PPAR modulators</span></div><div class="casAuthors">Rubenstrunk, Anne; Hanf, Remy; Hum, Dean W.; Fruchart, Jean-Charles; Staels, Bart</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular and Cell Biology of Lipids</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">1771</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1065-1081</span>CODEN:
                <span class="NLM_cas:coden">BBMLFG</span>;
        ISSN:<span class="NLM_cas:issn">1388-1981</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Because of their wide range of actions on glucose homeostasis, lipid metab. and vascular inflammation, peroxisome proliferator-activated receptors (PPARs) are promising targets for the development of new drugs for the treatment of metabolic disorders such as diabetes, dyslipidemia and atherosclerosis.  In clin. practice, PPARα agonists, such as the already available fibrates, improve dyslipidemia, while PPARγ agonists, such as thiazolidinediones, improve insulin resistance and diabetes.  The complementary action of simultaneous activation of each PPAR in patients suffering from metabolic syndrome and type 2 diabetes has led to new pharmacol. strategies focused on the development of agonists targeting more than one receptor such as the dual PPARα/γ agonists.  However, despite the proven benefits of targeting PPARs, safety concerns have recently led to late stage development failures of various PPAR agonists including novel specific PPARγ agonists and dual PPARα/γ agonists.  These safety concerns include potential carcinogenicity in rodents, signs of myopathy and rhabdomyolysis, increase in plasma creatinine and homocysteine, wt. gain, fluid retention, peripheral edema and potential increased risk of cardiac failure.  Although the discontinued compds. shared common side effects, the reason for discontinuation was always compd. specific and the toxicol. or adverse effects which have motivated the discontinuation could be either due to the activation of PPARγ, PPARα or both (class effect) or due to a PPAR unrelated effect.  Thus, the risk evaluation of each adverse effect should be viewed on a case by case basis considering both the PPAR profile of the drug, its absorption/distribution profile, the nature of the side effect and the putative PPAR-related mechanism of action.  This review mainly focuses on the preclin. and clin. adverse events of PPAR agonists that could be of concern when considering the development of new PPAR agonists.  The selective modulation of PPAR activities is a promising approach to develop new drugs with preserved efficacy but diminished adverse effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPSAxD3yDYDLVg90H21EOLACvtfcHk0lh3zWE_N9Prew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXovFensr4%253D&md5=36a85ef05206f38bfc6db3faa63262c5</span></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1016%2Fj.bbalip.2007.02.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbalip.2007.02.003%26sid%3Dliteratum%253Aachs%26aulast%3DRubenstrunk%26aufirst%3DA.%26aulast%3DHanf%26aufirst%3DR.%26aulast%3DHum%26aufirst%3DD.%2BW.%26aulast%3DFruchart%26aufirst%3DJ.%2BC.%26aulast%3DStaels%26aufirst%3DB.%26atitle%3DSafety%2520issues%2520and%2520prospects%2520for%2520future%2520generations%2520of%2520PPAR%2520modulators%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Cell%2520Biol.%2520Lipids%26date%3D2007%26volume%3D1771%26spage%3D1065%26epage%3D1081%26doi%3D10.1016%2Fj.bbalip.2007.02.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1MT5" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1MT5','PDB','1MT5'); return false;">PDB: 1MT5</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6DY1" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6DY1','PDB','6DY1'); return false;">PDB: 6DY1</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6DXW" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6DXW','PDB','6DXW'); return false;">PDB: 6DXW</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6DY0" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6DY0','PDB','6DY0'); return false;">PDB: 6DY0</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6DXX" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6DXX','PDB','6DXX'); return false;">PDB: 6DXX</a></li></ul></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.0c00191&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2020.63.issue-14%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.0c00191%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.0c00191" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                6MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"677aeda0dcb53d4e","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
